Citrus Sinensis ID: 015556
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 405 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.555 | 0.576 | 0.594 | 3e-80 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.535 | 0.236 | 0.381 | 4e-43 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.533 | 0.336 | 0.376 | 3e-38 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.553 | 0.173 | 0.346 | 2e-37 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.533 | 0.313 | 0.362 | 5e-36 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.533 | 0.130 | 0.353 | 2e-35 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.533 | 0.162 | 0.342 | 2e-35 | |
| P18161 | 1155 | Dual specificity protein | no | no | 0.530 | 0.186 | 0.333 | 1e-34 | |
| Q7T2V3 | 1005 | Mitogen-activated protein | N/A | no | 0.535 | 0.215 | 0.355 | 1e-34 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.540 | 0.134 | 0.330 | 5e-34 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 299 bits (766), Expect = 3e-80, Method: Compositional matrix adjust.
Identities = 135/227 (59%), Positives = 174/227 (76%), Gaps = 2/227 (0%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
+E T DLSQLF+G +FA GAHSR+Y GIYK VAVK++RIP E A+LE+QF
Sbjct: 77 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETR--AKLEQQFKS 134
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
EVALLSRL +PN+++F+AACKKPPVYC+ITEY+S+G+LR YL+K E +L + ++ +AL
Sbjct: 135 EVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLAL 194
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
DI+RGMEY+HSQGVIHRDLK N+L++ E +K+ADFG +C E C + GTYRWMA
Sbjct: 195 DISRGMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQCREAKGNMGTYRWMA 254
Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
PEMIK K Y RKVDVYSFG++LWE+ +P++ M P+QAAFAV K
Sbjct: 255 PEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 301
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 175 bits (444), Expect = 4e-43, Method: Compositional matrix adjust.
Identities = 85/223 (38%), Positives = 136/223 (60%), Gaps = 6/223 (2%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
+ S+L + + G +Y G+++ VA+K I+I +D N+ L ++F +E+ +
Sbjct: 657 ISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVL-----EEFRKELTI 711
Query: 236 LSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR 295
LSRL +PN++ +AAC PP C ITEYL GSL LH + K + + +A+ IA+
Sbjct: 712 LSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIK-MNMQLYKKLAIQIAQ 770
Query: 296 GMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI 355
GM Y+H GVIHRD+K N+L+D+ ++KI DFG++ + ++ G+ WM+PE++
Sbjct: 771 GMNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSIGSPIWMSPELL 830
Query: 356 KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
+ Y KVDVY+FG+ILWE+ G +PY ++ +Q A AV K
Sbjct: 831 MGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTK 873
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 159 bits (403), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 85/226 (37%), Positives = 133/226 (58%), Gaps = 10/226 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
D +D+ Q+ +G+R G + +Y G ++ VAVK ++P + NE + K+F+R
Sbjct: 365 DGKDIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVK--KLPAHNINENIL----KEFHR 418
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
E+ L+ L +PNVI+F+ +C PP C+ TEY+ GSL + LH + L LI + +
Sbjct: 419 EINLMKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHD-QALQLQWSLLIKMMI 477
Query: 292 DIARGMEYIHSQG--VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW 349
D A+G+ Y+H+ ++HRDLK N+L+D+ + +K+ADFG++ E A GT W
Sbjct: 478 DAAKGVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQ-GATMTACGTPCW 536
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
+PE+++ + Y K DVYSFG+ILWE PY + P Q FAV
Sbjct: 537 TSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAV 582
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 157 bits (396), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 81/234 (34%), Positives = 135/234 (57%), Gaps = 10/234 (4%)
Query: 164 RVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAA 223
++ V+ E V LS++ +G R G + +++ G ++ VAVK++ N+ +
Sbjct: 834 KIIEVEKPFEWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLF------NDNVNL 887
Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
+L +EV LL +L +PN++ F+ AC +P C++TEYLS GSL L E +
Sbjct: 888 KLISDLRKEVDLLCKLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILLD-ESIEMDW 946
Query: 284 PKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALS 341
+ + D ARGM Y+HS+ +IHRDLK +N+L+D + +K+ADFG+A + + A +
Sbjct: 947 GLRLQLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTFAKT 1006
Query: 342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
GT W+APE++ + Y K DVYS+ ++LWE++ IPY N +Q ++
Sbjct: 1007 -MCGTTGWVAPEVLAEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSI 1059
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 152 bits (383), Expect = 5e-36, Method: Compositional matrix adjust.
Identities = 82/226 (36%), Positives = 128/226 (56%), Gaps = 10/226 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
D +D Q+ +G+R G +Y G ++ VAVK ++P + NE + K+F+R
Sbjct: 382 DGKDIDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVK--KLPAHNINENIL----KEFHR 435
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
E+ L+ L +PNVI+F+ +C P C+ TEY+ GSL + LH E + + + +
Sbjct: 436 EINLMKNLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHN-EKIKISWSLVKRMMI 494
Query: 292 DIARGMEYIHSQG--VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW 349
D A+G+ Y+H ++HRDLK N+L+D+ + +K+ADFG++ E A GT W
Sbjct: 495 DAAKGIIYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQ-GATMTACGTPCW 553
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
+PE+++ + Y K DVYSFG+ILWE PY + P Q FAV
Sbjct: 554 TSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAV 599
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 150 bits (379), Expect = 2e-35, Method: Compositional matrix adjust.
Identities = 83/235 (35%), Positives = 137/235 (58%), Gaps = 19/235 (8%)
Query: 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFN 230
+D+ +D +L LG + GA ++ G ++ VAVK+I PD +T+ +E+ F
Sbjct: 776 SDDWEIDFHELELGEQLGTGAFGEVHKGTWRGTEVAVKMIS-PD----KTITKDIERNFK 830
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
EV +++ L +PNV+ F+AA KPP C++ E+++ GSL L +P + IA
Sbjct: 831 DEVRVMTTLRHPNVVLFMAASTKPPKMCIVMEFMALGSLHDLLKNELIPDIPFALKVKIA 890
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP----GT 346
++GM ++HS G+ HRDLK N+L+D ++++K++DFG+ + D S +P GT
Sbjct: 891 YQASKGMHFLHSSGITHRDLKSLNLLLDIKWNVKVSDFGLT--KFKSDVKSINPEKFAGT 948
Query: 347 YRWMAPEMIKHKSYGRKV-----DVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396
+W APE++ S R+V DVYSFG+I+WE++ PY M+P A +V+
Sbjct: 949 IQWTAPEIL---SEDREVDYILSDVYSFGIIMWELITRDQPYFGMSPAAIAVSVI 1000
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 150 bits (378), Expect = 2e-35, Method: Compositional matrix adjust.
Identities = 78/228 (34%), Positives = 133/228 (58%), Gaps = 12/228 (5%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
++ S + + G S++ G +K + VAVK + D E + ++F EV L
Sbjct: 1068 INYSDIKIDKEIGKGHFSKVLKGNWKGKDVAVKKLNSNKDKAREEMI----QEFKAEVEL 1123
Query: 236 LSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL---EHKTLPLPK--LIAIA 290
L L +PN++ P C++ E+L G+L +H + +++ L ++AIA
Sbjct: 1124 LGSLQHPNLVTCYGYSLNP--MCIVMEFLPSGNLFELIHSKPSEQQQSIKLDSTLILAIA 1181
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWM 350
DIARGM+++H++ +IHRDLK N+L+D+ F++KIAD GIA E + ++ GT W
Sbjct: 1182 FDIARGMQHLHTRNIIHRDLKSSNLLMDKHFNIKIADLGIARETSFTQTMT-TIGTVAWT 1240
Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
APE+++H+SY +K DVYS+ ++L+E++ G PY+ + P+ A V +K
Sbjct: 1241 APEILRHESYNQKADVYSYAIVLYELLTGEEPYQGIPPMNAGILVASK 1288
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18161|SPLB_DICDI Dual specificity protein kinase splB OS=Dictyostelium discoideum GN=splB PE=2 SV=2 | Back alignment and function description |
|---|
Score = 147 bits (372), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 77/231 (33%), Positives = 136/231 (58%), Gaps = 16/231 (6%)
Query: 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNRE 232
E+ +D++ + + GA S ++ G +K VA+K ++I D+E + +++F RE
Sbjct: 845 EYIIDINDIQFIQKVGEGAFSEVWEGWWKGIHVAIKKLKIIGDEE------QFKERFIRE 898
Query: 233 VALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT----LPLPKLIA 288
V L + ++ N++ F+ AC KP C+ITEY++ GSL LH T P ++
Sbjct: 899 VQNLKKGNHQNIVMFIGACYKPA--CIITEYMAGGSLYNILHNPNSSTPKVKYSFPLVLK 956
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY- 347
+A D+A G+ ++HS ++HRDL +N+L+D+ ++KI+DFG++ E+ +++ G
Sbjct: 957 MATDMALGLLHLHSITIVHRDLTSQNILLDELGNIKISDFGLSREKSREGSMTMTNGGIC 1016
Query: 348 --RWMAPEMIKHKS-YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
RW PE+ K+ Y KVDVY F L++WE++ G IP+ +++ QA+ V
Sbjct: 1017 NPRWRPPELTKNLGHYSEKVDVYCFSLVVWEILTGEIPFSDLDGSQASAQV 1067
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q7T2V3|M3K10_XENLA Mitogen-activated protein kinase kinase kinase 10 OS=Xenopus laevis GN=map3k10 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 147 bits (371), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 85/239 (35%), Positives = 130/239 (54%), Gaps = 22/239 (9%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIR-IPDDDENETLAARLEKQFNREVA 234
++ +L L G ++Y G+++DE VAVK +R PD+D N T + +E
Sbjct: 113 IEFDELNLDEIIGVGGFGKVYKGLWRDEEVAVKAVRHDPDEDINVTA-----ENVRQEAK 167
Query: 235 LLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIA 294
+ L +PN+I C KPP C++ EY G L L K +P L+ A+ IA
Sbjct: 168 IFCMLCHPNIIALTGVCLKPPHLCLVMEYARGGPLH---RALAGKKVPAHVLVNWAVQIA 224
Query: 295 RGMEYIHSQGV---IHRDLKPENVLI------DQEFH--LKIADFGIACEEVYCDALSDD 343
+GM Y+H++ + IHRDL N+LI D F+ L I DFG+A E +S
Sbjct: 225 KGMTYLHNEAIVPIIHRDLGSSNILILEKAENDDLFNKTLNITDFGLAREWQKTTKMSA- 283
Query: 344 PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV-VNKVNF 401
GTY WMAPE+I+ + + DV+SFG++LWE++ G +PY E++ + A+ V +NK+
Sbjct: 284 AGTYAWMAPEVIRLSLFSKSSDVWSFGVLLWELLTGEVPYREIDALAVAYGVAMNKLTL 342
|
Activates the JUN N-terminal pathway. Essential for pronephros and cement gland development. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 145 bits (366), Expect = 5e-34, Method: Compositional matrix adjust.
Identities = 76/230 (33%), Positives = 131/230 (56%), Gaps = 11/230 (4%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
++ +D S+L +G G + +Y I+K VAVK+I ++ ++ +E+ F
Sbjct: 777 NDWEIDFSELEIGETLGTGGYGEVYKSIWKGTEVAVKLI------SSKHVSKDMERSFFE 830
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
EV +++ L +PNV+ F+AA K P C++ E++S GSL L +P I +A
Sbjct: 831 EVKIMTSLRHPNVVLFMAASTKSPNMCIVMEFMSLGSLYDLLGNELIPEIPYALKIKMAY 890
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP---GTYR 348
++GM ++HS G++HRDLK N+L+D ++++K++DFG+ + D + GT
Sbjct: 891 QASKGMHFLHSSGIVHRDLKSLNLLLDSKWNVKVSDFGLTKVKSELDKKKTNDNIIGTIH 950
Query: 349 WMAPEMIKHKSYGRKV--DVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396
W+APE++ + + DVYSFG+ILWE++ PY+ M P A +V+
Sbjct: 951 WIAPEILNDSTEVDYILADVYSFGIILWELLTREQPYKGMTPAAIAVSVI 1000
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 405 | ||||||
| 10241603 | 480 | protein kinase (PK) [Fagus sylvatica] | 0.960 | 0.810 | 0.75 | 1e-173 | |
| 224081216 | 514 | predicted protein [Populus trichocarpa] | 0.972 | 0.766 | 0.710 | 1e-171 | |
| 224093814 | 464 | predicted protein [Populus trichocarpa] | 0.920 | 0.803 | 0.739 | 1e-169 | |
| 255536799 | 496 | protein-tyrosine kinase, putative [Ricin | 0.953 | 0.778 | 0.717 | 1e-169 | |
| 147862319 | 489 | hypothetical protein VITISV_022074 [Viti | 0.977 | 0.809 | 0.716 | 1e-165 | |
| 356521372 | 498 | PREDICTED: serine/threonine-protein kina | 0.967 | 0.787 | 0.682 | 1e-155 | |
| 449433834 | 492 | PREDICTED: serine/threonine-protein kina | 0.977 | 0.804 | 0.68 | 1e-151 | |
| 356548711 | 494 | PREDICTED: serine/threonine-protein kina | 0.955 | 0.783 | 0.668 | 1e-150 | |
| 255638494 | 494 | unknown [Glycine max] | 0.955 | 0.783 | 0.668 | 1e-150 | |
| 356549321 | 463 | PREDICTED: serine/threonine-protein kina | 0.923 | 0.807 | 0.665 | 1e-148 |
| >gi|10241603|emb|CAC09580.1| protein kinase (PK) [Fagus sylvatica] | Back alignment and taxonomy information |
|---|
Score = 615 bits (1585), Expect = e-173, Method: Compositional matrix adjust.
Identities = 300/400 (75%), Positives = 336/400 (84%), Gaps = 11/400 (2%)
Query: 1 MGDGANSWIRRTKFSHTVCHRLDSSILASLPLNL-PETISVLKSRPGPASSNQKSAPNSS 59
MG+ NSWIRRTKFSHTVCHRLD+S LAS P+ + PE S LKSRPG SS++K
Sbjct: 1 MGEEGNSWIRRTKFSHTVCHRLDASRLASFPIIIRPERNSGLKSRPGATSSSEKFGT--- 57
Query: 60 QSQQNPAANKPRSVSPLPETVLPDTFKEARSATKRFSTPHPRRKESDKGLVGKFLYKQPQ 119
NK RS+SPLPE+ L D FKEARS TKRF TP PRR+E KG++GKF++K
Sbjct: 58 ------IYNKQRSLSPLPESRLSDVFKEARSETKRFMTPLPRRREQAKGVMGKFVHKDFH 111
Query: 120 QETKASSNSYS-TSPLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDL 178
+ + S S + +S LRHL S++V ++ K RKES+W KYFDHGG RVNAV+ +DE TVDL
Sbjct: 112 EVKASDSKSLANSSALRHLSSMKVNDKSKYRKESSWAKYFDHGGGRVNAVETSDEWTVDL 171
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR 238
S+LFLGL+FAHGAHSRLYHGIY DEPVAVKIIR+P+DDEN L ARLEKQFNREV LLSR
Sbjct: 172 SKLFLGLKFAHGAHSRLYHGIYNDEPVAVKIIRVPEDDENGALGARLEKQFNREVTLLSR 231
Query: 239 LHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
LH N+IKFVAAC+KPPVYCV+TEYLSEGSLRAYLHKLE K+LPL KLIA ALDIARGME
Sbjct: 232 LHFHNIIKFVAACRKPPVYCVVTEYLSEGSLRAYLHKLERKSLPLQKLIAFALDIARGME 291
Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK 358
YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE YCD+L+DDPGTYRWMAPEMIKHK
Sbjct: 292 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEAYCDSLADDPGTYRWMAPEMIKHK 351
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
SYGRKVDVYSFGLILWEMVAGTIPYE+MNP+QAAFAVVNK
Sbjct: 352 SYGRKVDVYSFGLILWEMVAGTIPYEDMNPVQAAFAVVNK 391
|
Source: Fagus sylvatica Species: Fagus sylvatica Genus: Fagus Family: Fagaceae Order: Fagales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224081216|ref|XP_002306338.1| predicted protein [Populus trichocarpa] gi|222855787|gb|EEE93334.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 607 bits (1564), Expect = e-171, Method: Compositional matrix adjust.
Identities = 304/428 (71%), Positives = 340/428 (79%), Gaps = 34/428 (7%)
Query: 1 MGDGANSWIRRTKFSHTVCHRLDSSILASLPLNL-PETISVLKSRPGPASSN-------- 51
MG+ ANSWIRRTKFSHT+ +RLD S AS P+++ E IS LKSRPG +++
Sbjct: 1 MGEEANSWIRRTKFSHTIYYRLDPSRSASFPISIQAERISGLKSRPGTGTASPKQNSQQS 60
Query: 52 ------QKSAPN---------------SSQSQQNPAANKPRSVSPLPETVLPDTFKEARS 90
Q+S PN +SQ ++N NK RS+SPLPET L DTFKEARS
Sbjct: 61 LSNQNFQQSFPNQKSLSFPSQKSLVSDNSQMRRNLLTNKQRSLSPLPETNLSDTFKEARS 120
Query: 91 ATKRFSTPHPRRKESDKGLVGKFLYKQPQQETKASSNSYSTSPLRHLGSLRVTERYKSRK 150
KRFSTPHPRRK D G++GKFL+++ QE+K SN SPLRHL S++V K
Sbjct: 121 DKKRFSTPHPRRKNQDMGIIGKFLHRE-SQESKEKSNR---SPLRHLASMKVGHEKSRIK 176
Query: 151 ESAWTKYFDHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKII 210
ESAW KYFDHGG +VNAV+AADE VD+S+LFLGLRFAHGAHSRLYHG+YKD+PVAVKII
Sbjct: 177 ESAWAKYFDHGGGKVNAVEAADECIVDMSKLFLGLRFAHGAHSRLYHGLYKDKPVAVKII 236
Query: 211 RIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLR 270
R+PDDDEN LA RLE QFNREV LLS+LH+PNVIKFVAAC+KPPVYCVITEYLSEGSLR
Sbjct: 237 RVPDDDENGNLATRLENQFNREVMLLSQLHHPNVIKFVAACRKPPVYCVITEYLSEGSLR 296
Query: 271 AYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330
AYLHKLEHK L L KL+ IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI
Sbjct: 297 AYLHKLEHKALSLEKLMTIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 356
Query: 331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390
AC E YCD+L+DDPGTYRWMAPEMIK KSYGRK DVYSFGLILWEMVAGTIPYE+M PIQ
Sbjct: 357 ACGEAYCDSLADDPGTYRWMAPEMIKKKSYGRKADVYSFGLILWEMVAGTIPYEDMTPIQ 416
Query: 391 AAFAVVNK 398
AAFAVVNK
Sbjct: 417 AAFAVVNK 424
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224093814|ref|XP_002310003.1| predicted protein [Populus trichocarpa] gi|222852906|gb|EEE90453.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 600 bits (1548), Expect = e-169, Method: Compositional matrix adjust.
Identities = 295/399 (73%), Positives = 332/399 (83%), Gaps = 26/399 (6%)
Query: 1 MGDGANSWIRRTKFSHTVCHRLDSSILASLPLNLPETISVLKSRPGPASSNQKSAPNSSQ 60
M + ANSWIRRT FSHTV HRLDSS +AS P+N+ +T ++
Sbjct: 1 MEEEANSWIRRTNFSHTVYHRLDSSRMASFPINI-QTERII------------------- 40
Query: 61 SQQNPAANKPRSVSPLPETVLPDTFKEARSATKRFSTPHPRRKESDKGLVGKFLYKQPQQ 120
Q+NP +NK RS+SPLP+T+LPDTFKEARS KRFSTP PRRK+ D G++GKFL+K
Sbjct: 41 -QRNPLSNKQRSLSPLPKTILPDTFKEARSVNKRFSTPLPRRKDQDMGIIGKFLHK---- 95
Query: 121 ETKASSNSYSTSPLRHLGSLRVT-ERYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDLS 179
E K + +TSPLRHL ++ E+ +S+KESAWTKYFDHGG +VNAV+AADE +VDLS
Sbjct: 96 ELKETKEKLNTSPLRHLALMKGGHEKSRSKKESAWTKYFDHGGGKVNAVEAADECSVDLS 155
Query: 180 QLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL 239
+LFLGLRFAHGAHSRLYHG+YKDEPVAVK+IR+PDDDEN LA RLE QFNREV LLS L
Sbjct: 156 KLFLGLRFAHGAHSRLYHGLYKDEPVAVKLIRVPDDDENGNLAIRLENQFNREVMLLSHL 215
Query: 240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEY 299
H+PNVIKFVAAC+KPPVYCVITEYLSEGSLRAYLHKLEHKTL L KL+ IALDIARGMEY
Sbjct: 216 HHPNVIKFVAACRKPPVYCVITEYLSEGSLRAYLHKLEHKTLSLGKLMTIALDIARGMEY 275
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKS 359
IHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC + YCD+L+DDPGTYRWMAPEMIK KS
Sbjct: 276 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIACGDAYCDSLADDPGTYRWMAPEMIKKKS 335
Query: 360 YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
YGRKVDVYSFGLILWEMVAGTIPYE+M PIQAAFAVVNK
Sbjct: 336 YGRKVDVYSFGLILWEMVAGTIPYEDMTPIQAAFAVVNK 374
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255536799|ref|XP_002509466.1| protein-tyrosine kinase, putative [Ricinus communis] gi|223549365|gb|EEF50853.1| protein-tyrosine kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 600 bits (1548), Expect = e-169, Method: Compositional matrix adjust.
Identities = 300/418 (71%), Positives = 337/418 (80%), Gaps = 32/418 (7%)
Query: 1 MGDGANSWIRRTKFSHTVCHRLDSSILASLPLNLPETI-SVLKSRPGPASSNQKSAPNSS 59
M + +SWIRRTKFSHTVCHRLDSS LASL L + E S LKSRPG +S N+KS S+
Sbjct: 1 MEEENSSWIRRTKFSHTVCHRLDSSRLASLALAVQEERNSGLKSRPGTSSPNRKSLYFSN 60
Query: 60 QS-------------------QQNPAANKPRSVSPLPETVLPDTFKEARSATKRFSTPHP 100
Q Q+NP NK RS+SPLP+T L DTFKEARS KRFSTPHP
Sbjct: 61 QRSASFPNKKSSSSVTSNSQIQRNPVTNKLRSLSPLPQTALSDTFKEARSDRKRFSTPHP 120
Query: 101 RRKESDKGLVGKFLYKQPQQETKASSNSYSTSPLRHLGSLRVTERYKSRKESAWTKYFDH 160
R K+ DKG K S ++ +TSPLR L SL+ E+ KS+K+SAWTKYFDH
Sbjct: 121 RSKDQDKGFA------------KPSKHASNTSPLRQLASLKGHEKLKSKKDSAWTKYFDH 168
Query: 161 GGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENET 220
G RVNAV+AADE +VD+S+LFLGLRFAHGAHSRLYHG+YKDEPVAVKIIR PDDD+N T
Sbjct: 169 AGGRVNAVEAADEFSVDMSKLFLGLRFAHGAHSRLYHGVYKDEPVAVKIIRAPDDDDNGT 228
Query: 221 LAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT 280
L+ RL+ Q++REV LLSRLH+PNVIKFVAACK PPVYCVITEYLSEGSLRAYLHKLEHK+
Sbjct: 229 LSIRLKNQYDREVTLLSRLHHPNVIKFVAACKMPPVYCVITEYLSEGSLRAYLHKLEHKS 288
Query: 281 LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL 340
LPL KLIAIALDIARGMEYIHSQ +IHRDLKPENVLIDQEF +KIADFGIACEE YCD+L
Sbjct: 289 LPLEKLIAIALDIARGMEYIHSQSIIHRDLKPENVLIDQEFRMKIADFGIACEEAYCDSL 348
Query: 341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
+DDPGTYRWMAPEMIK KSYG++VDVYSFGLILWE+VAGTIPYE+MNPIQAAFAVVNK
Sbjct: 349 ADDPGTYRWMAPEMIKKKSYGKRVDVYSFGLILWELVAGTIPYEDMNPIQAAFAVVNK 406
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147862319|emb|CAN83589.1| hypothetical protein VITISV_022074 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 586 bits (1510), Expect = e-165, Method: Compositional matrix adjust.
Identities = 285/398 (71%), Positives = 331/398 (83%), Gaps = 2/398 (0%)
Query: 3 DGANSWIRRTKFSHTVCHRLDSSILASLPLNL-PETISVLKSRPGPASSNQKSAPNSSQS 61
+ ANSWIRRTKFSHT+ HRLDS+ LAS PL + PE S LKSRP S N KS P+ Q
Sbjct: 2 EDANSWIRRTKFSHTIFHRLDSTRLASFPLTISPERNSGLKSRPQRGSLNLKSEPSDPQG 61
Query: 62 QQNPAANKPRSVSPLPETVLPDTFKEARSATKRFSTPHPRRKESDKGLVGKFLYKQPQQE 121
++N NK RS+SPLPE+ L D FKEARS KRFSTP PRRKE +KG++GK K Q
Sbjct: 62 RRNAFTNKQRSLSPLPESKLSDEFKEARSDRKRFSTPVPRRKEHEKGIMGKLFSKDSQDP 121
Query: 122 TKASSNSYS-TSPLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDLSQ 180
++SN S TSPLRHL S + ++ K RKE +W KYFDHGG RV AV+AADE DLS+
Sbjct: 122 KASNSNKQSNTSPLRHLTSTKNHDKAKFRKEPSWIKYFDHGGGRVTAVEAADEWMADLSK 181
Query: 181 LFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
L+LGLRF+HGAHSRLYHG+Y+++PVAVK+I +PD++EN LA++LEKQFN EV+ LSRLH
Sbjct: 182 LYLGLRFSHGAHSRLYHGVYEEQPVAVKVIMVPDEEENGALASKLEKQFNGEVSCLSRLH 241
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
+ NVIKFVAA ++PPV+ VITEYLSEGSLRAYLHKLEHK+LPL KLI IALDIARGMEYI
Sbjct: 242 HQNVIKFVAAWRRPPVFVVITEYLSEGSLRAYLHKLEHKSLPLEKLITIALDIARGMEYI 301
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY 360
HSQG+IHRDLKPENVL+ ++FH+KIADFGIACEE YCD+L+DDPGTYRWMAPEMIKHKSY
Sbjct: 302 HSQGIIHRDLKPENVLVTKDFHMKIADFGIACEEAYCDSLADDPGTYRWMAPEMIKHKSY 361
Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
GRKVDVYSFGLILWEMVAGTIPYE+M PIQAAFAVVNK
Sbjct: 362 GRKVDVYSFGLILWEMVAGTIPYEDMAPIQAAFAVVNK 399
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521372|ref|XP_003529330.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 555 bits (1429), Expect = e-155, Method: Compositional matrix adjust.
Identities = 279/409 (68%), Positives = 324/409 (79%), Gaps = 17/409 (4%)
Query: 3 DGANSWIRRTKFSHTVCHRLDSSILASLPLNL---PETISVLKSRPGPASSNQKSAPNSS 59
D +NSWIRR KFSHTVCHRL+ S ++ + S LKSRP A +++ S S
Sbjct: 4 DSSNSWIRRAKFSHTVCHRLNYSSSGFGSFSIQPRAQHSSSLKSRPEVAFASKAS----S 59
Query: 60 QSQQNPAANKPRSVSPLPETVLPDTFKEARSATKRFSTPHPRRKESDKG--LVGKFLYK- 116
Q+Q+ P NK RS+SPLP+T L +TFKEAR KRFSTP PRRKE DK ++GK L K
Sbjct: 60 QAQKKPIMNKQRSLSPLPQTSLSETFKEARHEQKRFSTPGPRRKEQDKDKRIMGKLLNKD 119
Query: 117 ------QPQQETKASSNSYSTSPLRHLGSLRVTERYKS-RKESAWTKYFDHGGVRVNAVD 169
+ + ++ S +SP+RHL S++++++ K RK+ WTKYFDHGG +V AV+
Sbjct: 120 SHVFNSKSNHSSPITTKSPYSSPIRHLASMKLSDKSKQHRKDLGWTKYFDHGGGKVTAVE 179
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQF 229
A+E VDLS+LF+G+RFAHGAHSRLYHG+YKDE VAVKII +PDDDEN LA RLEKQF
Sbjct: 180 TAEEWNVDLSKLFVGVRFAHGAHSRLYHGMYKDEAVAVKIITVPDDDENGMLADRLEKQF 239
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
REV+LLSRLH+ NVIKFVAAC+KPPVYCVITEYLSEGSLR+YLHKLE KT+PL KLIA
Sbjct: 240 IREVSLLSRLHHQNVIKFVAACRKPPVYCVITEYLSEGSLRSYLHKLERKTIPLEKLIAF 299
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW 349
ALDIARGMEYIHSQGVIHRDLKPENVLI ++FHLKIADFGIACEE YCD +DDPGTYRW
Sbjct: 300 ALDIARGMEYIHSQGVIHRDLKPENVLIKEDFHLKIADFGIACEEAYCDLFADDPGTYRW 359
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
MAPEMIK KSYGRKVDVYSFGLILWEMV GTIPYE+M PIQAAFAVVNK
Sbjct: 360 MAPEMIKRKSYGRKVDVYSFGLILWEMVTGTIPYEDMTPIQAAFAVVNK 408
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449433834|ref|XP_004134702.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] gi|449479300|ref|XP_004155563.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 540 bits (1390), Expect = e-151, Method: Compositional matrix adjust.
Identities = 272/400 (68%), Positives = 318/400 (79%), Gaps = 4/400 (1%)
Query: 1 MGDGANSWIRRTKFSHTVCHRLDSSILASLPLNL-PETISVLKSRPGPASSNQKSAPNSS 59
M + ANSW+RRTKFSHTV HR DS L +P + P S LKSRP ASS QK P+ S
Sbjct: 1 MDEEANSWLRRTKFSHTVYHRWDSLKLNPVPFIVEPPRNSGLKSRPPSASSAQKPNPDIS 60
Query: 60 QSQQNPAANKPRSVSPLPETVLPDTFKEARSATKRFSTPHPRRKESDKGLVGKFLYKQPQ 119
+ Q++ +NK RS+SPLPE+ L + FKEA+S +KRFSTP PR +E K K K PQ
Sbjct: 61 KIQRSFISNKQRSLSPLPESNLSEVFKEAKSESKRFSTPTPRLRERTKEFKNKLFNKDPQ 120
Query: 120 QETKASSNSYSTS-PLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDL 178
++S S + PL+ L S + ++ K +K+S+WTKYFD G +V AV+ AD+ TVDL
Sbjct: 121 DSKSSNSKSSLNTSPLKQLSSGKGGDKSKLKKDSSWTKYFDSG--KVTAVETADDWTVDL 178
Query: 179 SQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR 238
S+LF+GLRFAHGAHSRLYHG Y DEPVAVKIIR+PDDDEN TLAARLEKQF REV LLSR
Sbjct: 179 SKLFVGLRFAHGAHSRLYHGKYNDEPVAVKIIRVPDDDENGTLAARLEKQFTREVTLLSR 238
Query: 239 LHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
L++PNVIKFVAAC+ PPVYCVITEYLS+GSLRAYLHKLEH++LPL KLI ALD+ARGME
Sbjct: 239 LYHPNVIKFVAACRNPPVYCVITEYLSQGSLRAYLHKLEHQSLPLQKLIKFALDVARGME 298
Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK 358
Y+HSQGVIHRDLKPENVLID++ HLKIADFGIAC E + D L+DDPGTYRWMAPEMIKHK
Sbjct: 299 YLHSQGVIHRDLKPENVLIDEDMHLKIADFGIACPEAFFDPLADDPGTYRWMAPEMIKHK 358
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
RKVDVYSFGL+LWEMV+G IPYE+M PIQAAFAVVNK
Sbjct: 359 PCSRKVDVYSFGLMLWEMVSGAIPYEDMTPIQAAFAVVNK 398
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356548711|ref|XP_003542743.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 537 bits (1383), Expect = e-150, Method: Compositional matrix adjust.
Identities = 274/410 (66%), Positives = 317/410 (77%), Gaps = 23/410 (5%)
Query: 3 DGANSWIRRTKFSHTVCHRLDSSILASLPLNLP----ETISVLKSRPGPASSNQKSAPNS 58
D +NSWIRR KFSHTVCHRL+ S ++ + S LKSRP A + S
Sbjct: 4 DSSNSWIRRAKFSHTVCHRLNYSSSGFGSFSIQPRAQHSSSSLKSRPEVAFA-------S 56
Query: 59 SQSQQNPAANKPRSVSPLPETVLPDTFKEARSATKRFSTPHPRRKES--DKGLVGKFL-- 114
+++Q+ P NK RS+SPLP T L +TFKEAR KRFSTP PRRKE DK ++GK L
Sbjct: 57 NKAQKKPIMNKQRSLSPLPRTSLSETFKEARHEQKRFSTPGPRRKEQNKDKRIMGKLLNK 116
Query: 115 ------YKQPQQETKASSNSYSTSPLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAV 168
K P+ + + YS SP+RHL S++++ + + RK+ WTKYFDHGG +V AV
Sbjct: 117 DSHVSNSKSPRSSPITTKSPYS-SPIRHLASMKLSSK-QHRKDLGWTKYFDHGGGKVTAV 174
Query: 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQ 228
+ A+E VDLS+LF+G+RFAHGAHSRLYHG+YKDE VAVKII +PDDDEN L RLEKQ
Sbjct: 175 ETAEEWNVDLSKLFVGVRFAHGAHSRLYHGMYKDEAVAVKIITVPDDDENGMLVDRLEKQ 234
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
F REV+LLS LH+ NVIKFVAAC+KP VYCVITEYLSEGSLR+YLHKLE KT+ L KLIA
Sbjct: 235 FIREVSLLSCLHHQNVIKFVAACRKPHVYCVITEYLSEGSLRSYLHKLERKTISLGKLIA 294
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR 348
ALDIARGMEYIHSQGVIHRDLKPENVLI+++FHLKIADFGIACEE YCD +DDPGTYR
Sbjct: 295 FALDIARGMEYIHSQGVIHRDLKPENVLINEDFHLKIADFGIACEEAYCDLFADDPGTYR 354
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
WMAPEMIK KSYGRKVDVYSFGLILWEMV GTIPYE+M PIQAAFAVVNK
Sbjct: 355 WMAPEMIKRKSYGRKVDVYSFGLILWEMVTGTIPYEDMTPIQAAFAVVNK 404
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255638494|gb|ACU19556.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 537 bits (1383), Expect = e-150, Method: Compositional matrix adjust.
Identities = 274/410 (66%), Positives = 317/410 (77%), Gaps = 23/410 (5%)
Query: 3 DGANSWIRRTKFSHTVCHRLDSSILASLPLNLP----ETISVLKSRPGPASSNQKSAPNS 58
D +NSWIRR KFSHTVCHRL+ S ++ + S LKSRP A + S
Sbjct: 4 DSSNSWIRRAKFSHTVCHRLNYSSSGFGSFSIQPRAQHSSSSLKSRPEVAFA-------S 56
Query: 59 SQSQQNPAANKPRSVSPLPETVLPDTFKEARSATKRFSTPHPRRKES--DKGLVGKFL-- 114
+++Q+ P NK RS+SPLP T L +TFKEAR KRFSTP PRRKE DK ++GK L
Sbjct: 57 NKAQKKPIMNKQRSLSPLPRTSLSETFKEARHEQKRFSTPGPRRKEQNKDKRIMGKLLNK 116
Query: 115 ------YKQPQQETKASSNSYSTSPLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAV 168
K P+ + + YS SP+RHL S++++ + + RK+ WTKYFDHGG +V AV
Sbjct: 117 DSHVSNSKSPRSSPITTKSPYS-SPIRHLASMKLSSK-QHRKDLGWTKYFDHGGGKVTAV 174
Query: 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQ 228
+ A+E VDLS+LF+G+RFAHGAHSRLYHG+YKDE VAVKII +PDDDEN L RLEKQ
Sbjct: 175 ETAEEWNVDLSKLFVGVRFAHGAHSRLYHGMYKDEAVAVKIITVPDDDENGMLVDRLEKQ 234
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
F REV+LLS LH+ NVIKFVAAC+KP VYCVITEYLSEGSLR+YLHKLE KT+ L KLIA
Sbjct: 235 FIREVSLLSCLHHQNVIKFVAACRKPHVYCVITEYLSEGSLRSYLHKLERKTISLGKLIA 294
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR 348
ALDIARGMEYIHSQGVIHRDLKPENVLI+++FHLKIADFGIACEE YCD +DDPGTYR
Sbjct: 295 FALDIARGMEYIHSQGVIHRDLKPENVLINEDFHLKIADFGIACEEAYCDLFADDPGTYR 354
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
WMAPEMIK KSYGRKVDVYSFGLILWEMV GTIPYE+M PIQAAFAVVNK
Sbjct: 355 WMAPEMIKRKSYGRKVDVYSFGLILWEMVTGTIPYEDMTPIQAAFAVVNK 404
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549321|ref|XP_003543042.1| PREDICTED: serine/threonine-protein kinase HT1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 531 bits (1369), Expect = e-148, Method: Compositional matrix adjust.
Identities = 265/398 (66%), Positives = 317/398 (79%), Gaps = 24/398 (6%)
Query: 1 MGDGANSWIRRTKFSHTVCHRLDSSILASLPLNLPETISVLKSRPGPASSNQKSAPNSSQ 60
MG+ SWIRRTKFSHTVCHRLD + L S+P+++ S QKS P +S+
Sbjct: 1 MGEDGYSWIRRTKFSHTVCHRLDPARLGSIPISV--------------QSEQKSRPAASK 46
Query: 61 SQQNPAANKPRSVSPLPETVLPDTFKEARSATKRFSTPHPRRKESDKGLVGKFLYKQPQQ 120
+Q++P NK RS+SPLPET L + F+EAR KRFSTP+PRR +K ++GK L K ++
Sbjct: 47 AQRHPITNKQRSLSPLPETYLSEAFREARHEQKRFSTPNPRR---EKRIMGKLLNKDSRE 103
Query: 121 ETKASSNSYSTSPLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDLSQ 180
++SS S S SP R + S K+RK+SAWTK D+GG ++ AV+ A+E VD+SQ
Sbjct: 104 TKESSSKSPSHSPNRQVKS-------KNRKDSAWTKLLDNGGGKITAVETAEEWNVDMSQ 156
Query: 181 LFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
LF GL+FAHGAHSRLYHG+YK+E VAVKII +P+DDEN LA+RLEKQF REV LLSRLH
Sbjct: 157 LFFGLKFAHGAHSRLYHGVYKEEAVAVKIIMVPEDDENGALASRLEKQFIREVTLLSRLH 216
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
+ NVIKF AAC+KPPVYC+ITEYL+EGSLRAYLHKLEH+T+ L KLIA ALDIARGMEYI
Sbjct: 217 HQNVIKFSAACRKPPVYCIITEYLAEGSLRAYLHKLEHQTVSLQKLIAFALDIARGMEYI 276
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY 360
HSQGVIHRDLKPENVLI+++ HLKIADFGIACEE CD L+DDPGTYRWMAPEMIK KSY
Sbjct: 277 HSQGVIHRDLKPENVLINEDNHLKIADFGIACEEASCDLLADDPGTYRWMAPEMIKRKSY 336
Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
G+KVDVYSFGL++WEM+ GTIPYE+MNPIQAAFAVVNK
Sbjct: 337 GKKVDVYSFGLMIWEMLTGTIPYEDMNPIQAAFAVVNK 374
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 405 | ||||||
| TAIR|locus:2154573 | 525 | AT5G58950 [Arabidopsis thalian | 0.804 | 0.620 | 0.689 | 2.6e-130 | |
| TAIR|locus:2102802 | 475 | AT3G46930 [Arabidopsis thalian | 0.802 | 0.684 | 0.555 | 3.5e-91 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.555 | 0.547 | 0.480 | 4.3e-61 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.555 | 0.546 | 0.484 | 3.9e-60 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.550 | 0.387 | 0.426 | 1.9e-51 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.550 | 0.408 | 0.4 | 1.5e-49 | |
| TAIR|locus:2168778 | 353 | AT5G40540 [Arabidopsis thalian | 0.575 | 0.660 | 0.421 | 1.8e-48 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.548 | 0.389 | 0.385 | 2.9e-48 | |
| TAIR|locus:2091423 | 356 | ATN1 [Arabidopsis thaliana (ta | 0.540 | 0.615 | 0.422 | 1.2e-47 | |
| TAIR|locus:2157717 | 346 | AT5G50180 [Arabidopsis thalian | 0.540 | 0.632 | 0.435 | 3.3e-47 |
| TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1193 (425.0 bits), Expect = 2.6e-130, Sum P(2) = 2.6e-130
Identities = 227/329 (68%), Positives = 271/329 (82%)
Query: 71 RSVSPLPETVLPDTFKEARSATKRFSTPHPRRKESDKGLVGKFLYKQPQQETKASSNSYS 130
RSVSP P+ +PD FKEARS KRFSTPHPRR ES+KG+ K +K K S N S
Sbjct: 98 RSVSPSPQMAVPDVFKEARSERKRFSTPHPRRVESEKGMKPKLSHKNSFD--KRSFNLRS 155
Query: 131 TS-PLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDLSQLFLGLRFAH 189
S P+R LG+LR+ ER KS+K++ W+K FD+ G RV+AV+A++E VD+S+LF GL+FAH
Sbjct: 156 PSGPIRDLGTLRIQERVKSKKDTGWSKLFDNTGRRVSAVEASEEFRVDMSKLFFGLKFAH 215
Query: 190 GAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249
G +SRLYHG Y+D+ VAVK+I +PDDD+N L ARLEKQF +EV LLSRL +PNVIKFV
Sbjct: 216 GLYSRLYHGKYEDKAVAVKLITVPDDDDNGCLGARLEKQFTKEVTLLSRLTHPNVIKFVG 275
Query: 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
A K PPVYCV+T+YL EGSLR++LHK E+++LPL KLI A+DIARGMEYIHS+ +IHRD
Sbjct: 276 AYKDPPVYCVLTQYLPEGSLRSFLHKPENRSLPLKKLIEFAIDIARGMEYIHSRRIIHRD 335
Query: 310 LKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSF 369
LKPENVLID+EFHLKIADFGIACEE YCD L+DDPGTYRWMAPEMIK K +GRK DVYSF
Sbjct: 336 LKPENVLIDEEFHLKIADFGIACEEEYCDMLADDPGTYRWMAPEMIKRKPHGRKADVYSF 395
Query: 370 GLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
GL+LWEMVAG IPYE+MNPIQAAFAVV+K
Sbjct: 396 GLVLWEMVAGAIPYEDMNPIQAAFAVVHK 424
|
|
| TAIR|locus:2102802 AT3G46930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 909 (325.0 bits), Expect = 3.5e-91, P = 3.5e-91
Identities = 184/331 (55%), Positives = 236/331 (71%)
Query: 71 RSVSPLPETVLPDTFKEARSATKRFSTPHPRRKESDKGLVGKFLYKQPQQETKASS-NSY 129
RSVSPLP L D F EA+S KRFSTPHPRR E +KG+ K ++ E K+ + S
Sbjct: 49 RSVSPLPHMALSDAFIEAKSDIKRFSTPHPRRVEPEKGMKAKSSSRKDSSEKKSVNLRSL 108
Query: 130 STS-PLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDLSQLFLGLRFA 188
S S P+R L + +V ER KS+ + +K D+ G +V++ +E +D+S+L G RFA
Sbjct: 109 SHSGPIRDLSTQKVKERGKSKIDKKSSKSVDYRGSKVSSAGVLEECLIDVSKLSYGDRFA 168
Query: 189 HGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248
HG +S++YHG Y+ + VA+KII P+D ++ L ARLEK+F E LLSRL +PNV+KFV
Sbjct: 169 HGKYSQIYHGEYEGKAVALKIITAPEDSDDIFLGARLEKEFIVEATLLSRLSHPNVVKFV 228
Query: 249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHR 308
C+ITEY+ GSLR+YLHKLE K+LPL +LI LDIA+GMEYIHS+ ++H+
Sbjct: 229 GVNTGN---CIITEYVPRGSLRSYLHKLEQKSLPLEQLIDFGLDIAKGMEYIHSREIVHQ 285
Query: 309 DLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYS 368
DLKPENVLID +FHLKIADFGIACEE YCD L D+ GTYRWMAPE++K +GRK DVYS
Sbjct: 286 DLKPENVLIDNDFHLKIADFGIACEEEYCDVLGDNIGTYRWMAPEVLKRIPHGRKCDVYS 345
Query: 369 FGLILWEMVAGTIPYEEMN-PIQAAFAVVNK 398
FGL+LWEMVAG +PYEEM Q A+AV+ K
Sbjct: 346 FGLLLWEMVAGALPYEEMKFAEQIAYAVIYK 376
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 625 (225.1 bits), Expect = 4.3e-61, P = 4.3e-61
Identities = 109/227 (48%), Positives = 166/227 (73%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
DE T+DL +L +G FA GA +LY G Y E VA+KI+ P++ + A +E+QF +
Sbjct: 121 DEWTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEK--AQFMEQQFQQ 178
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
EV++L+ L +PN+++F+ AC+KP V+C++TEY GS+R +L + +++ +PL + AL
Sbjct: 179 EVSMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 238
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
D+ARGM Y+H + IHRDLK +N+LI + +KIADFG+A EV + ++ + GTYRWMA
Sbjct: 239 DVARGMAYVHGRNFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMA 298
Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
PEMI+H++Y +KVDVYSFG++LWE++ G +P++ M +QAAFAVVN+
Sbjct: 299 PEMIQHRAYNQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNR 345
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 616 (221.9 bits), Expect = 3.9e-60, P = 3.9e-60
Identities = 110/227 (48%), Positives = 162/227 (71%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
+E T+DL +L +G FA GA +LY G Y E VA+K++ D N A LE+QF +
Sbjct: 122 EEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLE--RSDSNPEKAQALEQQFQQ 179
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
EV++L+ L +PN+++F+ AC KP V+C++TEY GS+R +L K +++ +PL + AL
Sbjct: 180 EVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQAL 239
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
D+ARGM Y+H + IHRDLK +N+LI + +KIADFG+A EV + ++ + GTYRWMA
Sbjct: 240 DVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETGTYRWMA 299
Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
PEMI+H+ Y +KVDVYSFG++LWE++ G +P++ M +QAAFAVVN+
Sbjct: 300 PEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNR 346
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 534 (193.0 bits), Expect = 1.9e-51, P = 1.9e-51
Identities = 98/230 (42%), Positives = 150/230 (65%)
Query: 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQ 228
D D ++L L G + A G++ LY G Y + VA+K+++ P E L + LEK+
Sbjct: 278 DGTDVWEINLKHLKFGHKIASGSYGDLYKGTYCSQEVAIKVLK-P-----ERLDSDLEKE 331
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
F +EV ++ ++ + NV++F+ AC KPP C++TE++ GS+ YLHK + LP L
Sbjct: 332 FAQEVFIMRKVRHKNVVQFIGACTKPPHLCIVTEFMPGGSVYDYLHK-QKGVFKLPTLFK 390
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR 348
+A+DI +GM Y+H +IHRDLK N+L+D+ +K+ADFG+A + ++ + GTYR
Sbjct: 391 VAIDICKGMSYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQTGVMTAETGTYR 450
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
WMAPE+I+HK Y K DV+S+G++LWE++ G +PYE M P+QAA VV K
Sbjct: 451 WMAPEVIEHKPYDHKADVFSYGIVLWELLTGKLPYEYMTPLQAAVGVVQK 500
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 516 (186.7 bits), Expect = 1.5e-49, P = 1.5e-49
Identities = 92/230 (40%), Positives = 152/230 (66%)
Query: 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQ 228
D DE +D++QL + + A G++ L+ G Y + VA+K ++ PD NE L ++
Sbjct: 274 DGTDEWEIDVTQLKIEKKVASGSYGDLHRGTYCSQEVAIKFLK-PDRVNNEML-----RE 327
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
F++EV ++ ++ + NV++F+ AC + P C++TE+++ GS+ +LHK + L L+
Sbjct: 328 FSQEVFIMRKVRHKNVVQFLGACTRSPTLCIVTEFMARGSIYDFLHK-QKCAFKLQTLLK 386
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR 348
+ALD+A+GM Y+H +IHRDLK N+L+D+ +K+ADFG+A ++ ++ + GTYR
Sbjct: 387 VALDVAKGMSYLHQNNIIHRDLKTANLLMDEHGLVKVADFGVARVQIESGVMTAETGTYR 446
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
WMAPE+I+HK Y K DV+S+ ++LWE++ G IPY + P+QAA VV K
Sbjct: 447 WMAPEVIEHKPYNHKADVFSYAIVLWELLTGDIPYAFLTPLQAAVGVVQK 496
|
|
| TAIR|locus:2168778 AT5G40540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 506 (183.2 bits), Expect = 1.8e-48, P = 1.8e-48
Identities = 104/247 (42%), Positives = 159/247 (64%)
Query: 162 GVRVNAVDAAD-EHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENET 220
G N V D + VD LF+G + GAH+++Y G YK++ VA+KI++ + E
Sbjct: 6 GFYSNEVFELDPKWVVDPQHLFVGPKIGEGAHAKIYEGKYKNKTVAIKIVKRGESPEE-- 63
Query: 221 LAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT 280
A+ E +F REV++LSR+ + N++KF+ ACK+P + ++TE L G+LR YL L +
Sbjct: 64 -IAKRESRFAREVSMLSRVQHKNLVKFIGACKEP-IMVIVTELLLGGTLRKYLVSLRPGS 121
Query: 281 LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVYCDA 339
L + + ALDIAR ME +HS GVIHRDLKPE++++ ++ +K+ADFG+A EE +
Sbjct: 122 LDIRVAVGYALDIARAMECLHSHGVIHRDLKPESLILTADYKTVKLADFGLAREESLTEM 181
Query: 340 LSDDPGTYRWMAPEM-----IKH---KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQA 391
++ + GTYRWMAPE+ ++H K Y KVD YSF ++LWE++ +P+E M+ +QA
Sbjct: 182 MTAETGTYRWMAPELYSTVTLRHGEKKHYNHKVDAYSFAIVLWELIHNKLPFEGMSNLQA 241
Query: 392 AFAVVNK 398
A+A K
Sbjct: 242 AYAAAFK 248
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 504 (182.5 bits), Expect = 2.9e-48, P = 2.9e-48
Identities = 89/231 (38%), Positives = 152/231 (65%)
Query: 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQ 228
D DE +D+ QL + + A G++ L+ G Y + VA+KI++ P E + A + ++
Sbjct: 280 DGTDEWEIDMKQLKIEKKVACGSYGELFRGTYCSQEVAIKILK-P-----ERVNAEMLRE 333
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLI 287
F++EV ++ ++ + NV++F+ AC + P C++TE+++ GS+ +LHK HK + L+
Sbjct: 334 FSQEVYIMRKVRHKNVVQFIGACTRSPNLCIVTEFMTRGSIYDFLHK--HKGVFKIQSLL 391
Query: 288 AIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY 347
+ALD+++GM Y+H +IHRDLK N+L+D+ +K+ADFG+A + ++ + GTY
Sbjct: 392 KVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHEVVKVADFGVARVQTESGVMTAETGTY 451
Query: 348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
RWMAPE+I+HK Y + DV+S+ ++LWE++ G +PY + P+QAA VV K
Sbjct: 452 RWMAPEVIEHKPYDHRADVFSYAIVLWELLTGELPYSYLTPLQAAVGVVQK 502
|
|
| TAIR|locus:2091423 ATN1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 498 (180.4 bits), Expect = 1.2e-47, P = 1.2e-47
Identities = 98/232 (42%), Positives = 151/232 (65%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
VD LF+G + GAH+++Y G Y+++ VA+KII+ + E A+ + +F RE+A+
Sbjct: 21 VDPRHLFVGPKIGEGAHAKVYEGKYRNQTVAIKIIKRGESPEE---IAKRDNRFAREIAM 77
Query: 236 LSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR 295
LS++ + N++KF+ ACK+P + ++TE L G+LR YL L K L + + ALDIAR
Sbjct: 78 LSKVQHKNLVKFIGACKEP-MMVIVTELLLGGTLRKYLVSLRPKRLDIRLAVGFALDIAR 136
Query: 296 GMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVYCDALSDDPGTYRWMAPEM 354
ME +HS G+IHRDLKPEN+++ + +K+ADFG+A EE + ++ + GTYRWMAPE+
Sbjct: 137 AMECLHSHGIIHRDLKPENLILSADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
Query: 355 I--------KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
+ K Y KVD YSF ++LWE++ +P+E M+ +QAA+A K
Sbjct: 197 YSTVTLRQGEKKHYNHKVDAYSFAIVLWELILNKLPFEGMSNLQAAYAAAFK 248
|
|
| TAIR|locus:2157717 AT5G50180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 494 (179.0 bits), Expect = 3.3e-47, P = 3.3e-47
Identities = 101/232 (43%), Positives = 148/232 (63%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
+D LF+G + GAH+++Y G YK++ VA+KI+ + E A+ + +F REV +
Sbjct: 15 IDPQLLFVGPKIGEGAHAKVYEGKYKNQTVAIKIVHRGETPEE---IAKRDSRFLREVEM 71
Query: 236 LSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR 295
LSR+ + N++KF+ ACK+P V ++TE L G+LR YL L L I ALDIAR
Sbjct: 72 LSRVQHKNLVKFIGACKEP-VMVIVTELLQGGTLRKYLLNLRPACLETRVAIGFALDIAR 130
Query: 296 GMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVYCDALSDDPGTYRWMAPEM 354
GME +HS G+IHRDLKPEN+L+ + +K+ADFG+A EE + ++ + GTYRWMAPE+
Sbjct: 131 GMECLHSHGIIHRDLKPENLLLTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPEL 190
Query: 355 I--------KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
+ K Y KVD YSF ++LWE++ +P+E M+ +QAA+A K
Sbjct: 191 YSTVTLRLGEKKHYNHKVDAYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 242
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 405 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-71 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-69 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-63 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-60 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-60 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-56 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-52 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-49 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-43 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-41 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-38 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-37 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-37 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-37 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-36 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-36 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-35 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-35 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-35 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-34 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-34 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-34 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-33 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-32 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-32 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-32 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-32 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-31 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-31 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-31 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-30 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-30 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-30 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-30 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-30 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-30 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-30 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-30 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-29 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-29 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-29 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-29 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-29 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-29 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-29 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-29 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-29 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-28 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-28 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-28 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-28 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-27 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-27 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-27 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-26 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-26 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-26 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-26 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-26 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-26 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-26 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-26 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-26 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-26 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-26 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-26 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-25 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-25 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-25 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-25 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-25 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-25 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-25 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-25 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-25 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-25 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-25 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-25 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-25 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-25 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-25 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-24 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-24 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-24 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-24 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-24 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-24 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-24 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-24 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-24 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-23 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-23 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-23 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-23 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-23 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-23 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-23 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-23 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-23 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-23 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-22 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-22 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-22 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-22 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-22 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-22 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-22 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-22 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-21 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-21 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-21 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-21 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-21 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-21 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-21 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-21 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-21 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-21 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-21 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-20 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-20 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-20 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-20 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-20 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-20 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-19 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-19 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-19 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-19 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-19 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-19 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-19 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-19 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-18 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-18 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-18 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-18 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-18 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-18 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-18 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-18 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-18 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-18 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-18 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-18 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-17 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-17 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-17 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-17 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-17 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-17 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-17 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-17 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-17 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-17 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-17 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-16 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-16 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-16 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-16 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-16 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-16 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-16 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-16 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-15 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-15 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-15 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-15 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-15 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-14 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-14 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-13 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-13 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-12 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-12 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-11 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-11 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-11 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-08 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 7e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 4e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 9e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.001 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.003 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 222 bits (569), Expect = 8e-71
Identities = 75/228 (32%), Positives = 116/228 (50%), Gaps = 20/228 (8%)
Query: 181 LFLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVA 234
L LG + GA +Y G K + VAVK ++ ++ ++F RE
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI-------EEFLREAR 53
Query: 235 LLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIA 294
++ +L +PN++K + C + ++ EY+ G L YL K K L L L++ AL IA
Sbjct: 54 IMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIA 113
Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE----EVYCDALSDDPGTYRWM 350
RGMEY+ S+ IHRDL N L+ + +KI+DFG++ + + Y P RWM
Sbjct: 114 RGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLP--IRWM 171
Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
APE +K + K DV+SFG++LWE+ G PY M+ + +
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKK 219
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 217 bits (556), Expect = 7e-69
Identities = 76/227 (33%), Positives = 116/227 (51%), Gaps = 19/227 (8%)
Query: 181 LFLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVA 234
L LG + GA +Y G K VAVK ++ ++ ++F RE
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI-------EEFLREAR 53
Query: 235 LLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIA 294
++ +L +PNV+K + C + ++ EY+ G L +YL K K L L L++ AL IA
Sbjct: 54 IMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-LSLSDLLSFALQIA 112
Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE---EVYCDALSDDPGTYRWMA 351
RGMEY+ S+ IHRDL N L+ + +KI+DFG++ + + Y RWMA
Sbjct: 113 RGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRK-RGGKLPIRWMA 171
Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
PE +K + K DV+SFG++LWE+ G PY M+ + + N
Sbjct: 172 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKN 218
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 204 bits (522), Expect = 1e-63
Identities = 63/207 (30%), Positives = 113/207 (54%), Gaps = 11/207 (5%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G+ ++Y K + VA+K+I+ ++ ++ RE+ +L +L +PN+++
Sbjct: 9 EGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR-------ERILREIKILKKLKHPNIVR 61
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+ ++ EY G L L K L + I +EY+HS+G++
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLLKK--RGRLSEDEARFYLRQILSALEYLHSKGIV 119
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDV 366
HRDLKPEN+L+D++ H+K+ADFG+A + + L+ GT +MAPE++ K YG+ VD+
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179
Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAF 393
+S G+IL+E++ G P+ + + F
Sbjct: 180 WSLGVILYELLTGKPPFPGDDQLLELF 206
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 4e-60
Identities = 71/200 (35%), Positives = 112/200 (56%), Gaps = 12/200 (6%)
Query: 190 GAHSRLYHGIYKDEP--VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
G+ +Y +K VAVKI++ + + ++ RE+ +L RL +PN+++
Sbjct: 10 GSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK------DQTARREIRILRRLSHPNIVRL 63
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
+ A + ++ EY G L YL + L + IAL I RG+EY+HS G+IH
Sbjct: 64 IDAFEDKDHLYLVMEYCEGGDLFDYLSR--GGPLSEDEAKKIALQILRGLEYLHSNGIIH 121
Query: 308 RDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-GTYRWMAPEMIK-HKSYGRKVD 365
RDLKPEN+L+D+ +KIADFG+A + + + GT +MAPE++ YG KVD
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVD 181
Query: 366 VYSFGLILWEMVAGTIPYEE 385
V+S G+IL+E++ G P+
Sbjct: 182 VWSLGVILYELLTGKPPFSG 201
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 7e-60
Identities = 65/193 (33%), Positives = 103/193 (53%), Gaps = 13/193 (6%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G +Y K + VA+KII+ D ++ RE+ +L +L++PN++K
Sbjct: 3 EGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL-------EELLREIEILKKLNHPNIVK 55
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+ ++ EY GSL+ L + E L +++ I L I G+EY+HS G+I
Sbjct: 56 LYGVFEDENHLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 307 HRDLKPENVLIDQ-EFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIKHK-SYGRK 363
HRDLKPEN+L+D +K+ADFG++ L GT +MAPE++ K Y K
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 364 VDVYSFGLILWEM 376
D++S G+IL+E+
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 1e-56
Identities = 68/217 (31%), Positives = 112/217 (51%), Gaps = 18/217 (8%)
Query: 189 HGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP 242
GA +Y G K + VAVK ++ +E ++F E +++ +L +P
Sbjct: 9 EGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEER-------EEFLEEASIMKKLSHP 61
Query: 243 NVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
N+++ + C + ++TEY+ G L +L K K L L L+ +AL IA+GMEY+ S
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLES 120
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---RWMAPEMIKHKS 359
+ +HRDL N L+ + +KI+DFG++ + D G +WMAPE +K
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 360 YGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV 395
+ K DV+SFG++LWE+ G PY M+ + +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL 217
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-52
Identities = 69/213 (32%), Positives = 109/213 (51%), Gaps = 28/213 (13%)
Query: 194 RLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253
+L K VAVK ++ +E K F +E ++ +L +PNV++ + C +
Sbjct: 15 KLKGKDGKTTEVAVKTLKEDASEEER-------KDFLKEARVMKKLGHPNVVRLLGVCTE 67
Query: 254 PPVYCVITEYLSEGSLRAYLHK-------LEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
++ EY+ G L YL K E TL L L++ A+ IA+GMEY+ S+ +
Sbjct: 68 EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFV 127
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY--------RWMAPEMIKHK 358
HRDL N L+ ++ +KI+DFG++ +VY DD RWMAPE +K
Sbjct: 128 HRDLAARNCLVGEDLVVKISDFGLS-RDVY----DDDYYRKKTGGKLPIRWMAPESLKDG 182
Query: 359 SYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQ 390
+ K DV+SFG++LWE+ G PY ++ +
Sbjct: 183 IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE 215
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 2e-49
Identities = 72/215 (33%), Positives = 114/215 (53%), Gaps = 16/215 (7%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G+ +Y + KD E +AVK + + D E E LE RE+ +LS L +PN+++
Sbjct: 10 RGSFGSVYLALDKDTGELMAVKSVELSGDSEEE--LEALE----REIRILSSLQHPNIVR 63
Query: 247 FVAACKKPP--VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304
+ + + + EY+S GSL + L K LP P + I G+ Y+HS G
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNG 121
Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGTYRWMAPEMIKHKSYG 361
++HRD+K N+L+D + +K+ADFG A + + GT WMAPE+I+ + YG
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181
Query: 362 RKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAV 395
R D++S G + EM G P+ E+ NP+ A + +
Sbjct: 182 RAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 3e-43
Identities = 77/211 (36%), Positives = 118/211 (55%), Gaps = 17/211 (8%)
Query: 183 LGLRFAHGAHSRLYHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN 241
L + G ++ G++K+ VA+KI++ ++ L + F +EV L RL +
Sbjct: 10 LERKLGSGYFGEVWEGLWKNRVRVAIKILK-----SDDLLKQQ---DFQKEVQALKRLRH 61
Query: 242 PNVIKFVAACKK-PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
++I A C PVY +ITE + +GSL A+L E + LP+ LI +A +A GM Y+
Sbjct: 62 KHLISLFAVCSVGEPVY-IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGTYRWMAPEMIKH 357
Q IHRDL N+L+ ++ K+ADFG+A E+VY + P Y+W APE H
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEAASH 178
Query: 358 KSYGRKVDVYSFGLILWEMVA-GTIPYEEMN 387
++ K DV+SFG++L+EM G +PY MN
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 7e-43
Identities = 63/220 (28%), Positives = 113/220 (51%), Gaps = 29/220 (13%)
Query: 190 GAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
GA +Y + + VA+K +R+ ++ + E+ ++ +PN++ +
Sbjct: 30 GASGEVYKATDRATGKEVAIKKMRLRKQNKELII---------NEILIMKDCKHPNIVDY 80
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL--PKLIAIALDIARGMEYIHSQGV 305
+ V+ EY+ GSL + + + + P++ + ++ +G+EY+HSQ V
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSL-TDI--ITQNFVRMNEPQIAYVCREVLQGLEYLHSQNV 137
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------GTYRWMAPEMIKHK 358
IHRD+K +N+L+ ++ +K+ADFG + L+ + GT WMAPE+IK K
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFG------FAAQLTKEKSKRNSVVGTPYWMAPEVIKRK 191
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
YG KVD++S G++ EM G PY P++A F + K
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK 231
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-41
Identities = 65/212 (30%), Positives = 114/212 (53%), Gaps = 25/212 (11%)
Query: 196 YHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA-CK 252
Y +K + VA+K+I++ ++ E + E+ +L + +PN++K+ + K
Sbjct: 17 YKARHKRTGKEVAIKVIKLESKEKKEKII--------NEIQILKKCKHPNIVKYYGSYLK 68
Query: 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKP 312
K ++ V+ E+ S GSL+ L TL ++ + ++ +G+EY+HS G+IHRD+K
Sbjct: 69 KDELWIVM-EFCSGGSLKDLLKSTNQ-TLTESQIAYVCKELLKGLEYLHSNGIIHRDIKA 126
Query: 313 ENVLIDQEFHLKIADFGIACEEVYCDALSDDP------GTYRWMAPEMIKHKSYGRKVDV 366
N+L+ + +K+ DFG++ + LSD GT WMAPE+I K Y K D+
Sbjct: 127 ANILLTSDGEVKLIDFGLSAQ------LSDTKARNTMVGTPYWMAPEVINGKPYDYKADI 180
Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
+S G+ E+ G PY E+ P++A F +
Sbjct: 181 WSLGITAIELAEGKPPYSELPPMKALFKIATN 212
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 5e-38
Identities = 54/202 (26%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
+ +K I + + E E A EV +L +L++PN+IK+ + ++ C++
Sbjct: 25 GKLYVLKEIDLSNMSEKEREDAL------NEVKILKKLNHPNIIKYYESFEEKGKLCIVM 78
Query: 262 EYLSEGSLRAYLH--KLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
EY G L + K E K P +++ + + ++Y+HS+ ++HRD+KP+N+ +
Sbjct: 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTS 138
Query: 320 EFHLKIADFGIACEEVY---CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
+K+ DFGI+ +V D GT +++PE+ ++K Y K D++S G +L+E+
Sbjct: 139 NGLVKLGDFGIS--KVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYEL 196
Query: 377 VAGTIPYEEMNPIQAAFAVVNK 398
P+E N ++ A ++
Sbjct: 197 CTLKHPFEGENLLELALKILKG 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 72/220 (32%), Positives = 112/220 (50%), Gaps = 27/220 (12%)
Query: 179 SQLFLGLRFAHGAHSRLYHGIY-KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLS 237
L L + G ++ G + VAVK ++ + A F +E ++
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLK----PGTMSPEA-----FLQEAQIMK 56
Query: 238 RLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARG 296
+L + +++ A C ++ P+Y ++TEY+S+GSL +L E K L LP+L+ +A IA G
Sbjct: 57 KLRHDKLVQLYAVCSEEEPIY-IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEG 115
Query: 297 MEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR-------- 348
M Y+ S+ IHRDL N+L+ + KIADFG+A + DD T R
Sbjct: 116 MAYLESRNYIHRDLAARNILVGENLVCKIADFGLA------RLIEDDEYTAREGAKFPIK 169
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMN 387
W APE + + K DV+SFG++L E+V G +PY M
Sbjct: 170 WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT 209
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 62/186 (33%), Positives = 96/186 (51%), Gaps = 26/186 (13%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--PVYCVI 260
E VAVK + E + + F RE+ +L L + N++K+ C+KP +I
Sbjct: 34 EQVAVKSLNH--SGEEQHRS-----DFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI 86
Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
EYL GSLR YL + + + L +L+ + I +GM+Y+ SQ IHRDL N+L++ E
Sbjct: 87 MEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE 145
Query: 321 FHLKIADFGIACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFG 370
+KI+DFG+A L +D Y W APE ++ + DV+SFG
Sbjct: 146 DLVKISDFGLA------KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFG 199
Query: 371 LILWEM 376
+ L+E+
Sbjct: 200 VTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 71/229 (31%), Positives = 122/229 (53%), Gaps = 18/229 (7%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
++ +L LG G + G Y+ + VAVK ++ DD + F E ++
Sbjct: 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLK---DDSTAA------QAFLAEASV 53
Query: 236 LSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIA 294
++ L +PN+++ + + P+Y ++TEY+++GSL YL + L + + ALD+
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNPLY-IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVC 112
Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEM 354
GMEY+ + +HRDL NVL+ ++ K++DFG+A E P +W APE
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP--VKWTAPEA 170
Query: 355 IKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVNFG 402
++ K + K DV+SFG++LWE+ + G +PY + P++ VV V G
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLK---DVVPHVEKG 215
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 70/216 (32%), Positives = 115/216 (53%), Gaps = 21/216 (9%)
Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
GA +Y G+ + + VA+K I + E K +E+ LL L +PN++K+
Sbjct: 11 GAFGVVYKGLNLETGDFVAIKQISLEKIKEEAL------KSIMQEIDLLKNLKHPNIVKY 64
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPK-LIAIAL-DIARGMEYIHSQGV 305
+ + + +I EY GSLR + K P P+ L+A+ + + +G+ Y+H QGV
Sbjct: 65 IGSIETSDSLYIILEYAENGSLRQIIKKFG----PFPESLVAVYVYQVLQGLAYLHEQGV 120
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP----GTYRWMAPEMIKHKSYG 361
IHRD+K N+L ++ +K+ADFG+A + +S D GT WMAPE+I+
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVA---TKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 362 RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
D++S G + E++ G PY ++NP+ A F +V
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ 213
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 7e-36
Identities = 69/202 (34%), Positives = 99/202 (49%), Gaps = 23/202 (11%)
Query: 201 KDEP--VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC 258
D P VAVK++R PD +N + F +EV +LSRL +PN+ + + C P C
Sbjct: 43 ADAPVLVAVKVLR-PDASDN------AREDFLKEVKILSRLSDPNIARLLGVCTVDPPLC 95
Query: 259 VITEYLSEGSLRAYLHKLE---------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
+I EY+ G L +L K K+L L+ +A IA GM Y+ S +HRD
Sbjct: 96 MIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRD 155
Query: 310 LKPENVLIDQEFHLKIADFGI---ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDV 366
L N L+ + + +KIADFG+ Y P RWMA E + + K DV
Sbjct: 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215
Query: 367 YSFGLILWE--MVAGTIPYEEM 386
++FG+ LWE + PYE +
Sbjct: 216 WAFGVTLWEILTLCREQPYEHL 237
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 1e-35
Identities = 64/211 (30%), Positives = 109/211 (51%), Gaps = 8/211 (3%)
Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
G+ +Y G+ D + AVK + + DD + KQ +E+ALLS+L +PN++++
Sbjct: 11 GSFGSVYEGLNLDDGDFFAVKEVSLADDGQ---TGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
+ ++ + E + GSL L K + + P P + I G+EY+H + +H
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRNTVH 125
Query: 308 RDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK-SYGRKVDV 366
RD+K N+L+D +K+ADFG+A + V G+ WMAPE+I + YG D+
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185
Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
+S G + EM G P+ ++ + A F +
Sbjct: 186 WSLGCTVLEMATGKPPWSQLEGVAAVFKIGR 216
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 3e-35
Identities = 66/212 (31%), Positives = 120/212 (56%), Gaps = 14/212 (6%)
Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
G++ +Y I+K+ + VA+K++ + +D + + K E+++L + +P ++K+
Sbjct: 14 GSYGSVYKAIHKETGQVVAIKVVPVEEDLQE------IIK----EISILKQCDSPYIVKY 63
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
+ K ++ EY GS+ + K+ +KTL ++ AI +G+EY+HS IH
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIH 122
Query: 308 RDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-GTYRWMAPEMIKHKSYGRKVDV 366
RD+K N+L+++E K+ADFG++ + A + GT WMAPE+I+ Y K D+
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADI 182
Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
+S G+ EM G PY +++P++A F + NK
Sbjct: 183 WSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK 214
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 6e-35
Identities = 57/179 (31%), Positives = 104/179 (58%), Gaps = 8/179 (4%)
Query: 206 AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLS 265
A+K+++ + + + + + E +LSR+++P ++K A + ++ EY
Sbjct: 22 AMKVLK-----KKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAP 76
Query: 266 EGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI 325
G L ++L K + + A A +I +EY+HS G+I+RDLKPEN+L+D + H+K+
Sbjct: 77 GGELFSHLSKEGRFSEERARFYA-A-EIVLALEYLHSLGIIYRDLKPENILLDADGHIKL 134
Query: 326 ADFGIACEEVYCDALSDDP-GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
DFG+A E + ++ GT ++APE++ K YG+ VD +S G++L+EM+ G P+
Sbjct: 135 TDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF 193
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 4e-34
Identities = 74/214 (34%), Positives = 117/214 (54%), Gaps = 19/214 (8%)
Query: 186 RFAHGAHSRLYHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
+ G +Y G+ K VAVK R TL L+++F +E +L + +PN+
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCR-------STLPPDLKRKFLQEAEILKQYDHPNI 54
Query: 245 IKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
+K + C +K P+Y ++ E + GSL +L K + L + KL+ ++LD A GMEY+ S+
Sbjct: 55 VKLIGVCVQKQPIY-IVMELVPGGSLLTFLRK-KKNRLTVKKLLQMSLDAAAGMEYLESK 112
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEE---VYCDALSDDPGT--YRWMAPEMIKHK 358
IHRDL N L+ + LKI+DFG++ EE +Y +SD +W APE + +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY--TVSDGLKQIPIKWTAPEALNYG 170
Query: 359 SYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
Y + DV+S+G++LWE + G PY M+ Q
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT 204
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 4e-34
Identities = 74/236 (31%), Positives = 121/236 (51%), Gaps = 27/236 (11%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQFNREVA 234
+D + + L + G ++ G++ + PVAVK ++ D + F E
Sbjct: 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD---------FLAEAQ 53
Query: 235 LLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDI 293
++ +L +P +I+ A C + P+Y ++TE + GSL YL + L LP+LI +A +
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEPIY-IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 294 ARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGT---Y 347
A GM Y+ +Q IHRDL NVL+ + K+ADFG+A E++Y G
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY----EAREGAKFPI 168
Query: 348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVNFG 402
+W APE + + K DV+SFG++L E+V G +PY M + V+ +V+ G
Sbjct: 169 KWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE----VLQQVDQG 220
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 6e-34
Identities = 67/213 (31%), Positives = 120/213 (56%), Gaps = 14/213 (6%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
++L +L LG G + G Y + VAVK I+ + T A LE E A+
Sbjct: 3 LNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKC-----DVTAQAFLE-----ETAV 52
Query: 236 LSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR 295
+++LH+ N+++ + +Y ++ E +S+G+L +L + + +L+ +LD+A
Sbjct: 53 MTKLHHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAE 111
Query: 296 GMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI 355
GMEY+ S+ ++HRDL N+L+ ++ K++DFG+A V + + +W APE +
Sbjct: 112 GMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLA--RVGSMGVDNSKLPVKWTAPEAL 169
Query: 356 KHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMN 387
KHK + K DV+S+G++LWE+ + G PY +M+
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 9e-33
Identities = 64/222 (28%), Positives = 109/222 (49%), Gaps = 19/222 (8%)
Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIP------DDDENETLAARLEKQFNREVALLSRLHN 241
G + R+Y + E +AVK + +P D + + L E+ L L +
Sbjct: 12 GTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKAL----RSEIETLKDLDH 67
Query: 242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
N+++++ + EY+ GS+ + L L + + G+ Y+H
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR--FFTEQVLEGLAYLH 125
Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYC-DALSDDPGTYRWMAPEMI--K 356
S+G++HRDLK +N+L+D + KI+DFGI+ +++Y D G+ WMAPE+I
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 357 HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
+ Y KVD++S G ++ EM AG P+ + I A F + NK
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK 227
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 31/210 (14%)
Query: 196 YHGIYKD--EPVAVKIIRI-PDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252
Y I K + VA+K+I + +DE E + +E+ LS+ +P + K+ +
Sbjct: 18 YKAIDKRTNQVVAIKVIDLEEAEDEIEDI--------QQEIQFLSQCRSPYITKYYGSFL 69
Query: 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP-KLIA-IALDIARGMEYIHSQGVIHRDL 310
K +I EY GS L K L IA I ++ G+EY+H +G IHRD+
Sbjct: 70 KGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEYLHEEGKIHRDI 124
Query: 311 KPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------GTYRWMAPEMIKHKSYGRK 363
K N+L+ +E +K+ADFG++ + L+ GT WMAPE+IK Y K
Sbjct: 125 KAANILLSEEGDVKLADFGVSGQ------LTSTMSKRNTFVGTPFWMAPEVIKQSGYDEK 178
Query: 364 VDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393
D++S G+ E+ G P +++P++ F
Sbjct: 179 ADIWSLGITAIELAKGEPPLSDLHPMRVLF 208
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 126 bits (316), Expect = 1e-32
Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 19/209 (9%)
Query: 189 HGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKF 247
G+ +Y + + VA+K++ + +++ ++F RE+ +L+ L H PN++K
Sbjct: 10 EGSFGEVYLARDR-KLVALKVLAKKLESKSK-----EVERFLREIQILASLNHPPNIVKL 63
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+ ++ EY+ GSL L K+ L + + I I +EY+HS+G+I
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGII 123
Query: 307 HRDLKPENVLIDQE-FHLKIADFGIACEEVYCDALSDDP-------GTYRWMAPEMIKHK 358
HRD+KPEN+L+D++ +K+ DFG+A + S P GT +MAPE++
Sbjct: 124 HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGL 183
Query: 359 S---YGRKVDVYSFGLILWEMVAGTIPYE 384
S D++S G+ L+E++ G P+E
Sbjct: 184 SLAYASSSSDIWSLGITLYELLTGLPPFE 212
|
Length = 384 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 60/206 (29%), Positives = 109/206 (52%), Gaps = 12/206 (5%)
Query: 203 EPVAVKIIRIPDDDE-NETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
E +AVK + +P ++ + RE+ALL L + N+++++ + +
Sbjct: 26 ELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFL 85
Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
EY+ GS+ A L+ + + I +G+ Y+H++G+IHRD+K N+L+D +
Sbjct: 86 EYVPGGSVAALLN--NYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG 143
Query: 322 HLKIADFGIACEEVYCDALSDDPGTYR--------WMAPEMIKHKSYGRKVDVYSFGLIL 373
+KI+DFGI+ +++ ++LS R WMAPE++K SY RK D++S G ++
Sbjct: 144 GIKISDFGIS-KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLV 202
Query: 374 WEMVAGTIPYEEMNPIQAAFAVVNKV 399
EM+ G P+ + +QA F +
Sbjct: 203 VEMLTGKHPFPDCTQLQAIFKIGENA 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-32
Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 33/224 (14%)
Query: 189 HGAHSRLYHGIYKDE--PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVI 245
G+ S + K+ A+KI+ D+ + + + K E +L+RL +P +I
Sbjct: 11 EGSFSTVVLAKEKETNKEYAIKIL-----DKRQLIKEKKVKYVKIEKEVLTRLNGHPGII 65
Query: 246 KFVAACKKPP-VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304
K + +Y V+ EY G L Y+ K + +L A +I +EY+HS+G
Sbjct: 66 KLYYTFQDEENLYFVL-EYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIAC-----------EEVYCDALSDDP--------- 344
+IHRDLKPEN+L+D++ H+KI DFG A + + S
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 345 -GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
GT +++PE++ K G+ D+++ G I+++M+ G P+ N
Sbjct: 183 VGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 62/164 (37%), Positives = 94/164 (57%), Gaps = 5/164 (3%)
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
F E L+ +L +P +++ A + P+Y +ITEY+ GSL +L E L + KLI
Sbjct: 48 FLAEANLMKQLQHPRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPEGIKLTINKLID 106
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY- 347
+A IA GM +I + IHRDL+ N+L+ + KIADFG+A + + + +
Sbjct: 107 MAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFP 166
Query: 348 -RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM-NP 388
+W APE I + ++ K DV+SFG++L E+V G IPY M NP
Sbjct: 167 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP 210
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 6e-32
Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 19/217 (8%)
Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
G ++Y + D E +AVK IRI D+D + K+ E+ +L L +PN++K+
Sbjct: 11 GTFGKVYTAVNLDTGELMAVKEIRIQDNDP------KTIKEIADEMKVLELLKHPNLVKY 64
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
+ EY S G+L L + L + L + G+ Y+HS G++H
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122
Query: 308 RDLKPENVLIDQEFHLKIADFGIACE-----EVYCDALSDDPGTYRWMAPEMI---KHKS 359
RD+KP N+ +D +K+ DFG A + + + GT +MAPE+I K K
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 360 YGRKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAV 395
+GR D++S G ++ EM G P+ E+ N Q F V
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHV 219
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 68/230 (29%), Positives = 108/230 (46%), Gaps = 34/230 (14%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G+ +Y +K + A+K I + D+E KQ RE+ L +P V+K
Sbjct: 11 QGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR-------KQLLRELKTLRSCESPYVVK 63
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GV 305
A K ++ EY+ GSL L K +P P L IA I +G++Y+H++ +
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHTKRHI 121
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIA--------CEEVYCDALSDDPGTYRWMAPEMIKH 357
IHRD+KP N+LI+ + +KIADFGI+ + GT +M+PE I+
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-------GTVTYMSPERIQG 174
Query: 358 KSYGRKVDVYSFGLILWEMVAGTIPY---EEMNPIQAAFAVVNKVNFGAS 404
+SY D++S GL L E G P+ + + F ++ + G
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF----FELMQAICDGPP 220
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
+AVK IR+ ++ ++KQ RE+ +L + ++P ++ F A + EY+
Sbjct: 29 MAVKTIRLEINEA-------IQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81
Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHL 323
GSL L K +P L IA+ + +G+ Y+H + +IHRD+KP N+L++ +
Sbjct: 82 DGGSLDKIL-KEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQI 140
Query: 324 KIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
K+ DFG++ + V A GT +MAPE I+ Y K D++S GL L E+ G PY
Sbjct: 141 KLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPY 199
Query: 384 -----EEMNPIQAAFAVVN 397
+ +VN
Sbjct: 200 PPENDPPDGIFELLQYIVN 218
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 66/214 (30%), Positives = 111/214 (51%), Gaps = 16/214 (7%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQFNREVA 234
+D S+L G ++ G ++ + VA+K+IR A E F E
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIR---------EGAMSEDDFIEEAK 51
Query: 235 LLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIA 294
++ +L +PN+++ C K ++TEY++ G L YL + + K L L+ + D+
Sbjct: 52 VMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVC 110
Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YRWMA 351
MEY+ S G IHRDL N L+ ++ +K++DFG+A V D + GT +W
Sbjct: 111 EAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLA-RYVLDDQYTSSQGTKFPVKWAP 169
Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYE 384
PE+ + + K DV+SFG+++WE+ + G +PYE
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 58/200 (29%), Positives = 109/200 (54%), Gaps = 16/200 (8%)
Query: 190 GAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
G + +Y G++K VAVK ++ +T+ ++F +E A++ + +PN+++
Sbjct: 17 GQYGEVYEGVWKKYSLTVAVKTLK------EDTMEV---EEFLKEAAVMKEIKHPNLVQL 67
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
+ C + P + +ITE+++ G+L YL + + + L+ +A I+ MEY+ + IH
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 127
Query: 308 RDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKV 364
RDL N L+ + +K+ADFG++ + Y A + +W APE + + + K
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 365 DVYSFGLILWEMVA-GTIPY 383
DV++FG++LWE+ G PY
Sbjct: 187 DVWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-30
Identities = 70/243 (28%), Positives = 119/243 (48%), Gaps = 40/243 (16%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEP-------VAVKIIRIPDDDENETLAARLEKQ 228
+ +L LG GA ++ VAVK+++ DD E +
Sbjct: 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK---DDATE----KDLSD 61
Query: 229 FNREVALLSRL-HNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLH------------ 274
E+ ++ + + N+I + C ++ P+Y V+ EY + G+LR +L
Sbjct: 62 LVSEMEMMKMIGKHKNIINLLGVCTQEGPLY-VVVEYAAHGNLRDFLRARRPPGEYASPD 120
Query: 275 --KLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332
+ +TL L++ A +ARGME++ S+ IHRDL NVL+ ++ +KIADFG+A
Sbjct: 121 DPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180
Query: 333 EEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMV--AGT----IPY 383
+ + D ++ +WMAPE + + Y + DV+SFG++LWE+ G+ IP
Sbjct: 181 DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240
Query: 384 EEM 386
EE+
Sbjct: 241 EEL 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 62/190 (32%), Positives = 100/190 (52%), Gaps = 26/190 (13%)
Query: 201 KDEPVAVKIIRIPDDDEN---ETLAARLEKQFNREVALLSRLHNPNVIKFV-AACKKPPV 256
E VA+K IR+ +++E L RE++LL L +PN++K + + +
Sbjct: 23 TGEIVALKKIRLDNEEEGIPSTAL---------REISLLKELKHPNIVKLLDVIHTERKL 73
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
Y ++ EY + L+ YL K L + +I + RG+ Y HS ++HRDLKP+N+L
Sbjct: 74 Y-LVFEYC-DMDLKKYLDKRPGP-LSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNIL 130
Query: 317 IDQEFHLKIADFGIACEEVYC---DALSDDPGT--YRWMAPEMI-KHKSYGRKVDVYSFG 370
I+++ LK+ADFG+A + + + T YR APE++ K Y VD++S G
Sbjct: 131 INRDGVLKLADFGLA--RAFGIPLRTYTHEVVTLWYR--APEILLGSKHYSTAVDIWSVG 186
Query: 371 LILWEMVAGT 380
I EM+ G
Sbjct: 187 CIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 73/205 (35%), Positives = 103/205 (50%), Gaps = 31/205 (15%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
VAVKI+R PD ++N AR F +EV +LSRL +PN+I+ + C C+ITEY+
Sbjct: 49 VAVKILR-PDANKN----AR--NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYM 101
Query: 265 SEGSLRAYL--HKLEHKTLP---------------LPKLIAIALDIARGMEYIHSQGVIH 307
G L +L H L+ K L+ +AL IA GM+Y+ S +H
Sbjct: 102 ENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161
Query: 308 RDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPG----TYRWMAPEMIKHKSYGRK 363
RDL N L+ + +KIADFG++ +Y G RWMA E I +
Sbjct: 162 RDLATRNCLVGENLTIKIADFGMS-RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA 220
Query: 364 VDVYSFGLILWE--MVAGTIPYEEM 386
DV++FG+ LWE M+ PY E+
Sbjct: 221 SDVWAFGVTLWEILMLCKEQPYGEL 245
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 33/215 (15%)
Query: 190 GAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
GA +Y G++ E PVA+K++R E + + K+ E +++ + +P+
Sbjct: 18 GAFGTVYKGVWIPEGEKVKIPVAIKVLR-------EETSPKANKEILDEAYVMASVDHPH 70
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEYIHS 302
V++ + C V +IT+ + G L Y+ HK + L+ + IA+GM Y+
Sbjct: 71 VVRLLGICLSSQV-QLITQLMPLGCLLDYVR--NHKDNIGSQYLLNWCVQIAKGMSYLEE 127
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---------RWMAPE 353
+ ++HRDL NVL+ H+KI DFG+A L D Y +WMA E
Sbjct: 128 KRLVHRDLAARNVLVKTPQHVKITDFGLA------KLLDVDEKEYHAEGGKVPIKWMALE 181
Query: 354 MIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMN 387
I H+ Y K DV+S+G+ +WE M G PYE +
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 24/196 (12%)
Query: 201 KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI 260
K+ VA+K ++ D+ RL+ F E +++ + +PN+I+ K +I
Sbjct: 31 KEIDVAIKTLKAGSSDK-----QRLD--FLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83
Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
TEY+ GSL +L + + K +L+ + IA GM+Y+ +HRDL N+L++
Sbjct: 84 TEYMENGSLDKFLRENDGKFTVG-QLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN 142
Query: 321 FHLKIADFGIACEEVYCDALSDDPGTY---------RWMAPEMIKHKSYGRKVDVYSFGL 371
K++DFG++ L D TY RW APE I ++ + DV+SFG+
Sbjct: 143 LVCKVSDFGLSRR------LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGI 196
Query: 372 ILWE-MVAGTIPYEEM 386
++WE M G PY +M
Sbjct: 197 VMWEVMSYGERPYWDM 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 58/198 (29%), Positives = 104/198 (52%), Gaps = 29/198 (14%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP-VYCVIT 261
+ A+KI+ + + + + + E +L + +P ++ + + +Y V+
Sbjct: 27 KYYALKIL-----SKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM- 80
Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKL----IAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
EY+ G L ++L K P+ + + +AL EY+HS +++RDLKPEN+L+
Sbjct: 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLAL------EYLHSLDIVYRDLKPENLLL 134
Query: 318 DQEFHLKIADFGIACEEVY-----CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLI 372
D + ++KI DFG A C GT ++APE+I K YG+ VD ++ G++
Sbjct: 135 DSDGYIKITDFGFAKRVKGRTYTLC-------GTPEYLAPEIILSKGYGKAVDWWALGIL 187
Query: 373 LWEMVAGTIPYEEMNPIQ 390
++EM+AG P+ + NPIQ
Sbjct: 188 IYEMLAGYPPFFDDNPIQ 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 9e-30
Identities = 71/228 (31%), Positives = 112/228 (49%), Gaps = 38/228 (16%)
Query: 190 GAHSRLYH----GIYKDEP---VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP 242
GA R++ G+ EP VAVK+++ E +A ++ F RE AL++ +P
Sbjct: 16 GAFGRVFQARAPGLLPYEPFTMVAVKMLK-------EEASADMQADFQREAALMAEFDHP 68
Query: 243 NVIKFVAACKKPPVYCVITEYLSEGSLRAYL--------HKLEHKT----------LPL- 283
N++K + C C++ EY++ G L +L L H T LPL
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 284 -PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE---EVYCDA 339
+ + IA +A GM Y+ + +HRDL N L+ + +KIADFG++ Y A
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 340 LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM 386
+D RWM PE I + Y + DV+++G++LWE+ + G PY M
Sbjct: 189 SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 9e-30
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 37/203 (18%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
VA+K ++ + E +++++F +E L+S L +PN++ + C K C++ EYL
Sbjct: 38 VAIKTLK----ENAE---PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYL 90
Query: 265 SEGSLRAYL-------------------HKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
+ G L +L L+ + IA+ IA GMEY+ S
Sbjct: 91 AHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC-----SDFLHIAIQIAAGMEYLSSHHF 145
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYG 361
+HRDL N L+ + +KI+DFG++ ++Y S RWM PE I + +
Sbjct: 146 VHRDLAARNCLVGEGLTVKISDFGLS-RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT 204
Query: 362 RKVDVYSFGLILWEMVA-GTIPY 383
+ D++SFG++LWE+ + G PY
Sbjct: 205 TESDIWSFGVVLWEIFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 48/155 (30%), Positives = 82/155 (52%), Gaps = 4/155 (2%)
Query: 231 REVALLSRLHNPNVIKFVAA-CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
E +L L++P ++ + + +Y V + L G LR +L + + K
Sbjct: 49 NERRILQELNHPFLVNLWYSFQDEENMYLV-VDLLLGGDLRYHLSQKVKFSEEQVKFWIC 107
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW 349
+I +EY+HS+G+IHRD+KP+N+L+D++ H+ I DF IA + + GT +
Sbjct: 108 --EIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGY 165
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384
MAPE++ + Y VD +S G+ +E + G PY
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 68/229 (29%), Positives = 108/229 (47%), Gaps = 29/229 (12%)
Query: 190 GAHSRLY---HGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA+ R++ D A+K+I D + Q E +LS+ +P V+K
Sbjct: 4 GAYGRVFLAKKKSTGD-IYAIKVI--KKAD---MIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 247 FVAA-CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA--IALDIARGMEYIHSQ 303
+ K +Y V EYL G L + L + L + +A +I +EY+HS
Sbjct: 58 LYYSFQGKKNLYLV-MEYLPGGDLASLLENVGS----LDEDVARIYIAEIVLALEYLHSN 112
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFG---IACEEVYCDALSDDP------GTYRWMAPEM 354
G+IHRDLKP+N+LID HLK+ DFG + + D+ GT ++APE+
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 355 IKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV--NKVNF 401
I + + + VD +S G IL+E + G P+ P + F + K+ +
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-EEIFQNILNGKIEW 220
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 30/216 (13%)
Query: 189 HGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN 241
G+ +Y G+ K + VA+K + +EN ++ R+E F E +++ +
Sbjct: 16 QGSFGMVYEGLAKGVVKGEPETRVAIKTV-----NENASMRERIE--FLNEASVMKEFNC 68
Query: 242 PNVIKF--VAACKKPPVYCVITEYLSEGSLRAYLHKL----EHKTLPLP----KLIAIAL 291
+V++ V + +P + V+ E +++G L++YL E+ P K I +A
Sbjct: 69 HHVVRLLGVVSTGQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---R 348
+IA GM Y+ ++ +HRDL N ++ ++ +KI DFG+ + D R
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPY 383
WMAPE +K + K DV+SFG++LWEM PY
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 70/209 (33%), Positives = 112/209 (53%), Gaps = 18/209 (8%)
Query: 190 GAHSRLYHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248
G ++ G KD+ PVAVK + E L L+ +F E +L + +PN++K +
Sbjct: 6 GNFGEVFKGTLKDKTPVAVKTCK-------EDLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 249 AAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
C ++ P+Y ++ E + G ++L K + L +L+ ALD A GM Y+ S+ IH
Sbjct: 59 GVCTQRQPIY-IVMELVPGGDFLSFLRK-KKDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 308 RDLKPENVLIDQEFHLKIADFGIACEE---VYCDA-LSDDPGTYRWMAPEMIKHKSYGRK 363
RDL N L+ + LKI+DFG++ +E +Y + L P +W APE + + Y +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP--IKWTAPEALNYGRYSSE 174
Query: 364 VDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
DV+S+G++LWE + G PY M QA
Sbjct: 175 SDVWSYGILLWETFSLGVCPYPGMTNQQA 203
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 72/232 (31%), Positives = 116/232 (50%), Gaps = 48/232 (20%)
Query: 190 GAHSRLYHGIY------KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
G R+++GI K+E V VK ++ D +E L + E LL L + N
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVK---DHASEIQVTLLLQ----ESCLLYGLSHQN 69
Query: 244 VIKFVAAC---KKPPVYCVITEYLSEGSLRAYLHKLEH------KTLPLPKLIAIALDIA 294
++ + C +PP V+ Y++ G+L+ +L + + L +L+ +A+ IA
Sbjct: 70 ILPILHVCIEDGEPPF--VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD--PGTY----- 347
GM Y+H +GVIH+D+ N +ID+E +KI D +ALS D P Y
Sbjct: 128 CGMSYLHKRGVIHKDIAARNCVIDEELQVKITD----------NALSRDLFPMDYHCLGD 177
Query: 348 ------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAA 392
+WMA E + +K Y DV+SFG++LWE++ G PY E++P + A
Sbjct: 178 NENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 195 LYHGIYKDEP--VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252
YH +++ VAVK ++ ++ K F RE LL+ + N++KF C
Sbjct: 26 CYHLEPENDKELVAVKTLKETASND-------ARKDFEREAELLTNFQHENIVKFYGVCT 78
Query: 253 KPPVYCVITEYLSEGSLRAYLH------------KLEHKTLPLPKLIAIALDIARGMEYI 300
+ ++ EY+ G L +L L L +L+ IA+ IA GM Y+
Sbjct: 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL 138
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDALSDDPGTY---RWMAPEMIK 356
SQ +HRDL N L+ + +KI DFG++ +VY D T RWM PE I
Sbjct: 139 ASQHFVHRDLATRNCLVGYDLVVKIGDFGMS-RDVYTTDYYRVGGHTMLPIRWMPPESIM 197
Query: 357 HKSYGRKVDVYSFGLILWEMVA-GTIPYEEMN 387
++ + + DV+SFG++LWE+ G P+ ++
Sbjct: 198 YRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 69/217 (31%), Positives = 107/217 (49%), Gaps = 32/217 (14%)
Query: 186 RFAHGAHSRLYHGIY-----KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
HG + G+Y K+ VAVK ++ E +AA +K+F RE +++++L
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLK------QEHIAA-GKKEFLREASVMAQLD 54
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
+P +++ + CK P ++ E G L YL K + +P+ L +A +A GM Y+
Sbjct: 55 HPCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKK--RREIPVSDLKELAHQVAMGMAYL 111
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR----------WM 350
S+ +HRDL NVL+ KI+DFG++ AL YR W
Sbjct: 112 ESKHFVHRDLAARNVLLVNRHQAKISDFGMS------RALGAGSDYYRATTAGRWPLKWY 165
Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM 386
APE I + + K DV+S+G+ LWE + G PY EM
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-29
Identities = 68/199 (34%), Positives = 109/199 (54%), Gaps = 14/199 (7%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVI 260
+ PVAVK R ETL L+ +F +E +L + +PN+++ + C +K P+Y V+
Sbjct: 20 NTPVAVKSCR-------ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 72
Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
E + G +L + E L + +LI + + A GMEY+ S+ IHRDL N L+ ++
Sbjct: 73 -ELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK 130
Query: 321 FHLKIADFGIACEE---VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMV 377
LKI+DFG++ EE VY +W APE + + Y + DV+SFG++LWE
Sbjct: 131 NVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAF 190
Query: 378 A-GTIPYEEMNPIQAAFAV 395
+ G +PY ++ Q A+
Sbjct: 191 SLGAVPYANLSNQQTREAI 209
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 7e-29
Identities = 61/173 (35%), Positives = 99/173 (57%), Gaps = 10/173 (5%)
Query: 207 VKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE 266
+K I + + + NET+ A E Q LLS+L +P ++KF A+ + +C+ITEY
Sbjct: 33 LKEIPVGELNPNETVQANQEAQ------LLSKLDHPAIVKFHASFLERDAFCIITEYCEG 86
Query: 267 GSLRAYLHKLEH--KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
L L +L+H KTL ++ + + G+ Y+H + ++HRDLK +N+ + LK
Sbjct: 87 RDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LK 145
Query: 325 IADFGIACEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
I DFG++ + CD + GT +M+PE +KH+ Y K D++S G IL+EM
Sbjct: 146 IGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 8e-29
Identities = 60/196 (30%), Positives = 106/196 (54%), Gaps = 17/196 (8%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEY 263
VA+K+I+ E+E F E ++ +L + +++ C K+ P+Y ++TEY
Sbjct: 31 VAIKMIKEGSMSEDE---------FIEEAKVMMKLSHEKLVQLYGVCTKQRPIY-IVTEY 80
Query: 264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323
+S G L YL + + P +L+ + D+ GM Y+ S+ IHRDL N L+D + +
Sbjct: 81 MSNGCLLNYLREHGKRFQPS-QLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCV 139
Query: 324 KIADFGIACEEVYCDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-G 379
K++DFG++ V D + G+ RW PE++ + + K DV++FG+++WE+ + G
Sbjct: 140 KVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLG 198
Query: 380 TIPYEEMNPIQAAFAV 395
+PYE N + V
Sbjct: 199 KMPYERFNNSETVEKV 214
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 69/211 (32%), Positives = 110/211 (52%), Gaps = 30/211 (14%)
Query: 195 LYHGIYKDEP-----VAVKII-RIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248
+YHG D AVK + RI D +E E QF +E ++ +PNV+ +
Sbjct: 11 VYHGTLIDSDGQKIHCAVKSLNRITDLEEVE--------QFLKEGIIMKDFSHPNVLSLL 62
Query: 249 AACKKP---PVYCVITEYLSEGSLRAYLHKLEHKTLPLPK-LIAIALDIARGMEYIHSQG 304
C P+ V+ Y+ G LR ++ H P K LI L +A+GMEY+ S+
Sbjct: 63 GICLPSEGSPL--VVLPYMKHGDLRNFIRSETHN--PTVKDLIGFGLQVAKGMEYLASKK 118
Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIACEEVY---CDALSDDPGT---YRWMAPEMIKHK 358
+HRDL N ++D+ F +K+ADFG+A ++Y ++ + G +WMA E ++ +
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLA-RDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 359 SYGRKVDVYSFGLILWE-MVAGTIPYEEMNP 388
+ K DV+SFG++LWE M G PY +++
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAPPYPDVDS 208
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 74/215 (34%), Positives = 112/215 (52%), Gaps = 24/215 (11%)
Query: 186 RFAHGAHSRLYHGIYKDEPVAVKIIRI--PDDDENETLAARLEKQFNREVALLSRLHN-- 241
R A+GA R H + VA+KII + PDDD ++ REVALLS+L
Sbjct: 11 RGAYGAVYRGKH-VPTGRVVALKIINLDTPDDDVSD---------IQREVALLSQLRQSQ 60
Query: 242 -PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLH--KLEHKTLPLPKLIAIALDIARGME 298
PN+ K+ + K P +I EY GS+R + + K + + I ++ ++
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-----IIREVLVALK 115
Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA-LSDDPGTYRWMAPEMIKH 357
YIH GVIHRD+K N+L+ ++K+ DFG+A + S GT WMAPE+I
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITE 175
Query: 358 -KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQA 391
K Y K D++S G+ ++EM G PY +++ +A
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA 210
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 69/208 (33%), Positives = 110/208 (52%), Gaps = 22/208 (10%)
Query: 197 HGIYKDEP---VAVKIIR-IPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFVAAC 251
+G+ K + VAVK+++ E E L + E+ ++S L N N++ + AC
Sbjct: 57 YGLSKSDAVMKVAVKMLKPTAHSSEREALMS--------ELKIMSHLGNHENIVNLLGAC 108
Query: 252 KKP-PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDL 310
P+ VITEY G L +L + L L L++ + +A+GM ++ S+ IHRDL
Sbjct: 109 TIGGPIL-VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDL 167
Query: 311 KPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR----WMAPEMIKHKSYGRKVDV 366
NVL+ +KI DFG+A ++ D+ G R WMAPE I + Y + DV
Sbjct: 168 AARNVLLTHGKIVKICDFGLA-RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV 226
Query: 367 YSFGLILWEMVA-GTIPYEEMNPIQAAF 393
+S+G++LWE+ + G+ PY M P+ + F
Sbjct: 227 WSYGILLWEIFSLGSNPYPGM-PVDSKF 253
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 66/171 (38%), Positives = 95/171 (55%), Gaps = 17/171 (9%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPK 285
+ F E L+ L + +++ A K+ P+Y +ITEY+++GSL +L E + LPK
Sbjct: 46 QAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY-IITEYMAKGSLLDFLKSDEGGKVLLPK 104
Query: 286 LIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPG 345
LI + IA GM YI + IHRDL+ NVL+ + KIADFG+A + D+
Sbjct: 105 LIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLA------RVIEDNEY 158
Query: 346 TYR--------WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMN 387
T R W APE I S+ K DV+SFG++L+E+V G IPY M+
Sbjct: 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 69/211 (32%), Positives = 109/211 (51%), Gaps = 14/211 (6%)
Query: 181 LFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL 239
L L + +G ++ G + + VAVK ++ P E+ F E ++ +L
Sbjct: 8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPES--------FLEEAQIMKKL 58
Query: 240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEY 299
+ +++ A + P+Y ++TEY+S+GSL +L E + L LP L+ +A +A GM Y
Sbjct: 59 RHDKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY 117
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYRWMAPEMIKH 357
I IHRDL+ N+L+ KIADFG+A E+ A +W APE +
Sbjct: 118 IERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 358 KSYGRKVDVYSFGLILWEMVA-GTIPYEEMN 387
+ K DV+SFG++L E+V G +PY MN
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 63/162 (38%), Positives = 90/162 (55%), Gaps = 4/162 (2%)
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
F E ++ L + ++K A K P+Y +ITE++++GSL +L E PLPKLI
Sbjct: 48 FLAEANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLID 106
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
+ IA GM +I + IHRDL+ N+L+ KIADFG+A E+ A
Sbjct: 107 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 166
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMN 387
+W APE I S+ K DV+SFG++L E+V G IPY M+
Sbjct: 167 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 54/162 (33%), Positives = 82/162 (50%), Gaps = 19/162 (11%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKP--PVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
+ F RE+ +L L + N++K+ C ++ EYL GSLR YL K + L
Sbjct: 50 RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER-LDHR 108
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344
KL+ A I +GMEY+ S+ +HRDL N+L++ E +KI DFG+ L D
Sbjct: 109 KLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT------KVLPQDK 162
Query: 345 GTYR----------WMAPEMIKHKSYGRKVDVYSFGLILWEM 376
Y+ W APE + + DV+SFG++L+E+
Sbjct: 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-27
Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 18/219 (8%)
Query: 190 GAHSRLYHGIY-KDEPVAVKIIRIPDDDENETLAARLEKQFNR---EVALLSRLHNPNVI 245
GA+ +Y G+ + + +AVK + + D + LAA EK++ + EV LL L + N++
Sbjct: 11 GAYGTVYCGLTNQGQLIAVKQVEL---DTSNVLAA--EKEYEKLQEEVDLLKSLKHVNIV 65
Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
+++ C + E++ GS+ + L++ LP P I G+ Y+H+ V
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIA-------CEEVYCDALSDDPGTYRWMAPEMIKHK 358
+HRD+K NV++ +K+ DFG A + + L GT WMAPE+I
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
YGRK D++S G ++EM G P M+ + A F +
Sbjct: 184 GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA 222
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 50/202 (24%), Positives = 101/202 (50%), Gaps = 27/202 (13%)
Query: 201 KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI 260
+ V VK ++ D+ L+ +F RE+ + +L + NV++ + C++ + +I
Sbjct: 34 GETLVLVKALQKTKDEN-------LQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMI 86
Query: 261 TEYLSEGSLRAYL-------HKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPE 313
EY G L+ +L KL+ L + +A+ IA GM+++ + +HRDL
Sbjct: 87 LEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAAR 146
Query: 314 NVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY-------RWMAPEMIKHKSYGRKVDV 366
N L+ + +K++ + ++VY + + RW+APE ++ + K DV
Sbjct: 147 NCLVSSQREVKVSLLSL-SKDVY----NSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDV 201
Query: 367 YSFGLILWEMVA-GTIPYEEMN 387
+SFG+++WE+ G +P+ ++
Sbjct: 202 WSFGVLMWEVFTQGELPFYGLS 223
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 16/211 (7%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA + +Y I E VA+K I + E ++ + +EV +S+ ++PNV+K
Sbjct: 11 VGATAVVYAAICLPNNEKVAIKRIDL------EKCQTSVD-ELRKEVQAMSQCNHPNVVK 63
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYL-HKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
+ + ++ YLS GSL + L + + ++ +G+EY+HS G
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ 123
Query: 306 IHRDLKPENVLIDQEFHLKIADFGI-ACEEVYCD----ALSDDPGTYRWMAPEMIK-HKS 359
IHRD+K N+L+ ++ +KIADFG+ A D GT WMAPE+++
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 360 YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390
Y K D++SFG+ E+ G PY + P++
Sbjct: 184 YDFKADIWSFGITAIELATGAAPYSKYPPMK 214
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 48/167 (28%), Positives = 93/167 (55%), Gaps = 5/167 (2%)
Query: 224 RLEKQFNREVAL-----LSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH 278
RL+K+ ++AL L ++ + ++ A + C++ ++ G L+ +++ +
Sbjct: 30 RLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGE 89
Query: 279 KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338
P + I A I G+E++H + +++RDLKPENVL+D +++I+D G+A E
Sbjct: 90 PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK 149
Query: 339 ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
+ GT +MAPE+++ + Y VD ++ G L+EM+AG P+ +
Sbjct: 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 73/230 (31%), Positives = 120/230 (52%), Gaps = 28/230 (12%)
Query: 177 DLSQLFLGL-RFAHGAHSRLYHGI--YKDEPVAVKIIRIPD-DDENETLAARLEKQFNRE 232
D +LF L R G+ +Y GI E VA+KII + + +DE E + +E
Sbjct: 1 DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDI--------QQE 52
Query: 233 VALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
+ +LS+ +P + ++ + K +I EYL GS L L+ L + I +
Sbjct: 53 ITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA---LDLLKPGPLEETYIATILRE 109
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------G 345
I +G++Y+HS+ IHRD+K NVL+ ++ +K+ADFG+A + L+D G
Sbjct: 110 ILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQ------LTDTQIKRNTFVG 163
Query: 346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
T WMAPE+IK +Y K D++S G+ E+ G P +++P++ F +
Sbjct: 164 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 16/214 (7%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIY-KDEPVAVKIIRIPDDDENETLAARLEKQFNREVA 234
+ S+L L G ++ G + + VA+K IR A E+ F E
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIR---------EGAMSEEDFIEEAQ 51
Query: 235 LLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIA 294
++ +L +P +++ C + C++ E++ G L YL + + L+ + LD+
Sbjct: 52 VMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVC 110
Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YRWMA 351
GM Y+ S VIHRDL N L+ + +K++DFG+ V D + GT +W +
Sbjct: 111 EGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMT-RFVLDDQYTSSTGTKFPVKWSS 169
Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYE 384
PE+ Y K DV+SFG+++WE+ + G PYE
Sbjct: 170 PEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 197 HGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256
VAVK + + E L FN EV ++ +PN+++ ++
Sbjct: 39 TDKSTGRQVAVKKMDLRKQQRRELL-------FN-EVVIMRDYQHPNIVEMYSSYLVGDE 90
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
V+ E+L G+L + H + ++ + L + + + ++H+QGVIHRD+K +++L
Sbjct: 91 LWVVMEFLEGGALTDIV---THTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSIL 147
Query: 317 IDQEFHLKIADFGIACEEVYCDALSDD-P------GTYRWMAPEMIKHKSYGRKVDVYSF 369
+ + +K++DFG +C +S + P GT WMAPE+I YG +VD++S
Sbjct: 148 LTSDGRVKLSDFG------FCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSL 201
Query: 370 GLILWEMVAGTIPYEEMNPIQA 391
G+++ EMV G PY P+QA
Sbjct: 202 GIMVIEMVDGEPPYFNEPPLQA 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 66/190 (34%), Positives = 115/190 (60%), Gaps = 19/190 (10%)
Query: 202 DEPVAVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP-- 255
DE A+KI++ I DDD T+ +EK R +AL + P + + +C +
Sbjct: 25 DELYAIKILKKDVIIQDDDVECTM---VEK---RVLALPGK---PPFLTQLHSCFQTMDR 75
Query: 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV 315
+Y V+ EY++ G L ++ ++ P + A +IA G+ ++HS+G+I+RDLK +NV
Sbjct: 76 LYFVM-EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNV 132
Query: 316 LIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILW 374
++D E H+KIADFG+ E ++ + GT ++APE+I ++ YG+ VD ++FG++L+
Sbjct: 133 MLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 192
Query: 375 EMVAGTIPYE 384
EM+AG P++
Sbjct: 193 EMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-26
Identities = 74/230 (32%), Positives = 121/230 (52%), Gaps = 28/230 (12%)
Query: 177 DLSQLFLGL-RFAHGAHSRLYHGI--YKDEPVAVKIIRIPD-DDENETLAARLEKQFNRE 232
D +LF L + G+ ++ GI + VA+KII + + +DE E + +E
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI--------QQE 52
Query: 233 VALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
+ +LS+ +P V K+ + K +I EYL GS L LE L ++ I +
Sbjct: 53 ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATILRE 109
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------G 345
I +G++Y+HS+ IHRD+K NVL+ + +K+ADFG+A + L+D G
Sbjct: 110 ILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ------LTDTQIKRNTFVG 163
Query: 346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
T WMAPE+IK +Y K D++S G+ E+ G P+ E++P++ F +
Sbjct: 164 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-26
Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 31/201 (15%)
Query: 201 KDEPVAVKIIRIPDDDENETLAARLEKQ---FNREVALLSRLHNPNVIKFVAACKKPPVY 257
++ PVA+K ++ A EKQ F E +++ + +PN+I K
Sbjct: 31 REIPVAIKTLK----------AGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
++TEY+ GSL A+L K + + + +L+ + IA GM+Y+ G +HRDL N+L+
Sbjct: 81 MIVTEYMENGSLDAFLRKHDGQ-FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV 139
Query: 318 DQEFHLKIADFGIACEEVYCDALSDDP-GTY---------RWMAPEMIKHKSYGRKVDVY 367
+ K++DFG++ L DDP Y RW APE I ++ + DV+
Sbjct: 140 NSNLVCKVSDFGLS------RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVW 193
Query: 368 SFGLILWE-MVAGTIPYEEMN 387
S+G+++WE M G PY EM+
Sbjct: 194 SYGIVMWEVMSYGERPYWEMS 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 57/186 (30%), Positives = 93/186 (50%), Gaps = 22/186 (11%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
E VA+K I++ + E K RE+ LL L++PN+IK + + ++
Sbjct: 24 GEIVAIKKIKLRFESEGI------PKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF 77
Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
E++ + L K + LP + + + +G+ + HS G++HRDLKPEN+LI+ E
Sbjct: 78 EFMDTDLYK--LIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG 135
Query: 322 HLKIADFGIACEEVYCDALSDDPGTY------RWM-APE-MIKHKSYGRKVDVYSFGLIL 373
LK+ADFG+A + Y RW APE ++ K Y VD++S G I
Sbjct: 136 VLKLADFGLA------RSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIF 189
Query: 374 WEMVAG 379
E+++
Sbjct: 190 AELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 73/219 (33%), Positives = 118/219 (53%), Gaps = 36/219 (16%)
Query: 197 HGIYKDEP-----VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251
+GI K P VAVK+++ D+ ++ LA + + E+ L H N+I + C
Sbjct: 34 YGIDKSRPDQTVTVAVKMLK--DNATDKDLADLISEM---ELMKLIGKHK-NIINLLGVC 87
Query: 252 KKP-PVYCVITEYLSEGSLRAYLH--------------KLEHKTLPLPKLIAIALDIARG 296
+ P+Y VI EY ++G+LR +L K+ + L L++ A +ARG
Sbjct: 88 TQEGPLY-VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARG 146
Query: 297 MEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEV-YCDALSDDPGTYRWMAPE 353
MEY+ S+ IHRDL NVL+ ++ +KIADFG+A ++ Y S+ +WMAPE
Sbjct: 147 MEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPE 206
Query: 354 MIKHKSYGRKVDVYSFGLILWEM--VAGT----IPYEEM 386
+ + Y + DV+SFG+++WE+ + G+ IP EE+
Sbjct: 207 ALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 79/237 (33%), Positives = 130/237 (54%), Gaps = 39/237 (16%)
Query: 198 GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAAC 251
GI KD+P VAVK+++ DD ++ L+ + E+ ++ + + N+I + AC
Sbjct: 35 GIDKDKPNKPVTVAVKMLK--DDATDKDLSDLVS-----EMEMMKMIGKHKNIINLLGAC 87
Query: 252 KKP-PVYCVITEYLSEGSLRAYLH--------------KLEHKTLPLPKLIAIALDIARG 296
+ P+Y V+ EY S+G+LR YL KL + L L++ A +ARG
Sbjct: 88 TQDGPLY-VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARG 146
Query: 297 MEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV----YCDALSDDPGTYRWMAP 352
MEY+ SQ IHRDL NVL+ ++ +KIADFG+A +V Y ++ +WMAP
Sbjct: 147 MEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA-RDVHNIDYYKKTTNGRLPVKWMAP 205
Query: 353 EMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVV---NKVNFGASC 405
E + + Y + DV+SFG++LWE+ G PY + P++ F ++ ++++ A+C
Sbjct: 206 EALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPANC 261
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 7e-26
Identities = 66/191 (34%), Positives = 113/191 (59%), Gaps = 21/191 (10%)
Query: 202 DEPVAVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--P 255
DE A+KI++ I DDD T+ + + + L++LH +C +
Sbjct: 25 DELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH---------SCFQTMDR 75
Query: 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV 315
+Y V+ EY++ G L + ++ P + A +IA G+ ++HS+G+I+RDLK +NV
Sbjct: 76 LYFVM-EYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNV 132
Query: 316 LIDQEFHLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
++D E H+KIADFG+ C+E D ++ GT ++APE+I ++ YG+ VD ++FG++L
Sbjct: 133 MLDSEGHIKIADFGM-CKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191
Query: 374 WEMVAGTIPYE 384
+EM+AG P+E
Sbjct: 192 YEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-26
Identities = 60/189 (31%), Positives = 103/189 (54%), Gaps = 16/189 (8%)
Query: 198 GIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC--KKPP 255
G Y+ VAVK I+ N+ A + F E +++++L + N+++ + +K
Sbjct: 25 GDYRGNKVAVKCIK------NDATA----QAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 74
Query: 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV 315
+Y ++TEY+++GSL YL L L+ +LD+ MEY+ + +HRDL NV
Sbjct: 75 LY-IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNV 133
Query: 316 LIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
L+ ++ K++DFG+ E P +W APE ++ K + K DV+SFG++LWE
Sbjct: 134 LVSEDNVAKVSDFGLTKEASSTQDTGKLP--VKWTAPEALREKKFSTKSDVWSFGILLWE 191
Query: 376 MVA-GTIPY 383
+ + G +PY
Sbjct: 192 IYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 9e-26
Identities = 58/186 (31%), Positives = 94/186 (50%), Gaps = 27/186 (14%)
Query: 205 VAVKIIRIPDDDEN---ETLAARLEKQFNREVALLSRLHN---PNVIKFVAACKKPPVYC 258
VA+K +R+P +E TL RE+ALL +L + PN+++ + C P
Sbjct: 27 VALKKVRVPLSEEGIPLSTL---------REIALLKQLESFEHPNIVRLLDVCHGPRTDR 77
Query: 259 VITEYL----SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314
+ L + L YL K LP + + + RG++++HS ++HRDLKP+N
Sbjct: 78 ELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQN 137
Query: 315 VLIDQEFHLKIADFGIACEEVYCDALSDDPGT----YRWMAPEMIKHKSYGRKVDVYSFG 370
+L+ + +KIADFG+A +Y ++ YR APE++ SY VD++S G
Sbjct: 138 ILVTSDGQVKIADFGLA--RIYSFEMALTSVVVTLWYR--APEVLLQSSYATPVDMWSVG 193
Query: 371 LILWEM 376
I E+
Sbjct: 194 CIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 61/204 (29%), Positives = 90/204 (44%), Gaps = 37/204 (18%)
Query: 204 PVAVKIIR------IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257
PVAVK ++ I DD F +E A++ L + N+I+ P+
Sbjct: 25 PVAVKCLKSDKLSDIMDD-------------FLKEAAIMHSLDHENLIRLYGVVLTHPLM 71
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
V TE GSL L K + L A+ IA GM Y+ S+ IHRDL N+L+
Sbjct: 72 MV-TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL 130
Query: 318 DQEFHLKIADFGIACEEVYCDALSDDPGTYR----------WMAPEMIKHKSYGRKVDVY 367
+ +KI DFG+ AL + Y W APE ++ +++ DV+
Sbjct: 131 ASDDKVKIGDFGLM------RALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVW 184
Query: 368 SFGLILWEMVA-GTIPYEEMNPIQ 390
FG+ LWEM G P+ ++ Q
Sbjct: 185 MFGVTLWEMFTYGEEPWAGLSGSQ 208
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 65/192 (33%), Positives = 100/192 (52%), Gaps = 35/192 (18%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
VAVK++R D ++N AR F +E+ ++SRL +PN+I+ +A C C+ITEY+
Sbjct: 49 VAVKMLR-EDANKN----AR--NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYM 101
Query: 265 SEGSLRAYLHKLEHK---------TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV 315
G L +L + E + T+ LI +A IA GM+Y+ S +HRDL N
Sbjct: 102 ENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161
Query: 316 LIDQEFHLKIADFGIACEEVYCDALSDDPGTY-----------RWMAPEMIKHKSYGRKV 364
L+ + + +KIADFG++ +Y G Y RWM+ E I +
Sbjct: 162 LVGKNYTIKIADFGMS-RNLY-------SGDYYRIQGRAVLPIRWMSWESILLGKFTTAS 213
Query: 365 DVYSFGLILWEM 376
DV++FG+ LWE+
Sbjct: 214 DVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 62/198 (31%), Positives = 93/198 (46%), Gaps = 35/198 (17%)
Query: 202 DEPVAVKIIRIPDDDENETLAAR-LEKQFNREVALLSRLHNPNVIKF--VAACKKPP--- 255
VA+K +I + ++ A R L RE+ LL L + N+I + P
Sbjct: 25 GRKVAIK--KISNVFDDLIDAKRIL-----REIKLLRHLRHENIIGLLDILRPPSPEDFN 77
Query: 256 -VYCVITEYLSEGSLRAYLHKLEHKTLPL-PKLIA-IALDIARGMEYIHSQGVIHRDLKP 312
VY ++TE + LHK+ PL I I RG++Y+HS VIHRDLKP
Sbjct: 78 DVY-IVTELM-----ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKP 131
Query: 313 ENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPGTY---RWM-APE-MIKHKSYGRK 363
N+L++ LKI DFG+A +E L++ Y RW APE ++ Y +
Sbjct: 132 SNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE----YVVTRWYRAPELLLSSSRYTKA 187
Query: 364 VDVYSFGLILWEMVAGTI 381
+D++S G I E++
Sbjct: 188 IDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 60/189 (31%), Positives = 102/189 (53%), Gaps = 15/189 (7%)
Query: 201 KDEPVAVKIIR---IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257
DE AVK+++ I DD+ E + V L+ H P + + + +
Sbjct: 19 TDELYAVKVLKKDVILQDDDVECT------MTEKRVLALAGKH-PFLTQLHSCFQTKDRL 71
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
+ EY++ G L H P+ A +I G++++H +G+I+RDLK +NVL+
Sbjct: 72 FFVMEYVNGGDL--MFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL 129
Query: 318 DQEFHLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
D E H+KIADFG+ C+E ++ GT ++APE++ ++ YG VD ++ G++L+E
Sbjct: 130 DSEGHIKIADFGM-CKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYE 188
Query: 376 MVAGTIPYE 384
M+AG P+E
Sbjct: 189 MLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 55/187 (29%), Positives = 101/187 (54%), Gaps = 17/187 (9%)
Query: 206 AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLS 265
A+K++ IP+ + + E+ + E +L + +P +I+ ++ EY+
Sbjct: 30 ALKVMAIPE-----VIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVP 84
Query: 266 EGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI 325
G L +YL + A +I +EY+HS+ +++RDLKPEN+L+D+E H+K+
Sbjct: 85 GGELFSYLRNSGRFSNSTGLFYAS--EIVCALEYLHSKEIVYRDLKPENILLDKEGHIKL 142
Query: 326 ADFGIACEEVYCDALSDDP----GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI 381
DFG A + L D GT ++APE+I+ K + + VD ++ G++++EM+ G
Sbjct: 143 TDFGFAKK------LRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196
Query: 382 PYEEMNP 388
P+ + NP
Sbjct: 197 PFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 24/193 (12%)
Query: 200 YKDEP--VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257
+ +P VAVK++R D + AR F +E+ ++SRL NPN+I+ + C
Sbjct: 40 FDGQPVLVAVKMLR-ADVTKT----AR--NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPL 92
Query: 258 CVITEYLSEGSLRAYLHKLEHKT----------LPLPKLIAIALDIARGMEYIHSQGVIH 307
C+ITEY+ G L +L + E ++ + + L+ +A+ IA GM+Y+ S +H
Sbjct: 93 CMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVH 152
Query: 308 RDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPG----TYRWMAPEMIKHKSYGRK 363
RDL N L+ + +KIADFG++ +Y G RWMA E I +
Sbjct: 153 RDLATRNCLVGNHYTIKIADFGMS-RNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTA 211
Query: 364 VDVYSFGLILWEM 376
DV++FG+ LWEM
Sbjct: 212 SDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 71/234 (30%), Positives = 110/234 (47%), Gaps = 37/234 (15%)
Query: 181 LFLGLRFAHGAHSRLYHGIYKDE--------PVAVKIIRIPDDDENETLAARLEKQFNRE 232
FLG GA +Y G D VAVK +R D+ + K+F +E
Sbjct: 1 NFLG----SGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-------KEFLKE 49
Query: 233 VALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP-----KL 286
L+S ++PN++K + C P Y +I E + G L +YL + P +L
Sbjct: 50 AHLMSNFNHPNIVKLLGVCLLNEPQY-IIMELMEGGDLLSYLRDARVERFGPPLLTLKEL 108
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-----LKIADFGIACEEVYCDALS 341
+ I LD+A+G Y+ IHRDL N L+ ++ + +KI DFG+A ++Y
Sbjct: 109 LDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA-RDIYKSDYY 167
Query: 342 DDPG----TYRWMAPEMIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMNPIQ 390
G RWMAPE + + + DV+SFG+++WE + G PY +N +
Sbjct: 168 RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 73/225 (32%), Positives = 116/225 (51%), Gaps = 32/225 (14%)
Query: 198 GIYKDEP-----VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252
GI KD+P VAVK+++ DD E + L + E+ + H N+I + AC
Sbjct: 38 GIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM--EMMKMIGKHK-NIINLLGACT 91
Query: 253 KPPVYCVITEYLSEGSLRAYLH--------------KLEHKTLPLPKLIAIALDIARGME 298
+ VI EY S+G+LR YL ++ + + L++ +ARGME
Sbjct: 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGME 151
Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV----YCDALSDDPGTYRWMAPEM 354
Y+ SQ IHRDL NVL+ + +KIADFG+A +V Y ++ +WMAPE
Sbjct: 152 YLASQKCIHRDLAARNVLVTENNVMKIADFGLA-RDVNNIDYYKKTTNGRLPVKWMAPEA 210
Query: 355 IKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398
+ + Y + DV+SFG+++WE+ G PY + P++ F ++ +
Sbjct: 211 LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKE 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 11/215 (5%)
Query: 190 GAHSRLY--HGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
GA R+Y + + +AVK ++P D ++ + E+ LL L + ++++
Sbjct: 13 GAFGRVYLCYDVDTGRELAVK--QVPFDPDSPETKKEV-NALECEIQLLKNLQHERIVQY 69
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
+ + EY+ GS++ L + L I G+EY+HS ++H
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLK--AYGALTETVTRKYTRQILEGVEYLHSNMIVH 127
Query: 308 RDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDP--GTYRWMAPEMIKHKSYGRK 363
RD+K N+L D ++K+ DFG + + + GT WM+PE+I + YGRK
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRK 187
Query: 364 VDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
DV+S G + EM+ P+ E + A F + +
Sbjct: 188 ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ 222
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 29/204 (14%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
E VA+K+I++ D+ E + +E+++L +PN++ + + + ++
Sbjct: 28 GELVAIKVIKLEPGDDFEII--------QQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79
Query: 262 EYLSEGSLRAYLHKLEHKTLPLP-KLIA-IALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
EY GSL+ PL IA + + +G+ Y+H G IHRD+K N+L+ +
Sbjct: 80 EYCGGGSLQDIYQVTRG---PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTE 136
Query: 320 EFHLKIADFGIACEEVYCDALSDDP-------GTYRWMAPEMI---KHKSYGRKVDVYSF 369
+ +K+ADFG++ + L+ GT WMAPE+ + Y K D+++
Sbjct: 137 DGDVKLADFGVSAQ------LTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWAL 190
Query: 370 GLILWEMVAGTIPYEEMNPIQAAF 393
G+ E+ P +++P++A F
Sbjct: 191 GITAIELAELQPPMFDLHPMRALF 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 26/202 (12%)
Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
AHG + E VA+K + + + + Q RE+ L +P V+K
Sbjct: 12 AHGIVFKAKD-RETGETVALKKVALRRLEGG------IPNQALREIKALQACQHPYVVKL 64
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA--IALDIARGMEYIHSQGV 305
+ + ++ EY+ L L E PLP+ + +G+ Y+H+ G+
Sbjct: 65 LDVFPHGSGFVLVMEYMPS-DLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHANGI 120
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY------RW-MAPEMI-KH 357
+HRDLKP N+LI + LKIADFG+A ++ ++P Y RW APE++
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLA--RLFS---EEEPRLYSHQVATRWYRAPELLYGA 175
Query: 358 KSYGRKVDVYSFGLILWEMVAG 379
+ Y VD+++ G I E++ G
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 60/195 (30%), Positives = 106/195 (54%), Gaps = 14/195 (7%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
+ VA+K I + + E + E+ ++ L NPN++ F+ + V+ E
Sbjct: 45 QEVAIKQINLQKQPKKELII--------NEILVMKELKNPNIVNFLDSFLVGDELFVVME 96
Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
YL+ GSL + + + ++ A+ + + +E++H+ VIHRD+K +NVL+ +
Sbjct: 97 YLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS 153
Query: 323 LKIADFGIACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT 380
+K+ DFG C ++ + S GT WMAPE++ K+YG KVD++S G++ EMV G
Sbjct: 154 VKLTDFGF-CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
Query: 381 IPYEEMNPIQAAFAV 395
PY NP++A + +
Sbjct: 213 PPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-25
Identities = 55/175 (31%), Positives = 93/175 (53%), Gaps = 19/175 (10%)
Query: 228 QFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL-HKLEHK------- 279
+F +E +L++ LH+PN++ + + C++ EYL++G L +L + H
Sbjct: 53 EFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSD 112
Query: 280 -------TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332
+L + IA+ IA GMEY+ S +H+DL N+LI ++ H+KI+D G++
Sbjct: 113 EDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
Query: 333 EEVYCDALSDDPGTY---RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPY 383
E D P + RWM PE I + + D++SFG++LWE+ + G PY
Sbjct: 173 EIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 34/200 (17%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC------KKPPVYC 258
VAVK +++ +E ++F E A + +PNV+K + C +K P
Sbjct: 30 VAVKTMKLDIHTYSEI------EEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM 83
Query: 259 VITEYLSEGSLRAYL--HKLEH--KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314
VI ++ G L ++L +L + LPL L+ +DIA GMEY+ ++ IHRDL N
Sbjct: 84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARN 143
Query: 315 VLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR----------WMAPEMIKHKSYGRKV 364
++ ++ + +ADFG++ +++Y S D YR W+A E + + Y K
Sbjct: 144 CMLREDMTVCVADFGLS-KKIY----SGD--YYRQGRIAKMPVKWIAIESLADRVYTSKS 196
Query: 365 DVYSFGLILWE-MVAGTIPY 383
DV++FG+ +WE G PY
Sbjct: 197 DVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 36/217 (16%)
Query: 190 GAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQ---FNREVALLSRLHN 241
G ++ GI K + VA+K ++ EKQ F E +++ + +
Sbjct: 16 GEFGEVFRGILKMPGRKEVAVAIKTLK----------PGYTEKQRQDFLSEASIMGQFSH 65
Query: 242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
N+I+ K +ITEY+ G+L YL + + +L+ + IA GM+Y+
Sbjct: 66 HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY-QLVGMLRGIAAGMKYLS 124
Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-GTY---------RWMA 351
+HRDL N+L++ K++DFG++ L DDP GTY RW A
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLS------RVLEDDPEGTYTTSGGKIPIRWTA 178
Query: 352 PEMIKHKSYGRKVDVYSFGLILWE-MVAGTIPYEEMN 387
PE I ++ + DV+SFG+++WE M G PY +M+
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 17/214 (7%)
Query: 190 GAHSRLYHGIYKDEPV--AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
GA ++Y +K+ + A KII+I ++E E F E+ +LS +PN++
Sbjct: 16 GAFGKVYKAQHKETGLFAAAKIIQIESEEELE--------DFMVEIDILSECKHPNIVGL 67
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
A ++ E+ G+L + + +LE L P++ + + + ++HS VIH
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHSHKVIH 126
Query: 308 RDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMI-----KHKSYG 361
RDLK N+L+ + +K+ADFG++ + D GT WMAPE++ K Y
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYD 186
Query: 362 RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
K D++S G+ L E+ P+ E+NP++ +
Sbjct: 187 YKADIWSLGITLIELAQMEPPHHELNPMRVLLKI 220
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 67/203 (33%), Positives = 100/203 (49%), Gaps = 28/203 (13%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
VAVK ++ P TLAAR K F RE LL+ L + +++KF C ++ EY+
Sbjct: 38 VAVKALKDP------TLAAR--KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM 89
Query: 265 SEGSLRAYLH--------------KLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDL 310
G L +L + L L +++ IA IA GM Y+ SQ +HRDL
Sbjct: 90 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDL 149
Query: 311 KPENVLIDQEFHLKIADFGIACEEVYCDALSDDPG----TYRWMAPEMIKHKSYGRKVDV 366
N L+ +KI DFG++ +VY G RWM PE I ++ + + DV
Sbjct: 150 ATRNCLVGANLLVKIGDFGMS-RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV 208
Query: 367 YSFGLILWEMVA-GTIPYEEMNP 388
+SFG+ILWE+ G P+ +++
Sbjct: 209 WSFGVILWEIFTYGKQPWFQLSN 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 9e-25
Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 24/209 (11%)
Query: 198 GIYKDEP---VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254
G+ KDEP VA+K + NE + R +F E +++ + +V++ + +
Sbjct: 29 GVVKDEPETRVAIKTV-------NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81
Query: 255 PVYCVITEYLSEGSLRAYLHKLEHKTL--------PLPKLIAIALDIARGMEYIHSQGVI 306
VI E ++ G L++YL L + L K+I +A +IA GM Y+++ +
Sbjct: 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFV 141
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT----YRWMAPEMIKHKSYGR 362
HRDL N ++ ++F +KI DFG+ ++Y G RWM+PE +K +
Sbjct: 142 HRDLAARNCMVAEDFTVKIGDFGMT-RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT 200
Query: 363 KVDVYSFGLILWEMVA-GTIPYEEMNPIQ 390
DV+SFG++LWE+ PY+ M+ Q
Sbjct: 201 YSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-25
Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 14/210 (6%)
Query: 181 LFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL 239
L L ++ G ++ G + VA+K ++ + + F +E ++ +L
Sbjct: 8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKP---------GTMMPEAFLQEAQIMKKL 58
Query: 240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEY 299
+ ++ A + P+Y ++TE++ +GSL +L + + K L LP+L+ +A IA GM Y
Sbjct: 59 RHDKLVPLYAVVSEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAY 117
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYRWMAPEMIKH 357
I IHRDL+ N+L+ KIADFG+A E+ A +W APE +
Sbjct: 118 IERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 358 KSYGRKVDVYSFGLILWEMVA-GTIPYEEM 386
+ K DV+SFG++L E+V G +PY M
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 65/175 (37%), Positives = 94/175 (53%), Gaps = 20/175 (11%)
Query: 227 KQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK---------- 275
+ F E+ +L +L H+PN+I + AC+ + EY G+L +L K
Sbjct: 47 RDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAF 106
Query: 276 -LEH---KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331
EH TL +L+ A D+A GM+Y+ + IHRDL NVL+ + KIADFG++
Sbjct: 107 AKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS 166
Query: 332 -CEEVYC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPY 383
EEVY + P RWMA E + + Y K DV+SFG++LWE+V+ G PY
Sbjct: 167 RGEEVYVKKTMGRLP--VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 63/191 (32%), Positives = 116/191 (60%), Gaps = 21/191 (10%)
Query: 202 DEPVAVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--P 255
DE A+KI++ I DDD T+ +EK+ +L+ P + + +C +
Sbjct: 25 DELYAIKILKKDVVIQDDDVECTM---VEKR------VLALQDKPPFLTQLHSCFQTVDR 75
Query: 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV 315
+Y V+ EY++ G L ++ ++ P+ + A +I+ G+ ++H +G+I+RDLK +NV
Sbjct: 76 LYFVM-EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNV 132
Query: 316 LIDQEFHLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
++D E H+KIADFG+ C+E D ++ GT ++APE+I ++ YG+ VD +++G++L
Sbjct: 133 MLDSEGHIKIADFGM-CKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLL 191
Query: 374 WEMVAGTIPYE 384
+EM+AG P++
Sbjct: 192 YEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-24
Identities = 51/171 (29%), Positives = 95/171 (55%), Gaps = 16/171 (9%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
E+ ++ +PN++ ++ + V+ EYL+ GSL + + + ++ A+
Sbjct: 66 EILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCR 122
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP------- 344
+ + +E++HS VIHRD+K +N+L+ + +K+ DFG +C ++ +
Sbjct: 123 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG------FCAQITPEQSKRSTMV 176
Query: 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
GT WMAPE++ K+YG KVD++S G++ EMV G PY NP++A + +
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 70/230 (30%), Positives = 118/230 (51%), Gaps = 28/230 (12%)
Query: 177 DLSQLFLGL-RFAHGAHSRLYHGI--YKDEPVAVKIIRIPD-DDENETLAARLEKQFNRE 232
D +LF L R G+ ++ GI + VA+KII + + +DE E + +E
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDI--------QQE 52
Query: 233 VALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
+ +LS+ +P V K+ + K +I EYL GS L + ++ +
Sbjct: 53 ITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---E 109
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------G 345
I +G++Y+HS+ IHRD+K NVL+ ++ +K+ADFG+A + L+D G
Sbjct: 110 ILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQ------LTDTQIKRNTFVG 163
Query: 346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
T WMAPE+I+ +Y K D++S G+ E+ G P +M+P++ F +
Sbjct: 164 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-24
Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 33/212 (15%)
Query: 190 GAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
GA +Y GI+ E PVA+KI+ NET + +F E +++ + +P+
Sbjct: 18 GAFGTVYKGIWVPEGETVKIPVAIKIL-------NETTGPKANVEFMDEALIMASMDHPH 70
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEYIHS 302
+++ + C P + ++T+ + G L Y+H EHK + L+ + IA+GM Y+
Sbjct: 71 LVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVH--EHKDNIGSQLLLNWCVQIAKGMMYLEE 127
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---------RWMAPE 353
+ ++HRDL NVL+ H+KI DFG+A L D Y +WMA E
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLA------RLLEGDEKEYNADGGKMPIKWMALE 181
Query: 354 MIKHKSYGRKVDVYSFGLILWE-MVAGTIPYE 384
I ++ + + DV+S+G+ +WE M G PY+
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 4e-24
Identities = 44/164 (26%), Positives = 83/164 (50%), Gaps = 13/164 (7%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
E +L++L + +I++ + ++ EY G L L + LP ++
Sbjct: 48 DEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF 107
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP------ 344
+ I G+ ++HS+ ++HRD+K N+ +D ++KI D G+A LSD+
Sbjct: 108 IQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVA------KLLSDNTNFANTI 161
Query: 345 -GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
GT +++PE+ + K Y K DV++ G++L+E G P++ N
Sbjct: 162 VGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 5e-24
Identities = 52/174 (29%), Positives = 88/174 (50%), Gaps = 26/174 (14%)
Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACK-KPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
++ E +L ++P ++K K K +Y ++ EY G L L
Sbjct: 35 GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIY-MLMEYCLGGELWTILRDRGL---- 89
Query: 283 LPKLIA---IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY--- 336
+ A IA + EY+H++G+I+RDLKPEN+L+D ++K+ DFG A +++
Sbjct: 90 FDEYTARFYIAC-VVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFA-KKLKSGQ 147
Query: 337 -----CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
C GT ++APE+I +K Y VD +S G++L+E++ G P+ E
Sbjct: 148 KTWTFC-------GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGE 194
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 59/186 (31%), Positives = 96/186 (51%), Gaps = 21/186 (11%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF---VAACKKPPVYCV 259
E VA+K IR+ ++E E RE+ LL +L +PN+++ V + K +Y +
Sbjct: 25 ELVALKKIRM--ENEKEGFPI----TAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIY-M 77
Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
+ EY+ + L L E K ++ + G++Y+HS G++HRD+K N+LI+
Sbjct: 78 VFEYM-DHDLTGLLDSPEVK-FTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINN 135
Query: 320 EFHLKIADFGIACEEVYCDALSDDPGTYR----WM-APEMIKH-KSYGRKVDVYSFGLIL 373
+ LK+ADFG+A Y + T R W PE++ YG +VD++S G IL
Sbjct: 136 DGVLKLADFGLA--RPYTKR-NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCIL 192
Query: 374 WEMVAG 379
E+ G
Sbjct: 193 AELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 6e-24
Identities = 66/211 (31%), Positives = 108/211 (51%), Gaps = 35/211 (16%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
VAVK+++ ++ + + L +FN LL ++++P+VIK AC + +I EY
Sbjct: 33 VAVKMLK---ENASSSELRDLLSEFN----LLKQVNHPHVIKLYGACSQDGPLLLIVEYA 85
Query: 265 SEGSLRAYLH---KLE-------------------HKTLPLPKLIAIALDIARGMEYIHS 302
GSLR++L K+ + L + LI+ A I+RGM+Y+
Sbjct: 86 KYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE 145
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD----ALSDDPGTYRWMAPEMIKHK 358
++HRDL NVL+ + +KI+DFG++ +VY + S +WMA E +
Sbjct: 146 MKLVHRDLAARNVLVAEGRKMKISDFGLS-RDVYEEDSYVKRSKGRIPVKWMAIESLFDH 204
Query: 359 SYGRKVDVYSFGLILWEMVA-GTIPYEEMNP 388
Y + DV+SFG++LWE+V G PY + P
Sbjct: 205 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 7e-24
Identities = 51/177 (28%), Positives = 91/177 (51%), Gaps = 13/177 (7%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
+E+ L++RL++P++I+ + A + + + E+++ GS+ L K + + I
Sbjct: 52 KEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG----AFKEAVIIN 107
Query: 291 --LDIARGMEYIHSQGVIHRDLKPENVLIDQE-FHLKIADFGIACEEVYCDALSDD---- 343
+ RG+ Y+H +IHRD+K N+LID L+IADFG A + +
Sbjct: 108 YTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167
Query: 344 -PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399
GT +MAPE+++ + YGR DV+S G ++ EM P+ A++ K+
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK-HSNHLALIFKI 223
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 8e-24
Identities = 55/161 (34%), Positives = 90/161 (55%), Gaps = 4/161 (2%)
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
F +E ++ +L + +++ A + P+Y ++TEY+S+GSL +L K L LP+L+
Sbjct: 48 FLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 106
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
+A IA GM Y+ +HRDL+ N+L+ + K+ADFG+A E+ A
Sbjct: 107 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 166
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM 386
+W APE + + K DV+SFG++L E+ G +PY M
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 8e-24
Identities = 60/175 (34%), Positives = 95/175 (54%), Gaps = 20/175 (11%)
Query: 227 KQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK---------- 275
+ F E+ +L +L H+PN+I + AC+ + EY G+L +L K
Sbjct: 52 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 111
Query: 276 -LEHKT---LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331
+ + T L +L+ A D+ARGM+Y+ + IHRDL N+L+ + + KIADFG++
Sbjct: 112 AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 171
Query: 332 -CEEVYC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPY 383
+EVY + P RWMA E + + Y DV+S+G++LWE+V+ G PY
Sbjct: 172 RGQEVYVKKTMGRLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 9e-24
Identities = 47/167 (28%), Positives = 99/167 (59%), Gaps = 5/167 (2%)
Query: 224 RLEKQFNREVALLSR-----LHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH 278
RL+K+ ++ALL + +++P ++ A + C++ ++ G L+ +++ +
Sbjct: 30 RLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGE 89
Query: 279 KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338
+ L + ++I + I G+ ++HS +++RD+KPENVL+D + + +++D G+A E
Sbjct: 90 RGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK 149
Query: 339 ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
++ GT +MAPE++K + Y VD ++ G ++EMVAG P+++
Sbjct: 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-23
Identities = 48/155 (30%), Positives = 84/155 (54%), Gaps = 3/155 (1%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLI--AI 289
E+ +L+ +++PN+I + A C++ EY G L + K + K +P+ I
Sbjct: 49 EIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW 349
+ + RG++ +H Q ++HRDLK N+L+ +KI D GI+ + + + GT +
Sbjct: 109 FIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGIS-KVLKKNMAKTQIGTPHY 167
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384
MAPE+ K + Y K D++S G +L+EM P+E
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 1e-23
Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 17/196 (8%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEY 263
VA+K I A E+ F E ++ +L +P +++ C ++ P+Y ++TE+
Sbjct: 31 VAIKAIN---------EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLY-IVTEF 80
Query: 264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323
+ G L YL + + K L L+++ D+ GMEY+ IHRDL N L+ +
Sbjct: 81 MENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVV 139
Query: 324 KIADFGIACEEVYCDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-G 379
K++DFG+ V D + G +W PE+ Y K DV+SFG+++WE+ G
Sbjct: 140 KVSDFGMT-RYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEG 198
Query: 380 TIPYEEMNPIQAAFAV 395
+P+E+ + + +
Sbjct: 199 KMPFEKKSNYEVVEMI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 1e-23
Identities = 60/175 (34%), Positives = 95/175 (54%), Gaps = 20/175 (11%)
Query: 227 KQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK---------- 275
+ F E+ +L +L H+PN+I + AC+ + EY G+L +L K
Sbjct: 40 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 99
Query: 276 -LEH---KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331
+ + TL +L+ A D+ARGM+Y+ + IHRDL N+L+ + + KIADFG++
Sbjct: 100 AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159
Query: 332 -CEEVYC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPY 383
+EVY + P RWMA E + + Y DV+S+G++LWE+V+ G PY
Sbjct: 160 RGQEVYVKKTMGRLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 54/167 (32%), Positives = 87/167 (52%), Gaps = 11/167 (6%)
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAAC--KKPPVYCVITEYLSEGSLRAYLHKLEHKTL- 281
L+KQ RE+ + +P ++K+ A + + EY GSL + K++ +
Sbjct: 42 LQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR 101
Query: 282 ----PLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337
L K IA + +G+ Y+HS+ +IHRD+KP N+L+ ++ +K+ DFG++ E V
Sbjct: 102 IGEKVLGK---IAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158
Query: 338 DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384
A GT +MAPE I+ K Y DV+S GL L E+ P+
Sbjct: 159 LA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-23
Identities = 45/125 (36%), Positives = 76/125 (60%), Gaps = 3/125 (2%)
Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
+ EYL+ G L H + A +I G++++H +G+I+RDLK +NVL+D+
Sbjct: 74 VMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK 131
Query: 320 EFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
+ H+KIADFG+ E + + + GT ++APE++K + Y VD +SFG++L+EM+
Sbjct: 132 DGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLI 191
Query: 379 GTIPY 383
G P+
Sbjct: 192 GQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 2e-23
Identities = 63/188 (33%), Positives = 94/188 (50%), Gaps = 16/188 (8%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--PVYCVI 260
E VAVK ++ +N + + +E+ +L L++ N++K+ C + +I
Sbjct: 34 EMVAVKTLKRECGQQNTS-------GWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86
Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
EY+ GSLR YL K HK L L +L+ A I GM Y+HSQ IHRDL NVL+D +
Sbjct: 87 MEYVPLGSLRDYLPK--HK-LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND 143
Query: 321 FHLKIADFGIACE----EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
+KI DFG+A Y D W A E +K + DV+SFG+ L+E+
Sbjct: 144 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYEL 203
Query: 377 VAGTIPYE 384
+ +
Sbjct: 204 LTHCDSKQ 211
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 3e-23
Identities = 52/166 (31%), Positives = 95/166 (57%), Gaps = 6/166 (3%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
E+ ++ NPN++ ++ + V+ EYL+ GSL + + + ++ A+
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCR 123
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD--ALSDDPGTYRW 349
+ + +E++HS VIHRD+K +N+L+ + +K+ DFG C ++ + S GT W
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF-CAQITPEQSKRSTMVGTPYW 182
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
MAPE++ K+YG KVD++S G++ EM+ G PY NP++A + +
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 4e-23
Identities = 62/175 (35%), Positives = 97/175 (55%), Gaps = 21/175 (12%)
Query: 243 NVIKFVAACKKP-PVYCVITEYLSEGSLRAYLHK-----LEH---------KTLPLPKLI 287
N+I + AC + P+Y VI EY S+G+LR YL +E+ + L L+
Sbjct: 85 NIINLLGACTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 288 AIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPG-- 345
+ A +ARGMEY+ S+ IHRDL NVL+ ++ +KIADFG+A + + D
Sbjct: 144 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 203
Query: 346 -TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398
+WMAPE + + Y + DV+SFG++LWE+ G PY + P++ F ++ +
Sbjct: 204 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKE 257
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 6e-23
Identities = 52/190 (27%), Positives = 89/190 (46%), Gaps = 20/190 (10%)
Query: 196 YHGIYKDE-----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250
Y G+Y VAVK + EK F +E ++ + +P+++K +
Sbjct: 23 YQGVYMSPENEKIAVAVKTCKNCTSPSVR------EK-FLQEAYIMRQFDHPHIVKLIGV 75
Query: 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDL 310
+ PV+ ++ E G LR+YL +L L LI + ++ + Y+ S+ +HRD+
Sbjct: 76 ITENPVW-IVMELAPLGELRSYLQV-NKYSLDLASLILYSYQLSTALAYLESKRFVHRDI 133
Query: 311 KPENVLIDQEFHLKIADFG----IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDV 366
NVL+ +K+ DFG + E Y + P +WMAPE I + + DV
Sbjct: 134 AARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP--IKWMAPESINFRRFTSASDV 191
Query: 367 YSFGLILWEM 376
+ FG+ +WE+
Sbjct: 192 WMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 6e-23
Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 26/196 (13%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA------ACKKPPVYC 258
VAVK+++ + ++ ++F RE A + +PNVIK + A + P+
Sbjct: 30 VAVKMLK------ADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM 83
Query: 259 VITEYLSEGSLRAYL--HKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314
VI ++ G L +L ++ E TLPL L+ +DIA GMEY+ S+ IHRDL N
Sbjct: 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARN 143
Query: 315 VLIDQEFHLKIADFGIACEEVYC------DALSDDPGTYRWMAPEMIKHKSYGRKVDVYS 368
++++ + +ADFG++ +++Y S P +W+A E + Y DV++
Sbjct: 144 CMLNENMTVCVADFGLS-KKIYSGDYYRQGCASKLP--VKWLALESLADNVYTTHSDVWA 200
Query: 369 FGLILWE-MVAGTIPY 383
FG+ +WE M G PY
Sbjct: 201 FGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 6e-23
Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 27/205 (13%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
VAVK ++ + +E+ AR + F RE LL+ L + ++++F C + ++ EY+
Sbjct: 38 VAVKALK----EASES--ARQD--FQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYM 89
Query: 265 SEGSLRAYL-------HKLEHKT------LPLPKLIAIALDIARGMEYIHSQGVIHRDLK 311
G L +L L L L +++AIA IA GM Y+ S +HRDL
Sbjct: 90 RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLA 149
Query: 312 PENVLIDQEFHLKIADFGIACEEVYCDALSDDPG----TYRWMAPEMIKHKSYGRKVDVY 367
N L+ Q +KI DFG++ ++Y G RWM PE I ++ + + D++
Sbjct: 150 TRNCLVGQGLVVKIGDFGMS-RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIW 208
Query: 368 SFGLILWEMVA-GTIPYEEMNPIQA 391
SFG++LWE+ G P+ +++ +A
Sbjct: 209 SFGVVLWEIFTYGKQPWYQLSNTEA 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 7e-23
Identities = 57/198 (28%), Positives = 104/198 (52%), Gaps = 18/198 (9%)
Query: 198 GIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253
G+YK ++ VAVKI++ ++D L+ + RE ++ +L NP +++ + C+
Sbjct: 14 GMYKMKKSEKTVAVKILKNDNNDPA------LKDELLREANVMQQLDNPYIVRMIGICEA 67
Query: 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPE 313
+ ++ E G L +L K +H T + + ++ GM+Y+ +HRDL
Sbjct: 68 ES-WMLVMELAELGPLNKFLQKNKHVTEK--NITELVHQVSMGMKYLEETNFVHRDLAAR 124
Query: 314 NVLIDQEFHLKIADFGIA----CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSF 369
NVL+ + + KI+DFG++ +E Y A + +W APE + + + K DV+SF
Sbjct: 125 NVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSF 184
Query: 370 GLILWEMVA-GTIPYEEM 386
G+++WE + G PY+ M
Sbjct: 185 GVLMWEAFSYGQKPYKGM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 7e-23
Identities = 55/182 (30%), Positives = 95/182 (52%), Gaps = 12/182 (6%)
Query: 206 AVKIIR---IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
A+K ++ I DE E+L EK R + +P ++ A + C + E
Sbjct: 28 AIKALKKGDIIARDEVESL--MCEK---RIFETANSERHPFLVNLFACFQTEDHVCFVME 82
Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
Y + G L ++H P+ + A + G++Y+H +++RDLK +N+L+D E
Sbjct: 83 YAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF 139
Query: 323 LKIADFGIACEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI 381
+KIADFG+ E + + D S GT ++APE++ SY R VD + G++++EM+ G
Sbjct: 140 VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199
Query: 382 PY 383
P+
Sbjct: 200 PF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 8e-23
Identities = 48/125 (38%), Positives = 81/125 (64%), Gaps = 3/125 (2%)
Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
+ EYL+ G L ++ HK LP+ A +I G++++HS+G+++RDLK +N+L+D
Sbjct: 74 VMEYLNGGDLMFHIQSC-HK-FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDT 131
Query: 320 EFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
+ H+KIADFG+ E + DA + GT ++APE++ + Y VD +SFG++L+EM+
Sbjct: 132 DGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLI 191
Query: 379 GTIPY 383
G P+
Sbjct: 192 GQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 9e-23
Identities = 60/214 (28%), Positives = 111/214 (51%), Gaps = 16/214 (7%)
Query: 186 RFAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
+ GA +Y I + VA+K + + + E + E+ ++ NPN
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELII--------NEILVMRENKNPN 77
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
++ ++ + V+ EYL+ GSL + + + ++ A+ + + ++++HS
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN 134
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYG 361
VIHRD+K +N+L+ + +K+ DFG C ++ + S GT WMAPE++ K+YG
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGF-CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193
Query: 362 RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
KVD++S G++ EMV G PY NP++A + +
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 9e-23
Identities = 55/212 (25%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
F RL ++ VA+K ++ + + + F E +++ + +PN+I
Sbjct: 17 FGEVCRGRLKLPGKREIFVAIKTLKSGYTE-------KQRRDFLSEASIMGQFDHPNIIH 69
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
K +ITE++ G+L ++L + + +L+ + IA GM+Y+ +
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFL-RQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY----------RWMAPEMIK 356
HRDL N+L++ K++DFG++ + + + DP TY RW APE I
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLS---RFLEDDTSDP-TYTSSLGGKIPIRWTAPEAIA 184
Query: 357 HKSYGRKVDVYSFGLILWE-MVAGTIPYEEMN 387
++ + DV+S+G+++WE M G PY +M+
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 1e-22
Identities = 58/182 (31%), Positives = 96/182 (52%), Gaps = 14/182 (7%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
+AVK+I P D + L+KQ E+ +L + +P +I F A + TE++
Sbjct: 29 LAVKVI--PLD-----ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81
Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
GSL Y + +P L IA+ + +G+ Y+ S ++HRD+KP N+L++ +K
Sbjct: 82 DGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVK 135
Query: 325 IADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384
+ DFG++ + V A + GT +MAPE I + YG DV+S G+ E+ G PY
Sbjct: 136 LCDFGVSTQLVNSIAKT-YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYP 194
Query: 385 EM 386
++
Sbjct: 195 QI 196
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-22
Identities = 56/170 (32%), Positives = 93/170 (54%), Gaps = 7/170 (4%)
Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
R E FN EV ++ H+ NV+ + V+ E+L G+L + H +
Sbjct: 62 RRELLFN-EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNE 117
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
++ + L + R + Y+H+QGVIHRD+K +++L+ + +K++DFG C +V +
Sbjct: 118 EQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGF-CAQVSKEVPKRK 176
Query: 344 P--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQA 391
GT WMAPE+I YG +VD++S G+++ EM+ G PY P+QA
Sbjct: 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 1e-22
Identities = 51/132 (38%), Positives = 71/132 (53%), Gaps = 7/132 (5%)
Query: 272 YLHKLEH-KTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFG 329
Y + T+P L IA+ I + +EY+HS+ VIHRD+KP NVLI++ +K+ DFG
Sbjct: 90 YKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFG 149
Query: 330 IACEEVYCDALSDDPGTYRWMAPEMI----KHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
I+ V A + D G +MAPE I K Y K DV+S G+ + E+ G PY+
Sbjct: 150 ISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209
Query: 386 M-NPIQAAFAVV 396
P Q VV
Sbjct: 210 WKTPFQQLKQVV 221
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-22
Identities = 50/184 (27%), Positives = 90/184 (48%), Gaps = 11/184 (5%)
Query: 206 AVKIIRIPD-DDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
A+K+++ D +N+ + E+ ++ + +P V K + + ++ EYL
Sbjct: 25 AIKVLKKSDMIAKNQVTNVKAERAI-----MMIQGESPYVAKLYYSFQSKDYLYLVMEYL 79
Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
+ G + + L LP ++ G+E +H +G+IHRD+KPEN+LIDQ HLK
Sbjct: 80 NGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLK 137
Query: 325 IADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384
+ DFG++ + GT ++APE I + D +S G +++E + G P+
Sbjct: 138 LTDFGLS-RNGLEN--KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194
Query: 385 EMNP 388
P
Sbjct: 195 AETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 24/213 (11%)
Query: 189 HGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
HGA +Y G+Y+ + V + +P+ + E F E ++S+ ++ N
Sbjct: 16 HGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQD-----ESDFLMEALIMSKFNHQN 70
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLH----KLEHKT-LPLPKLIAIALDIARGME 298
+++ + + ++ E ++ G L+++L + E + L + L+ A D+A+G +
Sbjct: 71 IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130
Query: 299 YIHSQGVIHRDLKPENVLIDQEFH---LKIADFGIACEEVYCDALSDDPGT----YRWMA 351
Y+ IHRD+ N L+ + KIADFG+A ++Y + G +WM
Sbjct: 131 YLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA-RDIYRASYYRKGGRAMLPIKWMP 189
Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPY 383
PE + K DV+SFG++LWE+ + G +PY
Sbjct: 190 PEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 2e-22
Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 5/150 (3%)
Query: 231 REVALLSRL-HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
REV L +L +PN++K ++ + EY+ EG+L + + K + +I
Sbjct: 46 REVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSI 104
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW 349
I +G+ +IH G HRDLKPEN+L+ +KIADFG+A E +D T RW
Sbjct: 105 IYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST-RW 163
Query: 350 M-APEMI-KHKSYGRKVDVYSFGLILWEMV 377
APE++ + SY VD+++ G I+ E+
Sbjct: 164 YRAPEILLRSTSYSSPVDIWALGCIMAELY 193
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 3e-22
Identities = 56/181 (30%), Positives = 95/181 (52%), Gaps = 14/181 (7%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV--I 260
E VAVK ++ P+ N +E+ +L L++ N++K+ C + + I
Sbjct: 34 EQVAVKSLK-PESGGNHI------ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 86
Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
E+L GSL+ YL + ++K + L + + A+ I +GM+Y+ S+ +HRDL NVL++ E
Sbjct: 87 MEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE 145
Query: 321 FHLKIADFG----IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
+KI DFG I ++ Y D W APE + + DV+SFG+ L+E+
Sbjct: 146 HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYEL 205
Query: 377 V 377
+
Sbjct: 206 L 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 3e-22
Identities = 56/182 (30%), Positives = 98/182 (53%), Gaps = 19/182 (10%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---NPNVIKFVAAC-----KKPPV 256
VA+K +R+ +++ L+ REVALL RL +PN+++ + C +
Sbjct: 28 VALKSVRVQTNEDGLPLSTV------REVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
++ E++ + LR YL K+ LP + + RG++++H+ ++HRDLKPEN+L
Sbjct: 82 VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENIL 140
Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLILW 374
+ +K+ADFG+A +Y ++ P T + APE++ +Y VD++S G I
Sbjct: 141 VTSGGQVKLADFGLA--RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFA 198
Query: 375 EM 376
EM
Sbjct: 199 EM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 4e-22
Identities = 57/186 (30%), Positives = 93/186 (50%), Gaps = 27/186 (14%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
VA+K + +DDE+ ++K REV +L +L + N++ A ++ ++ EY+
Sbjct: 29 VAIKKFKESEDDED------VKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82
Query: 265 SEGSLRAYLHKLEHKTLPLPKLI--AIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
R L LE LP + + + + Y HS +IHRD+KPEN+L+ +
Sbjct: 83 E----RTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV 138
Query: 323 LKIADFGIACEEVYCDALSDDPGTY-------RWM-APE-MIKHKSYGRKVDVYSFGLIL 373
LK+ DFG A AL P + RW APE ++ +YG+ VDV++ G I+
Sbjct: 139 LKLCDFGFA------RALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIM 192
Query: 374 WEMVAG 379
E++ G
Sbjct: 193 AELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 7e-22
Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 33/212 (15%)
Query: 190 GAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
GA +Y G++ E PVA+K +R E + + K+ E +++ + NP+
Sbjct: 18 GAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVDNPH 70
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEYIHS 302
V + + C V +IT+ + G L Y+ EHK + L+ + IA+GM Y+
Sbjct: 71 VCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNYLEE 127
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---------RWMAPE 353
+ ++HRDL NVL+ H+KI DFG+A L D Y +WMA E
Sbjct: 128 RRLVHRDLAARNVLVKTPQHVKITDFGLA------KLLGADEKEYHAEGGKVPIKWMALE 181
Query: 354 MIKHKSYGRKVDVYSFGLILWE-MVAGTIPYE 384
I H+ Y + DV+S+G+ +WE M G+ PY+
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 8e-22
Identities = 41/154 (26%), Positives = 87/154 (56%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
E +L ++++ V+ A + C++ ++ G L+ +++ + + + + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
+I G+E +H + +++RDLKPEN+L+D H++I+D G+A E + + GT +MA
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMA 169
Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
PE++K++ Y D + G +++EM+ G P+ +
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 40/127 (31%), Positives = 72/127 (56%), Gaps = 3/127 (2%)
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
C + EY + G L + H + + +I + Y+HS V++RDLK EN+++
Sbjct: 71 CFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML 128
Query: 318 DQEFHLKIADFGIACEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
D++ H+KI DFG+ E + + GT ++APE+++ YGR VD + G++++EM
Sbjct: 129 DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188
Query: 377 VAGTIPY 383
+ G +P+
Sbjct: 189 MCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-21
Identities = 42/154 (27%), Positives = 87/154 (56%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
E +L ++++ V+ A + C++ ++ G L+ +++ + + + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
+I G+E +H + +++RDLKPEN+L+D H++I+D G+A + GT +MA
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMA 169
Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
PE++K++ Y D ++ G +L+EM+AG P+++
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-21
Identities = 39/152 (25%), Positives = 85/152 (55%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
E +L ++++ V+ A + C++ ++ G L+ +++ + + + + A
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
+I G+E +H + ++RDLKPEN+L+D H++I+D G+A + +++ GT +MA
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMA 169
Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
PE++ ++ Y D + G +++EM+ G P+
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-21
Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 28/224 (12%)
Query: 187 FAHGAHSRLYHGIYKD----EP---VAVKIIRIPDDDENETLAARLEKQFNREVALLSRL 239
G+ +Y G +D E VAVK + NE+ + R +F E +++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTV-------NESASLRERIEFLNEASVMKGF 66
Query: 240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-----LPLPKL---IAIAL 291
+V++ + K V+ E ++ G L++YL L + P P L I +A
Sbjct: 67 TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT----Y 347
+IA GM Y++++ +HRDL N ++ +F +KI DFG+ ++Y G
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT-RDIYETDYYRKGGKGLLPV 185
Query: 348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQ 390
RWMAPE +K + D++SFG++LWE+ + PY+ ++ Q
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 229
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 190 GAHSRLYHGIYKDE--PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
G S +Y I + VA+K ++I E + A+ + +E+ LL +L +PNVIK+
Sbjct: 13 GQFSVVYKAICLLDGRVVALKKVQI-----FEMMDAKARQDCLKEIDLLKQLDHPNVIKY 67
Query: 248 VAACKKPPVYCVITEYLSEGSL-RAYLH-KLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
+A+ + ++ E G L R H K + + +P + + + +E++HS+ +
Sbjct: 68 LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRI 127
Query: 306 IHRDLKPENVLIDQEFHLKIADFGI----ACEEVYCDALSDDPGTYRWMAPEMIKHKSYG 361
+HRD+KP NV I +K+ D G+ + + +L GT +M+PE I Y
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPERIHENGYN 184
Query: 362 RKVDVYSFGLILWEMVAGTIPY--EEMN 387
K D++S G +L+EM A P+ ++MN
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKMN 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 47/131 (35%), Positives = 82/131 (62%), Gaps = 5/131 (3%)
Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL-DIARGMEYIHSQGVIHRDLKPENVLI 317
+I EYLS G L ++H LE + + + L +I+ +E++H QG+I+RDLKPEN+L+
Sbjct: 77 LILEYLSGGEL--FMH-LEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL 133
Query: 318 DQEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
D + H+K+ DFG+ E ++ ++ GT +MAPE++ +G+ VD +S G ++++M
Sbjct: 134 DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDM 193
Query: 377 VAGTIPYEEMN 387
+ G P+ N
Sbjct: 194 LTGAPPFTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-21
Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 31/218 (14%)
Query: 190 GAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249
G + +Y V + I IP+ D + + E+AL S L + N+++++
Sbjct: 19 GTYGIVYAARDLSTQVRIAIKEIPERDSRYV------QPLHEEIALHSYLKHRNIVQYLG 72
Query: 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL----PKLIAIALDIARGMEYIHSQGV 305
+ + + + E + GSL A L K PL +I I G++Y+H +
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129
Query: 306 IHRDLKPENVLIDQ-EFHLKIADFGIA--------CEEVYCDALSDDPGTYRWMAPEMIK 356
+HRD+K +NVL++ +KI+DFG + C E + GT ++MAPE+I
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF-------TGTLQYMAPEVID 182
Query: 357 H--KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAA 392
+ YG D++S G + EM G P+ E+ QAA
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA 220
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-21
Identities = 60/194 (30%), Positives = 101/194 (52%), Gaps = 24/194 (12%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
VAVK++ + E L FN EV ++ + NV++ + V+ E+L
Sbjct: 49 VAVKMMDLRKQQRRELL-------FN-EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100
Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
G+L + + L ++ + + + + Y+HSQGVIHRD+K +++L+ + +K
Sbjct: 101 QGGALTDIVSQTR---LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVK 157
Query: 325 IADFGIACEEVYCDALSDDP-------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMV 377
++DFG +C +S D GT WMAPE+I YG +VD++S G+++ EMV
Sbjct: 158 LSDFG------FCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211
Query: 378 AGTIPYEEMNPIQA 391
G PY +P+QA
Sbjct: 212 DGEPPYFSDSPVQA 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 4e-21
Identities = 66/231 (28%), Positives = 106/231 (45%), Gaps = 40/231 (17%)
Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIK 246
G + ++Y +K + VA+KI+ I +D+E E E +L + ++PN+
Sbjct: 17 GTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKE---------EYNILRKYSNHPNIAT 67
Query: 247 FVAACKKPPVYCV------ITEYLSEGSLRAYLHKLEHKTLPLPK-LIA-IALDIARGME 298
F A K + E GS+ + L K L + IA I + RG+
Sbjct: 68 FYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLA 127
Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP--------GTYRWM 350
Y+H VIHRD+K +N+L+ + +K+ DFG++ A D GT WM
Sbjct: 128 YLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS-------AQLDSTLGRRNTFIGTPYWM 180
Query: 351 APEMIKHK-----SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396
APE+I SY + DV+S G+ E+ G P +M+P++A F +
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP 231
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 4e-21
Identities = 52/174 (29%), Positives = 96/174 (55%), Gaps = 20/174 (11%)
Query: 224 RLEKQFNREVAL-----LSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-- 276
RL+K+ E A+ L+++H+ ++ A + C++ ++ G LR +++ +
Sbjct: 30 RLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDE 89
Query: 277 EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336
E+ P P+ I G+E++H + +I+RDLKPENVL+D + +++I+D G+A E
Sbjct: 90 ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVE--- 146
Query: 337 CDALSDD-------PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
L D GT +MAPE+++ + Y VD ++ G+ L+EM+A P+
Sbjct: 147 ---LKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 4e-21
Identities = 54/170 (31%), Positives = 93/170 (54%), Gaps = 7/170 (4%)
Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
R E FN EV ++ + NV++ + V+ E+L G+L + H +
Sbjct: 60 RRELLFN-EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNE 115
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
++ A+ L + + + +H+QGVIHRD+K +++L+ + +K++DFG C +V +
Sbjct: 116 EQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF-CAQVSKEVPRRK 174
Query: 344 P--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQA 391
GT WMAPE+I YG +VD++S G+++ EMV G PY P++A
Sbjct: 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 6e-21
Identities = 48/165 (29%), Positives = 89/165 (53%), Gaps = 6/165 (3%)
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
+ KQ RE+ ++ +P ++ F A C+ E++ GSL K +P+
Sbjct: 46 VRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKG--GPIPVE 103
Query: 285 KLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
L IA+ + G+ Y+++ ++HRD+KP N+L++ +K+ DFG++ E + ++++D
Sbjct: 104 ILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI--NSIADT 161
Query: 344 -PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
GT +M+PE I+ Y K DV+S G+ + E+ G P+ N
Sbjct: 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 6e-21
Identities = 54/192 (28%), Positives = 98/192 (51%), Gaps = 15/192 (7%)
Query: 201 KDEPVAVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256
DE A+K+++ + DDD + T+ + + L+ H P + +
Sbjct: 19 TDEVYAIKVLKKDVILQDDDVDCTMT-------EKRILALAAKH-PFLTALHCCFQTKDR 70
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
+ EY++ G L + + P + A + +A + ++H GVI+RDLK +N+L
Sbjct: 71 LFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA--LMFLHRHGVIYRDLKLDNIL 128
Query: 317 IDQEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
+D E H K+ADFG+ E + + GT ++APE+++ YG VD ++ G++++E
Sbjct: 129 LDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYE 188
Query: 376 MVAGTIPYEEMN 387
M+AG P+E N
Sbjct: 189 MMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 7e-21
Identities = 70/193 (36%), Positives = 98/193 (50%), Gaps = 32/193 (16%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVA---ACKKPPVYC 258
E VA+K +I D N T A R F RE+ L L +PN++K + A +Y
Sbjct: 33 EVVALK--KIFDAFRNATDAQR---TF-REIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86
Query: 259 VITEYLSEGSLRAYLHK--LE--HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314
V EY+ E L A + LE HK I + + ++YIHS VIHRDLKP N
Sbjct: 87 VF-EYM-ETDLHAVIRANILEDVHK-------RYIMYQLLKALKYIHSGNVIHRDLKPSN 137
Query: 315 VLIDQEFHLKIADFGIA------CEEVYCDALSDDPGTYRWM-APE-MIKHKSYGRKVDV 366
+L++ + +K+ADFG+A E L+D T RW APE ++ Y + VD+
Sbjct: 138 ILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT-RWYRAPEILLGSTRYTKGVDM 196
Query: 367 YSFGLILWEMVAG 379
+S G IL EM+ G
Sbjct: 197 WSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 8e-21
Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 28/186 (15%)
Query: 205 VAVKI-IRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEY 263
VA+K + DD + +A R E+ +L +L + N++ + ++ ++ E+
Sbjct: 29 VAIKKFLESEDDKMVKKIAMR-------EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81
Query: 264 LSE---GSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
+ L Y + L+ + I RG+E+ HS +IHRD+KPEN+L+ Q
Sbjct: 82 VDHTVLDDLEKYPNGLDESRVR-----KYLFQILRGIEFCHSHNIIHRDIKPENILVSQS 136
Query: 321 FHLKIADFGIA-----CEEVYCDALSDDPGTYRWM-APEM-IKHKSYGRKVDVYSFGLIL 373
+K+ DFG A EVY D ++ RW APE+ + YGR VD+++ G ++
Sbjct: 137 GVVKLCDFGFARTLAAPGEVYTDYVAT-----RWYRAPELLVGDTKYGRAVDIWAVGCLV 191
Query: 374 WEMVAG 379
EM+ G
Sbjct: 192 TEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 8e-21
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 38/202 (18%)
Query: 205 VAVKIIRIPDDDENETLAARLE-KQFNREVALLSRLHNPNVIKFVAACKKP------PVY 257
VAVK ++I + R E + F E + +PNV++ + C + P
Sbjct: 29 VAVKTMKI-------AICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81
Query: 258 CVITEYLSEGSLRAYL--HKLEHKTLPLPK--LIAIALDIARGMEYIHSQGVIHRDLKPE 313
VI ++ G L ++L +L LP L+ DIA GMEY+ S+ IHRDL
Sbjct: 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAAR 141
Query: 314 NVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY-----------RWMAPEMIKHKSYGR 362
N ++++ ++ +ADFG++ +++Y G Y +W+A E + + Y
Sbjct: 142 NCMLNENMNVCVADFGLS-KKIY-------NGDYYRQGRIAKMPVKWIAIESLADRVYTT 193
Query: 363 KVDVYSFGLILWEMVA-GTIPY 383
K DV+SFG+ +WE+ G PY
Sbjct: 194 KSDVWSFGVTMWEIATRGQTPY 215
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 9e-21
Identities = 56/202 (27%), Positives = 104/202 (51%), Gaps = 19/202 (9%)
Query: 194 RLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253
R+ E A+K ++ + E L + + +E ++L L +P ++ + + +
Sbjct: 35 RIAKHKGTGEYYAIKCLK-----KREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD 89
Query: 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPE 313
+ E++ G L +L K + K L +A EY+HS+ +I+RDLKPE
Sbjct: 90 ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA--FEYLHSKDIIYRDLKPE 147
Query: 314 NVLIDQEFHLKIADFGIA---CEEVY--CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYS 368
N+L+D + H+K+ DFG A + + C GT ++APE+I+ K +G+ VD ++
Sbjct: 148 NLLLDNKGHVKVTDFGFAKKVPDRTFTLC-------GTPEYLAPEVIQSKGHGKAVDWWT 200
Query: 369 FGLILWEMVAGTIPYEEMNPIQ 390
G++L+E +AG P+ + P +
Sbjct: 201 MGVLLYEFIAGYPPFFDDTPFR 222
|
Length = 329 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 58/185 (31%), Positives = 91/185 (49%), Gaps = 21/185 (11%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
VA+K +IP + TLA R RE+ +L + N+I + +PP Y+
Sbjct: 33 VAIK--KIPHAFDVPTLAKRTL----RELKILRHFKHDNIIA-IRDILRPPGADFKDVYV 85
Query: 265 SEGSLRAYLHKLEHKTLPLP-KLIAIAL-DIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
+ + LH + H PL + I L + RG++YIHS VIHRDLKP N+L++++
Sbjct: 86 VMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE 145
Query: 323 LKIADFGIACEEVYCDALSDDPGTY-------RWM-APE-MIKHKSYGRKVDVYSFGLIL 373
L+I DFG+A + + + RW APE ++ Y +D++S G I
Sbjct: 146 LRIGDFGMA--RGLSSS-PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIF 202
Query: 374 WEMVA 378
EM+
Sbjct: 203 AEMLG 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 57/187 (30%), Positives = 99/187 (52%), Gaps = 23/187 (12%)
Query: 220 TLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK 279
TL R + E +L+ +++P ++K A + +I ++L G L L K
Sbjct: 36 TLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF 95
Query: 280 TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV---- 335
T K L A ++++HS G+I+RDLKPEN+L+D+E H+K+ DFG++ E +
Sbjct: 96 TEEDVKFYLAEL--ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153
Query: 336 ----YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY------EE 385
+C GT +MAPE++ + + + D +SFG++++EM+ G++P+ E
Sbjct: 154 KAYSFC-------GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET 206
Query: 386 MNPIQAA 392
M I A
Sbjct: 207 MTMILKA 213
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-20
Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 25/199 (12%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
VAVK ++ D+ AR K F+RE LL+ L + +++KF C + ++ EY+
Sbjct: 38 VAVKTLKDASDN------AR--KDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM 89
Query: 265 SEGSLRAYLHKL-----------EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPE 313
G L +L L +++ IA IA GM Y+ SQ +HRDL
Sbjct: 90 KHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATR 149
Query: 314 NVLIDQEFHLKIADFGIACEEVYCDALSDDPG----TYRWMAPEMIKHKSYGRKVDVYSF 369
N L+ + +KI DFG++ +VY G RWM PE I ++ + + DV+S
Sbjct: 150 NCLVGENLLVKIGDFGMS-RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSL 208
Query: 370 GLILWEMVA-GTIPYEEMN 387
G++LWE+ G P+ +++
Sbjct: 209 GVVLWEIFTYGKQPWYQLS 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 3e-20
Identities = 57/188 (30%), Positives = 102/188 (54%), Gaps = 17/188 (9%)
Query: 206 AVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
AVK+++ + DDD T+ EK+ + L+R H P + + + P +
Sbjct: 24 AVKVLKKDVILQDDDVECTMT---EKR----ILSLARNH-PFLTQLYCCFQTPDRLFFVM 75
Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
E+++ G L ++ K + + A +I + ++H +G+I+RDLK +NVL+D E
Sbjct: 76 EFVNGGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG 133
Query: 322 HLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG 379
H K+ADFG+ C+E + + GT ++APE+++ YG VD ++ G++L+EM+ G
Sbjct: 134 HCKLADFGM-CKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
Query: 380 TIPYEEMN 387
P+E N
Sbjct: 193 HAPFEAEN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 60/209 (28%), Positives = 107/209 (51%), Gaps = 17/209 (8%)
Query: 190 GAHSRLYHGIYKDEPV--AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
GA ++Y K+ A K+I ++E E + E+ +L+ ++P ++K
Sbjct: 23 GAFGKVYKAKNKETGALAAAKVIETKSEEELE--------DYMVEIEILATCNHPYIVKL 74
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
+ A ++ E+ G++ A + +L+ + L P++ I + ++Y+HS +IH
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIH 133
Query: 308 RDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMI-----KHKSYG 361
RDLK NVL+ + +K+ADFG++ + V D GT WMAPE++ K Y
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD 193
Query: 362 RKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390
K D++S G+ L EM P+ E+NP++
Sbjct: 194 YKADIWSLGITLIEMAQIEPPHHELNPMR 222
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 3e-20
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 37/210 (17%)
Query: 208 KIIRIPDDDENETLA---------ARLEK-QFNREVALLSRLHNPNVIKFVAACKKPP-- 255
K+ R D + L EK Q EV +L L +PN++++
Sbjct: 18 KVRRKSD---GKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ 74
Query: 256 -VYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIH-----SQGVIH 307
+Y ++ EY G L + K E K + + I + + H V+H
Sbjct: 75 TLY-IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLH 133
Query: 308 RDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------GTYRWMAPEMIKHKSY 360
RDLKP N+ +D ++K+ DFG+A L D GT +M+PE + H SY
Sbjct: 134 RDLKPANIFLDANNNVKLGDFGLAKI------LGHDSSFAKTYVGTPYYMSPEQLNHMSY 187
Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390
K D++S G +++E+ A + P+ N +Q
Sbjct: 188 DEKSDIWSLGCLIYELCALSPPFTARNQLQ 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 56/237 (23%), Positives = 100/237 (42%), Gaps = 53/237 (22%)
Query: 199 IYKDEPVAVKIIRIPD-DDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257
+ A+K++R D N+ R E+ L+ +P ++K + +
Sbjct: 23 KDTGQVYAMKVLRKSDMIKRNQIAHVRAERDI------LADADSPWIVKLYYSFQDEEHL 76
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKL-------IAIALDIARGMEYIHSQGVIHRDL 310
++ EY+ G L L + + P + + +ALD +H G IHRD+
Sbjct: 77 YLVMEYMPGGDLMNLLIRKD--VFP-EETARFYIAELVLALD------SVHKLGFIHRDI 127
Query: 311 KPENVLIDQEFHLKIADFGIA-------CEEVYCDALSDDP------------------- 344
KP+N+LID + H+K+ADFG+ E Y + +
Sbjct: 128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRA 187
Query: 345 ----GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
GT ++APE+++ YG + D +S G+IL+EM+ G P+ + ++N
Sbjct: 188 NSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIIN 244
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 3e-20
Identities = 47/125 (37%), Positives = 79/125 (63%), Gaps = 3/125 (2%)
Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
+ E+L+ G L H + L + A +I G++++HS+G+I+RDLK +NV++D+
Sbjct: 74 VMEFLNGGDL--MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR 131
Query: 320 EFHLKIADFGIACEEVYCDA-LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
+ H+KIADFG+ E V+ D S GT ++APE+++ Y VD +SFG++L+EM+
Sbjct: 132 DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLI 191
Query: 379 GTIPY 383
G P+
Sbjct: 192 GQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-20
Identities = 60/214 (28%), Positives = 106/214 (49%), Gaps = 17/214 (7%)
Query: 190 GAHSRLYHGIYKDEPV--AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
GA ++Y K+ V A K+I ++E E + E+ +L+ +PN++K
Sbjct: 16 GAFGKVYKAQNKETGVLAAAKVIDTKSEEELE--------DYMVEIDILASCDHPNIVKL 67
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
+ A ++ E+ + G++ A + +LE + L P++ + + Y+H +IH
Sbjct: 68 LDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIH 126
Query: 308 RDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMI-----KHKSYG 361
RDLK N+L + +K+ADFG++ + D GT WMAPE++ K + Y
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 186
Query: 362 RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
K DV+S G+ L EM P+ E+NP++ +
Sbjct: 187 YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI 220
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-20
Identities = 54/198 (27%), Positives = 103/198 (52%), Gaps = 18/198 (9%)
Query: 198 GIYKDEP----VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253
G+YK VA+K+++ +ENE + + RE ++ +L NP +++ + C+
Sbjct: 14 GVYKMRKKQIDVAIKVLK----NENEK---SVRDEMMREAEIMHQLDNPYIVRMIGVCEA 66
Query: 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPE 313
+ V+ E S G L +L + + + ++ + ++ GM+Y+ + +HRDL
Sbjct: 67 EALMLVM-EMASGGPLNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAAR 124
Query: 314 NVLIDQEFHLKIADFG----IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSF 369
NVL+ + + KI+DFG + ++ Y A S +W APE I + + + DV+S+
Sbjct: 125 NVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSY 184
Query: 370 GLILWEMVA-GTIPYEEM 386
G+ +WE + G PY++M
Sbjct: 185 GITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 8e-20
Identities = 57/177 (32%), Positives = 95/177 (53%), Gaps = 9/177 (5%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
E VA+K IR+ + E A RE++LL L++PN++K + ++ E
Sbjct: 26 EVVALKKIRLDTETEGVPSTAI------REISLLKELNHPNIVKLLDVIHTENKLYLVFE 79
Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
+L + L+ ++ +PLP + + + +G+ + HS V+HRDLKP+N+LI+ E
Sbjct: 80 FLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 138
Query: 323 LKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMV 377
+K+ADFG+A V + + T + APE ++ K Y VD++S G I EMV
Sbjct: 139 IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 8e-20
Identities = 64/182 (35%), Positives = 91/182 (50%), Gaps = 20/182 (10%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--PVYCVI 260
+ VA+K I P L K+ RE+ LL L + N+I P +Y V
Sbjct: 36 QNVAIKKIMKPFS------TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV- 88
Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIA--IALDIARGMEYIHSQGVIHRDLKPENVLID 318
TE L LH+L + PL K I RG++Y+HS GV+HRDLKP N+LI+
Sbjct: 89 TELLGTD-----LHRL-LTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN 142
Query: 319 QEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMV 377
+ LKI DFG+A + ++ T + APE M+ + Y +VD++S G I EM+
Sbjct: 143 ENCDLKICDFGLA--RIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200
Query: 378 AG 379
G
Sbjct: 201 EG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 9e-20
Identities = 68/224 (30%), Positives = 103/224 (45%), Gaps = 18/224 (8%)
Query: 177 DLSQLFLGLR-FAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREV 233
D +LF LR HG+ +Y + +E VA+K + NE + +EV
Sbjct: 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDII-----KEV 66
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEY-LSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
L +L +PN I++ + ++ EY L S +HK K L ++ AI
Sbjct: 67 RFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHK---KPLQEVEIAAICHG 123
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
+G+ Y+HS IHRD+K N+L+ + +K+ADFG A + GT WMAP
Sbjct: 124 ALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSAS---LVSPANSFVGTPYWMAP 180
Query: 353 EMI---KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393
E+I Y KVDV+S G+ E+ P MN + A +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 67/202 (33%), Positives = 100/202 (49%), Gaps = 39/202 (19%)
Query: 196 YHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF-- 247
Y +YK E VA+K IR+ +DE A RE++LL L++PN+++
Sbjct: 12 YGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI------REISLLKELNHPNIVRLLD 65
Query: 248 -VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
V + K +Y V E+L L+ Y+ L P + + + +G+ Y HS V+
Sbjct: 66 VVHSENK--LYLVF-EFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121
Query: 307 HRDLKPENVLIDQEFHLKIADFGIA----------CEEVYCDALSDDPGTYRWMAPE-MI 355
HRDLKP+N+LID+E LK+ADFG+A EV T + APE ++
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILL 172
Query: 356 KHKSYGRKVDVYSFGLILWEMV 377
+ Y VD++S G I EMV
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 58/167 (34%), Positives = 84/167 (50%), Gaps = 28/167 (16%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITE-YLSEGSLRAYLHKLEHKTLPLPKLIAI 289
RE+ +L R + N+I + +PP + + Y+ + + L+KL KT L
Sbjct: 52 REIKILRRFKHENIIGILDI-IRPPSFESFNDVYIVQELMETDLYKLI-KTQHLSN---- 105
Query: 290 ALD--------IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALS 341
D I RG++YIHS V+HRDLKP N+L++ LKI DFG+A D
Sbjct: 106 --DHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA---RIADPEH 160
Query: 342 DDPGT---Y---RWM-APE-MIKHKSYGRKVDVYSFGLILWEMVAGT 380
D G Y RW APE M+ K Y + +D++S G IL EM++
Sbjct: 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 42/128 (32%), Positives = 76/128 (59%), Gaps = 5/128 (3%)
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
C + EY + G L + H + + +I +EY+HS+ V++RD+K EN+++
Sbjct: 71 CFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 128
Query: 318 DQEFHLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
D++ H+KI DFG+ C+E D + GT ++APE+++ YGR VD + G++++E
Sbjct: 129 DKDGHIKITDFGL-CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 187
Query: 376 MVAGTIPY 383
M+ G +P+
Sbjct: 188 MMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-19
Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 33/212 (15%)
Query: 190 GAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
GA +Y GI+ + PVA+K++R E + + K+ E +++ + +P
Sbjct: 18 GAFGTVYKGIWIPDGENVKIPVAIKVLR-------ENTSPKANKEILDEAYVMAGVGSPY 70
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEYIHS 302
V + + C V ++T+ + G L Y+ E+K + L+ + IA+GM Y+
Sbjct: 71 VCRLLGICLTSTVQ-LVTQLMPYGCLLDYVR--ENKDRIGSQDLLNWCVQIAKGMSYLEE 127
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---------RWMAPE 353
++HRDL NVL+ H+KI DFG+A L D Y +WMA E
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLA------RLLDIDETEYHADGGKVPIKWMALE 181
Query: 354 MIKHKSYGRKVDVYSFGLILWE-MVAGTIPYE 384
I H+ + + DV+S+G+ +WE M G PY+
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 1e-19
Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 25/195 (12%)
Query: 204 PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEY 263
PVA+K I+ D +T + + L + +++ + C + ++T+
Sbjct: 38 PVAIKTIQ--DRSGRQTFQEITDHMLA-----MGSLDHAYIVRLLGICPGASLQ-LVTQL 89
Query: 264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323
GSL ++ + P +L+ + IA+GM Y+ ++HR+L N+L+ + +
Sbjct: 90 SPLGSLLDHVRQHRDSLDP-QRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIV 148
Query: 324 KIADFGIACEEVYCDALSDDPGTY---------RWMAPEMIKHKSYGRKVDVYSFGLILW 374
+IADFG+A D L D Y +WMA E I Y + DV+S+G+ +W
Sbjct: 149 QIADFGVA------DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVW 202
Query: 375 EMVA-GTIPYEEMNP 388
EM++ G PY M P
Sbjct: 203 EMMSYGAEPYAGMRP 217
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 42/128 (32%), Positives = 77/128 (60%), Gaps = 5/128 (3%)
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
C + EY++ G L + H + + +I ++Y+HS +++RDLK EN+++
Sbjct: 71 CFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML 128
Query: 318 DQEFHLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
D++ H+KI DFG+ C+E DA + GT ++APE+++ YGR VD + G++++E
Sbjct: 129 DKDGHIKITDFGL-CKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 187
Query: 376 MVAGTIPY 383
M+ G +P+
Sbjct: 188 MMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 42/175 (24%), Positives = 83/175 (47%), Gaps = 17/175 (9%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
E+ +LS L +PN+I + + EY + G+L + + + + ++
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP------- 344
I + YIH G++HRD+K N+ + + +K+ DFGI+ L +
Sbjct: 109 QIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGIS------KILGSEYSMAETVV 162
Query: 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399
GT +M+PE+ + Y K D+++ G +L+E++ ++ NP+ +V K+
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL----NLVVKI 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 20/178 (11%)
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL----------- 273
L ++F E + SRL +PN++ + K +I Y S L +L
Sbjct: 51 LREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGS 110
Query: 274 ---HKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330
K TL + I IA GME++ S V+H+DL NVL+ + ++KI+D G+
Sbjct: 111 TDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL 170
Query: 331 ACEEVYC----DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPY 383
EVY + + RWM+PE I + + D++S+G++LWE+ + G PY
Sbjct: 171 F-REVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 3e-19
Identities = 49/184 (26%), Positives = 96/184 (52%), Gaps = 7/184 (3%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
V +K I + ++E LAA+ E +L L +PN+I++ + ++ EY
Sbjct: 28 VIIKQIPVEQMTKDERLAAQ------NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81
Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-EFHL 323
G+L Y+ K + L ++ + I + ++H++ ++HRDLK +N+L+D+ + +
Sbjct: 82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVV 141
Query: 324 KIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
KI DFGI+ GT +++PE+ + K Y +K D+++ G +L+E+ + +
Sbjct: 142 KIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAF 201
Query: 384 EEMN 387
E N
Sbjct: 202 EAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 4e-19
Identities = 54/154 (35%), Positives = 80/154 (51%), Gaps = 18/154 (11%)
Query: 231 REVALLSRLHNPNVIKFVAA-CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL-PKLI- 287
RE+ LL L +PN+I + K + V E++ E L + K++ L P I
Sbjct: 51 REIKLLQELKHPNIIGLLDVFGHKSNINLVF-EFM-ETDLEKVIKD---KSIVLTPADIK 105
Query: 288 AIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY 347
+ L RG+EY+HS ++HRDLKP N+LI + LK+ADFG+A + T+
Sbjct: 106 SYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS----PNRKMTH 161
Query: 348 ----RWM-APEMI-KHKSYGRKVDVYSFGLILWE 375
RW APE++ + YG VD++S G I E
Sbjct: 162 QVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-19
Identities = 46/108 (42%), Positives = 65/108 (60%), Gaps = 6/108 (5%)
Query: 281 LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL 340
L L LI+ + +ARGME++ S+ IHRDL N+L+ + +KI DFG+A ++Y D
Sbjct: 170 LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA-RDIYKDPD 228
Query: 341 SDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPY 383
G R WMAPE I K Y + DV+SFG++LWE+ + G PY
Sbjct: 229 YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 5e-19
Identities = 51/176 (28%), Positives = 87/176 (49%), Gaps = 34/176 (19%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
E +L+ NP V+ + + C++ EY+ G L + LP +
Sbjct: 51 ERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG----ALP------V 100
Query: 292 DIAR--------GMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA-------CEEVY 336
D+AR +EY+H+ G++HRDLKP+N+LI H+K+ DFG++ +Y
Sbjct: 101 DMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160
Query: 337 CDALSDDP---------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
+ D GT ++APE+I + YG+ VD ++ G+IL+E + G +P+
Sbjct: 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 5e-19
Identities = 56/180 (31%), Positives = 94/180 (52%), Gaps = 15/180 (8%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---NPNVIKFVAACK-----KPPV 256
VA+K +R+ +E L+ REVA+L L +PNV++ C +
Sbjct: 30 VALKRVRVQTGEEGMPLSTI------REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 83
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
++ E++ + L YL K+ +P + + + RG++++HS V+HRDLKP+N+L
Sbjct: 84 LTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNIL 142
Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
+ +K+ADFG+A + AL+ T + APE++ SY VD++S G I EM
Sbjct: 143 VTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 6e-19
Identities = 60/223 (26%), Positives = 110/223 (49%), Gaps = 24/223 (10%)
Query: 188 AHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNV 244
+G + ++Y G + + A+K++ + D+E E +E+ +L + H+ N+
Sbjct: 15 GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE---------IKQEINMLKKYSHHRNI 65
Query: 245 IKFVAAC--KKPP----VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
+ A K PP ++ E+ GS+ + + TL + I +I RG+
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIK- 356
++H VIHRD+K +NVL+ + +K+ DFG++ + + + GT WMAPE+I
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 357 ----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
+Y K D++S G+ EM G P +M+P++A F +
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 7e-19
Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 17/212 (8%)
Query: 186 RFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNV 244
R A G +++ H +AVK IR D+ + +K+ ++ ++ R + P +
Sbjct: 14 RGAFGTVNKMLHKPSGTI-MAVKRIRSTVDE-------KEQKRLLMDLDVVMRSSDCPYI 65
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLR---AYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
+KF A + C I L + SL Y++++ +P L IA+ + + Y+
Sbjct: 66 VKFYGALFREGD-CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK 124
Query: 302 SQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI---KH 357
+ +IHRD+KP N+L+D+ ++K+ DFGI+ + V A + D G +MAPE I
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAR 184
Query: 358 KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI 389
Y + DV+S G+ L+E+ G PY + N +
Sbjct: 185 DGYDVRSDVWSLGITLYEVATGKFPYPKWNSV 216
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 7e-19
Identities = 50/148 (33%), Positives = 78/148 (52%), Gaps = 4/148 (2%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYC-VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
E LL +++P+VI+ + C V+ Y S+ L YL K + LP+ + + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSD--LYTYLTK-RSRPLPIDQALIIE 163
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWM 350
I G+ Y+H+Q +IHRD+K EN+ I+ + I D G A V A GT
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETN 223
Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVA 378
APE++ Y K D++S G++L+EM+A
Sbjct: 224 APEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 17/226 (7%)
Query: 183 LGLRFAHGAHSRLY--HGIYKDEPVAVKIIRI-PDDDENETLAARLEKQFNREVALLSRL 239
LG GA R+Y + +AVK ++ P+ E LE E+ LL L
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALEC----EIQLLKNL 61
Query: 240 HNPNVIKFVAACKKPP--VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGM 297
+ ++++ + P + E++ GS++ L T + + I G+
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR--KYTRQILEGV 119
Query: 298 EYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-----PGTYRWMAP 352
Y+HS ++HRD+K N+L D ++K+ DFG A + + LS GT WM+P
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSVGNVKLGDFG-ASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 353 EMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
E+I + YGRK D++S G + EM+ P+ E + A F + +
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ 224
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-18
Identities = 46/145 (31%), Positives = 83/145 (57%), Gaps = 9/145 (6%)
Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318
++ EY++ G L H + LP A +I + ++H +G+I+RDLK +NVL+D
Sbjct: 73 LVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130
Query: 319 QEFHLKIADFGIACEEVY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMV 377
+ H+K+ D+G+ E + D S GT ++APE+++ + YG VD ++ G++++EM+
Sbjct: 131 ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMM 190
Query: 378 AGTIPYE------EMNPIQAAFAVV 396
AG P++ +MN F V+
Sbjct: 191 AGRSPFDIITDNPDMNTEDYLFQVI 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-18
Identities = 50/188 (26%), Positives = 92/188 (48%), Gaps = 15/188 (7%)
Query: 204 PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEY 263
PVA+ +R + + + F E L + + N+++ + ++TEY
Sbjct: 35 PVAIHTLR-------AGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEY 87
Query: 264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323
+S G+L ++L K E + L +L+ + +A GM+Y+ G +H+ L VL++ +
Sbjct: 88 MSNGALDSFLRKHEGQ-LVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVC 146
Query: 324 KIADFGIA----CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA- 378
KI+ F E +Y P W APE I++ + DV+SFG+++WE+++
Sbjct: 147 KISGFRRLQEDKSEAIYTTMSGKSPVL--WAAPEAIQYHHFSSASDVWSFGIVMWEVMSY 204
Query: 379 GTIPYEEM 386
G PY +M
Sbjct: 205 GERPYWDM 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 43/126 (34%), Positives = 77/126 (61%), Gaps = 3/126 (2%)
Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
+ EY++ G L H + LP + +I+ + Y+H +G+I+RDLK +NVL+D
Sbjct: 74 VIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 131
Query: 320 EFHLKIADFGIACEEVY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
E H+K+ D+G+ E + D S GT ++APE+++ + YG VD ++ G++++EM+A
Sbjct: 132 EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 191
Query: 379 GTIPYE 384
G P++
Sbjct: 192 GRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 69/226 (30%), Positives = 108/226 (47%), Gaps = 18/226 (7%)
Query: 177 DLSQLFLGL-RFAHGAHSRLYHGI--YKDEPVAVKIIRIPDDDENETLAARLEKQFNREV 233
D ++F+GL HG+ +Y + +E VAVK + NE + +EV
Sbjct: 18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKW-----QDIIKEV 72
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEY-LSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
L +L +PN I++ K ++ EY L S +HK K L ++ AI
Sbjct: 73 KFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAITHG 129
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
+G+ Y+HS +IHRD+K N+L+ + +K+ADFG A + ++ GT WMAP
Sbjct: 130 ALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV---GTPYWMAP 186
Query: 353 EMI---KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
E+I Y KVDV+S G+ E+ P MN + A + +
Sbjct: 187 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 68/226 (30%), Positives = 106/226 (46%), Gaps = 18/226 (7%)
Query: 177 DLSQLFLGLR-FAHGAHSRLY--HGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREV 233
D +LF LR HG+ +Y + +E VA+K + NE + +EV
Sbjct: 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKW-----QDIIKEV 76
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEY-LSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
L R+ +PN I++ + ++ EY L S +HK K L ++ AI
Sbjct: 77 KFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAITHG 133
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
+G+ Y+HS +IHRD+K N+L+ + +K+ADFG A ++ GT WMAP
Sbjct: 134 ALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV---GTPYWMAP 190
Query: 353 EMI---KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
E+I Y KVDV+S G+ E+ P MN + A + +
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 41/125 (32%), Positives = 74/125 (59%), Gaps = 3/125 (2%)
Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
+ ++++ G L + H ++ P P+ A +IA + Y+HS +++RDLKPEN+L+D
Sbjct: 74 VLDFVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDS 131
Query: 320 EFHLKIADFGIACEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
+ H+ + DFG+ E + D + GT ++APE+I+ + Y VD + G +L+EM+
Sbjct: 132 QGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLY 191
Query: 379 GTIPY 383
G P+
Sbjct: 192 GLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-18
Identities = 46/150 (30%), Positives = 82/150 (54%), Gaps = 3/150 (2%)
Query: 235 LLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIA 294
LL L +P ++ + + + +Y++ G L + H + P+ A ++A
Sbjct: 49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVA 106
Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-DALSDDPGTYRWMAPE 353
+ Y+HS +I+RDLKPEN+L+D + H+ + DFG+ E V + S GT ++APE
Sbjct: 107 SAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPE 166
Query: 354 MIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
+++ + Y R VD + G +L+EM+ G P+
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-18
Identities = 58/223 (26%), Positives = 111/223 (49%), Gaps = 24/223 (10%)
Query: 188 AHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNV 244
+G + ++Y G + + A+K++ + +D+E E E+ +L + H+ N+
Sbjct: 25 GNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEE---------IKLEINMLKKYSHHRNI 75
Query: 245 IKFVAAC--KKPPVY----CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
+ A K PP + ++ E+ GS+ + + L + I +I RG+
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135
Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIK- 356
++H+ VIHRD+K +NVL+ + +K+ DFG++ + + + GT WMAPE+I
Sbjct: 136 HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 357 ----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
+Y + D++S G+ EM G P +M+P++A F +
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 57/180 (31%), Positives = 93/180 (51%), Gaps = 18/180 (10%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
VA+K IR+ ++E A RE++LL L +PN++ + +I E+L
Sbjct: 28 VAMKKIRLESEEEGVPSTAI------REISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81
Query: 265 SEGSLRAYLHKL-EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323
S L+ YL L + + + + + I +G+ + HS+ V+HRDLKP+N+LID + +
Sbjct: 82 SM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVI 140
Query: 324 KIADFGIACE-----EVYCDALSDDPGTYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMV 377
K+ADFG+A VY + + T + APE ++ Y VD++S G I EM
Sbjct: 141 KLADFGLARAFGIPVRVY----THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 3e-18
Identities = 57/188 (30%), Positives = 95/188 (50%), Gaps = 21/188 (11%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP--VYCVITE 262
VA+K++R D E E AR F RE AL +RL++PN++ + + + PP ++ V E
Sbjct: 6 VAIKLLRT-DAPEEEHQRAR----FRRETALCARLYHPNIVALLDSGEAPPGLLFAVF-E 59
Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---DQ 319
Y+ +LR L LP + + L + + H+QG++HRDLKP+N+++
Sbjct: 60 YVPGRTLREVLAA--DGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 320 EFHLKIADFGI--------ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGL 371
H K+ DFGI + ++ GT + APE ++ + D+Y++GL
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 372 ILWEMVAG 379
I E + G
Sbjct: 178 IFLECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 43/125 (34%), Positives = 75/125 (60%), Gaps = 3/125 (2%)
Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
+ +Y++ G L + H ++ P P+ A +IA + Y+HS +I+RDLKPEN+L+D
Sbjct: 74 VLDYVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDS 131
Query: 320 EFHLKIADFGIACEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
+ H+ + DFG+ E + + S GT ++APE+++ + Y R VD + G +L+EM+
Sbjct: 132 QGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY 191
Query: 379 GTIPY 383
G P+
Sbjct: 192 GLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 42/126 (33%), Positives = 77/126 (61%), Gaps = 3/126 (2%)
Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
+ E++S G L H + LP + +I+ + ++H +G+I+RDLK +NVL+D
Sbjct: 74 VIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA 131
Query: 320 EFHLKIADFGIACEEVY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
E H+K+ D+G+ E + D S GT ++APE+++ + YG VD ++ G++++EM+A
Sbjct: 132 EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 191
Query: 379 GTIPYE 384
G P++
Sbjct: 192 GRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 45/108 (41%), Positives = 65/108 (60%), Gaps = 6/108 (5%)
Query: 281 LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL 340
L + LI + +ARGME++ S+ IHRDL N+L+ + +KI DFG+A ++Y D
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA-RDIYKDPD 229
Query: 341 SDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPY 383
G+ R WMAPE I K Y + DV+SFG++LWE+ + G PY
Sbjct: 230 YVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 5e-18
Identities = 39/154 (25%), Positives = 85/154 (55%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
E +L ++++ V+ A + C++ ++ G L+ +++ + + + I A
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
++ G+E + + +++RDLKPEN+L+D H++I+D G+A + + + GT +MA
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMA 169
Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
PE+I ++ Y D + G +++EM+ G P+ +
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 7e-18
Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 22/167 (13%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL-----EHKTL 281
K RE+ +L + + +I + A + C++ + Y L L
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV--------MPKYKCDLFTYVDRSGPL 182
Query: 282 PLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALS 341
PL + I I + + Y+H +G+IHRD+K EN+ +D+ + + DFG AC+ DA
Sbjct: 183 PLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACK---LDAHP 239
Query: 342 DDPGTYRWM------APEMIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
D P Y W +PE++ Y K D++S GL+L+EM +
Sbjct: 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 8e-18
Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 23/228 (10%)
Query: 184 GLRFAHGAHSRLY--HGIYKDEPVAVKIIRI-PDDDENETLAARLEKQFNREVALLSRLH 240
G GA R+Y + + +A K ++ P+ E + LE E+ LL L
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC----EIQLLKNLQ 62
Query: 241 NPNVIKFVAACKK--PPVYCVITEYLSEGS----LRAYLHKLEHKTLPLPKLIAIALDIA 294
+ ++++ + + EY+ GS L+AY E T + I
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR------QIL 116
Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE-EVYC---DALSDDPGTYRWM 350
GM Y+HS ++HRD+K N+L D ++K+ DFG + + C + GT WM
Sbjct: 117 EGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176
Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
+PE+I + YGRK DV+S G + EM+ P+ E + A F + +
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ 224
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 9e-18
Identities = 46/113 (40%), Positives = 66/113 (58%), Gaps = 6/113 (5%)
Query: 276 LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335
L K L L LI + +A+GME++ S+ IHRDL N+L+ + +KI DFG+A ++
Sbjct: 171 LYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA-RDI 229
Query: 336 YCDALSDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPY 383
Y D G R WMAPE I + Y + DV+SFG++LWE+ + G PY
Sbjct: 230 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 18/226 (7%)
Query: 177 DLSQLFLGLR-FAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREV 233
D +LF LR HG+ +Y + E VA+K + NE + +EV
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW-----QDIIKEV 66
Query: 234 ALLSRLHNPNVIKFVAACKKPPVYCVITEY-LSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
L +L +PN I++ + ++ EY L S +HK K L ++ A+
Sbjct: 67 RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHG 123
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
+G+ Y+HS +IHRD+K N+L+ + +K+ DFG A + GT WMAP
Sbjct: 124 ALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV---GTPYWMAP 180
Query: 353 EMI---KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
E+I Y KVDV+S G+ E+ P MN + A + +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 46/158 (29%), Positives = 86/158 (54%), Gaps = 12/158 (7%)
Query: 233 VALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
++L+S P ++ A P I + ++ G L + H +H ++ A +
Sbjct: 48 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEAEMRFYAAE 105
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP----GTYR 348
I G+E++H++ V++RDLKP N+L+D+ H++I+D G+A CD P GT+
Sbjct: 106 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHG 160
Query: 349 WMAPEMI-KHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
+MAPE++ K +Y D +S G +L++++ G P+ +
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 43/140 (30%), Positives = 78/140 (55%), Gaps = 3/140 (2%)
Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
+ +Y++ G L + H + P+ A +IA + Y+HS +++RDLKPEN+L+D
Sbjct: 74 VLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS 131
Query: 320 EFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
+ H+ + DFG+ E + + + GT ++APE++ + Y R VD + G +L+EM+
Sbjct: 132 QGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 191
Query: 379 GTIPYEEMNPIQAAFAVVNK 398
G P+ N + ++NK
Sbjct: 192 GLPPFYSRNTAEMYDNILNK 211
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 37/90 (41%), Positives = 54/90 (60%), Gaps = 4/90 (4%)
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV-YCDALSDDPGTYRWMAPEMIKHK 358
+H G IHRDLKPEN LID H+K+ DFG++ V Y +++ P +MAPE+++ K
Sbjct: 117 LHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSP---DYMAPEVLRGK 173
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNP 388
Y VD +S G +L+E + G P+ P
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-17
Identities = 48/160 (30%), Positives = 87/160 (54%), Gaps = 2/160 (1%)
Query: 219 ETLAARLEKQFNREVALLSRLHNPNVIKFVAACK-KPPVYCVITEYLSEGSLRAYLHKLE 277
+ R K +E LLS+L +PN++ + + + + + ++ + G L L + +
Sbjct: 36 RNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQK 95
Query: 278 HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVY 336
K LP +++ + IA ++Y+H + ++HRDLK +NV + + +K+ D GIA E
Sbjct: 96 GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155
Query: 337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
CD S GT +M+PE+ +K Y K DV++ G ++EM
Sbjct: 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-17
Identities = 59/220 (26%), Positives = 110/220 (50%), Gaps = 18/220 (8%)
Query: 178 LSQLFLGLRFAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
L+ + + G S +Y + +PVA+K ++I E + A+ + +E+ L
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQI-----FEMMDAKARQDCVKEIDL 55
Query: 236 LSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLH--KLEHKTLPLPKLIAIALDI 293
L +L++PNVIK++ + + ++ E G L + K + + +P + + +
Sbjct: 56 LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115
Query: 294 ARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI----ACEEVYCDALSDDPGTYRW 349
+E++HS+ V+HRD+KP NV I +K+ D G+ + + +L GT +
Sbjct: 116 CSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYY 172
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY--EEMN 387
M+PE I Y K D++S G +L+EM A P+ ++MN
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 49/180 (27%), Positives = 90/180 (50%), Gaps = 25/180 (13%)
Query: 216 DENETLAARLEKQFN--------REVALLSRL-HNPNVIKFVAACKKPPVYCV--ITEYL 264
++K F RE+ L RL +PN+++ + + + E L
Sbjct: 23 TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE-L 81
Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
+ +L + K + LP ++ + + + ++++H G+ HRD+KPEN+LI + LK
Sbjct: 82 MDMNLYELI-KGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILK 139
Query: 325 IADFGIACEEVYCDALSDDPGT-Y---RWM-APE-MIKHKSYGRKVDVYSFGLILWEMVA 378
+ADFG +C +Y S P T Y RW APE ++ YG K+D+++ G + +E+++
Sbjct: 140 LADFG-SCRGIY----SKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 12/209 (5%)
Query: 186 RFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
+ G S +Y PVA+K ++I D + A+ +E+ LL +L++PN
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFD-----LMDAKARADCIKEIDLLKQLNHPN 63
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLH--KLEHKTLPLPKLIAIALDIARGMEYIH 301
VIK+ A+ + ++ E G L + K + + +P + + + +E++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPEMIKHKSY 360
S+ V+HRD+KP NV I +K+ D G+ A GT +M+PE I Y
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 361 GRKVDVYSFGLILWEMVAGTIPY--EEMN 387
K D++S G +L+EM A P+ ++MN
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMN 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-17
Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 37/209 (17%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEY 263
VA+K IR D EN L+K+F RE + + L +P ++ + C PVY + Y
Sbjct: 30 VALKKIR-EDLSENP----LLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP-Y 83
Query: 264 LSEGSLRAYLH----------KLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPE 313
+ +L++ L +L KT + ++I I +EY+HS+GV+HRDLKP+
Sbjct: 84 IEGYTLKSLLKSVWQKESLSKELAEKT-SVGAFLSIFHKICATIEYVHSKGVLHRDLKPD 142
Query: 314 NVLIDQEFHLKIADFGIAC-----EEVYCDALSDDP--------------GTYRWMAPEM 354
N+L+ + I D+G A EE D D+ GT +MAPE
Sbjct: 143 NILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPER 202
Query: 355 IKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
+ D+Y+ G+IL++M+ + PY
Sbjct: 203 LLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 50/202 (24%), Positives = 94/202 (46%), Gaps = 33/202 (16%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
E +L+ L +P + A+ + C++ +Y G L L + K L A
Sbjct: 51 EQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA 110
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC------------------- 332
++ +EY+H G+++RDLKPEN+L+ + H+ ++DF ++
Sbjct: 111 EVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
Query: 333 ---EEVYCDALSDDP--------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI 381
+ + S++P GT ++APE+I +G VD ++ G++L+EM+ GT
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230
Query: 382 PYEEMNPIQAAFA--VVNKVNF 401
P++ N F+ + +V F
Sbjct: 231 PFKGSN-RDETFSNILKKEVTF 251
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 65/212 (30%), Positives = 95/212 (44%), Gaps = 34/212 (16%)
Query: 189 HGAH----SRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PN 243
GA+ S ++E VA+K +I + + LA R RE+ LL N
Sbjct: 10 QGAYGIVCSARNAETSEEETVAIK--KITNVFSKKILAKRAL----RELKLLRHFRGHKN 63
Query: 244 VIKFVAACKKPPVYCVITE-YLSEGSLRAYLHKLEHKTLPLPK--LIAIALDIARGMEYI 300
+ E YL E + A LH++ PL + I G++YI
Sbjct: 64 ITCLYDM--DIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYI 121
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPG----------TYRWM 350
HS V+HRDLKP N+L++ + LKI DFG+A S++PG RW
Sbjct: 122 HSANVLHRDLKPGNLLVNADCELKICDFGLAR------GFSENPGENAGFMTEYVATRWY 175
Query: 351 -APE-MIKHKSYGRKVDVYSFGLILWEMVAGT 380
APE M+ +SY + +DV+S G IL E++
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 3e-17
Identities = 41/165 (24%), Positives = 86/165 (52%), Gaps = 3/165 (1%)
Query: 238 RLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK--TLPLPKLIAIALDIAR 295
+L +PN++++ + ++ + + L + + L+ K ++ I + +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 296 GMEYIHSQG-VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEM 354
+ Y+H + ++HRDL P N+++ ++ + I DFG+A ++ L+ GT + PE+
Sbjct: 125 ALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEI 184
Query: 355 IKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399
+K++ YG K DV++FG IL++M P+ N + A +V V
Sbjct: 185 VKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 47/214 (21%), Positives = 94/214 (43%), Gaps = 16/214 (7%)
Query: 194 RLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK----FVA 249
+Y GI+ ++ V ++ + + E+ L R+ + N++K +
Sbjct: 35 SIYKGIFNNKEVIIRTFKKFHKGHKVLI-----DITENEIKNLRRIDSNNILKIYGFIID 89
Query: 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH-SQGVIHR 308
P +I EY + G LR L K K L + +A+D +G+ ++ ++
Sbjct: 90 IVDDLPRLSLILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYK 147
Query: 309 DLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKH--KSYGRKVDV 366
+L + L+ + + LKI G+ E++ + + + +M+ Y K D+
Sbjct: 148 NLTSVSFLVTENYKLKIICHGL--EKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDI 205
Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400
YS G++LWE+ G IP+E + + ++NK N
Sbjct: 206 YSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN 239
|
Length = 283 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 42/129 (32%), Positives = 76/129 (58%), Gaps = 6/129 (4%)
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVL 316
C + EY + G L + H + + +I ++Y+HS+ V++RDLK EN++
Sbjct: 71 CFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 128
Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLILW 374
+D++ H+KI DFG+ C+E D + GT ++APE+++ YGR VD + G++++
Sbjct: 129 LDKDGHIKITDFGL-CKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 187
Query: 375 EMVAGTIPY 383
EM+ G +P+
Sbjct: 188 EMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 4e-17
Identities = 47/158 (29%), Positives = 87/158 (55%), Gaps = 12/158 (7%)
Query: 233 VALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
++L+S P ++ A P C I + ++ G L + H +H ++ A +
Sbjct: 48 LSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDL--HYHLSQHGVFSEKEMRFYATE 105
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP----GTYR 348
I G+E++H++ V++RDLKP N+L+D+ H++I+D G+A CD P GT+
Sbjct: 106 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHG 160
Query: 349 WMAPEMI-KHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
+MAPE++ K +Y D +S G +L++++ G P+ +
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 38/223 (17%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF-------------- 247
D+ VAVK I + D + K RE+ ++ RL + N++K
Sbjct: 30 DKRVAVKKIVLTD--------PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
V + + ++ EY+ E L L E L + RG++YIHS V+H
Sbjct: 82 VGSLTELNSVYIVQEYM-ETDLANVL---EQGPLSEEHARLFMYQLLRGLKYIHSANVLH 137
Query: 308 RDLKPENVLIDQE-FHLKIADFGIA----CEEVYCDALSDDPGTYRWMAPEMIKH-KSYG 361
RDLKP NV I+ E LKI DFG+A + LS+ T + +P ++ +Y
Sbjct: 138 RDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYT 197
Query: 362 RKVDVYSFGLILWEMV------AGTIPYEEMNPIQAAFAVVNK 398
+ +D+++ G I EM+ AG E+M I + VV +
Sbjct: 198 KAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 5e-17
Identities = 52/199 (26%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
+ G ++ +Y G + E VA+K I + D E T + + RE++L+ L + N
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHL--DAEEGTPSTAI-----REISLMKELKHEN 59
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEYIHS 302
+++ ++ EY+ + L+ Y+ + L + + + +G+ + H
Sbjct: 60 IVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSY 360
V+HRDLKP+N+LI++ LK+ADFG+A + + S++ T + AP+ ++ ++Y
Sbjct: 119 NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY 178
Query: 361 GRKVDVYSFGLILWEMVAG 379
+D++S G I+ EM+ G
Sbjct: 179 STSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 49/164 (29%), Positives = 89/164 (54%), Gaps = 15/164 (9%)
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
F E +++ ++P V++ A + ++ EY+ G L ++ + + +P
Sbjct: 90 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL---VNLMSNYDVPEKWAKF 146
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE-----EVYCDALSDD 343
++ ++ IHS G+IHRD+KP+N+L+D+ HLK+ADFG + V CD
Sbjct: 147 YTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-- 204
Query: 344 PGTYRWMAPEMIKHKS----YGRKVDVYSFGLILWEMVAGTIPY 383
GT +++PE++K + YGR+ D +S G+ L+EM+ G P+
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 8e-17
Identities = 65/231 (28%), Positives = 106/231 (45%), Gaps = 27/231 (11%)
Query: 183 LGLRFAHGAHSRLYHGIYKDEPVAVKIIRIP-DDDENETLAARLEKQFNR---EVALLSR 238
LG GA +Y D + + ++P D D ET K+ N E+ LL
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQET-----SKEVNALECEIQLLKN 60
Query: 239 LHNPNVIKFVAACKKPP--VYCVITEYLSEGS----LRAYLHKLEHKTLPLPKLIAIALD 292
L + ++++ + P + EY+ GS L+AY E+ T +
Sbjct: 61 LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR------Q 114
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-----PGTY 347
I +G+ Y+HS ++HRD+K N+L D ++K+ DFG A + + +S GT
Sbjct: 115 ILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFG-ASKRIQTICMSGTGIKSVTGTP 173
Query: 348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
WM+PE+I + YGRK DV+S + EM+ P+ E + A F + +
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQ 224
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 59/180 (32%), Positives = 92/180 (51%), Gaps = 12/180 (6%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
E VA+K + P ++E A K+ RE+ LL + + NVI + +
Sbjct: 41 EKVAIKKLSRPF--QSEIFA----KRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94
Query: 263 -YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
YL ++ L K+ L K+ + + G++YIHS G+IHRDLKP N+ ++++
Sbjct: 95 FYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC 154
Query: 322 HLKIADFGIACEEVYCDALSDDPGTYRWM-APEMIKH-KSYGRKVDVYSFGLILWEMVAG 379
LKI DFG+A + DA RW APE+I + Y + VD++S G I+ EM+ G
Sbjct: 155 ELKILDFGLA---RHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 56/177 (31%), Positives = 89/177 (50%), Gaps = 15/177 (8%)
Query: 220 TLAARLEKQFNREVALLSRLHNPNVIKFVAACK-KPPVYCVITEYLSEGSLRAYLHKLEH 278
LA F E +LS ++P + + A + K +Y V+ EY G L + L++ E
Sbjct: 39 LLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM-EYQPGGDLLSLLNRYED 97
Query: 279 KTLPLPKLIA--IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE-EV 335
+ +A ++ + +H G +HRD+KPENVLID+ H+K+ADFG A
Sbjct: 98 ---QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154
Query: 336 YCDALSDDP-GTYRWMAPEMIK------HKSYGRKVDVYSFGLILWEMVAGTIPYEE 385
S P GT ++APE++ +YG + D +S G+I +EM+ G P+ E
Sbjct: 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 54/176 (30%), Positives = 95/176 (53%), Gaps = 19/176 (10%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYC-----VITEYLSEGSLRAYLHKLEHKTL 281
K+ RE+ +L + NV+ + + P + V+TE + ++ LHK+
Sbjct: 44 KRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELM-----QSDLHKIIVSPQ 98
Query: 282 PL-PKLIAIAL-DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA 339
PL + + L I RG++Y+HS G++HRD+KP N+L++ LKI DFG+A E ++
Sbjct: 99 PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158
Query: 340 --LSDDPGTYRWMAPEMI---KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390
++ + T + APE++ +H Y VD++S G I E++ I ++ +PIQ
Sbjct: 159 KHMTQEVVTQYYRAPEILMGSRH--YTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-16
Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 14/183 (7%)
Query: 228 QFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPK-- 285
F +EV L++PNV++ + C + Y ++ E+ G L+ YL + +
Sbjct: 41 LFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD 100
Query: 286 -LIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344
L +A ++A G+ ++H IH DL N + + +KI D+G+A E+ D
Sbjct: 101 VLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160
Query: 345 GTY---RWMAPEM-------IKHKSYGRKVDVYSFGLILWEMV-AGTIPYEEMNPIQAAF 393
RW+APE+ + K +K +++S G+ +WE+ A PY +++ Q
Sbjct: 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLK 220
Query: 394 AVV 396
VV
Sbjct: 221 QVV 223
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 55/222 (24%), Positives = 100/222 (45%), Gaps = 24/222 (10%)
Query: 183 LGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP 242
+G F L + VAVK I + D E L K +E+ +L +P
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINL-DSCSKEDL-----KLLQQEIITSRQLQHP 59
Query: 243 NVIKFVAA-CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL---DIARGME 298
N++ +V + +Y V++ ++ GS L H LP+L AIA D+ ++
Sbjct: 60 NILPYVTSFIVDSELY-VVSPLMAYGSCEDLLK--THFPEGLPEL-AIAFILKDVLNALD 115
Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTY-----RWM 350
YIHS+G IHR +K ++L+ + + ++ + + + D W+
Sbjct: 116 YIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175
Query: 351 APEMIKH--KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390
+PE+++ + Y K D+YS G+ E+ G +P+++M Q
Sbjct: 176 SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 41/136 (30%), Positives = 79/136 (58%), Gaps = 20/136 (14%)
Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318
+I +Y++ G L +L++ EH T ++ + +A ++++H G+I+RD+K EN+L+D
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLA--LDHLHQLGIIYRDIKLENILLD 139
Query: 319 QEFHLKIADFGIACEEV---------YCDALSDDPGTYRWMAPEMIKHKS--YGRKVDVY 367
E H+ + DFG++ E + +C GT +MAPE+I+ S + + VD +
Sbjct: 140 SEGHVVLTDFGLSKEFLAEEEERAYSFC-------GTIEYMAPEVIRGGSGGHDKAVDWW 192
Query: 368 SFGLILWEMVAGTIPY 383
S G++ +E++ G P+
Sbjct: 193 SLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 4e-16
Identities = 43/165 (26%), Positives = 91/165 (55%), Gaps = 14/165 (8%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
+EV LL+++ +PN++ F A+ ++ ++ EY G L +++ ++++
Sbjct: 48 KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF 107
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL-KIADFGIACEEVYCDALSDD------ 343
+ I+ G+++IH + ++HRD+K +N+ + + + K+ DFGIA L+D
Sbjct: 108 VQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIA------RQLNDSMELAYT 161
Query: 344 -PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
GT +++PE+ +++ Y K D++S G +L+E+ P+E N
Sbjct: 162 CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 55/198 (27%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
+ G ++ +Y G K D VA+K IR+ ++ A R EV+LL L + N
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-------EVSLLKDLKHAN 65
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
++ ++ EYL + L+ YL + ++ + + + RG+ Y H +
Sbjct: 66 IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRR 123
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
V+HRDLKP+N+LI++ LK+ADFG+A + + S++ T + P+ ++ Y
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 362 RKVDVYSFGLILWEMVAG 379
++D++ G I +EM G
Sbjct: 184 TQIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 35/176 (19%)
Query: 231 REVALLSRLHNPNVIKFV--------AACKKPPVYCVITEYLSEGSLRAYLH----KLEH 278
RE+ +L +L +PNV+ + + +K ++T Y+ + L L KL
Sbjct: 56 REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKLTE 114
Query: 279 KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338
++ L + G+ Y+H ++HRD+K N+LID + LKIADFG+A Y
Sbjct: 115 -----SQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA--RPYDG 167
Query: 339 ALSDDPG-------TY------RWM-APEMIKH-KSYGRKVDVYSFGLILWEMVAG 379
+ G Y RW PE++ + Y VD++ G + EM
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 49/164 (29%), Positives = 88/164 (53%), Gaps = 15/164 (9%)
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
F E +++ ++P V++ A + ++ EY+ G L ++ + + +P
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARF 146
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE-----EVYCDALSDD 343
++ ++ IHS G IHRD+KP+N+L+D+ HLK+ADFG + V CD
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-- 204
Query: 344 PGTYRWMAPEMIKHKS----YGRKVDVYSFGLILWEMVAGTIPY 383
GT +++PE++K + YGR+ D +S G+ L+EM+ G P+
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 4e-16
Identities = 40/127 (31%), Positives = 74/127 (58%), Gaps = 4/127 (3%)
Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318
++T+Y+S G L +L K + K L +A +E++H +++RDLKPEN+L+D
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLA--LEHLHKYDIVYRDLKPENILLD 130
Query: 319 QEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPE-MIKHKSYGRKVDVYSFGLILWEM 376
H+ + DFG++ + + ++ GT ++APE ++ K Y + VD +S G++++EM
Sbjct: 131 ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190
Query: 377 VAGTIPY 383
G P+
Sbjct: 191 CCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 44/138 (31%), Positives = 72/138 (52%), Gaps = 8/138 (5%)
Query: 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKP 312
+P Y + ++ ++ L + L L++ +ARGME++ S+ +HRDL
Sbjct: 210 RPASY----KGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAA 265
Query: 313 ENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---RWMAPEMIKHKSYGRKVDVYSF 369
NVL+ Q +KI DFG+A + ++ T+ +WMAPE I Y DV+S+
Sbjct: 266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSY 325
Query: 370 GLILWEMVA-GTIPYEEM 386
G++LWE+ + G PY M
Sbjct: 326 GILLWEIFSLGGTPYPGM 343
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 5e-16
Identities = 63/187 (33%), Positives = 96/187 (51%), Gaps = 22/187 (11%)
Query: 200 YKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF--VAACKKPPVY 257
+E +A+K IR+ +DE A RE++LL + + N+++ V +K +Y
Sbjct: 25 VTNETIALKKIRLEQEDEGVPSTAI------REISLLKEMQHGNIVRLQDVVHSEKR-LY 77
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPL---PKLIAIAL-DIARGMEYIHSQGVIHRDLKPE 313
V EYL L K + P+LI L I RG+ Y HS V+HRDLKP+
Sbjct: 78 LVF-EYLDLD-----LKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQ 131
Query: 314 NVLIDQEFH-LKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYGRKVDVYSFG 370
N+LID+ + LK+ADFG+A + + + T + APE ++ + Y VD++S G
Sbjct: 132 NLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVG 191
Query: 371 LILWEMV 377
I EMV
Sbjct: 192 CIFAEMV 198
|
Length = 294 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 29/218 (13%)
Query: 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
LS+L R GA +Y I++ A+K+I +D + +Q RE+ +
Sbjct: 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDT-------VRRQICREIEI 125
Query: 236 LSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR 295
L +++PNV+K V+ E++ GSL + + L +A I
Sbjct: 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG--THIADE----QFLADVARQILS 179
Query: 296 GMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-----GTYRWM 350
G+ Y+H + ++HRD+KP N+LI+ ++KIADFG++ A + DP GT +M
Sbjct: 180 GIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVS----RILAQTMDPCNSSVGTIAYM 235
Query: 351 APEMI----KHKSY-GRKVDVYSFGLILWEMVAGTIPY 383
+PE I H +Y G D++S G+ + E G P+
Sbjct: 236 SPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 37/89 (41%), Positives = 56/89 (62%), Gaps = 5/89 (5%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW-MA 351
I RG++YIHS G+IHRDLKP N+ ++++ LKI DFG+A + D RW A
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRA 183
Query: 352 PEMIKHK-SYGRKVDVYSFGLILWEMVAG 379
PE++ + Y + VD++S G I+ E++ G
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 42/106 (39%), Positives = 62/106 (58%), Gaps = 18/106 (16%)
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE-----EVYCDALS 341
+ +ALD IHS G IHRD+KP+N+L+D+ HLK+ADFG + V CD
Sbjct: 151 VVLALDA------IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV 204
Query: 342 DDPGTYRWMAPEMIK----HKSYGRKVDVYSFGLILWEMVAGTIPY 383
GT +++PE++K YGR+ D +S G+ L+EM+ G P+
Sbjct: 205 ---GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 8e-16
Identities = 42/119 (35%), Positives = 67/119 (56%), Gaps = 7/119 (5%)
Query: 280 TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA 339
L L++ + +A+GM ++ S+ IHRDL N+L+ KI DFG+A ++ D+
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA-RDIRNDS 268
Query: 340 LSDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAF 393
G R WMAPE I + Y + DV+S+G++LWE+ + G+ PY M P+ + F
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM-PVDSKF 326
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 23/166 (13%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCV--ITEYLSEGSLRAYLH-KLEHKTLPLPKLI 287
RE+ALL L + NV+ V + V + +Y +E L + + K + +P +
Sbjct: 51 REIALLRELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSM 109
Query: 288 --AIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH----LKIADFGIACEEVYCDAL- 340
++ I G+ Y+HS V+HRDLKP N+L+ E +KI D G+A ++ L
Sbjct: 110 VKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA--RLFNAPLK 167
Query: 341 ---SDDPG--TYRWMAPEMI---KHKSYGRKVDVYSFGLILWEMVA 378
DP T + APE++ +H Y + +D+++ G I E++
Sbjct: 168 PLADLDPVVVTIWYRAPELLLGARH--YTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 45/154 (29%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLI--A 288
RE+ +L +L +PN++ + ++ ++ EY L++LE +P+ +
Sbjct: 49 REIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD----HTVLNELEKNPRGVPEHLIKK 104
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTY 347
I + + + H IHRD+KPEN+LI ++ +K+ DFG A D +D T
Sbjct: 105 IIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVAT- 163
Query: 348 RWM-APEMI-KHKSYGRKVDVYSFGLILWEMVAG 379
RW APE++ YG VDV++ G + E++ G
Sbjct: 164 RWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 55/187 (29%), Positives = 95/187 (50%), Gaps = 7/187 (3%)
Query: 204 PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE- 262
VAVK + P +N+T A R RE+ LL +++ N+I + +
Sbjct: 48 NVAVKKLSRPF--QNQTHAKRAY----RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV 101
Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
YL + A L ++ H L ++ + + G++++HS G+IHRDLKP N+++ +
Sbjct: 102 YLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 161
Query: 323 LKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
LKI DFG+A ++ T + APE+I Y VD++S G I+ E+V G++
Sbjct: 162 LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVI 221
Query: 383 YEEMNPI 389
++ + I
Sbjct: 222 FQGTDHI 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 6/158 (3%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
Q RE+ +L ++P ++ F A + E++ GSL L K +P L
Sbjct: 44 NQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPENIL 101
Query: 287 IAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-P 344
I++ + RG+ Y+ + ++HRD+KP N+L++ +K+ DFG++ + + D++++
Sbjct: 102 GKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV 159
Query: 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
GT +M+PE ++ Y + D++S GL L EM G P
Sbjct: 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 55/198 (27%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
+ G ++ ++ G K + VA+K IR+ ++ A R EV+LL L + N
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-------EVSLLKDLKHAN 65
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
++ ++ EYL + L+ Y+ + + + + I RG+ Y H +
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGN-IMSMHNVKIFLYQILRGLAYCHRR 123
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPEMIKHKS-YG 361
V+HRDLKP+N+LI++ LK+ADFG+A + V S++ T + P+++ S Y
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183
Query: 362 RKVDVYSFGLILWEMVAG 379
++D++ G I +EM +G
Sbjct: 184 TQIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-15
Identities = 55/224 (24%), Positives = 111/224 (49%), Gaps = 21/224 (9%)
Query: 186 RFAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
R G + +Y + E A+K+I++ ++ + +E+ ++ + N
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVV--------QQEIIMMKDCKHSN 67
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL-IA-IALDIARGMEYIH 301
++ + + + + E+ GSL+ + H T PL + IA ++ + +G+ Y+H
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQ----DIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMI---KH 357
S+G +HRD+K N+L+ H+K+ADFG++ + A GT WMAPE+ +
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 358 KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNF 401
Y + D+++ G+ E+ P +++P++A F ++ K NF
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMTKSNF 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 48/174 (27%), Positives = 93/174 (53%), Gaps = 8/174 (4%)
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
+ Q RE+ +L ++P ++ F A + E++ GSL L E K +P
Sbjct: 46 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--EAKRIPEE 103
Query: 285 KLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
L +++ + RG+ Y+ + ++HRD+KP N+L++ +K+ DFG++ + + D++++
Sbjct: 104 ILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS 161
Query: 344 -PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG--TIPYEEMNPIQAAFA 394
GT +M+PE ++ Y + D++S GL L E+ G IP + ++A F
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG 215
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 45/122 (36%), Positives = 67/122 (54%), Gaps = 7/122 (5%)
Query: 277 EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336
E L L+ + +A GME++ S+ +HRDL NVLI + +KI DFG+A ++
Sbjct: 232 ESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLA-RDIM 290
Query: 337 CDALSDDPGT----YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391
D+ G+ +WMAPE I + Y DV+SFG++LWE+ G PY E+ P+
Sbjct: 291 RDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL-PMNE 349
Query: 392 AF 393
F
Sbjct: 350 QF 351
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 65/239 (27%), Positives = 120/239 (50%), Gaps = 30/239 (12%)
Query: 173 EHTVDLSQLFLGLRFAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFN 230
+H +L Q R G + +Y ++ E AVKII++ D+ +
Sbjct: 8 QHDYELIQ-----RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLI--------Q 54
Query: 231 REVALLSRLHNPNVIKFVAA--CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL-I 287
+E+ ++ + N++ + + ++ C+ EY GSL+ + H T PL +L I
Sbjct: 55 QEIFMVKECKHCNIVAYFGSYLSREKLWICM--EYCGGGSLQ----DIYHVTGPLSELQI 108
Query: 288 A-IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PG 345
A + + +G+ Y+HS+G +HRD+K N+L+ +K+ADFG+A + A G
Sbjct: 109 AYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIG 168
Query: 346 TYRWMAPEMI---KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNF 401
T WMAPE+ K+ Y + D+++ G+ E+ P +++P++A F +++K NF
Sbjct: 169 TPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMSKSNF 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 48/195 (24%), Positives = 86/195 (44%), Gaps = 28/195 (14%)
Query: 199 IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP--- 255
+ VA+K + + ++ E + A RE+ +L L + NV+ + C+
Sbjct: 34 KKTKQIVALKKVLMENEKEGFPITAL------REIKILQLLKHENVVNLIEICRTKATPY 87
Query: 256 ------VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
Y V E L L ++ L ++ + + G+ YIH ++HRD
Sbjct: 88 NRYKGSFYLVFE--FCEHDLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRD 144
Query: 310 LKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR------WM-APE-MIKHKSYG 361
+K N+LI ++ LK+ADFG+A + + + P Y W PE ++ + YG
Sbjct: 145 MKAANILITKDGILKLADFGLA--RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYG 202
Query: 362 RKVDVYSFGLILWEM 376
+D++ G I+ EM
Sbjct: 203 PPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
G + ++ ++ E VA+K +R+ DDDE +A RE+ LL L + N+++
Sbjct: 11 GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------REICLLKELKHKNIVRL 64
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
++ EY + L+ Y P + + + +G+ + HS V+H
Sbjct: 65 YDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDP-EIVKSFMFQLLKGLAFCHSHNVLH 122
Query: 308 RDLKPENVLIDQEFHLKIADFGIACE---EVYCDALSDDPGTYRWMAPE-MIKHKSYGRK 363
RDLKP+N+LI++ LK+ADFG+A V C S + T + P+ + K Y
Sbjct: 123 RDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTS 180
Query: 364 VDVYSFGLILWEMVAGTIP 382
+D++S G I E+ P
Sbjct: 181 IDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
+ G ++ ++ G K + VA+K IR+ ++ A R EV+LL L + N
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-------EVSLLKNLKHAN 64
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
++ ++ EYL + L+ YL + + + + + RG+ Y H +
Sbjct: 65 IVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHKR 122
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
++HRDLKP+N+LI+++ LK+ADFG+A + V S++ T + P+ ++ Y
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 362 RKVDVYSFGLILWEMVAG 379
+D++ G IL+EM G
Sbjct: 183 TPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 3e-15
Identities = 42/125 (33%), Positives = 66/125 (52%), Gaps = 10/125 (8%)
Query: 282 PLPKLIA--IALDIARGMEYI-HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338
P+P+ I + + I + + Y+ GVIHRD+KP N+L+D ++K+ DFGI+ V
Sbjct: 110 PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169
Query: 339 ALSDDPGTYRWMAPEMI----KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFA 394
A + G +MAPE I + Y + DV+S G+ L E+ G PY+ F
Sbjct: 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK---TEFE 226
Query: 395 VVNKV 399
V+ K+
Sbjct: 227 VLTKI 231
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 4e-15
Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 26/193 (13%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
D+ A+K IR+P +R +E LL+++ +PN++ F + + ++
Sbjct: 25 DQKYAMKEIRLPKSSSA-VEDSR------KEAVLLAKMKHPNIVAFKESFEADGHLYIVM 77
Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
EY G L + K P ++ + + G+++IH + V+HRD+K +N+ + Q
Sbjct: 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG 137
Query: 322 HLKIADFG----------IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGL 371
+K+ DFG AC V GT ++ PE+ ++ Y K D++S G
Sbjct: 138 KVKLGDFGSARLLTSPGAYACTYV---------GTPYYVPPEIWENMPYNNKSDIWSLGC 188
Query: 372 ILWEMVAGTIPYE 384
IL+E+ P++
Sbjct: 189 ILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 42/150 (28%), Positives = 74/150 (49%), Gaps = 5/150 (3%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
E +L +++P++I+ C+I L Y + + + + ++AI
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIER 189
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA--LSDDPGTYRW 349
+ R ++Y+H +IHRD+K EN+ I+ + + DFG AC V +A GT
Sbjct: 190 SVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAG 379
APE++ YG VD++S G++L+EM
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 8e-15
Identities = 44/158 (27%), Positives = 85/158 (53%), Gaps = 5/158 (3%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
E +L++++ P ++ + + P ++ +++ G L +L + L + L
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL 102
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP--GTYRW 349
A +E +H VI+RDLKPEN+L+D + H+ + DFG+ C+ D + GT +
Sbjct: 103 LCA--LENLHKFNVIYRDLKPENILLDYQGHIALCDFGL-CKLNMKDDDKTNTFCGTPEY 159
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
+APE++ Y + VD ++ G++L+EM+ G P+ + N
Sbjct: 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 40/133 (30%), Positives = 81/133 (60%), Gaps = 15/133 (11%)
Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318
+I +Y+S G + +L++ ++ ++ + +I +E++H G+++RD+K EN+L+D
Sbjct: 82 LILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD 139
Query: 319 QEFHLKIADFGIACEEVYCDALSDDP-------GTYRWMAPEMIKHKS-YGRKVDVYSFG 370
E H+ + DFG++ E LS++ GT +MAPE+I+ K +G+ VD +S G
Sbjct: 140 SEGHVVLTDFGLSKE-----FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLG 194
Query: 371 LILWEMVAGTIPY 383
++++E++ G P+
Sbjct: 195 ILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 51/157 (32%), Positives = 84/157 (53%), Gaps = 7/157 (4%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE-YLSEGSLRAYLHKL-EHKTLPLP 284
K+ RE+ LL + + NVI + + YL + L KL +H+ L
Sbjct: 59 KRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSED 118
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344
++ + + +G++YIH+ G+IHRDLKP N+ ++++ LKI DFG+A + D+
Sbjct: 119 RIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ---TDSEMTGY 175
Query: 345 GTYRWM-APEMIKH-KSYGRKVDVYSFGLILWEMVAG 379
RW APE+I + Y + VD++S G I+ EM+ G
Sbjct: 176 VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 1e-14
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
+ G+++ +Y G K + VA+K+IR+ +++ A R E +LL L + N
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-------EASLLKGLKHAN 64
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL-DIARGMEYIHS 302
++ ++ EY+ L Y+ K H P+ + + L + RG+ YIH
Sbjct: 65 IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSY 360
+ ++HRDLKP+N+LI LK+ADFG+A + V S++ T + P+ ++ Y
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390
+D++ G I EM+ G + M IQ
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 57/205 (27%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 189 HGAHSRLYHGIYKDEPV--AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G + +Y +++ V A+K IR+ D+ ++ Q E+ +L + +P ++
Sbjct: 11 KGNYGSVYKVLHRPTGVTMAMKEIRLELDE------SKF-NQIIMELDILHKAVSPYIVD 63
Query: 247 FVAACKKPPVYCVITEYLSEGSL-RAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-G 304
F A + EY+ GSL + Y + + +P L I + +G++++ +
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIK------HK 358
+IHRD+KP NVL++ +K+ DFG++ V A + + G +MAPE IK +
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT-NIGCQSYMAPERIKSGGPNQNP 182
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPY 383
+Y + DV+S GL + EM G PY
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 25/205 (12%)
Query: 206 AVKIIR-IPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFVAACKKPPVYC----- 258
AVKI+ I D DE +E ++N +L L N PNV+KF K
Sbjct: 51 AVKILDPISDVDE------EIEAEYN----ILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100
Query: 259 VITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
++ E + GS+ + L + L + I G++++H+ +IHRD+K N+L
Sbjct: 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNIL 160
Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDP-GTYRWMAPEMIKHK-----SYGRKVDVYSFG 370
+ E +K+ DFG++ + + GT WMAPE+I + SY + DV+S G
Sbjct: 161 LTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLG 220
Query: 371 LILWEMVAGTIPYEEMNPIQAAFAV 395
+ E+ G P +M+P++ F +
Sbjct: 221 ITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 44/160 (27%), Positives = 86/160 (53%), Gaps = 6/160 (3%)
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
+ Q RE+ +L ++P ++ F A + E++ GSL L K +P
Sbjct: 46 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQ 103
Query: 285 KLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
L +++ + +G+ Y+ + ++HRD+KP N+L++ +K+ DFG++ + + D++++
Sbjct: 104 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS 161
Query: 344 -PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
GT +M+PE ++ Y + D++S GL L EM G P
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 34/86 (39%), Positives = 53/86 (61%)
Query: 296 GMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI 355
G++++HS G+IHRDLKP N+++ + LKI DFG+A ++ T + APE+I
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 189
Query: 356 KHKSYGRKVDVYSFGLILWEMVAGTI 381
Y VD++S G I+ EM+ GT+
Sbjct: 190 LGMGYKENVDIWSVGCIMGEMIRGTV 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 55/183 (30%), Positives = 95/183 (51%), Gaps = 14/183 (7%)
Query: 202 DEPVAVKIIRIPDDDENETLA-ARLEKQFNREVALLSRLHNPNVI--KFVAACKKPPVYC 258
E VA+K +R+ D+E + + + L RE+ LL L +PN++ K V K
Sbjct: 32 GEIVALKKVRM--DNERDGIPISSL-----REITLLLNLRHPNIVELKEVVVGKHLDSIF 84
Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318
++ EY E L + L + ++ + L + RG++Y+H +IHRDLK N+L+
Sbjct: 85 LVMEY-CEQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT 142
Query: 319 QEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEM 376
+ LKIADFG+A + ++ T + APE++ +Y +D+++ G IL E+
Sbjct: 143 DKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAEL 202
Query: 377 VAG 379
+A
Sbjct: 203 LAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 4e-14
Identities = 53/189 (28%), Positives = 91/189 (48%), Gaps = 21/189 (11%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAA------CKKPPVY 257
VA+K R+ D+E A RE++LL L + +++ + KP +Y
Sbjct: 29 VALKKTRLEMDEEGIPPTAL------REISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82
Query: 258 CVITEYLSEGSLRAYL---HKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314
V EYL L+ ++ + + LP + + + +G+ + H GV+HRDLKP+N
Sbjct: 83 LVF-EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQN 140
Query: 315 VLIDQEFH-LKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSYGRKVDVYSFGL 371
+L+D++ LKIAD G+ + + + + T + APE ++ Y VD++S G
Sbjct: 141 LLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGC 200
Query: 372 ILWEMVAGT 380
I EM
Sbjct: 201 IFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 44/182 (24%), Positives = 76/182 (41%), Gaps = 46/182 (25%)
Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
+ +Y+ G + + L +L L + L A +E +H G IHRD+KP+N+LID+
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCA--IESVHKMGFIHRDIKPDNILIDR 136
Query: 320 EFHLKIADFGIAC--------------EEVYCDALSDDP--------------------- 344
+ H+K+ DFG+ + D++
Sbjct: 137 DGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQH 196
Query: 345 ---------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
GT ++APE++ Y + D +S G+IL+EM+ G P+ P + V
Sbjct: 197 QRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKV 256
Query: 396 VN 397
+N
Sbjct: 257 IN 258
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 60/196 (30%), Positives = 91/196 (46%), Gaps = 46/196 (23%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP------- 255
E VA+K +I + +N A R RE+ LL L + NVI + PP
Sbjct: 31 EKVAIK--KIANAFDNRIDAKRTL----REIKLLRHLDHENVIA-IKDIMPPPHREAFND 83
Query: 256 VYCVI-------------TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
VY V ++ LS+ + +L++L RG++YIHS
Sbjct: 84 VYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQL-----------------LRGLKYIHS 126
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPEMIKHKS-Y 360
V+HRDLKP N+L++ LKI DFG+A D +++ T + APE++ + S Y
Sbjct: 127 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEY 186
Query: 361 GRKVDVYSFGLILWEM 376
+DV+S G I E+
Sbjct: 187 TTAIDVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 6e-14
Identities = 50/203 (24%), Positives = 101/203 (49%), Gaps = 12/203 (5%)
Query: 190 GAHSRLYHGIYKDE---PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G+ R+ YK+E PVA+K ++++ + + E +L+ +++P +
Sbjct: 41 GSFGRVILATYKNEDFPPVAIKRF-----EKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+ K ++ E++ G +L + +K P A I EY+ S ++
Sbjct: 96 LYGSFKDESYLYLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSLNIV 153
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDV 366
+RDLKPEN+L+D++ +K+ DFG A +V GT ++APE++ + +G+ D
Sbjct: 154 YRDLKPENLLLDKDGFIKMTDFGFA--KVVDTRTYTLCGTPEYIAPEILLNVGHGKAADW 211
Query: 367 YSFGLILWEMVAGTIPYEEMNPI 389
++ G+ ++E++ G P+ P+
Sbjct: 212 WTLGIFIYEILVGCPPFYANEPL 234
|
Length = 340 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 36/147 (24%), Positives = 84/147 (57%), Gaps = 1/147 (0%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
+EVA+LS + +PN++++ + ++ ++ +Y G L ++ P +++
Sbjct: 48 KEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF 107
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRW 349
+ I ++++H + ++HRD+K +N+ + ++ +K+ DFGIA L+ GT +
Sbjct: 108 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYY 167
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEM 376
++PE+ +++ Y K D+++ G +L+EM
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 52/192 (27%), Positives = 96/192 (50%), Gaps = 8/192 (4%)
Query: 190 GAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249
GA+ + +K+ V I + D +ENE +++ RE+ +L L N+++
Sbjct: 12 GAYGVVLKCRHKETKEIVAIKKFKDSEENE----EVKETTLRELKMLRTLKQENIVELKE 67
Query: 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
A ++ ++ EY+ E ++ L ++ + P K+ + + + + + H ++HRD
Sbjct: 68 AFRRRGKLYLVFEYV-EKNMLELLEEMPNGVPP-EKVRSYIYQLIKAIHWCHKNDIVHRD 125
Query: 310 LKPENVLIDQEFHLKIADFGIACE-EVYCDALSDDPGTYRWM-APEMIKHKSYGRKVDVY 367
+KPEN+LI LK+ DFG A +A + RW +PE++ YG+ VD++
Sbjct: 126 IKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMW 185
Query: 368 SFGLILWEMVAG 379
S G IL E+ G
Sbjct: 186 SVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 39/91 (42%), Positives = 57/91 (62%), Gaps = 13/91 (14%)
Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT----YRWM 350
RG++YIHS G+IHRDLKP NV ++++ L+I DFG+A + +DD T RW
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ-------ADDEMTGYVATRWY 181
Query: 351 -APE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
APE M+ Y + VD++S G I+ E++ G
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 36/88 (40%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP 352
I RG++YIHS +IHRDLKP N+ ++++ LKI DFG+A D ++ T + AP
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 186
Query: 353 E-MIKHKSYGRKVDVYSFGLILWEMVAG 379
E M+ Y + VD++S G I+ E++ G
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 29/207 (14%)
Query: 206 AVKIIR-IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV-----YCV 259
AVKI+ I D DE +E ++N AL +PNV+KF K V +
Sbjct: 47 AVKILDPIHDIDE------EIEAEYNILKALSD---HPNVVKFYGMYYKKDVKNGDQLWL 97
Query: 260 ITEYLSEGSL----RAYLHKLEHKTLPLPKLIAIALDIA-RGMEYIHSQGVIHRDLKPEN 314
+ E + GS+ + +L + E P+ IA L A G++++H IHRD+K N
Sbjct: 98 VLELCNGGSVTDLVKGFLKRGERMEEPI---IAYILHEALMGLQHLHVNKTIHRDVKGNN 154
Query: 315 VLIDQEFHLKIADFGIACEEVYCDALSDDP-GTYRWMAPEMIK-----HKSYGRKVDVYS 368
+L+ E +K+ DFG++ + + GT WMAPE+I +Y + DV+S
Sbjct: 155 ILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWS 214
Query: 369 FGLILWEMVAGTIPYEEMNPIQAAFAV 395
G+ E+ G P +++P++A F +
Sbjct: 215 LGITAIELGDGDPPLADLHPMRALFKI 241
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 22/169 (13%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
E+A + +L +PN++K + C+ +I EY+ +L L + L + IA+
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-----RNLSWERRRKIAI 787
Query: 292 DIARGMEYIH---SQGVIHRDLKPENVLID--QEFHLKIADFGIACEEVYCDALSDDPGT 346
IA+ + ++H S V+ +L PE ++ID E HL+++ G+ C + C S
Sbjct: 788 GIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISS----- 842
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
++APE + K K D+Y FGLIL E++ G +P A F V
Sbjct: 843 -AYVAPETRETKDITEKSDIYGFGLILIELLTGK------SPADAEFGV 884
|
Length = 968 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 40/111 (36%), Positives = 62/111 (55%), Gaps = 6/111 (5%)
Query: 281 LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL 340
L L L+ + +A+GM+++ S+ IHRD+ NVL+ KI DFG+A ++ D+
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLA-RDIMNDSN 267
Query: 341 SDDPGTYR----WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM 386
G R WMAPE I Y + DV+S+G++LWE+ + G PY +
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 58/235 (24%), Positives = 101/235 (42%), Gaps = 52/235 (22%)
Query: 205 VAVKIIRIPDDDENETLA-ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEY 263
A+K +R + E E +A R E+ +L+ NP V+K + + +I EY
Sbjct: 29 YAMKKLRKSEMLEKEQVAHVRAERD------ILAEADNPWVVKLYYSFQDENYLYLIMEY 82
Query: 264 LSEGSLRAYLHKLEHKTLPLPKL-IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
L G + L K + T + IA + ++ IH G IHRD+KP+N+L+D + H
Sbjct: 83 LPGGDMMTLLMKKDTFTEEETRFYIA---ETILAIDSIHKLGYIHRDIKPDNLLLDAKGH 139
Query: 323 LKIADFGIACEEVYCDALSDDP-------------------------------------- 344
+K++DFG+ C + ++
Sbjct: 140 IKLSDFGL-CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYS 198
Query: 345 --GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
GT ++APE+ Y ++ D +S G+I++EM+ G P+ NP + ++N
Sbjct: 199 TVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIIN 253
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 49/151 (32%), Positives = 78/151 (51%), Gaps = 13/151 (8%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYC-VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
E LL RL +P V+ + + C V+ +Y S+ L YL + L L ++ A+A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSD--LYTYLGA-RLRPLGLAQVTAVA 266
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP------ 344
+ ++YIH +G+IHRD+K ENVL++ + + DFG AC + P
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAAC---FARGSWSTPFHYGIA 323
Query: 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
GT APE++ Y VD++S GL+++E
Sbjct: 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 37/110 (33%), Positives = 61/110 (55%), Gaps = 2/110 (1%)
Query: 296 GMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI 355
G++++HS G+IHRDLKP N+++ + LKI DFG+A ++ T + APE+I
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 356 KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNFGASC 405
Y VD++S G I+ EM+ G + + + I V+ ++ G C
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL--GTPC 245
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 44/168 (26%), Positives = 76/168 (45%), Gaps = 25/168 (14%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAI 289
RE+ +++ + + N++ V + ++ + + L+ + + K L ++ I
Sbjct: 69 RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV---DRKIRLTESQVKCI 124
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGT 346
L I G+ +H +HRDL P N+ I+ + KIADFG+A Y D LS D
Sbjct: 125 LLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 347 --------------YRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAG 379
YR APE++ + Y VD++S G I E++ G
Sbjct: 185 QRREEMTSKVVTLWYR--APELLMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 53/199 (26%), Positives = 96/199 (48%), Gaps = 15/199 (7%)
Query: 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
+ G+++ +Y GI + + VA+K+I + ++ A R E +LL L + N
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-------EASLLKGLKHAN 64
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL-DIARGMEYIHS 302
++ + EY+ L Y+ ++H P + + + + RG+ YIH
Sbjct: 65 IVLLHDIIHTKETLTFVFEYM-HTDLAQYM--IQHPGGLHPYNVRLFMFQLLRGLAYIHG 121
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPE-MIKHKSY 360
Q ++HRDLKP+N+LI LK+ADFG+A + + S + T + P+ ++ Y
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDY 181
Query: 361 GRKVDVYSFGLILWEMVAG 379
+D++ G I EM+ G
Sbjct: 182 SSALDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 54/191 (28%), Positives = 93/191 (48%), Gaps = 30/191 (15%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK---FVAACKKPPVYC 258
E VA+K +++ + E + + RE+ +L +L +PN++ V +Y
Sbjct: 30 GEIVALKKLKMEKEKEGFPITSL------REINILLKLQHPNIVTVKEVVVGSNLDKIYM 83
Query: 259 VITEYLSEGSLRAYLHKLEHKTLPL--PKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
V+ EY+ E L++ + E P ++ + L + G+ ++H ++HRDLK N+L
Sbjct: 84 VM-EYV-EHDLKSLM---ETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLL 138
Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDPGT-------YRWMAPE-MIKHKSYGRKVDVYS 368
++ LKI DFG+A E Y L P T YR APE ++ K Y +D++S
Sbjct: 139 LNNRGILKICDFGLARE--YGSPL--KPYTQLVVTLWYR--APELLLGAKEYSTAIDMWS 192
Query: 369 FGLILWEMVAG 379
G I E++
Sbjct: 193 VGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 41/135 (30%), Positives = 75/135 (55%), Gaps = 16/135 (11%)
Query: 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIA---IALDIARGMEYIHSQGVIHRDLKPENVL 316
+ +Y G L L K E + LP+ +A +A ++ ++ +H G +HRD+KP+NVL
Sbjct: 79 VMDYYVGGDLLTLLSKFEDR---LPEDMARFYLA-EMVLAIDSVHQLGYVHRDIKPDNVL 134
Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDP---GTYRWMAPEMIK-----HKSYGRKVDVYS 368
+D+ H+++ADFG +C + D GT +++PE+++ YG + D +S
Sbjct: 135 LDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWS 193
Query: 369 FGLILWEMVAGTIPY 383
G+ ++EM+ G P+
Sbjct: 194 LGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 52/204 (25%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP------- 255
E VA+K +I D E+ + A R+ RE+ LL L +P++++ + PP
Sbjct: 26 EKVAIK--KINDVFEHVSDATRIL----REIKLLRLLRHPDIVE-IKHIMLPPSRREFKD 78
Query: 256 VYCVITEYLSEGSLRAYLHKL---------EHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+Y V S+ LH++ EH L +L+ R ++YIH+ V
Sbjct: 79 IYVVFELMESD------LHQVIKANDDLTPEHHQFFLYQLL-------RALKYIHTANVF 125
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWM---------APEMIK- 356
HRDLKP+N+L + + LKI DFG+A A +D P W APE+
Sbjct: 126 HRDLKPKNILANADCKLKICDFGLARV-----AFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 357 -HKSYGRKVDVYSFGLILWEMVAG 379
Y +D++S G I E++ G
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 41/153 (26%), Positives = 76/153 (49%), Gaps = 18/153 (11%)
Query: 239 LHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL-----HKLEHKTLPLPKLIAIALDI 293
L +PN+++ + C + Y ++ EY G L++YL H+ + L L ++ A +I
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM---ACEI 108
Query: 294 ARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGTYRWM 350
A G+ ++H +H DL N + + +K+ D+GI +E Y + D RW+
Sbjct: 109 AAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL 168
Query: 351 APEMIKHKSYG-------RKVDVYSFGLILWEM 376
APE++ G + +V++ G+ LWE+
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 27/201 (13%)
Query: 190 GAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
G+++ +Y G K + VA+K IR+ + +E A RE +LL L + N++
Sbjct: 16 GSYATVYKGRSKLTGQLVALKEIRL-EHEEGAPFTAI------REASLLKDLKHANIVTL 68
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL-DIARGMEYIHSQGVI 306
++ EYL + L+ Y+ + + L + RG+ Y H + V+
Sbjct: 69 HDIIHTKKTLTLVFEYL-DTDLKQYMDD--CGGGLSMHNVRLFLFQLLRGLAYCHQRRVL 125
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR------WMAPE--MIKHK 358
HRDLKP+N+LI + LK+ADFG+A A S TY W P ++
Sbjct: 126 HRDLKPQNLLISERGELKLADFGLA------RAKSVPSKTYSNEVVTLWYRPPDVLLGST 179
Query: 359 SYGRKVDVYSFGLILWEMVAG 379
Y +D++ G I +EM G
Sbjct: 180 EYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 52/177 (29%), Positives = 88/177 (49%), Gaps = 7/177 (3%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
D VA+K + P +N+T A R RE+ L+ +++ N+I +
Sbjct: 42 DRNVAIKKLSRPF--QNQTHAKRAY----RELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95
Query: 262 E-YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
+ YL + A L ++ L ++ + + G++++HS G+IHRDLKP N+++ +
Sbjct: 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 155
Query: 321 FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMV 377
LKI DFG+A ++ T + APE+I Y VD++S G I+ EMV
Sbjct: 156 CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 41/135 (30%), Positives = 73/135 (54%), Gaps = 14/135 (10%)
Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIA--IALDIARGMEYIHSQGVIHRDLKPENVL 316
++ +Y G L L K E + LP+ +A ++ + IH +HRD+KP+NVL
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDR---LPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVL 134
Query: 317 IDQEFHLKIADFGIACEEVYCDAL---SDDPGTYRWMAPEMIKHKS-----YGRKVDVYS 368
+D H+++ADFG +C ++ D S GT +++PE+++ YG + D +S
Sbjct: 135 LDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWS 193
Query: 369 FGLILWEMVAGTIPY 383
G+ ++EM+ G P+
Sbjct: 194 LGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 36/129 (27%), Positives = 74/129 (57%), Gaps = 6/129 (4%)
Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318
+I +Y++ G L + H + + ++ + +I +E++H G+I+RD+K EN+L+D
Sbjct: 82 LILDYINGGEL--FTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD 139
Query: 319 QEFHLKIADFGIACE--EVYCDALSDDPGTYRWMAPEMIKHKSYG--RKVDVYSFGLILW 374
H+ + DFG++ E E + GT +MAP++++ G + VD +S G++++
Sbjct: 140 SNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMY 199
Query: 375 EMVAGTIPY 383
E++ G P+
Sbjct: 200 ELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 45/172 (26%), Positives = 82/172 (47%), Gaps = 14/172 (8%)
Query: 226 EKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLH---KLEHKTLP 282
+ +F E L + N+++ + C + Y ++ E+ G L+ YL K E T
Sbjct: 39 QMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPD 98
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
L +A +IA G+ ++H IH DL N L+ + +KI D+G++ + D
Sbjct: 99 PTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158
Query: 343 DPGTY---RWMAPEMIK--HKSY-----GRKVDVYSFGLILWEMVA-GTIPY 383
+ RW+APE++ H + ++ +V+S G+ +WE+ G+ PY
Sbjct: 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 41/147 (27%), Positives = 73/147 (49%), Gaps = 6/147 (4%)
Query: 240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEY 299
NPN IK + + +I +Y+ +G L L K + K I L +
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQL--VEALND 124
Query: 300 IHSQGVIHRDLKPENVLIDQ-EFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK 358
+H +IH D+K ENVL D+ + + + D+G+ C+ + + D GT + +PE IK
Sbjct: 125 LHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL-CKIIGTPSCYD--GTLDYFSPEKIKGH 181
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEE 385
+Y D ++ G++ +E++ G P++E
Sbjct: 182 NYDVSFDWWAVGVLTYELLTGKHPFKE 208
|
Length = 267 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 183 LGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP 242
LG +G+ +Y I D V I ++ D + + NRE+ ++ L++
Sbjct: 70 LGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK----------NRELLIMKNLNHI 119
Query: 243 NVI--------KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA--IALD 292
N+I + +K V+ E++ + ++ Y+ LP + +
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQ 178
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVYCDALSDDPGTYRWMA 351
+ R + YIHS+ + HRDLKP+N+LID H LK+ DFG A + + + A
Sbjct: 179 LCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRA 238
Query: 352 PE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
PE M+ +Y +D++S G I+ EM+ G
Sbjct: 239 PELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 43/228 (18%)
Query: 206 AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLS 265
A+KI+R D E E +A E +L V+K + + +I E+L
Sbjct: 30 AMKILRKADMLEKEQVA-----HIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP 84
Query: 266 EGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI 325
G + L K + TL + ++ IH G IHRD+KP+N+L+D + H+K+
Sbjct: 85 GGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKL 142
Query: 326 ADFGIAC-------EEVYCDALSDDP-----------------------------GTYRW 349
+DFG+ E Y + + P GT +
Sbjct: 143 SDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDY 202
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
+APE+ Y + D +S G+I++EM+ G P+ P + V+N
Sbjct: 203 IAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMN 250
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 52/189 (27%), Positives = 93/189 (49%), Gaps = 17/189 (8%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
E V K + + +DE + AR E+ L+ + ++K K +I E
Sbjct: 94 EKVVAKFVML--NDERQAAYAR------SELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145
Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIAL--DIARGMEYIHSQGVIHRDLKPENVLIDQE 320
Y S G L + + + LP + L I ++ +HS+ ++HRDLK N+ +
Sbjct: 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT 205
Query: 321 FHLKIADFGIACEEVYCDALSDDP-----GTYRWMAPEMIKHKSYGRKVDVYSFGLILWE 375
+K+ DFG + + Y D++S D GT ++APE+ + K Y +K D++S G+IL+E
Sbjct: 206 GIIKLGDFGFSKQ--YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYE 263
Query: 376 MVAGTIPYE 384
++ P++
Sbjct: 264 LLTLHRPFK 272
|
Length = 478 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 40/150 (26%), Positives = 66/150 (44%), Gaps = 48/150 (32%)
Query: 296 GMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC--------------EEVYCDALS 341
+E +H G IHRD+KP+N+LID++ H+K+ DFG+ + V D++
Sbjct: 113 AVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMD 172
Query: 342 -----DDP-----------------------------GTYRWMAPEMIKHKSYGRKVDVY 367
DP GT ++APE++ Y + D +
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232
Query: 368 SFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
S G+IL+EM+ G P+ P++ V+N
Sbjct: 233 SVGVILYEMLVGQPPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 39/149 (26%), Positives = 79/149 (53%), Gaps = 14/149 (9%)
Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIA--IALDIARGMEYIHSQGVIHRDLKPENVL 316
++ +Y G L L K E + LP+ +A ++ ++ +H +HRD+KP+N+L
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDR---LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 134
Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDP---GTYRWMAPEMIK-----HKSYGRKVDVYS 368
+D H+++ADFG +C ++ D GT +++PE+++ YG + D +S
Sbjct: 135 MDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWS 193
Query: 369 FGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
G+ ++EM+ G P+ + ++ ++N
Sbjct: 194 LGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 50/214 (23%)
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
E +L+ N V+K + + + +Y+ G + + L ++E L + L
Sbjct: 51 ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAEL 110
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC--------------EEVYC 337
+A +E +H G IHRD+KP+N+LID + H+K+ DFG+ +
Sbjct: 111 TLA--IESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQ 168
Query: 338 DALS-----DDPGTYR-----------------------------WMAPEMIKHKSYGRK 363
D++ DD R ++APE++ K Y +
Sbjct: 169 DSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL 228
Query: 364 VDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
D +S G+IL+EM+ G P+ P + V+N
Sbjct: 229 CDWWSVGVILFEMLVGQPPFLAPTPTETQLKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 9e-11
Identities = 32/96 (33%), Positives = 60/96 (62%), Gaps = 7/96 (7%)
Query: 297 MEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPG-----TYRWMA 351
+ ++HS+ +IHRD+K N+L+ +K+ DFG + ++Y +SDD G T ++A
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS--KMYAATVSDDVGRTFCGTPYYVA 213
Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
PE+ + K Y +K D++S G++L+E++ P++ N
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 34/119 (28%), Positives = 54/119 (45%), Gaps = 16/119 (13%)
Query: 276 LEHKTLPL--PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF-GIAC 332
LE + PL ++ A+ L + +H Q K N+L+ + LK+
Sbjct: 7 LEVRGRPLNEEEIWAVCLQCLGALRELHRQA------KSGNILLTWDGLLKLDGSVAFKT 60
Query: 333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQA 391
E P Y +MAPE+I+ +SY K D+YS G+ L+E + +PY E + A
Sbjct: 61 PE------QSRPDPY-FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA 112
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 50/206 (24%), Positives = 96/206 (46%), Gaps = 39/206 (18%)
Query: 196 YHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF-- 247
Y +YK E VA+K +R+ ++ E + A RE+ +L +L++ N++
Sbjct: 20 YGQVYKARDKDTGELVALKKVRLDNEKEGFPITAI------REIKILRQLNHRNIVNLKE 73
Query: 248 VAACKKPPV--------YCVITEYLSE---GSLRAYLHKLEHKTLPLPKLIAIALDIARG 296
+ K+ + + ++ EY+ G L + L + + + G
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED-----HIKSFMKQLLEG 128
Query: 297 MEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR----WMAP 352
+ Y H + +HRD+K N+L++ + +K+ADFG+A +Y ++ P T + W P
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA--RLY-NSEESRPYTNKVITLWYRP 185
Query: 353 E--MIKHKSYGRKVDVYSFGLILWEM 376
++ + YG +DV+S G IL E+
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 56/228 (24%), Positives = 94/228 (41%), Gaps = 43/228 (18%)
Query: 206 AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLS 265
A+KI+R D E E + E +L + V+K + + +I E+L
Sbjct: 30 AMKILRKADMLEKEQVG-----HIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84
Query: 266 EGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI 325
G + L K + TL + + ++ IH G IHRD+KP+N+L+D + H+K+
Sbjct: 85 GGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKL 142
Query: 326 ADFGIAC-------EEVYCDALSDDP-----------------------------GTYRW 349
+DFG+ E Y + P GT +
Sbjct: 143 SDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDY 202
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
+APE+ Y + D +S G+I++EM+ G P+ P + V+N
Sbjct: 203 IAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMN 250
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 9e-10
Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 16/166 (9%)
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPP-VYCVITEYLSEGSLRAYLHKLEHKTL 281
+R Q E+ L RL++ N++K + Y + +Y + Y + K
Sbjct: 204 SRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDR 263
Query: 282 PLPKLI-AIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC--EEVYCD 338
PL K AI + +EYIH + +IHRD+K EN+ ++ + + + DFG A E+
Sbjct: 264 PLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK---- 319
Query: 339 ALSDDPGTYRWM------APEMIKHKSYGRKVDVYSFGLILWEMVA 378
+ Y W+ +PE++ Y D++S GLIL +M++
Sbjct: 320 --EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 31/77 (40%), Positives = 50/77 (64%), Gaps = 5/77 (6%)
Query: 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLP-KLIAIALDIARGMEYIHSQGVIHRDLKPEN 314
VY V+ EYL G +++ LH + + K I+ ++A ++Y+H G+IHRDLKP+N
Sbjct: 79 VYLVM-EYLIGGDVKSLLHIYGYFDEEMAVKYIS---EVALALDYLHRHGIIHRDLKPDN 134
Query: 315 VLIDQEFHLKIADFGIA 331
+LI E H+K+ DFG++
Sbjct: 135 MLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 9e-09
Identities = 42/186 (22%), Positives = 85/186 (45%), Gaps = 25/186 (13%)
Query: 201 KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI 260
++ V +K+ D ++LA F +L+S+L + +++K C + ++
Sbjct: 29 QEVSVVLKV---LGSDHRDSLA------FFETASLMSQLSHKHLVKLYGVCVRDE-NIMV 78
Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
EY+ G L +LH+ E + L + +A +A + Y+ + ++H ++ +N+L+ +
Sbjct: 79 EEYVKFGPLDVFLHR-EKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARY 137
Query: 321 -------FHLKIADFGIA-CEEVYCDALSDDPGTYRWMAPEMIK--HKSYGRKVDVYSFG 370
+K++D GI + + P W+APE I+ S D +SFG
Sbjct: 138 GLNEGYVPFIKLSDPGIPITVLSREERVERIP----WIAPECIRNGQASLTIAADKWSFG 193
Query: 371 LILWEM 376
L E+
Sbjct: 194 TTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 41/176 (23%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL------HKLEH------ 278
RE+ALL L +PNVI +LS + +L H L H
Sbjct: 47 REIALLRELKHPNVIALQKV------------FLSHSDRKVWLLFDYAEHDLWHIIKFHR 94
Query: 279 ------KTLPLPKLIAIAL--DIARGMEYIHSQGVIHRDLKPENVLI----DQEFHLKIA 326
K + LP+ + +L I G+ Y+H+ V+HRDLKP N+L+ + +KIA
Sbjct: 95 ASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154
Query: 327 DFGIA-CEEVYCDALSD-DP--GTYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMV 377
D G A L+D DP T+ + APE ++ + Y + +D+++ G I E++
Sbjct: 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 41/176 (23%)
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL------HKLEH------ 278
RE+ALL L +PNVI +LS + +L H L H
Sbjct: 47 REIALLRELKHPNVISLQKV------------FLSHADRKVWLLFDYAEHDLWHIIKFHR 94
Query: 279 ------KTLPLPKLIAIAL--DIARGMEYIHSQGVIHRDLKPENVLI----DQEFHLKIA 326
K + LP+ + +L I G+ Y+H+ V+HRDLKP N+L+ + +KIA
Sbjct: 95 ASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154
Query: 327 DFGIA-CEEVYCDALSD-DP--GTYRWMAPE-MIKHKSYGRKVDVYSFGLILWEMV 377
D G A L+D DP T+ + APE ++ + Y + +D+++ G I E++
Sbjct: 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 36/149 (24%), Positives = 66/149 (44%), Gaps = 48/149 (32%)
Query: 297 MEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC------------------------ 332
+E +H G IHRD+KP+N+LID+ H+K++DFG++
Sbjct: 114 IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173
Query: 333 ---EEVYCDALS------DDPGTYR---------------WMAPEMIKHKSYGRKVDVYS 368
V D+++ D T++ ++APE+ + YG++ D +S
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233
Query: 369 FGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
G I++E + G P+ N + ++N
Sbjct: 234 LGAIMFECLIGWPPFCSENSHETYRKIIN 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 5e-08
Identities = 41/178 (23%), Positives = 76/178 (42%), Gaps = 18/178 (10%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
K EV L +PN++ VI+ +++ GS + L + + +
Sbjct: 44 KALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALI 103
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC--------D 338
I RG+ Y+H G IHR++K ++LI + + ++ +Y
Sbjct: 104 GNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGL----SHLYSLVRNGQKAK 159
Query: 339 ALSDDP----GTYRWMAPEMIKHKSYGRKV--DVYSFGLILWEMVAGTIPYEEMNPIQ 390
+ D P W++PE+++ YG V D+YS G+ E+ G +P+++M Q
Sbjct: 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 20/53 (37%), Positives = 29/53 (54%)
Query: 279 KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331
K + I D+ +EYIH G+ H D+KPEN+++D I D+GIA
Sbjct: 121 KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 30/120 (25%), Positives = 58/120 (48%), Gaps = 6/120 (5%)
Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
++ G L +++ K + +P + A ++ ++ +H +G++ RDL P N+L+D
Sbjct: 65 QHAEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG 122
Query: 322 HLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT 380
H+++ F E E CD + + APE+ D +S G IL+E++ G
Sbjct: 123 HIQLTYFSRWSEVEDSCDG---EAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 47/198 (23%), Positives = 94/198 (47%), Gaps = 32/198 (16%)
Query: 221 LAARLEKQFNREVALLSRLHNPNVIKFVAAC--KKPPVYCVITEYLSEGSLRAYLHKL-- 276
L R + Q EV ++ L + N+++++ K ++ E+ G L + K
Sbjct: 51 LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYK 110
Query: 277 ------EHKTLPLPKLIAIALDIARGM-EYIHSQGVIHRDLKPENVLID----------- 318
EH + + + + AL + + + + V+HRDLKP+N+ +
Sbjct: 111 MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170
Query: 319 QEFHL------KIADFGIACEEVYCDALSDD-PGTYRWMAPEMIKH--KSYGRKVDVYSF 369
Q +L KI DFG++ + + ++++ GT + +PE++ H KSY K D+++
Sbjct: 171 QANNLNGRPIAKIGDFGLS-KNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWAL 229
Query: 370 GLILWEMVAGTIPYEEMN 387
G I++E+ +G P+ + N
Sbjct: 230 GCIIYELCSGKTPFHKAN 247
|
Length = 1021 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 49/211 (23%), Positives = 97/211 (45%), Gaps = 34/211 (16%)
Query: 189 HGAHSRLYHGIYKDEPVAVKIIRIPDDDE---NETLAARLEK-------QFNREVALLSR 238
G ++++ GI ++ + D E E L L+K F +++S+
Sbjct: 5 QGTFTKIFKGIRRE---------VGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQ 55
Query: 239 LHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
L + +++ C ++ EY+ GSL YL K ++ KL +A +A +
Sbjct: 56 LSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKL-EVAKQLAWALH 114
Query: 299 YIHSQGVIHRDLKPENVLIDQE---------FHLKIADFGIACEEVYCDALSDDPGTYRW 349
++ +G+ H ++ +NVL+ +E F +K++D GI+ + + L + W
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREEDRKTGNPPF-IKLSDPGISITVLPKEILLE---RIPW 170
Query: 350 MAPEMIKH-KSYGRKVDVYSFGLILWEMVAG 379
+ PE I++ ++ D +SFG LWE+ +G
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 39/164 (23%), Positives = 79/164 (48%), Gaps = 14/164 (8%)
Query: 239 LHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL-IA-IALDIARG 296
++PN++ + A V+T +++ GS + + H + +L IA I + +
Sbjct: 56 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI--CTHFMDGMSELAIAYILQGVLKA 113
Query: 297 MEYIHSQGVIHRDLKPENVLI--DQEFHLK--IADFGIACEEVYCDALSDDP----GTYR 348
++YIH G +HR +K ++LI D + +L ++ + + D P
Sbjct: 114 LDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP 173
Query: 349 WMAPEMIKH--KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390
W++PE+++ + Y K D+YS G+ E+ G +P+++M Q
Sbjct: 174 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 19/49 (38%), Positives = 32/49 (65%), Gaps = 2/49 (4%)
Query: 296 GMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344
G+ +H G++HRD+KPEN+L+ + +KI DFG A + C ++ +P
Sbjct: 321 GLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVD--MCTGINFNP 367
|
Length = 507 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 7e-05
Identities = 31/150 (20%), Positives = 57/150 (38%), Gaps = 22/150 (14%)
Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFN-REVALLSRLHN----- 241
GA + +Y + P VK RIP + L +L ++ RE +L++
Sbjct: 5 KQGAEAIIYLTDFLGLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPV 63
Query: 242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
P V P ++ EY+ L+ L + L + + + +H
Sbjct: 64 PIVYDV-----DPDNGLIVMEYIEGELLKDAL-----EEARPDLLREVGRLVGK----LH 109
Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIA 331
G++H DL N+++ + DFG+
Sbjct: 110 KAGIVHGDLTTSNIILSGG-RIYFIDFGLG 138
|
Length = 204 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 4e-04
Identities = 38/154 (24%), Positives = 67/154 (43%), Gaps = 25/154 (16%)
Query: 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR-EVALLSRLHNPNVI 245
GA + +Y G + +K RIP + L R+ ++ R E ++SR V
Sbjct: 4 IKRGAEAEIYLGDFLGIKAVIKW-RIPKRYRHPELDERIRRERTRREARIMSRARKAGV- 61
Query: 246 KFVAACKKPPVYCV-------ITEYLSEG-SLRAYLHKLEHKTLPLPKLIAIALDIARGM 297
P VY V + EY+ EG L+ ++ + + ++ +I R +
Sbjct: 62 ------NVPAVYFVDPENFIIVMEYI-EGEPLKDLINSNG------MEELELSREIGRLV 108
Query: 298 EYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331
+HS G+IH DL N+++ + + DFG+A
Sbjct: 109 GKLHSAGIIHGDLTTSNMILSGG-KIYLIDFGLA 141
|
Length = 211 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 36/112 (32%), Positives = 54/112 (48%), Gaps = 19/112 (16%)
Query: 180 QLFLGLRFAHGAHSRLY----HGIYKDEP---VAVKIIRIPDDDENETLAARLEKQ-FNR 231
L LG GA R+ HG+ + VAVK+++ + A EKQ
Sbjct: 38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLK--------STARSSEKQALMS 89
Query: 232 EVALLSRLH-NPNVIKFVAACKK-PPVYCVITEYLSEGSLRAYLHKLEHKTL 281
E+ ++S L + N++ + AC K P+Y +ITEY G L YLH+ +H L
Sbjct: 90 ELKIMSHLGPHLNIVNLLGACTKGGPIY-IITEYCRYGDLVDYLHRNKHTFL 140
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 7e-04
Identities = 41/172 (23%), Positives = 79/172 (45%), Gaps = 19/172 (11%)
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
F +L+S++ + ++ C + ++ E++ G L L K E +P+ I
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKIT 121
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLI--------DQEFHLKIADFGIACEEVYCDAL 340
+A +A + Y+ + ++H ++ +N+L+ F +K++D G++ AL
Sbjct: 122 VAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPF-IKLSDPGVS-----FTAL 175
Query: 341 SDDPGTYR--WMAPEMIKH-KSYGRKVDVYSFGLILWEMV-AGTIPYEEMNP 388
S + R W+APE + S D +SFG L E+ G +P +E P
Sbjct: 176 SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 9e-04
Identities = 34/149 (22%), Positives = 63/149 (42%), Gaps = 24/149 (16%)
Query: 190 GAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR-EVALLSRLH----NPNV 244
GA + +Y G + +K R+P + L R+ ++ R E LLSR N V
Sbjct: 5 GAEAIIYLGDFLGLKAVIKE-RVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPV 63
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304
+ V P ++ EY+ L+ + + + L I + + +H G
Sbjct: 64 VYDV----DPDNKTIVMEYIEGKPLKDVIEEGNDELLR-----EIGRLVGK----LHKAG 110
Query: 305 VIHRDLKPENVLI--DQEFHLKIADFGIA 331
++H DL N+++ D+ + + DFG+
Sbjct: 111 IVHGDLTTSNIIVRDDKLY---LIDFGLG 136
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 37/138 (26%), Positives = 67/138 (48%), Gaps = 17/138 (12%)
Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL-- 316
++ E++ G L ++H+ + L P +A +A + Y+ + ++H ++ +N+L
Sbjct: 81 MVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLA 139
Query: 317 ---IDQEF--HLKIADFGIACEEVYCDALSDDPGTYR--WMAPEMIK-HKSYGRKVDVYS 368
ID E +K++D GI LS R W+APE ++ K+ D +S
Sbjct: 140 REGIDGECGPFIKLSDPGIPIT-----VLSRQECVERIPWIAPECVEDSKNLSIAADKWS 194
Query: 369 FGLILWEMV-AGTIPYEE 385
FG LWE+ G IP ++
Sbjct: 195 FGTTLWEICYNGEIPLKD 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 30/126 (23%), Positives = 56/126 (44%), Gaps = 19/126 (15%)
Query: 276 LEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVL-------IDQEFH----- 322
++H L I ++Y H++ ++H DLKPEN+L +D +
Sbjct: 223 MKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282
Query: 323 ----LKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
++I D G C+E + YR +PE++ + D++S G I++E+
Sbjct: 283 DPCRVRICDLGGCCDERHSRTAIVSTRHYR--SPEVVLGLGWMYSTDMWSMGCIIYELYT 340
Query: 379 GTIPYE 384
G + Y+
Sbjct: 341 GKLLYD 346
|
Length = 467 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 14/33 (42%), Positives = 22/33 (66%), Gaps = 1/33 (3%)
Query: 300 IHSQGVIHRDLKPENVLIDQEFH-LKIADFGIA 331
+HS G++HRD+KP+N++ + KI D G A
Sbjct: 271 LHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.003
Identities = 34/150 (22%), Positives = 56/150 (37%), Gaps = 27/150 (18%)
Query: 190 GAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVA-LLSRLHNPNVIKFV 248
GA + + G Y +K R+P + L RL + R A LLS V
Sbjct: 344 GAEADIKKGEYLGRDAVIKE-RVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPT-- 400
Query: 249 AACKKPPVYCV-------ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
P +Y V + EY+ L+ L + + +A+ +H
Sbjct: 401 -----PVIYDVDPEEKTIVMEYIGGKDLKDVLEGNPEL------VRKVGEIVAK----LH 445
Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIA 331
G++H DL N ++ + L + DFG+
Sbjct: 446 KAGIVHGDLTTSNFIVRDD-RLYLIDFGLG 474
|
Length = 535 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 405 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.64 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.58 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.54 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.5 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.47 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.47 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.47 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.46 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.35 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.26 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.17 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.16 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.08 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.04 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.0 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.99 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.96 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.88 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.75 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.64 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.6 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.58 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.52 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.52 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.45 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.42 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.37 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.28 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.23 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.18 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.17 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.15 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.05 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.89 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.84 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.8 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.77 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.76 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.73 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.61 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.45 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.43 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.4 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.37 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.27 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.21 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.74 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.62 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.61 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.51 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.47 | |
| PLN02236 | 344 | choline kinase | 96.42 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.4 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.3 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.17 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.17 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.12 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.09 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.04 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.81 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.58 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.51 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.47 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.05 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.71 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-49 Score=374.98 Aligned_cols=215 Identities=27% Similarity=0.468 Sum_probs=194.8
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
..+|.++++||+|+|++||+|+++ +..||||.+....- ..+..+-+..|+.||+.++|||||.|++++..++
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l------~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~ 82 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL------NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD 82 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc------CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence 478889999999999999999986 68999999975432 2334667889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC------CcEEEEecC
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE------FHLKIADFG 329 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~------~~vkL~DFG 329 (405)
.+|||||||.||+|.+||++ .+.+++..+..++.||+.||++||+++||||||||+||||+.. -.+||+|||
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRR--RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 99999999999999999998 5689999999999999999999999999999999999999764 469999999
Q ss_pred CcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 330 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
+|+...........+|++.|||||++....|+.|+|+||+|++||+|++|..||+..++.|....+-++..
T Consensus 161 fAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~ 231 (429)
T KOG0595|consen 161 FARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE 231 (429)
T ss_pred hhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc
Confidence 99888777777888999999999999999999999999999999999999999999999887776655543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=384.09 Aligned_cols=226 Identities=47% Similarity=0.848 Sum_probs=205.2
Q ss_pred ccccccccCCCeeecceeeeeeeEEEEEEEECCcc-EEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 015556 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP-VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248 (405)
Q Consensus 170 ~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~-vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 248 (405)
...++.+|..++.+++.||.|+||+||+|.+.|+. ||||++...+..... .+.|.+|+.+|.+|+|||||+|+
T Consensus 32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~------~~~f~~E~~il~~l~HpNIV~f~ 105 (362)
T KOG0192|consen 32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES------RKAFRREASLLSRLRHPNIVQFY 105 (362)
T ss_pred cccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH------HHHHHHHHHHHHhCCCCCeeeEE
Confidence 45678899999999999999999999999999988 999999876655432 67899999999999999999999
Q ss_pred eEeecCC-eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCcEEECCCC-cEEE
Q 015556 249 AACKKPP-VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG-VIHRDLKPENVLIDQEF-HLKI 325 (405)
Q Consensus 249 g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g-IiHrDIkp~NILl~~~~-~vkL 325 (405)
|+|.++. .++||||||++|+|.++++......+++..++.++.|||+||+|||+++ |||||||++||||+.++ ++||
T Consensus 106 G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI 185 (362)
T KOG0192|consen 106 GACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKI 185 (362)
T ss_pred EEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEE
Confidence 9999988 7999999999999999998865688999999999999999999999999 99999999999999998 9999
Q ss_pred EecCCccccccc-CCCCCCCCCCcccCccccc--cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Q 015556 326 ADFGIACEEVYC-DALSDDPGTYRWMAPEMIK--HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNF 401 (405)
Q Consensus 326 ~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~~ 401 (405)
+|||++...... ...+...||+.|||||++. ...|+.|+||||||++||||+||..||.++.+.+.+..++.+..-
T Consensus 186 ~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~R 264 (362)
T KOG0192|consen 186 ADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLR 264 (362)
T ss_pred CCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC
Confidence 999999765543 4445578999999999999 669999999999999999999999999999999999999866543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=355.21 Aligned_cols=218 Identities=26% Similarity=0.442 Sum_probs=198.4
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
.+..++|.+.+.||+|+||+||.++.+ ++.+|+|+++.....+. +-.++...|..||..++||+||+++..|+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-----~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-----KEVRHTKAERNILSKIKHPFIVKLIYSFQ 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-----hhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence 466788999999999999999999875 68999999986554433 23577889999999999999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
+...+|||+||+.||.|+.+|.+ .+.+++..+..++.+|+.||.|||++|||||||||+|||||++|+++|+|||++.
T Consensus 96 t~~kLylVld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k 173 (357)
T KOG0598|consen 96 TEEKLYLVLDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCK 173 (357)
T ss_pred cCCeEEEEEeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccch
Confidence 99999999999999999999987 6789999999999999999999999999999999999999999999999999997
Q ss_pred cccc-cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 333 EEVY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 333 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
.... +......+||+.|||||++.+..|+..+|.||||+++||||+|..||...+..+...+|.++.
T Consensus 174 ~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k 241 (357)
T KOG0598|consen 174 EDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK 241 (357)
T ss_pred hcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc
Confidence 5443 345556799999999999999999999999999999999999999999999999999998876
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=354.48 Aligned_cols=215 Identities=32% Similarity=0.498 Sum_probs=193.8
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
.+..+++..++.||+|..|+||+++++ ++.+|+|++....+ ....+|+.+|++|++.++|||||.+||+|.
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~-------~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNID-------PALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCC-------HHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 355667788899999999999999997 79999999954332 234789999999999999999999999999
Q ss_pred cCC-eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 253 KPP-VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 253 ~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
.++ .+.|+||||++|+|.+++... +.+++..+.+|+.+|++||.|||+ ++||||||||+||||+..|++||||||.
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccc
Confidence 999 499999999999999999873 789999999999999999999995 9999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCC-----CCHHHHHHHHHhcc
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE-----MNPIQAAFAVVNKV 399 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~-----~~~~e~~~~i~~~~ 399 (405)
+...... .-...+||..|||||.+.+..|+.++||||||+.++||++|+.||.. .+..+.+-+|+++.
T Consensus 226 S~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p 298 (364)
T KOG0581|consen 226 SGILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP 298 (364)
T ss_pred cHHhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC
Confidence 9776665 44678899999999999999999999999999999999999999977 47888888888754
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=357.26 Aligned_cols=218 Identities=27% Similarity=0.399 Sum_probs=186.8
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.+.|.+++.||+|+||.|-+|..+ |+.||||++.......... ...-.....+|++||++|+|||||+++++|+.+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~-~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSR-AIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccc-cccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 367889999999999999999886 7999999998655443221 0111233569999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC---CcEEEEecCCcc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE---FHLKIADFGIAC 332 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~---~~vkL~DFG~a~ 332 (405)
..|+||||+.||.|.+++.. ++.+.+..-..+++|++.|+.|||++||+||||||+|||+..+ ..+||+|||+|.
T Consensus 250 s~YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred ceEEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999999999987 6778888889999999999999999999999999999999665 789999999999
Q ss_pred cccccCCCCCCCCCCcccCccccccccC---CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 333 EEVYCDALSDDPGTYRWMAPEMIKHKSY---GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 333 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.......+...|||+.|.|||++.++.+ ..++|+|||||+||-+|+|.+||.+......+.+-+.+
T Consensus 328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~ 396 (475)
T KOG0615|consen 328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK 396 (475)
T ss_pred ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc
Confidence 8888888899999999999999976653 45889999999999999999999886665534443333
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=362.31 Aligned_cols=213 Identities=25% Similarity=0.425 Sum_probs=193.7
Q ss_pred CCeeecceeeeeeeEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
..|..|+.||+|||+++|.+++ .|+.||+|++........ .....+.+||+|.+.|+|||||+|+++|++...
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~-----~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKP-----KQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCc-----chHHHHHHHHHHHHhcCCCcEEeeeeEeecCCc
Confidence 5799999999999999999998 389999999975433322 235678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc-
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV- 335 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~- 335 (405)
+|||.|+|+.++|-.++++ .+.+++.+++.+++||+.||.|||+++|||||||..|+|++++.++||+|||+|....
T Consensus 93 VYivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred eEEEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999999999985 6899999999999999999999999999999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 336 YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 336 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
..+.....+||+-|.|||++....++..+||||+||+||.||+|++||+..+-.+.+.+|..+
T Consensus 171 ~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~ 233 (592)
T KOG0575|consen 171 DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN 233 (592)
T ss_pred cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc
Confidence 447778889999999999999999999999999999999999999999998877777777654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=362.60 Aligned_cols=219 Identities=33% Similarity=0.664 Sum_probs=195.3
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
.++|.|..+++.++.+||+|.||+||+|.|.|. ||||++...+..... .+.|++|+.++++-+|.||+-|.||
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd-VAVK~Lnv~~pt~~q------lqaFKnEVa~lkkTRH~NIlLFMG~ 456 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD-VAVKLLNVDDPTPEQ------LQAFKNEVAVLKKTRHENILLFMGA 456 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccccc-eEEEEEecCCCCHHH------HHHHHHHHHHHhhcchhhheeeehh
Confidence 489999999999999999999999999999985 999999987776542 6789999999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
|..++. .||+.||.|-+|+.+|+-.+ ..++..+.+.|+.||+.||.|||.++|||||||..||++.+++.|||+|||+
T Consensus 457 ~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 457 CMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred hcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccc
Confidence 999888 89999999999999998743 6789999999999999999999999999999999999999999999999999
Q ss_pred cccc---cccCCCCCCCCCCcccCccccc---cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 331 ACEE---VYCDALSDDPGTYRWMAPEMIK---HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 331 a~~~---~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
+... .-........|...|||||+++ ..+|++.+||||||+++|||+||.+||......+.+|.+-.+
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG 608 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG 608 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc
Confidence 8421 1122334455889999999985 347899999999999999999999999988888888877665
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=332.26 Aligned_cols=215 Identities=29% Similarity=0.443 Sum_probs=197.7
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 253 (405)
..+++|.+...||.|+||+|.+++.+ +..+|+|++...+ -+..+......+|..+|+.+.||+++++++.|.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~-----vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQK-----VVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHH-----HHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 55678889999999999999999986 7899999997433 4555667888999999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
...+|+||||++||.|+.+|++ .+.+++..+..++.||+.||+|||+++|++|||||+|||||.+|.+||+|||+|..
T Consensus 116 ~~~lymvmeyv~GGElFS~Lrk--~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~ 193 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELFSYLRK--SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKR 193 (355)
T ss_pred CCeEEEEEeccCCccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEE
Confidence 9999999999999999999998 57899999999999999999999999999999999999999999999999999976
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
.... .-..|||+.|+|||++..++|+.++|.|+|||++|||++|..||.+.++++...+|+++.
T Consensus 194 v~~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~ 257 (355)
T KOG0616|consen 194 VSGR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK 257 (355)
T ss_pred ecCc--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc
Confidence 5432 456789999999999999999999999999999999999999999999999999998764
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=355.22 Aligned_cols=223 Identities=31% Similarity=0.543 Sum_probs=201.6
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEECCc-cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~-~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
.+.|.++.+.+.++++||+|-||.|+.|.+++. .||||.++..... ...|.+|+++|++|+|+|||+++|
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~---------~~~f~~Ea~iMk~L~H~~lV~l~g 268 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS---------PEAFLREAQIMKKLRHEKLVKLYG 268 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC---------hhHHHHHHHHHHhCcccCeEEEEE
Confidence 688999999999999999999999999999985 9999999864333 356779999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
+|..+..+|||||||+.|+|.+||+...+..+...+++.++.|||.||+||+++++|||||.++||||+++..+||+|||
T Consensus 269 V~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFG 348 (468)
T KOG0197|consen 269 VCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFG 348 (468)
T ss_pred EEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccc
Confidence 99998899999999999999999998777889999999999999999999999999999999999999999999999999
Q ss_pred CcccccccC--CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccCC
Q 015556 330 IACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVNFG 402 (405)
Q Consensus 330 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~~~ 402 (405)
+|+...... ......-...|.|||.+....++.++|||||||+||||+| |+.||++++..+.+..+-++-..+
T Consensus 349 LAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp 424 (468)
T KOG0197|consen 349 LARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP 424 (468)
T ss_pred cccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC
Confidence 998433222 2223335778999999999999999999999999999999 999999999999999998887664
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=331.39 Aligned_cols=213 Identities=23% Similarity=0.378 Sum_probs=190.8
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
+.|+.+.++|+|+||.||+++.+ |+.||||.+....++.. ..+-..+|+.+|++|+|+|+|.++.+|.....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~------VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk 75 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPV------VKKIALREIRMLKQLKHENLVNLIEVFRRKRK 75 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHH------HHHHHHHHHHHHHhcccchHHHHHHHHHhcce
Confidence 56778889999999999999976 79999999986555432 25677899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc-
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV- 335 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~- 335 (405)
++||+|||+. ++.+-|... ...++.+.+..++.|++.|+.|||+++||||||||+||||+.+|.+||||||+|+...
T Consensus 76 lhLVFE~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 76 LHLVFEYCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred eEEEeeecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 9999999976 444555553 4567888999999999999999999999999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 336 YCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 336 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
.++.+++.+.|..|.|||++.+ .+|+..+|||++||++.||++|..-|++.+.++.++.|++..
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktL 218 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTL 218 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHH
Confidence 7788899999999999999977 789999999999999999999999999999999999998754
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=345.77 Aligned_cols=218 Identities=28% Similarity=0.519 Sum_probs=193.2
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEee
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACK 252 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~ 252 (405)
...+.|.+++.||+|+||+|++|... ++.||||++......... ....+.+.+|+.++++++ ||||++++.++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~---~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~ 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS---QKLDELIKREISILRRLRSHPNIIRLLEVFA 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc---cccchhhHHHHHHHHHhccCCCEeEEEEEEe
Confidence 34578999999999999999999874 799999977653111010 123566779999999999 999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC-CcEEEEecCCc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE-FHLKIADFGIA 331 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~-~~vkL~DFG~a 331 (405)
....+++||||+.||+|.+++.. .+.+.+..+..++.|++.|++|||++||+||||||+|||++.+ +++||+|||++
T Consensus 91 t~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 91 TPTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred cCCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999999999998 6789999999999999999999999999999999999999999 99999999999
Q ss_pred ccc-cccCCCCCCCCCCcccCcccccccc-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 332 CEE-VYCDALSDDPGTYRWMAPEMIKHKS-Y-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 332 ~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
... .........+||+.|+|||++.+.. | +.++||||+||+||.|++|..||++.+.......|.++
T Consensus 169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~ 238 (370)
T KOG0583|consen 169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG 238 (370)
T ss_pred cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC
Confidence 876 5667888999999999999999887 8 58999999999999999999999998888888776665
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=348.97 Aligned_cols=215 Identities=27% Similarity=0.419 Sum_probs=189.2
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEee
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACK 252 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~ 252 (405)
....+|.+|+.||+|+|++||+|+.. ++.||||++...-. +..+-.+.+..|-++|.+| .||.|++|+..|.
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~I-----ike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ 144 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYI-----IKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ 144 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHH-----HhhcccchhhHHHHHHHHhhCCCCeEEEEEEee
Confidence 34578899999999999999999986 69999999864322 2222356678899999999 7999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
|...+|+|+||+++|+|.++|++ -+.+++.-+..++.+|+.||+|||++|||||||||+|||||.++++||+|||.|.
T Consensus 145 D~~sLYFvLe~A~nGdll~~i~K--~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 145 DEESLYFVLEYAPNGDLLDLIKK--YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred cccceEEEEEecCCCcHHHHHHH--hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccc
Confidence 99999999999999999999998 4789999999999999999999999999999999999999999999999999985
Q ss_pred cccccC------------C--CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 333 EEVYCD------------A--LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 333 ~~~~~~------------~--~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
...... . ....+||..|++||++.....+..+|||+|||+||+||.|.+||.+.+..-...+|++
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~ 301 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA 301 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH
Confidence 322111 1 1347899999999999999999999999999999999999999999999888888775
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=344.23 Aligned_cols=217 Identities=28% Similarity=0.417 Sum_probs=192.2
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
.+..++|.++..||+||||.||+++.+ |+.+|+|+++..+... ....+.+..|-.||...++|+||+||..|+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~-----~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ 211 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLK-----KNQVEHVRAERDILAEVDSPWVVKLYYSFQ 211 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHh-----hhhHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence 557789999999999999999999875 7999999998654332 223567889999999999999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
+...+||||||++||++..+|.+ .+.|++..+..++.+++.||+.||+.|+|||||||+|+|||..|++||+|||++.
T Consensus 212 D~~~LYLiMEylPGGD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 212 DKEYLYLIMEYLPGGDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred CCCeeEEEEEecCCccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccc
Confidence 99999999999999999999987 5789999999999999999999999999999999999999999999999999983
Q ss_pred cccc----------------------cCCC--------------------------CCCCCCCcccCccccccccCCchh
Q 015556 333 EEVY----------------------CDAL--------------------------SDDPGTYRWMAPEMIKHKSYGRKV 364 (405)
Q Consensus 333 ~~~~----------------------~~~~--------------------------~~~~gt~~y~aPE~~~~~~~~~k~ 364 (405)
.... .... ...+|||.|||||++.++.|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 1100 0000 012499999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 365 DVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 365 DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
|.||||||+||||.|.+||...+|.+.+.+|++-
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nw 403 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNW 403 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9999999999999999999999999999999874
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=328.51 Aligned_cols=217 Identities=24% Similarity=0.392 Sum_probs=187.3
Q ss_pred cCCCeeecceeeeeeeEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee-Eee-
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA-ACK- 252 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g-~~~- 252 (405)
.+.+|.+.++||+|.||.||++.. .|..||.|.+.-.. +..+...+...|+.+|++|+|||||++++ -+.
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~------md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~ 90 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM------MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE 90 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh------ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc
Confidence 456788999999999999999986 48999999987322 23444778899999999999999999999 444
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceecCCCCCcEEECCCCcEEEE
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHS--QG--VIHRDLKPENVLIDQEFHLKIA 326 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~--~g--IiHrDIkp~NILl~~~~~vkL~ 326 (405)
+...++||||||..|+|.+.++.. ..+.+++..+++++.|++.||..||. .. |+||||||.||+|+.+|.+||.
T Consensus 91 ~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG 170 (375)
T KOG0591|consen 91 DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG 170 (375)
T ss_pred cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence 445599999999999999999864 46779999999999999999999998 44 9999999999999999999999
Q ss_pred ecCCccccccc-CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 327 DFGIACEEVYC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 327 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
|||+++..... ......+|||.||+||++...+|+.++||||+||++|||+.-+.||.+.+-.+...+|-++.
T Consensus 171 DfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd 244 (375)
T KOG0591|consen 171 DFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGD 244 (375)
T ss_pred cchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCC
Confidence 99999764432 23346689999999999999999999999999999999999999999987777777766653
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=342.08 Aligned_cols=211 Identities=32% Similarity=0.564 Sum_probs=178.0
Q ss_pred cccCCCeeeecccccccccccCCCeeecceeeeeeeEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHH
Q 015556 157 YFDHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235 (405)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~i 235 (405)
.|.+..+..++.+|.+. .+||+|+||.||+|...+ +.||||.+....... .++|.+|+.+
T Consensus 64 ~fs~~el~~AT~~Fs~~-----------~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--------~~eF~~Ei~~ 124 (361)
T KOG1187|consen 64 SFSYDELRKATNNFSES-----------NLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--------EREFLNEVEI 124 (361)
T ss_pred eeeHHHHHHHHhCCchh-----------cceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--------hhHHHHHHHH
Confidence 34444455555444443 456999999999999986 899999776543321 2459999999
Q ss_pred HHhcCCCCeeEEeeEeecCC-eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCC
Q 015556 236 LSRLHNPNVIKFVAACKKPP-VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG---VIHRDLK 311 (405)
Q Consensus 236 l~~l~HpnIv~l~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IiHrDIk 311 (405)
+.+++|||+|+|+|||.+.+ ..+||+|||++|+|.++|+......++|..+++|+.++|+||+|||... |||||||
T Consensus 125 ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiK 204 (361)
T KOG1187|consen 125 LSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIK 204 (361)
T ss_pred HhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCC
Confidence 99999999999999999988 5999999999999999999743338899999999999999999999854 9999999
Q ss_pred CCcEEECCCCcEEEEecCCcccccc-cCCCCCC-CCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 312 PENVLIDQEFHLKIADFGIACEEVY-CDALSDD-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 312 p~NILl~~~~~vkL~DFG~a~~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
++|||+|+++++||+|||+|..... ....... .||.+|+|||++..+..+.++|||||||+|+||++|+.|.+..
T Consensus 205 ssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 205 SSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred HHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 9999999999999999999965443 3333333 8999999999999999999999999999999999999888753
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=326.25 Aligned_cols=223 Identities=25% Similarity=0.461 Sum_probs=198.3
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 248 (405)
...|..+.++|.+.+.||.|..++||+|+.. ++.||||++...+...+ .+.+.+|+..|+.++||||+.++
T Consensus 18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-------ld~l~kE~~~msl~~HPNIv~~~ 90 (516)
T KOG0582|consen 18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-------LDALRKEVQTMSLIDHPNIVTYH 90 (516)
T ss_pred cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-------HHHHHHHHHHhhhcCCCCcceEE
Confidence 3567788899999999999999999999985 79999999998665543 46788999999999999999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEec
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF 328 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DF 328 (405)
..|..+..+|+||.||.+|++.+.+...-...+.+..+..|++++++||.|||++|.||||||+.||||+.+|.|||+||
T Consensus 91 ~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadF 170 (516)
T KOG0582|consen 91 CSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADF 170 (516)
T ss_pred EEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCc
Confidence 99999999999999999999999999877778999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccC-----CCCCCCCCCcccCccccc--cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 329 GIACEEVYCD-----ALSDDPGTYRWMAPEMIK--HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 329 G~a~~~~~~~-----~~~~~~gt~~y~aPE~~~--~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
|.+....... .+...+||++|||||++. ...|+.|+||||||++..||++|+.||..+.|++++-.-+++..
T Consensus 171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~p 249 (516)
T KOG0582|consen 171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDP 249 (516)
T ss_pred eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCC
Confidence 9864322211 115668999999999964 34799999999999999999999999999999999887776643
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=329.45 Aligned_cols=214 Identities=25% Similarity=0.435 Sum_probs=197.9
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
.+|.+.+.||.|.||.|-++... |+.||||.|+.....+..+ .-.+++|++||+.|+||||+.+|..|++...
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqD-----lvhIRREIeIMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQD-----LVHIRREIEIMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHH-----HHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence 46778899999999999999874 8999999998766555433 3578899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+.|||||..+|.|++|+.. .+.+++.++..+++||+.|+.|||+++++|||||.+|||+|+++++||+|||++.....
T Consensus 128 IvivMEYaS~GeLYDYiSe--r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISE--RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEEEEecCCccHHHHHHH--hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999999999987 57899999999999999999999999999999999999999999999999999988888
Q ss_pred cCCCCCCCCCCcccCccccccccC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 337 CDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 337 ~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
...+..+||++-|.+||++.+.+| ++.+|-|||||+||.|+.|..||++.+..-...+|.++.
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga 269 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA 269 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc
Confidence 888999999999999999999999 789999999999999999999999999988888877664
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=346.38 Aligned_cols=213 Identities=32% Similarity=0.607 Sum_probs=195.5
Q ss_pred cccccccccCCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 015556 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248 (405)
Q Consensus 169 ~~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 248 (405)
...+.|.|.++.+.-++-||.|+.|-||+|++.++.||||.++. .-..+|.-|++|+|||||.|.
T Consensus 114 qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~e---------------lkETdIKHLRkLkH~NII~Fk 178 (904)
T KOG4721|consen 114 QQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRE---------------LKETDIKHLRKLKHPNIITFK 178 (904)
T ss_pred hhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhh---------------hhhhhHHHHHhccCcceeeEe
Confidence 45678999999999999999999999999999999999998751 223688899999999999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEec
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF 328 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DF 328 (405)
|.|.....+|||||||+.|-|+..|+. ...++...+..+..+||.||.|||.++|||||||.-||||..+..|||+||
T Consensus 179 GVCtqsPcyCIiMEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDF 256 (904)
T KOG4721|consen 179 GVCTQSPCYCIIMEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDF 256 (904)
T ss_pred eeecCCceeEEeeeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccc
Confidence 999999999999999999999999987 678888899999999999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 329 GIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 329 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
|-+...........++||..|||||+++..+.++|+|||||||+|||||||..||.+.+...+++.+-.+
T Consensus 257 GTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsN 326 (904)
T KOG4721|consen 257 GTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSN 326 (904)
T ss_pred cchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCC
Confidence 9987766666677889999999999999999999999999999999999999999999988877766543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=339.89 Aligned_cols=212 Identities=30% Similarity=0.520 Sum_probs=191.3
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||+|.||+||+|+.+ .+.||+|.+......+.+ .+.+.+|++|++.|+|||||.++++|+....
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~------l~~l~~ev~i~r~lkHpniv~m~esfEt~~~ 75 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKE------LKNLRQEVRILRSLKHPNIVEMLESFETSAH 75 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHH------HHHHHHHHHHHHhcCCcchhhHHHhhcccce
Confidence 57888999999999999999876 489999999876655432 5678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+|+|+||+.| +|+.+|.. .+.++++.+..|+.+++.||.|||+.+|+|||+||.|||++.++.+|+||||+|+....
T Consensus 76 ~~vVte~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 76 LWVVTEYAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred EEEEehhhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 9999999966 99999987 68899999999999999999999999999999999999999999999999999976554
Q ss_pred cC-CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 337 CD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 337 ~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
.. ..+...||+.|||||++.+.+|+..+|+||||||+|||++|++||....-.+....|.+..
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~ 216 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDP 216 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCC
Confidence 33 3456679999999999999999999999999999999999999999988888777777654
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=309.87 Aligned_cols=218 Identities=27% Similarity=0.429 Sum_probs=196.9
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
....+++|++|+.||.|-||.||.|+.+ +-.||+|++.... -...+...|+.+|++|.++|+||||+++|++|
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq-----i~~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ-----ILKTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH-----HHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 3445679999999999999999999986 4789999997533 23455688999999999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
.+....||++||..+|+|+..|.......+++.....+..|+|.||.|||..+||||||||+|+|++..+.+||+|||.+
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGws 171 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWS 171 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCce
Confidence 99999999999999999999999777788999999999999999999999999999999999999999999999999998
Q ss_pred ccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 332 CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 332 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
.... +......+||..|++||+..+..++..+|+|++|++.||+|.|..||+.....+.+.+|.+
T Consensus 172 V~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k 236 (281)
T KOG0580|consen 172 VHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK 236 (281)
T ss_pred eecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH
Confidence 6544 5566788999999999999999999999999999999999999999999986666666654
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=343.39 Aligned_cols=217 Identities=26% Similarity=0.455 Sum_probs=196.0
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeE
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAA 250 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~ 250 (405)
..+.+++|.+...||+|.||+|+++..+ ++.+|||+++..+.-.+.+ ....+.|..|+...+ ||.+++++.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~-----Ve~~~~EkrI~~la~~HPFL~~L~~~ 437 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDE-----VESLMCEKRIFELANRHPFLVNLFSC 437 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecccc-----HHHHHHHHHHHHHhccCCeEeecccc
Confidence 4677899999999999999999999987 5899999998766544433 356778888888885 9999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
|+...++|+||||+.||++..+.+ .+.+++..+..++..|+.||.|||++||||||||.+|||+|.+|++||+|||+
T Consensus 438 fQT~~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 438 FQTKEHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred cccCCeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccc
Confidence 999999999999999999544443 37899999999999999999999999999999999999999999999999999
Q ss_pred ccccc-ccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 331 ACEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 331 a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
+.+.. .+......+||+.|||||++.+..|+..+|.|+|||||||||.|..||++.+..+....|++.
T Consensus 515 cKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d 583 (694)
T KOG0694|consen 515 CKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND 583 (694)
T ss_pred ccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC
Confidence 98765 677788999999999999999999999999999999999999999999999999988888764
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=330.59 Aligned_cols=212 Identities=25% Similarity=0.363 Sum_probs=184.6
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||+|+||+||++... ++.||||++...... .......+..|+.++.+++|+||+++++++.+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-----EKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-----HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCe
Confidence 36788999999999999999885 689999999743211 12234678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999999999986 46789999999999999999999999999999999999999999999999999853221
Q ss_pred cC------------------------------------CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCC
Q 015556 337 CD------------------------------------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT 380 (405)
Q Consensus 337 ~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~ 380 (405)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 00 012347999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHh
Q 015556 381 IPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 381 ~Pf~~~~~~e~~~~i~~ 397 (405)
.||.+.++.+...++++
T Consensus 234 ~Pf~~~~~~~~~~~i~~ 250 (363)
T cd05628 234 PPFCSETPQETYKKVMN 250 (363)
T ss_pred CCCCCCCHHHHHHHHHc
Confidence 99999998888887775
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=331.64 Aligned_cols=218 Identities=27% Similarity=0.393 Sum_probs=190.3
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
..+.|..+++||+|.||.||+|++. |+.||+|.++....++.. .....+||.||++|+|||||+|.+...+.
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~------~~t~~REI~ILr~l~HpNIikL~eivt~~ 188 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGF------PITAIREIKILRRLDHPNIIKLEEIVTSK 188 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcc------hHHHHHHHHHHHhcCCCcccceeeEEEec
Confidence 3467888999999999999999985 789999999876544322 34556999999999999999999998876
Q ss_pred --CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 255 --PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 255 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
..+|||+|||+. +|.-++.. ..-.+++.++..++.||+.||+|||.+||+|||||..|||||.+|.+||+|||+|.
T Consensus 189 ~~~siYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 189 LSGSIYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred CCceEEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEecccccee
Confidence 789999999965 77777765 33478999999999999999999999999999999999999999999999999998
Q ss_pred cccc--cCCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Q 015556 333 EEVY--CDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNFG 402 (405)
Q Consensus 333 ~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~~~ 402 (405)
+... ...++..+.|..|.|||++.+. .|+..+|+||.||||.||++|+..|++.+.++++..|.+-.+-|
T Consensus 267 ~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP 339 (560)
T KOG0600|consen 267 FYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSP 339 (560)
T ss_pred eccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCC
Confidence 5443 3367888999999999999765 68999999999999999999999999999999999998766544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=339.89 Aligned_cols=214 Identities=29% Similarity=0.494 Sum_probs=195.3
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
+-|.+|+.||.|+.|.|-+|+.. |+.+|||++.....-. ......+.+|+.||+.+.||||+++|+.+++...
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s-----~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ 86 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS-----SSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH 86 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccc-----cccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence 56789999999999999999874 8999999997542111 1124567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+|||.||++||.|++|+.. .+.+++.++.+++.||+.|+.|||..+|+||||||+|+|||.++++||+|||+|.....
T Consensus 87 lylvlEyv~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EEEEEEecCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999999999987 68999999999999999999999999999999999999999999999999999999888
Q ss_pred cCCCCCCCCCCcccCccccccccC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 337 CDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 337 ~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
+..+...||++.|.|||++.+.+| +.++||||.|||||.||+|++||++.+....+.++.++.
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~ 228 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV 228 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc
Confidence 899999999999999999999999 789999999999999999999999988887777776664
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=337.32 Aligned_cols=213 Identities=29% Similarity=0.527 Sum_probs=193.2
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
...|..-.+||+|+.|.||.+... ++.||||.+....... +..+.+|+.+|+..+|+|||+++..|....
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--------keLilnEi~Vm~~~~H~NiVnfl~Sylv~d 343 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--------KELLLNEILVMRDLHHPNIVNFLDSYLVGD 343 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--------hhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence 356777789999999999999875 6889999998766554 345779999999999999999999999889
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+|+|||||+||+|.+.+.. ..+++.++..|+++++.||+|||.+||+|||||.+|||++.+|.+||+|||++....
T Consensus 344 eLWVVMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred eeEEEEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 99999999999999998876 569999999999999999999999999999999999999999999999999997655
Q ss_pred ccC-CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Q 015556 336 YCD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNF 401 (405)
Q Consensus 336 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~~ 401 (405)
... .....+||++|||||++..+.|+.++||||||++++||+.|..||-..+|..+++.|..+...
T Consensus 421 ~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P 487 (550)
T KOG0578|consen 421 EEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP 487 (550)
T ss_pred cccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCC
Confidence 443 566778999999999999999999999999999999999999999999999999998876543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=330.51 Aligned_cols=218 Identities=25% Similarity=0.379 Sum_probs=197.0
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeec
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKK 253 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~ 253 (405)
-.++|.+.++||.|.||.||+|+.. ++.||||.++..-.. ++ +-.-.+|+..|++|+ |||||+|...+.+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~e------e~~nLREvksL~kln~hpniikL~Evi~d 80 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WE------ECMNLREVKSLRKLNPHPNIIKLKEVIRD 80 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HH------HHHHHHHHHHHHhcCCCCcchhhHHHhhc
Confidence 3478899999999999999999875 789999999764443 22 122348999999999 9999999999988
Q ss_pred CC-eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 254 PP-VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 254 ~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
.. .+|+||||| ..+|+++++.. ++.+++..+..|+.||+.||+|+|.+|+.|||+||+|||+..+..+||+|||+|+
T Consensus 81 ~~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 81 NDRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred cCceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccc
Confidence 77 999999999 56999999885 7899999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCcccCcccc-ccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Q 015556 333 EEVYCDALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNFGA 403 (405)
Q Consensus 333 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~~~~ 403 (405)
.......++..+.|..|.|||++ +..-|+.+.|||++|||++|+++-+..|++.+..+.+++|..-.+-|.
T Consensus 159 ev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~ 230 (538)
T KOG0661|consen 159 EVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPD 230 (538)
T ss_pred ccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCc
Confidence 99888999999999999999987 556789999999999999999999999999999999999998777653
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=322.21 Aligned_cols=215 Identities=27% Similarity=0.433 Sum_probs=187.7
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
...+++|.+.+.||+|+||.||+|.+. ++.||||++..... ........+.+|+.++++++||||+++++++.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI-----LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-----hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 345688999999999999999999986 68999999974221 11223467889999999999999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
++..+|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 166 (329)
T PTZ00263 89 DENRVYFLLEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166 (329)
T ss_pred cCCEEEEEEcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCce
Confidence 99999999999999999999986 4678899999999999999999999999999999999999999999999999986
Q ss_pred cccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 333 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.++.+....+.++
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 230 (329)
T PTZ00263 167 KVPD--RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG 230 (329)
T ss_pred EcCC--CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC
Confidence 5432 223456999999999999999999999999999999999999999998888777766654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=320.25 Aligned_cols=212 Identities=30% Similarity=0.537 Sum_probs=182.8
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC-
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP- 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~- 255 (405)
.++..++.||+|+||.||++.+. |+..|||.....+... .+.+.+|+.+|.+|+|||||+++|......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--------~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~ 88 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--------SESLEREIRILSRLNHPNIVQYYGSSSSREN 88 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--------HHHHHHHHHHHHhCCCCCEEeeCCccccccC
Confidence 45667889999999999999987 5999999997653221 456889999999999999999999855444
Q ss_pred -eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC-CCcEEEEecCCccc
Q 015556 256 -VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-EFHLKIADFGIACE 333 (405)
Q Consensus 256 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~-~~~vkL~DFG~a~~ 333 (405)
.++++|||+++|+|.+++.+..+ .+++..+..+..||+.||+|||++|||||||||+|||++. ++.+||+|||++..
T Consensus 89 ~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 89 DEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 69999999999999999998655 8999999999999999999999999999999999999999 79999999999865
Q ss_pred ccc----cCCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcc
Q 015556 334 EVY----CDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEE-MNPIQAAFAVVNKV 399 (405)
Q Consensus 334 ~~~----~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~-~~~~e~~~~i~~~~ 399 (405)
... ........||+.|||||++..+ ....++|||||||++.||+||..||.+ ....+..+.+....
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~ 239 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED 239 (313)
T ss_pred cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC
Confidence 442 2234457799999999999853 334599999999999999999999999 78888888887665
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=326.28 Aligned_cols=212 Identities=25% Similarity=0.385 Sum_probs=183.8
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||+|+||.||++.+. ++.||||++...... .......+.+|+.+|..++||||+++++++.++..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-----EKEQVAHVRAERDILAEADNPWVVKLYYSFQDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCe
Confidence 36888999999999999999985 689999999743211 12234567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 76 ~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred EEEEECCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999999999976 45789999999999999999999999999999999999999999999999998853211
Q ss_pred cC---------------------------------------CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHH
Q 015556 337 CD---------------------------------------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMV 377 (405)
Q Consensus 337 ~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ell 377 (405)
.. .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 10 011246999999999999899999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHh
Q 015556 378 AGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 378 tG~~Pf~~~~~~e~~~~i~~ 397 (405)
+|..||...++.+....+++
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~ 253 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIIN 253 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHc
Confidence 99999999998887777765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=317.06 Aligned_cols=211 Identities=27% Similarity=0.428 Sum_probs=184.5
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||+|+||.||+|.+. ++.||||++...... ..+....+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-----RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-----hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCe
Confidence 36788899999999999999986 789999999743221 11234668899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred EEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999999999976 45789999999999999999999999999999999999999999999999999865432
Q ss_pred cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 337 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..+
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 213 (291)
T cd05612 154 --RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG 213 (291)
T ss_pred --CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 223456999999999999888999999999999999999999999998887777666554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=300.19 Aligned_cols=217 Identities=24% Similarity=0.372 Sum_probs=191.6
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
.+|...++||+|.||.||+|++. |+.||||.++.....+.. .....+|+..|+.++|+||+.++++|.+...
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi------~~talREIK~Lqel~h~nIi~LiD~F~~~~~ 75 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI------NRTALREIKLLQELKHPNIIELIDVFPHKSN 75 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc------cHHHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence 46777889999999999999986 799999999987655443 2345699999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+.||+|||+. +|+..++. ....++...+..++.++++||+|||++.|+||||||+|+||+.+|.+||+|||+|+....
T Consensus 76 l~lVfEfm~t-dLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 76 LSLVFEFMPT-DLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred eEEEEEeccc-cHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 9999999964 99998876 456788899999999999999999999999999999999999999999999999976443
Q ss_pred -cCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Q 015556 337 -CDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNFGA 403 (405)
Q Consensus 337 -~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~~~~ 403 (405)
.......+-|..|.|||++.+ +.|+..+|+||.||++.||+.|.+-|++.+.+|++..|....+.|.
T Consensus 154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~ 222 (318)
T KOG0659|consen 154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPT 222 (318)
T ss_pred CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCC
Confidence 334444578999999999876 4689999999999999999999999999999999999998877664
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=327.24 Aligned_cols=212 Identities=24% Similarity=0.355 Sum_probs=181.8
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+++.||+|+||.||++... ++.||||++..... ........+.+|++++++++||||+++++++.++..
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-----FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-----HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCe
Confidence 36788999999999999999875 68999999864221 112235678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999999999976 46788999999999999999999999999999999999999999999999999852110
Q ss_pred cC------------------------------------------------CCCCCCCCCcccCccccccccCCchhhHHH
Q 015556 337 CD------------------------------------------------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYS 368 (405)
Q Consensus 337 ~~------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DVwS 368 (405)
.. .....+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 00 001246999999999999899999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 369 FGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 369 lGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
|||++|||++|..||...++.+....+++
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~ 262 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIIN 262 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999999999998888777666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=322.65 Aligned_cols=217 Identities=22% Similarity=0.392 Sum_probs=188.7
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEECC---ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKD---EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~---~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
+.++.++|.+.+.||.|+||.||+|.+.+ ..||||++...... .......+.+|+.++..++||||++++++
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~ 99 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-----KQKQVDHVFSERKILNYINHPFCVNLYGS 99 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCCcceEEE
Confidence 45677889999999999999999998653 57999999743211 12224568899999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
+.+...+|+||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~~~~~~lv~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~ 177 (340)
T PTZ00426 100 FKDESYLYLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGF 177 (340)
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCC
Confidence 9999999999999999999999986 45789999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
+..... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.++......+.++.
T Consensus 178 a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~ 244 (340)
T PTZ00426 178 AKVVDT--RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI 244 (340)
T ss_pred CeecCC--CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Confidence 865322 2234579999999999998889999999999999999999999999998887777776653
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=312.76 Aligned_cols=203 Identities=21% Similarity=0.379 Sum_probs=177.0
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeE
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC 258 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 258 (405)
|.+.+.||+|+||.||++... ++.||||.+....... ......+.+|+.++.+++|+||+.+++++.++..++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----RKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-----hhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEE
Confidence 567789999999999999874 7899999987433221 112356778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccC
Q 015556 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~ 338 (405)
+||||+++|+|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999999999998876555678999999999999999999999999999999999999999999999999986544333
Q ss_pred CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 015556 339 ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP 388 (405)
Q Consensus 339 ~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~ 388 (405)
......||..|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 34456799999999999999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=327.69 Aligned_cols=211 Identities=25% Similarity=0.392 Sum_probs=181.7
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
.|.+++.||+|+||+||+|.+. ++.||||++....... ......+.+|+.++..++|+||+++++++.+...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~-----~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLN-----RNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----hHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEE
Confidence 5788999999999999999985 5899999997533211 22246788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 77 ~lv~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred EEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999999999976 456889999999999999999999999999999999999999999999999986421000
Q ss_pred ------------------------------------------------CCCCCCCCCCcccCccccccccCCchhhHHHH
Q 015556 338 ------------------------------------------------DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSF 369 (405)
Q Consensus 338 ------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSl 369 (405)
......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00123469999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 370 GLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 370 Gvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
||++|||++|..||...++.+....+++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~ 262 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVIN 262 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHc
Confidence 9999999999999999888777776664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=314.43 Aligned_cols=223 Identities=25% Similarity=0.407 Sum_probs=196.0
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEECC--ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
....+.++.|.+.++||.|.-|+||++.+.+ ..+|+|++....... .+-..+...|.+||+.++||.+..||+
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~-----rkKl~Ra~tE~eIL~~lDHPFlPTLYa 144 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS-----RKKLKRAQTEREILSLLDHPFLPTLYA 144 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh-----hhHHHHHHHHHHHHHhcCCCccchhhh
Confidence 4556788899999999999999999999986 899999997433221 223567788999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
.++.+...|||||||+||+|...++++.++.+++..+..++.+++.||+|||.+|||+|||||+||||-++|+|.|+||.
T Consensus 145 ~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFD 224 (459)
T KOG0610|consen 145 SFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFD 224 (459)
T ss_pred eeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred Ccccccc---------------------------------c-C-----------------------CCCCCCCCCcccCc
Q 015556 330 IACEEVY---------------------------------C-D-----------------------ALSDDPGTYRWMAP 352 (405)
Q Consensus 330 ~a~~~~~---------------------------------~-~-----------------------~~~~~~gt~~y~aP 352 (405)
++..... . . .....+||-.|+||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 8731100 0 0 01123589999999
Q ss_pred cccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 353 EMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 353 E~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
|++.+...+.++|.|+|||+|||||.|..||.+.+..+.+..|+.+.
T Consensus 305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~ 351 (459)
T KOG0610|consen 305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQP 351 (459)
T ss_pred eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCC
Confidence 99999999999999999999999999999999999999999887654
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=325.88 Aligned_cols=211 Identities=24% Similarity=0.403 Sum_probs=182.2
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
.|.+++.||+|+||.||+|+.. ++.||||++..... ........+.+|+.++++++|+||+++++++.++..+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-----~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-----LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-----hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEE
Confidence 5788999999999999999985 68999999974221 1223356788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
|+|||||++|+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 77 ~lv~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999999999976 356889999999999999999999999999999999999999999999999987421100
Q ss_pred ------------------------------------------------CCCCCCCCCCcccCccccccccCCchhhHHHH
Q 015556 338 ------------------------------------------------DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSF 369 (405)
Q Consensus 338 ------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSl 369 (405)
......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 00112469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 370 GLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 370 Gvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
||+||||++|+.||...++.+....+++
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~ 262 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQMKVIN 262 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 9999999999999999998887777765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=331.65 Aligned_cols=221 Identities=31% Similarity=0.540 Sum_probs=193.6
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEECC------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI 244 (405)
...|.+..+++.++++||+|+||.||+|.+.- ..||||..+.... ......++|.+|.++|++++||||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~-----~~~~~~~e~m~EArvMr~l~H~NV 223 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE-----LTKEQIKEFMKEARVMRQLNHPNV 223 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc-----ccHHHHHHHHHHHHHHHhCCCCCE
Confidence 46799999999999999999999999999852 2389999885321 122337889999999999999999
Q ss_pred eEEeeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEE
Q 015556 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324 (405)
Q Consensus 245 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vk 324 (405)
|+|||++.....++||||+|.||+|.+||++.. ..++..+.+.++.+.|.||+|||++++|||||..+|+|++.++.+|
T Consensus 224 Vr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 224 VRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEEEEEEcCCCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEE
Confidence 999999999999999999999999999999843 3699999999999999999999999999999999999999999999
Q ss_pred EEecCCcccccccC-CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015556 325 IADFGIACEEVYCD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 325 L~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~ 397 (405)
|+|||++....... ......-..+|+|||.+....|+.++|||||||++||+++ |..||+++...+....|+.
T Consensus 303 ISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~ 377 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK 377 (474)
T ss_pred eCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh
Confidence 99999987654111 1112246789999999999999999999999999999999 8999999999998888844
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=326.39 Aligned_cols=212 Identities=25% Similarity=0.385 Sum_probs=181.5
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||+|+||.||++... ++.||||++..... ........+.+|+.+|.+++|+||+++++.+.+++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV-----LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH-----HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCE
Confidence 46889999999999999999975 68999999863221 112234668899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred EEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 9999999999999999976 45688999999999999999999999999999999999999999999999998732100
Q ss_pred c--------------------------------------------CCCCCCCCCCcccCccccccccCCchhhHHHHHHH
Q 015556 337 C--------------------------------------------DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLI 372 (405)
Q Consensus 337 ~--------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvl 372 (405)
. .......||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 0 00112469999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 373 LWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 373 l~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
+|||++|..||.+.++.+....+..
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~ 258 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVIN 258 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhc
Confidence 9999999999999888777666654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=318.52 Aligned_cols=210 Identities=25% Similarity=0.369 Sum_probs=183.9
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||+|+||.||+|++. ++.||||++...... .......+.+|+.++..++||||+++++++.+...
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-----KLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCE
Confidence 36889999999999999999985 689999999743211 11224678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred EEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999999999976 45789999999999999999999999999999999999999999999999999865433
Q ss_pred cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 337 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
......||+.|+|||++.+..++.++|||||||++|||++|..||...++.+....+..
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 212 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY 212 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh
Confidence 33456799999999999988999999999999999999999999999888776655543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=314.41 Aligned_cols=210 Identities=24% Similarity=0.428 Sum_probs=184.5
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC---
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--- 254 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--- 254 (405)
.|.-.+.+|.|+||.||.|+.. ++.||||.........+ +|+++|+.++|||||++.-+|...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~kn------------rEl~im~~l~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKN------------RELQIMRKLDHPNIVRLLYFFSSSTES 92 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCc------------HHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence 3556678999999999999986 58999999876665544 799999999999999999988542
Q ss_pred --CeeEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC-CcEEEEecC
Q 015556 255 --PVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE-FHLKIADFG 329 (405)
Q Consensus 255 --~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~-~~vkL~DFG 329 (405)
-...||||||+. +|.++++.. .+..++...+.-+..||++||.|||..||+||||||.|+|+|.+ |.+||||||
T Consensus 93 d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 93 DEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred chhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCC
Confidence 245689999976 999998853 34567777888899999999999999999999999999999977 999999999
Q ss_pred CcccccccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Q 015556 330 IACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNFG 402 (405)
Q Consensus 330 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~~~ 402 (405)
.|.....++.......|..|.|||++.+ ..|+.+.||||.||++.||+.|++-|++.+..+++..|++-.+.|
T Consensus 172 SAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~P 245 (364)
T KOG0658|consen 172 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTP 245 (364)
T ss_pred cceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCC
Confidence 9998888888777889999999999876 468999999999999999999999999999999999999877765
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=319.15 Aligned_cols=216 Identities=31% Similarity=0.520 Sum_probs=178.1
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCee
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVI 245 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv 245 (405)
|.|..++|.+++.||.|+||.||+|.+. ++.||||++....... ....+.+|+.++..+ +||||+
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~~h~niv 74 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATAS-------EHKALMSELKILIHIGNHLNVV 74 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchH-------HHHHHHHHHHHHHHhccCccee
Confidence 6778889999999999999999999752 3689999987433221 145688999999999 899999
Q ss_pred EEeeEeecC-CeeEEEEeecCCCCHHHHHHHhc-----------------------------------------------
Q 015556 246 KFVAACKKP-PVYCVITEYLSEGSLRAYLHKLE----------------------------------------------- 277 (405)
Q Consensus 246 ~l~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~----------------------------------------------- 277 (405)
+++++|... ..+++||||+++|+|.+++....
T Consensus 75 ~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (338)
T cd05102 75 NLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTS 154 (338)
T ss_pred eEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccC
Confidence 999988764 46889999999999999997532
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccC---CCC
Q 015556 278 -------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALS 341 (405)
Q Consensus 278 -------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~ 341 (405)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 155 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~ 234 (338)
T cd05102 155 GSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 234 (338)
T ss_pred cccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhccc
Confidence 1347788899999999999999999999999999999999999999999999986432211 112
Q ss_pred CCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 015556 342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 342 ~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~ 396 (405)
...++..|+|||++.+..++.++|||||||+||||++ |..||.+....+.....+
T Consensus 235 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~ 290 (338)
T cd05102 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL 290 (338)
T ss_pred CCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH
Confidence 3346678999999998899999999999999999997 999998866544444333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=323.14 Aligned_cols=225 Identities=28% Similarity=0.457 Sum_probs=185.2
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhH------HHHHHHHHHHHHHHHHHHhcCCCC
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENE------TLAARLEKQFNREVALLSRLHNPN 243 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~------~~~~~~~~~~~~Ei~il~~l~Hpn 243 (405)
.+....+++|+++..||+|.||.|-+|+.. ++.||||++.......+. .....-..+..+||.||++|+|||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 344566789999999999999999999986 699999999643322110 000011347889999999999999
Q ss_pred eeEEeeEeecC--CeeEEEEeecCCCCHHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC
Q 015556 244 VIKFVAACKKP--PVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320 (405)
Q Consensus 244 Iv~l~g~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~ 320 (405)
||+|+.+..+. ..+|||+|||..|.+...- .... +++.++++++++++.||+|||.+|||||||||.|+||+++
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC
Confidence 99999999875 5799999999988764322 2334 8999999999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccc------cccCCCCCCCCCCcccCccccccc---cC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 015556 321 FHLKIADFGIACEE------VYCDALSDDPGTYRWMAPEMIKHK---SY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390 (405)
Q Consensus 321 ~~vkL~DFG~a~~~------~~~~~~~~~~gt~~y~aPE~~~~~---~~-~~k~DVwSlGvll~elltG~~Pf~~~~~~e 390 (405)
|++||+|||.+... .....+...+||+.|+|||++.++ .+ +.+.||||+||+||.|+.|+.||-+....+
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 99999999998644 222334457899999999998763 23 689999999999999999999999999999
Q ss_pred HHHHHHhcc
Q 015556 391 AAFAVVNKV 399 (405)
Q Consensus 391 ~~~~i~~~~ 399 (405)
...+|++..
T Consensus 327 l~~KIvn~p 335 (576)
T KOG0585|consen 327 LFDKIVNDP 335 (576)
T ss_pred HHHHHhcCc
Confidence 999998764
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=316.53 Aligned_cols=206 Identities=24% Similarity=0.388 Sum_probs=177.3
Q ss_pred ceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEe
Q 015556 185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 262 (405)
+.||+|+||.||++... ++.||||++...... .......+.+|+.++++++||||+++++++.....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII-----AKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEe
Confidence 35899999999999875 689999999743211 11224567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc-ccCCCC
Q 015556 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV-YCDALS 341 (405)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~-~~~~~~ 341 (405)
|+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... ......
T Consensus 76 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 153 (323)
T cd05571 76 YANGGELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence 9999999999976 4678999999999999999999999999999999999999999999999999986432 222334
Q ss_pred CCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 342 ~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
...||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~ 209 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 209 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc
Confidence 45699999999999999999999999999999999999999998877666555543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=320.90 Aligned_cols=212 Identities=25% Similarity=0.367 Sum_probs=183.6
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||+|+||.||++... ++.||||++...+.. .......+..|+.++..++|+||+++++.+.+...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-----EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-----hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 36788899999999999999985 689999999742211 12235678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+|+||||+++|+|.+++.+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 76 ~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred EEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999999999976 46789999999999999999999999999999999999999999999999999753211
Q ss_pred cC------------------------------------CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCC
Q 015556 337 CD------------------------------------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT 380 (405)
Q Consensus 337 ~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~ 380 (405)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 00 011346999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHh
Q 015556 381 IPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 381 ~Pf~~~~~~e~~~~i~~ 397 (405)
.||.+.++.+....+++
T Consensus 234 ~Pf~~~~~~~~~~~i~~ 250 (360)
T cd05627 234 PPFCSETPQETYRKVMN 250 (360)
T ss_pred CCCCCCCHHHHHHHHHc
Confidence 99999998887777765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=313.20 Aligned_cols=206 Identities=25% Similarity=0.406 Sum_probs=177.1
Q ss_pred ceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEe
Q 015556 185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 262 (405)
+.||+|+||.||++... ++.||+|++...... .......+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEe
Confidence 35899999999999875 689999999743211 11224567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc-cCCCC
Q 015556 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDALS 341 (405)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~ 341 (405)
|+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 76 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 153 (323)
T cd05595 76 YANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence 9999999998876 45789999999999999999999999999999999999999999999999999864322 22233
Q ss_pred CCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 342 ~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
...||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~ 209 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 209 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 45699999999999989999999999999999999999999998887776665543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=320.94 Aligned_cols=212 Identities=25% Similarity=0.411 Sum_probs=186.4
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+++.||+|+||.||+|.+. ++.||||++....... ......+..|+.++..++|+||+++++++.++..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK-----RNQIAHVRAERDILADADSPWIVKLYYSFQDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh-----ccHHHHHHHHHHHHHhcCCCCccchhhheecCCe
Confidence 36889999999999999999987 7999999997432111 1235678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+|+||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999999999873 6789999999999999999999999999999999999999999999999999865433
Q ss_pred cC------------------------------CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 337 CD------------------------------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 337 ~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 22 223456999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHh
Q 015556 387 NPIQAAFAVVN 397 (405)
Q Consensus 387 ~~~e~~~~i~~ 397 (405)
+..+...++++
T Consensus 234 ~~~~~~~~i~~ 244 (350)
T cd05573 234 TLQETYNKIIN 244 (350)
T ss_pred CHHHHHHHHhc
Confidence 88887777765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=321.05 Aligned_cols=217 Identities=24% Similarity=0.376 Sum_probs=185.1
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
..+..++|.+.+.||+|+||.||++.+. ++.||+|++...... .......+.+|+.+++.++||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~ 112 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAFANSPWVVQLFCAF 112 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3455678999999999999999999986 689999999642211 111245678899999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
.++..+|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 113 QDDKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccc
Confidence 999999999999999999999975 46889999999999999999999999999999999999999999999999998
Q ss_pred ccccccC--CCCCCCCCCcccCcccccccc----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 332 CEEVYCD--ALSDDPGTYRWMAPEMIKHKS----YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 332 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+...+++..
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~ 262 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH 262 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 6543221 123456999999999986543 788999999999999999999999998888877777753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=306.55 Aligned_cols=219 Identities=27% Similarity=0.437 Sum_probs=192.2
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC-eeEEeeEeecC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN-VIKFVAACKKP 254 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~ 254 (405)
+..|...++||+|+||+||+|+.. |+.||+|.++.....+- .-....+|+.+|++|+|+| |+.+++.+...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG------~P~taiREisllk~L~~~~~iv~L~dv~~~~ 83 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG------VPSTAIREISLLKRLSHANHIVRLHDVIHTS 83 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC------CCchhhHHHHHHHHhCCCcceEEEEeeeeec
Confidence 456777888999999999999985 78999999998765321 1233458999999999999 99999999877
Q ss_pred C------eeEEEEeecCCCCHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEE
Q 015556 255 P------VYCVITEYLSEGSLRAYLHKLEH--KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA 326 (405)
Q Consensus 255 ~------~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~ 326 (405)
. .+++|+||++ -+|.+|+..... ..++...+..++.||+.||+|||+++|+||||||+||||+.+|.+||+
T Consensus 84 ~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKla 162 (323)
T KOG0594|consen 84 NNHRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLA 162 (323)
T ss_pred ccccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeee
Confidence 6 8999999995 599999988543 367778899999999999999999999999999999999999999999
Q ss_pred ecCCccccc-ccCCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Q 015556 327 DFGIACEEV-YCDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNFGA 403 (405)
Q Consensus 327 DFG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~~~~ 403 (405)
|||+|.... ....++..++|..|.|||++.+. .|+...||||+|||++||++++.-|++....+.+.+|.+..+.|+
T Consensus 163 DFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 163 DFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN 241 (323)
T ss_pred ccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC
Confidence 999997544 44557888899999999999876 689999999999999999999999999999999999999888775
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=319.41 Aligned_cols=218 Identities=24% Similarity=0.371 Sum_probs=186.1
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
+..+..++|.+.+.||+|+||.||++.+. ++.||+|++...... .......+.+|+.++..++||||++++++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~e~~i~~~~~hp~iv~~~~~ 111 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAFANSPWVVQLFYA 111 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 44566789999999999999999999986 689999998642211 11224567889999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
+.++..+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 112 FQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred EEcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 9999999999999999999999975 4588889999999999999999999999999999999999999999999999
Q ss_pred cccccccC--CCCCCCCCCcccCcccccccc----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 331 ACEEVYCD--ALSDDPGTYRWMAPEMIKHKS----YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 331 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
+....... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||...+..+....+++.
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 262 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 262 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 86543221 123456999999999986543 789999999999999999999999998888777777754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=305.81 Aligned_cols=213 Identities=25% Similarity=0.458 Sum_probs=181.5
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
++++|.+.+.||.|+||.||+|... ++.||||++........ ...+.+|+.++++++||||+++++++.+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-------PCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCc-------chhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 4578999999999999999999885 68999999975443221 23566899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
...++||||+++ +|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 76 ~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~ 153 (288)
T cd07871 76 RCLTLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAK 153 (288)
T ss_pred CeEEEEEeCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeec
Confidence 999999999975 999998763 345788999999999999999999999999999999999999999999999998543
Q ss_pred cc-cCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 335 VY-CDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 335 ~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.. ........+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.+.
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 219 (288)
T cd07871 154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRL 219 (288)
T ss_pred cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 22 122344568999999999865 56899999999999999999999999998888877766554
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=310.81 Aligned_cols=205 Identities=22% Similarity=0.384 Sum_probs=177.5
Q ss_pred eeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEeec
Q 015556 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264 (405)
Q Consensus 187 lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 264 (405)
||+|+||.||++.+. ++.||||++...... .......+.+|+.++.+++||||+++++++.+...+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-----SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCC
Confidence 699999999999986 688999999742211 1122456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc-cCCCCCC
Q 015556 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDALSDD 343 (405)
Q Consensus 265 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~~~ 343 (405)
++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......
T Consensus 76 ~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 153 (312)
T cd05585 76 NGGELFHHLQR--EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF 153 (312)
T ss_pred CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccc
Confidence 99999999976 45789999999999999999999999999999999999999999999999999864322 2223345
Q ss_pred CCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 344 PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 344 ~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.+.
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~ 208 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE 208 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC
Confidence 6999999999999999999999999999999999999999998887777666553
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=311.82 Aligned_cols=212 Identities=27% Similarity=0.432 Sum_probs=180.9
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecCCe
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPV 256 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 256 (405)
+|.+.+.||+|+||.||+|.+. ++.||||++....... ......+..|..++..+ +|++|+++++++.+...
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-----DDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCE
Confidence 4778899999999999999986 4799999997532211 11234566788888887 47999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred EEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999999999876 45689999999999999999999999999999999999999999999999999864322
Q ss_pred -cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 337 -CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 337 -~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+...
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~ 216 (323)
T cd05616 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 216 (323)
T ss_pred CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 22334557999999999999999999999999999999999999999998887777766653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=314.17 Aligned_cols=205 Identities=23% Similarity=0.407 Sum_probs=176.4
Q ss_pred ceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEe
Q 015556 185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 262 (405)
+.||+|+||.||++... ++.||||++....... ......+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIA-----KDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEe
Confidence 35899999999999875 6899999997432211 1224577889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc-cCCCC
Q 015556 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDALS 341 (405)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~ 341 (405)
|+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 76 y~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 153 (328)
T cd05593 76 YVNGGELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK 153 (328)
T ss_pred CCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence 9999999999876 45789999999999999999999999999999999999999999999999999864322 22234
Q ss_pred CCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015556 342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 342 ~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~ 396 (405)
...||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~ 208 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc
Confidence 4569999999999998899999999999999999999999999887766555543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=304.02 Aligned_cols=220 Identities=23% Similarity=0.356 Sum_probs=191.1
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 253 (405)
-.+++|....+|++|.||.||+|+++ ++.||+|.++.....+--- ---.+||.+|.+++|||||.+-.....
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFP------ItsLREIniLl~~~H~NIV~vkEVVvG 146 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFP------ITSLREINILLKARHPNIVEVKEVVVG 146 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCc------chhHHHHHHHHhcCCCCeeeeEEEEec
Confidence 34578888999999999999999996 7999999998765333211 123489999999999999999887754
Q ss_pred --CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 254 --PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 254 --~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
-..+|+|||||+. +|...+..+. ..+...++..++.|+++|++|||.+.|+|||||++|+|+++.|.+||+|||+|
T Consensus 147 ~~~d~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLA 224 (419)
T KOG0663|consen 147 SNMDKIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLA 224 (419)
T ss_pred cccceeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchh
Confidence 3569999999965 9999998865 67888899999999999999999999999999999999999999999999999
Q ss_pred cccc-ccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Q 015556 332 CEEV-YCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNFGA 403 (405)
Q Consensus 332 ~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~~~~ 403 (405)
+... ....++..+-|..|.|||++.+ ..|+...|+||+|||+.|||++.+-|++...++++.+|.+-.+.|.
T Consensus 225 R~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPt 298 (419)
T KOG0663|consen 225 REYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPS 298 (419)
T ss_pred hhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCc
Confidence 7644 3456788889999999999866 4689999999999999999999999999999999999998877765
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=318.59 Aligned_cols=218 Identities=22% Similarity=0.357 Sum_probs=185.5
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
...+..++|.+.+.||+|+||.||++... ++.||||++...... .......+.+|+.+++.++||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~il~~~~h~~iv~~~~~ 111 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAHANSEWIVQLHYA 111 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 34566789999999999999999999985 689999999642111 11123557789999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
+.++..+|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~ 188 (370)
T cd05596 112 FQDDKYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (370)
T ss_pred EecCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccc
Confidence 9999999999999999999999876 4688889999999999999999999999999999999999999999999999
Q ss_pred cccccccC--CCCCCCCCCcccCccccccc----cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 331 ACEEVYCD--ALSDDPGTYRWMAPEMIKHK----SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 331 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~----~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
+....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||...+..+....+++.
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 262 (370)
T cd05596 189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH 262 (370)
T ss_pred eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC
Confidence 86543221 12345699999999998653 4789999999999999999999999998888777777654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=305.04 Aligned_cols=215 Identities=27% Similarity=0.454 Sum_probs=181.7
Q ss_pred CCeeecceeeeeeeEEEEEEEEC---CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc---CCCCeeEEeeEee
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK---DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL---HNPNVIKFVAACK 252 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~---~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~ 252 (405)
++|.+.+.||+|+||.||+|.+. ++.||||.+......+.. ...+.+|+.+++.+ +||||++++++|.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------PLSTIREVAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc------hHHHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence 36888999999999999999873 578999999765433321 23445677777766 6999999999985
Q ss_pred -----cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEe
Q 015556 253 -----KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327 (405)
Q Consensus 253 -----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~D 327 (405)
....+++||||+. ++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 75 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred cccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEcc
Confidence 3456899999996 6999999876666789999999999999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 328 FGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 328 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
||++.............|+..|+|||++.+..++.++|||||||++|||++|..||.+....+.+..+++...
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~ 226 (290)
T cd07862 154 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 226 (290)
T ss_pred ccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC
Confidence 9998655444444556789999999999888899999999999999999999999999998888888876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=313.20 Aligned_cols=208 Identities=25% Similarity=0.408 Sum_probs=177.9
Q ss_pred ceeeeeeeEEEEEEEE-----CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEE
Q 015556 185 LRFAHGAHSRLYHGIY-----KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV 259 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~-----~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 259 (405)
+.||+|+||.||++.. .++.||||++....... .......+..|+.+|+.++||||+++++++..++.+|+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l 77 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR----NQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYL 77 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHh----hhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEE
Confidence 5789999999999986 36789999997432111 11224567899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc-cC
Q 015556 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CD 338 (405)
Q Consensus 260 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~-~~ 338 (405)
||||+++++|.+++.. ...+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 78 ILEYLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred EEeCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 9999999999999976 45688889999999999999999999999999999999999999999999999864322 22
Q ss_pred CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 339 ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 339 ~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.++
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~ 215 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG 215 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 233456999999999999888999999999999999999999999998887777766554
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=316.66 Aligned_cols=213 Identities=30% Similarity=0.458 Sum_probs=193.0
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeecCC
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPP 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~ 255 (405)
..|.+++.||.|.||.||+++.. |+.+|+|++......... ....+.+|+.||+++. |||||.++++|++..
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~-----~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE-----DREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc-----cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 57889999999999999999986 689999999865543321 1457889999999998 999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC----CCcEEEEecCCc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ----EFHLKIADFGIA 331 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~----~~~vkL~DFG~a 331 (405)
.+++|||+|.||.|++.+... .+++..+..++.|++.++.|||+.||+||||||+|+|+.. ++.+|++|||++
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999999999885 3999999999999999999999999999999999999943 358999999999
Q ss_pred ccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 332 CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 332 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
............+||+.|+|||++....|+..+||||+||++|.|++|..||.+.+..+...+|.++.
T Consensus 187 ~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~ 254 (382)
T KOG0032|consen 187 KFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGD 254 (382)
T ss_pred eEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCC
Confidence 88777777888999999999999999999999999999999999999999999999988888887764
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=310.78 Aligned_cols=212 Identities=27% Similarity=0.419 Sum_probs=180.2
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC-CCeeEEeeEeecCCe
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFVAACKKPPV 256 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~~ 256 (405)
+|.+.+.||+|+||.||+|.+. ++.||||++....... ......+..|+.++..+.| ++|+.+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ-----DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCE
Confidence 4778899999999999999986 4789999997432111 1124567789999999976 568889999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc-
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV- 335 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~- 335 (405)
+|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 76 ~~lv~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred EEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999999999976 4568899999999999999999999999999999999999999999999999985422
Q ss_pred ccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 336 YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 336 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.+.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~ 216 (324)
T cd05587 154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH 216 (324)
T ss_pred CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 122233456999999999999999999999999999999999999999998887777766543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=311.21 Aligned_cols=214 Identities=22% Similarity=0.354 Sum_probs=182.0
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+++.||+|+||.||++... ++.||||++...+. ......+.+.+|+.++..++|+||+.+++++.++..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-----LKRAETACFREERDVLVNGDRRWITNLHYAFQDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-----hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCe
Confidence 46889999999999999999985 68999999973211 112224668899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+|+||||+++|+|.+++.+. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred EEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999999999752 45689999999999999999999999999999999999999999999999999854332
Q ss_pred cCC--CCCCCCCCcccCcccccc-----ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 337 CDA--LSDDPGTYRWMAPEMIKH-----KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 337 ~~~--~~~~~gt~~y~aPE~~~~-----~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
... .....||+.|+|||++.. ..++.++|||||||++|+|++|+.||...+..+....++..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~ 223 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 221 123469999999999863 45788999999999999999999999998888777776653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=311.02 Aligned_cols=210 Identities=26% Similarity=0.444 Sum_probs=177.7
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHH---HhcCCCCeeEEeeEeecCC
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALL---SRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il---~~l~HpnIv~l~g~~~~~~ 255 (405)
|.+.+.||+|+||.||+|.+. ++.||||++....... ......+.+|+.++ ..++||||+++++++.+..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA-----RDEVESLMCEKRIFETANSERHPFLVNLFACFQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence 567889999999999999885 6899999997432111 11134566666554 5668999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+|+||||+++++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999999999988864 578999999999999999999999999999999999999999999999999985432
Q ss_pred -ccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 336 -YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 336 -~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.........|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.+.
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~ 216 (324)
T cd05589 153 GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND 216 (324)
T ss_pred CCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 222334557999999999999889999999999999999999999999998887777766654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=311.30 Aligned_cols=214 Identities=23% Similarity=0.339 Sum_probs=182.2
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||+|+||.||+++.. ++.||||++.... .........+..|+.++..++|+||+++++++.+...
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE-----MLKRAETACFREERNVLVNGDCQWITTLHYAFQDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH-----HHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 46889999999999999999986 5889999986321 1112224567889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
.|+||||+++|+|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999999999863 35788999999999999999999999999999999999999999999999999865432
Q ss_pred cCC--CCCCCCCCcccCcccccc-----ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 337 CDA--LSDDPGTYRWMAPEMIKH-----KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 337 ~~~--~~~~~gt~~y~aPE~~~~-----~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
... .....||+.|+|||++.+ ..++.++|||||||+||+|++|+.||...+..+....++..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~ 223 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC
Confidence 221 123469999999999875 46788999999999999999999999998888877776653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=301.84 Aligned_cols=215 Identities=21% Similarity=0.391 Sum_probs=182.2
Q ss_pred cccCCCeeec--ceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 175 TVDLSQLFLG--LRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 175 ~i~~~~~~~~--~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
.++.+++... ..||+|+++.||+|.++|+.||||.+........ ...+.|.+|+.+|.+++||||++++|++.
T Consensus 14 ~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~g~~~ 88 (283)
T PHA02988 14 CIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHK-----VLIDITENEIKNLRRIDSNNILKIYGFII 88 (283)
T ss_pred ecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccH-----HHHHHHHHHHHHHHhcCCCCEEEEeeeEE
Confidence 4444445444 5689999999999999999999999975443221 22467889999999999999999999987
Q ss_pred c----CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEECCCCcEEEEe
Q 015556 253 K----PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIAD 327 (405)
Q Consensus 253 ~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDIkp~NILl~~~~~vkL~D 327 (405)
+ ...+++||||+++|+|.+++.. ...+++...+.++.+++.||.|||+. +++||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~d 166 (283)
T PHA02988 89 DIVDDLPRLSLILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIIC 166 (283)
T ss_pred ecccCCCceEEEEEeCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcc
Confidence 6 3578999999999999999986 45788999999999999999999984 999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCCcccCcccccc--ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 328 FGIACEEVYCDALSDDPGTYRWMAPEMIKH--KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 328 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
||++..... ......|+..|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+....++++
T Consensus 167 fg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~ 237 (283)
T PHA02988 167 HGLEKILSS--PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINK 237 (283)
T ss_pred cchHhhhcc--ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 999854322 1234568999999999976 67899999999999999999999999999888877777654
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=302.45 Aligned_cols=210 Identities=24% Similarity=0.392 Sum_probs=178.9
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||+|+||.||++++. ++.||||++......+. ..+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEE------VKETTLRELKMLRTLKQENIVELKEAFRRRGK 74 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccccc------chhhHHHHHHHHHhCCCccccchhhhEecCCE
Confidence 36889999999999999999986 58999999976543221 24567789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+++||||++++.+..+... ...+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 75 ~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 75 LYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred EEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 9999999988766554432 45789999999999999999999999999999999999999999999999999865432
Q ss_pred c--CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015556 337 C--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 337 ~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~ 396 (405)
. .......|+..|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~ 214 (287)
T cd07848 153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQ 214 (287)
T ss_pred cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 1 12234568999999999998889999999999999999999999999888776655543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=308.88 Aligned_cols=214 Identities=23% Similarity=0.357 Sum_probs=182.1
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||+|+||.||++.+. ++.||||++.... .........+..|+.++..++|+||+++++++.+...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE-----MLKRAETACFREERDVLVNGDNQWITTLHYAFQDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHH-----HHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCE
Confidence 36888999999999999999986 5789999986321 1112224558889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+|+||||+++|+|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred EEEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999999999763 35689999999999999999999999999999999999999999999999999854322
Q ss_pred cC--CCCCCCCCCcccCccccc-----cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 337 CD--ALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 337 ~~--~~~~~~gt~~y~aPE~~~-----~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.. ......||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+.+.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~ 223 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Confidence 11 122356999999999986 345789999999999999999999999999988888877664
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=309.95 Aligned_cols=207 Identities=27% Similarity=0.455 Sum_probs=174.9
Q ss_pred ceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHH-HHHhcCCCCeeEEeeEeecCCeeEEEE
Q 015556 185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVA-LLSRLHNPNVIKFVAACKKPPVYCVIT 261 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~ 261 (405)
+.||+|+||+||+|.+. ++.||||++....... ......+..|.. +++.++||||+++++++.+...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-----KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-----hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEE
Confidence 36899999999999985 6899999997432111 111234445544 567899999999999999999999999
Q ss_pred eecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc-cCCC
Q 015556 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDAL 340 (405)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~-~~~~ 340 (405)
||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 76 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (323)
T cd05575 76 DYVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT 153 (323)
T ss_pred cCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence 99999999999976 46789999999999999999999999999999999999999999999999999864322 2223
Q ss_pred CCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 341 ~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 211 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK 211 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC
Confidence 3456999999999999999999999999999999999999999998887777776654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=307.23 Aligned_cols=207 Identities=27% Similarity=0.415 Sum_probs=177.1
Q ss_pred ceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecCCeeEEEE
Q 015556 185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVIT 261 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 261 (405)
+.||+|+||.||++.+. ++.||||++....... ......+..|+.++..+ +||||+++++++.....+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQ-----DDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh-----ccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEE
Confidence 36899999999999986 6899999997422111 11245667888888877 6999999999999999999999
Q ss_pred eecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc-ccCCC
Q 015556 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV-YCDAL 340 (405)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~-~~~~~ 340 (405)
||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.... .....
T Consensus 76 Ey~~~g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 76 EFVNGGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred cCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence 99999999999876 4578999999999999999999999999999999999999999999999999986432 22233
Q ss_pred CCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 341 ~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~ 211 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 211 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC
Confidence 4456999999999999889999999999999999999999999998888777776654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=321.98 Aligned_cols=212 Identities=25% Similarity=0.384 Sum_probs=190.4
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-C-----CCeeEEeeE
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-N-----PNVIKFVAA 250 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~g~ 250 (405)
.+|.+.+.||+|.||.|.+|.+. ++.||||+++... .+..|-..|+.||..|+ | -|+|+++++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---------~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---------RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---------HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 48899999999999999999986 6999999998533 23566678999999997 4 489999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC--CcEEEEec
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE--FHLKIADF 328 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~--~~vkL~DF 328 (405)
|...+++|||+|.+ ..+|++||+.+....++...+..|+.||+.||.+||+.||||+||||+||||.+- ..|||+||
T Consensus 257 F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 257 FYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred cccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEec
Confidence 99999999999998 5699999999888899999999999999999999999999999999999999543 47999999
Q ss_pred CCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Q 015556 329 GIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNFG 402 (405)
Q Consensus 329 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~~~ 402 (405)
|.++......- ...-+..|.|||++.+.+|+.+.||||||||++||++|.+.|++.+..+.+..|++-.+.|
T Consensus 336 GSSc~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~P 407 (586)
T KOG0667|consen 336 GSSCFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLP 407 (586)
T ss_pred ccccccCCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCC
Confidence 99987654322 5567889999999999999999999999999999999999999999999999999887765
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=300.88 Aligned_cols=205 Identities=22% Similarity=0.384 Sum_probs=177.8
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
.|.+.+.||+|+||.||++... ++.||||++....... ......+.+|+.++++++|+||+++++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh-----hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeE
Confidence 3667889999999999999975 6899999997432211 11245677899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
++||||+++|+|.+++.......+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999999999987655567999999999999999999999999999999999999999999999999998654433
Q ss_pred CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 015556 338 DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI 389 (405)
Q Consensus 338 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~ 389 (405)
.......|+..|+|||++.+..++.++|||||||++|||++|..||.+.+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~ 207 (285)
T cd05605 156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK 207 (285)
T ss_pred CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh
Confidence 3334457899999999999888999999999999999999999999876553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=302.95 Aligned_cols=202 Identities=27% Similarity=0.459 Sum_probs=172.5
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||+|+||.||+|... ++.||||++........ ...+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-------PFTAIREASLLKGLKHANIVLLHDIIHTKET 77 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc-------chhHHHHHHHHhhCCCCCcCeEEEEEecCCe
Confidence 67889999999999999999985 68999999975443221 2346689999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc-
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV- 335 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~- 335 (405)
.++||||+. ++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 78 LTLVFEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred EEEEEECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 999999995 6888888763 3568889999999999999999999999999999999999999999999999985432
Q ss_pred ccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 015556 336 YCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI 389 (405)
Q Consensus 336 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~ 389 (405)
.........+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+....
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 210 (303)
T cd07869 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI 210 (303)
T ss_pred CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH
Confidence 1223344568999999999865 45789999999999999999999999886544
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=311.41 Aligned_cols=205 Identities=23% Similarity=0.399 Sum_probs=175.2
Q ss_pred ceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEe
Q 015556 185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 262 (405)
+.||+|+||.||++.+. ++.||||++....... ......+..|+.++..++||||+++++++.....+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-----KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEe
Confidence 35899999999999874 6899999997432211 1224567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEECCCCcEEEEecCCccccc-ccCCC
Q 015556 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIADFGIACEEV-YCDAL 340 (405)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~-~~~~~ 340 (405)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++.... .....
T Consensus 76 ~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (325)
T cd05594 76 YANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 153 (325)
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence 9999999998876 4578999999999999999999997 799999999999999999999999999986432 22233
Q ss_pred CCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015556 341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 341 ~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~ 396 (405)
....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~ 209 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 209 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh
Confidence 34569999999999998999999999999999999999999998877766555543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=309.11 Aligned_cols=207 Identities=25% Similarity=0.401 Sum_probs=177.1
Q ss_pred eeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecCCeeEEEEe
Q 015556 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVITE 262 (405)
Q Consensus 186 ~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E 262 (405)
.||+|+||.||+|.+. ++.||||++....... ......+..|..++..+ +||||+++++++.+...+|+|||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E 76 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ-----DDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVME 76 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-----hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEe
Confidence 5899999999999986 5799999997432111 11235567888888876 79999999999999999999999
Q ss_pred ecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc-cCCCC
Q 015556 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDALS 341 (405)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~ 341 (405)
|+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 77 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 77 YVNGGDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence 9999999999876 45789999999999999999999999999999999999999999999999999864322 22233
Q ss_pred CCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 342 ~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
...||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~ 212 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD 212 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 4569999999999998899999999999999999999999999998888777776543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=333.45 Aligned_cols=223 Identities=27% Similarity=0.552 Sum_probs=195.6
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI 244 (405)
....+..+++.+.+.||+|+||+||+|+.. .+.||||.++..... +...+|++|+++|..|+||||
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~-------~~~~dF~REaeLla~l~H~nI 551 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN-------QARQDFRREAELLAELQHPNI 551 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH-------HHHHHHHHHHHHHHhccCCCe
Confidence 345667788899999999999999999874 268999999844332 247899999999999999999
Q ss_pred eEEeeEeecCCeeEEEEeecCCCCHHHHHHHhc--------CCC----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 015556 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------HKT----LPLPKLIAIALDIARGMEYIHSQGVIHRDLKP 312 (405)
Q Consensus 245 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~----l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp 312 (405)
|+|+|.|.+++.+|+|+|||..|+|.+||.... +.. ++..+.+.|+.|||.||+||-++.+|||||..
T Consensus 552 VrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLAT 631 (774)
T KOG1026|consen 552 VRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLAT 631 (774)
T ss_pred EEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhh
Confidence 999999999999999999999999999998642 222 77889999999999999999999999999999
Q ss_pred CcEEECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 015556 313 ENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNP 388 (405)
Q Consensus 313 ~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~ 388 (405)
+|+||+++..|||+|||+++.....+ ......-..+||+||.|.-++|+.++|||||||+|||+++ |..||.++..
T Consensus 632 RNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn 711 (774)
T KOG1026|consen 632 RNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN 711 (774)
T ss_pred hhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch
Confidence 99999999999999999997643322 2234557899999999999999999999999999999999 9999999999
Q ss_pred HHHHHHHHhcccC
Q 015556 389 IQAAFAVVNKVNF 401 (405)
Q Consensus 389 ~e~~~~i~~~~~~ 401 (405)
.|.+..|-++..+
T Consensus 712 ~EVIe~i~~g~lL 724 (774)
T KOG1026|consen 712 QEVIECIRAGQLL 724 (774)
T ss_pred HHHHHHHHcCCcc
Confidence 9999988887764
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=307.00 Aligned_cols=205 Identities=27% Similarity=0.418 Sum_probs=173.0
Q ss_pred eeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecCCeeEEEEe
Q 015556 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVITE 262 (405)
Q Consensus 186 ~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E 262 (405)
.||+|+||.||+|.+. ++.||||+++....... .....+..|..++..+ +||||+++++++..+..+|+|||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e 76 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED-----DDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVME 76 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-----hhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEc
Confidence 5899999999999986 57899999975321111 1133445666777654 79999999999999999999999
Q ss_pred ecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc-cCCCC
Q 015556 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDALS 341 (405)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~ 341 (405)
|+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 77 ~~~gg~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 77 YLNGGDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence 9999999999876 45789999999999999999999999999999999999999999999999999864322 22334
Q ss_pred CCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 342 ~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
...||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~ 210 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 45699999999999988999999999999999999999999999888776666544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=319.52 Aligned_cols=210 Identities=28% Similarity=0.502 Sum_probs=186.7
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
.|...+.||+|+||.||+|.+. ++.||+|++......+. ...+.+|+.+|.+++++||.++||.+..+..+
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de-------Iediqqei~~Ls~~~~~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE-------IEDIQQEISVLSQCDSPNITEYYGSYLKGTKL 86 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchh-------hHHHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence 4556688999999999999986 69999999987665553 35677999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
|++||||.||++.+.|.. +..+++..+..|+++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+......
T Consensus 87 wiiMey~~gGsv~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKS--GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HHHHHHhcCcchhhhhcc--CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech
Confidence 999999999999999976 344588889999999999999999999999999999999999999999999998664433
Q ss_pred -CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 338 -DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 338 -~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
......+||+.|||||++....|+.++||||||++.+||++|.+||.++.|+..++-|-+.
T Consensus 165 ~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~ 226 (467)
T KOG0201|consen 165 VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS 226 (467)
T ss_pred hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC
Confidence 2336788999999999999889999999999999999999999999999997776665544
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=312.17 Aligned_cols=214 Identities=25% Similarity=0.353 Sum_probs=183.6
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||+|+||.||++... ++.||||++...... .....+.+..|+.++..++|+||+++++++.+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-----AQETVSFFEEERDILSISNSPWIPQLQYAFQDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCe
Confidence 36888999999999999999885 689999999743221 12235678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+|+||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred EEEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 99999999999999999873 35789999999999999999999999999999999999999999999999999865432
Q ss_pred cCC--CCCCCCCCcccCccccc------cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 337 CDA--LSDDPGTYRWMAPEMIK------HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 337 ~~~--~~~~~gt~~y~aPE~~~------~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
... .....||+.|+|||++. ...++.++|||||||++|+|++|..||......+.+..+++.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~ 224 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF 224 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC
Confidence 221 12346899999999986 456789999999999999999999999998888877777654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=297.19 Aligned_cols=216 Identities=25% Similarity=0.479 Sum_probs=183.5
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
++..+|.+++.||+|+||.||+|.+. +..||+|.++...... ....|.+|+.++.+++||||++++++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~ 74 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK-------QRRGFLAEALTLGQFDHSNIVRLEGV 74 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHH-------HHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 56678999999999999999999864 4689999987543221 14568899999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
+..+...++||||+++|+|.+++... ...+++..++.++.||+.||+|||++|++||||||+|||++.++.++++|||.
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~ 153 (266)
T cd05064 75 ITRGNTMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRR 153 (266)
T ss_pred EecCCCcEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcc
Confidence 99999999999999999999999763 35789999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCC--CCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 331 ACEEVYCDAL--SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 331 a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
+......... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.++.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~ 225 (266)
T cd05064 154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF 225 (266)
T ss_pred cccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC
Confidence 7543222111 12335678999999998999999999999999999875 999999988887777665543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=316.01 Aligned_cols=219 Identities=24% Similarity=0.382 Sum_probs=200.2
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
+++|..++.+|+|+||.++..+.+ ++.|++|.+......+.. +....+|+.++++++|||||.+++.|.+++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~------r~~A~~E~~lis~~~hP~iv~y~ds~~~~~ 76 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE------RRSAIQEMDLLSKLLHPNIVEYKDSFEEDG 76 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh------hHHHHHHHHHHHhccCCCeeeeccchhcCC
Confidence 467889999999999999988876 589999999987766654 346679999999999999999999999888
Q ss_pred e-eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 256 V-YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 256 ~-~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
. .||||+||+||+|.+.|.+.++..++++.++.++.|++.|+.|||++.|+|||||+.||+++.++.|+|.|||+|...
T Consensus 77 ~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 77 QLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKIL 156 (426)
T ss_pred ceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhc
Confidence 7 999999999999999999988788999999999999999999999999999999999999999999999999999876
Q ss_pred cccC-CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Q 015556 335 VYCD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNFG 402 (405)
Q Consensus 335 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~~~ 402 (405)
.... .....+||+.||.||++.+.+|+.|+|||||||++|||++-+.+|...+......+|++..-.|
T Consensus 157 ~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P 225 (426)
T KOG0589|consen 157 NPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP 225 (426)
T ss_pred CCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC
Confidence 6554 5567789999999999999999999999999999999999999999999999999998887544
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=308.38 Aligned_cols=207 Identities=27% Similarity=0.443 Sum_probs=173.7
Q ss_pred ceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHH-HHHHhcCCCCeeEEeeEeecCCeeEEEE
Q 015556 185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREV-ALLSRLHNPNVIKFVAACKKPPVYCVIT 261 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei-~il~~l~HpnIv~l~g~~~~~~~~~lV~ 261 (405)
+.||+|+||.||++++. ++.||||++....... ......+..|. .+++.++|+||+++++++.....+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILK-----KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHh-----hhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEE
Confidence 35899999999999986 5789999997422111 11123344444 4567889999999999999999999999
Q ss_pred eecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc-cCCC
Q 015556 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDAL 340 (405)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~-~~~~ 340 (405)
||+++++|.+++.. ...+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 76 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~ 153 (325)
T cd05602 76 DYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT 153 (325)
T ss_pred eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence 99999999999976 45688889999999999999999999999999999999999999999999999864322 2233
Q ss_pred CCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 341 ~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 211 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 211 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC
Confidence 4556999999999999999999999999999999999999999998888777766654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=307.81 Aligned_cols=207 Identities=26% Similarity=0.424 Sum_probs=173.5
Q ss_pred ceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHH-HHHhcCCCCeeEEeeEeecCCeeEEEE
Q 015556 185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVA-LLSRLHNPNVIKFVAACKKPPVYCVIT 261 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~ 261 (405)
+.||+|+||.||+|.+. ++.||||++....... ......+..|.. +++.++||||+++++++.+....|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-----KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-----hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEE
Confidence 36899999999999985 6899999997422111 112344555554 678899999999999999999999999
Q ss_pred eecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc-cCCC
Q 015556 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDAL 340 (405)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~-~~~~ 340 (405)
||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ....
T Consensus 76 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (321)
T cd05603 76 DYVNGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT 153 (321)
T ss_pred cCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence 99999999998876 45788899999999999999999999999999999999999999999999999864322 2223
Q ss_pred CCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 341 ~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 211 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK 211 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC
Confidence 4456899999999999889999999999999999999999999998877766666543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=308.07 Aligned_cols=194 Identities=25% Similarity=0.441 Sum_probs=168.8
Q ss_pred ceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecCCeeEEEE
Q 015556 185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVIT 261 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 261 (405)
+.||+|+||.||++.+. ++.||||+++.....+. ...+.+..|+.++..+ +||||+++++++.+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~-----~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD-----EDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-----hHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEE
Confidence 36899999999999985 68999999975322211 1245678899999998 6999999999999999999999
Q ss_pred eecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc-cccCCC
Q 015556 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-VYCDAL 340 (405)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~-~~~~~~ 340 (405)
||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++... ......
T Consensus 76 e~~~~g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 76 EFVSGGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence 99999999998876 467999999999999999999999999999999999999999999999999998642 222333
Q ss_pred CCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 341 ~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
....||..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 455799999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=305.49 Aligned_cols=205 Identities=25% Similarity=0.365 Sum_probs=171.4
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC---
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--- 254 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--- 254 (405)
+|.+++.||+|+||.||+|++. ++.||||.+........ ...++.+|+.++++++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS------DATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccch------hHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence 4788999999999999999975 68999999874322111 134678999999999999999999988543
Q ss_pred --CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 255 --PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 255 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
..+|+|||||. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 75 ~~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 75 EFKDIYVVFELME-SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred CCceEEEEEecCC-CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 35799999995 689998876 4568999999999999999999999999999999999999999999999999986
Q ss_pred ccccc----CCCCCCCCCCcccCcccccc--ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015556 333 EEVYC----DALSDDPGTYRWMAPEMIKH--KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393 (405)
Q Consensus 333 ~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~ 393 (405)
..... .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~ 218 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 218 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Confidence 43221 11234579999999999865 678999999999999999999999998877655443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=314.28 Aligned_cols=223 Identities=28% Similarity=0.480 Sum_probs=185.8
Q ss_pred ccccccccccCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-
Q 015556 168 VDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL- 239 (405)
Q Consensus 168 ~~~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l- 239 (405)
....+.|.+..++|.+++.||+|+||.||+|++. ++.||||++......+. ...+.+|+.+++.+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~il~~l~ 99 (374)
T cd05106 27 LPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDE-------REALMSELKILSHLG 99 (374)
T ss_pred ccccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHH-------HHHHHHHHHHHHhhc
Confidence 3445678888899999999999999999999853 24799999975443221 35678999999999
Q ss_pred CCCCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhc------------------------------------------
Q 015556 240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE------------------------------------------ 277 (405)
Q Consensus 240 ~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------------------------------------ 277 (405)
+|+||++++++|.....+++||||+++|+|.+++....
T Consensus 100 ~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (374)
T cd05106 100 QHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSD 179 (374)
T ss_pred cCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccc
Confidence 89999999999999999999999999999999986531
Q ss_pred --------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 278 --------------------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 278 --------------------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
...+++..++.++.||+.||.|||++||+||||||+|||+++++.+||+|||++
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla 259 (374)
T cd05106 180 TYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLA 259 (374)
T ss_pred cccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceee
Confidence 124788889999999999999999999999999999999999999999999998
Q ss_pred ccccccCC---CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015556 332 CEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 332 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~ 397 (405)
........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~ 329 (374)
T cd05106 260 RDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK 329 (374)
T ss_pred eeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH
Confidence 64332211 112235678999999998899999999999999999997 9999988776655555554
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=308.89 Aligned_cols=207 Identities=25% Similarity=0.435 Sum_probs=175.2
Q ss_pred ceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHH-HHHhcCCCCeeEEeeEeecCCeeEEEE
Q 015556 185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVA-LLSRLHNPNVIKFVAACKKPPVYCVIT 261 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~ 261 (405)
+.||+|+||.||++... ++.||||++....... ......+..|.. +++.++||||+++++++..+..+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN-----RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEE
Confidence 35899999999999985 6899999997432111 112344555554 567789999999999999999999999
Q ss_pred eecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc-ccCCC
Q 015556 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV-YCDAL 340 (405)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~-~~~~~ 340 (405)
||+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .....
T Consensus 76 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 153 (325)
T cd05604 76 DFVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT 153 (325)
T ss_pred cCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence 99999999998876 4678999999999999999999999999999999999999999999999999986432 22233
Q ss_pred CCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 341 ~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~ 211 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK 211 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC
Confidence 4556999999999999999999999999999999999999999998887777766654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=306.16 Aligned_cols=211 Identities=26% Similarity=0.411 Sum_probs=179.0
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeecCCee
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPVY 257 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~ 257 (405)
|.+.+.||+|+||.||++... ++.||||++....... ....+.+..|+.++..+. |++|+++++++.+...+
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 76 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-----DDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRL 76 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEE
Confidence 567789999999999999885 6899999997422111 112356778899998886 57788899999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 77 ~lv~Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 77 YFVMEYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred EEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 999999999999999976 457899999999999999999999999999999999999999999999999998643221
Q ss_pred -CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 338 -DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 338 -~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~ 216 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH 216 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 2233456999999999999889999999999999999999999999998887777766653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=309.94 Aligned_cols=206 Identities=24% Similarity=0.439 Sum_probs=178.2
Q ss_pred ceeeeeeeEEEEEEEE-----CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEE
Q 015556 185 LRFAHGAHSRLYHGIY-----KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV 259 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~-----~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 259 (405)
+.||+|+||.||++.. .++.||||++...... ......+..|+++|++++||||+++++++.++..+|+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK------VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence 5689999999999875 3689999999743211 1124567789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc-C
Q 015556 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-D 338 (405)
Q Consensus 260 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~-~ 338 (405)
||||+.+|+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 76 v~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 76 ILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred EEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 9999999999999976 457899999999999999999999999999999999999999999999999998654332 2
Q ss_pred CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 339 ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 339 ~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
......|++.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.+.
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~ 213 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA 213 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC
Confidence 233456999999999999888999999999999999999999999998888777766543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=293.85 Aligned_cols=221 Identities=27% Similarity=0.473 Sum_probs=198.5
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecCC
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPP 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 255 (405)
..|.-.+.||.|..+.|.++..+ ++.+|+|++.........+....+...-.+|+.||+++ .||+|+++.+.|+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 44556678899999999999875 68999999987665555444667788889999999999 5999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+++|+|.|+.|.|+|||.. .-.+++.....|++|++.|++|||.++||||||||+|||++++.++||+|||+++...
T Consensus 97 F~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 99999999999999999987 4578999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCCcccCccccc------cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Q 015556 336 YCDALSDDPGTYRWMAPEMIK------HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNF 401 (405)
Q Consensus 336 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~~ 401 (405)
.++.+...+||++|+|||.+. +..|+..+|+|++|||+|.||.|..||--..++-++.-|+++.-.
T Consensus 175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq 246 (411)
T KOG0599|consen 175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ 246 (411)
T ss_pred CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence 999999999999999999884 356889999999999999999999999888888888888877643
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=312.40 Aligned_cols=222 Identities=27% Similarity=0.460 Sum_probs=185.1
Q ss_pred ccccccccCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CC
Q 015556 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HN 241 (405)
Q Consensus 170 ~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~H 241 (405)
....|.++.++|.+++.||+|+||.||+|.+. +..||||+++...... ....+.+|+.+|..+ +|
T Consensus 26 ~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~-------~~~~~~~Ei~il~~l~~H 98 (375)
T cd05104 26 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLT-------EREALMSELKVLSYLGNH 98 (375)
T ss_pred CccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcH-------HHHHHHHHHHHHHHhcCC
Confidence 44577888889999999999999999999742 4589999987433221 145688999999999 89
Q ss_pred CCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhc--------------------------------------------
Q 015556 242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE-------------------------------------------- 277 (405)
Q Consensus 242 pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------------- 277 (405)
|||++++++|.+....++|||||++|+|.+++....
T Consensus 99 pnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 178 (375)
T cd05104 99 INIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYV 178 (375)
T ss_pred cceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccc
Confidence 999999999999999999999999999999997532
Q ss_pred -----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEec
Q 015556 278 -----------------------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF 328 (405)
Q Consensus 278 -----------------------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DF 328 (405)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Df 258 (375)
T cd05104 179 VPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDF 258 (375)
T ss_pred cccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecC
Confidence 124788899999999999999999999999999999999999999999999
Q ss_pred CCcccccccCC---CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 329 GIACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 329 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
|++........ .....++..|+|||++.+..++.++|||||||++|||++ |..||..........+.++.
T Consensus 259 G~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~ 332 (375)
T cd05104 259 GLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE 332 (375)
T ss_pred ccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh
Confidence 99864332211 112335677999999999999999999999999999998 99999887766666655554
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=307.62 Aligned_cols=210 Identities=26% Similarity=0.389 Sum_probs=178.4
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.++|.+.+.||+|+||.||++.+. ++.||||++........ ....+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQT------HAKRAYRELVLLKCVNHKNIISLLNVFTPQK 93 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchh------HHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 578999999999999999999875 68999999975432221 1456778999999999999999999986543
Q ss_pred ------eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 256 ------VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 256 ------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
.+|+||||+.+ +|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 94 SLEEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred CccccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCC
Confidence 57999999965 67776643 57888999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 330 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
++.............||..|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+++.
T Consensus 169 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~ 237 (359)
T cd07876 169 LARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ 237 (359)
T ss_pred CccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 986544434445567899999999999999999999999999999999999999988877766555544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=308.71 Aligned_cols=200 Identities=24% Similarity=0.389 Sum_probs=170.5
Q ss_pred CeeecceeeeeeeEEEEEEEE-----CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeec
Q 015556 180 QLFLGLRFAHGAHSRLYHGIY-----KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKK 253 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~ 253 (405)
+|.+++.||+|+||.||++.. .++.||||++....... .....+.+..|+.++.+++ |+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ----KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh----hhhHHHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 477899999999999999876 36899999997422111 1122456789999999995 8999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
...+++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 77 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 77 EAKLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred CCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999999999999976 45789999999999999999999999999999999999999999999999999864
Q ss_pred cccc--CCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 334 EVYC--DALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 334 ~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
.... .......||..|+|||++.+. .++.++|||||||++|||++|..||..
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 3221 122345699999999999765 478899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=318.26 Aligned_cols=214 Identities=22% Similarity=0.311 Sum_probs=183.5
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC---CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK---DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~---~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
...|.+.+.||+|++|.||++... ++.||+|.+...+.. ....+.+|+.+|+.++|||||+++++|..+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~--------~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~ 137 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDER--------QAAYARSELHCLAACDHFGIVKHFDDFKSD 137 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHH--------HHHHHHHHHHHHHhCCCCCEeEEEEEEEEC
Confidence 345889999999999999999864 467888876543211 134677899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
+.+||||||+++|+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 138 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 138 DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK 217 (478)
T ss_pred CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCce
Confidence 9999999999999999988653 34568899999999999999999999999999999999999999999999999986
Q ss_pred cccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 333 EEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 333 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..+.
T Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~ 287 (478)
T PTZ00267 218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK 287 (478)
T ss_pred ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 543221 2234569999999999998999999999999999999999999999988888777776654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=299.54 Aligned_cols=211 Identities=31% Similarity=0.541 Sum_probs=175.7
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC------------------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHh
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK------------------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR 238 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~------------------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~ 238 (405)
..++|.+.++||+|+||.||++.+. +..||||++...... .....|.+|+.++.+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~ 75 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK-------NARNDFLKEVKILSR 75 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH-------HHHHHHHHHHHHHhh
Confidence 3467889999999999999999753 236999998753321 125678899999999
Q ss_pred cCCCCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhc-----------------CCCCCHHHHHHHHHHHHHHHHHHH
Q 015556 239 LHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE-----------------HKTLPLPKLIAIALDIARGMEYIH 301 (405)
Q Consensus 239 l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~qi~~aL~yLH 301 (405)
++||||+++++++.+....++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||
T Consensus 76 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 155 (304)
T cd05096 76 LKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS 155 (304)
T ss_pred cCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999987531 124677889999999999999999
Q ss_pred HCCceecCCCCCcEEECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh
Q 015556 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378 (405)
Q Consensus 302 ~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt 378 (405)
+.||+||||||+|||++.++.+||+|||++....... ......++..|+|||++.+..++.++||||||+++|||++
T Consensus 156 ~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 156 SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred HCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 9999999999999999999999999999986432221 1123346788999999988889999999999999999986
Q ss_pred --CCCCCCCCCHHHHHHH
Q 015556 379 --GTIPYEEMNPIQAAFA 394 (405)
Q Consensus 379 --G~~Pf~~~~~~e~~~~ 394 (405)
+..||...+..+....
T Consensus 236 ~~~~~p~~~~~~~~~~~~ 253 (304)
T cd05096 236 LCKEQPYGELTDEQVIEN 253 (304)
T ss_pred ccCCCCCCcCCHHHHHHH
Confidence 6789988776665443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=303.06 Aligned_cols=205 Identities=23% Similarity=0.388 Sum_probs=179.9
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
..++|.+.+.||+|+||.||++.+. +..||+|++..... ......+.+|+++|++++||||+++++++.++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 75 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-------PAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 75 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-------HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence 4578889999999999999999986 68899999975322 12356788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
+.+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 153 (331)
T cd06649 76 GEISICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (331)
T ss_pred CEEEEEeecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccc
Confidence 999999999999999999976 45689999999999999999999986 699999999999999999999999999864
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQA 391 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~ 391 (405)
... .......|+..|+|||++.+..++.++|||||||++|||++|+.||...+..+.
T Consensus 154 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~ 210 (331)
T cd06649 154 LID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210 (331)
T ss_pred ccc-cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 432 223445699999999999988999999999999999999999999987776553
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=304.89 Aligned_cols=193 Identities=25% Similarity=0.467 Sum_probs=168.0
Q ss_pred ceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecCCeeEEEE
Q 015556 185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVIT 261 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 261 (405)
+.||+|+||.||++... ++.||||++....... ....+.+.+|+.++.++ +||||+.+++++.+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD-----DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEE
Confidence 36899999999999885 5899999997532211 12245688999999998 5999999999999999999999
Q ss_pred eecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc-ccCCC
Q 015556 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV-YCDAL 340 (405)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~-~~~~~ 340 (405)
||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .....
T Consensus 76 e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 76 EYVNGGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred eCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence 99999999998876 4579999999999999999999999999999999999999999999999999986422 22233
Q ss_pred CCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCC
Q 015556 341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384 (405)
Q Consensus 341 ~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~ 384 (405)
....||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~ 197 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCC
Confidence 45679999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=303.23 Aligned_cols=196 Identities=30% Similarity=0.478 Sum_probs=165.3
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
.+++|.+++.||.|+||.||+|.+. ++.||||++...... .....+.+|+++++.++|+||+++++++.+.
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED-------TVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcH-------HHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 3456677889999999999999986 689999999643321 2256788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
..+++||||+++++|.+. ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 145 ~~~~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218 (353)
T ss_pred CeEEEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence 999999999999998653 23567788899999999999999999999999999999999999999999998653
Q ss_pred ccc-CCCCCCCCCCcccCcccccc-----ccCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 335 VYC-DALSDDPGTYRWMAPEMIKH-----KSYGRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 335 ~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
... .......||..|+|||++.. ...+.++|||||||++|||++|+.||..
T Consensus 219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 219 AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred ccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 321 22244579999999998743 2235689999999999999999999974
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=303.62 Aligned_cols=205 Identities=27% Similarity=0.397 Sum_probs=173.0
Q ss_pred ceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecCCeeEEEE
Q 015556 185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVIT 261 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 261 (405)
+.||+|+||.||+|.+. ++.||||++....... ......+..|..++..+ +||||+++++++.+...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI-----DDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----cchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEE
Confidence 36899999999999986 6899999997432111 11134556788888765 8999999999999999999999
Q ss_pred eecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc-cCCC
Q 015556 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDAL 340 (405)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~-~~~~ 340 (405)
||+.+|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..... ....
T Consensus 76 E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05620 76 EFLNGGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA 153 (316)
T ss_pred CCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence 99999999999876 45789999999999999999999999999999999999999999999999999854221 1223
Q ss_pred CCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015556 341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 341 ~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~ 396 (405)
....||..|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~ 209 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR 209 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 44569999999999999999999999999999999999999999887766555543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=295.69 Aligned_cols=196 Identities=25% Similarity=0.454 Sum_probs=169.7
Q ss_pred eeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEeec
Q 015556 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264 (405)
Q Consensus 187 lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 264 (405)
||+|+||.||++... ++.||+|.+....... ....+.+..|++++++++||||+++++++.++..+++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-----KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-----chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecC
Confidence 699999999999875 7899999986422111 111345667999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCCCCCCC
Q 015556 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344 (405)
Q Consensus 265 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 344 (405)
++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.............
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 155 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA 155 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccC
Confidence 99999999877555678999999999999999999999999999999999999999999999999986544333334557
Q ss_pred CCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 345 gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
|+..|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999999988889999999999999999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=294.74 Aligned_cols=208 Identities=21% Similarity=0.358 Sum_probs=179.0
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeE
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC 258 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 258 (405)
|...+.||.|+||+||++.+. ++.||||.+....... ......+.+|++++++++|+||+.+++++..+...+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK-----RKGESMALNEKQILEKVNSQFVVNLAYAYETKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh-----hhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEE
Confidence 556688999999999999985 6899999986433211 112355778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccC
Q 015556 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~ 338 (405)
+||||+.+++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999999999999877555679999999999999999999999999999999999999999999999999986543333
Q ss_pred CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015556 339 ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393 (405)
Q Consensus 339 ~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~ 393 (405)
......|+..|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~ 211 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE 211 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 3345579999999999998889999999999999999999999998876654433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=310.13 Aligned_cols=220 Identities=30% Similarity=0.507 Sum_probs=184.0
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CC
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NP 242 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-Hp 242 (405)
...|.++.++|.+++.||.|+||.||+|.+.+ ..||||++....... ....+.+|+.+|.++. ||
T Consensus 29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~-------~~~~~~~Ei~~l~~l~~Hp 101 (400)
T cd05105 29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSS-------EKQALMSELKIMTHLGPHL 101 (400)
T ss_pred CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChH-------HHHHHHHHHHHHHhcCCCC
Confidence 45788999999999999999999999998642 369999986543221 1457889999999996 99
Q ss_pred CeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhc---------------------------------------------
Q 015556 243 NVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------------------------------------------- 277 (405)
Q Consensus 243 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------- 277 (405)
||++++++|.+...+|+|||||++|+|.++|....
T Consensus 102 nIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (400)
T cd05105 102 NIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMK 181 (400)
T ss_pred CeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccc
Confidence 99999999999999999999999999999987531
Q ss_pred -------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 015556 278 -------------------------------------------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHR 308 (405)
Q Consensus 278 -------------------------------------------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHr 308 (405)
...+++..++.++.||+.||.|||+.+|+||
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~ 261 (400)
T cd05105 182 QADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHR 261 (400)
T ss_pred cccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence 1247788889999999999999999999999
Q ss_pred CCCCCcEEECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCC
Q 015556 309 DLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYE 384 (405)
Q Consensus 309 DIkp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~ 384 (405)
||||+|||++.++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 262 dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~ 341 (400)
T cd05105 262 DLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYP 341 (400)
T ss_pred CCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCc
Confidence 999999999999999999999986432211 1123346788999999998889999999999999999997 999998
Q ss_pred CCCHHHHHHHHHh
Q 015556 385 EMNPIQAAFAVVN 397 (405)
Q Consensus 385 ~~~~~e~~~~i~~ 397 (405)
.....+.....+.
T Consensus 342 ~~~~~~~~~~~~~ 354 (400)
T cd05105 342 GMIVDSTFYNKIK 354 (400)
T ss_pred ccchhHHHHHHHh
Confidence 8765555444433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=291.11 Aligned_cols=217 Identities=33% Similarity=0.526 Sum_probs=187.5
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
|.++.++|.+.++||+|++|.||+|.+. ++.||||.+...... .+.+.+|+.++++++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---------VQAFLEEANLMKTLQHDKLVRLYAVVT 71 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchh---------HHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 6788899999999999999999999876 478999987642211 356889999999999999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
+....++||||+++++|.+++.......+++..++.++.|++.||+|||+.+++||||||+||+++.++.++|+|||++.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 151 (261)
T cd05072 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR 151 (261)
T ss_pred CCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccce
Confidence 99999999999999999999987666778999999999999999999999999999999999999999999999999986
Q ss_pred cccccC--CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 333 EEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 333 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
...... ......++..|+|||++....++.++|||||||++|+|++ |..||......+....+.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~ 221 (261)
T cd05072 152 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY 221 (261)
T ss_pred ecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC
Confidence 533211 1122345678999999988889999999999999999998 999999888777766665543
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=302.82 Aligned_cols=207 Identities=27% Similarity=0.429 Sum_probs=176.2
Q ss_pred ceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecCCeeEEEE
Q 015556 185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVIT 261 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 261 (405)
+.||+|+||.||++.+. ++.||||++....... ......+..|+.++..+ +||||+++++++.+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ-----DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-----hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence 36899999999999986 5799999997432111 11245567889999888 6999999999999999999999
Q ss_pred eecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc-cCCC
Q 015556 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDAL 340 (405)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~-~~~~ 340 (405)
||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 76 e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 76 EYVNGGDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred cCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence 99999999999876 45789999999999999999999999999999999999999999999999999854222 2222
Q ss_pred CCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 341 ~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
....|+..|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.+.
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~ 211 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED 211 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 3446899999999999999999999999999999999999999988877766665543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=300.21 Aligned_cols=205 Identities=25% Similarity=0.416 Sum_probs=172.7
Q ss_pred ceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecCCeeEEEE
Q 015556 185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVIT 261 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 261 (405)
+.||+|+||.||+|.+. ++.||||++....... ......+..|..++..+ +||||+++++++.+...+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM-----DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----cchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEE
Confidence 36899999999999986 5789999997432110 11134456777888764 8999999999999999999999
Q ss_pred eecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc-cCCC
Q 015556 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDAL 340 (405)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~-~~~~ 340 (405)
||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 76 ey~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05619 76 EYLNGGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT 153 (316)
T ss_pred eCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence 99999999999976 35788999999999999999999999999999999999999999999999999864322 1223
Q ss_pred CCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015556 341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 341 ~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~ 396 (405)
....||..|+|||++.+..++.++|||||||++|||++|..||...+..+....+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~ 209 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR 209 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 34568999999999998899999999999999999999999999888766655544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=314.55 Aligned_cols=208 Identities=25% Similarity=0.410 Sum_probs=174.2
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec--
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK-- 253 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-- 253 (405)
..+|.+++.||+|+||.||+|... ++.||||.+.... ....+|+.+|+.++|||||++++++..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------------~~~~~Ei~il~~l~h~niv~l~~~~~~~~ 132 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------------QYKNRELLIMKNLNHINIIFLKDYYYTEC 132 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------------chHHHHHHHHHhcCCCCCcceeeeEeecc
Confidence 367999999999999999999985 6899999886322 123379999999999999999887642
Q ss_pred ------CCeeEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCC-cEE
Q 015556 254 ------PPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-HLK 324 (405)
Q Consensus 254 ------~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~-~vk 324 (405)
...+++||||+++ +|.+++... ....+++..+..++.||+.||.|||++||+||||||+||||+.++ .+|
T Consensus 133 ~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vk 211 (440)
T PTZ00036 133 FKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLK 211 (440)
T ss_pred cccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCcee
Confidence 1246799999975 787777642 346789999999999999999999999999999999999998664 799
Q ss_pred EEecCCcccccccCCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 325 IADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 325 L~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
|+|||++.............||+.|+|||++.+. .|+.++|||||||++|||++|..||.+.+..+.+.++++.
T Consensus 212 L~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 286 (440)
T PTZ00036 212 LCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286 (440)
T ss_pred eeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 9999999765444444556789999999998654 6899999999999999999999999999888888777654
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=303.93 Aligned_cols=193 Identities=25% Similarity=0.470 Sum_probs=167.5
Q ss_pred ceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecCCeeEEEE
Q 015556 185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVIT 261 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 261 (405)
+.||+|+||.||++.+. ++.||||++........ .....+..|+.++.++ +||||+++++++.....+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD-----EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcch-----hHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEE
Confidence 36899999999999986 58899999985432221 1245677899988877 7999999999999999999999
Q ss_pred eecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc-ccCCC
Q 015556 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV-YCDAL 340 (405)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~-~~~~~ 340 (405)
||+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .....
T Consensus 76 E~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 76 EYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence 99999999998876 4678999999999999999999999999999999999999999999999999986422 22233
Q ss_pred CCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCC
Q 015556 341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384 (405)
Q Consensus 341 ~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~ 384 (405)
....||..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 44579999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=306.13 Aligned_cols=212 Identities=24% Similarity=0.376 Sum_probs=181.6
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC-
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP- 254 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~- 254 (405)
.++|.+++.||+|+||.||++.+. ++.||||++........ ....+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~ 96 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT------HAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 96 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCch------hHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence 478999999999999999999875 68899999875433221 135677899999999999999999987543
Q ss_pred -----CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 255 -----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 255 -----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
..+|+||||+++ +|.+++.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 97 SLEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred cccccCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999964 78887753 57888999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 330 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
++.............||..|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...+++....
T Consensus 172 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 242 (364)
T cd07875 172 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242 (364)
T ss_pred CccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99765444444556799999999999999999999999999999999999999999998888887776433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=308.97 Aligned_cols=207 Identities=19% Similarity=0.381 Sum_probs=170.8
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC------CCeeEEe
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN------PNVIKFV 248 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~ 248 (405)
..++|.+.+.||+|+||+||+|.+. ++.||||+++.... ....+..|+.++..++| .++++++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---------~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---------YTRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---------hHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 4578999999999999999999885 68899999964211 12334456666666654 5689999
Q ss_pred eEeecC-CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEECCCC-----
Q 015556 249 AACKKP-PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEF----- 321 (405)
Q Consensus 249 g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDIkp~NILl~~~~----- 321 (405)
+++... ..+|+|||++ +++|.+++.+ ...+++..+..|+.||+.||.|||+ .|||||||||+|||++.++
T Consensus 198 ~~~~~~~~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 198 RYFQNETGHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EEEEcCCceEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccc
Confidence 988764 5789999988 7799999876 4679999999999999999999998 5999999999999998665
Q ss_pred -----------cEEEEecCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 015556 322 -----------HLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390 (405)
Q Consensus 322 -----------~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e 390 (405)
.+||+|||.+.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred ccccccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 49999999875432 22345679999999999999999999999999999999999999999988877
Q ss_pred HHHHHHh
Q 015556 391 AAFAVVN 397 (405)
Q Consensus 391 ~~~~i~~ 397 (405)
.+..+.+
T Consensus 353 ~~~~i~~ 359 (467)
T PTZ00284 353 HLHLMEK 359 (467)
T ss_pred HHHHHHH
Confidence 6665544
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=293.82 Aligned_cols=217 Identities=29% Similarity=0.592 Sum_probs=184.0
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 248 (405)
++.++|.+.+.||+|+||.||+|...+ ..||+|.+...... .....|.+|+.++.+++||||++++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~-------~~~~~~~~ei~~l~~l~h~~i~~~~ 74 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-------KVQQEFRQEAELMSDLQHPNIVCLL 74 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH-------HHHHHHHHHHHHHHhcCCcccceEE
Confidence 456788899999999999999998753 46999998743321 1246788999999999999999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLEH--------------KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~N 314 (405)
+++.+....|++|||+++++|.+++..... ..+++..++.++.|++.||.|||++|++||||||+|
T Consensus 75 ~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~N 154 (283)
T cd05048 75 GVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARN 154 (283)
T ss_pred EEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccce
Confidence 999999999999999999999999986421 457888999999999999999999999999999999
Q ss_pred EEECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 015556 315 VLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQ 390 (405)
Q Consensus 315 ILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e 390 (405)
||+++++.++|+|||++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+..+.+
T Consensus 155 il~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~ 234 (283)
T cd05048 155 CLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE 234 (283)
T ss_pred EEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999999999986432221 1233456788999999988889999999999999999998 999999988877
Q ss_pred HHHHHHhcc
Q 015556 391 AAFAVVNKV 399 (405)
Q Consensus 391 ~~~~i~~~~ 399 (405)
....+.++.
T Consensus 235 ~~~~i~~~~ 243 (283)
T cd05048 235 VIEMIRSRQ 243 (283)
T ss_pred HHHHHHcCC
Confidence 766665543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=288.32 Aligned_cols=216 Identities=31% Similarity=0.517 Sum_probs=185.3
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
|+++.++|.+.+.||+|++|.||+|.+. ++.||||.++..... .+++.+|+.++++++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---------PKDFLAEAQIMKKLRHPKLIQLYAVCT 71 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---------HHHHHHHHHHHHHCCCCCccceeEEEe
Confidence 5677788999999999999999999975 478999998753321 346788999999999999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
..+..++||||+++++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 151 (261)
T cd05068 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR 151 (261)
T ss_pred cCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEE
Confidence 99999999999999999999987555678999999999999999999999999999999999999999999999999986
Q ss_pred cccccCC--CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 333 EEVYCDA--LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 333 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
....... ......+..|+|||++.+..++.++||||||+++|+|++ |+.||.+....+....+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05068 152 VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG 220 (261)
T ss_pred EccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 5432111 111123457999999998889999999999999999999 99999998887777766554
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=287.91 Aligned_cols=215 Identities=25% Similarity=0.506 Sum_probs=184.0
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
+|.++|.+.+.||+|+||.||++.+.+ ..+|+|.+...... ..++.+|+.++++++||||++++++|...
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd05114 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---------EEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71 (256)
T ss_pred CCHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---------HHHHHHHHHHHHHCCCCCceeEEEEEccC
Confidence 356788999999999999999999874 58999987633221 34678899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
...++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++||+||||+|+||+++.++.+||+|||.+...
T Consensus 72 ~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~ 150 (256)
T cd05114 72 KPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV 150 (256)
T ss_pred CCEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCcccc
Confidence 99999999999999999997633 46889999999999999999999999999999999999999999999999988643
Q ss_pred cccCCC--CCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 015556 335 VYCDAL--SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 335 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
...... ....++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+.++..
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~ 219 (256)
T cd05114 151 LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR 219 (256)
T ss_pred CCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC
Confidence 221111 22235678999999988889999999999999999999 9999999888888777776543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=332.27 Aligned_cols=219 Identities=31% Similarity=0.584 Sum_probs=189.2
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEECC---c----cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYKD---E----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~~---~----~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 248 (405)
+....+++++.||+|+||.||+|.+.+ . .||||.+....+.+ ...+|.+|..+|+.++|||||+++
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~-------~~~~Fl~Ea~~m~~f~HpNiv~li 761 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQ-------EVSDFLKEALLMSKFDHPNIVSLI 761 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHH-------HHHHHHHHHHHHhcCCCcceeeEE
Confidence 447888999999999999999999863 2 37788776433322 267899999999999999999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcE
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLE-----HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~v 323 (405)
|.|.+....+|++|||.+|+|..||++.. ...++...++.++.|||+|+.||+++++|||||..+|+||++...+
T Consensus 762 Gv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~V 841 (1025)
T KOG1095|consen 762 GVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVV 841 (1025)
T ss_pred EeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcE
Confidence 99999999999999999999999999852 4568899999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccCCCC---CCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 324 KIADFGIACEEVYCDALS---DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 324 kL~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
||+|||+|+.......+. ...-..+|||||.+..+.++.|+|||||||+|||+++ |..||.+.+..+...-++++.
T Consensus 842 KIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg 921 (1025)
T KOG1095|consen 842 KIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG 921 (1025)
T ss_pred EEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC
Confidence 999999997443322221 1235689999999999999999999999999999999 999999999999888777665
Q ss_pred cC
Q 015556 400 NF 401 (405)
Q Consensus 400 ~~ 401 (405)
.+
T Consensus 922 RL 923 (1025)
T KOG1095|consen 922 RL 923 (1025)
T ss_pred cc
Confidence 43
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=304.40 Aligned_cols=212 Identities=25% Similarity=0.360 Sum_probs=180.5
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
-.++|.+.+.||+|+||.||++.+. ++.||||.+........ ....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 88 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT------HAKRAYRELVLMKCVNHKNIISLLNVFTPQ 88 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChH------HHHHHHHHHHHHHHhCCCchhceeeeeecc
Confidence 3578999999999999999999875 68999999875443322 135677899999999999999999988643
Q ss_pred ------CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEec
Q 015556 255 ------PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF 328 (405)
Q Consensus 255 ------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DF 328 (405)
...|+||||+++ +|.+++.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 89 KSLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred ccccccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeC
Confidence 357999999965 77777753 5788899999999999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 329 GIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 329 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
|++.............||..|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+++..
T Consensus 164 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (355)
T cd07874 164 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234 (355)
T ss_pred cccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99976544444455679999999999998899999999999999999999999999988877777666543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=292.74 Aligned_cols=211 Identities=28% Similarity=0.433 Sum_probs=176.9
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc---CCCCeeEEeeEeec-
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL---HNPNVIKFVAACKK- 253 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~- 253 (405)
+|.+.+.||+|+||.||+|.+. ++.||||.+......+.. ...+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL------PLSTVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC------chHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 4778899999999999999985 689999998764332211 22345677777665 69999999998864
Q ss_pred ----CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 254 ----PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 254 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
...+++||||+. ++|.+++.......+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 75 RTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred cCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccC
Confidence 345899999997 489999987655668999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 330 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
++.............|+..|+|||++.+..++.++|||||||++|+|++|..||......+...++..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~ 221 (288)
T cd07863 154 LARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 221 (288)
T ss_pred ccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHH
Confidence 98655443344456789999999999888899999999999999999999999998888777666654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=295.90 Aligned_cols=212 Identities=25% Similarity=0.459 Sum_probs=179.3
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
.+++|.+.+.||+|+||.||+|.+. ++.||||.+........ ...+.+|+.++++++||||+++++++..+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-------PCTAIREVSLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc-------chhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 3467899999999999999999885 68899999976443322 23466899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
...++||||+++ +|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 77 ~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 154 (309)
T cd07872 77 KSLTLVFEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAK 154 (309)
T ss_pred CeEEEEEeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceec
Confidence 999999999965 888888763 345788999999999999999999999999999999999999999999999998643
Q ss_pred cc-cCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 335 VY-CDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 335 ~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
.. ........++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.+
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 219 (309)
T cd07872 155 SVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR 219 (309)
T ss_pred CCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 22 122334568999999998865 4578999999999999999999999999887776665554
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=291.66 Aligned_cols=212 Identities=30% Similarity=0.586 Sum_probs=179.2
Q ss_pred eecceeeeeeeEEEEEEEEC------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 182 FLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 182 ~~~~~lG~G~~g~Vy~~~~~------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.+.+.||.|+||.||+|.+. +..|+||++......+ ..+.|.+|++++.+++||||++++|+|.+..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~-------~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~ 74 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEE-------EEEEFLNEIQILRKLRHPNIVKLYGFCIENE 74 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHH-------HHHHHHHHHHHHHTHSBTTBE-EEEEEESSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccc-------cceeeeecccccccccccccccccccccccc
Confidence 46788999999999999998 5789999995432221 1577889999999999999999999999888
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+++||||+++|+|.++|.......+++..++.|+.||+.||.|||+++++|+||+++|||++.++.+||+|||++....
T Consensus 75 ~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 75 PLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp SEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 89999999999999999998656789999999999999999999999999999999999999999999999999986542
Q ss_pred cc---CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 015556 336 YC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 336 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
.. .......+...|+|||.+....++.++||||||+++|||++ |..||.+.+..+....+.++..
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~ 223 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR 223 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 11 12233457889999999988889999999999999999999 7899999998887777755544
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=292.52 Aligned_cols=202 Identities=23% Similarity=0.402 Sum_probs=175.8
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeE
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC 258 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 258 (405)
|.+.+.||+|+||.||++.+. ++.||||.+........ .....+.+|+.++++++|+||+.+++.+.+...+|
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-----KGESMALNEKQILEKVNSRFVVSLAYAYETKDALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccch-----HHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEE
Confidence 556788999999999999986 68999999875332221 12356778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccC
Q 015556 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~ 338 (405)
+||||+++++|.+++.......+++..++.++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 77 lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999999999976555678999999999999999999999999999999999999999999999999986544333
Q ss_pred CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 339 ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 339 ~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
......|+..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 3344579999999999998899999999999999999999999998644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=292.87 Aligned_cols=196 Identities=25% Similarity=0.427 Sum_probs=167.8
Q ss_pred eeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEeec
Q 015556 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264 (405)
Q Consensus 187 lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 264 (405)
||+|+||+||++.+. ++.||||.+....... ......+..|+.+++.++|+||+++++++.....+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK-----RKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhh-----hHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCC
Confidence 699999999999875 6899999987432211 112356778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccC-CCC
Q 015556 265 SEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD-ALS 341 (405)
Q Consensus 265 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~ 341 (405)
++|+|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... ...
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 155 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK 155 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence 999999888643 24568999999999999999999999999999999999999999999999999986433221 223
Q ss_pred CCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 342 ~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 3468999999999999999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=299.65 Aligned_cols=204 Identities=24% Similarity=0.398 Sum_probs=177.6
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
..++|.+.++||.|+||.||++.+. +..+|+|++...... .....+.+|+++++.++|+||++++++|.++
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 75 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP-------AIRNQIIRELQVLHECNSPYIVGFYGAFYSD 75 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH-------HHHHHHHHHHHHHHHCCCCcccceeEEEEEC
Confidence 4478889999999999999999986 678999998754321 1246788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
+.+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 76 GEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (333)
T ss_pred CEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence 999999999999999999976 45688999999999999999999985 799999999999999999999999999854
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e 390 (405)
... .......|+..|+|||++.+..++.++|||||||++|+|++|..||......+
T Consensus 154 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 209 (333)
T cd06650 154 LID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209 (333)
T ss_pred hhh-hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH
Confidence 322 22234568999999999998889999999999999999999999998765543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=308.83 Aligned_cols=193 Identities=26% Similarity=0.443 Sum_probs=168.9
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 253 (405)
+....|.+.+.||.|+||.||++.+. ++.||||... ...+.+|+++|++|+||||+++++++..
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------------~~~~~~E~~il~~l~HpnIv~~~~~~~~ 154 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------------RGGTATEAHILRAINHPSIIQLKGTFTY 154 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------------hhhhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence 44567999999999999999999985 6899999643 2345689999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
+...++|||++. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 155 ~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~ 231 (391)
T PHA03212 155 NKFTCLILPRYK-TDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACF 231 (391)
T ss_pred CCeeEEEEecCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence 999999999994 689998876 35688999999999999999999999999999999999999999999999999854
Q ss_pred ccc--cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 334 EVY--CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 334 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
... ........||+.|+|||++.+..++.++|||||||++|||++|..||-.
T Consensus 232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 232 PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 221 1223345799999999999988999999999999999999999987743
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=288.07 Aligned_cols=215 Identities=27% Similarity=0.541 Sum_probs=184.2
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
|.++..+|.+.+.||+|++|.||+|.+. ++.||+|++..... . ...+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~--------~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-E--------VEEFLKEAAVMKEIKHPNLVQLLGVC 71 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch-H--------HHHHHHHHHHHHhCCCCChhheEEEE
Confidence 5677888999999999999999999985 68999999863221 1 35678999999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
.....+++||||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+|||+++++.+||+|||++
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~ 151 (263)
T cd05052 72 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 151 (263)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccc
Confidence 99999999999999999999998755567899999999999999999999999999999999999999999999999998
Q ss_pred ccccccCC--CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015556 332 CEEVYCDA--LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 332 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~ 397 (405)
........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||+..+..+....+.+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 220 (263)
T cd05052 152 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 220 (263)
T ss_pred cccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC
Confidence 65432211 112234668999999998899999999999999999998 9999998877666555544
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=294.73 Aligned_cols=214 Identities=28% Similarity=0.384 Sum_probs=185.9
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec----
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK---- 253 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~---- 253 (405)
.|...+.||.|+||.|..+.++ |+.||||.+...-.... ..++..+|+.+|++++|+||+.+++.+..
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~------~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQI------DAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchH------HHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 3444688999999999999986 79999999974443322 24677899999999999999999998865
Q ss_pred -CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 254 -PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 254 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
-..+|+|+|+| +.+|...++. +..++.+.+..+++||++||.|+|+.+|+||||||.|+|++.+..+||+|||+|+
T Consensus 97 ~f~DvYiV~elM-etDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 97 KFNDVYLVFELM-ETDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred ccceeEEehhHH-hhHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecccccee
Confidence 45789999999 6689998886 4559999999999999999999999999999999999999999999999999997
Q ss_pred ccc---ccCCCCCCCCCCcccCcccc-ccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Q 015556 333 EEV---YCDALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNFG 402 (405)
Q Consensus 333 ~~~---~~~~~~~~~gt~~y~aPE~~-~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~~~ 402 (405)
... ....++..+.|..|.|||++ ....|+...||||.||||.|||+|+.-|++.+..+.+..|++-.+-|
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP 247 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP 247 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence 654 24556788899999999987 45679999999999999999999999999999999999988876655
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=313.43 Aligned_cols=216 Identities=22% Similarity=0.345 Sum_probs=183.2
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
..++|.+.+.||+|+||.||++.+. ++.||||++........ ....+.+|+.++..++|+||++++..+...
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~------~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEA------DKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHH------HHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 3468999999999999999999874 78999999976544332 145678999999999999999998876532
Q ss_pred C--------eeEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEE
Q 015556 255 P--------VYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324 (405)
Q Consensus 255 ~--------~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vk 324 (405)
. .+++||||+++|+|.+++... ....+++..+..++.|++.||.|||+++|+||||||+|||++.++.+|
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEE
Confidence 2 368999999999999999753 235689999999999999999999999999999999999999999999
Q ss_pred EEecCCcccccc---cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 325 IADFGIACEEVY---CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 325 L~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
|+|||++..... ........||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+..+
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~ 260 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG 260 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 999999854322 12233456999999999999999999999999999999999999999998887777666654
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=293.70 Aligned_cols=222 Identities=30% Similarity=0.522 Sum_probs=183.2
Q ss_pred cccccccccCCCeeecceeeeeeeEEEEEEEECC---------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc
Q 015556 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD---------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL 239 (405)
Q Consensus 169 ~~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~---------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l 239 (405)
...+.|.+..++|.+++.||+|+||.||++.+.+ ..+|+|.+....... ....+..|+.+++.+
T Consensus 8 ~~~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~e~~~l~~l 80 (307)
T cd05098 8 PEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK-------DLSDLISEMEMMKMI 80 (307)
T ss_pred CCCCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChH-------HHHHHHHHHHHHHHh
Confidence 3456788888999999999999999999998632 469999987432211 135678899999999
Q ss_pred -CCCCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 015556 240 -HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH--------------KTLPLPKLIAIALDIARGMEYIHSQG 304 (405)
Q Consensus 240 -~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~g 304 (405)
+|+||++++++|......|+||||+++|+|.+++..... ..+++..++.++.|++.||+|||++|
T Consensus 81 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g 160 (307)
T cd05098 81 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK 160 (307)
T ss_pred cCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 799999999999999999999999999999999986421 34788999999999999999999999
Q ss_pred ceecCCCCCcEEECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CC
Q 015556 305 VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GT 380 (405)
Q Consensus 305 IiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~ 380 (405)
++||||||+|||++.++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 161 i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~ 240 (307)
T cd05098 161 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 240 (307)
T ss_pred cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999985432211 1122234578999999988889999999999999999998 89
Q ss_pred CCCCCCCHHHHHHHHHh
Q 015556 381 IPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 381 ~Pf~~~~~~e~~~~i~~ 397 (405)
.||......+....+..
T Consensus 241 ~p~~~~~~~~~~~~~~~ 257 (307)
T cd05098 241 SPYPGVPVEELFKLLKE 257 (307)
T ss_pred CCCCcCCHHHHHHHHHc
Confidence 99987666554444433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=286.53 Aligned_cols=214 Identities=27% Similarity=0.525 Sum_probs=182.5
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
++.++|.+++.||+|+||.||.|.+.+ ..||||.+...... ...+.+|+.++++++||||++++++|.+.
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd05113 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71 (256)
T ss_pred CChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---------HHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 356788999999999999999998875 46999998743321 24578999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
..+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+|||++.++.+||+|||.+...
T Consensus 72 ~~~~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~ 150 (256)
T cd05113 72 RPIYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV 150 (256)
T ss_pred CCcEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceec
Confidence 89999999999999999997633 36899999999999999999999999999999999999999999999999987543
Q ss_pred cccCC--CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 335 VYCDA--LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 335 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
..... .....++..|++||++.+..++.++||||||+++|+|++ |..||......+....+.++.
T Consensus 151 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~ 218 (256)
T cd05113 151 LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL 218 (256)
T ss_pred CCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCC
Confidence 22211 112235678999999988889999999999999999999 999999888877766666653
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=288.98 Aligned_cols=218 Identities=28% Similarity=0.513 Sum_probs=181.3
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeE
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 246 (405)
|.+..++|.+.+.||+|+||.||+|.+.+ ..||||.+...... ....++.+|+.+++.++|+||++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~iv~ 73 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM-------RERIEFLNEASVMKEFNCHHVVR 73 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH-------HHHHHHHHHHHHHHhCCCCCeee
Confidence 56677889999999999999999998643 56999988532211 11456889999999999999999
Q ss_pred EeeEeecCCeeEEEEeecCCCCHHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEC
Q 015556 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEH--------KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318 (405)
Q Consensus 247 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~ 318 (405)
+++++.+....++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.|++||||||+|||++
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~ 153 (277)
T cd05062 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 153 (277)
T ss_pred EEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc
Confidence 99999999999999999999999999976321 2357788999999999999999999999999999999999
Q ss_pred CCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 015556 319 QEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFA 394 (405)
Q Consensus 319 ~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~ 394 (405)
+++.++|+|||++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....
T Consensus 154 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~ 233 (277)
T cd05062 154 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF 233 (277)
T ss_pred CCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999985432211 1122345788999999998889999999999999999999 7999998887766665
Q ss_pred HHhc
Q 015556 395 VVNK 398 (405)
Q Consensus 395 i~~~ 398 (405)
+.+.
T Consensus 234 ~~~~ 237 (277)
T cd05062 234 VMEG 237 (277)
T ss_pred HHcC
Confidence 5554
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=303.49 Aligned_cols=210 Identities=26% Similarity=0.384 Sum_probs=177.1
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC--
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP-- 255 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-- 255 (405)
+|.+++.||+|+||.||++.+. ++.||||.+........ ..+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV------SCKRVFRELKMLCFFKHDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchH------HHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence 3667889999999999999974 78999999864322211 1456789999999999999999999998776
Q ss_pred ---eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 256 ---VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 256 ---~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
..|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 75 PFEEIYVVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred ccceEEEEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEecccccee
Confidence 7899999996 588888765 4678999999999999999999999999999999999999999999999999986
Q ss_pred ccccc--CCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 333 EEVYC--DALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 333 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
..... .......++..|+|||++.+. .++.++|||||||++|||++|+.||.+.++.+.+..+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 220 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDL 220 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 43221 223345689999999998764 4789999999999999999999999999888877666553
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=285.12 Aligned_cols=212 Identities=28% Similarity=0.534 Sum_probs=182.1
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee-
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK- 252 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~- 252 (405)
|.++..+|.+.+.||+|+||.||++...+..||+|.+..... .+.+.+|+.++++++|+|++++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~----------~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT----------AQAFLAEASVMTQLRHSNLVQLLGVIVE 70 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCch----------HHHHHHHHHHHHhCCCCCeeeEEEEEEc
Confidence 567888999999999999999999999999999999863221 346789999999999999999999764
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
.+...++||||+++++|.+++.......+++..++.++.|++.||.|||++||+||||||+||++++++.+||+|||++.
T Consensus 71 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~ 150 (256)
T cd05082 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK 150 (256)
T ss_pred CCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccce
Confidence 55678999999999999999987555568999999999999999999999999999999999999999999999999986
Q ss_pred cccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015556 333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 333 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~ 397 (405)
...... ....++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.+
T Consensus 151 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~ 214 (256)
T cd05082 151 EASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 214 (256)
T ss_pred eccccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Confidence 433221 23345678999999998889999999999999999998 9999998777665554433
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=283.22 Aligned_cols=215 Identities=27% Similarity=0.457 Sum_probs=183.1
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
+.|.+++.||.|++|.||++... ++.||||.+......... ....+.+.+|++++++++||||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 78 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPET---KKEVNALECEIQLLKNLQHERIVQYYGCLRDDET 78 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhh---HHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCe
Confidence 45778999999999999999874 689999998755433211 1224678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.....
T Consensus 79 ~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 79 LSIFMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEEEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 9999999999999999976 35688999999999999999999999999999999999999999999999999854322
Q ss_pred cC----CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 337 CD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 337 ~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.. ......++..|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 222 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ 222 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc
Confidence 11 113345788999999999888999999999999999999999999988887776665543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=289.24 Aligned_cols=216 Identities=29% Similarity=0.553 Sum_probs=180.3
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEE------CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIY------KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
+++++|.+.+.||+|+||.||+|.+ .++.||||.+....... ....+.+|+.+++.++||||+++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~ 74 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQ-------QWGEFQQEASLMAELHHPNIVCLLG 74 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHH-------HHHHHHHHHHHHhhCCCCCeeeEEE
Confidence 4567889999999999999999985 24789999987433211 1456889999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLE---------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~N 314 (405)
++......|+||||+++++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+|
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~n 154 (283)
T cd05090 75 VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARN 154 (283)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccce
Confidence 9999999999999999999999986421 2347888999999999999999999999999999999
Q ss_pred EEECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 015556 315 VLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQ 390 (405)
Q Consensus 315 ILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e 390 (405)
||+++++.+||+|||++....... ......++..|+|||++.+..++.++||||||+++|||++ |..||.+.++.+
T Consensus 155 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~ 234 (283)
T cd05090 155 ILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE 234 (283)
T ss_pred EEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999999999986432211 1233446778999999988889999999999999999998 999999887765
Q ss_pred HHHHHHhc
Q 015556 391 AAFAVVNK 398 (405)
Q Consensus 391 ~~~~i~~~ 398 (405)
....+..+
T Consensus 235 ~~~~~~~~ 242 (283)
T cd05090 235 VIEMVRKR 242 (283)
T ss_pred HHHHHHcC
Confidence 55554443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=300.99 Aligned_cols=204 Identities=23% Similarity=0.374 Sum_probs=170.5
Q ss_pred eeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc---CCCCeeEEeeEeecCCeeEEEE
Q 015556 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL---HNPNVIKFVAACKKPPVYCVIT 261 (405)
Q Consensus 187 lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~~~~~~lV~ 261 (405)
||+|+||+||+|.+. ++.||||++....... ......+..|..++..+ +||||+++++++.+...+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA-----KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh-----hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEE
Confidence 699999999999885 6899999996422111 11233455677777665 6999999999999999999999
Q ss_pred eecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc-cCCC
Q 015556 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDAL 340 (405)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~-~~~~ 340 (405)
||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..... ....
T Consensus 76 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~ 153 (330)
T cd05586 76 DYMSGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT 153 (330)
T ss_pred cCCCCChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCc
Confidence 99999999999876 46789999999999999999999999999999999999999999999999999864322 2223
Q ss_pred CCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 341 SDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 341 ~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
....||..|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~ 211 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF 211 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc
Confidence 455799999999998754 479999999999999999999999998887776665543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=281.72 Aligned_cols=213 Identities=22% Similarity=0.387 Sum_probs=184.5
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+.+.||+|++|.||++... ++.|++|.+........ ....+.+|+.++++++||||+++++++.+...+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR------EREEAIDEARVLAKLDSSYIIRYYESFLDKGKL 74 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHH------HHHHHHHHHHHHHhcCCCCeehheeeeccCCEE
Confidence 4677889999999999999985 68999999875433321 246788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
++||||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 99999999999999998865678899999999999999999999999999999999999999999999999987643322
Q ss_pred C-CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 338 D-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 338 ~-~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
. ......|+..|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.++
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 216 (256)
T cd08529 155 TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG 216 (256)
T ss_pred cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 1 223346889999999999888999999999999999999999999988877766666554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=283.16 Aligned_cols=217 Identities=31% Similarity=0.516 Sum_probs=187.2
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
|.++.++|.+++.||+|++|.||++.+.+ +.||||.+...... .+.+.+|+.++++++|+||+++++++.
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---------PEAFLQEAQIMKKLRHDKLVQLYAVCS 71 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---------HHHHHHHHHHHhhCCCCCEeeeeeeee
Confidence 56788999999999999999999998864 78999998743322 246789999999999999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
.....++||||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~ 151 (261)
T cd05034 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLAR 151 (261)
T ss_pred cCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccce
Confidence 98899999999999999999987655678999999999999999999999999999999999999999999999999985
Q ss_pred cccccC--CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 333 EEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 333 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
...... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+....+...++..+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~ 221 (261)
T cd05034 152 LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY 221 (261)
T ss_pred eccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 432211 1112234568999999998889999999999999999999 999999988877777776543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=283.71 Aligned_cols=202 Identities=35% Similarity=0.645 Sum_probs=177.1
Q ss_pred eeecceeeeeeeEEEEEEEECC--ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeE
Q 015556 181 LFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC 258 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~~--~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 258 (405)
|++++.||+|+||+||++...+ +.||+|++......... .....+|+.++.+++||||+++++++.+....+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 74 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE------REENIREIKILRRLRHPNIVQILDVFQDDNYLY 74 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH------HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc------cchhhhhhhcccccccccccccccccccccccc
Confidence 6789999999999999999974 57999999865543321 223445999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc-cccc
Q 015556 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE-EVYC 337 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~-~~~~ 337 (405)
+||||+.+++|.+++.. ...+++..++.++.||+.||.+||++||+|+||||+|||++.++.++|+|||.+.. ....
T Consensus 75 ~v~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~ 152 (260)
T PF00069_consen 75 IVMEYCPGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN 152 (260)
T ss_dssp EEEEEETTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred ccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999983 46789999999999999999999999999999999999999999999999999864 2333
Q ss_pred CCCCCCCCCCcccCccccc-cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 015556 338 DALSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390 (405)
Q Consensus 338 ~~~~~~~gt~~y~aPE~~~-~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e 390 (405)
.......++..|+|||++. +..++.++||||||+++|+|++|..||......+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~ 206 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD 206 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchh
Confidence 4555677999999999998 7888999999999999999999999999884333
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=285.23 Aligned_cols=215 Identities=27% Similarity=0.477 Sum_probs=181.6
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
|.+..++|.++++||+|+||.||+|.+.+ ..||||++...... ...+.+|++++++++|+||+++++.+.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---------~~~~~~E~~~l~~l~~~~i~~~~~~~~ 71 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYAVVS 71 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---------HHHHHHHHHHHHhCCCCCcceEEEEEC
Confidence 45667889999999999999999998864 57999998743321 246789999999999999999999876
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
+ ...++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+|+||||||+|||+++++.++|+|||.+.
T Consensus 72 ~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~ 150 (262)
T cd05071 72 E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 150 (262)
T ss_pred C-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCcee
Confidence 5 457899999999999999987555668999999999999999999999999999999999999999999999999985
Q ss_pred cccccCC--CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 333 EEVYCDA--LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 333 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
....... .....++..|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+..+
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~ 219 (262)
T cd05071 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 219 (262)
T ss_pred eccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC
Confidence 4332211 122346678999999988889999999999999999999 89999988877766665544
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=282.17 Aligned_cols=213 Identities=29% Similarity=0.584 Sum_probs=185.8
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 253 (405)
|.++..+|.+.+.||.|+||.||+|...++.||||.+..... ..+++.+|+.++..++|+||+++++++.+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 71 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---------AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---------HHHHHHHHHHHHHhcCCcceeeeEEEEcC
Confidence 345678889999999999999999999999999999974332 25678899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
....++||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||.+..
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~ 151 (256)
T cd05039 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE 151 (256)
T ss_pred CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccc
Confidence 99999999999999999999875555799999999999999999999999999999999999999999999999999865
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~ 397 (405)
.... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.+
T Consensus 152 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 214 (256)
T cd05039 152 ASQG--QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK 214 (256)
T ss_pred cccc--cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Confidence 5322 123345678999999988889999999999999999998 9999998876665554443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=293.84 Aligned_cols=208 Identities=27% Similarity=0.519 Sum_probs=173.2
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--Cc----cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DE----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~----~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
...+|.+.+.||+|+||.||+|.+. ++ .||||++....... ...++.+|+.+++.++||||++++|+
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~g~ 77 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-------ANKEILDEAYVMASVDNPHVCRLLGI 77 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHH-------HHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 3467888999999999999999863 33 48999986432211 24568899999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
|... ..++|+||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 78 ~~~~-~~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~ 155 (316)
T cd05108 78 CLTS-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGL 155 (316)
T ss_pred EcCC-CceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccc
Confidence 9875 467999999999999999863 34688899999999999999999999999999999999999999999999999
Q ss_pred cccccccCC---CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 015556 331 ACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAF 393 (405)
Q Consensus 331 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~ 393 (405)
+........ .....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+...
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~ 222 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 222 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 865432221 112234678999999998999999999999999999998 999999877665443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=287.23 Aligned_cols=212 Identities=24% Similarity=0.390 Sum_probs=186.5
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+-+.||+|.|+.||++... |+.+|+|++....-... --..+.+|+.|.+.|+|||||+|...+.....
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~------~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR------DFQKLEREARICRKLQHPNIVRLHDSIQEESF 84 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc------cHHHHHHHHHHHHhcCCCcEeehhhhhcccce
Confidence 56778889999999999998874 79999999865433222 24568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEC---CCCcEEEEecCCccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID---QEFHLKIADFGIACE 333 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~---~~~~vkL~DFG~a~~ 333 (405)
.|+|+|+|.|++|..-|... ..+++..+-..+.||+.+|.|||.+||||||+||+|+|+- ...-+||+|||+|..
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred eEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999999999998777663 5678888999999999999999999999999999999993 345699999999988
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
...+..-...+||+.|||||+++..+|+..+|||+.||+||-||.|.+||-+.+....+.+|+++
T Consensus 163 l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g 227 (355)
T KOG0033|consen 163 VNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG 227 (355)
T ss_pred eCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc
Confidence 77666666778999999999999999999999999999999999999999999988888888765
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=300.74 Aligned_cols=212 Identities=26% Similarity=0.395 Sum_probs=191.3
Q ss_pred CCeeecceeeeeeeEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
+-|.+.+.||+|-|..|-++++ .|+.||||++.....++-. ..++.+|+..|+.++|||||+||........
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s------t~hlfqEVRCMKLVQHpNiVRLYEViDTQTK 91 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS------TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK 91 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh------hhHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence 3466778899999999998875 5999999999876655432 5688999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE-CCCCcEEEEecCCccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI-DQEFHLKIADFGIACEEV 335 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl-~~~~~vkL~DFG~a~~~~ 335 (405)
+|||+|.-++|+|++||.+.. ..+.++.+.+++.||+.|+.|||+..+|||||||+|+++ ..-|-+||.|||++....
T Consensus 92 lyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999999999999998843 568899999999999999999999999999999999987 455899999999999999
Q ss_pred ccCCCCCCCCCCcccCccccccccCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 336 YCDALSDDPGTYRWMAPEMIKHKSYG-RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 336 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
.+..+...+|+..|.|||++.+..|+ +++||||||||||-|+||+.||+..+..|.+-.|+.
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImD 233 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMD 233 (864)
T ss_pred CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhc
Confidence 99999999999999999999999995 789999999999999999999999998888776653
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=286.46 Aligned_cols=218 Identities=26% Similarity=0.487 Sum_probs=184.1
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeE
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 246 (405)
|.++.++|.+++.||+|+||.||+|.+.+ ..||+|.+....... ....+.+|+.+++.++|+||++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~-------~~~~~~~e~~~l~~~~~~~i~~ 73 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR-------ERIEFLNEASVMKEFNCHHVVR 73 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHH-------HHHHHHHHHHHHHhCCCCceeE
Confidence 56778899999999999999999998753 579999986432211 1356789999999999999999
Q ss_pred EeeEeecCCeeEEEEeecCCCCHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEC
Q 015556 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318 (405)
Q Consensus 247 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~ 318 (405)
+++++......++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+|+||||||+|||++
T Consensus 74 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~ 153 (277)
T cd05032 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA 153 (277)
T ss_pred EEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEc
Confidence 9999999999999999999999999997532 23468889999999999999999999999999999999999
Q ss_pred CCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 015556 319 QEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFA 394 (405)
Q Consensus 319 ~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~ 394 (405)
.++.+||+|||++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...++.+....
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 233 (277)
T cd05032 154 EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF 233 (277)
T ss_pred CCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHH
Confidence 99999999999986433221 1233446789999999988889999999999999999998 9999998887776666
Q ss_pred HHhc
Q 015556 395 VVNK 398 (405)
Q Consensus 395 i~~~ 398 (405)
+..+
T Consensus 234 ~~~~ 237 (277)
T cd05032 234 VIDG 237 (277)
T ss_pred HhcC
Confidence 6543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=299.12 Aligned_cols=216 Identities=32% Similarity=0.518 Sum_probs=178.3
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCee
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVI 245 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv 245 (405)
|.+..++|.+++.||+|+||.||+|... ++.||||++....... ..+.+.+|+.++.++ +|+||+
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~-------~~~~~~~E~~~~~~l~~h~niv 74 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATAS-------EYKALMTELKILIHIGHHLNVV 74 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHH-------HHHHHHHHHHHHHhhccCcchh
Confidence 6777889999999999999999999753 3689999987433221 135677899999999 799999
Q ss_pred EEeeEeec-CCeeEEEEeecCCCCHHHHHHHhcC----------------------------------------------
Q 015556 246 KFVAACKK-PPVYCVITEYLSEGSLRAYLHKLEH---------------------------------------------- 278 (405)
Q Consensus 246 ~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------- 278 (405)
+++++|.. +..++++|||+++++|.+++.....
T Consensus 75 ~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (337)
T cd05054 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLS 154 (337)
T ss_pred heeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchh
Confidence 99998865 4578899999999999999865321
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccC---CCCC
Q 015556 279 -------------KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSD 342 (405)
Q Consensus 279 -------------~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~ 342 (405)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... ....
T Consensus 155 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~ 234 (337)
T cd05054 155 DVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 234 (337)
T ss_pred hcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccC
Confidence 267899999999999999999999999999999999999999999999999986532211 1123
Q ss_pred CCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 015556 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 343 ~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~ 396 (405)
..++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.....+
T Consensus 235 ~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~ 289 (337)
T cd05054 235 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL 289 (337)
T ss_pred CCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH
Confidence 345678999999999999999999999999999998 999998765555444443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=272.96 Aligned_cols=218 Identities=31% Similarity=0.420 Sum_probs=187.5
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEe
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAAC 251 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~ 251 (405)
.+..+.+..+..||+|+||.|-+-++ .|+..|||.++..-. .+..+++.+|+.+..+. ..|.+|.|||++
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-------~q~q~r~L~dldi~~r~~~CPf~V~FyGa~ 114 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-------SQEQKRLLMDLDIIMRTVDCPFTVHFYGAL 114 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-------hHHHHHHHHhhhhhccCCCCCeEEEeehhh
Confidence 44456677788999999998866655 589999999985433 34478888999998876 589999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEECCCCcEEEEec
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADF 328 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDIkp~NILl~~~~~vkL~DF 328 (405)
.+.+..|+.||.|+ .+|..|-.+. .+..+++..+-+|+..++.||.|||++ .|||||+||+||||+.+|++|||||
T Consensus 115 ~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDF 193 (282)
T KOG0984|consen 115 FREGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDF 193 (282)
T ss_pred hccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccc
Confidence 99999999999994 5888876653 467899999999999999999999976 7999999999999999999999999
Q ss_pred CCcccccccCCCCCCCCCCcccCccccc----cccCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccc
Q 015556 329 GIACEEVYCDALSDDPGTYRWMAPEMIK----HKSYGRKVDVYSFGLILWEMVAGTIPYEE-MNPIQAAFAVVNKVN 400 (405)
Q Consensus 329 G~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~k~DVwSlGvll~elltG~~Pf~~-~~~~e~~~~i~~~~~ 400 (405)
|++....+.-..+...|...|||||.+. ...|+.++||||||++++||.+++.||+. ..|.+.+.++++...
T Consensus 194 GIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 194 GISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPS 270 (282)
T ss_pred ccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCC
Confidence 9997777666666678999999999984 34789999999999999999999999987 679999999987653
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=286.44 Aligned_cols=210 Identities=28% Similarity=0.428 Sum_probs=183.3
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||+|++|.||++.+. ++.||||++...... .......+.+|++++++++||||+++++++.+...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-----KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCe
Confidence 36888999999999999999985 689999998743221 12235678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||+|.|||++.++.+||+|||++.....
T Consensus 76 ~~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred EEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999999999987 36789999999999999999999999999999999999999999999999999865433
Q ss_pred cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 337 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....++.
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 212 (290)
T cd05580 154 R--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE 212 (290)
T ss_pred C--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 2 3445689999999999888889999999999999999999999998887666665553
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=282.69 Aligned_cols=215 Identities=30% Similarity=0.501 Sum_probs=183.1
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
|.+..++|.+.++||+|+||.||+|.+. +..||+|.+...... ...+.+|+.++++++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~E~~~l~~l~~~~i~~~~~~~~ 71 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---------PESFLEEAQIMKKLRHDKLVQLYAVVS 71 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---------HHHHHHHHHHHHhcCCCceEEEEeEEC
Confidence 5567788999999999999999999876 478999998754332 245789999999999999999999886
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
+ ...++||||+++++|.+++.......+++..++.++.|++.||.|||+++|+||||||+||++++++.++|+|||++.
T Consensus 72 ~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~ 150 (260)
T cd05070 72 E-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR 150 (260)
T ss_pred C-CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeee
Confidence 4 457899999999999999987555678999999999999999999999999999999999999999999999999986
Q ss_pred cccccC--CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 333 EEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 333 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
...... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05070 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG 219 (260)
T ss_pred eccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 433211 1122235668999999988889999999999999999999 99999998888777766654
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=283.64 Aligned_cols=214 Identities=27% Similarity=0.519 Sum_probs=181.8
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
+.++|.+.+.||+|+||.||+|.+. ...||||.+....... ....|.+|+.++++++|+||+++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDK-------QRLDFLTEASIMGQFDHPNIIRLEGVV 74 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChH-------HHHHHHHHHHHHHhCCCCCcceEeEEE
Confidence 4567889999999999999999874 2479999886443221 245688999999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
.+....++||||+++++|.+++... ...+++..++.++.|++.||.|||+++|+||||||+|||+++++.++|+|||++
T Consensus 75 ~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~ 153 (266)
T cd05033 75 TKSRPVMIITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS 153 (266)
T ss_pred ecCCceEEEEEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchh
Confidence 9999999999999999999999763 347899999999999999999999999999999999999999999999999998
Q ss_pred ccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 332 CEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 332 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~ 224 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG 224 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC
Confidence 6543111 1112235678999999998889999999999999999998 99999888877766666554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=289.09 Aligned_cols=215 Identities=30% Similarity=0.508 Sum_probs=178.1
Q ss_pred CCCeeecceeeeeeeEEEEEEEECC--c--cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEee
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYKD--E--PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACK 252 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~--~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~ 252 (405)
+++|.+.+.||+|+||.||+|.+.+ . .+++|.++...... ..+.+.+|+.++.++ +||||+++++++.
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 73 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEN-------DHRDFAGELEVLCKLGHHPNIINLLGACE 73 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHH-------HHHHHHHHHHHHHhhcCCCchhheEEEEc
Confidence 3678899999999999999998753 2 46888776322211 145688999999999 7999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEC
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~ 318 (405)
....+++||||+++++|.+++.... ...+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~ 153 (297)
T cd05089 74 NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG 153 (297)
T ss_pred cCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEEC
Confidence 9999999999999999999997632 13578899999999999999999999999999999999999
Q ss_pred CCCcEEEEecCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015556 319 QEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 319 ~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~ 397 (405)
+++.+||+|||++..............+..|+|||++.+..++.++|||||||++|||++ |..||......+....+.+
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~ 233 (297)
T cd05089 154 ENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233 (297)
T ss_pred CCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence 999999999999854322111122234567999999988889999999999999999997 9999999888877776665
Q ss_pred cc
Q 015556 398 KV 399 (405)
Q Consensus 398 ~~ 399 (405)
+.
T Consensus 234 ~~ 235 (297)
T cd05089 234 GY 235 (297)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=281.40 Aligned_cols=213 Identities=26% Similarity=0.460 Sum_probs=179.2
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC--
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-- 254 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-- 254 (405)
.+|.+++.||+|+||.||+|.+. ++.||||.+......... ......+.+|+.++++++||||+++++++.+.
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPET---SKEVNALECEIQLLKNLLHERIVQYYGCLRDPME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCccc---HHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC
Confidence 46888999999999999999975 689999998754322111 12246788999999999999999999998763
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
..+++||||+++++|.+++.. ...+++..++.++.|++.||+|||+++|+|+||+|+|||++.++.++|+|||++...
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 568899999999999999976 356788899999999999999999999999999999999999999999999988643
Q ss_pred cc----cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015556 335 VY----CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 335 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~ 396 (405)
.. ........|+..|+|||.+.+..++.++|||||||++|+|++|+.||..........++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~ 222 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA 222 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh
Confidence 21 112234468899999999988888999999999999999999999999887777665544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=282.77 Aligned_cols=212 Identities=30% Similarity=0.570 Sum_probs=182.4
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 253 (405)
|.+++++|.+++.||+|+||.||++...++.||||.+..... ...+.+|+.++++++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~----------~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 70 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVT----------AQAFLEETAVMTKLHHKNLVRLLGVILH 70 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcch----------HHHHHHHHHHHHhCCCCCcCeEEEEEcC
Confidence 567788999999999999999999999999999999864221 3467899999999999999999999876
Q ss_pred CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
+. .++||||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+|||++.++.++|+|||++..
T Consensus 71 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~ 149 (254)
T cd05083 71 NG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV 149 (254)
T ss_pred CC-cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCcccee
Confidence 55 68999999999999999875555789999999999999999999999999999999999999999999999999854
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
.... ......+..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.++
T Consensus 150 ~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 213 (254)
T cd05083 150 GSMG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG 213 (254)
T ss_pred cccc--CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC
Confidence 3221 223335678999999988889999999999999999998 99999988877665555443
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=281.97 Aligned_cols=212 Identities=29% Similarity=0.536 Sum_probs=179.9
Q ss_pred cCCCeeecceeeeeeeEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
+..+|.+++.||+|+||.||++.+.+ ..+|||++...... ...+.+|+.++++++|+||+++++++....
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---------EDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---------HHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 55678899999999999999998864 68999998643322 235778999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~ 151 (256)
T cd05059 73 PIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL 151 (256)
T ss_pred ceEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecc
Confidence 9999999999999999997633 468999999999999999999999999999999999999999999999999886433
Q ss_pred ccCCC--CCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 336 YCDAL--SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 336 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
..... ....++..|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+...
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~ 217 (256)
T cd05059 152 DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG 217 (256)
T ss_pred cccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC
Confidence 22111 11224457999999998889999999999999999999 89999988877776665544
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=286.82 Aligned_cols=215 Identities=30% Similarity=0.555 Sum_probs=182.4
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
..++|.+.+.||+|+||.||+|... ++.||||.+......+ ....+.+|+++++.++|+||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~ 75 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND-------ARKDFEREAELLTNFQHENIVKFYG 75 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHH-------HHHHHHHHHHHHHhcCCCCchheee
Confidence 4567888999999999999999863 3689999987543321 2467889999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLE------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl 317 (405)
++......++||||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+|||+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili 155 (280)
T cd05049 76 VCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV 155 (280)
T ss_pred EEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE
Confidence 9999999999999999999999997632 2457888999999999999999999999999999999999
Q ss_pred CCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 015556 318 DQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAF 393 (405)
Q Consensus 318 ~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~ 393 (405)
+.++.++|+|||++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+...
T Consensus 156 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05049 156 GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235 (280)
T ss_pred cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 999999999999986432211 1223346788999999999999999999999999999998 999999888777666
Q ss_pred HHHhc
Q 015556 394 AVVNK 398 (405)
Q Consensus 394 ~i~~~ 398 (405)
.+.++
T Consensus 236 ~~~~~ 240 (280)
T cd05049 236 CITQG 240 (280)
T ss_pred HHHcC
Confidence 65543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=321.26 Aligned_cols=208 Identities=25% Similarity=0.400 Sum_probs=176.0
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
+++|.++++||+|+||.||+|.+. ++.||||++....... ....+.+.+|+.++++++||||+++++++.+++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~-----e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~ 75 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSEN-----PLLKKRFLREAKIAADLIHPGIVPVYSICSDGD 75 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccC-----HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence 367899999999999999999985 6899999997432221 223567889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEE
Q 015556 256 VYCVITEYLSEGSLRAYLHKLE---------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA 326 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~ 326 (405)
..++||||++|++|.+++.... ....++..++.++.||+.||+|||++||+||||||+|||++.++.++|+
T Consensus 76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLi 155 (932)
T PRK13184 76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVIL 155 (932)
T ss_pred EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEE
Confidence 9999999999999999987531 1235567788999999999999999999999999999999999999999
Q ss_pred ecCCccccccc-------------------CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 327 DFGIACEEVYC-------------------DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 327 DFG~a~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
|||++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 156 DFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~ 235 (932)
T PRK13184 156 DWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235 (932)
T ss_pred ecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence 99998643110 01112469999999999999999999999999999999999999998755
Q ss_pred HHH
Q 015556 388 PIQ 390 (405)
Q Consensus 388 ~~e 390 (405)
..+
T Consensus 236 ~~k 238 (932)
T PRK13184 236 GRK 238 (932)
T ss_pred hhh
Confidence 443
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=301.71 Aligned_cols=222 Identities=30% Similarity=0.531 Sum_probs=185.5
Q ss_pred ccccccccCCCeeecceeeeeeeEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-C
Q 015556 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-N 241 (405)
Q Consensus 170 ~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-H 241 (405)
...+|.+..++|.+++.||+|+||.||+|++.+ +.||||++....... ....+.+|+.+|.++. |
T Consensus 28 ~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~-------~~~~~~~E~~~l~~l~~H 100 (401)
T cd05107 28 YDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS-------EKQALMSELKIMSHLGPH 100 (401)
T ss_pred CCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh-------HHHHHHHHHHHHHhcCCC
Confidence 345688889999999999999999999998643 579999997543222 1346789999999997 9
Q ss_pred CCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhcC-------------------------------------------
Q 015556 242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH------------------------------------------- 278 (405)
Q Consensus 242 pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------- 278 (405)
|||++++++|......++||||+++|+|.++++....
T Consensus 101 ~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (401)
T cd05107 101 LNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMD 180 (401)
T ss_pred CCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccc
Confidence 9999999999999999999999999999999976321
Q ss_pred -----------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 015556 279 -----------------------------------------------------KTLPLPKLIAIALDIARGMEYIHSQGV 305 (405)
Q Consensus 279 -----------------------------------------------------~~l~~~~~~~i~~qi~~aL~yLH~~gI 305 (405)
..+++..++.++.||+.||.|||+.+|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i 260 (401)
T cd05107 181 MSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNC 260 (401)
T ss_pred cCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCc
Confidence 235677788999999999999999999
Q ss_pred eecCCCCCcEEECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCC
Q 015556 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTI 381 (405)
Q Consensus 306 iHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~ 381 (405)
+||||||+|||++.++.+||+|||++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..
T Consensus 261 vHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~ 340 (401)
T cd05107 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGT 340 (401)
T ss_pred CcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999986432211 1223356788999999988889999999999999999998 999
Q ss_pred CCCCCCHHHHHHHHHhc
Q 015556 382 PYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 382 Pf~~~~~~e~~~~i~~~ 398 (405)
||......+.....+.+
T Consensus 341 P~~~~~~~~~~~~~~~~ 357 (401)
T cd05107 341 PYPELPMNEQFYNAIKR 357 (401)
T ss_pred CCCCCCchHHHHHHHHc
Confidence 99887766666555443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=280.80 Aligned_cols=212 Identities=24% Similarity=0.376 Sum_probs=183.7
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+.+.||.|+||.||++.+. ++.||+|.++...... ..+.+.+|+.+++.++|+||+++++++.+...+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 73 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSS-------AVEDSRKEAVLLAKMKHPNIVAFKESFEADGHL 73 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchH-------HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence 4678899999999999999885 6899999997543221 245677899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
++||||+++++|.+++.......+++..++.++.|++.||.|||++||+|+||||+|||+++++.++|+|||.+......
T Consensus 74 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 74 YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 99999999999999998755667899999999999999999999999999999999999999999999999998544322
Q ss_pred -CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 338 -DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 338 -~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.......|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+.++
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~ 215 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG 215 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC
Confidence 1223456889999999999888999999999999999999999999988877766666544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=313.17 Aligned_cols=199 Identities=29% Similarity=0.512 Sum_probs=173.3
Q ss_pred cceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC------
Q 015556 184 GLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP------ 255 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 255 (405)
-+.||+||||.||+|+.+ |+.||||.++....... .....+|+++|++|+|+|||++.+.=+...
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~-------~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRP-------RERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccch-------HHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 467999999999999965 89999999986543332 455678999999999999999998765443
Q ss_pred eeEEEEeecCCCCHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE--CCCC--cEEEEecCC
Q 015556 256 VYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI--DQEF--HLKIADFGI 330 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl--~~~~--~vkL~DFG~ 330 (405)
...+|||||.+|+|+..|.+- +...+++.+.+.++.+++.||.|||++||+||||||.||++ .++| ..||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 467999999999999999875 34679999999999999999999999999999999999998 3334 479999999
Q ss_pred cccccccCCCCCCCCCCcccCccccc-cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI 389 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~ 389 (405)
|+...........+||..|++||++. .+.|+..+|.|||||++|+++||..||.-....
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 99988888889999999999999998 488999999999999999999999999654433
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=287.72 Aligned_cols=221 Identities=29% Similarity=0.522 Sum_probs=186.4
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCC
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNP 242 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~Hp 242 (405)
...+.++.++|.+.+.||+|+||.||++...+ ..+|+|.+....... ....+.+|+.++.++ +|+
T Consensus 4 ~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~-------~~~~~~~E~~~l~~l~~h~ 76 (293)
T cd05053 4 DPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-------DLSDLVSEMEMMKMIGKHK 76 (293)
T ss_pred CcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHH-------HHHHHHHHHHHHHhhcCCC
Confidence 45778888999999999999999999998742 579999987433221 135688999999999 799
Q ss_pred CeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 015556 243 NVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL--------------EHKTLPLPKLIAIALDIARGMEYIHSQGVIHR 308 (405)
Q Consensus 243 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHr 308 (405)
||+++++++..+..+++||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+|+||
T Consensus 77 ~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~ 156 (293)
T cd05053 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHR 156 (293)
T ss_pred CeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 9999999999999999999999999999999752 23568899999999999999999999999999
Q ss_pred CCCCCcEEECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCC
Q 015556 309 DLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYE 384 (405)
Q Consensus 309 DIkp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~ 384 (405)
||||+|||++.++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 157 dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 236 (293)
T cd05053 157 DLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236 (293)
T ss_pred ccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCC
Confidence 999999999999999999999986533221 1122235678999999988889999999999999999998 999999
Q ss_pred CCCHHHHHHHHHhc
Q 015556 385 EMNPIQAAFAVVNK 398 (405)
Q Consensus 385 ~~~~~e~~~~i~~~ 398 (405)
.....+....+..+
T Consensus 237 ~~~~~~~~~~~~~~ 250 (293)
T cd05053 237 GIPVEELFKLLKEG 250 (293)
T ss_pred CCCHHHHHHHHHcC
Confidence 88877766655544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=322.07 Aligned_cols=219 Identities=22% Similarity=0.388 Sum_probs=181.9
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
.....+.+|.+++.||.|+||.||++.+. ++.||+|++........ ....|..|+.+|.+|+|||||+++++
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~------~~~~~~~EI~IL~~L~HPNIVrl~d~ 80 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKER------EKSQLVIEVNVMRELKHKNIVRYIDR 80 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHH------HHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence 34556689999999999999999999986 57899999976543322 24678899999999999999999998
Q ss_pred eec--CCeeEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-------CceecCCCCCcEEECC
Q 015556 251 CKK--PPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQ-------GVIHRDLKPENVLIDQ 319 (405)
Q Consensus 251 ~~~--~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~-------gIiHrDIkp~NILl~~ 319 (405)
|.+ ...+||||||+++|+|.++|... ....+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 854 46789999999999999999763 235799999999999999999999985 4999999999999954
Q ss_pred -----------------CCcEEEEecCCcccccccCCCCCCCCCCcccCcccccc--ccCCchhhHHHHHHHHHHHHhCC
Q 015556 320 -----------------EFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKH--KSYGRKVDVYSFGLILWEMVAGT 380 (405)
Q Consensus 320 -----------------~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DVwSlGvll~elltG~ 380 (405)
.+.+||+|||++.............||+.|+|||++.+ ..++.++||||||||||+|++|.
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 34589999999865543333445579999999999854 45789999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHh
Q 015556 381 IPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 381 ~Pf~~~~~~e~~~~i~~ 397 (405)
.||...+..+.+...+.
T Consensus 241 ~PF~~~~~~~qli~~lk 257 (1021)
T PTZ00266 241 TPFHKANNFSQLISELK 257 (1021)
T ss_pred CCCCcCCcHHHHHHHHh
Confidence 99988776666555544
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=291.10 Aligned_cols=224 Identities=23% Similarity=0.404 Sum_probs=194.9
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
....+.+++|.+++.||+|.||.|.+++.+ ++.+|+|+++..-.-...+ ...-..|-++|+..+||.+..|--
T Consensus 161 ~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdE-----VAHTlTE~RVL~~~~HPFLt~LKY 235 (516)
T KOG0690|consen 161 RKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDE-----VAHTLTENRVLQNCRHPFLTSLKY 235 (516)
T ss_pred ccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHH-----hhhhhhHHHHHHhccCcHHHHhhh
Confidence 456778889999999999999999999886 7999999998654333333 345568999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
.|+....+|+||||..||.|+-+|.+ ...++++.+..+..+|+.||.|||+++||+||||.+|.|+|.+|++||+|||
T Consensus 236 sFQt~drlCFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFG 313 (516)
T KOG0690|consen 236 SFQTQDRLCFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFG 313 (516)
T ss_pred hhccCceEEEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecc
Confidence 99999999999999999999988876 5789999999999999999999999999999999999999999999999999
Q ss_pred Cccc-ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhcccCC
Q 015556 330 IACE-EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV-VNKVNFG 402 (405)
Q Consensus 330 ~a~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i-~~~~~~~ 402 (405)
++.+ ..++......+||+.|+|||++....|+..+|.|.+||++|||+||++||.+-+......-| +....||
T Consensus 314 LCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP 388 (516)
T KOG0690|consen 314 LCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP 388 (516)
T ss_pred cchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC
Confidence 9976 45667778899999999999999999999999999999999999999999987665443322 3344444
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=280.71 Aligned_cols=215 Identities=29% Similarity=0.543 Sum_probs=183.1
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChh-HHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDEN-ETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~-~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
|.++..||.|++|.||+|.+. ++.||||.+........ ........+.+.+|+.++++++||||+++++++.+....
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 567889999999999999875 58999999876544332 222334467889999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+|||++.++.++|+|||.+......
T Consensus 82 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred EEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 999999999999999976 467889999999999999999999999999999999999999999999999988544311
Q ss_pred -------CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 338 -------DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 338 -------~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
.......|+..|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 226 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE 226 (267)
T ss_pred cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc
Confidence 111223578899999999888899999999999999999999999998887776666554
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=290.65 Aligned_cols=215 Identities=28% Similarity=0.506 Sum_probs=176.6
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC--Cc--cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeE
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DE--PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAA 250 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~--~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~ 250 (405)
+.+++|.+.+.||+|+||.||+|.+. +. .+|+|.+..... ......+.+|+.++.++ +|+||++++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~ 76 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-------KDDHRDFAGELEVLCKLGHHPNIINLLGA 76 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCC-------HHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 45678889999999999999999875 33 456666543221 11246788999999999 89999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEE
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NIL 316 (405)
+.....+++||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nil 156 (303)
T cd05088 77 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 156 (303)
T ss_pred ECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEE
Confidence 999999999999999999999997632 135789999999999999999999999999999999999
Q ss_pred ECCCCcEEEEecCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 015556 317 IDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV 395 (405)
Q Consensus 317 l~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i 395 (405)
++.++.+||+|||++.............++..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 157 VGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred ecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 99999999999999853221111122234678999999988889999999999999999998 99999887776655544
Q ss_pred Hh
Q 015556 396 VN 397 (405)
Q Consensus 396 ~~ 397 (405)
..
T Consensus 237 ~~ 238 (303)
T cd05088 237 PQ 238 (303)
T ss_pred hc
Confidence 33
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=286.03 Aligned_cols=218 Identities=27% Similarity=0.497 Sum_probs=181.4
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeE
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 246 (405)
|.++.++|.+.+.||+|+||.||+|..+ +..||||.+....... ....+.+|+.+++.++|+||++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~ 73 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-------ERIEFLNEASVMKGFTCHHVVR 73 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHH-------HHHHHHHHHHHHHhCCCCCeee
Confidence 6778899999999999999999999754 2479999876433211 1345778999999999999999
Q ss_pred EeeEeecCCeeEEEEeecCCCCHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEC
Q 015556 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318 (405)
Q Consensus 247 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~ 318 (405)
+++++.+....++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+|||++
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~ 153 (288)
T cd05061 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA 153 (288)
T ss_pred EEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc
Confidence 9999999999999999999999999997632 13356778899999999999999999999999999999999
Q ss_pred CCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 015556 319 QEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFA 394 (405)
Q Consensus 319 ~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~ 394 (405)
.++.++|+|||++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....
T Consensus 154 ~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~ 233 (288)
T cd05061 154 HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF 233 (288)
T ss_pred CCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999986432211 1122345678999999998889999999999999999999 8999998887776665
Q ss_pred HHhc
Q 015556 395 VVNK 398 (405)
Q Consensus 395 i~~~ 398 (405)
++.+
T Consensus 234 ~~~~ 237 (288)
T cd05061 234 VMDG 237 (288)
T ss_pred HHcC
Confidence 5544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=308.30 Aligned_cols=208 Identities=30% Similarity=0.456 Sum_probs=183.8
Q ss_pred ecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEE
Q 015556 183 LGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI 260 (405)
Q Consensus 183 ~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 260 (405)
-++.||+|+||-||.+.+. .+.||||.+.......++. ...+.+|+..|.+|+|||+|.+-|||......|||
T Consensus 30 dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EK-----WqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 30 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK-----WQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHhcCCccceeEEeeccCccceeeeeeccccccccHHH-----HHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 4567899999999999985 5899999998766554432 57788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCCC
Q 015556 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL 340 (405)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 340 (405)
||||- |+..|.|.- ..+++.+.++..|..+.+.||+|||+.+.||||||..|||+++.|.|||+|||.|.... .-
T Consensus 105 MEYCl-GSAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---PA 179 (948)
T KOG0577|consen 105 MEYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA---PA 179 (948)
T ss_pred HHHHh-ccHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC---ch
Confidence 99994 577777754 23688999999999999999999999999999999999999999999999999985443 33
Q ss_pred CCCCCCCcccCcccc---ccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 341 SDDPGTYRWMAPEMI---KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 341 ~~~~gt~~y~aPE~~---~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
..++||++|||||++ ..+.|+-++||||||++..||...++|+-+|+.+.+++.|..+..
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes 242 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 242 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC
Confidence 567899999999988 356799999999999999999999999999999999999987654
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=283.06 Aligned_cols=218 Identities=27% Similarity=0.521 Sum_probs=182.3
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
++..+|.+++.||+|+||.||+|.+. +..+|||.+....... ....+.+|+.++.+++||||++++++
T Consensus 1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~ 73 (267)
T cd05066 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK-------QRRDFLSEASIMGQFDHPNIIHLEGV 73 (267)
T ss_pred CCHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHH-------HHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 35578889999999999999999874 2368999886433211 14578899999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
+..+...|+||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+|||++.++.++|+|||+
T Consensus 74 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~ 152 (267)
T cd05066 74 VTKSKPVMIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGL 152 (267)
T ss_pred EecCCccEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCc
Confidence 99999999999999999999999763 35689999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC----CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccC
Q 015556 331 ACEEVYCDA----LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVNF 401 (405)
Q Consensus 331 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~~ 401 (405)
+........ .....++..|+|||++.+..++.++||||||+++|++++ |..||.+....+....+.+...+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd05066 153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL 228 (267)
T ss_pred ccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC
Confidence 864332111 112223568999999998889999999999999999887 99999998887777766665433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=296.98 Aligned_cols=209 Identities=25% Similarity=0.387 Sum_probs=176.4
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC-
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP- 254 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~- 254 (405)
.++|.+++.||.|+||.||+|.+. ++.||||.+....... .....+.+|+.++++++||||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL------IHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh------HHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 367889999999999999999875 5889999986432211 1245677899999999999999999987543
Q ss_pred -----CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 255 -----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 255 -----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
..+|++||++ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCc
Confidence 4578999988 7899888754 579999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 330 IACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 330 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
++..... ......||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.+.
T Consensus 164 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 231 (343)
T cd07878 164 LARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEV 231 (343)
T ss_pred cceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence 9865432 2344578999999999876 56899999999999999999999999988877777666543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=280.08 Aligned_cols=215 Identities=29% Similarity=0.537 Sum_probs=182.5
Q ss_pred CeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeE
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC 258 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 258 (405)
+|++++.||.|+||.||+|... ++.+|||.+........ ...+...++.+|++++++++|+||++++++|.+...++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVL--AAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchh--hHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEE
Confidence 4678899999999999999874 68899999876433221 12233567999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc--
Q 015556 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-- 336 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~-- 336 (405)
+||||+++++|.+++.+ ...+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 79 IFMEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 99999999999999976 35688999999999999999999999999999999999999999999999998854321
Q ss_pred -----cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 337 -----CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 337 -----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
........|+..|+|||++.+..++.++||||||+++|+|++|..||...+..+....+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~ 223 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH 223 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhc
Confidence 11223446899999999999888999999999999999999999999988877666555443
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=316.60 Aligned_cols=207 Identities=24% Similarity=0.416 Sum_probs=174.6
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC-C-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeE-
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK-D-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAA- 250 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~-~-~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~- 250 (405)
+|...++++.+.|++|||+.||++.+. + ..||+|++...+. ...+.+.+||++|++|. |+|||.+++.
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de--------~~L~~v~~EI~~MK~L~gh~nIV~yidss 104 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDE--------EALNAVKREIDIMKLLSGHKNIVSYIDSS 104 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCH--------HHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence 445566778899999999999999986 3 8999999987632 12567889999999997 9999999993
Q ss_pred eec----C--CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEECCCCc
Q 015556 251 CKK----P--PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLIDQEFH 322 (405)
Q Consensus 251 ~~~----~--~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IiHrDIkp~NILl~~~~~ 322 (405)
... . -.++|.||||.||.|-+++..+....|++.++++|+.|+++|+.+||..+ |||||||-|||||+.++.
T Consensus 105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~ 184 (738)
T KOG1989|consen 105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN 184 (738)
T ss_pred cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC
Confidence 221 1 35789999999999999999877777999999999999999999999998 999999999999999999
Q ss_pred EEEEecCCcccccccCCCC----------CCCCCCcccCcccc---ccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 015556 323 LKIADFGIACEEVYCDALS----------DDPGTYRWMAPEMI---KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI 389 (405)
Q Consensus 323 vkL~DFG~a~~~~~~~~~~----------~~~gt~~y~aPE~~---~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~ 389 (405)
+||||||.|.......... ...-|+.|.|||++ .+.+.++|+|||+|||+||-|+....||++..+.
T Consensus 185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l 264 (738)
T KOG1989|consen 185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL 264 (738)
T ss_pred EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce
Confidence 9999999986433222111 11268999999987 6778899999999999999999999999987443
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=285.81 Aligned_cols=216 Identities=28% Similarity=0.517 Sum_probs=182.6
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 248 (405)
+...+|.+.+.||+|+||.||++... +..+|||.+..... .....+.+|++++++++|+||++++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD--------NARKDFHREAELLTNLQHEHIVKFY 73 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH--------HHHHHHHHHHHHHHhCCCCCcceEE
Confidence 34567889999999999999999852 24688898864321 1246788999999999999999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLE-----------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl 317 (405)
+++.....+++||||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+|||+
T Consensus 74 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili 153 (288)
T cd05093 74 GVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV 153 (288)
T ss_pred EEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE
Confidence 99999999999999999999999997532 1348999999999999999999999999999999999999
Q ss_pred CCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 015556 318 DQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAF 393 (405)
Q Consensus 318 ~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~ 393 (405)
++++.++|+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......+...
T Consensus 154 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~ 233 (288)
T cd05093 154 GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233 (288)
T ss_pred ccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999986432211 1223345778999999998889999999999999999998 999999988888777
Q ss_pred HHHhcc
Q 015556 394 AVVNKV 399 (405)
Q Consensus 394 ~i~~~~ 399 (405)
.+.++.
T Consensus 234 ~i~~~~ 239 (288)
T cd05093 234 CITQGR 239 (288)
T ss_pred HHHcCC
Confidence 777654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=287.53 Aligned_cols=218 Identities=27% Similarity=0.495 Sum_probs=183.8
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 248 (405)
+++.+|.+.+.||.|+||.||+|.+. ++.||||++...... .....+..|+.++..++||||++++
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~~~~l~h~~iv~~~ 74 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG-------PLREEFKHEAMMRSRLQHPNIVCLL 74 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH-------HHHHHHHHHHHHHhcCCCCCcCeEE
Confidence 56678889999999999999999864 368999998743321 1246788999999999999999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~N 314 (405)
+++......++++||+.+++|.+++.... ...+++..++.++.|++.||.|||++||+||||||.|
T Consensus 75 ~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~N 154 (283)
T cd05091 75 GVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRN 154 (283)
T ss_pred EEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhh
Confidence 99999999999999999999999986321 2347888899999999999999999999999999999
Q ss_pred EEECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 015556 315 VLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQ 390 (405)
Q Consensus 315 ILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e 390 (405)
||+++++.+||+|||++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+
T Consensus 155 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 234 (283)
T cd05091 155 VLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 234 (283)
T ss_pred eEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999999999976432221 1223446788999999988889999999999999999998 999999988887
Q ss_pred HHHHHHhccc
Q 015556 391 AAFAVVNKVN 400 (405)
Q Consensus 391 ~~~~i~~~~~ 400 (405)
....+.++..
T Consensus 235 ~~~~i~~~~~ 244 (283)
T cd05091 235 VIEMIRNRQV 244 (283)
T ss_pred HHHHHHcCCc
Confidence 7777766553
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=287.86 Aligned_cols=220 Identities=29% Similarity=0.517 Sum_probs=183.6
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEEC---------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CC
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK---------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HN 241 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~---------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~H 241 (405)
..|.+...+|.+++.||+|+||.||++.+. +..||||.+...... .....+.+|+.+++.+ +|
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~~~E~~~l~~l~~h 80 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE-------KDLSDLVSEMEMMKMIGKH 80 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch-------HHHHHHHHHHHHHHhhccC
Confidence 467788899999999999999999999752 246999988633211 1145788999999999 79
Q ss_pred CCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 015556 242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVIH 307 (405)
Q Consensus 242 pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiH 307 (405)
|||+++++++......++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+|
T Consensus 81 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH 160 (304)
T cd05101 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIH 160 (304)
T ss_pred CCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 999999999999999999999999999999998642 135778889999999999999999999999
Q ss_pred cCCCCCcEEECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCC
Q 015556 308 RDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPY 383 (405)
Q Consensus 308 rDIkp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf 383 (405)
|||||+|||++.++.+||+|||++....... ......++..|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 161 ~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 240 (304)
T cd05101 161 RDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240 (304)
T ss_pred cccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 9999999999999999999999986432211 1223345678999999988889999999999999999998 89999
Q ss_pred CCCCHHHHHHHHHhc
Q 015556 384 EEMNPIQAAFAVVNK 398 (405)
Q Consensus 384 ~~~~~~e~~~~i~~~ 398 (405)
......+....+.+.
T Consensus 241 ~~~~~~~~~~~~~~~ 255 (304)
T cd05101 241 PGIPVEELFKLLKEG 255 (304)
T ss_pred ccCCHHHHHHHHHcC
Confidence 988777666555443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=283.22 Aligned_cols=213 Identities=34% Similarity=0.587 Sum_probs=184.3
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
..+|.+++.||.|+||.||+|.+. ++.+|+|++....... ..++..|+.+++.++|+||+++++++.+...
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~--------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 76 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK--------QQDFQKEVQALKRLRHKHLISLFAVCSVGEP 76 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhh--------HHHHHHHHHHHhcCCCcchhheeeeEecCCC
Confidence 457889999999999999999987 5899999987543211 3467899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||+|+|||+++++.+||+|||.+.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999999999999876667789999999999999999999999999999999999999999999999999854322
Q ss_pred cC-CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 337 CD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 337 ~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
.. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.++
T Consensus 157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05148 157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG 220 (261)
T ss_pred ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC
Confidence 11 1123346678999999988889999999999999999998 89999998887777766654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=277.16 Aligned_cols=213 Identities=22% Similarity=0.336 Sum_probs=184.7
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+.+.||.|+||.||.+... ++.+++|.+........ ..+++.+|++++++++|+||+++++++.+...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 74 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK------ERRDALNEIVILSLLQHPNIIAYYNHFMDDNTL 74 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchh------HHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeE
Confidence 4778899999999988888764 68999999876543332 145678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
++||||+++++|.+++.......+++..+..++.|++.+|.|||+.|++|+||+|+||++++++.+||+|||++......
T Consensus 75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999999999998754567899999999999999999999999999999999999999999999999998654332
Q ss_pred C-CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 338 D-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 338 ~-~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
. ......++..|+|||++.+..++.++||||||+++|+|++|..||....+.+....+..+
T Consensus 155 ~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~ 216 (256)
T cd08221 155 YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG 216 (256)
T ss_pred cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC
Confidence 2 223456899999999998888899999999999999999999999998888777776654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=288.99 Aligned_cols=221 Identities=29% Similarity=0.515 Sum_probs=184.0
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEEC---------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-C
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK---------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-H 240 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~---------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~ 240 (405)
..+|.+..++|.+++.||+|+||.||++... ...||+|++....... ....+.+|+.+++++ +
T Consensus 4 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~E~~~l~~l~~ 76 (314)
T cd05099 4 DPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDK-------DLADLISEMELMKLIGK 76 (314)
T ss_pred cccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChH-------HHHHHHHHHHHHHhccC
Confidence 3567888899999999999999999999752 3469999987433221 145678999999999 5
Q ss_pred CCCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 015556 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVI 306 (405)
Q Consensus 241 HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIi 306 (405)
||||++++++|.+...+++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+
T Consensus 77 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~ 156 (314)
T cd05099 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCI 156 (314)
T ss_pred CCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 9999999999999999999999999999999997632 23588899999999999999999999999
Q ss_pred ecCCCCCcEEECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCC
Q 015556 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIP 382 (405)
Q Consensus 307 HrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~P 382 (405)
||||||+|||++.++.+||+|||++....... ......++..|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 157 H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p 236 (314)
T cd05099 157 HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236 (314)
T ss_pred eccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999986432211 1122234567999999988889999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHhc
Q 015556 383 YEEMNPIQAAFAVVNK 398 (405)
Q Consensus 383 f~~~~~~e~~~~i~~~ 398 (405)
|......+....+..+
T Consensus 237 ~~~~~~~~~~~~~~~~ 252 (314)
T cd05099 237 YPGIPVEELFKLLREG 252 (314)
T ss_pred CCCCCHHHHHHHHHcC
Confidence 9988776666655544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=286.48 Aligned_cols=211 Identities=26% Similarity=0.464 Sum_probs=178.4
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
+++|.+.+.||.|+||.||+|.+. ++.||+|.+........ ...+.+|+.+++.++|+||+++++++....
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~ 77 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA-------PCTAIREVSLLKDLKHANIVTLHDIIHTEK 77 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc-------hhHHHHHHHHHHhcCCCCcceEEEEEecCC
Confidence 567899999999999999999885 68999999975443321 234568999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+++||||+. ++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 78 SLTLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred eEEEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 9999999996 5999988763 3568899999999999999999999999999999999999999999999999985432
Q ss_pred cc-CCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 336 YC-DALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 336 ~~-~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
.. .......++..|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+..
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~ 219 (301)
T cd07873 156 IPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFR 219 (301)
T ss_pred CCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 21 222344578999999988654 578899999999999999999999998887666555443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=287.65 Aligned_cols=219 Identities=28% Similarity=0.488 Sum_probs=185.0
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCC
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPN 243 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~Hpn 243 (405)
..|.+..++|.+++.||+|+||.||++.+. +..||||+++...... ....+.+|+.+++++ +|+|
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~~h~~ 100 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS-------EREALMSELKIMSHLGNHEN 100 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChH-------HHHHHHHHHHHHHhccCCCC
Confidence 456777789999999999999999999752 3479999987543221 145688999999999 7999
Q ss_pred eeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcE
Q 015556 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323 (405)
Q Consensus 244 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~v 323 (405)
|+++++++...+..++||||+++|+|.+++.......+++..++.++.|++.||.|||+++|+|+||||+|||++.++.+
T Consensus 101 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~ 180 (302)
T cd05055 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIV 180 (302)
T ss_pred cceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeE
Confidence 99999999999999999999999999999987544558999999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015556 324 KIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 324 kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~ 397 (405)
+|+|||++....... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+...+.+.
T Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~ 258 (302)
T cd05055 181 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK 258 (302)
T ss_pred EECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH
Confidence 999999986432211 1112345778999999998889999999999999999998 9999998877666555544
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=279.44 Aligned_cols=215 Identities=29% Similarity=0.489 Sum_probs=180.9
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
|.+..++|.+.+.||.|++|.||++.+.+ ..+|+|.+...... ...+.+|+.++++++|+|++++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~ 71 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM---------PEAFLQEAQIMKKLRHDKLVPLYAVVS 71 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc---------HHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 44566788999999999999999999864 57999987643321 345778999999999999999999886
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
. ...++||||+.+++|.+++.......+++..+..++.|++.||.|||+.||+|+||+|+||++++++.++|+|||++.
T Consensus 72 ~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~ 150 (260)
T cd05069 72 E-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR 150 (260)
T ss_pred C-CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccce
Confidence 5 457899999999999999987555668999999999999999999999999999999999999999999999999985
Q ss_pred cccccC--CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 333 EEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 333 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05069 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG 219 (260)
T ss_pred EccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 432221 1122346678999999988889999999999999999999 99999998877766665544
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=298.96 Aligned_cols=212 Identities=23% Similarity=0.373 Sum_probs=188.9
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
-+.+..+.|..-+.||+||||.||-+.. +|+-||+|.+....... ..-+.....|..||.+++.+.||.+--+
T Consensus 179 ~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk-----r~ge~maLnEk~iL~kV~s~FiVslaYA 253 (591)
T KOG0986|consen 179 LQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK-----RKGETMALNEKQILEKVSSPFIVSLAYA 253 (591)
T ss_pred hhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH-----hhhhHHhhHHHHHHHHhccCcEEEEeee
Confidence 3556667777888999999999998765 48999999875322111 1124566789999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
|+....+||||..|.||+|.-+|.+..+..+++..++.++.+|+.||++||.++||+||+||+|||+|+.|+++|+|+|+
T Consensus 254 feTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGL 333 (591)
T KOG0986|consen 254 FETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGL 333 (591)
T ss_pred ecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccce
Confidence 99999999999999999999999887778999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI 389 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~ 389 (405)
|.....+......+||.+|||||++.++.|+...|.|+|||+||||+.|+.||......
T Consensus 334 Avei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK 392 (591)
T KOG0986|consen 334 AVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK 392 (591)
T ss_pred EEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh
Confidence 99998888888889999999999999999999999999999999999999999875443
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=279.75 Aligned_cols=215 Identities=31% Similarity=0.508 Sum_probs=182.0
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
|.+..++|.++++||+|+||.||+|... ++.||||.+...... ..++.+|+.++++++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~ 71 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---------PEAFLAEANLMKQLQHPRLVRLYAVVT 71 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---------HHHHHHHHHHHHhcCCcCeeeEEEEEc
Confidence 4566678999999999999999999985 589999998743322 246788999999999999999999875
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
+ ..+++||||+.+++|.+++.......+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.
T Consensus 72 ~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 150 (260)
T cd05067 72 Q-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR 150 (260)
T ss_pred c-CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCccee
Confidence 4 467899999999999999987666678999999999999999999999999999999999999999999999999985
Q ss_pred cccccCC--CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 333 EEVYCDA--LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 333 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
....... .....++..|+|||++....++.++||||||+++|||++ |+.||.+.+..+....+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05067 151 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG 219 (260)
T ss_pred ecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Confidence 4332111 122345678999999988889999999999999999999 99999988877666555443
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=303.90 Aligned_cols=210 Identities=29% Similarity=0.495 Sum_probs=188.4
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
....|.+.+.||.|.|+.|.+++.. +..||||++.....+.. ....+.+|+++|+.|+|||||+++.+....
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~------~~~k~~rev~imk~l~HPnIvkl~~v~~t~ 127 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS------KRQKLGREVDIMKSLNHPNIVKLFSVIETE 127 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH------HHHHHHHHHHHHHhcCCcceeeeeeeeeec
Confidence 3467888999999999999999875 78999999975544322 234489999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
..+|+||||+.+|.+++||.+ ++...+..+..++.|++.|++|||+++|+|||||++||||+.+..+||+|||++...
T Consensus 128 ~~lylV~eya~~ge~~~yl~~--~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVK--HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred ceeEEEEEeccCchhHHHHHh--cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceee
Confidence 999999999999999999998 556666889999999999999999999999999999999999999999999999988
Q ss_pred cccCCCCCCCCCCcccCccccccccC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015556 335 VYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFA 394 (405)
Q Consensus 335 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~ 394 (405)
.........+|++.|.|||++.+..| ++++|+||+|++||-|++|.+||++.+-.+.-.+
T Consensus 206 ~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r 266 (596)
T KOG0586|consen 206 DYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR 266 (596)
T ss_pred cccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch
Confidence 88888999999999999999999988 7899999999999999999999998765554433
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=282.54 Aligned_cols=211 Identities=28% Similarity=0.441 Sum_probs=177.5
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+.+.||+|++|.||+|... ++.||||.+......+. ..+.+.+|+.++.+++||||+++++++.++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEG------VPSTAIREISLLKELQHPNIVCLQDVLMQESRL 74 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCC------chHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeE
Confidence 4778899999999999999985 68999999876433221 135677899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLE-HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
|+||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||+|+|||++.++.++|+|||++.....
T Consensus 75 ~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 153 (285)
T cd07861 75 YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153 (285)
T ss_pred EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence 99999997 68999887643 35789999999999999999999999999999999999999999999999999854322
Q ss_pred -cCCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 337 -CDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 337 -~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
........++..|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~ 216 (285)
T cd07861 154 PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFR 216 (285)
T ss_pred CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 1222334578899999988654 468999999999999999999999998877766665543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=281.88 Aligned_cols=211 Identities=22% Similarity=0.387 Sum_probs=179.4
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+...||+|++|.||+|.+. ++.||+|++........ ..+.+.+|+.++++++|+||+++++++..+..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 74 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV------IKKIALREIRMLKQLKHPNLVNLIEVFRRKRK 74 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCcc------ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE
Confidence 36788899999999999999986 68999999875432221 13567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+++||||++++.|..++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 75 LHLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred EEEEEeccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 9999999999888877654 35689999999999999999999999999999999999999999999999999865433
Q ss_pred cC-CCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 337 CD-ALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 337 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
.. ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+.+
T Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~ 215 (286)
T cd07847 153 PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRK 215 (286)
T ss_pred CcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 22 2234457889999999876 4578999999999999999999999999888777666543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=280.02 Aligned_cols=213 Identities=27% Similarity=0.485 Sum_probs=177.1
Q ss_pred eeecceeeeeeeEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~-----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
|.+++.||+|+||.||+|... +..||||.+........ ....+.+|+.+++.++|+||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS------EIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHH------HHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 457889999999999999874 26799999875433322 1457889999999999999999999886654
Q ss_pred e------eEEEEeecCCCCHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEE
Q 015556 256 V------YCVITEYLSEGSLRAYLHKLE----HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI 325 (405)
Q Consensus 256 ~------~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL 325 (405)
. .++||||+++++|..++.... ...+++..++.++.|++.||.|||+++|+||||||+||++++++.+||
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl 154 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCV 154 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEE
Confidence 4 799999999999999986532 236889999999999999999999999999999999999999999999
Q ss_pred EecCCcccccccCC---CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 326 ADFGIACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 326 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
+|||++........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+.++.
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 232 (273)
T cd05035 155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN 232 (273)
T ss_pred CCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999865432221 112235678999999988889999999999999999999 999999988877776666543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=286.48 Aligned_cols=213 Identities=24% Similarity=0.385 Sum_probs=184.3
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+.+.||+|++|.||++... ++.||||.+........ ...+.+..|++++..++|+||+++++.+.+....
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKR-----NKVKRVLTEQEILATLDHPFLPTLYASFQTETYL 76 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchH-----HHHHHHHHHHHHHHhCCCCCchhheeeeecCCEE
Confidence 6788899999999999999985 58999999986543321 1256788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
|+||||+.+++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999999999998755567999999999999999999999999999999999999999999999999987532211
Q ss_pred C------------------------------CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 338 D------------------------------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 338 ~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
. ......|+..|+|||++.+..++.++||||||+++|+|++|..||.+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1 1112357889999999998889999999999999999999999999888
Q ss_pred HHHHHHHHHh
Q 015556 388 PIQAAFAVVN 397 (405)
Q Consensus 388 ~~e~~~~i~~ 397 (405)
..+....+..
T Consensus 237 ~~~~~~~~~~ 246 (316)
T cd05574 237 RDETFSNILK 246 (316)
T ss_pred hHHHHHHHhc
Confidence 8777766654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=277.46 Aligned_cols=205 Identities=30% Similarity=0.556 Sum_probs=171.6
Q ss_pred ceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEe
Q 015556 185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 262 (405)
+.||+|+||.||+|.+. ++.||||.+...... .....+.+|++++++++||||++++++|.....+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 73 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP-------DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 73 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCH-------HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEe
Confidence 36899999999999884 788999988643221 124678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCCC--
Q 015556 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL-- 340 (405)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~~-- 340 (405)
|+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 74 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 74 LVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred eccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 99999999999752 346889999999999999999999999999999999999999999999999998543221111
Q ss_pred -CCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015556 341 -SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 341 -~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~ 397 (405)
....++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+.+
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~ 211 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ 211 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc
Confidence 11123456999999988889999999999999999998 9999988877665555544
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=281.02 Aligned_cols=207 Identities=25% Similarity=0.427 Sum_probs=176.3
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.++|.+++.||+|+||.||+|... ++.||||++....... ...+.+|+.++++++||||+++++++....
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~--------~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~ 79 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD--------FSLIQQEIFMVKECKHCNIVAYFGSYLSRE 79 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch--------HHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Confidence 357889999999999999999974 6889999997543221 245778999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 80 KLWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred EEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 99999999999999999875 3578999999999999999999999999999999999999999999999999986543
Q ss_pred cc-CCCCCCCCCCcccCccccc---cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015556 336 YC-DALSDDPGTYRWMAPEMIK---HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFA 394 (405)
Q Consensus 336 ~~-~~~~~~~gt~~y~aPE~~~---~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~ 394 (405)
.. .......|+..|+|||.+. ...++.++|||||||++|||++|..||....+.+....
T Consensus 158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~ 220 (267)
T cd06646 158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL 220 (267)
T ss_pred ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee
Confidence 21 1223446889999999884 34578899999999999999999999987766554443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=276.74 Aligned_cols=211 Identities=25% Similarity=0.450 Sum_probs=182.7
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||.|++|.||++... ++.+|+|++...... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 74 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--------DFEIIQQEISMLKECRHPNIVAYFGSYLRRDK 74 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--------hHHHHHHHHHHHHhCCCCChhceEEEEEeCCE
Confidence 57888999999999999999985 588999999865432 14678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+|++|||+.+++|.+++... ...+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++.....
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 99999999999999998763 25789999999999999999999999999999999999999999999999999865332
Q ss_pred cC-CCCCCCCCCcccCccccccc---cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 337 CD-ALSDDPGTYRWMAPEMIKHK---SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 337 ~~-~~~~~~gt~~y~aPE~~~~~---~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.. ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...++.+....+...
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~ 219 (262)
T cd06613 154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS 219 (262)
T ss_pred hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 21 22345688899999999776 7899999999999999999999999988877766655443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=290.65 Aligned_cols=221 Identities=30% Similarity=0.529 Sum_probs=184.5
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEECC---------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-C
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD---------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-H 240 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~---------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~ 240 (405)
.++|.+...+|.+++.||+|+||.||++.+.+ ..||+|.+....... ..+.+.+|+.++.++ +
T Consensus 4 ~~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~~ 76 (334)
T cd05100 4 DPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK-------DLSDLVSEMEMMKMIGK 76 (334)
T ss_pred CcccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHH-------HHHHHHHHHHHHHhhcC
Confidence 36788888999999999999999999997531 368999886432211 246788999999999 7
Q ss_pred CCCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 015556 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVI 306 (405)
Q Consensus 241 HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIi 306 (405)
|+||++++++|.+...+++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++||+
T Consensus 77 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~giv 156 (334)
T cd05100 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCI 156 (334)
T ss_pred CCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 9999999999999999999999999999999997632 23478889999999999999999999999
Q ss_pred ecCCCCCcEEECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCC
Q 015556 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIP 382 (405)
Q Consensus 307 HrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~P 382 (405)
||||||+|||++.++.+||+|||++....... ......++..|+|||++.+..++.++||||||+++|||++ |..|
T Consensus 157 H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 236 (334)
T cd05100 157 HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236 (334)
T ss_pred ccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCC
Confidence 99999999999999999999999986433211 1122334567999999998899999999999999999998 8999
Q ss_pred CCCCCHHHHHHHHHhc
Q 015556 383 YEEMNPIQAAFAVVNK 398 (405)
Q Consensus 383 f~~~~~~e~~~~i~~~ 398 (405)
|...+..+....+.++
T Consensus 237 ~~~~~~~~~~~~~~~~ 252 (334)
T cd05100 237 YPGIPVEELFKLLKEG 252 (334)
T ss_pred CCCCCHHHHHHHHHcC
Confidence 9988877766655544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=282.42 Aligned_cols=211 Identities=25% Similarity=0.461 Sum_probs=173.3
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC--Cc----cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DE----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~----~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
+..++|.+++.||+|+||.||+|.+. ++ .|++|.+..... ......+..|+.++.+++||||+++++
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~~~~~l~~l~h~~iv~~~~ 76 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG-------RQTFQEITDHMLAMGSLDHAYIVRLLG 76 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc-------hHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 34567888999999999999999984 44 467777643211 122456778999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
++.. ...++|+||+++|+|.+++... ...+++..++.++.||+.||.|||+++++||||||+|||+++++.+||+|||
T Consensus 77 ~~~~-~~~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg 154 (279)
T cd05111 77 ICPG-ASLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFG 154 (279)
T ss_pred EECC-CccEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCc
Confidence 8864 4567899999999999999763 3578999999999999999999999999999999999999999999999999
Q ss_pred CcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 015556 330 IACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV 395 (405)
Q Consensus 330 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i 395 (405)
++....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+..+.+....+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~ 224 (279)
T cd05111 155 VADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224 (279)
T ss_pred cceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 986432221 1223456788999999988889999999999999999998 99999988776544333
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=292.60 Aligned_cols=204 Identities=26% Similarity=0.487 Sum_probs=182.4
Q ss_pred eecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEE
Q 015556 182 FLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV 259 (405)
Q Consensus 182 ~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 259 (405)
.+.++||+|+||.||+++++ |+.+|||..-...+ ..++.+|+.||+++..|+||++||.|.....+|+
T Consensus 36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD----------LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD----------LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred HHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch----------HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence 37889999999999999886 79999998865332 4567899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc-C
Q 015556 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-D 338 (405)
Q Consensus 260 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~-~ 338 (405)
|||||.-|++.+.++. +++++++.++..++...+.||+|||...-||||||..|||++.+|..||+|||.|...... .
T Consensus 106 VMEYCGAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred ehhhcCCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 9999999999998875 5689999999999999999999999999999999999999999999999999999654332 2
Q ss_pred CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015556 339 ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 339 ~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~ 396 (405)
......||+.|||||++..-.|+.++||||||++..||..|++||.+..|+.++|-|-
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP 242 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP 242 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc
Confidence 3345669999999999999999999999999999999999999999999987776543
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=275.43 Aligned_cols=213 Identities=22% Similarity=0.379 Sum_probs=181.6
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec-CCe
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK-PPV 256 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~ 256 (405)
.|.+++.||.|++|.||++... ++.||||.+........ ..+.+.+|++++++++|+|++++++.+.. ...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRR------ERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGL 74 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHH------HHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCE
Confidence 4788999999999999999875 58899999975433222 24567899999999999999999998764 456
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+++||||+++++|.+++.......+++..++.++.+++.||.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 75 ~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred EEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 89999999999999999875556789999999999999999999999999999999999999999999999999854322
Q ss_pred c-CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 337 C-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 337 ~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
. .......+++.|+|||++.+..++.++||||||+++|+|++|..||...+..+..+.+..+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~ 217 (257)
T cd08223 155 QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG 217 (257)
T ss_pred cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc
Confidence 1 2223446889999999999888999999999999999999999999988877766666554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=280.42 Aligned_cols=214 Identities=25% Similarity=0.489 Sum_probs=179.2
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--C---ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--D---EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~---~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
+.++|.+.+.||+|+||.||+|.+. + ..||||++...... .....|..|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~ni~~~~~~~ 74 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE-------KQRRDFLSEASIMGQFDHPNIIHLEGVV 74 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCH-------HHHHHHHHHHHHHHhCCCcCcceEEEEE
Confidence 5577889999999999999999875 2 35999998643221 1246788999999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
.++..+++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+|||++.++.++|+|||++
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~ 153 (269)
T cd05065 75 TKSRPVMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS 153 (269)
T ss_pred CCCCceEEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccc
Confidence 9999999999999999999999763 356899999999999999999999999999999999999999999999999987
Q ss_pred ccccccCC---CCCCC---CCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 332 CEEVYCDA---LSDDP---GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 332 ~~~~~~~~---~~~~~---gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
........ ..... .+..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~ 227 (269)
T cd05065 154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD 227 (269)
T ss_pred cccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence 54322111 11111 2457999999998899999999999999999987 99999988877766666443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=275.18 Aligned_cols=219 Identities=25% Similarity=0.429 Sum_probs=190.3
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEE
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKF 247 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l 247 (405)
.+....|++++.++..||.|.-|.|++++.. |...|||.+...+..++ .+++.+.+.++...+ .|+||+.
T Consensus 84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee-------~kRILmDldvv~~s~dcpyIV~c 156 (391)
T KOG0983|consen 84 GQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE-------NKRILMDLDVVLKSHDCPYIVQC 156 (391)
T ss_pred CcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH-------HHHHHHhhhHHhhccCCCeeeee
Confidence 4567788899999999999999999999986 59999999986654433 467788888877775 8999999
Q ss_pred eeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEECCCCcEEEE
Q 015556 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIA 326 (405)
Q Consensus 248 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDIkp~NILl~~~~~vkL~ 326 (405)
+|+|..+...++.||.|. ..+..++.. ..+++++..+-++...++.||.||-+ +||||||+||+|||+|+.|++|||
T Consensus 157 ~GyFi~n~dV~IcMelMs-~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlC 234 (391)
T KOG0983|consen 157 FGYFITNTDVFICMELMS-TCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLC 234 (391)
T ss_pred eeEEeeCchHHHHHHHHH-HHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEee
Confidence 999999999999999984 356666655 45679999999999999999999975 589999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCCcccCcccccc---ccCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhc
Q 015556 327 DFGIACEEVYCDALSDDPGTYRWMAPEMIKH---KSYGRKVDVYSFGLILWEMVAGTIPYEEMN-PIQAAFAVVNK 398 (405)
Q Consensus 327 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DVwSlGvll~elltG~~Pf~~~~-~~e~~~~i~~~ 398 (405)
|||++.+.......+...|.+.|||||.+.- ..|+.++||||||+.|+||.||+.||.+.+ ..+.+-+|++.
T Consensus 235 DFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ 310 (391)
T KOG0983|consen 235 DFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE 310 (391)
T ss_pred cccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc
Confidence 9999999888888888999999999999853 468999999999999999999999999854 56777777774
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=289.28 Aligned_cols=209 Identities=20% Similarity=0.372 Sum_probs=173.3
Q ss_pred ecceeeee--eeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeE
Q 015556 183 LGLRFAHG--AHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC 258 (405)
Q Consensus 183 ~~~~lG~G--~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 258 (405)
+++.||+| +|++||++... ++.||||.+........ ....+.+|+.+++.++||||++++++|..+...+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 75 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNE------MVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 75 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHH------HHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEE
Confidence 45678999 78999999885 68999999975443221 2456778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc-
Q 015556 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC- 337 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~- 337 (405)
+||||+++|+|.+++.......+++..++.++.|++.||.|||+++|+||||||+|||++.++.++++||+........
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999999999999997655566899999999999999999999999999999999999999999999999865322110
Q ss_pred -------CCCCCCCCCCcccCcccccc--ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 338 -------DALSDDPGTYRWMAPEMIKH--KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 338 -------~~~~~~~gt~~y~aPE~~~~--~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
.......++..|+|||++.+ ..++.++|||||||++|||++|..||......+......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 224 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 224 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc
Confidence 01122346778999999975 4589999999999999999999999998776665544443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=280.37 Aligned_cols=207 Identities=26% Similarity=0.475 Sum_probs=168.9
Q ss_pred eeeeeeeEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEE
Q 015556 186 RFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261 (405)
Q Consensus 186 ~lG~G~~g~Vy~~~~~----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 261 (405)
.||+|+||.||+|... ...+|||.+....... ....+.+|+.+++.++|+||+++++.|.+...+++||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~ 74 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPD-------EQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVL 74 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChH-------HHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEE
Confidence 5799999999999753 2467888765433211 2456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccC
Q 015556 262 EYLSEGSLRAYLHKLEH---KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338 (405)
Q Consensus 262 E~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~ 338 (405)
||+++|+|.+++..... ...++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence 99999999999986432 335677889999999999999999999999999999999999999999999985422211
Q ss_pred ---CCCCCCCCCcccCcccccc-------ccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 339 ---ALSDDPGTYRWMAPEMIKH-------KSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 339 ---~~~~~~gt~~y~aPE~~~~-------~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
......++..|+|||++.. ..++.++|||||||++|||++ |..||....+.+....++...
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 226 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ 226 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhcc
Confidence 1123346778999998742 356889999999999999999 899999988877777666544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=277.85 Aligned_cols=215 Identities=32% Similarity=0.510 Sum_probs=182.6
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
|++..++|.+.++||+|+||.||++.+. +..+|||.+..... ....+.+|+.+++.++|+||+++++.+.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---------SVEAFLAEANVMKTLQHDKLVKLHAVVT 71 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh---------HHHHHHHHHHHHHhcCCCCcceEEEEEc
Confidence 6677889999999999999999999875 46799998863211 1356889999999999999999999988
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
+ ..+++||||+++++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+.
T Consensus 72 ~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 150 (260)
T cd05073 72 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR 150 (260)
T ss_pred C-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCccee
Confidence 7 678999999999999999987656678899999999999999999999999999999999999999999999999885
Q ss_pred cccccC--CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 333 EEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 333 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
...... ......++..|+|||++....++.++|+|||||++|+|++ |..||...+..+....+.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05073 151 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 219 (260)
T ss_pred eccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Confidence 432211 1122335677999999988889999999999999999999 99999988776666555443
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=277.27 Aligned_cols=204 Identities=26% Similarity=0.557 Sum_probs=171.2
Q ss_pred eeeeeeeEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEE
Q 015556 186 RFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261 (405)
Q Consensus 186 ~lG~G~~g~Vy~~~~~----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 261 (405)
.||+|+||.||+|.+. ++.+|||++....... ...+++..|+.+++.+.|+||+++++++.. ..+++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 74 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP------ALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVM 74 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcH------HHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEE
Confidence 5799999999999763 5789999987544322 235778899999999999999999999864 4668999
Q ss_pred eecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCC--
Q 015556 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA-- 339 (405)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~-- 339 (405)
||+++++|.+++.. ...+++..++.++.|++.||+|||++||+||||||.|||++.++.+||+|||++........
T Consensus 75 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 75 ELAELGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred ecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 99999999999976 35789999999999999999999999999999999999999999999999999864332211
Q ss_pred --CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 340 --LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 340 --~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
.....++..|+|||.+....++.++|||||||++|||++ |..||......+....+.++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~ 214 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG 214 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC
Confidence 122334678999999988888999999999999999998 99999988877666655543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=280.55 Aligned_cols=209 Identities=23% Similarity=0.440 Sum_probs=178.1
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.++|.+.+.||+|+||.||+|.+. ++.||||+++...... ...+.+|+.+++.++||||+++++.+....
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--------~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED--------FAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhH--------HHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 357788899999999999999885 6899999997543221 245678999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+++||||+++++|.+++.. .+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred EEEEEEeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 99999999999999999876 4578999999999999999999999999999999999999999999999999985432
Q ss_pred cc-CCCCCCCCCCcccCccccc---cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015556 336 YC-DALSDDPGTYRWMAPEMIK---HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 336 ~~-~~~~~~~gt~~y~aPE~~~---~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~ 396 (405)
.. .......|+..|+|||++. ...++.++|||||||++|+|++|..||....+........
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~ 222 (267)
T cd06645 158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT 222 (267)
T ss_pred CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh
Confidence 21 1223446899999999874 4567899999999999999999999998777666555443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=283.94 Aligned_cols=213 Identities=30% Similarity=0.533 Sum_probs=179.6
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
..+|.+.+.||+|+||.||+|... +..+++|.+..... ...+.+.+|++++++++|+||++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 75 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--------AARKDFQREAELLTNLQHEHIVKFYGV 75 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH--------HHHHHHHHHHHHHhcCCCCCcceEEEE
Confidence 457888899999999999999853 24688888763221 124678899999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEE
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NIL 316 (405)
+......++||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 155 (291)
T cd05094 76 CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 155 (291)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEE
Confidence 999999999999999999999997632 234789999999999999999999999999999999999
Q ss_pred ECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 015556 317 IDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAA 392 (405)
Q Consensus 317 l~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~ 392 (405)
++.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||...++.+..
T Consensus 156 ~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 235 (291)
T cd05094 156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 235 (291)
T ss_pred EccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999986432211 1233456788999999998889999999999999999999 99999988887766
Q ss_pred HHHHhc
Q 015556 393 FAVVNK 398 (405)
Q Consensus 393 ~~i~~~ 398 (405)
..+.++
T Consensus 236 ~~~~~~ 241 (291)
T cd05094 236 ECITQG 241 (291)
T ss_pred HHHhCC
Confidence 655443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=282.76 Aligned_cols=216 Identities=28% Similarity=0.529 Sum_probs=181.6
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 248 (405)
|+..+|.+.++||+|+||.||++... +..+|+|.+..... .....+.+|+++++.++|+||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--------SARQDFQREAELLTVLQHQHIVRFY 73 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH--------HHHHHHHHHHHHHhcCCCCCCceEE
Confidence 45677888999999999999999742 35788888763221 1246788999999999999999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLEH-------------KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV 315 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NI 315 (405)
+++.+....++||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 74 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~ni 153 (280)
T cd05092 74 GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNC 153 (280)
T ss_pred EEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhE
Confidence 999999999999999999999999986421 3578899999999999999999999999999999999
Q ss_pred EECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 015556 316 LIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391 (405)
Q Consensus 316 Ll~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~ 391 (405)
|+++++.++|+|||++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+.
T Consensus 154 l~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 233 (280)
T cd05092 154 LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA 233 (280)
T ss_pred EEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH
Confidence 99999999999999985432211 1122335678999999998889999999999999999998 9999998888777
Q ss_pred HHHHHhcc
Q 015556 392 AFAVVNKV 399 (405)
Q Consensus 392 ~~~i~~~~ 399 (405)
...+.++.
T Consensus 234 ~~~~~~~~ 241 (280)
T cd05092 234 IECITQGR 241 (280)
T ss_pred HHHHHcCc
Confidence 77666653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=283.31 Aligned_cols=207 Identities=27% Similarity=0.521 Sum_probs=179.5
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
.+|.+.+.||+|++|.||+|++. ++.||||.+....... ...+.+|+.+++.+.|+||+++++.+..+..
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--------~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~ 91 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--------KELIINEILVMRENKNPNIVNYLDSYLVGDE 91 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch--------HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCE
Confidence 57888899999999999999874 6899999987644332 3457799999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
.|+||||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 92 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 92 LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred EEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 9999999999999999865 4578999999999999999999999999999999999999999999999998864322
Q ss_pred cC-CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015556 337 CD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 337 ~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~ 396 (405)
.. ......+++.|+|||++.+..++.++|||||||++|+|++|..||....+.+....+.
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~ 229 (296)
T cd06654 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229 (296)
T ss_pred cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh
Confidence 21 2234568999999999988888999999999999999999999998887766555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=278.30 Aligned_cols=212 Identities=28% Similarity=0.499 Sum_probs=174.3
Q ss_pred eecceeeeeeeEEEEEEEECC----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC---
Q 015556 182 FLGLRFAHGAHSRLYHGIYKD----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--- 254 (405)
Q Consensus 182 ~~~~~lG~G~~g~Vy~~~~~~----~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--- 254 (405)
.+++.||+|+||.||+|.+.+ ..||||.+......... ...+.+|+.+++.++|+||+++++++...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE------MEDFLSEAVCMKEFDHPNVMRLIGVCLQTVES 75 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHH------HHHHHHHHHHHHhCCCCCcceEEEEEccCCcc
Confidence 477899999999999999863 25899988754332221 46778999999999999999999987532
Q ss_pred ---CeeEEEEeecCCCCHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEe
Q 015556 255 ---PVYCVITEYLSEGSLRAYLHKL----EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327 (405)
Q Consensus 255 ---~~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~D 327 (405)
...++||||+.+|+|.+++... ....+++..++.++.|++.||.|||+++|+||||||+|||++.++.++|+|
T Consensus 76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D 155 (272)
T cd05075 76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVAD 155 (272)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECC
Confidence 3568999999999999988532 224578999999999999999999999999999999999999999999999
Q ss_pred cCCcccccccCC---CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 328 FGIACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 328 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
||++........ .....+++.|++||.+.+..++.++||||||+++|||++ |..||......+....+.++.
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 231 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999865432211 122346778999999998899999999999999999999 899999888877666666544
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=277.11 Aligned_cols=203 Identities=26% Similarity=0.438 Sum_probs=174.4
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||+|+||.||+|+.. ++.||||.+......+. .....+.+|+.+++.++||||+++++++.+...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDA-----KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCH-----HHHHHHHHHHHHHHhCCCcceeeeeeeEEECCe
Confidence 57889999999999999999874 68999998875433222 124678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 257 YCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
.++||||+++++|.+++... ....+++..++.++.|++.||.|||++|++|+||||+|||++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 99999999999999988643 2355888999999999999999999999999999999999999999999999988643
Q ss_pred cccC-CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 335 VYCD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 335 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
.... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred cchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 2211 122346888999999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=286.16 Aligned_cols=219 Identities=28% Similarity=0.407 Sum_probs=185.5
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEe
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFV 248 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 248 (405)
.-|++..+++.-.+.||.|+||+|++-..+ |+..|||.|+..... +..++|..|.+...+- +.||||+||
T Consensus 57 ~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~-------keq~rll~e~d~~mks~~cp~IVkfy 129 (361)
T KOG1006|consen 57 HLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE-------KEQKRLLMEHDTVMKSSNCPNIVKFY 129 (361)
T ss_pred cccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch-------HHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence 456666777777888999999999999886 799999999865542 2267888998876665 589999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHH---HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEECCCCcEE
Q 015556 249 AACKKPPVYCVITEYLSEGSLRA---YLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLK 324 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~---~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDIkp~NILl~~~~~vk 324 (405)
|++..++.+|+.||.|+ .+|.. ++.......+++..+..|...+++||.||-. ..||||||||+|||++..|.+|
T Consensus 130 Ga~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vK 208 (361)
T KOG1006|consen 130 GALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVK 208 (361)
T ss_pred hhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEe
Confidence 99999999999999994 45544 4444466789999999999999999999974 5899999999999999999999
Q ss_pred EEecCCcccccccCCCCCCCCCCcccCccccc--cccCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhc
Q 015556 325 IADFGIACEEVYCDALSDDPGTYRWMAPEMIK--HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP-IQAAFAVVNK 398 (405)
Q Consensus 325 L~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~-~e~~~~i~~~ 398 (405)
|||||++......-..+...|...|||||.+. +..|+.++||||||++|||+.||+.||+.++. .+.+-.++.+
T Consensus 209 LCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g 285 (361)
T KOG1006|consen 209 LCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG 285 (361)
T ss_pred eecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC
Confidence 99999998877777778889999999999994 34699999999999999999999999998664 4555566554
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=279.82 Aligned_cols=213 Identities=26% Similarity=0.504 Sum_probs=176.0
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC--Cc----cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DE----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~----~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
+...+|.+.+.||.|+||.||+|.+. ++ .||||++....... ....+.+|+.++..+.|+||+++++
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~-------~~~~~~~e~~~l~~~~~~~i~~~~~ 76 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-------ANKEILDEAYVMAGVGSPYVCRLLG 76 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHH-------HHHHHHHHHHHHHhcCCCCCceEEE
Confidence 34567888999999999999999864 33 48999987543321 2467889999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
++... ..+++|||+++|+|.+++... ...+++..++.++.|++.||.|||+++|+||||||+|||+++++.+||+|||
T Consensus 77 ~~~~~-~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG 154 (279)
T cd05109 77 ICLTS-TVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFG 154 (279)
T ss_pred EEcCC-CcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCC
Confidence 99764 467999999999999999763 3568999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCC---CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015556 330 IACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 330 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~ 397 (405)
++........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 226 (279)
T cd05109 155 LARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK 226 (279)
T ss_pred ceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC
Confidence 9865432211 122335678999999988889999999999999999998 9999988776655544433
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=285.57 Aligned_cols=202 Identities=24% Similarity=0.400 Sum_probs=175.1
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||+|+||.||++.+. ++.+|+|.+...... ....++.+|++++++++||||++++++|.+++.
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 73 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP-------AIRNQIIRELKVLHECNSPYIVGFYGAFYSDGE 73 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCH-------HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCE
Confidence 36788999999999999999885 578999988743221 125678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++....
T Consensus 74 ~~lv~ey~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 74 ISICMEHMDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred EEEEeeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 9999999999999999986 3678999999999999999999997 599999999999999999999999999885432
Q ss_pred ccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 015556 336 YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390 (405)
Q Consensus 336 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e 390 (405)
. .......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+..+
T Consensus 152 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 205 (308)
T cd06615 152 D-SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE 205 (308)
T ss_pred c-cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh
Confidence 2 22234568999999999988889999999999999999999999998665433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=275.83 Aligned_cols=214 Identities=26% Similarity=0.461 Sum_probs=180.4
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC--
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-- 254 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-- 254 (405)
.+|.+++.||+|+||.||+|.+. ++.||+|.+........ .......+.+|++++++++|+||+++++++.+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQE---TSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccch---hhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC
Confidence 46889999999999999999874 68999999864332211 122356788999999999999999999998764
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
..+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 468899999999999999976 345888999999999999999999999999999999999999999999999998643
Q ss_pred cc----cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 335 VY----CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 335 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
.. ........++..|+|||++.+..++.++|||||||++|+|++|+.||.+....+...++..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 223 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT 223 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc
Confidence 21 1112234588999999999888889999999999999999999999998887777666554
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=278.90 Aligned_cols=210 Identities=28% Similarity=0.487 Sum_probs=176.5
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecC-
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKP- 254 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~- 254 (405)
+.|.+.+.||.|+||.||+|... ++.||||++...... ...+.+|+.++.++ +|+||++++++|...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---------EEEIKQEINMLKKYSHHRNIATYYGAFIKKN 76 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc---------HHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence 35677888999999999999885 589999999754322 24567899999998 699999999998753
Q ss_pred -----CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 255 -----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 255 -----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
..+++||||+.+++|.+++.......+++..+..++.|++.||.|||+++|+||||+|+||++++++.++|+|||
T Consensus 77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCC
Confidence 468999999999999999987555678999999999999999999999999999999999999999999999999
Q ss_pred Cccccccc-CCCCCCCCCCcccCccccc-----cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 330 IACEEVYC-DALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 330 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
++...... .......|+..|+|||++. +..++.++|||||||++|||++|..||....+......+..
T Consensus 157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~ 230 (272)
T cd06637 157 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 230 (272)
T ss_pred CceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc
Confidence 98643221 2233456899999999985 34578899999999999999999999988777666655443
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=294.08 Aligned_cols=213 Identities=31% Similarity=0.516 Sum_probs=185.0
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 253 (405)
++..+.+.++++||+|.||.|.++...+ ..||||+++..+.. ...+.|.+|+.+|.+|+|||||.++|.|..
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~-------~~r~~F~kEIkiLsqLkhPNIveLvGVC~~ 606 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK-------NARNDFLKEIKILSRLKHPNIVELLGVCVQ 606 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccch-------hHHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence 4556788899999999999999999987 99999999854332 236899999999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
++.+|+|||||++|+|.+||.+.....+.-.....|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||.++.
T Consensus 607 DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 607 DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccc
Confidence 99999999999999999999986545555667788999999999999999999999999999999999999999999974
Q ss_pred ccccCCC---CCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHH
Q 015556 334 EVYCDAL---SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA--GTIPYEEMNPIQAAFA 394 (405)
Q Consensus 334 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt--G~~Pf~~~~~~e~~~~ 394 (405)
...++.. ...+...+|||+|.+..++++.++|||+||+++||++. ...||..+...+....
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven 752 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN 752 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh
Confidence 3332222 23356899999999999999999999999999999865 8999999887776543
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=274.40 Aligned_cols=213 Identities=23% Similarity=0.357 Sum_probs=183.8
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+.+.||+|++|.||++... ++.+|||.+........ ....+.+|+.++++++||||+++++.+......
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD------ERLAAQNECQVLKLLSHPNIIEYYENFLEDKAL 74 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccH------HHHHHHHHHHHHhhCCCCchhheeeeEecCCEE
Confidence 4778899999999999999875 68999999976543322 246788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC-CcEEEEecCCcccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE-FHLKIADFGIACEEVY 336 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~-~~vkL~DFG~a~~~~~ 336 (405)
++||||+++++|.+++.......+++..++.++.+++.+|.|||++||+|+||+|+||+++.+ +.++|+|||.+.....
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 999999999999999987655678999999999999999999999999999999999999755 5689999999865544
Q ss_pred cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 337 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
........++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+..+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 216 (256)
T cd08220 155 KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG 216 (256)
T ss_pred CccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc
Confidence 33334456899999999999888899999999999999999999999988877766666554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=291.99 Aligned_cols=215 Identities=31% Similarity=0.514 Sum_probs=175.6
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEE-------CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCee
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIY-------KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVI 245 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv 245 (405)
|.+..++|.+++.||.|+||.||+|.+ .++.||||+++...... ....+.+|+.++.++ +|+||+
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~~h~niv 74 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-------EHRALMSELKILIHIGHHLNVV 74 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChH-------HHHHHHHHHHHHHhccCCccHh
Confidence 667778999999999999999999974 25789999997543221 135678999999999 689999
Q ss_pred EEeeEeec-CCeeEEEEeecCCCCHHHHHHHhc-----------------------------------------------
Q 015556 246 KFVAACKK-PPVYCVITEYLSEGSLRAYLHKLE----------------------------------------------- 277 (405)
Q Consensus 246 ~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~----------------------------------------------- 277 (405)
+++++|.. +..+++||||+++|+|.+++....
T Consensus 75 ~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (343)
T cd05103 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVE 154 (343)
T ss_pred hhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccC
Confidence 99998865 456789999999999999997532
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccC-
Q 015556 278 ------------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD- 338 (405)
Q Consensus 278 ------------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~- 338 (405)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 234 (343)
T cd05103 155 EKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD 234 (343)
T ss_pred CCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc
Confidence 1236788889999999999999999999999999999999999999999999986432211
Q ss_pred --CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 015556 339 --ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV 395 (405)
Q Consensus 339 --~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i 395 (405)
......++..|+|||++.+..++.++||||||+++|+|++ |..||......+.....
T Consensus 235 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 294 (343)
T cd05103 235 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 294 (343)
T ss_pred hhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH
Confidence 1112335678999999988889999999999999999997 99999886654443333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=274.12 Aligned_cols=212 Identities=30% Similarity=0.550 Sum_probs=182.4
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeE
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC 258 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 258 (405)
|..++.||+|++|.||+|... ++.|++|.+........ .....+.+.+|+.+++.++|+||+++++++.+...++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 78 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQT---GQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLY 78 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccccc---chHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEE
Confidence 567788999999999999985 68999999876443221 1222567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccC
Q 015556 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~ 338 (405)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 79 IFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 99999999999999976 3568899999999999999999999999999999999999999999999999986544333
Q ss_pred CCCCCCCCCcccCcccccccc-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 339 ALSDDPGTYRWMAPEMIKHKS-YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 339 ~~~~~~gt~~y~aPE~~~~~~-~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
......|+..|++||.+.... ++.++|+||||+++|+|++|..||....+.+....+..
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 216 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR 216 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh
Confidence 334566899999999987766 89999999999999999999999998887777666554
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=286.49 Aligned_cols=192 Identities=27% Similarity=0.389 Sum_probs=158.5
Q ss_pred cceeeeeeeEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec--CCee
Q 015556 184 GLRFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK--PPVY 257 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~ 257 (405)
+.+||+|+||.||+|... ++.||||.+..... ...+.+|+.+|++++||||+++++++.. +..+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 75 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----------SMSACREIALLRELKHPNVISLQKVFLSHADRKV 75 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEE
Confidence 568999999999999864 47899999864332 1235689999999999999999998854 4578
Q ss_pred EEEEeecCCCCHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE----CCCCcEEEE
Q 015556 258 CVITEYLSEGSLRAYLHKLE-------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI----DQEFHLKIA 326 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl----~~~~~vkL~ 326 (405)
|+||||+. ++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 76 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07868 76 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence 99999985 58888876421 2358899999999999999999999999999999999999 456799999
Q ss_pred ecCCccccccc----CCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 327 DFGIACEEVYC----DALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 327 DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
|||++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 99998643221 123345689999999998764 5899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=301.48 Aligned_cols=218 Identities=28% Similarity=0.581 Sum_probs=193.7
Q ss_pred ccccccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEE
Q 015556 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247 (405)
Q Consensus 170 ~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 247 (405)
..++|+++..++.+..+||-|.||.||.|+|+ .-.||||.++.... -..+|..|..+|+.++|||+|+|
T Consensus 258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---------eveEFLkEAAvMKeikHpNLVqL 328 (1157)
T KOG4278|consen 258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---------EVEEFLKEAAVMKEIKHPNLVQL 328 (1157)
T ss_pred CcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---------hHHHHHHHHHHHHhhcCccHHHH
Confidence 35899999999999999999999999999998 47899999873221 15689999999999999999999
Q ss_pred eeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEe
Q 015556 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327 (405)
Q Consensus 248 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~D 327 (405)
+|.|+....+|||+|||..|+|.+||+......++...++.++.||..||+||..+++|||||...|+|+.++..+||+|
T Consensus 329 LGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvAD 408 (1157)
T KOG4278|consen 329 LGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVAD 408 (1157)
T ss_pred hhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeec
Confidence 99999999999999999999999999998878888889999999999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCC---CCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015556 328 FGIACEEVYCDALSDDPG---TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 328 FG~a~~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~ 397 (405)
||+++.+.- +.++...| .+.|.|||-+.-..++.|+|||+|||+|||+.| |..||++.+-.+.+.-+-+
T Consensus 409 FGLsRlMtg-DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk 481 (1157)
T KOG4278|consen 409 FGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK 481 (1157)
T ss_pred cchhhhhcC-CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc
Confidence 999976543 33444443 567999999988899999999999999999999 9999999887776554433
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=296.03 Aligned_cols=194 Identities=25% Similarity=0.421 Sum_probs=168.6
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 253 (405)
..+|.+++.||.|+||.||++... ++.||||.+... +.+.+|+.+|++++||||+++++++..
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------------~~~~~E~~il~~l~h~~iv~~~~~~~~ 157 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------------KTPGREIDILKTISHRAIINLIHAYRW 157 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------------ccHHHHHHHHHhcCCCCccceeeeEee
Confidence 457999999999999999999764 367999987532 123479999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
....|+|||++. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 158 ~~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 158 KSTVCMVMPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred CCEEEEEehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 999999999985 689999854 46799999999999999999999999999999999999999999999999999865
Q ss_pred ccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 334 EVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 334 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
..... ......||..|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 33221 1224469999999999998999999999999999999999999997643
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=281.03 Aligned_cols=193 Identities=31% Similarity=0.531 Sum_probs=168.5
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+.+.||+|+||.||+|.+. ++.||||++......+ ....+.+|+.++.+++||||+++++++......
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 74 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE-------LQKQIMSELEILYKCDSPYIIGFYGAFFVENRI 74 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChH-------HHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEE
Confidence 5677889999999999999874 6899999987543211 245788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
++||||+++++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++.....
T Consensus 75 ~lv~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~- 147 (279)
T cd06619 75 SICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN- 147 (279)
T ss_pred EEEEecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc-
Confidence 999999999999654 2467888999999999999999999999999999999999999999999999865432
Q ss_pred CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 338 DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 338 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
.......|+..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 148 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 148 SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 2234457899999999999888999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=278.05 Aligned_cols=205 Identities=24% Similarity=0.456 Sum_probs=168.3
Q ss_pred eeeeeeeEEEEEEEECC----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEE
Q 015556 186 RFAHGAHSRLYHGIYKD----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261 (405)
Q Consensus 186 ~lG~G~~g~Vy~~~~~~----~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 261 (405)
.||+|+||.||+|.+.+ ..+|+|.++...... ....+.+|+.++++++||||+++++++.+...+++||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 74 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ-------EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVM 74 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChH-------HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEE
Confidence 57999999999998653 468999886544321 1356888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccC
Q 015556 262 EYLSEGSLRAYLHKLE---HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338 (405)
Q Consensus 262 E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~ 338 (405)
||+++|+|.+++.... ...+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++.......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 9999999999997642 2345677888999999999999999999999999999999999999999999985432211
Q ss_pred ---CCCCCCCCCcccCccccccc-------cCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015556 339 ---ALSDDPGTYRWMAPEMIKHK-------SYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 339 ---~~~~~~gt~~y~aPE~~~~~-------~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~ 397 (405)
......++..|+|||++.+. .++.++||||||+++|||++ |..||....+.+.....+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 224 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR 224 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh
Confidence 11234577889999998542 35789999999999999997 9999998887776555443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=276.29 Aligned_cols=203 Identities=25% Similarity=0.551 Sum_probs=169.3
Q ss_pred eeeeeeEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEe
Q 015556 187 FAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262 (405)
Q Consensus 187 lG~G~~g~Vy~~~~~----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 262 (405)
||+|+||.||+|.+. +..||||++...... ...+.+.+|+.++++++|+||+++++++.. ...++|||
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e 74 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK-------SVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVME 74 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccCh-------HHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEE
Confidence 799999999999874 346999998643221 124678899999999999999999999864 46789999
Q ss_pred ecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCC---
Q 015556 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA--- 339 (405)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~--- 339 (405)
|+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++........
T Consensus 75 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 75 MASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred eCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 99999999999752 45789999999999999999999999999999999999999999999999999854322111
Q ss_pred -CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 340 -LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 340 -~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
.....++..|+|||.+....++.++|||||||++|+|++ |..||.+..+.+....+.++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 214 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG 214 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC
Confidence 122234678999999988889999999999999999997 99999998887766555543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=281.70 Aligned_cols=210 Identities=31% Similarity=0.548 Sum_probs=174.5
Q ss_pred CeeecceeeeeeeEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~~-------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
+|.+.+.||+|+||.||+|.... ..+|+|.+....... ...++.+|+.+++.++||||++++++|.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSS-------ELRDLLSEFNLLKQVNHPHVIKLYGACS 73 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHH-------HHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 36678899999999999998742 468888886433211 1357889999999999999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLE----------------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDL 310 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDI 310 (405)
.....++||||+.+++|.+++.... ...+++..++.++.|++.||.|||+++|+||||
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~di 153 (290)
T cd05045 74 QDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDL 153 (290)
T ss_pred cCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhh
Confidence 9999999999999999999987531 134788899999999999999999999999999
Q ss_pred CCCcEEECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 015556 311 KPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM 386 (405)
Q Consensus 311 kp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~ 386 (405)
||+|||+++++.+||+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.
T Consensus 154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999999986432211 1123345778999999988889999999999999999999 99999987
Q ss_pred CHHHHHHHHH
Q 015556 387 NPIQAAFAVV 396 (405)
Q Consensus 387 ~~~e~~~~i~ 396 (405)
.+.+....+.
T Consensus 234 ~~~~~~~~~~ 243 (290)
T cd05045 234 APERLFNLLK 243 (290)
T ss_pred CHHHHHHHHh
Confidence 7766544433
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=279.10 Aligned_cols=210 Identities=29% Similarity=0.520 Sum_probs=181.9
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||.|++|.||+|.+. ++.||||++........ ...+.+|+.+++.++|+||+++++++.++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-------IEDIQQEIQFLSQCRSPYITKYYGSFLKGSK 73 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchH-------HHHHHHHHHHHHHcCCCCeeeeeEEEEECCe
Confidence 35778889999999999999985 68999999875432221 3567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+|+|+||+++++|.+++.. ..+++..++.++.|++.||.|||+++++||||+|+||+++.++.++|+|||++.....
T Consensus 74 ~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 74 LWIIMEYCGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred EEEEEEeeCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 9999999999999999976 3789999999999999999999999999999999999999999999999999865443
Q ss_pred c-CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 337 C-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 337 ~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
. .......++..|+|||++.+..++.++||||||+++|+|++|..||...++.+....+.+.
T Consensus 151 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 213 (274)
T cd06609 151 TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN 213 (274)
T ss_pred cccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc
Confidence 2 2233456888999999998888999999999999999999999999988777666555443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=280.09 Aligned_cols=209 Identities=29% Similarity=0.533 Sum_probs=181.7
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
..+|.+.+.||.|++|.||+|.+. ++.||||.+....... ...+.+|+.+++.++|+||+++++++....
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK--------KELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch--------HHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 356889999999999999999864 6899999987543322 345778999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+++||||+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++....
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred eEEEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 99999999999999999875 468999999999999999999999999999999999999999999999999876433
Q ss_pred ccC-CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 336 YCD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 336 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
... ......++..|+|||.+.+..++.++|||||||++|+|++|..||...++.+....+..
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~ 229 (296)
T cd06655 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 229 (296)
T ss_pred cccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 222 12334688999999999988899999999999999999999999999888776665543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=281.44 Aligned_cols=214 Identities=26% Similarity=0.456 Sum_probs=179.7
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
...-+.|.++++||.|+||.||+|... ++.||+|++...+.. ....+.+|+.+++.++|+||+++++++.
T Consensus 8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (292)
T cd06644 8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE--------ELEDYMVEIEILATCNHPYIVKLLGAFY 79 (292)
T ss_pred cCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHH--------HHHHHHHHHHHHHhCCCCcEeeeEEEEE
Confidence 333467889999999999999999985 589999998753311 2456788999999999999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
.+..+++||||+++++|..++.+. ...+++..+..++.|++.+|.|||++||+||||||+||+++.++.++|+|||++.
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 80 WDGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred eCCeEEEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccce
Confidence 999999999999999999887653 3568999999999999999999999999999999999999999999999999875
Q ss_pred ccccc-CCCCCCCCCCcccCccccc-----cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 333 EEVYC-DALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 333 ~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
..... .......++..|+|||++. ...++.++|||||||++|+|++|..||...++.+...++.+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 229 (292)
T cd06644 159 KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 229 (292)
T ss_pred eccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc
Confidence 43221 1123345888999999984 34568899999999999999999999998887766655543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=278.86 Aligned_cols=217 Identities=29% Similarity=0.540 Sum_probs=181.7
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEECC------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYKD------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
++.++|.+.+.||+|+||.||+|.+.+ ..|++|.+...... .....+.+|+.+++.++|+||+++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~-------~~~~~~~~e~~~l~~l~h~ni~~~~~ 75 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE-------IQVTLLLQESCLLYGLSHQNILPILH 75 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCH-------HHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 566789999999999999999999753 78999987633221 12466889999999999999999999
Q ss_pred Eeec-CCeeEEEEeecCCCCHHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCc
Q 015556 250 ACKK-PPVYCVITEYLSEGSLRAYLHKLEH------KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322 (405)
Q Consensus 250 ~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~ 322 (405)
++.. +...++++||+++++|.+++..... ..+++..++.++.|++.||+|||+++++||||||+|||++.++.
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~ 155 (280)
T cd05043 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ 155 (280)
T ss_pred EEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc
Confidence 8776 5678899999999999999976432 45889999999999999999999999999999999999999999
Q ss_pred EEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 323 LKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 323 vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
+||+|||++....... ......++..|+|||++.+..++.++||||||+++||+++ |+.||...++.+....+...
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 235 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG 235 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC
Confidence 9999999986432211 1123346778999999988889999999999999999999 99999998887766655554
Q ss_pred c
Q 015556 399 V 399 (405)
Q Consensus 399 ~ 399 (405)
.
T Consensus 236 ~ 236 (280)
T cd05043 236 Y 236 (280)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=310.88 Aligned_cols=220 Identities=25% Similarity=0.493 Sum_probs=196.9
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
+||.+.+.+.+.||.|.||.|++|+++ ...||||.++....+ +.+..|..|..||.++.||||++|-|
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte-------kqrrdFL~EAsIMGQFdHPNIIrLEG 697 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE-------KQRRDFLSEASIMGQFDHPNIIRLEG 697 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH-------HHHhhhhhhhhhcccCCCCcEEEEEE
Confidence 688899999999999999999999986 368999999865443 34788999999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
..+.....+||+|||++|+|..||+... +.+++.++..++++|+.||.||-++++|||||...||||+.+...|++|||
T Consensus 698 VVTks~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFG 776 (996)
T KOG0196|consen 698 VVTKSKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFG 776 (996)
T ss_pred EEecCceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecccc
Confidence 9999999999999999999999999855 669999999999999999999999999999999999999999999999999
Q ss_pred CcccccccC--CCCCCC--CCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccCC
Q 015556 330 IACEEVYCD--ALSDDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVNFG 402 (405)
Q Consensus 330 ~a~~~~~~~--~~~~~~--gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~~~ 402 (405)
+++...+.. ..+... -..+|.|||.+...+++.++||||||+++||+++ |..||=+++..+.+.+|-++-.+|
T Consensus 777 LSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLP 854 (996)
T KOG0196|consen 777 LSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLP 854 (996)
T ss_pred ceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCC
Confidence 997543322 112221 3578999999999999999999999999999999 999999999999999999887765
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=273.62 Aligned_cols=207 Identities=32% Similarity=0.617 Sum_probs=180.5
Q ss_pred ceeeeeeeEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEE
Q 015556 185 LRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV 259 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~-----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 259 (405)
+.||+|+||.||++.+. +..||||++....... ....+.+|+.++..++|+||+++++++.....+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 73 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-------ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYL 73 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-------HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEE
Confidence 35899999999999986 6799999997544322 25678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 260 ITEYLSEGSLRAYLHKLE-------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 260 V~E~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+.
T Consensus 74 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~ 153 (262)
T cd00192 74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR 153 (262)
T ss_pred EEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccc
Confidence 999999999999998742 3678999999999999999999999999999999999999999999999999986
Q ss_pred ccccc---CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 333 EEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 333 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
..... .......++..|+|||.+....++.++||||||+++|+|++ |..||......+....+.++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~ 223 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG 223 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 54432 22334557889999999988889999999999999999999 69999999888777777654
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=276.21 Aligned_cols=216 Identities=26% Similarity=0.478 Sum_probs=179.7
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--C---ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--D---EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~---~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
..++|+..+.||+|+||.||+|... + ..+|||.+....... ....+.+|+.++++++|+||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK-------QRQDFLSEASIMGQFSHHNIIRLEGVV 75 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHH-------HHHHHHHHHHHHhcCCCCCeeEEEEEE
Confidence 3457788899999999999999975 2 268999886432211 145688999999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
.+....++||||+++++|.+++... ...+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~ 154 (268)
T cd05063 76 TKFKPAMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLS 154 (268)
T ss_pred ccCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccc
Confidence 9999999999999999999999763 357899999999999999999999999999999999999999999999999998
Q ss_pred ccccccCCC----CCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 015556 332 CEEVYCDAL----SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 332 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
......... .....+..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+.+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~ 228 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR 228 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC
Confidence 543221110 11223457999999988889999999999999999998 9999998888777666655433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=274.98 Aligned_cols=212 Identities=26% Similarity=0.457 Sum_probs=178.6
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec--CC
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK--PP 255 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~ 255 (405)
+|..++.||+|+||.||++... +..||+|.+......... .+....+.+|+.++++++||||+++++++.+ ..
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPET---SKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEK 79 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchh---HHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCC
Confidence 5778899999999999999874 689999998765432211 2234678899999999999999999999875 36
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.++++|||+++++|.+++.. ...+++...+.++.|++.||+|||+++|+||||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 78899999999999999976 3468899999999999999999999999999999999999999999999999985432
Q ss_pred c----cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015556 336 Y----CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 336 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~ 396 (405)
. ........++..|+|||.+.+..++.++|||||||++|||++|..||....+.+....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~ 222 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA 222 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh
Confidence 1 111223458899999999998889999999999999999999999999887777666544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=281.58 Aligned_cols=213 Identities=32% Similarity=0.562 Sum_probs=179.5
Q ss_pred cCCCeeecceeeeeeeEEEEEEEECC------------------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHh
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYKD------------------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR 238 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------------------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~ 238 (405)
..++|.+++.||+|+||.||++.+.+ ..||+|.+...... ...+.+.+|++++.+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-------~~~~~~~~e~~~l~~ 75 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-------NAREDFLKEVKILSR 75 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-------HHHHHHHHHHHHHHh
Confidence 34678899999999999999988653 45899998754322 225678899999999
Q ss_pred cCCCCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q 015556 239 LHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE---------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309 (405)
Q Consensus 239 l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrD 309 (405)
++||||++++++|..+...++||||+++++|.+++.... ...+++..++.++.|++.||.|||++||+|||
T Consensus 76 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~d 155 (296)
T cd05051 76 LSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRD 155 (296)
T ss_pred cCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Confidence 999999999999999999999999999999999998643 12689999999999999999999999999999
Q ss_pred CCCCcEEECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh--CCCCCC
Q 015556 310 LKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA--GTIPYE 384 (405)
Q Consensus 310 Ikp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt--G~~Pf~ 384 (405)
|||+|||++.++.++|+|||++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 99999999999999999999986432221 1223346778999999988889999999999999999998 788998
Q ss_pred CCCHHHHHHHHH
Q 015556 385 EMNPIQAAFAVV 396 (405)
Q Consensus 385 ~~~~~e~~~~i~ 396 (405)
..+..+.+..+.
T Consensus 236 ~~~~~~~~~~~~ 247 (296)
T cd05051 236 HLTDQQVIENAG 247 (296)
T ss_pred CcChHHHHHHHH
Confidence 877766655544
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=277.78 Aligned_cols=211 Identities=27% Similarity=0.437 Sum_probs=181.7
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+++.||+|++|.||+|.+. ++.||||++......+. ....+.+|+.++++++||||+++++++.+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 74 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGG------IPNQALREIKALQACQHPYVVKLLDVFPHGSGF 74 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccch------hhHHHHHHHHHHHhCCCCCCcceeeEEecCCee
Confidence 4788899999999999999975 68999999986543321 245788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 75 ~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 75 VLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred EEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9999999 999999987633 67899999999999999999999999999999999999999999999999998654332
Q ss_pred C--CCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 338 D--ALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 338 ~--~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
. ......++..|+|||++.+. .++.++||||||+++|+|++|..||......+....++..
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~ 216 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRT 216 (286)
T ss_pred CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHH
Confidence 2 23445689999999998654 4689999999999999999999999988887777666654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=279.32 Aligned_cols=213 Identities=27% Similarity=0.483 Sum_probs=174.8
Q ss_pred CCCeeecceeeeeeeEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
.++|.+.+.||+|++|.||+|.+.+ ..||+|.+....... .+..|.+|+.+++.++|+||++++++
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~ 77 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ-------DESDFLMEALIMSKFNHQNIVRLIGV 77 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHH-------HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3567888999999999999999854 578888775332211 14568899999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCC---c
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEH-----KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF---H 322 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~---~ 322 (405)
+.+....++||||+++++|.+++..... ..+++..++.++.||+.||+|||+++++||||||+|||++.++ .
T Consensus 78 ~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 78 SFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred EccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcc
Confidence 9998899999999999999999986432 2588999999999999999999999999999999999997654 6
Q ss_pred EEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015556 323 LKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 323 vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~ 397 (405)
+||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~ 236 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999986542111 1112233567999999998889999999999999999997 9999998877665554443
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=278.66 Aligned_cols=215 Identities=27% Similarity=0.521 Sum_probs=179.6
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC--Cc----cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DE----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~----~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
+...+|.+++.||+|+||.||+|.+. ++ .||+|.+...... .....+.+|+.++++++|+||+++++
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~ 76 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP-------KANKEILDEAYVMASVDHPHVVRLLG 76 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCH-------HHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 34577889999999999999999874 22 5899987644331 12467889999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
+|.. ...++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 77 ~~~~-~~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg 154 (279)
T cd05057 77 ICLS-SQVQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFG 154 (279)
T ss_pred EEec-CceEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCc
Confidence 9987 7788999999999999999863 3458999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCC---CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 330 IACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 330 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
++........ .....++..|+|||.+....++.++||||||+++|||++ |..||......+....+.++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 228 (279)
T cd05057 155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE 228 (279)
T ss_pred ccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Confidence 9864332111 112224568999999988889999999999999999999 999999988877666665543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=281.17 Aligned_cols=211 Identities=27% Similarity=0.469 Sum_probs=179.9
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||.|++|.||++.+. ++.||+|++...... ....+.+|+.++++++|+||+++++.+..+..
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE--------ELEDFMVEIDILSECKHPNIVGLYEAYFYENK 76 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHH--------HHHHHHHHHHHHHhCCCCceeEEEEEEecCCe
Confidence 56888999999999999999985 689999999743211 14568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
.|+||||+++++|.+++... ...+++..++.++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 77 LWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred EEEEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 99999999999999998763 35689999999999999999999999999999999999999999999999998754322
Q ss_pred c-CCCCCCCCCCcccCccccc-----cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 337 C-DALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 337 ~-~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
. .......++..|+|||++. ...++.++||||||+++|+|++|..||...++.+....+.+.
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 223 (280)
T cd06611 156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS 223 (280)
T ss_pred cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC
Confidence 1 1223345899999999874 345678999999999999999999999998887766665543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=275.28 Aligned_cols=213 Identities=29% Similarity=0.481 Sum_probs=182.7
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+++.||.|++|+||+|... +..+|||++....... ..+.+.+|+.+++.++|+||+++++.+.....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-------SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDE 73 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-------HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCE
Confidence 36889999999999999999874 5889999987543322 14678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEH-KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
+++|||++++++|.+++..... ..+++..+..++.|++.||.|||++||+||||+|+||++++++.++|+|||++....
T Consensus 74 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 74 LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA 153 (267)
T ss_pred EEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence 9999999999999999987433 578999999999999999999999999999999999999999999999999985433
Q ss_pred ccC-----CCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 336 YCD-----ALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 336 ~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
... ......|+..|+|||++... .++.++|+|||||++|+|++|..||...++.+...+++..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~ 222 (267)
T cd06610 154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN 222 (267)
T ss_pred cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC
Confidence 221 12334689999999998766 7899999999999999999999999988877666655544
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=278.45 Aligned_cols=207 Identities=26% Similarity=0.440 Sum_probs=173.3
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
+++|.+++.||.|++|.||+|... ++.||||.+........ ...+.+|++++++++|+||+++++++.++.
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 76 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-------PFTAIREASLLKDLKHANIVTLHDIIHTKK 76 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC-------chhHHHHHHHHhhCCCcceeeEEEEEecCC
Confidence 467889999999999999999985 68999999975443221 234568999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
..++||||+.+ +|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 77 ~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 77 TLTLVFEYLDT-DLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred eEEEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence 99999999975 999998763 3478899999999999999999999999999999999999999999999999985432
Q ss_pred cc-CCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHH
Q 015556 336 YC-DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMN-PIQAAF 393 (405)
Q Consensus 336 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~-~~e~~~ 393 (405)
.. .......++..|+|||++.+ ..++.++||||||+++|+|++|..||.+.. ..+...
T Consensus 155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~ 215 (291)
T cd07844 155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLH 215 (291)
T ss_pred CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH
Confidence 21 11223357889999999865 457899999999999999999999998765 444333
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=294.19 Aligned_cols=191 Identities=29% Similarity=0.472 Sum_probs=165.5
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
..|.+++.||+|+||.||+|... ++.||+|+... .....|+.++++++|+||+++++++.....
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~--------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 131 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK--------------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAI 131 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc--------------cccHHHHHHHHhCCCCCCcChhheEEeCCe
Confidence 46889999999999999999986 47899997532 123369999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
.++|||++. ++|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 132 ~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 132 TCMVLPHYS-SDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred eEEEEEccC-CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 999999994 689998876 346789999999999999999999999999999999999999999999999999865443
Q ss_pred cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhC-CCCCCC
Q 015556 337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG-TIPYEE 385 (405)
Q Consensus 337 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG-~~Pf~~ 385 (405)
........||..|+|||++.+..++.++|||||||++|||+++ ..+|..
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 3334455699999999999988999999999999999999985 445544
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=300.57 Aligned_cols=219 Identities=22% Similarity=0.351 Sum_probs=200.7
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEECCcc--EEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDEP--VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~--vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
..+.++++.....||-||||+|-++..+++. +|+|+++.....+. +.+..+..|-.||..++.|.||++|-.|
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdt-----kQqeHv~sEr~Im~~~~s~fIvrLYrTf 489 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDT-----KQQEHVFSERNIMMECRSDFIVRLYRTF 489 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccch-----hHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence 3455678888889999999999999998755 89999876543332 2356788999999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
.+...+|++||-|-||.|...|+. .+.++...+..++..++.|++|||.+|||+|||||+|+|++.+|-+||.|||+|
T Consensus 490 rd~kyvYmLmEaClGGElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFA 567 (732)
T KOG0614|consen 490 RDSKYVYMLMEACLGGELWTILRD--RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFA 567 (732)
T ss_pred ccchhhhhhHHhhcCchhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhH
Confidence 999999999999999999999987 578999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 332 CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 332 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
.....+...-..+||+.|+|||++.++..+..+|.|+||+++||||+|.+||.+.+|+..+..|+++.
T Consensus 568 Kki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi 635 (732)
T KOG0614|consen 568 KKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI 635 (732)
T ss_pred HHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh
Confidence 99888888889999999999999999999999999999999999999999999999999999998875
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=280.04 Aligned_cols=212 Identities=26% Similarity=0.411 Sum_probs=179.8
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+.+.||+|+||.||++... ++.||||.+...... .......+.+|+.+++.++||||+++++.+..+..+
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 76 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLI-----LRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHL 76 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhh-----hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEE
Confidence 6778899999999999999986 578999998743221 112245788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++......
T Consensus 77 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 77 CMVMEYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999999999976 356899999999999999999999999999999999999999999999999987521100
Q ss_pred ----------------CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 338 ----------------DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 338 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.......++..|+|||.+.+..++.++||||||+++|||++|..||.+..+.+....+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~ 231 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 231 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 0111235788999999998888999999999999999999999999988877766665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=276.82 Aligned_cols=206 Identities=30% Similarity=0.530 Sum_probs=169.2
Q ss_pred eeeeeeeEEEEEEEECC--c--cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecCCeeEEE
Q 015556 186 RFAHGAHSRLYHGIYKD--E--PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVI 260 (405)
Q Consensus 186 ~lG~G~~g~Vy~~~~~~--~--~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 260 (405)
.||+|+||.||+|.+.+ . .+|+|.+....... ....+.+|++++.++ +||||++++++|.....+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 74 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-------DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 74 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHH-------HHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEE
Confidence 57999999999999853 3 46888776322211 145678999999999 799999999999999999999
Q ss_pred EeecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEE
Q 015556 261 TEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA 326 (405)
Q Consensus 261 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~ 326 (405)
|||+++++|.+++.... ...+++..++.++.|++.||+|||+.|++||||||+|||++.++.+||+
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence 99999999999997632 1247889999999999999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 327 DFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 327 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
|||++..............+..|+|||++....++.++|||||||++|||++ |..||.+.+..+....+..+
T Consensus 155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 227 (270)
T cd05047 155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 227 (270)
T ss_pred CCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC
Confidence 9999853221111122234667999999988889999999999999999997 99999888776666555443
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=278.37 Aligned_cols=209 Identities=25% Similarity=0.462 Sum_probs=177.2
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeE
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC 258 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 258 (405)
|++.+.||.|+||.||+|.+. +..+++|.+..... .....+.+|+++++.++|+||++++++|......+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~ 78 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--------EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 78 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH--------HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEE
Confidence 457788999999999999986 57788888854321 11456788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc-
Q 015556 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC- 337 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~- 337 (405)
+||||+++++|..++.+ ....+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 79 ~v~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 79 ILIEFCAGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 99999999999998865 2357899999999999999999999999999999999999999999999999998543221
Q ss_pred CCCCCCCCCCcccCccccc-----cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 338 DALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 338 ~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.......++..|+|||++. +..++.++|||||||++|+|++|..||...++.+....+.+.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~ 223 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS 223 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc
Confidence 2223456899999999983 445788999999999999999999999998888777776554
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=272.32 Aligned_cols=212 Identities=27% Similarity=0.547 Sum_probs=180.1
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
++.++|.+.+.||.|+||.||++.+. ++.+|||.+...... ..+|.+|++++++++||||+++++++...
T Consensus 1 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05112 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---------EEDFIEEAQVMMKLSHPKLVQLYGVCTER 71 (256)
T ss_pred CChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---------HHHHHHHHHHHHhCCCCCeeeEEEEEccC
Confidence 35678889999999999999999886 688999988643332 24577899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
...++||||+.+++|.+++... ...++++.+..++.|++.+|+|||+++++||||||+||+++.++.++|+|||.+...
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 150 (256)
T cd05112 72 SPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFV 150 (256)
T ss_pred CceEEEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeec
Confidence 9999999999999999999763 346789999999999999999999999999999999999999999999999988543
Q ss_pred cccCC--CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015556 335 VYCDA--LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 335 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~ 397 (405)
..... .....++..|+|||++.+..++.++||||||+++|||++ |..||......+....+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 216 (256)
T cd05112 151 LDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA 216 (256)
T ss_pred ccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC
Confidence 22111 112235678999999988889999999999999999998 9999998777666655544
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=279.68 Aligned_cols=217 Identities=28% Similarity=0.536 Sum_probs=181.2
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 248 (405)
++.++|.+...||+|+||.||++.+. +..||||++...... ...+++.+|+.++++++||||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~ei~~l~~l~h~~iv~~~ 74 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-------DMQADFQREAALMAEFDHPNIVKLL 74 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH-------HHHHHHHHHHHHHHhcCCCchheEE
Confidence 35567889999999999999999863 478999998743321 1246788999999999999999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhc--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLE--------------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHR 308 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHr 308 (405)
+++.++...++||||+++++|.+++.... ...+++..++.++.|++.||.|||+++++||
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~ 154 (288)
T cd05050 75 GVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHR 154 (288)
T ss_pred EEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 99999999999999999999999997532 1247788899999999999999999999999
Q ss_pred CCCCCcEEECCCCcEEEEecCCccccccc---CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCC
Q 015556 309 DLKPENVLIDQEFHLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYE 384 (405)
Q Consensus 309 DIkp~NILl~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~ 384 (405)
||||+|||++.++.++|+|||++...... ........+..|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus 155 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred cccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999988543221 11223345677999999988899999999999999999998 889999
Q ss_pred CCCHHHHHHHHHhcc
Q 015556 385 EMNPIQAAFAVVNKV 399 (405)
Q Consensus 385 ~~~~~e~~~~i~~~~ 399 (405)
+....+....+.++.
T Consensus 235 ~~~~~~~~~~~~~~~ 249 (288)
T cd05050 235 GMAHEEVIYYVRDGN 249 (288)
T ss_pred CCCHHHHHHHHhcCC
Confidence 888877666655443
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=275.72 Aligned_cols=215 Identities=24% Similarity=0.472 Sum_probs=178.4
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEECC-----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
++..+|.+.+.||+|+||.||+|.+.+ ..||||.+...... ...+.+.+|+.+++++.|+||++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~-------~~~~~~~~e~~~l~~~~h~~i~~~~~~ 75 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP-------SVREKFLQEAYIMRQFDHPHIVKLIGV 75 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH-------HHHHHHHHHHHHHHhCCCCchhceeEE
Confidence 445678899999999999999998743 37899988644321 124678899999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
+.+. ..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++||||||+|||++.++.++|+|||+
T Consensus 76 ~~~~-~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~ 153 (270)
T cd05056 76 ITEN-PVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGL 153 (270)
T ss_pred EcCC-CcEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCce
Confidence 8765 467999999999999999763 34689999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC--CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 331 ACEEVYCDA--LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 331 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
+........ .....++..|+|||.+....++.++||||||+++|||++ |..||......+....+.++.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~ 225 (270)
T cd05056 154 SRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE 225 (270)
T ss_pred eeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC
Confidence 854332211 112234567999999988889999999999999999996 999999888877766665543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=273.78 Aligned_cols=207 Identities=29% Similarity=0.545 Sum_probs=180.9
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||.|+||.||+|... ++.||+|.+..... ..++.+|+.+++.++|+||+++++++.+...
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~ 72 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----------LQEIIKEISILKQCDSPYIVKYYGSYFKNTD 72 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----------HHHHHHHHHHHHhCCCCcEeeeeeeeecCCc
Confidence 56788899999999999999986 58999999864211 4678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+|+++||+++++|.+++.. ....+++..+..++.|++.||.|||+.+|+||||+|+||+++.++.++|+|||++.....
T Consensus 73 ~~l~~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 73 LWIVMEYCGAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred EEEEEecCCCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 9999999999999999975 346789999999999999999999999999999999999999999999999999865433
Q ss_pred cC-CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015556 337 CD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 337 ~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~ 396 (405)
.. ......++..|+|||++.+..++.++||||||+++|+|++|..||....+.+....+.
T Consensus 152 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~ 212 (256)
T cd06612 152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP 212 (256)
T ss_pred CccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc
Confidence 22 2233458899999999998889999999999999999999999999887766555443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=271.94 Aligned_cols=214 Identities=20% Similarity=0.369 Sum_probs=184.2
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+.+.||+|+||.||.+... ++.||||.+........ ..+.+.+|+.++++++|+||+++++++.+....
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK------EREESRKEVAVLSNMKHPNIVQYQESFEENGNL 74 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChH------HHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeE
Confidence 4778899999999999999875 68999999975433221 245788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
++||||+.+++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++......
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 99999999999999998755556889999999999999999999999999999999999999999999999988543221
Q ss_pred C-CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 338 D-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 338 ~-~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
. ......|+..|+|||++.+..++.++|+|||||++|+|++|..||...+..+....++.+.
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~ 217 (256)
T cd08218 155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS 217 (256)
T ss_pred hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC
Confidence 1 1123458889999999988889999999999999999999999999888887777766544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=281.61 Aligned_cols=204 Identities=28% Similarity=0.527 Sum_probs=177.2
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
.+|.+.+.||.|++|.||++... ++.||||.+....... ...+.+|+.+++.++|+||+++++++..+..
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 90 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK--------KELIINEILVMRENKNPNIVNYLDSYLVGDE 90 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch--------HHHHHHHHHHHHhCCCCCEeeEEEEEecCCE
Confidence 67888999999999999999974 7899999997544322 3457789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred EEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 9999999999999999975 5688899999999999999999999999999999999999999999999998854332
Q ss_pred cC-CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015556 337 CD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393 (405)
Q Consensus 337 ~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~ 393 (405)
.. ......+++.|+|||.+.+..++.++|||||||++|+|++|..||...++.+...
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~ 225 (297)
T cd06656 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225 (297)
T ss_pred CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee
Confidence 21 1233468899999999998889999999999999999999999998766654443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=274.38 Aligned_cols=216 Identities=29% Similarity=0.497 Sum_probs=180.8
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChh--HHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDEN--ETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~--~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
+|.+++.||.|++|.||+|... ++.||||.++....... ........+.+.+|+.+++.++|+||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4678889999999999999864 68999999875432211 1122234567889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999999999999873 578999999999999999999999999999999999999999999999999985432
Q ss_pred cc---CCCCCCCCCCcccCcccccccc--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 336 YC---DALSDDPGTYRWMAPEMIKHKS--YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 336 ~~---~~~~~~~gt~~y~aPE~~~~~~--~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
.. .......|+..|+|||++.... ++.++|+||||+++|+|++|..||......+....+..
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 226 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN 226 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc
Confidence 11 1123345889999999987654 78999999999999999999999998887776665443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=271.10 Aligned_cols=205 Identities=31% Similarity=0.546 Sum_probs=173.0
Q ss_pred eeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEeec
Q 015556 186 RFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264 (405)
Q Consensus 186 ~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 264 (405)
.||+|+||.||+|... ++.||+|.+...... .....+.+|+++++.++||||++++++|......++||||+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ-------ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELV 74 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCH-------HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECC
Confidence 5899999999999875 578999988643321 12456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCC--CCC
Q 015556 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA--LSD 342 (405)
Q Consensus 265 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~--~~~ 342 (405)
++++|.+++... ...+++..++.++.|++.+|.|||++|++||||+|+||+++.++.+||+|||++........ ...
T Consensus 75 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 75 PGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 999999998763 35688999999999999999999999999999999999999999999999999854322111 112
Q ss_pred CCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 343 ~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
..++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+..+
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~ 210 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG 210 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence 234667999999988889999999999999999999 99999988877766655543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.36 Aligned_cols=216 Identities=24% Similarity=0.386 Sum_probs=188.6
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHH-HHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAAR-LEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
.+..++|.+.+.||+|+||.|..++.+ ++.||+|++..-. +..+ -...|..|-.||..-+.+-|++++-+|
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~e------MlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF 144 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWE------MLKRAETACFREERDIMVFGNSEWIVQLHYAF 144 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHH------HhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence 345688999999999999999999986 6899999986411 1111 145788999999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
.++..+|+|||||+||+|..++.+.. .++++-+..++..|+-||..||+.|+|||||||+|||||..|++||+|||.+
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred cCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhH
Confidence 99999999999999999999998843 7999999999999999999999999999999999999999999999999988
Q ss_pred ccccccC--CCCCCCCCCcccCccccc----c-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 332 CEEVYCD--ALSDDPGTYRWMAPEMIK----H-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 332 ~~~~~~~--~~~~~~gt~~y~aPE~~~----~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
....... .....+|||.|.+||++. + +.|+..+|.||+||++||||.|..||...+-.+.+-+|++-
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h 296 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH 296 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch
Confidence 6544222 223557999999999984 2 56899999999999999999999999999999999999875
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=277.98 Aligned_cols=195 Identities=31% Similarity=0.481 Sum_probs=165.2
Q ss_pred eecceeeeeeeEEEEEEEE------CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec--
Q 015556 182 FLGLRFAHGAHSRLYHGIY------KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK-- 253 (405)
Q Consensus 182 ~~~~~lG~G~~g~Vy~~~~------~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-- 253 (405)
.+.+.||+|+||+||++.+ .++.||||++....... ....+.+|+++++.++||||+++++++..
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ-------NTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChH-------HHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 7788999999999988764 25789999987543211 24567889999999999999999998865
Q ss_pred CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
...+++||||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccc
Confidence 3468899999999999999976 4689999999999999999999999999999999999999999999999999864
Q ss_pred ccccCC----CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 334 EVYCDA----LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 334 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
...... .....++..|+|||.+....++.++||||||+++|+|++|..||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 332111 12234567799999998888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=276.62 Aligned_cols=206 Identities=30% Similarity=0.531 Sum_probs=177.7
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
.|...++||.|+||.||+|.+. ++.||||++....... ....+.+|+.++++++|+||+++++++.++...
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-------EIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKL 77 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHH-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 4566788999999999999875 6899999987543221 246788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 78 WIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred EEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 999999999999999875 56889999999999999999999999999999999999999999999999998543322
Q ss_pred C-CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015556 338 D-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395 (405)
Q Consensus 338 ~-~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i 395 (405)
. ......++..|+|||++.+..++.++|||||||++|||++|..||....+......+
T Consensus 155 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 213 (277)
T cd06640 155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213 (277)
T ss_pred ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh
Confidence 2 122345788999999998888999999999999999999999999988776655543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=272.60 Aligned_cols=203 Identities=26% Similarity=0.401 Sum_probs=176.8
Q ss_pred eeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEeec
Q 015556 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264 (405)
Q Consensus 187 lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 264 (405)
||.|++|.||++.+. ++.||||++....... ....+.+.+|+.+++.++||||+++++.+.++..+++||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE-----TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchh-----hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecC
Confidence 589999999999997 7899999997543222 123567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCCCCCCC
Q 015556 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344 (405)
Q Consensus 265 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 344 (405)
++++|.+++.+ ...+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++.............
T Consensus 76 ~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~ 153 (262)
T cd05572 76 LGGELWTILRD--RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC 153 (262)
T ss_pred CCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccccc
Confidence 99999999986 3468999999999999999999999999999999999999999999999999986554432333456
Q ss_pred CCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHH
Q 015556 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN--PIQAAFAVV 396 (405)
Q Consensus 345 gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~--~~e~~~~i~ 396 (405)
++..|++||.+.+..++.++|+||||+++|+|++|..||.... +.+....+.
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 207 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL 207 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHh
Confidence 8899999999988889999999999999999999999998777 666666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=277.21 Aligned_cols=212 Identities=27% Similarity=0.429 Sum_probs=177.9
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||.|++|.||+|.+. ++.||||.+........ ..+.+.+|+.++++++|+||+++++++.+...
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEG------VPSTAIREISLLKEMQHGNIVRLQDVVHSEKR 75 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccccc------chHHHHHHHHHHHhccCCCEeeEEEEEecCCe
Confidence 57889999999999999999975 68899999865433221 23567789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC-CCcEEEEecCCccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-EFHLKIADFGIACEEV 335 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~-~~~vkL~DFG~a~~~~ 335 (405)
+++||||++ ++|.+++.......+++..+..++.||+.||+|||+++++||||+|+||+++. ++.+||+|||++....
T Consensus 76 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 76 LYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred EEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 999999995 58888887654455788889999999999999999999999999999999985 5679999999985432
Q ss_pred c-cCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 336 Y-CDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 336 ~-~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
. ........++..|+|||++.+ ..++.++||||||+++|+|++|..||......+...++.+
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~ 218 (294)
T PLN00009 155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFR 218 (294)
T ss_pred CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2 122234467889999998865 4578999999999999999999999999888877777654
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=271.49 Aligned_cols=203 Identities=30% Similarity=0.548 Sum_probs=169.9
Q ss_pred ceeeeeeeEEEEEEEECC-----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEE
Q 015556 185 LRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV 259 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~~-----~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 259 (405)
++||+|+||.||+|.+.. ..||+|.+...... ...+++.+|+.+++.+.|+||+++++++.. ..+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 72 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-------AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLML 72 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEE
Confidence 368999999999998742 57999998754332 225678899999999999999999998874 45789
Q ss_pred EEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCC
Q 015556 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA 339 (405)
Q Consensus 260 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~ 339 (405)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+++++||||||+|||++.++.+||+|||++........
T Consensus 73 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 73 VMELAPLGPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred EEEeCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 9999999999999987 34789999999999999999999999999999999999999999999999999864432221
Q ss_pred ----CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015556 340 ----LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 340 ----~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~ 397 (405)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~ 213 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES 213 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence 111223567999999998889999999999999999998 9999998887665555443
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=270.85 Aligned_cols=210 Identities=35% Similarity=0.644 Sum_probs=179.8
Q ss_pred eecceeeeeeeEEEEEEEECC------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 182 FLGLRFAHGAHSRLYHGIYKD------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 182 ~~~~~lG~G~~g~Vy~~~~~~------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.+++.||.|+||.||++.+.+ ..||+|++......+ ..+.+..|+.++..++|+||+++++++.+..
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 74 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ-------QIEEFLREARIMRKLDHPNIVKLLGVCTEEE 74 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH-------HHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 467889999999999999874 789999996543321 2567889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
..++||||+++++|.+++.......+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++....
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 99999999999999999987443338999999999999999999999999999999999999999999999999986544
Q ss_pred ccCCCC--CCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 336 YCDALS--DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 336 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
...... ...++..|+|||.+....++.++||||||+++|+|++ |..||...+..+....+.+.
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~ 220 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG 220 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence 322211 2337789999999988889999999999999999998 89999988777766665544
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=277.23 Aligned_cols=210 Identities=27% Similarity=0.410 Sum_probs=179.3
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||+|++|.||+|.+. ++.||||.+....... ...+.+.+|++++++++|+||+++++++..+..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 74 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE------DVKKTALREVKVLRQLRHENIVNLKEAFRRKGR 74 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccc------cchhHHHHHHHHHHhcCCCCeeehhheEEECCE
Confidence 36889999999999999999986 6899999987543322 124678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
.++||||++++.+..++.. ...+++..+..++.||+.||.|||+.+++|+||+|+||++++++.+||+|||++.....
T Consensus 75 ~~iv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 75 LYLVFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred EEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 9999999988766665544 35689999999999999999999999999999999999999999999999999865443
Q ss_pred cC--CCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015556 337 CD--ALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 337 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~ 396 (405)
.. ......++..|+|||++.+. .++.++||||||+++|+|++|..||......+.+..+.
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 215 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQ 215 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 32 33445688899999999887 78999999999999999999999999887776665543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=278.46 Aligned_cols=209 Identities=24% Similarity=0.396 Sum_probs=172.5
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+.+.||.|++|.||+|.+. |+.||+|.+........ ....+.+|+.++++++|+||+++++++.+...+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~------~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 74 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG------VPSSALREICLLKELKHKNIVRLYDVLHSDKKL 74 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccccc------CccchhHHHHHHHhcCCCCeeeHHHHhccCCce
Confidence 4678889999999999999985 78999999976433221 134567899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
++|+||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 75 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 75 TLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred EEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 99999996 5888888753 356899999999999999999999999999999999999999999999999998643221
Q ss_pred -CCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHH
Q 015556 338 -DALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPY-EEMNPIQAAFAVV 396 (405)
Q Consensus 338 -~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf-~~~~~~e~~~~i~ 396 (405)
.......++..|+|||++.+. .++.++|||||||++|+|++|..|| .+.+..+.+..+.
T Consensus 153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~ 214 (284)
T cd07839 153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 214 (284)
T ss_pred CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHH
Confidence 222345678999999998764 4689999999999999999988885 5555544444443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=276.16 Aligned_cols=204 Identities=27% Similarity=0.440 Sum_probs=175.3
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||.|++|.||++... ++.||||.+...+..+ ......+.+|+.+++.++|+||+++++++.++..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD-----AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhh-----HHHHHHHHHHHHHHHHccCCchhhhhheeEeCCe
Confidence 56788899999999999999964 7899999887544322 1224678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 257 YCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
.++||||+++++|.+++... ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 99999999999999998753 2356899999999999999999999999999999999999999999999999987543
Q ss_pred cccC-CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 335 VYCD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 335 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
.... ......|+..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred ccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 3221 2233468899999999988889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=276.62 Aligned_cols=213 Identities=28% Similarity=0.471 Sum_probs=180.0
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+.+.||.|++|.||+|.+. ++.||||.+........ ....+.+|++++++++||||+++++++.+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG------VPSTAIREISLLKELNHPNIVKLLDVIHTENKL 74 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccc------cchHHHHHHHHHHhcCCCCCcchhhhcccCCcE
Confidence 3678889999999999999885 68999999875433221 135678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
++||||+. ++|.+++.......+++..++.++.|++.||+|||+.+++||||+|+||+++.++.+||+|||++......
T Consensus 75 ~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 75 YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999995 68999998766677899999999999999999999999999999999999999999999999998543221
Q ss_pred -CCCCCCCCCCcccCcccccccc-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 338 -DALSDDPGTYRWMAPEMIKHKS-YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 338 -~~~~~~~gt~~y~aPE~~~~~~-~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
.......++..|+|||++.+.. ++.++||||||+++|+|++|..||...+..+..+++++..
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~ 217 (284)
T cd07860 154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 217 (284)
T ss_pred ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence 2223345788999999886644 5889999999999999999999999888777777666543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=272.06 Aligned_cols=203 Identities=26% Similarity=0.432 Sum_probs=175.5
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||.|++|.||+|... ++.||+|.++.....+. ...+.+.+|+.++++++|+||+++++++.+...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDA-----KARQDCLKEIDLLKQLDHPNVIKYLASFIENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccch-----hhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence 57889999999999999999986 78999999875443222 124678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 257 YCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
.++||||+++++|.+++... ....+++..++.++.+++.||.|||+.||+||||+|+||+++.++.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 99999999999999998753 2355889999999999999999999999999999999999999999999999988543
Q ss_pred cccC-CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 335 VYCD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 335 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
.... ......++..|+|||.+.+..++.++|||||||++|+|++|..||...
T Consensus 157 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred cCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 3221 123345888999999999888999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=298.14 Aligned_cols=190 Identities=26% Similarity=0.385 Sum_probs=164.7
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
...|.+.+.||+|+||.||++.+. ++.||||... ...+.+|+++|++|+|+|||++++++..++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~ 233 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------------YASSVHEARLLRRLSHPAVLALLDVRVVGG 233 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------------ccCHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence 357889999999999999999986 5789999643 123458999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
..++|||++ .++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 234 ~~~lv~e~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 234 LTCLVLPKY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred EEEEEEEcc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 999999999 46999988763 3478999999999999999999999999999999999999999999999999986432
Q ss_pred ccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCC
Q 015556 336 YCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383 (405)
Q Consensus 336 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf 383 (405)
... ......||..|+|||++.+..++.++|||||||+||||++|..|+
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 211 122346999999999999999999999999999999999987654
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=274.52 Aligned_cols=202 Identities=25% Similarity=0.398 Sum_probs=178.4
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+.+.||.|+||.||++.+. ++.||+|++....... .+..+.+.+|++++++++||||+++++++.++...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE-----KGSVRNVLNERRILQELNHPFLVNLWYSFQDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcc-----hhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeE
Confidence 4778899999999999999986 7899999997533222 12356788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
++||||+.+++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred EEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999999999873 57899999999999999999999999999999999999999999999999998654443
Q ss_pred CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 015556 338 DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP 388 (405)
Q Consensus 338 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~ 388 (405)
.......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 154 TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred ccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 333455688999999999888899999999999999999999999998774
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=276.27 Aligned_cols=197 Identities=25% Similarity=0.421 Sum_probs=170.6
Q ss_pred eeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEeec
Q 015556 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264 (405)
Q Consensus 187 lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 264 (405)
||+|+||+||++... ++.||||++....... ......+..|+.++++++||||+++++++.....+|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK-----RKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh-----hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecC
Confidence 589999999999875 6899999987432211 112456678999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCCCCCCC
Q 015556 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344 (405)
Q Consensus 265 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 344 (405)
++++|.+++.......+++..++.++.|++.||.|||+.|++||||+|+|||++.++.++|+|||++.............
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 155 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA 155 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccccc
Confidence 99999999987555578999999999999999999999999999999999999999999999999986544333334456
Q ss_pred CCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 015556 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP 388 (405)
Q Consensus 345 gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~ 388 (405)
++..|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 88899999999888899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=285.40 Aligned_cols=211 Identities=24% Similarity=0.374 Sum_probs=178.5
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC-
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP- 254 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~- 254 (405)
..+|.+.+.||+|+||.||++.+. ++.||||.+........ ....+.+|+.++++++|+||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVT------HAKRAYRELVLMKLVNHKNIIGLLNVFTPQK 88 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChh------HHHHHHHHHHHHHhcCCCCCcceeeeeccCC
Confidence 467889999999999999999975 68999999864332221 134567899999999999999999988643
Q ss_pred -----CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 255 -----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 255 -----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
...|+||||+. ++|.+++.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 89 SLEEFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CccccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999995 588888865 28899999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 330 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
++.............++..|+|||++.+..++.++|||||||++|+|++|..||...+.......+++..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 233 (353)
T cd07850 164 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL 233 (353)
T ss_pred cceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence 9865444333344568899999999999999999999999999999999999999888777766665543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=277.62 Aligned_cols=204 Identities=26% Similarity=0.434 Sum_probs=172.8
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||+|+||.||++.+. ++.||+|.+....... ....+.+|+.++++++|+||+++++++..+..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~-------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDES-------KFNQIIMELDILHKAVSPYIVDFYGAFFIEGA 73 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHH-------HHHHHHHHHHHHHhcCCCcHHhhhhheecCCe
Confidence 36788899999999999999986 7899999987532211 13578899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLE-HKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
+++||||+++++|.+++.... ...+++..+..++.|++.||.|||+ .||+||||||+|||++.++.++|+|||++...
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 153 (286)
T cd06622 74 VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL 153 (286)
T ss_pred EEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999999999999987632 2378999999999999999999997 59999999999999999999999999998543
Q ss_pred cccCCCCCCCCCCcccCccccccc------cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 015556 335 VYCDALSDDPGTYRWMAPEMIKHK------SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390 (405)
Q Consensus 335 ~~~~~~~~~~gt~~y~aPE~~~~~------~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e 390 (405)
.. .......++..|+|||++.+. .++.++|||||||++|+|++|..||.......
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 214 (286)
T cd06622 154 VA-SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN 214 (286)
T ss_pred cC-CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh
Confidence 22 222344688899999998543 35789999999999999999999997655443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=277.86 Aligned_cols=213 Identities=27% Similarity=0.391 Sum_probs=178.6
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+++.||.|++|.||+|.+. ++.||||.+......... ......+..|+.++++++|+||+++++++.+....
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 77 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAK---DGINFTALREIKLLQELKHPNIIGLLDVFGHKSNI 77 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccccc---chhhHHHHHHHHHHhhcCCCCChhhhheeecCCEE
Confidence 3677889999999999999985 689999999865443111 12245677899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++......
T Consensus 78 ~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 78 NLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999999 899999997632 37899999999999999999999999999999999999999999999999998654322
Q ss_pred -CCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 338 -DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 338 -~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|..||......+....+..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~ 217 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFE 217 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHH
Confidence 22233457888999998854 4578999999999999999999999988777666555543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=271.50 Aligned_cols=205 Identities=27% Similarity=0.460 Sum_probs=175.0
Q ss_pred ceeeeeeeEEEEEEEECC-----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEE
Q 015556 185 LRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV 259 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~~-----~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 259 (405)
+.||+|++|.||+|.+.. ..||||.+...... ...+.+.+|+.++++++|+||+++++.+.+ ..+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 72 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMM 72 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-------HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEE
Confidence 357999999999998742 36899998754432 336788899999999999999999999988 88999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccC-
Q 015556 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD- 338 (405)
Q Consensus 260 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~- 338 (405)
||||+++++|.+++.......+++..++.++.|++.||.|||++|++||||+|+|||++.++.+||+|||++.......
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 73 VTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred EEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccc
Confidence 9999999999999987443578999999999999999999999999999999999999999999999999985432211
Q ss_pred ---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015556 339 ---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 339 ---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~ 397 (405)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+..
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 215 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK 215 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 1123457789999999998899999999999999999999 9999998888876665553
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=280.78 Aligned_cols=192 Identities=26% Similarity=0.390 Sum_probs=157.7
Q ss_pred ecceeeeeeeEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee--cCCe
Q 015556 183 LGLRFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK--KPPV 256 (405)
Q Consensus 183 ~~~~lG~G~~g~Vy~~~~~----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~ 256 (405)
.+.+||+|+||.||+|... +..||||.+..... ...+.+|+.+++.++||||+++++++. .+..
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 74 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----------SMSACREIALLRELKHPNVIALQKVFLSHSDRK 74 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCe
Confidence 3468999999999999964 36899998864322 134568999999999999999999885 3567
Q ss_pred eEEEEeecCCCCHHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE----CCCCcEEE
Q 015556 257 YCVITEYLSEGSLRAYLHKL-------EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI----DQEFHLKI 325 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl----~~~~~vkL 325 (405)
+++||||+. ++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07867 75 VWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEE
Confidence 899999985 5888887532 12357888999999999999999999999999999999999 56689999
Q ss_pred EecCCccccccc----CCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 326 ADFGIACEEVYC----DALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 326 ~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
+|||++...... .......||..|+|||++.+. .++.++|||||||++|||++|..||..
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 999998643221 122344689999999998764 579999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=277.85 Aligned_cols=210 Identities=30% Similarity=0.545 Sum_probs=174.3
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC------------------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK------------------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL 239 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~------------------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l 239 (405)
.++|++.+.||+|+||.||++.+. +..||||++...... ....++.+|+.+++.+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~-------~~~~~~~~E~~~l~~l 76 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK-------NARNDFLKEIKIMSRL 76 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH-------HHHHHHHHHHHHHHhC
Confidence 357889999999999999998643 236899998744321 1246788999999999
Q ss_pred CCCCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q 015556 240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH---------KTLPLPKLIAIALDIARGMEYIHSQGVIHRDL 310 (405)
Q Consensus 240 ~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDI 310 (405)
+|+||+++++++......++||||+++++|.+++..... ..+++..++.++.|++.||+|||++|++||||
T Consensus 77 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl 156 (296)
T cd05095 77 KDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDL 156 (296)
T ss_pred CCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccC
Confidence 999999999999999999999999999999999986421 24677889999999999999999999999999
Q ss_pred CCCcEEECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 015556 311 KPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA--GTIPYEE 385 (405)
Q Consensus 311 kp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt--G~~Pf~~ 385 (405)
||+|||++.++.++|+|||++....... ......++..|++||...+..++.++|||||||++|||++ |..||..
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 9999999999999999999986432211 1112234678999999888889999999999999999998 7899988
Q ss_pred CCHHHHHHH
Q 015556 386 MNPIQAAFA 394 (405)
Q Consensus 386 ~~~~e~~~~ 394 (405)
.+..+....
T Consensus 237 ~~~~~~~~~ 245 (296)
T cd05095 237 LSDEQVIEN 245 (296)
T ss_pred cChHHHHHH
Confidence 776665443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=273.91 Aligned_cols=212 Identities=31% Similarity=0.459 Sum_probs=172.2
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHH-HHhcCCCCeeEEeeEeecCC
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVAL-LSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~g~~~~~~ 255 (405)
++|.+.+.||+|+||.||++.+. ++.||||.+......+. ..++..|+.+ ++.++||||+++++++..+.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~ 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-------QKRLLMDLDISMRSVDCPYTVTFYGALFREG 73 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-------HHHHHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence 36788899999999999999985 78999999875433221 2345556665 56678999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 256 VYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
..|+||||++ |+|.+++... ....+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++.
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~ 152 (283)
T cd06617 74 DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG 152 (283)
T ss_pred cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 9999999996 6898888653 235689999999999999999999997 99999999999999999999999999986
Q ss_pred cccccCCCCCCCCCCcccCcccccc----ccCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhc
Q 015556 333 EEVYCDALSDDPGTYRWMAPEMIKH----KSYGRKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVVNK 398 (405)
Q Consensus 333 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~DVwSlGvll~elltG~~Pf~~~-~~~e~~~~i~~~ 398 (405)
............++..|+|||.+.+ ..++.++|+|||||++|+|++|..||... ...+....++++
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 223 (283)
T cd06617 153 YLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE 223 (283)
T ss_pred ccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc
Confidence 5433333334568899999998854 45688999999999999999999999753 344555555443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=278.38 Aligned_cols=211 Identities=31% Similarity=0.536 Sum_probs=174.6
Q ss_pred CCCeeecceeeeeeeEEEEEEEECC----------------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYKD----------------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN 241 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~~----------------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H 241 (405)
..+|.+.++||+|+||.||++...+ ..||||.+...... .....|.+|++++++++|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~ei~~l~~l~h 76 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK-------TARNDFLKEIKIMSRLKN 76 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH-------HHHHHHHHHHHHHHhCCC
Confidence 3578899999999999999987642 24899998743221 124578899999999999
Q ss_pred CCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 015556 242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE----------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLK 311 (405)
Q Consensus 242 pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIk 311 (405)
+||+++++++......++||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++|||||
T Consensus 77 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlk 156 (295)
T cd05097 77 PNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLA 156 (295)
T ss_pred CCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccC
Confidence 999999999999999999999999999999996532 1246888999999999999999999999999999
Q ss_pred CCcEEECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh--CCCCCCCC
Q 015556 312 PENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA--GTIPYEEM 386 (405)
Q Consensus 312 p~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt--G~~Pf~~~ 386 (405)
|+|||++.++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 999999999999999999985432211 1122345778999999988889999999999999999988 77899887
Q ss_pred CHHHHHHHH
Q 015556 387 NPIQAAFAV 395 (405)
Q Consensus 387 ~~~e~~~~i 395 (405)
...+....+
T Consensus 237 ~~~~~~~~~ 245 (295)
T cd05097 237 SDEQVIENT 245 (295)
T ss_pred ChHHHHHHH
Confidence 766654443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=276.80 Aligned_cols=194 Identities=25% Similarity=0.449 Sum_probs=165.1
Q ss_pred cceeeeeeeEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeecCCeeEEE
Q 015556 184 GLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPVYCVI 260 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~--~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV 260 (405)
++.||+|+|+.|--++. +|..||||++..... ..++++.+|++++.+++ |+||++|+.+|+++..+|||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g--------HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG--------HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCc--------hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence 35789999999987764 689999999975422 23678889999999996 99999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC---CcEEEEecCCcccccc-
Q 015556 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE---FHLKIADFGIACEEVY- 336 (405)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~---~~vkL~DFG~a~~~~~- 336 (405)
||-|.||.|...|++ +..+++.++..+..+|+.||.+||.+||.||||||+|||-... .-+|||||.++.....
T Consensus 155 fEKm~GGplLshI~~--~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~ 232 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQK--RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN 232 (463)
T ss_pred EecccCchHHHHHHH--hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence 999999999999987 5689999999999999999999999999999999999998544 3589999998743221
Q ss_pred -------cCCCCCCCCCCcccCcccc-----ccccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 337 -------CDALSDDPGTYRWMAPEMI-----KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 337 -------~~~~~~~~gt~~y~aPE~~-----~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
...+...+|+..|||||+. ....|+.++|.||||||||-||+|..||.++-
T Consensus 233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred CCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence 1223445689999999986 23468999999999999999999999997643
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=276.78 Aligned_cols=213 Identities=22% Similarity=0.358 Sum_probs=179.9
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC-
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP- 254 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~- 254 (405)
.++|.+.+.||.|+||.||+|.+. ++.+|||.++.....+ .....+.+|+.++.+++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 77 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE------GFPITSLREINILLKLQHPNIVTVKEVVVGSN 77 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc------cchhhHHHHHHHHHhcCCCCEEEEEEEEEecC
Confidence 467888899999999999999986 6889999997554332 1234567899999999999999999998877
Q ss_pred -CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 255 -PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 255 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
...|+||||+. ++|.+++... ...+++..++.++.||+.||+|||+.|++|+||+|+|||++.++.++|+|||++..
T Consensus 78 ~~~~~lv~e~~~-~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~ 155 (293)
T cd07843 78 LDKIYMVMEYVE-HDLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLARE 155 (293)
T ss_pred CCcEEEEehhcC-cCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceee
Confidence 88999999996 5999988763 24689999999999999999999999999999999999999999999999998865
Q ss_pred cccc-CCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 334 EVYC-DALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 334 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||......+...++...
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~ 222 (293)
T cd07843 156 YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKL 222 (293)
T ss_pred ccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 4332 223344578899999998654 4689999999999999999999999988887777666543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=277.93 Aligned_cols=214 Identities=24% Similarity=0.381 Sum_probs=179.9
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
..++|.+.+.||.|+||.||+|.+. ++.||+|.+......... ...+.+|+.++++++|+||+++++++.+.
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGI------PISSLREITLLLNLRHPNIVELKEVVVGK 78 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCC------cchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence 4578999999999999999999985 789999999764432211 22455799999999999999999998754
Q ss_pred --CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 255 --PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 255 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
..+++||||+. ++|.+++... ...+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++.
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~ 156 (309)
T cd07845 79 HLDSIFLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLAR 156 (309)
T ss_pred CCCeEEEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceee
Confidence 56899999996 5899988763 3678999999999999999999999999999999999999999999999999986
Q ss_pred ccccc-CCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 333 EEVYC-DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 333 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
..... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||...++.+.+..+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~ 224 (309)
T cd07845 157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQL 224 (309)
T ss_pred ecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 54322 22233446788999999865 45789999999999999999999999999988888777664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=274.27 Aligned_cols=210 Identities=27% Similarity=0.477 Sum_probs=176.3
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeec--
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKK-- 253 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~-- 253 (405)
+.|.+.+.||.|+||.||+|.+. ++.||+|++..... ...++..|+.++.++ +|+||+++++++..
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~---------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED---------EEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH---------HHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 56778889999999999999985 68999999864321 134577899999999 69999999999853
Q ss_pred ----CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 254 ----PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 254 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
...+|+||||+++|+|.+++.......+++..++.++.||+.||.|||++||+|+||+|+||++++++.++|+|||
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg 166 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG 166 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCc
Confidence 4578999999999999999987666678899999999999999999999999999999999999999999999999
Q ss_pred Ccccccc-cCCCCCCCCCCcccCccccc-----cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 330 IACEEVY-CDALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 330 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
++..... ........|+..|+|||.+. ...++.++|||||||++|||++|..||....+.+....+.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 240 (282)
T cd06636 167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 240 (282)
T ss_pred chhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh
Confidence 9854322 12223456899999999885 34678899999999999999999999988877666655443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=273.07 Aligned_cols=201 Identities=25% Similarity=0.441 Sum_probs=169.4
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
.+|.+.+.||+|+||.||+|... ++.||||++........ ...+.+|+.+++.++|+||+++++++..+..
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 77 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-------PFTAIREASLLKGLKHANIVLLHDIIHTKET 77 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCC-------cHHHHHHHHHHHhcCCCCEeEEEEEEecCCe
Confidence 57888999999999999999875 68999999975443221 2355689999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
.|+||||+. ++|.+++... ...+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++.....
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred EEEEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 999999995 6888877653 34578888999999999999999999999999999999999999999999998854322
Q ss_pred -cCCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 015556 337 -CDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNP 388 (405)
Q Consensus 337 -~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~ 388 (405)
........++..|+|||++.+. .++.++|||||||++|+|++|..||.....
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 156 PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 1223344578999999998754 578899999999999999999999987554
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=276.34 Aligned_cols=202 Identities=26% Similarity=0.438 Sum_probs=176.5
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
..++|.+.+.||+|+||+||++... ++.||+|++....... ..+++.+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSS-------VRKQILRELQIMHECRSPYIVSFYGAFLNE 75 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcch-------HHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence 3467889999999999999999986 7899999987543221 256788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
..+++||||+++++|.+++.. .+.+++..+..++.+++.+|.|||+ .+++||||+|+||+++.++.++|+|||++..
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~ 153 (284)
T cd06620 76 NNICMCMEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGE 153 (284)
T ss_pred CEEEEEEecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccc
Confidence 999999999999999999876 4578999999999999999999997 6899999999999999999999999998754
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP 388 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~ 388 (405)
.... ......|+..|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 154 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 154 LINS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred hhhh-ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 3221 22345689999999999888899999999999999999999999987554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=276.51 Aligned_cols=210 Identities=25% Similarity=0.403 Sum_probs=177.6
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||+|+||.||+|.+. ++.||||++....... ...+.+.+|+++++.++||||+++++++..+..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 74 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK------MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR 74 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc------hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe
Confidence 36788899999999999999985 6899999986433322 124567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
.++||||++++.|..+... ...+++..++.++.||+.||.|||+.||+|+||+|+||++++++.++|+|||++.....
T Consensus 75 ~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 75 LYLVFEFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred EEEEEecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999999999888887654 34589999999999999999999999999999999999999999999999999864322
Q ss_pred c-CCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015556 337 C-DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 337 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~ 396 (405)
. .......++..|+|||++.+ ..++.++||||||+++|||++|..||......+....+.
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 214 (286)
T cd07846 153 PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII 214 (286)
T ss_pred CccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 2 22233458889999999875 346889999999999999999999998877766665554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=271.80 Aligned_cols=204 Identities=28% Similarity=0.490 Sum_probs=173.2
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|..++.||+|++|.||++... ++.||||++........ ......+.+.+|+.++++++|+||+++++++.+.+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSS--EQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCch--hHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeE
Confidence 3667889999999999999874 68999999975443221 1123467889999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCC-cEEEEecCCcccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-HLKIADFGIACEEVY 336 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~-~vkL~DFG~a~~~~~ 336 (405)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 79 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEEEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999999999976 35788999999999999999999999999999999999998775 699999999855432
Q ss_pred cC-----CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 337 CD-----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 337 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
.. ......++..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 11 1123457889999999988889999999999999999999999997544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=268.98 Aligned_cols=200 Identities=31% Similarity=0.551 Sum_probs=174.2
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+.+.||+|++|.||+|... ++.||||.+...... ....+.+..|+.++++++|+||+++++.+.....+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 74 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND------PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV 74 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc------hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEE
Confidence 4778899999999999999874 689999999865543 12357889999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||++++++.+||+|||++......
T Consensus 75 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 75 YIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred EEEEecCCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 999999999999999986 345788999999999999999999999999999999999999999999999998654322
Q ss_pred CC-----CCCCCCCCcccCcccccccc---CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 338 DA-----LSDDPGTYRWMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 338 ~~-----~~~~~gt~~y~aPE~~~~~~---~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
.. .....++..|+|||++.+.. ++.++||||||+++|+|++|..||...+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~ 210 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence 11 12346788999999997766 7899999999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=277.55 Aligned_cols=206 Identities=31% Similarity=0.538 Sum_probs=175.9
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
.|...+.||.|+||.||+|.+. ++.||||.+....... ..+.+.+|+.++++++|+||+++++++..+..+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED-------EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKL 77 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH-------HHHHHHHHHHHHHcCCCCccHhhhcccccCCce
Confidence 3556678999999999999875 6789999987443221 246788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
++||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred EEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 999999999999998864 56889999999999999999999999999999999999999999999999998543322
Q ss_pred C-CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015556 338 D-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395 (405)
Q Consensus 338 ~-~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i 395 (405)
. ......++..|+|||.+.+..++.++|||||||++|||++|..||....+.+....+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 213 (277)
T cd06642 155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213 (277)
T ss_pred chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh
Confidence 1 112345888999999999888999999999999999999999999877666554443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=268.10 Aligned_cols=211 Identities=25% Similarity=0.380 Sum_probs=178.0
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec--CC
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK--PP 255 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~ 255 (405)
+|.+.+.||.|+||.||++... ++.||+|++........ ..+++..|+++++.++|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK------EKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHH------HHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence 4678889999999999999875 68899999876544322 14678899999999999999999998754 45
Q ss_pred eeEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH-----HCCceecCCCCCcEEECCCCcEEEEec
Q 015556 256 VYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIH-----SQGVIHRDLKPENVLIDQEFHLKIADF 328 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH-----~~gIiHrDIkp~NILl~~~~~vkL~DF 328 (405)
..+++|||+++++|.+++... ....+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.+||+||
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~ 154 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF 154 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecc
Confidence 689999999999999999764 2457899999999999999999999 889999999999999999999999999
Q ss_pred CCcccccccCC-CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015556 329 GIACEEVYCDA-LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 329 G~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~ 396 (405)
|++........ .....++..|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.
T Consensus 155 g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 223 (265)
T cd08217 155 GLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK 223 (265)
T ss_pred cccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh
Confidence 99865433222 334568999999999988889999999999999999999999999877554444433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=271.91 Aligned_cols=206 Identities=31% Similarity=0.538 Sum_probs=176.9
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeE
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC 258 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 258 (405)
|.+.+.||.|+||.||+|.+. ++.||||++....... ..+.+.+|+.++.+++||||+++++++.++..++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 78 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-------EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 78 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchH-------HHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEE
Confidence 557788999999999999874 6899999986433221 2467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccC
Q 015556 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~ 338 (405)
+||||+++++|.+++.. ..+++..+..++.|++.++.|||+.|++|+||+|.||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 79 IIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 99999999999999875 568999999999999999999999999999999999999999999999999885432211
Q ss_pred -CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015556 339 -ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 339 -~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~ 396 (405)
......++..|+|||.+.+..++.++|||||||++|+|++|..||....+......+.
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 214 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP 214 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh
Confidence 1223458889999999988888999999999999999999999999887766555543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=299.53 Aligned_cols=210 Identities=25% Similarity=0.473 Sum_probs=181.6
Q ss_pred eeecceeeeeeeEEEEEEEECC--ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeE
Q 015556 181 LFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC 258 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~~--~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 258 (405)
+.+++.||.|+||.||++..+. -..|-|+|......+ ...|.-||+||..+.||+||+|+++|...+.+|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEE--------LEDylVEIeILa~CdHP~ivkLl~ayy~enkLw 105 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEE--------LEDYLVEIEILAECDHPVIVKLLSAYYFENKLW 105 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhH--------HhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence 3467789999999999998874 455667776443322 467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc-ccc
Q 015556 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-VYC 337 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~-~~~ 337 (405)
++.|||.||-....+-. .+..+++.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+... ...
T Consensus 106 iliEFC~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~ 184 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR 184 (1187)
T ss_pred EEEeecCCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHH
Confidence 99999999988877766 3578999999999999999999999999999999999999999999999999987542 223
Q ss_pred CCCCCCCCCCcccCcccc-----ccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 338 DALSDDPGTYRWMAPEMI-----KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 338 ~~~~~~~gt~~y~aPE~~-----~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
.....+.||++|||||++ ...+|+.++||||||++|.||..+.+|..+.+|+-.+.+|.+..
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe 251 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE 251 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC
Confidence 344567899999999986 45689999999999999999999999999999999998887653
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=272.21 Aligned_cols=213 Identities=24% Similarity=0.482 Sum_probs=178.5
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
..++|.+...||.|+||.||+|... .+.|++|.+...... .....+.+|+.++++++|+||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~ 75 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE-------NLQSEFRRELDMFRKLSHKNVVRLLG 75 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch-------HHHHHHHHHHHHHHhcCCcceeeeEE
Confidence 3467888899999999999999863 367999987643321 12466889999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCc
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEH-------KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~ 322 (405)
++.+....|+||||+++++|.+++..... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~ 155 (275)
T cd05046 76 LCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE 155 (275)
T ss_pred EECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc
Confidence 99999999999999999999999986431 26899999999999999999999999999999999999999999
Q ss_pred EEEEecCCccccccc--CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 015556 323 LKIADFGIACEEVYC--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 323 vkL~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~ 396 (405)
++|+|||++...... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.
T Consensus 156 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~ 232 (275)
T cd05046 156 VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ 232 (275)
T ss_pred EEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH
Confidence 999999987533211 12233346778999999988888999999999999999999 899998877766655554
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=271.11 Aligned_cols=207 Identities=22% Similarity=0.454 Sum_probs=167.7
Q ss_pred eeeeeeeEEEEEEEEC-Cc---cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEE
Q 015556 186 RFAHGAHSRLYHGIYK-DE---PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261 (405)
Q Consensus 186 ~lG~G~~g~Vy~~~~~-~~---~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 261 (405)
.||+|+||.||+|... +. .+++|.+...... ...+.+.+|+.++..++||||+++++.|.+....|+||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~ 74 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS-------KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVF 74 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh-------HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEE
Confidence 5799999999999754 32 4556665543221 12467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc--
Q 015556 262 EYLSEGSLRAYLHKLE--HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-- 337 (405)
Q Consensus 262 E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~-- 337 (405)
||+++|+|.+++.... ....++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh
Confidence 9999999999998642 234667778899999999999999999999999999999999999999999987532211
Q ss_pred -CCCCCCCCCCcccCcccccc-------ccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 338 -DALSDDPGTYRWMAPEMIKH-------KSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 338 -~~~~~~~gt~~y~aPE~~~~-------~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
.......++..|+|||++.. ..++.++||||||+++|||++ |..||...+..+....++++.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 225 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQ 225 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhc
Confidence 11234467889999998743 245789999999999999997 688999888888777766554
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=273.16 Aligned_cols=211 Identities=25% Similarity=0.426 Sum_probs=174.6
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEee-
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACK- 252 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~- 252 (405)
-.++|.+.+.||+|+||.||++.+. ++.+|||++...... ..++..|+.+++.+ +|+||+++++++.
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---------~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI---------DEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch---------HHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 3467888999999999999999885 689999987532211 24577899999999 6999999999884
Q ss_pred ----cCCeeEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEE
Q 015556 253 ----KPPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA 326 (405)
Q Consensus 253 ----~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~ 326 (405)
.+..+++||||+++++|.+++... ....+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 345789999999999999988643 23568889999999999999999999999999999999999999999999
Q ss_pred ecCCccccccc-CCCCCCCCCCcccCcccccc-----ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015556 327 DFGIACEEVYC-DALSDDPGTYRWMAPEMIKH-----KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 327 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~ 396 (405)
|||++...... .......|+..|+|||++.. ..++.++|||||||++|+|++|..||....+.+....+.
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 242 (286)
T cd06638 167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP 242 (286)
T ss_pred cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc
Confidence 99998643321 12233468999999998853 457889999999999999999999999887766655443
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=270.61 Aligned_cols=211 Identities=29% Similarity=0.484 Sum_probs=178.6
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecCC
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPP 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 255 (405)
++|.+.+.||.|++|.||+|... ++.+++|++..... ...++.+|+.+++++ .|+||+++++++....
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---------EEEEIKEEYNILRKYSNHPNIATFYGAFIKKN 76 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---------hHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence 67889999999999999999985 57899999875432 135688999999999 6999999999997644
Q ss_pred ------eeEEEEeecCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEe
Q 015556 256 ------VYCVITEYLSEGSLRAYLHKLE--HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327 (405)
Q Consensus 256 ------~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~D 327 (405)
.+++||||+++++|.+++.... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECC
Confidence 4899999999999999987644 56789999999999999999999999999999999999999999999999
Q ss_pred cCCccccccc-CCCCCCCCCCcccCcccccc-----ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 328 FGIACEEVYC-DALSDDPGTYRWMAPEMIKH-----KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 328 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
||++...... .......|+..|+|||++.. ..++.++||||||+++|+|++|..||....+......+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 233 (275)
T cd06608 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN 233 (275)
T ss_pred CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc
Confidence 9988543221 22234558899999998753 34678999999999999999999999988777776666554
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=279.57 Aligned_cols=203 Identities=27% Similarity=0.499 Sum_probs=174.2
Q ss_pred ecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEE
Q 015556 183 LGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI 260 (405)
Q Consensus 183 ~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 260 (405)
....||+|+||.||++... ++.||||.+..... ...+.+.+|+.+++.++|+||+++++.+..++..++|
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv 97 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ--------QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVV 97 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH--------HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEE
Confidence 3467899999999999874 68999999864221 1245688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc-cCC
Q 015556 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDA 339 (405)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~-~~~ 339 (405)
|||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..... ...
T Consensus 98 ~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 98 MEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred EeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence 999999999998864 4688999999999999999999999999999999999999999999999998854321 112
Q ss_pred CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015556 340 LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 340 ~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~ 396 (405)
.....|+..|+|||++.+..++.++||||||+++|||++|..||...++.+....+.
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~ 231 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR 231 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 233458899999999988889999999999999999999999999888776655543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=267.07 Aligned_cols=199 Identities=33% Similarity=0.500 Sum_probs=176.4
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+.+.||.|++|.||++... ++.||||++...... .....+.+|+.++.+++|+||+++++++..+...
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-------EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEI 74 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeE
Confidence 5778899999999999999986 689999999765432 1256788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||.+.....
T Consensus 75 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999999999863 678999999999999999999999 9999999999999999999999999999865433
Q ss_pred cCCC-CCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 337 CDAL-SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 337 ~~~~-~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
.... ....++..|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 153 TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred CCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 2222 24458899999999998889999999999999999999999998874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=269.09 Aligned_cols=206 Identities=28% Similarity=0.545 Sum_probs=168.1
Q ss_pred ceeeeeeeEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee-cCCeeE
Q 015556 185 LRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK-KPPVYC 258 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~-----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~-~~~~~~ 258 (405)
+.||+|+||.||+|.+. ...||||.+...... .....+.+|+.+++.++||||+++++++. .+...+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 73 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL-------EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPL 73 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCH-------HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcE
Confidence 35799999999999863 247999987532211 11457889999999999999999999775 456688
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc-
Q 015556 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC- 337 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~- 337 (405)
+||||+.+++|.+++... ...+++..++.++.|++.||.|||+.+++||||||+|||+++++.+||+|||++......
T Consensus 74 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 74 VVLPYMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred EEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 999999999999999763 345677788899999999999999999999999999999999999999999998543211
Q ss_pred ----CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 338 ----DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 338 ----~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+..+
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~ 218 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG 218 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 11123346778999999988889999999999999999999 67788888887766666554
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=284.67 Aligned_cols=220 Identities=26% Similarity=0.434 Sum_probs=189.0
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEECC--ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEee
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVA 249 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g 249 (405)
...+...+|.++..||.|+||.|.++..+| +.+|||+++..-.-++.++ .--..|..+|... +-|.+++++.
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDv-----ectm~EKrvLAL~~kppFL~qlHS 417 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDV-----ECTMVEKRVLALPGKPPFLVQLHS 417 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcc-----cceehhhhheecCCCCchHHHHHH
Confidence 446778899999999999999999998875 8999999875432221111 1223577777766 4689999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
+|+.-..+|+||||+.||+|--.++. -+.+.+..+..++.+|+-||-+||++|||+||||..|||+|.+|++||+|||
T Consensus 418 cFQTmDRLyFVMEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFG 495 (683)
T KOG0696|consen 418 CFQTMDRLYFVMEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFG 495 (683)
T ss_pred HhhhhhheeeEEEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecc
Confidence 99999999999999999999888877 4678888999999999999999999999999999999999999999999999
Q ss_pred Ccccccc-cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 330 IACEEVY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 330 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
++.+... .......+||+.|+|||++.-.+|+..+|.||+||+|||||.|+.||++.+..+...+|+..+
T Consensus 496 mcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn 566 (683)
T KOG0696|consen 496 MCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN 566 (683)
T ss_pred cccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc
Confidence 9977544 344557789999999999999999999999999999999999999999999988888887643
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=271.70 Aligned_cols=212 Identities=27% Similarity=0.438 Sum_probs=177.2
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKP 254 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~ 254 (405)
.++|.+.+.||+|+||.||++... ++.+|||++..... ....+.+|+.++.++ +||||++++++|...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---------~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---------VDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---------HHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 467889999999999999999985 68999999864221 134567899999999 799999999998753
Q ss_pred -----CeeEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEe
Q 015556 255 -----PVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327 (405)
Q Consensus 255 -----~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~D 327 (405)
..+++||||+++++|.+++... ....+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~d 171 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVD 171 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEee
Confidence 3589999999999999998743 345789999999999999999999999999999999999999999999999
Q ss_pred cCCcccccccC-CCCCCCCCCcccCccccccc-----cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 328 FGIACEEVYCD-ALSDDPGTYRWMAPEMIKHK-----SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 328 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
||++....... ......|+..|+|||++... .++.++|||||||++|+|++|+.||...++.+....+.+.
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 248 (291)
T cd06639 172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN 248 (291)
T ss_pred cccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC
Confidence 99986433211 12334688999999998543 3678999999999999999999999998887777766544
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=272.47 Aligned_cols=205 Identities=33% Similarity=0.581 Sum_probs=171.3
Q ss_pred eeeeeeeEEEEEEEECC--------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 186 RFAHGAHSRLYHGIYKD--------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 186 ~lG~G~~g~Vy~~~~~~--------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
.||+|+||.||+|...+ +.+|||.+....... ....+.+|+.+++.++||||++++++|......
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ-------EKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQ 74 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchh-------hHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCe
Confidence 57999999999998753 579999886432211 145688899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCC-----cEEEEe
Q 015556 258 CVITEYLSEGSLRAYLHKLE-----HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-----HLKIAD 327 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~-----~vkL~D 327 (405)
++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+++|+||+|+|||++.++ .++|+|
T Consensus 75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence 99999999999999997632 23478899999999999999999999999999999999998877 899999
Q ss_pred cCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015556 328 FGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 328 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~ 397 (405)
||++....... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+..
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 228 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA 228 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc
Confidence 99985432221 1122345788999999998899999999999999999998 9999998887776655543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=270.83 Aligned_cols=211 Identities=24% Similarity=0.441 Sum_probs=177.6
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+.+.||.|++|.||+|.+. ++.||||.+........ ...+.+|+.++++++|+||+++++++.+.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 73 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT-------PSTAIREISLMKELKHENIVRLHDVIHTENKL 73 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccc-------hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcE
Confidence 4778899999999999999985 68999999986543321 24566899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLE-HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
++||||+++ +|.+++.... ...+++..+..++.|++.||.|||+.|++||||+|+||++++++.++|+|||++.....
T Consensus 74 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 74 MLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI 152 (284)
T ss_pred EEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence 999999975 8999887643 24689999999999999999999999999999999999999999999999999854322
Q ss_pred c-CCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 337 C-DALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 337 ~-~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
. .......++..|++||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.+.
T Consensus 153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~ 216 (284)
T cd07836 153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRI 216 (284)
T ss_pred CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 1 122344578899999988654 5689999999999999999999999988877766665543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=271.86 Aligned_cols=195 Identities=21% Similarity=0.453 Sum_probs=161.2
Q ss_pred eeeeeeeEEEEEEEEC--------------------------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc
Q 015556 186 RFAHGAHSRLYHGIYK--------------------------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL 239 (405)
Q Consensus 186 ~lG~G~~g~Vy~~~~~--------------------------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l 239 (405)
.||+|+||.||+|... ...||||++.... ......|.+|+.+++.+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--------~~~~~~~~~~~~~~~~l 73 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--------RDIALAFFETASLMSQV 73 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--------HHHHHHHHHHHHHHhcC
Confidence 5899999999999742 1358888875321 12245688899999999
Q ss_pred CCCCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC
Q 015556 240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319 (405)
Q Consensus 240 ~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~ 319 (405)
+||||++++++|.+....++||||+++|+|..++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 74 ~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~ 152 (274)
T cd05076 74 SHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLAR 152 (274)
T ss_pred CCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEec
Confidence 999999999999999999999999999999999875 3457889999999999999999999999999999999999975
Q ss_pred CC-------cEEEEecCCcccccccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHH
Q 015556 320 EF-------HLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMV-AGTIPYEEMNPIQ 390 (405)
Q Consensus 320 ~~-------~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~ell-tG~~Pf~~~~~~e 390 (405)
.+ .+||+|||++..... .....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||....+.+
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cCcccCccceeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 43 489999998743321 123457888999998865 56799999999999999995 6999998877655
Q ss_pred HH
Q 015556 391 AA 392 (405)
Q Consensus 391 ~~ 392 (405)
..
T Consensus 230 ~~ 231 (274)
T cd05076 230 KE 231 (274)
T ss_pred HH
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=265.70 Aligned_cols=205 Identities=32% Similarity=0.580 Sum_probs=173.9
Q ss_pred ceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEee
Q 015556 185 LRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEY 263 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 263 (405)
++||.|++|.||++.+. ++.||+|.+......+ ....+.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPD-------LKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHH-------HHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEc
Confidence 36899999999999986 7999999987544331 246788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCC---C
Q 015556 264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA---L 340 (405)
Q Consensus 264 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~---~ 340 (405)
+.+++|.+++... ...+++..++.++.+++.+|.|||+++++||||+|+|||++.++.++|+|||++........ .
T Consensus 74 ~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 74 VPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 9999999999763 34678999999999999999999999999999999999999999999999999864321111 0
Q ss_pred CCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015556 341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 341 ~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~ 397 (405)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||....+.+....+..
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~ 210 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES 210 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc
Confidence 11223567999999988889999999999999999999 8999998887665555544
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=278.43 Aligned_cols=204 Identities=27% Similarity=0.466 Sum_probs=175.0
Q ss_pred eecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEE
Q 015556 182 FLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV 259 (405)
Q Consensus 182 ~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 259 (405)
.....||+|+||.||++.+. ++.||||++....... ...+.+|+.++..++||||+++++++..+...++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~i 95 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR--------RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWV 95 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch--------HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEE
Confidence 34457899999999999875 7899999986533221 3557789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc-C
Q 015556 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-D 338 (405)
Q Consensus 260 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~-~ 338 (405)
||||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||+|+|||++.++.++|+|||++...... .
T Consensus 96 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 96 LMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred EEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 9999999999998765 56899999999999999999999999999999999999999999999999988532221 1
Q ss_pred CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015556 339 ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 339 ~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~ 396 (405)
......|+..|+|||++.+..++.++|||||||++|||++|..||...++.+....+.
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~ 230 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 230 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 2234568999999999988889999999999999999999999998888777665543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=277.21 Aligned_cols=211 Identities=23% Similarity=0.400 Sum_probs=178.1
Q ss_pred eeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEE
Q 015556 181 LFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI 260 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 260 (405)
+.+++.+|.|+++.||++...++.||||++........ ..+.+.+|+.+++.++|+||+++++++.+....+++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~------~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 77 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKE------DLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVV 77 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchh------HHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEE
Confidence 34677778888888998888899999999986532221 246788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc---
Q 015556 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC--- 337 (405)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~--- 337 (405)
|||+++++|.+++.......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||.+......
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 99999999999998765567899999999999999999999999999999999999999999999999987543211
Q ss_pred -----CCCCCCCCCCcccCcccccc--ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 338 -----DALSDDPGTYRWMAPEMIKH--KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 338 -----~~~~~~~gt~~y~aPE~~~~--~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
.......++..|+|||++.+ ..++.++|||||||++|||++|..||............++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~ 224 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR 224 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 11233457788999999865 3578999999999999999999999998877666554443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=270.44 Aligned_cols=212 Identities=28% Similarity=0.458 Sum_probs=180.1
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc---CCCCeeEEeeEeecCC
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL---HNPNVIKFVAACKKPP 255 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~~~ 255 (405)
|.+.+.||.|+||.||+|.+. ++.||||++......+.. ...+.+|+.++.++ +|+||+++++++....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI------PLSTLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchh------hhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 467789999999999999986 689999999865443211 23455788777766 5999999999998776
Q ss_pred e-----eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 256 V-----YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 256 ~-----~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
. ++++|||+.+ +|.+++.......+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+
T Consensus 75 ~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 75 TDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred CCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCc
Confidence 6 9999999964 899998875545689999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
+.............++..|+|||++.+..++.++|||||||++|+|++|..||......+...++....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 222 (287)
T cd07838 154 ARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVI 222 (287)
T ss_pred ceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHc
Confidence 866544444445568899999999998889999999999999999999999999988888777776543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=271.24 Aligned_cols=198 Identities=30% Similarity=0.511 Sum_probs=174.5
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+.+.||.|++|.||++.+. ++.||+|.+...... ....++.+|++++++++||||+++++++.....+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 74 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-------AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDI 74 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-------HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEE
Confidence 5677889999999999999986 689999998764332 1256788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+ .|++|+||+|+||++++++.++|+|||.+.....
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred EEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 99999999999999998743 678899999999999999999999 9999999999999999999999999999855432
Q ss_pred cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 337 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
... ....++..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 154 ~~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 154 SLA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred HHh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 222 1267889999999999889999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=272.44 Aligned_cols=213 Identities=24% Similarity=0.396 Sum_probs=176.0
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeecCC
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPP 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~ 255 (405)
++|.+.+.||+|+||.||+|.+. ++.||||.+........ ....+.+|+.+++.+. |+||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG------IPPTALREISLLQMLSESIYIVRLLDVEHVEE 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccC------CchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence 36788899999999999999985 68999999875432221 1356778999999995 699999999987765
Q ss_pred e-----eEEEEeecCCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC-CCcEEEE
Q 015556 256 V-----YCVITEYLSEGSLRAYLHKLE---HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-EFHLKIA 326 (405)
Q Consensus 256 ~-----~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~-~~~vkL~ 326 (405)
. .|+||||+++ +|.+++.... ...+++..++.++.||+.||.|||++||+||||+|+||+++. ++.+||+
T Consensus 75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~ 153 (295)
T cd07837 75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIA 153 (295)
T ss_pred CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEe
Confidence 5 8999999975 8999887542 346899999999999999999999999999999999999998 8999999
Q ss_pred ecCCcccccc-cCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 327 DFGIACEEVY-CDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 327 DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
|||++..... ........+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+...
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~ 227 (295)
T cd07837 154 DLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL 227 (295)
T ss_pred ecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 9999864322 122233457888999998865 45789999999999999999999999998888877766553
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=271.34 Aligned_cols=211 Identities=29% Similarity=0.465 Sum_probs=177.8
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeE
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC 258 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 258 (405)
|.+.+.||.|++|.||+|.+. ++.||||++........ ....+.+|+.++++++|+||+++++++.++...+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~------~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~ 74 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG------VPSTAIREISLLKELNHPNIVRLLDVVHSENKLY 74 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccccc------chhHHHHHHHHHHhcCCCCccCHhheeccCCeEE
Confidence 456788999999999999874 78999999976443221 1345778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc-c
Q 015556 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-C 337 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~-~ 337 (405)
+||||+. ++|.+++.......+++..++.++.|++.||+|||+++++||||+|+||+++.++.++|+|||++..... .
T Consensus 75 iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 75 LVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred EEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 9999994 6999999875445789999999999999999999999999999999999999999999999999854322 1
Q ss_pred CCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 338 DALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 338 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.......++..|+|||++.+. .++.++||||||+++|+|++|..||...+..+...++++.
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRT 215 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 222334568899999988654 5689999999999999999999999988887777666553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=292.80 Aligned_cols=223 Identities=25% Similarity=0.507 Sum_probs=193.2
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEECC------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI 244 (405)
..++.++.+.+++++.||.|.||.||.|++.+ -.||||.++.....++ ...|..|.-+|++++||||
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-------tekflqEa~iMrnfdHphI 453 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-------TEKFLQEASIMRNFDHPHI 453 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-------HHHHHHHHHHHHhCCCcch
Confidence 45778888999999999999999999999863 3688999886555443 4678999999999999999
Q ss_pred eEEeeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEE
Q 015556 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324 (405)
Q Consensus 245 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vk 324 (405)
|+|+|.|.+.. .|||||.++-|.|+.||+. +...++...+..+++||+.||.|||+...|||||..+|||+....++|
T Consensus 454 ikLIGv~~e~P-~WivmEL~~~GELr~yLq~-nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVK 531 (974)
T KOG4257|consen 454 IKLIGVCVEQP-MWIVMELAPLGELREYLQQ-NKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVK 531 (974)
T ss_pred hheeeeeeccc-eeEEEecccchhHHHHHHh-ccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceee
Confidence 99999999765 5799999999999999987 456789999999999999999999999999999999999999999999
Q ss_pred EEecCCcccccccCCCC--CCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccC
Q 015556 325 IADFGIACEEVYCDALS--DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVNF 401 (405)
Q Consensus 325 L~DFG~a~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~~ 401 (405)
|+|||+++...+...+. .......|||||-+.=..++.++|||.|||++||++. |.-||.+....+.+-.+=++..+
T Consensus 532 LaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRl 611 (974)
T KOG4257|consen 532 LADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERL 611 (974)
T ss_pred ecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCC
Confidence 99999997655443333 3345778999999998899999999999999999999 99999998888777666666555
Q ss_pred C
Q 015556 402 G 402 (405)
Q Consensus 402 ~ 402 (405)
|
T Consensus 612 P 612 (974)
T KOG4257|consen 612 P 612 (974)
T ss_pred C
Confidence 4
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=289.13 Aligned_cols=199 Identities=29% Similarity=0.478 Sum_probs=176.1
Q ss_pred eecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEE
Q 015556 182 FLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV 259 (405)
Q Consensus 182 ~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 259 (405)
.-.+.||.|.||+||-|+.+ |+.||||+|..-.-.... +.++++|+.||++++||.||.|-..|+..+.+++
T Consensus 567 f~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq------esqlR~EVaILq~l~HPGiV~le~M~ET~ervFV 640 (888)
T KOG4236|consen 567 FADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ------ESQLRNEVAILQNLHHPGIVNLECMFETPERVFV 640 (888)
T ss_pred hhHhhccCCcceeeecceecccCceeeeeeeecccCCCch------HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEE
Confidence 44578999999999999875 899999999754433222 5788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC---CcEEEEecCCcccccc
Q 015556 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE---FHLKIADFGIACEEVY 336 (405)
Q Consensus 260 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~---~~vkL~DFG~a~~~~~ 336 (405)
|||-+.| +..+.|-..+.+.+++.....++.||+.||.|||.++|+|+||||+|||+... -++||||||+|+....
T Consensus 641 VMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE 719 (888)
T KOG4236|consen 641 VMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE 719 (888)
T ss_pred Eehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence 9999955 55566656677899999999999999999999999999999999999999543 5799999999988877
Q ss_pred cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 337 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
.......+||+.|+|||++..+.|....|+||.|||+|--|.|..||....
T Consensus 720 ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 720 KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence 777788899999999999999999999999999999999999999997643
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=252.31 Aligned_cols=215 Identities=24% Similarity=0.391 Sum_probs=187.5
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.-.++||+|.||+||+|+.. ++.||+|..+..++++.. -....+|+-+|+.|+|.|||++++....+..+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegv------pssalreicllkelkhknivrl~dvlhsdkkl 76 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV------PSSALREICLLKELKHKNIVRLHDVLHSDKKL 76 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC------cHHHHHHHHHHHHhhhcceeehhhhhccCcee
Confidence 4556688999999999999876 589999999987776543 23445899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc-cc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-VY 336 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~-~~ 336 (405)
.+|+|||.. .|..|... .++.++.+....++.|+++||.+||++++.|||+||.|.||+.+|.+|++|||+++.. ..
T Consensus 77 tlvfe~cdq-dlkkyfds-lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 77 TLVFEFCDQ-DLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred EEeHHHhhH-HHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 999999965 89998877 4678999999999999999999999999999999999999999999999999999643 23
Q ss_pred cCCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccCC
Q 015556 337 CDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVNFG 402 (405)
Q Consensus 337 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~~~ 402 (405)
..-++..+.|..|.+|.++.+. -|+...|+||.||++.|+.. |++.|++.+-.+.+.+|....+.+
T Consensus 155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p 222 (292)
T KOG0662|consen 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222 (292)
T ss_pred eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCC
Confidence 3344566789999999999775 47999999999999999998 899999999999999998776554
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=267.66 Aligned_cols=212 Identities=23% Similarity=0.420 Sum_probs=179.9
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+++.||.|+||.||+|... +..||+|.+........ ..+.+.+|+.+++.++|+||+++++++......
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~------~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~ 74 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK------EKEASKKEVILLAKMKHPNIVTFFASFQENGRL 74 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccch------hhHHHHHHHHHHHhCCCCChhhhhheeccCCeE
Confidence 4678899999999999999985 58899999875432211 145677999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCC-cEEEEecCCcccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-HLKIADFGIACEEVY 336 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~-~vkL~DFG~a~~~~~ 336 (405)
++|+||+++++|.+++.......+++..++.++.|++.||.|||+.+++|+||+|+||++++++ .++|+|||.+.....
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999999999999875555689999999999999999999999999999999999998875 569999998854332
Q ss_pred cC-CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 337 CD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 337 ~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
.. ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.+
T Consensus 155 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 216 (257)
T cd08225 155 SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ 216 (257)
T ss_pred CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc
Confidence 21 12234588999999999888899999999999999999999999998777666655544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=272.47 Aligned_cols=198 Identities=30% Similarity=0.486 Sum_probs=165.1
Q ss_pred CCeeecceeeeeeeEEEEEEEE------CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIY------KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
.+|.+.+.||+|+||.||++.+ .++.||||.+..... ...+.|.+|+++++.++||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 75 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA--------EHLRDFEREIEILKSLQHDNIVKYKGVCY 75 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH--------HHHHHHHHHHHHHHhCCCCCeeEEEEEEc
Confidence 4677889999999999999975 257899999864321 12457889999999999999999999875
Q ss_pred c--CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 253 K--PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 253 ~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
. ...+++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 76 SAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred cCCCCceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcc
Confidence 4 35689999999999999999763 34689999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC----CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 331 ACEEVYCDA----LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 331 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
+........ .....++..|+|||++.+..++.++||||||+++|||++|..|+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 864322111 1122344569999999888899999999999999999998777643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=275.21 Aligned_cols=210 Identities=27% Similarity=0.541 Sum_probs=171.5
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--Cc----cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DE----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~----~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
..++|...+.||+|+||.||+|.+. ++ .||+|.+...... .....+.+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~~~~l~h~niv~~~~~ 77 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP-------KANVEFMDEALIMASMDHPHLVRLLGV 77 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH-------HHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence 3466778889999999999999873 43 4788887643221 113468899999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
|... ..++++||+++|+|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 78 ~~~~-~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~ 155 (303)
T cd05110 78 CLSP-TIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGL 155 (303)
T ss_pred EcCC-CceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccc
Confidence 9765 467999999999999998763 34688999999999999999999999999999999999999999999999999
Q ss_pred cccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 015556 331 ACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV 395 (405)
Q Consensus 331 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i 395 (405)
+....... ......++..|+|||++.+..++.++||||||+++|||++ |..||.+....+....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~ 224 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 86432211 1122335678999999998889999999999999999997 99999887665544333
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=269.86 Aligned_cols=194 Identities=21% Similarity=0.460 Sum_probs=161.2
Q ss_pred ceeeeeeeEEEEEEEECC--------------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 185 LRFAHGAHSRLYHGIYKD--------------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~~--------------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
+.||+|+||.||+|.... ..||||++..... .....|..|+.++..++||||++++++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--------~~~~~~~~~~~~l~~l~hp~iv~~~~~ 72 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR--------DISLAFFETASMMRQVSHKHIVLLYGV 72 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh--------hHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 358999999999998532 2588888753221 124568889999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCc-------E
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-------L 323 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~-------v 323 (405)
+..+...++||||+++++|..++... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++. +
T Consensus 73 ~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 73 CVRDVENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred EecCCCCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCcee
Confidence 99999999999999999999988752 356899999999999999999999999999999999999987654 8
Q ss_pred EEEecCCcccccccCCCCCCCCCCcccCccccc-cccCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHH
Q 015556 324 KIADFGIACEEVYCDALSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMV-AGTIPYEEMNPIQ 390 (405)
Q Consensus 324 kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DVwSlGvll~ell-tG~~Pf~~~~~~e 390 (405)
+++|||++..... .....++..|+|||.+. +..++.++|||||||++|||+ .|..||......+
T Consensus 152 ~l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (262)
T cd05077 152 KLSDPGIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE 217 (262)
T ss_pred EeCCCCCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence 9999998854322 22345788999999886 466899999999999999998 4999998765433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=270.73 Aligned_cols=204 Identities=33% Similarity=0.549 Sum_probs=174.1
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC---CCCeeEEeeEeecC
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---NPNVIKFVAACKKP 254 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~ 254 (405)
.|.+.+.||.|+||.||+|.+. ++.||||.+........ ..++.+|+.+++.++ ||||+++++++.++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-------VSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchh-------HHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 3567788999999999999974 68999999875433221 356778999999997 99999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
..+|+||||+++++|.+++.. ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++...
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 75 PRLWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred CEEEEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 999999999999999999865 47899999999999999999999999999999999999999999999999988654
Q ss_pred cccC-CCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015556 335 VYCD-ALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393 (405)
Q Consensus 335 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~ 393 (405)
.... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||..........
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~ 212 (277)
T cd06917 152 NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM 212 (277)
T ss_pred CCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh
Confidence 3222 2233468899999998865 446899999999999999999999998877655443
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=295.01 Aligned_cols=225 Identities=24% Similarity=0.413 Sum_probs=195.0
Q ss_pred ccccccccCCCeeecceeeeeeeEEEEEEEEC---C--ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 015556 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK---D--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244 (405)
Q Consensus 170 ~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~---~--~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI 244 (405)
......|-.+++.++++||+|.||.|++|.|+ | -.||||+++...... ....|.+|+.+|.+|+|+|+
T Consensus 101 ~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-------~mddflrEas~M~~L~H~hl 173 (1039)
T KOG0199|consen 101 IDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-------IMDDFLREASHMLKLQHPHL 173 (1039)
T ss_pred CCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-------hHHHHHHHHHHHHhccCcce
Confidence 34456677788899999999999999999997 3 489999998533321 36789999999999999999
Q ss_pred eEEeeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEE
Q 015556 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324 (405)
Q Consensus 245 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vk 324 (405)
|+|||...+ ....+|||.++.|+|.+.|++.....|-...+..++.|||.||.||..+++|||||...|+||-....||
T Consensus 174 iRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVK 252 (1039)
T KOG0199|consen 174 IRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVK 252 (1039)
T ss_pred eEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceee
Confidence 999999988 6778999999999999999996667788889999999999999999999999999999999998899999
Q ss_pred EEecCCcccccccCCC----CCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 325 IADFGIACEEVYCDAL----SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 325 L~DFG~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
|+|||+.+-....+.. ....-.+.|+|||.+++..++.++|||+|||++|||++ |..||.+....+++..|=++.
T Consensus 253 I~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e 332 (1039)
T KOG0199|consen 253 ICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE 332 (1039)
T ss_pred eecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc
Confidence 9999998643332221 22335778999999999999999999999999999999 999999999999999887776
Q ss_pred cCC
Q 015556 400 NFG 402 (405)
Q Consensus 400 ~~~ 402 (405)
.++
T Consensus 333 rLp 335 (1039)
T KOG0199|consen 333 RLP 335 (1039)
T ss_pred cCC
Confidence 654
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=273.87 Aligned_cols=202 Identities=29% Similarity=0.453 Sum_probs=169.0
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeecC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKP 254 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~ 254 (405)
.++|...+.||+|+||.||++.+. ++.||||.+....... ....+.+|+.++.++. |+||+++++++..+
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~ 75 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEK-------EQKRLLMDLDVVMRSSDCPYIVKFYGALFRE 75 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChH-------HHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence 356667788999999999999985 6899999987543321 2467889999999996 99999999999999
Q ss_pred CeeEEEEeecCCCCHHHHH---HHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEECCCCcEEEEecCC
Q 015556 255 PVYCVITEYLSEGSLRAYL---HKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l---~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
...+++|||+.. +|.++. .......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||+
T Consensus 76 ~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 154 (288)
T cd06616 76 GDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGI 154 (288)
T ss_pred CcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecch
Confidence 999999999854 555443 333346789999999999999999999975 999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccCccccccc---cCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKHK---SYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
+.............|+..|+|||++.+. .++.++|||||||++|+|++|..||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 155 SGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred hHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 8654433333445689999999999766 68999999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=267.67 Aligned_cols=192 Identities=22% Similarity=0.467 Sum_probs=162.2
Q ss_pred ceeeeeeeEEEEEEEECCc------------cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 185 LRFAHGAHSRLYHGIYKDE------------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~~~------------~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
+.||+|+||.||+|.+.+. .|++|++...... ...|.+|+.+++.++||||+++++++.
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---------SLAFFETASLMSQLSHKHLVKLYGVCV 71 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---------HHHHHHHHHHHHcCCCcchhheeeEEe
Confidence 3589999999999998643 3777776532211 457789999999999999999999998
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCC-------cEEE
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-------HLKI 325 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~-------~vkL 325 (405)
. ...++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 72 ~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 72 R-DENIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred c-CCcEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEe
Confidence 8 77899999999999999998732 3788999999999999999999999999999999999999887 7999
Q ss_pred EecCCcccccccCCCCCCCCCCcccCccccccc--cCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 015556 326 ADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK--SYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQ 390 (405)
Q Consensus 326 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e 390 (405)
+|||++..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||...++.+
T Consensus 150 ~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~ 214 (259)
T cd05037 150 SDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE 214 (259)
T ss_pred CCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh
Confidence 99999865432 2234577889999999776 78999999999999999999 688998776443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=272.79 Aligned_cols=200 Identities=22% Similarity=0.374 Sum_probs=168.9
Q ss_pred CeeecceeeeeeeEEEEEEEE-----CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeec
Q 015556 180 QLFLGLRFAHGAHSRLYHGIY-----KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKK 253 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~ 253 (405)
+|.+.+.||.|+||.||++.. .++.||+|++....... .....+.+.+|+.++.++ +|+||+.+++++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ----KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhh----cchHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 367889999999999999986 46889999987432211 112246678899999999 58999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
+..+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+|||++.++.++|+|||++..
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 77 DTKLHLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred CCeEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999999999986 35688999999999999999999999999999999999999999999999999865
Q ss_pred cccc--CCCCCCCCCCcccCccccccc--cCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 334 EVYC--DALSDDPGTYRWMAPEMIKHK--SYGRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 334 ~~~~--~~~~~~~gt~~y~aPE~~~~~--~~~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
.... .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 3321 112234588999999998653 467899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=268.58 Aligned_cols=207 Identities=21% Similarity=0.352 Sum_probs=172.4
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeecC--C
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKP--P 255 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~--~ 255 (405)
|.+.+.||+|+||.||+|... ++.||||.+........ .....+|+.++.++. |+||+++++++.++ +
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-------~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-------QVNNLREIQALRRLSPHPNILRLIEVLFDRKTG 73 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-------hhhHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence 457788999999999999885 68999999875432221 123447889999985 99999999999987 8
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+++||||+. ++|.+++... ...+++..++.++.|++.||.|||+.|++||||+|+||+++. +.+||+|||++....
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 74 RLALVFELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred cEEEEEecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 8999999996 5888888763 357899999999999999999999999999999999999999 999999999986554
Q ss_pred ccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 336 YCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 336 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
.........++..|+|||++.. ..++.++|||||||++|||++|..||.+.++.+....+.+
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~ 213 (282)
T cd07831 151 SKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHD 213 (282)
T ss_pred cCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHH
Confidence 4334445568899999997644 4568899999999999999999999999888776655543
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=266.08 Aligned_cols=203 Identities=26% Similarity=0.408 Sum_probs=169.5
Q ss_pred ceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHH-HhcCCCCeeEEeeEeecCCeeEEEE
Q 015556 185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALL-SRLHNPNVIKFVAACKKPPVYCVIT 261 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~g~~~~~~~~~lV~ 261 (405)
+.||.|+||.||+|... ++.||||++...+.... .....+..|..++ ..++|+||+++++++..+..+++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK-----NQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHH-----HHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEE
Confidence 46899999999999984 68999999864332111 1123344555444 4558999999999999999999999
Q ss_pred eecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCCCC
Q 015556 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALS 341 (405)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 341 (405)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++||||+|.||++++++.++|+|||++..... ..
T Consensus 77 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~ 151 (260)
T cd05611 77 EYLNGGDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NK 151 (260)
T ss_pred eccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cc
Confidence 99999999999976 35688999999999999999999999999999999999999999999999998854332 23
Q ss_pred CCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 342 ~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
...++..|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 207 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS 207 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 44688999999999888889999999999999999999999998887776665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=275.01 Aligned_cols=205 Identities=28% Similarity=0.520 Sum_probs=176.6
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||+|+||.||++... ++.||+|.+....... ...+.+|+.+++.++||||+++++.|.....
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~ 90 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK--------KELIINEILVMRENKHPNIVNYLDSYLVGDE 90 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchH--------HHHHHHHHHHHhhcCCCCeeehhheeeeCCc
Confidence 67888899999999999999874 6889999986433221 3567889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
.|+|+||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred EEEEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999999999999976 4678999999999999999999999999999999999999999999999998754322
Q ss_pred c-CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015556 337 C-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFA 394 (405)
Q Consensus 337 ~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~ 394 (405)
. .......+++.|++||.+.+..++.++||||||+++|+|++|..||...++.+....
T Consensus 168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~ 226 (293)
T cd06647 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (293)
T ss_pred cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee
Confidence 1 122334588899999999888899999999999999999999999988776655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=269.02 Aligned_cols=199 Identities=30% Similarity=0.446 Sum_probs=171.4
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec--CC
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK--PP 255 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~ 255 (405)
+|...++||.|++|.||++.+. ++.||+|.+...... ....++.+|++++++++||||++++++|.+ ..
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 74 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-------DLQKQILRELEINKSCKSPYIVKYYGAFLDESSS 74 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-------HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCC
Confidence 5778899999999999999985 689999998754332 125678899999999999999999998865 34
Q ss_pred eeEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
.+++||||+++++|.+++... ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 75 SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccc
Confidence 789999999999999987653 345688899999999999999999999999999999999999999999999999855
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
..... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 155 ~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 155 LVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 43321 22445788999999999889999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=272.65 Aligned_cols=209 Identities=22% Similarity=0.381 Sum_probs=172.1
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 253 (405)
-++++|.+.+.||+|+||.||+|... ++.||||.+......+.. ...+.+|+.++++++||||++++++|..
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF------PITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCc------hhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 35678999999999999999999985 689999998754432211 2345689999999999999999999876
Q ss_pred CC--------eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEE
Q 015556 254 PP--------VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI 325 (405)
Q Consensus 254 ~~--------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL 325 (405)
.. ..++||||+. ++|.+++... ...+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl 160 (310)
T cd07865 83 KATPYNRYKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKL 160 (310)
T ss_pred ccccccCCCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEE
Confidence 53 4599999995 5888888652 346899999999999999999999999999999999999999999999
Q ss_pred EecCCcccccccC-----CCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015556 326 ADFGIACEEVYCD-----ALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAA 392 (405)
Q Consensus 326 ~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~ 392 (405)
+|||++....... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||...++....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~ 233 (310)
T cd07865 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL 233 (310)
T ss_pred CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999986433221 11234578889999988654 4688999999999999999999999887765443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=268.36 Aligned_cols=220 Identities=22% Similarity=0.433 Sum_probs=182.0
Q ss_pred CeeecceeeeeeeEEEEEEEECC---ccEEEEEEecCCCChhH--HHHHHHHHHHHHHHHHHHh-cCCCCeeEEeeEeec
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYKD---EPVAVKIIRIPDDDENE--TLAARLEKQFNREVALLSR-LHNPNVIKFVAACKK 253 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~~---~~vAVK~~~~~~~~~~~--~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~g~~~~ 253 (405)
.|.+.+.||+|+||.||+|.+.+ +.+|||.+......... .........+.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36678899999999999999864 78999998654322110 0112224567788988875 799999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
+...++||||+++++|.+++... ....+++..++.++.|++.+|.|||+ .+++|+||+|+|||++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999999998653 34568999999999999999999996 7899999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
+.............|+..|++||++.+..++.++||||||+++|+|++|..||...+.......+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~ 229 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc
Confidence 865444334445668999999999998889999999999999999999999998887776666665543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=270.82 Aligned_cols=193 Identities=25% Similarity=0.428 Sum_probs=159.4
Q ss_pred eeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHH---HHhcCCCCeeEEeeEeecCCeeEEE
Q 015556 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVAL---LSRLHNPNVIKFVAACKKPPVYCVI 260 (405)
Q Consensus 186 ~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~i---l~~l~HpnIv~l~g~~~~~~~~~lV 260 (405)
.||+|+||.||++.+. ++.||||.+.......... ...+.+|..+ +...+|+||+.+++++...+..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-----ETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH-----HHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEE
Confidence 3799999999999985 6899999987543322111 1223344433 3445799999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCCC
Q 015556 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL 340 (405)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 340 (405)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+|||+++++.++|+|||++...... ..
T Consensus 76 ~e~~~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~ 152 (279)
T cd05633 76 LDLMNGGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KP 152 (279)
T ss_pred EecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-Cc
Confidence 999999999999876 457999999999999999999999999999999999999999999999999998644322 22
Q ss_pred CCCCCCCcccCccccc-cccCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 341 SDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 341 ~~~~gt~~y~aPE~~~-~~~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
....|+..|+|||.+. +..++.++|||||||++|+|++|..||...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 3346899999999986 456799999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=261.76 Aligned_cols=209 Identities=32% Similarity=0.568 Sum_probs=182.1
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+++.||+|++|.||++... ++.||||.+......+ .....+.+|++++.+++|+|++++++++.+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE------EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL 74 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH------HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Confidence 4678899999999999999875 5899999997654321 1246788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
++||||+++++|.+++... ..+++..+..++.|++.+|.|||+.||+||||+|+||+++.++.++|+|||.+......
T Consensus 75 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 75 YIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred EEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999999999999763 67899999999999999999999999999999999999999999999999998654332
Q ss_pred CC-CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015556 338 DA-LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 338 ~~-~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~ 396 (405)
.. .....++..|+|||.+.+..++.++|||+||+++|+|++|..||...++......+.
T Consensus 153 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~ 212 (254)
T cd06627 153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212 (254)
T ss_pred cccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 22 234468899999999988888999999999999999999999999888777666654
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=267.26 Aligned_cols=200 Identities=27% Similarity=0.423 Sum_probs=166.2
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
+....-..||+|+||.||+|.+. +..||||.+...... ..+.+.+|+.++++++|+||+++++++..+..
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--------YVQPLHEEIALHSYLKHRNIVQYLGSDSENGF 79 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH--------HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence 33434457999999999999875 478999988643321 14578899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC-CCcEEEEecCCccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTL--PLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-EFHLKIADFGIACE 333 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~-~~~vkL~DFG~a~~ 333 (405)
+++||||+++++|.+++.... ..+ ++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||++..
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999999999998632 334 78888999999999999999999999999999999976 67999999998854
Q ss_pred ccc-cCCCCCCCCCCcccCcccccccc--CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 334 EVY-CDALSDDPGTYRWMAPEMIKHKS--YGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 334 ~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
... ........|+..|+|||++.+.. ++.++||||||+++|+|++|..||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 322 11223345889999999986543 7899999999999999999999997654
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=260.98 Aligned_cols=208 Identities=29% Similarity=0.578 Sum_probs=181.7
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+.+.||+|++|.||++.+. ++.+++|++..... ...+.+.+|+++++.++|+||+++++++..+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 72 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--------EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDEL 72 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 3677889999999999999986 68899999975443 1256788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
++++||+++++|.+++.... ..+++..+..++.|++.+|.|||++|++||||+|+||+++.++.++|+|||.+......
T Consensus 73 ~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 73 WIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred EEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 99999999999999987732 57899999999999999999999999999999999999999999999999998655443
Q ss_pred CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015556 338 DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 338 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~ 396 (405)
.......++..|++||.+.+..++.++||||||+++|+|++|..||...+..+....+.
T Consensus 152 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 210 (253)
T cd05122 152 KARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA 210 (253)
T ss_pred ccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH
Confidence 32345568999999999988888999999999999999999999999886666555444
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=261.08 Aligned_cols=209 Identities=32% Similarity=0.591 Sum_probs=181.1
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC--C
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--P 255 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~ 255 (405)
+|.+.+.||+|++|.||+|... ++.|+||++...... ....+.+.+|+.++++++|+||+++++.+.+. .
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS------EEELEALEREIRILSSLQHPNIVRYYGSERDEEKN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence 3667789999999999999987 789999999765533 12256788999999999999999999999988 8
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+++||||+++++|.+++... ..+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 899999999999999999873 388999999999999999999999999999999999999999999999999986554
Q ss_pred ccCC---CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHH
Q 015556 336 YCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN-PIQAAFAVV 396 (405)
Q Consensus 336 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~-~~e~~~~i~ 396 (405)
.... .....++..|++||.+.+..++.++||||||+++|+|++|..||.... .......+.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 217 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIG 217 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcc
Confidence 4332 345678999999999988889999999999999999999999998766 444444443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=271.10 Aligned_cols=209 Identities=30% Similarity=0.436 Sum_probs=176.5
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
..|.+.+.||+|+||.||+|... ++.||+|.+......... ..+.+.+|+.+++.++||||++++++|.++..
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~-----~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE-----KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHT 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHH-----HHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCe
Confidence 44778889999999999999875 689999998754333221 24568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
.++||||+. |+|.+++... ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.....
T Consensus 90 ~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 90 AWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred EEEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 999999996 5787777642 35689999999999999999999999999999999999999999999999998854322
Q ss_pred cCCCCCCCCCCcccCccccc---cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 337 CDALSDDPGTYRWMAPEMIK---HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 337 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
.....++..|+|||++. ...++.++||||||+++|||++|..||.+.+.....+.+..
T Consensus 168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~ 228 (307)
T cd06607 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228 (307)
T ss_pred ---CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc
Confidence 23456888999999874 35678899999999999999999999998887776665543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=271.25 Aligned_cols=209 Identities=16% Similarity=0.225 Sum_probs=158.7
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEECC-----ccEEEEEEecCCCChhHHH---HHHHHHHHHHHHHHHHhcCCCCeeEE
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETL---AARLEKQFNREVALLSRLHNPNVIKF 247 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~vAVK~~~~~~~~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l 247 (405)
+.-.+|.++++||+|+||.||+|.+.+ ..+|+|+..........+. ..........+...+..+.|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 334689999999999999999999754 3667776543332211110 00011223344455667789999999
Q ss_pred eeEeecCC----eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcE
Q 015556 248 VAACKKPP----VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323 (405)
Q Consensus 248 ~g~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~v 323 (405)
++++.... ..++++|++. .++.+.+.. ....++..+..++.|++.||.|||+++|+||||||+|||++.++.+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 99876543 3467888774 477777665 2345788899999999999999999999999999999999999999
Q ss_pred EEEecCCccccccc--------CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 324 KIADFGIACEEVYC--------DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 324 kL~DFG~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
+|+|||++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999998643211 11223469999999999999999999999999999999999999998774
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=277.10 Aligned_cols=205 Identities=26% Similarity=0.393 Sum_probs=169.2
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC--
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-- 254 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-- 254 (405)
++|.+++.||+|+||.||+|.+. ++.||||.+....... ....+.+|+.++++++|+||+++++++...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT-------FCQRTLREIKILRRFKHENIIGILDIIRPPSF 77 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccch-------hHHHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence 57889999999999999999875 6899999986422221 135567899999999999999999987644
Q ss_pred ---CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 255 ---PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 255 ---~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
...++||||+. ++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 78 ~~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 78 ESFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred cccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccce
Confidence 35799999996 488887754 57899999999999999999999999999999999999999999999999998
Q ss_pred ccccccC----CCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015556 332 CEEVYCD----ALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFA 394 (405)
Q Consensus 332 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~ 394 (405)
....... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~ 221 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNL 221 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 5432211 1223468899999998754 5679999999999999999999999988765544433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=272.62 Aligned_cols=197 Identities=27% Similarity=0.453 Sum_probs=166.0
Q ss_pred CCeeecceeeeeeeEEEEEEEE------CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIY------KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
.-|.+.+.||+|+||.||++.+ .++.||||.+....... ....+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN-------HIADLKKEIEILRNLYHENIVKYKGICT 76 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHH-------HHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 3467788999999999999975 25789999986433221 2456889999999999999999999988
Q ss_pred cC--CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 253 KP--PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 253 ~~--~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
+. ...++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus 77 ~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 77 EDGGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred cCCCCceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcc
Confidence 75 5689999999999999999763 34689999999999999999999999999999999999999999999999999
Q ss_pred cccccccC----CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCC
Q 015556 331 ACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383 (405)
Q Consensus 331 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf 383 (405)
+....... ......++..|+|||++.+..++.++||||||+++|+|+++..|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 86433211 112345677899999998888999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=261.76 Aligned_cols=213 Identities=24% Similarity=0.467 Sum_probs=184.0
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+.+.||.|++|.||++.+. ++.||+|++........ ....+.+|+++++.++|+|++++++.+......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 74 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK------EREDALNEVKILKKLNHPNIIKYYESFEEKGKL 74 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChH------HHHHHHHHHHHHHhcCCCChhheEEEEecCCEE
Confidence 4677889999999999999987 78999999976544322 246678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLE--HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
++||||+++++|.+++.... ...+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 154 (258)
T cd08215 75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS 154 (258)
T ss_pred EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecc
Confidence 99999999999999998753 4778999999999999999999999999999999999999999999999999985433
Q ss_pred ccC-CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 336 YCD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 336 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+...
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~ 218 (258)
T cd08215 155 STVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG 218 (258)
T ss_pred cCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcC
Confidence 322 223346888999999998888999999999999999999999999988877666655443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=275.92 Aligned_cols=205 Identities=21% Similarity=0.373 Sum_probs=170.1
Q ss_pred eeeeeEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEeecC
Q 015556 188 AHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLS 265 (405)
Q Consensus 188 G~G~~g~Vy~~~~--~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 265 (405)
|.|+||+||++.+ .++.||||++........ ..+.+.+|+.+++.++||||++++++|..+...++||||+.
T Consensus 9 g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 9 GFCNLTSVYLARHTPTGTLVTVRITDLENCTEE------HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred cccCceeEEEEEEcCCCcEEEEEEeccccCCHH------HHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 4449999999998 479999999876543321 14678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccC-------
Q 015556 266 EGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD------- 338 (405)
Q Consensus 266 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~------- 338 (405)
+++|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.++.++++||+.+.......
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 9999999987655678999999999999999999999999999999999999999999999998542211100
Q ss_pred -CCCCCCCCCcccCccccccc--cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 339 -ALSDDPGTYRWMAPEMIKHK--SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 339 -~~~~~~gt~~y~aPE~~~~~--~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
......++..|+|||++.+. .++.++|||||||++|+|++|..||......+.....+..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 225 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKG 225 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcC
Confidence 01112356679999999764 4789999999999999999999999998877766655544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=270.64 Aligned_cols=218 Identities=26% Similarity=0.456 Sum_probs=178.7
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEe
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFV 248 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~ 248 (405)
..+.++.++|.+.+.||+|++|.||+|.+. ++.||||.+........ ...+..|+.++.++. |+||++++
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-------~~~~~~e~~~~~~~~~~~~i~~~~ 80 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE-------NKRILMDLDVVLKSHDCPYIVKCY 80 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHH-------HHHHHHHHHHHHhccCCCchHhhh
Confidence 456778899999999999999999999997 78999999975433221 345566777777775 99999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEECCCCcEEEEe
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIAD 327 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDIkp~NILl~~~~~vkL~D 327 (405)
++|.+....|+||||+. ++|.+++... ...+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~v~e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~d 158 (296)
T cd06618 81 GYFITDSDVFICMELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCD 158 (296)
T ss_pred eeeecCCeEEEEeeccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECc
Confidence 99999999999999984 5787777653 3578999999999999999999997 5999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCCcccCcccccccc----CCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhc
Q 015556 328 FGIACEEVYCDALSDDPGTYRWMAPEMIKHKS----YGRKVDVYSFGLILWEMVAGTIPYEEMNP-IQAAFAVVNK 398 (405)
Q Consensus 328 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DVwSlGvll~elltG~~Pf~~~~~-~e~~~~i~~~ 398 (405)
||++.............++..|+|||.+.+.. ++.++||||||+++|+|++|..||..... .+.+..++..
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 234 (296)
T cd06618 159 FGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE 234 (296)
T ss_pred cccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC
Confidence 99986544333334456888999999986553 78899999999999999999999987543 3444444443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=265.25 Aligned_cols=204 Identities=30% Similarity=0.475 Sum_probs=175.9
Q ss_pred eeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEeec
Q 015556 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264 (405)
Q Consensus 187 lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 264 (405)
||.|+||.||++.+. ++.||+|++....... ......+.+|++++++++|+||+++++.+..+...|+||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR-----KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhh-----hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecC
Confidence 589999999999986 7899999986433211 223567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccC------
Q 015556 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD------ 338 (405)
Q Consensus 265 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~------ 338 (405)
++++|.+++.+. ..+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 76 ~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 76 PGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 999999999873 478999999999999999999999999999999999999999999999999985433221
Q ss_pred ---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 339 ---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 339 ---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
......++..|++||.+....++.++||||||+++|+|++|..||....+.+....+..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 215 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN 215 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 22334578899999999888889999999999999999999999998887776665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=268.47 Aligned_cols=197 Identities=21% Similarity=0.431 Sum_probs=163.3
Q ss_pred ceeeeeeeEEEEEEEECC---------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 185 LRFAHGAHSRLYHGIYKD---------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~~---------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
+.||.|+||.||+|...+ ..||+|.+.... ......+..|+.+++.+.||||+++++++..+.
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~ 72 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--------RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD 72 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--------HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC
Confidence 358999999999998742 348888875321 122457888999999999999999999999988
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCc--------EEEEe
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH--------LKIAD 327 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~--------vkL~D 327 (405)
..++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. ++++|
T Consensus 73 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 73 ESIMVQEYVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred CcEEEEecCCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecc
Confidence 999999999999999999863 346889999999999999999999999999999999999977654 69999
Q ss_pred cCCcccccccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHH
Q 015556 328 FGIACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAG-TIPYEEMNPIQAAF 393 (405)
Q Consensus 328 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG-~~Pf~~~~~~e~~~ 393 (405)
||++..... .....++..|+|||++.+ ..++.++||||||+++|+|++| ..||...++.....
T Consensus 152 ~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~ 216 (258)
T cd05078 152 PGISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ 216 (258)
T ss_pred cccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH
Confidence 998854332 233468889999999976 4578999999999999999998 57877776655433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=268.75 Aligned_cols=207 Identities=26% Similarity=0.481 Sum_probs=176.5
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeE
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC 258 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 258 (405)
|.....||.|++|.||++... ++.+|+|.+...... ..+.+.+|+.+++.++|+||+++++++......+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~ 92 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ--------RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELW 92 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh--------HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEE
Confidence 334468999999999999875 588999998643321 1356789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc-
Q 015556 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC- 337 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~- 337 (405)
+|+||+++++|.+++.. ..+++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||++......
T Consensus 93 ~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 93 VVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred EEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 99999999999999876 56889999999999999999999999999999999999999999999999987543221
Q ss_pred CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 338 DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 338 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.......|+..|+|||.+.+..++.++||||||+++|+|++|..||...++.+....+...
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~ 230 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN 230 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc
Confidence 1122345889999999998888999999999999999999999999988877766655543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=268.29 Aligned_cols=209 Identities=30% Similarity=0.532 Sum_probs=181.3
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
..|.+...||+|++|.||+|.+. ++.||+|++..... ....+.+|+++++.++|+||+++++++.....
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 89 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---------NKELIINEILIMKDCKHPNIVDYYDSYLVGDE 89 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCE
Confidence 45677889999999999999997 78999999975443 14567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
.++|+||+++++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 999999999999999998732 3799999999999999999999999999999999999999999999999998754322
Q ss_pred c-CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 337 C-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 337 ~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
. .......++..|++||++.+..++.++||||||+++|+|++|..||...++.+....+..
T Consensus 169 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~ 230 (286)
T cd06614 169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT 230 (286)
T ss_pred chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 1 112233478899999999888899999999999999999999999999888776665544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=266.78 Aligned_cols=209 Identities=25% Similarity=0.437 Sum_probs=176.5
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC--Ce
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP--PV 256 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~ 256 (405)
|.+.+.||.|++|.||+|... ++.+|||.+....... .....+.+|+.++++++|+|++++++++.+. ..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKE------GFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS 74 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccc------cchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence 457789999999999999986 5899999998654221 1135677899999999999999999999988 88
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
.++||||+++ +|.+++... ...+++..++.++.||+.||+|||+.|++|+||+|+|||+++++.++|+|||++.....
T Consensus 75 ~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 75 IYMVFEYMDH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred EEEEeccccc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 9999999974 898888763 25789999999999999999999999999999999999999999999999999865433
Q ss_pred cC--CCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 337 CD--ALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 337 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+.+
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~ 216 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE 216 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 22 2334457888999998765 4578999999999999999999999998887776666554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=261.65 Aligned_cols=203 Identities=22% Similarity=0.345 Sum_probs=173.2
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
.|+-++|.+.++||+|||+.||++.. ++..||+|.+.....++ .+...+|++..++++||||+++++++.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~--------~e~~~rEid~~rkf~s~~vl~l~dh~l 88 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQED--------IEEALREIDNHRKFNSPNVLRLVDHQL 88 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHH--------HHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence 46678999999999999999999884 47899999998766333 456679999999999999999999876
Q ss_pred cCC-----eeEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEECCCCcE
Q 015556 253 KPP-----VYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLIDQEFHL 323 (405)
Q Consensus 253 ~~~-----~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IiHrDIkp~NILl~~~~~v 323 (405)
.+. ..||+++|...|+|.+.+... ++..+++.+++.|+.+|++||++||+.. +.||||||.|||+.+.+.+
T Consensus 89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~ 168 (302)
T KOG2345|consen 89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLP 168 (302)
T ss_pred HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCce
Confidence 544 489999999999999999865 4457999999999999999999999998 9999999999999999999
Q ss_pred EEEecCCcccccccC----------CCCCCCCCCcccCcccccc---ccCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 324 KIADFGIACEEVYCD----------ALSDDPGTYRWMAPEMIKH---KSYGRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 324 kL~DFG~a~~~~~~~----------~~~~~~gt~~y~aPE~~~~---~~~~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
+|+|||.+......- .......|..|.|||++.- ...+.++|||||||+||+|+.|..||+.
T Consensus 169 vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 169 VLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred EEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 999999985432211 1122347999999999854 4568999999999999999999999975
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=265.74 Aligned_cols=212 Identities=28% Similarity=0.500 Sum_probs=172.7
Q ss_pred eeecceeeeeeeEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~-----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
|.+++.||+|+||.||+|.+. ++.||||++........ ..+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSS------DIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChH------HHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 456788999999999999863 47899999975432221 1456889999999999999999999886532
Q ss_pred ------eeEEEEeecCCCCHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEE
Q 015556 256 ------VYCVITEYLSEGSLRAYLHKLE----HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI 325 (405)
Q Consensus 256 ------~~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL 325 (405)
..++++||+.+|+|.+++.... ...+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl 154 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCV 154 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEE
Confidence 3478999999999999876421 235788899999999999999999999999999999999999999999
Q ss_pred EecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 326 ADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 326 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
+|||++....... ......++..|++||.+....++.++|||||||++|+|++ |..||...+..+....+.+.
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 231 (273)
T cd05074 155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG 231 (273)
T ss_pred CcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999986543221 1123345678999999988889999999999999999999 99999988876665555544
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=268.72 Aligned_cols=209 Identities=28% Similarity=0.405 Sum_probs=177.9
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeecCCee
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPVY 257 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~ 257 (405)
|.+.+.||.|++|.||+|... ++.||||.+........ .....+|+..+.+++ |+||+++++++.++...
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 73 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-------ECMNLREVKSLRKLNEHPNIVKLKEVFRENDEL 73 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-------HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcE
Confidence 567889999999999999985 58899999875433211 233457999999999 99999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
++||||+ +|+|.+++.......+++..++.++.|++.+|.|||++|++|+||+|.||+++.++.++|+|||++......
T Consensus 74 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 74 YFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred EEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 9999999 889999998755467899999999999999999999999999999999999999999999999998655443
Q ss_pred CCCCCCCCCCcccCccccc-cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 338 DALSDDPGTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 338 ~~~~~~~gt~~y~aPE~~~-~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
.......++..|+|||++. ...++.++|+||||+++|+|++|..||......+.+..+..
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~ 213 (283)
T cd07830 153 PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICS 213 (283)
T ss_pred CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHH
Confidence 3444566889999999874 44578999999999999999999999998887776665543
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=292.03 Aligned_cols=211 Identities=33% Similarity=0.532 Sum_probs=174.1
Q ss_pred eecceeeeeeeEEEEEEEECCc--cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC--ee
Q 015556 182 FLGLRFAHGAHSRLYHGIYKDE--PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP--VY 257 (405)
Q Consensus 182 ~~~~~lG~G~~g~Vy~~~~~~~--~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~~ 257 (405)
.+...||+|+|-+||+|.+... .||=-.++..+... ..+-...|..|+.+|+.|+|||||+||..+.+.. .+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q----~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQ----SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhc----ChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 4556899999999999998743 44422222211111 1223578999999999999999999999998754 48
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEECC-CCcEEEEecCCcccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLIDQ-EFHLKIADFGIACEE 334 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IiHrDIkp~NILl~~-~~~vkL~DFG~a~~~ 334 (405)
-+|+|.+..|+|+.|+.+ ++.+....+..+++||++||.|||++. |||||||-+||+|+. .|.|||+|+|+|...
T Consensus 119 n~iTEL~TSGtLr~Y~kk--~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKK--HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeeeecccCCcHHHHHHH--hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 899999999999999998 577888899999999999999999985 999999999999965 599999999999766
Q ss_pred cccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccc
Q 015556 335 VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE-MNPIQAAFAVVNKVN 400 (405)
Q Consensus 335 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~-~~~~e~~~~i~~~~~ 400 (405)
....... ..|||.|||||++. ..|++.+||||||++++||+|+..||.. .++.+.+.+++.|..
T Consensus 197 r~s~aks-vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK 261 (632)
T KOG0584|consen 197 RKSHAKS-VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK 261 (632)
T ss_pred hccccce-eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC
Confidence 5544433 78999999999998 8999999999999999999999999976 556666667766653
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=266.69 Aligned_cols=193 Identities=25% Similarity=0.422 Sum_probs=159.8
Q ss_pred eeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHH---HHHHHhcCCCCeeEEeeEeecCCeeEEE
Q 015556 186 RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNRE---VALLSRLHNPNVIKFVAACKKPPVYCVI 260 (405)
Q Consensus 186 ~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~E---i~il~~l~HpnIv~l~g~~~~~~~~~lV 260 (405)
.||+|+||.||++.+. ++.||||++.......... ...+..| +.++....||||+.+++++.+...+++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-----ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchh-----HHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEE
Confidence 3799999999999875 6899999987543221110 1122333 3445556799999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCCC
Q 015556 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL 340 (405)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 340 (405)
|||+.+++|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++...... ..
T Consensus 76 ~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~ 152 (278)
T cd05606 76 LDLMNGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KP 152 (278)
T ss_pred EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CC
Confidence 999999999998875 457899999999999999999999999999999999999999999999999998643322 22
Q ss_pred CCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 341 SDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 341 ~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
....|+..|+|||++.+. .++.++||||||+++|+|++|..||.+.
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 345699999999998754 6899999999999999999999999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=268.91 Aligned_cols=209 Identities=29% Similarity=0.453 Sum_probs=177.1
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeE
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC 258 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 258 (405)
|...+.||+|+||.||++... ++.||||.+........ .....+.+|++++++++|+|++++++++.++...+
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN-----EKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW 101 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCch-----HHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence 556778999999999999874 68999999875433321 12457889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccC
Q 015556 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~ 338 (405)
+||||+. |+|.+++... ...+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++....
T Consensus 102 lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~--- 176 (317)
T cd06635 102 LVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS--- 176 (317)
T ss_pred EEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC---
Confidence 9999996 4787777642 4568999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCCCCCCcccCccccc---cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 339 ALSDDPGTYRWMAPEMIK---HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 339 ~~~~~~gt~~y~aPE~~~---~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
......|+..|+|||++. ...++.++|||||||++|+|++|..||......+....+....
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~ 240 (317)
T cd06635 177 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 240 (317)
T ss_pred CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcc
Confidence 223456889999999873 4567899999999999999999999999888888777776654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=294.26 Aligned_cols=219 Identities=22% Similarity=0.325 Sum_probs=166.3
Q ss_pred CCCeeecceeeeeeeEEEEEEEECC---ccEEEEEEecCCCCh---------hHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYKD---EPVAVKIIRIPDDDE---------NETLAARLEKQFNREVALLSRLHNPNVI 245 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~~---~~vAVK~~~~~~~~~---------~~~~~~~~~~~~~~Ei~il~~l~HpnIv 245 (405)
.++|.+++.||+|+||+||++..+. ..+++|.+....... ..........++.+|+.+|.+++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999987642 223333211110000 0001122356788999999999999999
Q ss_pred EEeeEeecCCeeEEEEeecCCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCc
Q 015556 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLE---HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322 (405)
Q Consensus 246 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~ 322 (405)
++++++.+....|+|||++ +++|.+++.... ........+..|+.||+.||.|||++|||||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 9999999999999999998 457888776421 122345677889999999999999999999999999999999999
Q ss_pred EEEEecCCcccccccC--CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCC-CCCC--CCHHHHHHHHHh
Q 015556 323 LKIADFGIACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI-PYEE--MNPIQAAFAVVN 397 (405)
Q Consensus 323 vkL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~-Pf~~--~~~~e~~~~i~~ 397 (405)
+||+|||++....... ......||..|+|||++.+..++.++|||||||++|||++|.. ||.. ..+.+.+.+++.
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~ 385 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID 385 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence 9999999986543221 2223569999999999999999999999999999999999765 5543 344555555554
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=261.72 Aligned_cols=211 Identities=25% Similarity=0.419 Sum_probs=180.6
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+.+.||.|++|.||++... ++.+|||.+......+. ....+.+|+.+++.++|+||+++++++.+....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK------EREDAVNEIRILASVNHPNIISYKEAFLDGNKL 74 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHH------HHHHHHHHHHHHHhCCCCCchhhhhhhccCCEE
Confidence 4678889999999999999875 68899999875443221 145667899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 258 CVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
++||||+++++|.+++... ....+++..++.++.|++.||.|||+.|++|+||+|.||+++.++.+||+|||++....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~ 154 (256)
T cd08530 75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK 154 (256)
T ss_pred EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence 9999999999999998763 23568899999999999999999999999999999999999999999999999986543
Q ss_pred ccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 336 YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 336 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
.. ......++..|++||.+.+..++.++|+||||+++|+|++|+.||...+..+....+..
T Consensus 155 ~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 215 (256)
T cd08530 155 KN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215 (256)
T ss_pred cC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 33 33345688999999999988899999999999999999999999998887665554443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=269.35 Aligned_cols=213 Identities=21% Similarity=0.370 Sum_probs=176.1
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
-.++|.+.+.||.|++|.||+|... ++.||||.++.....+. ....+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~------~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~ 78 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG------FPITAIREIKILRQLNHRNIVNLKEIVTDK 78 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC------chHHHHHHHHHHHhCCCCCeeeeeheecCc
Confidence 3467888999999999999999985 68999999976543221 134567899999999999999999998765
Q ss_pred C----------eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEE
Q 015556 255 P----------VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324 (405)
Q Consensus 255 ~----------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vk 324 (405)
. .+++||||+++ +|.+++... ...+++..++.++.|++.||.|||+.||+||||+|+||++++++.+|
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 79 QDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred chhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEE
Confidence 4 78999999975 787877653 35789999999999999999999999999999999999999999999
Q ss_pred EEecCCcccccccC--CCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 325 IADFGIACEEVYCD--ALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 325 L~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
|+|||++....... ......++..|+|||.+.+. .++.++|||||||++|+|++|+.||...+..+.+..+.+
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99999986433221 22233467889999988653 568899999999999999999999998887776655544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=269.51 Aligned_cols=191 Identities=24% Similarity=0.402 Sum_probs=169.8
Q ss_pred ceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeec----CCee
Q 015556 185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKK----PPVY 257 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~----~~~~ 257 (405)
..||-|-.|.|..+..+ ++.+|+|++.. ....++|+++.-.. .|||||.+++.|++ ...+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLD-------------SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhc-------------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 46899999999998875 78999999862 23445899887666 49999999998875 3467
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEC---CCCcEEEEecCCcccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID---QEFHLKIADFGIACEE 334 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~---~~~~vkL~DFG~a~~~ 334 (405)
.+|||+|+||.|+..+.......+++.++..|+.||..|+.|||+.+|.||||||+|+|.. .+..+||+|||+|...
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence 7899999999999999998888899999999999999999999999999999999999995 4567999999999887
Q ss_pred cccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 015556 335 VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP 388 (405)
Q Consensus 335 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~ 388 (405)
.....+...+.|++|.|||++....|+..+|+||+||++|-||||.+||.....
T Consensus 215 ~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg 268 (400)
T KOG0604|consen 215 QEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_pred CCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC
Confidence 766777888999999999999999999999999999999999999999987654
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=276.76 Aligned_cols=210 Identities=26% Similarity=0.381 Sum_probs=174.1
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec---
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK--- 253 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--- 253 (405)
++|.+.+.||.|++|.||+|... ++.||||++........ ..+.+.+|+.+|++++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPT------LAKRTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccccc------chHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 57888899999999999999875 78999999875432211 14567789999999999999999998753
Q ss_pred -CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 254 -PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 254 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
...+++||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 79 DFKDVYVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred CCceEEEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccce
Confidence 356899999995 689998865 3558999999999999999999999999999999999999999999999999985
Q ss_pred cccccC-----CCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 333 EEVYCD-----ALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 333 ~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
...... ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILS 226 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHH
Confidence 432211 1123468899999999865 4578999999999999999999999998877665554444
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=273.86 Aligned_cols=208 Identities=25% Similarity=0.376 Sum_probs=173.7
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC--
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-- 254 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-- 254 (405)
++|.+++.||+|+||.||+|.+. ++.||||.+....... .....+.+|+.++.+++|+||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI------IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhh------HHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 77999999999999999999874 6899999987532221 1135677899999999999999999988643
Q ss_pred ----CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 255 ----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 255 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~ 166 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 166 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccc
Confidence 3478888887 7899888764 4689999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
+..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+....++..
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (345)
T cd07877 167 ARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233 (345)
T ss_pred cccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 865322 2234568899999998865 46789999999999999999999999988777666555443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=271.44 Aligned_cols=203 Identities=23% Similarity=0.337 Sum_probs=167.3
Q ss_pred CeeecceeeeeeeEEEEEEEE----CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC-
Q 015556 180 QLFLGLRFAHGAHSRLYHGIY----KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP- 254 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~----~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~- 254 (405)
.|.+.+.||+|++|.||+|.+ .++.||||.+......... ....+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTG-----ISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccC-----ccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 367888999999999999998 4589999999864321111 134567899999999999999999999988
Q ss_pred -CeeEEEEeecCCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC----CCcEEEE
Q 015556 255 -PVYCVITEYLSEGSLRAYLHKLE---HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ----EFHLKIA 326 (405)
Q Consensus 255 -~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~----~~~vkL~ 326 (405)
..+++||||+.+ +|.+++.... ...+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+
T Consensus 76 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 76 DKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred CceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence 889999999964 7777775432 236889999999999999999999999999999999999999 9999999
Q ss_pred ecCCcccccccC----CCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 015556 327 DFGIACEEVYCD----ALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNP 388 (405)
Q Consensus 327 DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~ 388 (405)
|||++....... ......++..|+|||++.+. .++.++|||||||++|+|++|+.||.....
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 999986532211 12234578899999988654 578999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=273.09 Aligned_cols=208 Identities=25% Similarity=0.430 Sum_probs=174.6
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.++|.+.+.||+|+||.||++... ++.||||.+....... .....+.+|+.+|++++|+||+++++++..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSE------LFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccch------HHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 356889999999999999999875 6899999986432221 12456789999999999999999999987653
Q ss_pred ------eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 256 ------VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 256 ------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
.+++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 468999998 7799888864 578999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 330 IACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 330 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
++..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+++
T Consensus 164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~ 230 (343)
T cd07880 164 LARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK 230 (343)
T ss_pred ccccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9864322 2233467889999999875 4578999999999999999999999998877666655544
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=273.73 Aligned_cols=211 Identities=28% Similarity=0.400 Sum_probs=180.6
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC--
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP-- 255 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-- 255 (405)
+|.+.+.||.|++|.||+|... ++.||||.+....... ...+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL------IDAKRILREIKLLRHLRHENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccc------hhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence 4778899999999999999985 6899999987543211 12467889999999999999999999998775
Q ss_pred ---eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 256 ---VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 256 ---~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
.+|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||.|||++.++.++|+|||++.
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 75 DFNDVYIVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred cccceEEEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 7899999997 589888875 3488999999999999999999999999999999999999999999999999986
Q ss_pred cccccC----CCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 333 EEVYCD----ALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 333 ~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
...... ......++..|+|||++.+. .++.++||||||+++|+|++|..||...+..+....++...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 223 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVL 223 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhc
Confidence 544332 23445688899999999877 78999999999999999999999999988887777666543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=264.53 Aligned_cols=210 Identities=28% Similarity=0.429 Sum_probs=179.1
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeE
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC 258 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 258 (405)
|.+.+.||.|++|.||++... ++.+++|.+....... .....+.+|+.++++++|+||+++++++.++..++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE------GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLY 74 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc------hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEE
Confidence 456678999999999999985 6899999987554332 12457778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccC
Q 015556 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~ 338 (405)
+||||+++ +|.+++... ...+++..++.++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||.+.......
T Consensus 75 ~v~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 75 LVFEFMDT-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred EEEeccCC-CHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 99999965 888888763 3678999999999999999999999999999999999999999999999999985543322
Q ss_pred -CCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 339 -ALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 339 -~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+....+...
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~ 214 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRT 214 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 23345688899999998776 7899999999999999999999999998888877666544
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=266.77 Aligned_cols=201 Identities=30% Similarity=0.526 Sum_probs=170.8
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
...|.+.+.||+|+||.||++.+. ++.||||++...... .....|.+|+.+++.+.|+||+++++++
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~ei~~l~~l~~~~i~~~~~~~ 75 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-------QHRSDFEREIEILRTLDHENIVKYKGVC 75 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-------HHHHHHHHHHHHHHhCCCCChheEEeee
Confidence 356778899999999999999864 578999999754432 2256789999999999999999999999
Q ss_pred ec--CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 252 KK--PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 252 ~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
.. ....++||||+++++|.+++... ...+++..++.++.|++.||+|||+.|++|+||||+|||++.++.++|+|||
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg 154 (284)
T cd05038 76 EKPGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFG 154 (284)
T ss_pred ecCCCCceEEEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccc
Confidence 87 55789999999999999999863 2358999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCC----CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 330 IACEEVYCDA----LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 330 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
++........ .....++..|++||.+.+..++.++||||||+++|||++|..||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred cccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 9865432111 11234566799999998888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=273.88 Aligned_cols=210 Identities=28% Similarity=0.418 Sum_probs=173.5
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecC-
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKP- 254 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~- 254 (405)
++|.+.+.||+|+||.||+|.+. ++.+|||.+........ ....+.+|+.++.++ +|+||++++++|...
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~------~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~ 80 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT------DAQRTFREIMFLQELGDHPNIVKLLNVIKAEN 80 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcch------hhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence 56788899999999999999985 68999998864322211 134566899999999 999999999998653
Q ss_pred -CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 255 -PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 255 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
..+|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||+|+|||++.++.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 81 DKDIYLVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred CceEEEEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 46899999996 599998876 3788889999999999999999999999999999999999999999999998854
Q ss_pred cccc------CCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 334 EVYC------DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 334 ~~~~------~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.... .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||....+.+...++...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~ 228 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV 228 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 3221 12233458899999998754 45788999999999999999999999988877766655443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=264.44 Aligned_cols=211 Identities=28% Similarity=0.472 Sum_probs=179.9
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeecCC
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPP 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~ 255 (405)
++|.+.+.||+|++|.||++... ++.||+|++....... ......+..|+.++.+++ |+||+++++++.++.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK-----EKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccc-----hHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence 36888999999999999999985 7899999987533221 122467889999999998 999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
..++||||+.+++|.+++.+ ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999999999987 3479999999999999999999999999999999999999999999999999885432
Q ss_pred cc---------------------CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015556 336 YC---------------------DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFA 394 (405)
Q Consensus 336 ~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~ 394 (405)
.. .......++..|+|||.+....++.++||||||+++|+|++|..||......+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 21 112234578899999999888889999999999999999999999998776555444
Q ss_pred HH
Q 015556 395 VV 396 (405)
Q Consensus 395 i~ 396 (405)
+.
T Consensus 234 ~~ 235 (280)
T cd05581 234 IL 235 (280)
T ss_pred HH
Confidence 43
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=288.99 Aligned_cols=201 Identities=29% Similarity=0.499 Sum_probs=168.8
Q ss_pred eeeeeeeEEEEEEEECC--ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEee
Q 015556 186 RFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEY 263 (405)
Q Consensus 186 ~lG~G~~g~Vy~~~~~~--~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 263 (405)
.||+|.||+||-|++.. ..+|||-+...+... ..-+..|+.+.++|+|.|||+++|+|.+++.+-+.||-
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~--------~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEq 653 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSRE--------VQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQ 653 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchh--------hccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeec
Confidence 58999999999999875 466777775433222 45678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEC-CCCcEEEEecCCccccc-ccCC
Q 015556 264 LSEGSLRAYLHKLEHKTL--PLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIACEEV-YCDA 339 (405)
Q Consensus 264 ~~~gsL~~~l~~~~~~~l--~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~-~~~~vkL~DFG~a~~~~-~~~~ 339 (405)
++||+|.++|+..- +++ .+.++..+..||+.||.|||++.|||||||-+|+||+ -.|.+||+|||-+.... ...-
T Consensus 654 VPGGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 654 VPGGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CCCCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 99999999998743 444 5677888999999999999999999999999999995 57999999999886532 2333
Q ss_pred CCCCCCCCcccCccccccc--cCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHH
Q 015556 340 LSDDPGTYRWMAPEMIKHK--SYGRKVDVYSFGLILWEMVAGTIPYEEMN-PIQAAFAV 395 (405)
Q Consensus 340 ~~~~~gt~~y~aPE~~~~~--~~~~k~DVwSlGvll~elltG~~Pf~~~~-~~e~~~~i 395 (405)
.....||..|||||++..+ .|+.++|||||||++.||.||++||-.+. |..+.|++
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV 791 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV 791 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh
Confidence 4566799999999999765 58999999999999999999999997755 44455544
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.64 Aligned_cols=148 Identities=26% Similarity=0.471 Sum_probs=133.1
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
+++|.++++||.|+||.||+|.+. ++.||||++....... .....++..|+.++..++|+||+++++++....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~-----~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMIN-----KNMVHQVQAERDALALSKSPFIVHLYYSLQSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccC-----HHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC
Confidence 578999999999999999999997 7899999997543322 123567889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
.+||||||+.+++|.+++.. ...+++..++.|+.||+.||.|||.++|+||||||+||||+.++.+||+|||++.
T Consensus 78 ~~~lVmEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999999976 3568899999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=270.72 Aligned_cols=212 Identities=22% Similarity=0.363 Sum_probs=174.3
Q ss_pred ecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHH------HHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 183 LGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETL------AARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 183 ~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~------~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
+.+.||.|+||.||+|.+. ++.||||.+........... .......+.+|+.++.+++|+||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 5677999999999999875 68999999976443321100 000123577999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
...++||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+|||++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~ 169 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRY 169 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeec
Confidence 99999999996 699999875 456899999999999999999999999999999999999999999999999988543
Q ss_pred cc---------------cCCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 335 VY---------------CDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 335 ~~---------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
.. ........++..|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..++.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~ 248 (335)
T PTZ00024 170 GYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE 248 (335)
T ss_pred ccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 20 1112233468889999998764 468999999999999999999999999888777666654
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=262.41 Aligned_cols=191 Identities=24% Similarity=0.362 Sum_probs=159.5
Q ss_pred Ceeecce--eeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecC
Q 015556 180 QLFLGLR--FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKP 254 (405)
Q Consensus 180 ~~~~~~~--lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~ 254 (405)
+|.+.+. ||+|+||.||++... ++.+|+|.+....... .|+.+...+ +|+||+++++++...
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------------~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------------IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------------hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444444 599999999999875 6889999987432211 122222222 699999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCC-cEEEEecCCccc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-HLKIADFGIACE 333 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~-~vkL~DFG~a~~ 333 (405)
..+|+||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++..
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 9999999999999999999863 4889999999999999999999999999999999999999988 999999998854
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP 388 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~ 388 (405)
... .....++..|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 160 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 211 (267)
T PHA03390 160 IGT---PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211 (267)
T ss_pred cCC---CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc
Confidence 332 1234689999999999988999999999999999999999999986543
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=265.15 Aligned_cols=208 Identities=31% Similarity=0.481 Sum_probs=175.3
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeE
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC 258 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 258 (405)
|...+.||+|+||.||+|... ++.||||.+......... ....+.+|+++++.++|+|++++++++.+....|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-----KWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 344567999999999999874 689999999754433221 1356788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccC
Q 015556 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~ 338 (405)
+||||+. ++|.+++... ...+++..++.++.||+.+|.|||++||+|+||+|+||+++.++.++|+|||++....
T Consensus 98 lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~--- 172 (313)
T cd06633 98 LVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS--- 172 (313)
T ss_pred EEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---
Confidence 9999995 5888887652 4568999999999999999999999999999999999999999999999999885432
Q ss_pred CCCCCCCCCcccCccccc---cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 339 ALSDDPGTYRWMAPEMIK---HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 339 ~~~~~~gt~~y~aPE~~~---~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
......|+..|+|||++. ...++.++|||||||++|+|++|..||...+.......+...
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~ 235 (313)
T cd06633 173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 235 (313)
T ss_pred CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Confidence 223456899999999984 456788999999999999999999999988887777766543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=282.58 Aligned_cols=219 Identities=24% Similarity=0.369 Sum_probs=186.7
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
...+|-+-|..++.||-|+||.|.++... ...||.|.++..+. +..+.......|-.||...+.+-||+||-.
T Consensus 623 RaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV-----l~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 623 RAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV-----LMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHH-----HhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 44667788899999999999999998764 47899999875432 223335677889999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
|.++..+|+||+|++||++-.+|-+ -+-+.+..+..++.++..|+++.|..|+|||||||+|||||.+|+|||+|||+
T Consensus 698 FQDkdnLYFVMdYIPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGL 775 (1034)
T KOG0608|consen 698 FQDKDNLYFVMDYIPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 775 (1034)
T ss_pred eccCCceEEEEeccCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccc
Confidence 9999999999999999999999887 36788889999999999999999999999999999999999999999999999
Q ss_pred ccccc---------ccCC----------------------------------CCCCCCCCcccCccccccccCCchhhHH
Q 015556 331 ACEEV---------YCDA----------------------------------LSDDPGTYRWMAPEMIKHKSYGRKVDVY 367 (405)
Q Consensus 331 a~~~~---------~~~~----------------------------------~~~~~gt~~y~aPE~~~~~~~~~k~DVw 367 (405)
+.-.. .+.. ....+||+-|+|||++....|+..+|.|
T Consensus 776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdww 855 (1034)
T KOG0608|consen 776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWW 855 (1034)
T ss_pred cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhh
Confidence 83110 0000 0011499999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 368 SFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 368 SlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
|.|||||||+.|+.||-...|.+.-.+|++=
T Consensus 856 s~gvil~em~~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 856 SVGVILYEMLVGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred HhhHHHHHHhhCCCCccCCCCCcceeeeeeh
Confidence 9999999999999999998888877777653
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=267.05 Aligned_cols=212 Identities=23% Similarity=0.372 Sum_probs=173.0
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC-
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP- 254 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~- 254 (405)
.++|.+.+.||.|+||.||+|.+. ++.||||.+......+.. ...+.+|+++++.++|+||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF------PITALREIKILKKLKHPNVVPLIDMAVERP 80 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc------chhHHHHHHHHHhcCCCCccchhhheeccc
Confidence 578999999999999999999985 688999998754432211 23456899999999999999999987543
Q ss_pred -------CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEe
Q 015556 255 -------PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327 (405)
Q Consensus 255 -------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~D 327 (405)
..+++||||+.+ +|..++.. ....+++..+..++.|++.||.|||++||+||||||+|||+++++.++|+|
T Consensus 81 ~~~~~~~~~~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 81 DKSKRKRGSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred ccccccCceEEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECc
Confidence 357999999864 77777765 245799999999999999999999999999999999999999999999999
Q ss_pred cCCcccccccC------------CCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015556 328 FGIACEEVYCD------------ALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFA 394 (405)
Q Consensus 328 FG~a~~~~~~~------------~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~ 394 (405)
||++....... ......++..|+|||++.+. .++.++|||||||++|||++|..||.+.+..+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~ 238 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99985432211 11233468889999988654 578999999999999999999999998887766655
Q ss_pred HHh
Q 015556 395 VVN 397 (405)
Q Consensus 395 i~~ 397 (405)
+..
T Consensus 239 ~~~ 241 (311)
T cd07866 239 IFK 241 (311)
T ss_pred HHH
Confidence 543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=269.34 Aligned_cols=211 Identities=25% Similarity=0.349 Sum_probs=172.1
Q ss_pred CeeecceeeeeeeEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeec-
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKK- 253 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~- 253 (405)
+|.+.+.||+|+||.||++.+. ++.||||.+....... ...+.+.+|+.+++++ .||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 74 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK------ILAKRALRELKLLRHFRGHKNITCLYDMDIVF 74 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccc------hhHHHHHHHHHHHHHhcCCCChheeeeeeeec
Confidence 3678889999999999999986 4589999986432221 1245677899999999 59999999987543
Q ss_pred ---CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 254 ---PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 254 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
...++++|||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus 75 ~~~~~~~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 75 PGNFNELYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred cccCCcEEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 245788999985 689998865 46789999999999999999999999999999999999999999999999999
Q ss_pred ccccccc-----CCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 331 ACEEVYC-----DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 331 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
+...... .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+++..
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 226 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVL 226 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHh
Confidence 8643221 11233468999999998765 468999999999999999999999999888776666655543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=266.48 Aligned_cols=201 Identities=26% Similarity=0.477 Sum_probs=172.0
Q ss_pred cceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEE
Q 015556 184 GLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 261 (405)
..+||+|+||.||++... ++.||||.+..... .....+.+|+.+++.++|+||+++++++......++||
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ--------QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 96 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch--------hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEE
Confidence 357899999999999884 68999998754321 12456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccC-CC
Q 015556 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD-AL 340 (405)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~-~~ 340 (405)
||+++++|.+++.. ..+++..+..++.|++.+|+|||+.|++||||+|+||+++.++.++|+|||++....... ..
T Consensus 97 e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~ 173 (292)
T cd06657 97 EFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 173 (292)
T ss_pred ecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence 99999999998754 468899999999999999999999999999999999999999999999999875432211 12
Q ss_pred CCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015556 341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395 (405)
Q Consensus 341 ~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i 395 (405)
....|+..|+|||.+.+..++.++||||||+++|+|++|..||......+....+
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~ 228 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 3345889999999998888899999999999999999999999887776554433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=278.88 Aligned_cols=215 Identities=26% Similarity=0.365 Sum_probs=175.5
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEee
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACK 252 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~ 252 (405)
.|.-..|.+.++||.||.+.||++...+ +.||+|.+.....+.. ...-|.+|+.+|.+|+ |.+||+||+|-.
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~q------tl~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQ------TLDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHH------HHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 4566789999999999999999999874 7888887765444332 2567899999999996 899999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
.++.+|+||||- +.+|..+|.+.......| .+..+..||+.++.++|++||||.||||.|+|+ -.|.+||+|||+|.
T Consensus 431 ~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 431 TDGYLYMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIAN 507 (677)
T ss_pred cCceEEEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhc
Confidence 999999999975 669999999854444444 788899999999999999999999999999998 56799999999995
Q ss_pred ccccc---CCCCCCCCCCcccCcccccccc-----------CCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHh
Q 015556 333 EEVYC---DALSDDPGTYRWMAPEMIKHKS-----------YGRKVDVYSFGLILWEMVAGTIPYEEMN-PIQAAFAVVN 397 (405)
Q Consensus 333 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~-----------~~~k~DVwSlGvll~elltG~~Pf~~~~-~~e~~~~i~~ 397 (405)
..... -.....+||+-||+||.+.... .++++||||||||||+|+.|+.||.... ....+.+|..
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~ 587 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITD 587 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcC
Confidence 43322 1224557999999999884322 4678999999999999999999998766 4445555554
Q ss_pred c
Q 015556 398 K 398 (405)
Q Consensus 398 ~ 398 (405)
.
T Consensus 588 P 588 (677)
T KOG0596|consen 588 P 588 (677)
T ss_pred C
Confidence 4
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=264.98 Aligned_cols=200 Identities=24% Similarity=0.371 Sum_probs=168.7
Q ss_pred CeeecceeeeeeeEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeec
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKK 253 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~-----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~ 253 (405)
+|.+.+.||+|++|.||++... ++.||||++....... .....+.+..|+.++.++ +|+||+++++++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~----~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQ----KAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHh----hhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 3678899999999999998853 4789999987432211 122356788999999999 59999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
+...++||||+++++|.+++.. ...+++..+..++.|++.+|.|||+.+++||||+|.||+++.++.++|+|||++..
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 77 DTKLHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred CCEEEEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999999999876 35688999999999999999999999999999999999999999999999998854
Q ss_pred ccccCC--CCCCCCCCcccCcccccccc--CCchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 334 EVYCDA--LSDDPGTYRWMAPEMIKHKS--YGRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 334 ~~~~~~--~~~~~gt~~y~aPE~~~~~~--~~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
...... .....|+..|+|||.+.+.. .+.++||||||+++|+|++|..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 332211 12345889999999987654 68899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=271.53 Aligned_cols=209 Identities=27% Similarity=0.436 Sum_probs=173.5
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC--
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-- 254 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-- 254 (405)
++|.+.+.||.|+||.||+|... ++.||||.+...+... .+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~--------~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS--------VKHALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCch--------HHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 67889999999999999999985 6899999997655422 35677899999999999999999876543
Q ss_pred ------------CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEC-CCC
Q 015556 255 ------------PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEF 321 (405)
Q Consensus 255 ------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~-~~~ 321 (405)
...|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ +++
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~ 152 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc
Confidence 35789999996 589888864 5688999999999999999999999999999999999997 556
Q ss_pred cEEEEecCCcccccc----cCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015556 322 HLKIADFGIACEEVY----CDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 322 ~vkL~DFG~a~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~ 396 (405)
.++|+|||++..... ........++..|+|||++.. ..++.++|||||||++|+|++|+.||...++.+....+.
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 799999999854321 111223457889999998754 567889999999999999999999999988888777666
Q ss_pred hcc
Q 015556 397 NKV 399 (405)
Q Consensus 397 ~~~ 399 (405)
...
T Consensus 233 ~~~ 235 (342)
T cd07854 233 ESV 235 (342)
T ss_pred Hhc
Confidence 543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=271.59 Aligned_cols=207 Identities=28% Similarity=0.447 Sum_probs=172.2
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC--
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-- 254 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-- 254 (405)
.+|.+...||+|+||.||+|.+. ++.||||.+......+. ....+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 88 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI------FAKRAYRELTLLKHMQHENVIGLLDVFTSAVS 88 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccccc------chhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence 57888899999999999999874 78999999875432221 134677899999999999999999998754
Q ss_pred ----CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 255 ----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 255 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
..+++||||+. .+|..++ ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 89 GDEFQDFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred CCCCceEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 34689999995 4777655 24689999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
+..... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..++..
T Consensus 164 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~ 230 (342)
T cd07879 164 ARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 230 (342)
T ss_pred CcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 864322 2234467889999999876 45789999999999999999999999988877766666553
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=311.64 Aligned_cols=208 Identities=28% Similarity=0.465 Sum_probs=177.7
Q ss_pred ecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEE
Q 015556 183 LGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVI 260 (405)
Q Consensus 183 ~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 260 (405)
-|..||.|.||.||-|+.. |+..|||-++..+... +..+.+.+|+.++..|+|||+|++||.=.+.+..+|.
T Consensus 1239 rg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~------k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1239 RGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDH------KTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred cccccCCcceeeeEEeecCCccchhhhhhhhcCcccc------ccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 4667899999999999874 7999999998876652 2356788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc---
Q 015556 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC--- 337 (405)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~--- 337 (405)
||||.+|+|.+.+.. ++..++.....+..|++.|+.|||+.|||||||||+|||++.+|.+|+.|||.|......
T Consensus 1313 MEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 999999999999987 456777788889999999999999999999999999999999999999999999654432
Q ss_pred --CCCCCCCCCCcccCccccccc---cCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhc
Q 015556 338 --DALSDDPGTYRWMAPEMIKHK---SYGRKVDVYSFGLILWEMVAGTIPYEEMN-PIQAAFAVVNK 398 (405)
Q Consensus 338 --~~~~~~~gt~~y~aPE~~~~~---~~~~k~DVwSlGvll~elltG~~Pf~~~~-~~e~~~~i~~~ 398 (405)
.......||+.|||||++.+. ....++|||||||++.||+||+.||..++ .-+..+.+.-+
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~g 1457 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAG 1457 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhcc
Confidence 233456799999999999653 45789999999999999999999998755 45555555433
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=270.88 Aligned_cols=205 Identities=27% Similarity=0.384 Sum_probs=170.5
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC--
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-- 254 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-- 254 (405)
.+|.+.+.||.|+||+||++... ++.||||.+........ ....+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~ 78 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI------DAKRTLREIKLLRHLDHENVIAIKDIMPPPHR 78 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccc------hhHHHHHHHHHHHhcCCCCccchHHheecccc
Confidence 46888899999999999999975 68999999875322211 134567899999999999999999988654
Q ss_pred ---CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 255 ---PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 255 ---~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
...|+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++
T Consensus 79 ~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 79 EAFNDVYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred cccCcEEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 34799999995 689998875 467999999999999999999999999999999999999999999999999998
Q ss_pred cccccc-CCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015556 332 CEEVYC-DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAA 392 (405)
Q Consensus 332 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~ 392 (405)
...... .......++..|+|||.+.. ..++.++|||||||++|+|++|..||.+.+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 218 (337)
T cd07858 156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQL 218 (337)
T ss_pred cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHH
Confidence 654322 22234468889999998864 46889999999999999999999999876654433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=266.33 Aligned_cols=202 Identities=29% Similarity=0.411 Sum_probs=170.0
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec-CC
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK-PP 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~ 255 (405)
++|.+.+.||.|+||.||++... ++.||||.+........ ..+.+.+|+.++..++||||++++++|.. ..
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPV------LAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccc------hhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 56888999999999999999875 68899998864332211 14567789999999999999999999865 56
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+++||||+ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||+|.|||++.++.++|+|||++....
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 788999998 5689888864 567888899999999999999999999999999999999999999999999986432
Q ss_pred ccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015556 336 YCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAA 392 (405)
Q Consensus 336 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~ 392 (405)
. ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||....+....
T Consensus 160 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~ 215 (328)
T cd07856 160 P--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF 215 (328)
T ss_pred C--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 2 2234467889999998865 56899999999999999999999999887764433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=255.22 Aligned_cols=204 Identities=28% Similarity=0.442 Sum_probs=175.6
Q ss_pred eeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEeec
Q 015556 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264 (405)
Q Consensus 187 lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 264 (405)
||.|+||.||++... ++.||||++........ .....+..|+.++++++|+||+++++.+..+...++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR-----KEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcch-----HHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecC
Confidence 589999999999986 68999999875433221 12457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc-CCCCCC
Q 015556 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-DALSDD 343 (405)
Q Consensus 265 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~ 343 (405)
++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... ......
T Consensus 76 ~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (250)
T cd05123 76 PGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF 153 (250)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCC
Confidence 999999999873 46899999999999999999999999999999999999999999999999998654332 233455
Q ss_pred CCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 344 PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 344 ~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
.++..|++||.+.+...+.++|+||||+++|+|++|..||...+..+....+..
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 207 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK 207 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 688999999999888889999999999999999999999988776555555443
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=273.84 Aligned_cols=193 Identities=32% Similarity=0.525 Sum_probs=164.5
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHh--cCCCCeeEEeeEe
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR--LHNPNVIKFVAAC 251 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~ 251 (405)
..++...+.+.+.||+|.||.||+|.+.++.||||++... -...|..|-+|.+. +.|+||++|+++-
T Consensus 205 pl~~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~-----------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~e 273 (534)
T KOG3653|consen 205 PLLELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ-----------EKQSFQNEKNIYSLPGMKHENILQFIGAE 273 (534)
T ss_pred ccccCCchhhHHHhhcCccceeehhhccCceeEEEecCHH-----------HHHHHHhHHHHHhccCccchhHHHhhchh
Confidence 3455778888999999999999999999999999999732 24567788887766 4799999999988
Q ss_pred ecCC----eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCcEEEC
Q 015556 252 KKPP----VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ---------GVIHRDLKPENVLID 318 (405)
Q Consensus 252 ~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---------gIiHrDIkp~NILl~ 318 (405)
.... .++||+||-+.|+|.+||.. ..++|....+|+..+++||+|||+. .|+|||||..||||.
T Consensus 274 kr~t~~~~eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK 350 (534)
T KOG3653|consen 274 KRGTADRMEYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK 350 (534)
T ss_pred ccCCccccceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc
Confidence 7655 89999999999999999987 7899999999999999999999964 499999999999999
Q ss_pred CCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccC------CchhhHHHHHHHHHHHHhCC
Q 015556 319 QEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY------GRKVDVYSFGLILWEMVAGT 380 (405)
Q Consensus 319 ~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~------~~k~DVwSlGvll~elltG~ 380 (405)
.|++.-|+|||+|....... .....+||.+|||||++.+..- -.+.||||+|.+||||++.-
T Consensus 351 ~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC 421 (534)
T KOG3653|consen 351 NDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC 421 (534)
T ss_pred cCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence 99999999999996544322 2334679999999999965432 24799999999999999853
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=291.58 Aligned_cols=221 Identities=31% Similarity=0.564 Sum_probs=187.4
Q ss_pred cccccccccCCCeeecceeeeeeeEEEEEEEEC---------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc
Q 015556 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK---------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL 239 (405)
Q Consensus 169 ~~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~---------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l 239 (405)
...+.|+++.+++.+++.||+|+||.|++|... ...||||.++......+ .+.+..|+.+|+.+
T Consensus 286 ~~~~~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~-------~~~~~~El~~m~~~ 358 (609)
T KOG0200|consen 286 PEDPKWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSE-------KKDLMSELNVLKEL 358 (609)
T ss_pred CcCCceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHH-------HHHHHHHHHHHHHh
Confidence 344589999999999999999999999999864 24799999986555422 57889999999999
Q ss_pred -CCCCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhc------------C--CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 015556 240 -HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE------------H--KTLPLPKLIAIALDIARGMEYIHSQG 304 (405)
Q Consensus 240 -~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~qi~~aL~yLH~~g 304 (405)
.|+||+.++|+|...+..++|+||+..|+|.+||+... . ..++...++.++.|||.||+||++.+
T Consensus 359 g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~ 438 (609)
T KOG0200|consen 359 GKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP 438 (609)
T ss_pred cCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC
Confidence 49999999999999999999999999999999999754 0 13888999999999999999999999
Q ss_pred ceecCCCCCcEEECCCCcEEEEecCCcccccccCCCC--CCC--CCCcccCccccccccCCchhhHHHHHHHHHHHHh-C
Q 015556 305 VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALS--DDP--GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-G 379 (405)
Q Consensus 305 IiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~--~~~--gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G 379 (405)
+|||||..+|||+..+..+||+|||+|+......... ... -...|||||.+....|+.++|||||||+||||++ |
T Consensus 439 ~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG 518 (609)
T KOG0200|consen 439 CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLG 518 (609)
T ss_pred ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCC
Confidence 9999999999999999999999999997533322222 111 3566999999999999999999999999999999 9
Q ss_pred CCCCCCCCHHHHHHHHH
Q 015556 380 TIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 380 ~~Pf~~~~~~e~~~~i~ 396 (405)
..||++..+.+.+.+.+
T Consensus 519 ~~PYp~~~~~~~l~~~l 535 (609)
T KOG0200|consen 519 GTPYPGIPPTEELLEFL 535 (609)
T ss_pred CCCCCCCCcHHHHHHHH
Confidence 99999977444444433
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=260.94 Aligned_cols=209 Identities=30% Similarity=0.470 Sum_probs=177.4
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeE
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC 258 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 258 (405)
|.+.+.||+|++|.||+|... ++.||+|++......+ .....+..|+.+++.++|+||+++++++.+...++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 74 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE------GIPSTALREISLLKELKHPNIVKLLDVIHTERKLY 74 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccc------cccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceE
Confidence 446678999999999999986 6899999998654221 12356678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccC
Q 015556 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~ 338 (405)
+||||+. ++|.+++.... ..+++..+..++.|++.||.|||++||+||||+|+||++++++.++|+|||++.......
T Consensus 75 ~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 75 LVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred EEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 9999997 58999998732 478999999999999999999999999999999999999999999999999986543221
Q ss_pred -CCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 339 -ALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 339 -~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
......++..|+|||++.+. .++.++||||||+++|||++|..||......+....+..
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 213 (282)
T cd07829 153 RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ 213 (282)
T ss_pred cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHH
Confidence 23344567889999998766 789999999999999999999999999887777666554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=269.80 Aligned_cols=204 Identities=32% Similarity=0.586 Sum_probs=168.3
Q ss_pred CCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHh--cCCCCeeEEeeEeecCC-
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR--LHNPNVIKFVAACKKPP- 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~~~~- 255 (405)
.++.+.+.||+|-||.||+|.|.|+.||||++...+ +....+|.+|.+. |+|+||+.|+++-..+.
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----------ERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccc-----------hhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 567889999999999999999999999999998544 3445678887776 49999999999876543
Q ss_pred ---eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCcEEECCCCcEE
Q 015556 256 ---VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ--------GVIHRDLKPENVLIDQEFHLK 324 (405)
Q Consensus 256 ---~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------gIiHrDIkp~NILl~~~~~vk 324 (405)
.+|||++|-+.|+|+|||.. ..++-+..+++++.+|.||++||.. .|.|||||..||||..++..-
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 68999999999999999987 7899999999999999999999954 399999999999999999999
Q ss_pred EEecCCccccccc-----CCCCCCCCCCcccCcccccccc----C--CchhhHHHHHHHHHHHHhC----------CCCC
Q 015556 325 IADFGIACEEVYC-----DALSDDPGTYRWMAPEMIKHKS----Y--GRKVDVYSFGLILWEMVAG----------TIPY 383 (405)
Q Consensus 325 L~DFG~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~----~--~~k~DVwSlGvll~elltG----------~~Pf 383 (405)
|+|+|+|...... ......+||.+|||||++...- + -..+||||||.++||++.. ++||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 9999999543222 2345668999999999985432 1 2469999999999999752 5799
Q ss_pred CCCCHHHHHHHHH
Q 015556 384 EEMNPIQAAFAVV 396 (405)
Q Consensus 384 ~~~~~~e~~~~i~ 396 (405)
.+.-|.+.-++-+
T Consensus 437 yd~Vp~DPs~eeM 449 (513)
T KOG2052|consen 437 YDVVPSDPSFEEM 449 (513)
T ss_pred ccCCCCCCCHHHH
Confidence 7765554444333
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=282.54 Aligned_cols=206 Identities=24% Similarity=0.383 Sum_probs=177.3
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC---CCCeeEEeeEe
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---NPNVIKFVAAC 251 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~ 251 (405)
.+.+|.....+|.|+||.|+.++++ ...|+||+|.....-.+.=++.+-.-.+..|++||..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3467899999999999999999997 478999999754332221122222234568999999998 99999999999
Q ss_pred ecCCeeEEEEeec-CCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 252 KKPPVYCVITEYL-SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 252 ~~~~~~~lV~E~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
++++.+||+||-- +|.+|++||.. ...+++.++..|+.|++.|+++||+.||||||||-+|+.++.+|.+||+|||.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~--kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEF--KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhc--cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 9999999999974 56699999986 57899999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCCCCCCCCcccCccccccccC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
|... ....+...+||..|.|||++.+.+| +..-|||+||++||.++....||.+
T Consensus 717 aa~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 8543 3356678899999999999999998 7889999999999999999999975
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=262.22 Aligned_cols=218 Identities=26% Similarity=0.452 Sum_probs=188.8
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEe
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFV 248 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 248 (405)
..|.+.+.+|.++..||+|+|.+|..+++. ++.||+|+++..-..++++ ..-...|..+..+. +||.+|.++
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndded-----idwvqtek~vfe~asn~pflvglh 317 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDED-----IDWVQTEKHVFEQASNNPFLVGLH 317 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCccc-----chhHHhhHHHHHhccCCCeEEehh
Confidence 456778889999999999999999999886 6899999987643333322 12344677776666 699999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEec
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF 328 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DF 328 (405)
.||.....+++|.||++||+|--++++ .+.++++.+..+..+|+-||.|||++|||+||||..|+|+|..|++||+|+
T Consensus 318 scfqtesrlffvieyv~ggdlmfhmqr--qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdy 395 (593)
T KOG0695|consen 318 SCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDY 395 (593)
T ss_pred hhhcccceEEEEEEEecCcceeeehhh--hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeeccc
Confidence 999999999999999999998655554 578999999999999999999999999999999999999999999999999
Q ss_pred CCcccc-cccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCC-------CCCHHHHHHHHH
Q 015556 329 GIACEE-VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE-------EMNPIQAAFAVV 396 (405)
Q Consensus 329 G~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~-------~~~~~e~~~~i~ 396 (405)
|.+.+. ..+...+..+||+.|.|||++++..|+..+|.|+|||+++||+.|+.||+ +++..+.+++++
T Consensus 396 gmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi 471 (593)
T KOG0695|consen 396 GMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI 471 (593)
T ss_pred chhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH
Confidence 998764 45567778899999999999999999999999999999999999999994 466777888776
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=269.64 Aligned_cols=208 Identities=26% Similarity=0.416 Sum_probs=176.2
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+...||.|++|.||+|.+. ++.||||++....... .....+.+|+.+++.++|+||+++++++.....
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA------IHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh------hHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 57889999999999999999985 6899999986432211 123567789999999999999999998866544
Q ss_pred ------eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 257 ------YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 257 ------~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||+
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 6799998875 5789999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
+..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+.+..+.+.
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~ 231 (343)
T cd07851 165 ARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNL 231 (343)
T ss_pred cccccc--cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Confidence 865432 2344568889999999865 36789999999999999999999999998887777766553
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=262.49 Aligned_cols=208 Identities=29% Similarity=0.443 Sum_probs=174.4
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeE
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC 258 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 258 (405)
|...+.||.|++|.||+|++. ++.||||.+......... ...++.+|+.+++.++|+|++++++++......+
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-----KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChH-----HHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 556678999999999999985 688999998753322211 1356778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccC
Q 015556 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~ 338 (405)
+||||+. |+|.+++... ...+++..++.++.|++.||.|||+++++||||+|+|||++.++.++|+|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-- 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (308)
T ss_pred EEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence 9999996 5888877642 35688999999999999999999999999999999999999999999999998854332
Q ss_pred CCCCCCCCCcccCccccc---cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 339 ALSDDPGTYRWMAPEMIK---HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 339 ~~~~~~gt~~y~aPE~~~---~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.....++..|+|||.+. ...++.++|||||||++|+|++|..||...+..+....+..+
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 229 (308)
T cd06634 168 -ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229 (308)
T ss_pred -cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhc
Confidence 23446889999999874 356788999999999999999999999988877776665543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=281.19 Aligned_cols=213 Identities=27% Similarity=0.463 Sum_probs=183.9
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEee---
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACK--- 252 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~--- 252 (405)
+.+.+.+.||.|.+|.||+++.. ++.+|||++....+.+ .++.-|.+||+.+ .|||++.+||+|.
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---------eEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---------EEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---------HHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 34567789999999999998764 7999999987544443 2355788899888 5999999999885
Q ss_pred --cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 253 --KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 253 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
.++.+|||||||.+|+.-|+++...+..+.|+.+..|++.++.||.+||...++|||||-.|||++.++.|||+|||.
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence 356899999999999999999988888999999999999999999999999999999999999999999999999999
Q ss_pred ccccc-ccCCCCCCCCCCcccCcccccc-----ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 331 ACEEV-YCDALSDDPGTYRWMAPEMIKH-----KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 331 a~~~~-~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
+.... .........||+.|||||++.. ..|+.++|+||||++..||..|.+|+-++.|.-++|.|..+..
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP 245 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 245 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC
Confidence 86533 2334456679999999999843 3578899999999999999999999999999999999876643
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=255.22 Aligned_cols=215 Identities=30% Similarity=0.481 Sum_probs=174.7
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
+|.+.+.||+|+||.||++.+. +..+++|+++.....+.. .....++..|+.++++++||||+++++++.+....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELN---PNETVQANQEAQLLSKLDHPAIVKFHASFLERDAF 77 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccC---cchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCce
Confidence 4778899999999999999886 355667776542221110 00133566899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 258 CVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
++||||+++++|.+++... ....+++..++.++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++....
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999999998753 3457899999999999999999999999999999999999975 569999999885432
Q ss_pred cc-CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 336 YC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 336 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.. .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......+....+..+
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 220 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG 220 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC
Confidence 21 2223445888999999998888899999999999999999999999887776666665443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=264.57 Aligned_cols=209 Identities=26% Similarity=0.440 Sum_probs=175.9
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee-cC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK-KP 254 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~-~~ 254 (405)
-++|.++.+||+|||+.||++.+- .+.||||+-.......++ -.+++.+...+|..|.+.|+||.||++|++|. +.
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdE-KKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDE-KKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhH-hhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 478889999999999999999864 689999998765544432 23556788899999999999999999999996 56
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEE---CCCCcEEEEecC
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLI---DQEFHLKIADFG 329 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IiHrDIkp~NILl---~~~~~vkL~DFG 329 (405)
..+|-|+|||+|.+|.-||.. ++.+++.++..|+.||+.||.||.+.. |||.||||.|||+ +..|.+||+|||
T Consensus 541 dsFCTVLEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccceeeeeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 789999999999999999987 678899999999999999999999874 9999999999999 345889999999
Q ss_pred Cccccccc--------CCCCCCCCCCcccCccccccc----cCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 015556 330 IACEEVYC--------DALSDDPGTYRWMAPEMIKHK----SYGRKVDVYSFGLILWEMVAGTIPYEEMNPI 389 (405)
Q Consensus 330 ~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~----~~~~k~DVwSlGvll~elltG~~Pf~~~~~~ 389 (405)
++...... +......||..|++||.+.-+ ..+.++||||+|||+|.+|.|+-||...-..
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ 690 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ 690 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence 98543221 223456799999999987432 4688999999999999999999999865433
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=247.74 Aligned_cols=179 Identities=20% Similarity=0.296 Sum_probs=153.5
Q ss_pred eeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEeecCCC
Q 015556 190 GAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEG 267 (405)
Q Consensus 190 G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 267 (405)
|.+|.||++.+. ++.||+|.+.... .+.+|...+....||||+++++++.+....++||||+++|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 70 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGG 70 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCC
Confidence 889999999985 6899999997432 1224555556667999999999999999999999999999
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCCCCCCCCCC
Q 015556 268 SLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY 347 (405)
Q Consensus 268 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~ 347 (405)
+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||.+..... ......++.
T Consensus 71 ~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~--~~~~~~~~~ 146 (237)
T cd05576 71 KLWSHISK--FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED--SCDGEAVEN 146 (237)
T ss_pred CHHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc--ccccCCcCc
Confidence 99999976 34689999999999999999999999999999999999999999999999997644322 123345677
Q ss_pred cccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 348 ~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
.|+|||.+.+..++.++||||||+++|||++|..||..
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 89999999888899999999999999999999988764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=270.94 Aligned_cols=204 Identities=24% Similarity=0.366 Sum_probs=171.0
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKP 254 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~ 254 (405)
.+.|.+...+|.|+|+.|-.+... ++..+||++.....+. .+|+.++... .||||+++++.+.++
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~------------~~e~~~~~~~~~h~niv~~~~v~~~~ 388 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDN------------QDEIPISLLVRDHPNIVKSHDVYEDG 388 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccccc------------ccccchhhhhcCCCcceeecceecCC
Confidence 466777788999999999999875 6899999998663322 2678777666 699999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE-CCCCcEEEEecCCccc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI-DQEFHLKIADFGIACE 333 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl-~~~~~vkL~DFG~a~~ 333 (405)
...|+|||.+.|+.|.+.+... ......+..|+.+|+.++.|||++|||||||||+|||+ +..++++|+|||.+..
T Consensus 389 ~~~~~v~e~l~g~ell~ri~~~---~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 389 KEIYLVMELLDGGELLRRIRSK---PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred ceeeeeehhccccHHHHHHHhc---chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhh
Confidence 9999999999999998888762 22236777899999999999999999999999999999 6999999999999865
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.... ....+-|..|.|||++....|++++|+||||++||+||+|+.||........+...++.
T Consensus 466 ~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~ 528 (612)
T KOG0603|consen 466 LERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM 528 (612)
T ss_pred Cchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC
Confidence 4433 34456788999999999999999999999999999999999999886655444444433
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=255.30 Aligned_cols=219 Identities=26% Similarity=0.341 Sum_probs=176.4
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
++..|++.+.||+|.||.||+++-+ ++.+|+|.++...+..-. .....+|+.+++.++|||||.|...
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi------S~SAcREiaL~REl~h~nvi~Lv~V 95 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI------SMSACREIALLRELKHPNVISLVKV 95 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc------CHHHHHHHHHHHHhcCCcchhHHHH
Confidence 4567888899999999999999654 248999999876443221 2334589999999999999999998
Q ss_pred eec-CCeeEEEEeecCCCCHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC----Cc
Q 015556 251 CKK-PPVYCVITEYLSEGSLRAYLHKL---EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE----FH 322 (405)
Q Consensus 251 ~~~-~~~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~----~~ 322 (405)
+.. +..+++++||.+. +|.+.|+-. ....++...+..|+.||+.|+.|||++-|+||||||.||||..+ |+
T Consensus 96 fl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 96 FLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred HhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCe
Confidence 876 8899999999854 888887643 23568888999999999999999999999999999999999766 99
Q ss_pred EEEEecCCccccccc----CCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCC---------H
Q 015556 323 LKIADFGIACEEVYC----DALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMN---------P 388 (405)
Q Consensus 323 vkL~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~---------~ 388 (405)
+||+|||+++..... ......+.|+.|.|||++.+. .|+.+.|||++|||+.|||+-.+-|.+.. .
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq 254 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ 254 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence 999999999653321 233456689999999998765 58999999999999999999999886532 2
Q ss_pred HHHHHHHHhcccCC
Q 015556 389 IQAAFAVVNKVNFG 402 (405)
Q Consensus 389 ~e~~~~i~~~~~~~ 402 (405)
.+.+.+|.+-.++|
T Consensus 255 ~dQl~rIf~vLG~P 268 (438)
T KOG0666|consen 255 HDQLDRIFEVLGTP 268 (438)
T ss_pred HHHHHHHHHHcCCC
Confidence 34555666655554
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=238.30 Aligned_cols=211 Identities=32% Similarity=0.509 Sum_probs=178.7
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeE
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC 258 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 258 (405)
|.+++.||.|++|.||++... ++.+|||.+...... ...+.+.+|++.+.+++|+|++++++++......+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~ 73 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-------KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLY 73 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-------HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceE
Confidence 456788999999999999986 489999999754432 12567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccC
Q 015556 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~ 338 (405)
+++||+++++|.+++..... .+++..+..++.+++.++.+||+.+++|+||++.||+++.++.++|+|||.+.......
T Consensus 74 ~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 74 LVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred EEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 99999999999999987321 18899999999999999999999999999999999999999999999999886544332
Q ss_pred --CCCCCCCCCcccCcccc-ccccCCchhhHHHHHHHHHHHHhCCCCCCC-CCHH-HHHHHHHhcc
Q 015556 339 --ALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAGTIPYEE-MNPI-QAAFAVVNKV 399 (405)
Q Consensus 339 --~~~~~~gt~~y~aPE~~-~~~~~~~k~DVwSlGvll~elltG~~Pf~~-~~~~-e~~~~i~~~~ 399 (405)
......++..|++||++ ....++.++|||+||+++|+|++|+.||.. .++. ++...+.++.
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 33445688899999998 666778899999999999999999999988 5666 4444555444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=285.41 Aligned_cols=205 Identities=30% Similarity=0.509 Sum_probs=161.6
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC--
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-- 254 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-- 254 (405)
.+|+....||+||||.||+++.+ |+.||||.|.... . ......+.+|+.+|.+|+|||||+++.++.+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s------~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-S------DKLYSKILREVKLLARLNHPNVVRYYSAWVESTA 551 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-H------HHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence 44556678999999999999875 8999999998755 2 22356788999999999999999886543100
Q ss_pred --------------------------------------------------------------------------------
Q 015556 255 -------------------------------------------------------------------------------- 254 (405)
Q Consensus 255 -------------------------------------------------------------------------------- 254 (405)
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence
Q ss_pred -------------------------------------CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Q 015556 255 -------------------------------------PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGM 297 (405)
Q Consensus 255 -------------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL 297 (405)
..+||-||||+...|+++++.+.... .-..+++++++|+.||
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGL 710 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHH
Confidence 13688999999988888887732221 4668999999999999
Q ss_pred HHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc-------------------ccCCCCCCCCCCcccCccccccc
Q 015556 298 EYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV-------------------YCDALSDDPGTYRWMAPEMIKHK 358 (405)
Q Consensus 298 ~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~ 358 (405)
.|+|++|||||||||.||++++++.|||+|||+|.... .....+..+||..|+|||++.+.
T Consensus 711 aYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 711 AYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 99999999999999999999999999999999996511 11133455799999999999655
Q ss_pred c---CCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHH
Q 015556 359 S---YGRKVDVYSFGLILWEMVAGTIPYEE-MNPIQAAFA 394 (405)
Q Consensus 359 ~---~~~k~DVwSlGvll~elltG~~Pf~~-~~~~e~~~~ 394 (405)
. |+.|+|+|||||+|+||+. ||.. |.....+..
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~ 827 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTN 827 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHh
Confidence 4 9999999999999999984 4643 333333333
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=275.80 Aligned_cols=212 Identities=26% Similarity=0.505 Sum_probs=178.5
Q ss_pred CeeecceeeeeeeEEEEEEEEC------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 253 (405)
++...+.||+|+||+||+|.+- +-+||+|++......+ .-.++..|+-+|.+|+|||+++|+|+|..
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~-------~s~e~LdeAl~masldHpnl~RLLgvc~~ 769 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK-------ASIELLDEALRMASLDHPNLLRLLGVCML 769 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch-------hhHHHHHHHHHHhcCCCchHHHHhhhccc
Confidence 3445678999999999999984 3589999987544332 24678899999999999999999999987
Q ss_pred CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
.. +.||++||+.|+|.+|++. ....+-...++.+..||++||.|||+++++||||..+|+||..-..+||.|||++..
T Consensus 770 s~-~qlvtq~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 770 ST-LQLVTQLMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred ch-HHHHHHhcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 76 7799999999999999987 446788889999999999999999999999999999999999999999999999965
Q ss_pred ccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 015556 334 EVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 334 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
..... ......-.+.|||-|.+....|+.++|||||||++||++| |..||.+....+.-.-+-++..
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR 918 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER 918 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc
Confidence 33211 1222234678999999999999999999999999999999 9999999988876655444443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=293.40 Aligned_cols=185 Identities=25% Similarity=0.406 Sum_probs=158.0
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
.+.....||+|+||.||+|.+. +..||||.+....... ..|++++++++|||||+++|+|.+....
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~l~~l~HpnIv~~~~~~~~~~~~ 758 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP------------SSEIADMGKLQHPNIVKLIGLCRSEKGA 758 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc------------HHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence 4556678999999999999974 6899999886433211 2468889999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH---SQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
|+||||+++|+|.++++. ++|..+..|+.|++.||+||| +.+|+||||||+||+++.++..++. ||.....
T Consensus 759 ~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred EEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 999999999999999963 789999999999999999999 6699999999999999999888775 6654322
Q ss_pred cccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 335 VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 335 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
. ......++..|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 833 ~---~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 833 C---TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred c---cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 1 11234688999999999999999999999999999999999999854
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=240.31 Aligned_cols=208 Identities=24% Similarity=0.450 Sum_probs=180.5
Q ss_pred cCCCeeecceeeeeeeEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeec
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKK 253 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~ 253 (405)
..++|.+.+++|+|.|+.||.|+. +++.++||+++.- -.+.+.+|+.||..|+ |||||+|++...+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----------kkkKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----------KKKKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----------HHHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 457889999999999999999984 5789999999731 2678999999999997 9999999999987
Q ss_pred C--CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC-CcEEEEecCC
Q 015556 254 P--PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE-FHLKIADFGI 330 (405)
Q Consensus 254 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~-~~vkL~DFG~ 330 (405)
+ ....||+||+.+.++..... .++...+..++.+++.||.|||++||+|||+||.|++||.. ..++|+|+|+
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGL 179 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
T ss_pred ccccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecch
Confidence 5 46789999999887776553 57777899999999999999999999999999999999865 5699999999
Q ss_pred cccccccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhccc
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPY-EEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf-~~~~~~e~~~~i~~~~~ 400 (405)
|.+...+......+.+..|--||++.. ..|+...|+|||||+|..|+..+.|| .+.+..+++.+|.+-.+
T Consensus 180 AEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLG 251 (338)
T KOG0668|consen 180 AEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLG 251 (338)
T ss_pred HhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhC
Confidence 988888888888889999999999865 45799999999999999999987776 67788888888876544
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=257.05 Aligned_cols=203 Identities=22% Similarity=0.350 Sum_probs=177.2
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC--CC----eeEEee
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN--PN----VIKFVA 249 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pn----Iv~l~g 249 (405)
..+|.+...+|+|.||.|..+++. +..||||+++.- .+......-|+++|.++.+ |+ +|++.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---------~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---------DKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---------HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 578999999999999999999986 589999999742 2334556689999999943 32 788889
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC----------
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ---------- 319 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~---------- 319 (405)
||.-.+..|+|+|.+ |-++++||..+...+++...+..++.|++.++++||+.+++|-||||+|||+-.
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccC
Confidence 999999999999988 779999999988888999999999999999999999999999999999999931
Q ss_pred ----------CCcEEEEecCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 015556 320 ----------EFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI 389 (405)
Q Consensus 320 ----------~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~ 389 (405)
+..|+|+|||.|....... ...+.|..|.|||++.+-+.+..+||||+||||+|+++|...|+..+..
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 2359999999997655433 5677899999999999999999999999999999999999999998877
Q ss_pred HHH
Q 015556 390 QAA 392 (405)
Q Consensus 390 e~~ 392 (405)
|.+
T Consensus 316 EHL 318 (415)
T KOG0671|consen 316 EHL 318 (415)
T ss_pred HHH
Confidence 754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=262.34 Aligned_cols=212 Identities=18% Similarity=0.301 Sum_probs=157.9
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEE------------------CCccEEEEEEecCCCChhHHH------HHHHHHHHH
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIY------------------KDEPVAVKIIRIPDDDENETL------AARLEKQFN 230 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~------------------~~~~vAVK~~~~~~~~~~~~~------~~~~~~~~~ 230 (405)
.+..++|.+.++||+|+||.||+|.+ .++.||||.+.........+. .........
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 34678999999999999999999974 235799999875432211110 011123345
Q ss_pred HHHHHHHhcCCCCe-----eEEeeEeec--------CCeeEEEEeecCCCCHHHHHHHhc--------------------
Q 015556 231 REVALLSRLHNPNV-----IKFVAACKK--------PPVYCVITEYLSEGSLRAYLHKLE-------------------- 277 (405)
Q Consensus 231 ~Ei~il~~l~HpnI-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~-------------------- 277 (405)
.|+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++...
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 67788888877654 677887753 356799999999999999987521
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCCCC--CCCCCCcccCcc
Q 015556 278 --HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALS--DDPGTYRWMAPE 353 (405)
Q Consensus 278 --~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~--~~~gt~~y~aPE 353 (405)
...+++..+..++.|++.+|.|||+++|+||||||+|||++.++.+||+|||++.......... ...+++.|+|||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 1234567888999999999999999999999999999999999999999999986433222222 223578999999
Q ss_pred cccccc--------------------C--CchhhHHHHHHHHHHHHhCCC-CCCCC
Q 015556 354 MIKHKS--------------------Y--GRKVDVYSFGLILWEMVAGTI-PYEEM 386 (405)
Q Consensus 354 ~~~~~~--------------------~--~~k~DVwSlGvll~elltG~~-Pf~~~ 386 (405)
.+.... | ..+.||||+||++|+|++|.. ||.+.
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~ 436 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANI 436 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccch
Confidence 875322 1 234799999999999999876 87653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=234.28 Aligned_cols=199 Identities=33% Similarity=0.575 Sum_probs=171.5
Q ss_pred eeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEeecCCCC
Q 015556 191 AHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGS 268 (405)
Q Consensus 191 ~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 268 (405)
+||.||+|... ++.+|+|++........ .+.+.+|++++++++|+||+++++++......+++|||+.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 73 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-------RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGD 73 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-------HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCC
Confidence 58999999986 48999999976543321 4678899999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCCCCCCCCCCc
Q 015556 269 LRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR 348 (405)
Q Consensus 269 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~ 348 (405)
|.+++... ..+++..++.++.+++.+|.|||+.+++|+||+|.||+++.++.++|+|||.+.............++..
T Consensus 74 L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T smart00220 74 LFDLLKKR--GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPE 151 (244)
T ss_pred HHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcC
Confidence 99999863 2388999999999999999999999999999999999999999999999999876554434556678999
Q ss_pred ccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 349 y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
|++||.+.+..++.++|||+||+++|+|++|..||......+.....+..
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~ 201 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK 201 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc
Confidence 99999998888899999999999999999999999884444444444443
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=248.45 Aligned_cols=210 Identities=24% Similarity=0.379 Sum_probs=176.0
Q ss_pred cceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC-----Ce
Q 015556 184 GLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-----PV 256 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~ 256 (405)
.+-||.|+||.||.+.+. |+.||+|.+..... .--.-+.+.+|+.+|..++|.||+..+++..-. +.
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq------~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQ------NLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHH------HHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 356899999999998874 79999998753211 112257889999999999999999988877644 34
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc--
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE-- 334 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~-- 334 (405)
+|+|+|.| ..+|...|.. ...++.+.+.-+++||++||.|||+.+|.||||||.|.|++.+..+||||||+++..
T Consensus 132 iYV~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 132 LYVLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch
Confidence 67889988 4577776655 567888899999999999999999999999999999999999999999999999643
Q ss_pred cccCCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Q 015556 335 VYCDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNFG 402 (405)
Q Consensus 335 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~~~ 402 (405)
.....++..+.|.+|.|||++++. .|+...||||.|||+.|||..+..|...+|++.+.-|..-.+.|
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTP 277 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTP 277 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCC
Confidence 334456677789999999999875 58999999999999999999999999999999998887765544
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=244.37 Aligned_cols=212 Identities=25% Similarity=0.387 Sum_probs=182.4
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC--
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-- 254 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-- 254 (405)
.+|.-...+|.|+- .|..+-+. +++||+|....+...... .+...+|+.++..++|+||++++.+|.-.
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~------akra~rel~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTH------AKRAYRELKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCcc------chhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence 45555666788888 66666654 799999998776433222 35667999999999999999999998643
Q ss_pred ----CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 255 ----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 255 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
..+|+|||+| ..+|.+.+. ..++-+.+..|++|++.|+.|||+.||+||||||+||++..+..+||+|||+
T Consensus 90 l~~~~e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 90 LEEFQEVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HHHHHhHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchh
Confidence 4689999999 569999887 3677788999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNFG 402 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~~~ 402 (405)
|......-.+++.+.|..|.|||++.+..|...+||||+||++.||++|..-|++.+.++.+.+++...+-+
T Consensus 165 ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtp 236 (369)
T KOG0665|consen 165 ARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTP 236 (369)
T ss_pred hcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCC
Confidence 977665557788889999999999998889999999999999999999999999999999999999877654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=257.82 Aligned_cols=200 Identities=23% Similarity=0.310 Sum_probs=142.6
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEEC------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeE
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 246 (405)
...+..++|.+++.||+|+||.||+|.+. +..||||.+......+. ...| .+.+..+.++..
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~----------~~~e--~l~~~~~~~~~~ 193 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI----------WMNE--RVRRACPNSCAD 193 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH----------HHHH--HHHhhchhhHHH
Confidence 34556789999999999999999999985 56899998763221110 0011 112222222222
Q ss_pred EeeE------eecCCeeEEEEeecCCCCHHHHHHHhcCC------------------CCCHHHHHHHHHHHHHHHHHHHH
Q 015556 247 FVAA------CKKPPVYCVITEYLSEGSLRAYLHKLEHK------------------TLPLPKLIAIALDIARGMEYIHS 302 (405)
Q Consensus 247 l~g~------~~~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~qi~~aL~yLH~ 302 (405)
++.. +.....+++||||+.+++|.+++...... ......+..++.||+.||.|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~ 273 (566)
T PLN03225 194 FVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS 273 (566)
T ss_pred HHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH
Confidence 2211 34567789999999999999998753210 11123456799999999999999
Q ss_pred CCceecCCCCCcEEECC-CCcEEEEecCCccccccc--CCCCCCCCCCcccCccccccc---------------------
Q 015556 303 QGVIHRDLKPENVLIDQ-EFHLKIADFGIACEEVYC--DALSDDPGTYRWMAPEMIKHK--------------------- 358 (405)
Q Consensus 303 ~gIiHrDIkp~NILl~~-~~~vkL~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~--------------------- 358 (405)
++|+||||||+|||++. ++.+||+|||++...... .......+++.|+|||.+...
T Consensus 274 ~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~ 353 (566)
T PLN03225 274 TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 353 (566)
T ss_pred CCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcc
Confidence 99999999999999985 589999999999643221 222455789999999965322
Q ss_pred -cCCchhhHHHHHHHHHHHHhCCCCCC
Q 015556 359 -SYGRKVDVYSFGLILWEMVAGTIPYE 384 (405)
Q Consensus 359 -~~~~k~DVwSlGvll~elltG~~Pf~ 384 (405)
.++.++|||||||+||||+++..|++
T Consensus 354 ~~~~~k~DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 354 LNLPDRFDIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred ccCCCCcccHHHHHHHHHHHhCcCCCc
Confidence 23456799999999999999877654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=251.44 Aligned_cols=208 Identities=24% Similarity=0.347 Sum_probs=178.3
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC------CCeeEEeeE
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN------PNVIKFVAA 250 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~g~ 250 (405)
++|.+....|+|-|++|.+|.+. |+.||||+|+... . ..+.=..|++||++|+. -++++|+-.
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-----~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-----V----MHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-----H----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 67888888999999999999986 6899999998422 1 13455689999999963 478999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC-CcEEEEec
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLE-HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE-FHLKIADF 328 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~-~~vkL~DF 328 (405)
|...+++|||+|-+ -.+|.+.|.+.. +-.|....+..++.|++-||..|-..||+|.||||.||||++. ..+|||||
T Consensus 503 F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred hhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccC
Confidence 99999999999988 569999999863 3457778899999999999999999999999999999999876 56899999
Q ss_pred CCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 329 GIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 329 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
|.|...... ..+....+..|.|||++.+.+|+...|+||.||+||||+||..-|++...-+++.-.+.
T Consensus 582 GSA~~~~en-eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 582 GSASFASEN-EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred ccccccccc-cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 999765543 34555677789999999999999999999999999999999999999888887765543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-31 Score=236.77 Aligned_cols=214 Identities=22% Similarity=0.394 Sum_probs=174.3
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
..+.+.|.-..+||+|.||.||+++.. ++.||+|.+......+. +-....+|+.+|..|.|+|++.++..|.
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeG------fpitalreikiL~~lkHenv~nliEic~ 86 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEG------FPITALREIKILQLLKHENVVNLIEICR 86 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccC------CcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence 445677888889999999999999875 57899987654222211 1123458999999999999999999885
Q ss_pred c--------CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEE
Q 015556 253 K--------PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324 (405)
Q Consensus 253 ~--------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vk 324 (405)
. ...+|+||.+|+. +|.-.|.. ..-.++..++.+++.+++.||.|+|...|+|||+|++|+||+.+|.+|
T Consensus 87 tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilk 164 (376)
T KOG0669|consen 87 TKATPTNRDRATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILK 164 (376)
T ss_pred hccCCcccccceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEE
Confidence 3 2458999999964 78777765 235688889999999999999999999999999999999999999999
Q ss_pred EEecCCccccc-----ccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015556 325 IADFGIACEEV-----YCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 325 L~DFG~a~~~~-----~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~ 396 (405)
|+|||+++... ....++..+.|..|.+||.+.+ ..|+.+.|||..||++.||.+|.+-|.+....+.+..|.
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 99999995432 2234566677999999998865 568999999999999999999999999988777666553
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-30 Score=261.40 Aligned_cols=193 Identities=27% Similarity=0.472 Sum_probs=158.8
Q ss_pred ceeeeeeeE-EEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeecCCeeEEEEe
Q 015556 185 LRFAHGAHS-RLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPVYCVITE 262 (405)
Q Consensus 185 ~~lG~G~~g-~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E 262 (405)
+.+|.|+.| .||+|.+.++.||||.+.. .......+|+..|+.-+ |||||++++.-.+.+..||+.|
T Consensus 515 eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~-----------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYEGREVAVKRLLE-----------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred HHcccCCCCcEEEEEeeCCceehHHHHhh-----------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 457899988 5799999999999998752 22445679999999985 9999999999999999999999
Q ss_pred ecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC---C--CcEEEEecCCccccc
Q 015556 263 YLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ---E--FHLKIADFGIACEEV 335 (405)
Q Consensus 263 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~---~--~~vkL~DFG~a~~~~ 335 (405)
.| ..+|.+++... ..........+.++.|++.||++||+.+||||||||.||||+. + .+++|+|||++....
T Consensus 584 LC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 584 LC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred Hh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 99 45999999873 1111111356778999999999999999999999999999965 2 579999999996533
Q ss_pred cc----CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 015556 336 YC----DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPI 389 (405)
Q Consensus 336 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~ 389 (405)
.. .......||.+|+|||++....-+..+|||||||++|++++ |.+||.+.-..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R 721 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER 721 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh
Confidence 22 22456679999999999988888889999999999999999 69999875443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=229.24 Aligned_cols=148 Identities=24% Similarity=0.426 Sum_probs=123.8
Q ss_pred ccccCCCeeeecccccccccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHH
Q 015556 156 KYFDHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREV 233 (405)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei 233 (405)
+.+..+|.....++ ..+.-.+|.+.++||.|-|++||++.+. .+.||+|+.+. +..+......||
T Consensus 59 ~dY~kGGYHpV~IG----D~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---------AqhYtEaAlDEI 125 (590)
T KOG1290|consen 59 EDYRKGGYHPVRIG----DVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---------AQHYTEAALDEI 125 (590)
T ss_pred hhhhcCCCceeecc----ccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh---------hhHHHHHHHHHH
Confidence 34445565554443 3455589999999999999999999996 58999999873 233455667899
Q ss_pred HHHHhcC-----C---CCeeEEeeEeec----CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 015556 234 ALLSRLH-----N---PNVIKFVAACKK----PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301 (405)
Q Consensus 234 ~il~~l~-----H---pnIv~l~g~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH 301 (405)
.+|++++ | ..||+|++.|.. +.++|+|+|++ |.+|..+|.+...+.++...+..|++||+.||.|||
T Consensus 126 klL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH 204 (590)
T KOG1290|consen 126 KLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLH 204 (590)
T ss_pred HHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHH
Confidence 9999994 3 469999999975 56899999998 889999999999999999999999999999999999
Q ss_pred H-CCceecCCCCCcEEE
Q 015556 302 S-QGVIHRDLKPENVLI 317 (405)
Q Consensus 302 ~-~gIiHrDIkp~NILl 317 (405)
. .||||-||||+|||+
T Consensus 205 ~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 205 RECGIIHTDLKPENVLL 221 (590)
T ss_pred HhcCccccCCCcceeee
Confidence 6 599999999999999
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-26 Score=206.99 Aligned_cols=182 Identities=36% Similarity=0.623 Sum_probs=158.9
Q ss_pred eeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEeec
Q 015556 187 FAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264 (405)
Q Consensus 187 lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 264 (405)
||.|++|.||++... ++.++||++....... ....+.+|+++++.+.|++|+++++++......+++|||+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~ 73 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-------LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYC 73 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecC
Confidence 589999999999997 7999999998544322 2467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC-CCcEEEEecCCcccccccC-CCCC
Q 015556 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-EFHLKIADFGIACEEVYCD-ALSD 342 (405)
Q Consensus 265 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~-~~~vkL~DFG~a~~~~~~~-~~~~ 342 (405)
.+++|.+++.... ..+++..+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+....... ....
T Consensus 74 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (215)
T cd00180 74 EGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT 152 (215)
T ss_pred CCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence 9899999998632 46889999999999999999999999999999999999999 8999999999986443321 1344
Q ss_pred CCCCCcccCccccccc-cCCchhhHHHHHHHHHHH
Q 015556 343 DPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEM 376 (405)
Q Consensus 343 ~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~el 376 (405)
..+...|++||.+... .++.+.|+|+||+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 5688899999999877 788999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-29 Score=250.04 Aligned_cols=212 Identities=26% Similarity=0.458 Sum_probs=186.9
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+..++|.|.||.||++++. ++..|||+++..-.++- +-+.+|+.+++.++|+|||.++|.|.....
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~--------~~iqqei~~~~dc~h~nivay~gsylr~dk 86 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDF--------SGIQQEIGMLRDCRHPNIVAYFGSYLRRDK 86 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccc--------cccccceeeeecCCCcChHHHHhhhhhhcC
Confidence 57888899999999999999986 79999999998766553 456689999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc-
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV- 335 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~- 335 (405)
.|++||||.+|+|.+.-+- .+.+++.++..+.+..+.||+|||++|-+|||||-.|||+++.|.+|+.|||.+....
T Consensus 87 lwicMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred cEEEEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh
Confidence 9999999999999986654 5789999999999999999999999999999999999999999999999999985533
Q ss_pred ccCCCCCCCCCCcccCcccc---ccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 336 YCDALSDDPGTYRWMAPEMI---KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 336 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
.........||++|||||+- +.+.|...+|||++|+...|+-.-+.|--+..|.++++-+-+...
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~ 232 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGF 232 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCC
Confidence 22334566799999999976 567899999999999999999999999999999999887665543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-27 Score=222.99 Aligned_cols=219 Identities=25% Similarity=0.484 Sum_probs=179.7
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEE
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 247 (405)
.+...++.+...+-+|.||+||+|++.+ +.|-||.++..... -....+..|--++..+.|||+..+
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~-------iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQ-------IQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccH-------HHHHHHHHHHHHHhcCcCCCccce
Confidence 4455667788889999999999998752 46667766532221 124567889999999999999999
Q ss_pred eeEeec-CCeeEEEEeecCCCCHHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC
Q 015556 248 VAACKK-PPVYCVITEYLSEGSLRAYLHKLE------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320 (405)
Q Consensus 248 ~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~ 320 (405)
.+.+.+ ....++++.++.-|+|..||...+ ...++-.++..++.|++.|++|||.+||||.||..+|++||+.
T Consensus 353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh
Confidence 998754 557789999999999999998432 2346667888999999999999999999999999999999999
Q ss_pred CcEEEEecCCccccccc---CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 015556 321 FHLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVV 396 (405)
Q Consensus 321 ~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~ 396 (405)
.++||+|=.+++..... -.....-....||+||.+.+..|+..+|||||||+||||+| |+.||.+.+|.|+..-+.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk 512 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK 512 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence 99999999988653322 22334446788999999999999999999999999999999 999999999999887776
Q ss_pred hccc
Q 015556 397 NKVN 400 (405)
Q Consensus 397 ~~~~ 400 (405)
++-.
T Consensus 513 dGyR 516 (563)
T KOG1024|consen 513 DGYR 516 (563)
T ss_pred ccce
Confidence 6543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-28 Score=221.69 Aligned_cols=198 Identities=20% Similarity=0.415 Sum_probs=158.8
Q ss_pred CCeeecceeeeeeeEEEEEEEECC--ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEee-EeecC
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVA-ACKKP 254 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~~--~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g-~~~~~ 254 (405)
+.|.+.+.||+|.||.+-++.+++ +.+++|.+..+-.. .+.|.+|...--.|. |.||+.-|+ +|+..
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt---------~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~ 94 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT---------QADFVREFHYSFFLSPHQHIIDTYEVAFQTS 94 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh---------HHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence 567888999999999999999974 78999988644322 567889988777774 899998766 56777
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE-C-CCCcEEEEecCCcc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI-D-QEFHLKIADFGIAC 332 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl-~-~~~~vkL~DFG~a~ 332 (405)
+.+.++|||++.|+|.+-+.. ..+-+.....++.|++.||+|+|+.++||||||.+|||| + +..++||||||+..
T Consensus 95 d~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 95 DAYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred ceEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccc
Confidence 888899999999999886654 667888889999999999999999999999999999999 3 34589999999985
Q ss_pred cccccCCCCCCCCCCcccCcccccc---c--cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 015556 333 EEVYCDALSDDPGTYRWMAPEMIKH---K--SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390 (405)
Q Consensus 333 ~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e 390 (405)
.... .......+..|.+||+... + ...+..|||.||+++|.+|||..||+.....+
T Consensus 172 k~g~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d 232 (378)
T KOG1345|consen 172 KVGT--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD 232 (378)
T ss_pred ccCc--eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC
Confidence 4322 1122234567899997632 2 23678999999999999999999998644433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-26 Score=213.18 Aligned_cols=198 Identities=22% Similarity=0.347 Sum_probs=170.0
Q ss_pred CCCeeecceeeeeeeEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeecC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKP 254 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~ 254 (405)
.-.|.+|++||+|.||.+|.|.. ++++||||.--.... ..|++.|....+.|. .++|...|-+..++
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----------APQLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----------APQLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCC----------cchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 35788999999999999999975 689999998754333 246778999999986 59999999888888
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC-----CcEEEEecC
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE-----FHLKIADFG 329 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~-----~~vkL~DFG 329 (405)
-.-.||+|.+ |-+|+|++.- +++.++..+++.++.|++.-++|+|++.+|+|||||+|+||..- ..+.|+|||
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEecc
Confidence 8888999988 7899987765 67899999999999999999999999999999999999999643 459999999
Q ss_pred CcccccccCCCC--------CCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 330 IACEEVYCDALS--------DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 330 ~a~~~~~~~~~~--------~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
+|.......... ...||.+||+-....+...+.+.|+-|||-++++.|-|.+||++..
T Consensus 175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 997655433322 3349999999999999999999999999999999999999999854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=217.40 Aligned_cols=200 Identities=24% Similarity=0.338 Sum_probs=167.7
Q ss_pred CeeecceeeeeeeEEEEEEEECC---ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC----CCeeEEeeEe-
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYKD---EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN----PNVIKFVAAC- 251 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~~---~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H----pnIv~l~g~~- 251 (405)
+|.++++||+|+||.||.+.... ..+|+|+......... ..+..|+.++..+.. .++..+++..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--------~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--------SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--------ccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 78999999999999999999865 3699999876433321 145678888888863 6889999988
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC-----CcEEEE
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE-----FHLKIA 326 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~-----~~vkL~ 326 (405)
..+...++||+.+ |.+|.++......+.++..+++.|+.|++.+|++||+.|++||||||.|+++... ..+.|+
T Consensus 91 ~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 91 STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEE
Confidence 5777889999987 8899998876666889999999999999999999999999999999999999765 469999
Q ss_pred ecCCcc--cccccC--------C-CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 015556 327 DFGIAC--EEVYCD--------A-LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP 388 (405)
Q Consensus 327 DFG~a~--~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~ 388 (405)
|||++. ...... . .....||.+|+++....+...+.+.|+||++.++.+++.|.+||.....
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 999997 321111 1 1234599999999999999999999999999999999999999987664
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=221.27 Aligned_cols=203 Identities=21% Similarity=0.367 Sum_probs=165.8
Q ss_pred CCeeecceeeeeeeEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEee
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACK 252 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~ 252 (405)
..|...++||.|.|+.||++.+. ++.||+|.+...... ..+..|+++|..+. +.||+++.+++.
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----------~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----------SRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----------hHHHHHHHHHHHhccchhhhcchhhhc
Confidence 55678889999999999999763 478999999765443 34679999999996 899999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC-CCcEEEEecCCc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-EFHLKIADFGIA 331 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~-~~~vkL~DFG~a 331 (405)
.+...++|+||++.....+++.. ++...+..+++.++.||.++|..|||||||||.|||.+. .+.-.|+|||+|
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred cCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhH
Confidence 99999999999999999998865 668899999999999999999999999999999999975 477899999998
Q ss_pred cc-c----------------cc--c--------------------------CCCCCCCCCCcccCccccccc-cCCchhh
Q 015556 332 CE-E----------------VY--C--------------------------DALSDDPGTYRWMAPEMIKHK-SYGRKVD 365 (405)
Q Consensus 332 ~~-~----------------~~--~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~k~D 365 (405)
.. . .. + .......||++|.|||++... ..+.++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 51 0 00 0 000112399999999998654 4588999
Q ss_pred HHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHH
Q 015556 366 VYSFGLILWEMVAGTIPYE-EMNPIQAAFAVV 396 (405)
Q Consensus 366 VwSlGvll~elltG~~Pf~-~~~~~e~~~~i~ 396 (405)
|||.|||+.-+++++.||- ..+..+++.+++
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~ 292 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIA 292 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHH
Confidence 9999999999999999984 344444444443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=218.20 Aligned_cols=166 Identities=17% Similarity=0.139 Sum_probs=125.9
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC---CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeE-EeeEe
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK---DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK-FVAAC 251 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~---~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~-l~g~~ 251 (405)
.-.+.|.+++.||+|+||+||+|.+. ++.||||.+......... ......|.+|+++|++|+|+|++. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~---~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSK---PLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEeccccccccc---HHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 34577999999999999999999873 577899987532110000 112456899999999999999985 4432
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCcEEECCCCcEEEEecCC
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDL-KPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDI-kp~NILl~~~~~vkL~DFG~ 330 (405)
+..|+||||++|++|.. +.. .. ...++.+++.+|.|||++||+|||| ||+|||++.++.+||+|||+
T Consensus 91 ---~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred ---CCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 35789999999999963 211 11 1467899999999999999999999 99999999999999999999
Q ss_pred ccccccc---------CCCCCCCCCCcccCcccccc
Q 015556 331 ACEEVYC---------DALSDDPGTYRWMAPEMIKH 357 (405)
Q Consensus 331 a~~~~~~---------~~~~~~~gt~~y~aPE~~~~ 357 (405)
|...... .......+++.|+|||++..
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 8643221 11234568889999999854
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=200.37 Aligned_cols=204 Identities=21% Similarity=0.303 Sum_probs=172.7
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC-CCeeEEee
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFVA 249 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~g 249 (405)
+..+....|.+.++||.|+||.+|.|+. .|+.||||+-...... .++..|..+...|++ ..|..+..
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----------pqL~yEskvY~iL~~g~GiP~i~~ 78 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----------PQLLYESKVYRILQGGVGIPHIRH 78 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----------cchhHHHHHHHHhccCCCCchhhh
Confidence 4466778999999999999999999987 4799999998654432 356689999999986 77888888
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC---CCcEEEE
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ---EFHLKIA 326 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~---~~~vkL~ 326 (405)
+..+...-.+||+.+ |-+|.+++.- +...++..+++.++-|++.-++|+|.++.|||||||+|+|+.- ..++.++
T Consensus 79 y~~e~~ynvlVMdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LI 156 (341)
T KOG1163|consen 79 YGTEKDYNVLVMDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLI 156 (341)
T ss_pred hccccccceeeeecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEE
Confidence 888888889999988 7899887654 5678999999999999999999999999999999999999953 4579999
Q ss_pred ecCCcccccccC--------CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 015556 327 DFGIACEEVYCD--------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP 388 (405)
Q Consensus 327 DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~ 388 (405)
|||+|....... ....-.||.+|.+-....+...+.+.|+-|+|.+|+++.-|.+||++..+
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 999996543221 22344699999998888888889999999999999999999999998654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-23 Score=199.70 Aligned_cols=213 Identities=27% Similarity=0.485 Sum_probs=177.3
Q ss_pred eeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCC-CeeEEeeEeecCCeeEE
Q 015556 181 LFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP-NVIKFVAACKKPPVYCV 259 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp-nIv~l~g~~~~~~~~~l 259 (405)
|.+...||.|+|+.||++.+. ..+++|.+........ .....+.+|+.++..+.|+ +|+++++.+......++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS-----KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch-----hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEE
Confidence 567788999999999999998 8899999976554432 2367788999999999988 79999999987777899
Q ss_pred EEeecCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCC-cEEEEecCCccccccc
Q 015556 260 ITEYLSEGSLRAYLHKLEH-KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-HLKIADFGIACEEVYC 337 (405)
Q Consensus 260 V~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~-~vkL~DFG~a~~~~~~ 337 (405)
+++++.+++|.+++..... ..++......++.|++.++.|+|+.+++|||+||+|||++..+ .++++|||.+......
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999999977765221 2788999999999999999999999999999999999999988 7999999998633222
Q ss_pred C-------CCCCCCCCCcccCcccccc---ccCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcc
Q 015556 338 D-------ALSDDPGTYRWMAPEMIKH---KSYGRKVDVYSFGLILWEMVAGTIPYEEMNP---IQAAFAVVNKV 399 (405)
Q Consensus 338 ~-------~~~~~~gt~~y~aPE~~~~---~~~~~k~DVwSlGvll~elltG~~Pf~~~~~---~e~~~~i~~~~ 399 (405)
. ......|+..|++||.+.+ ..+....|+|++|++++++++|..||..... .......+...
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 230 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL 230 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc
Confidence 1 3466679999999999987 5778999999999999999999999987764 44444444433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-25 Score=240.55 Aligned_cols=147 Identities=18% Similarity=0.206 Sum_probs=115.2
Q ss_pred HhcCC-CCeeEEeeEe-------ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 015556 237 SRLHN-PNVIKFVAAC-------KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHR 308 (405)
Q Consensus 237 ~~l~H-pnIv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHr 308 (405)
+.++| +||++++++| .+...++++|||+ +++|.++|... ...+++..++.++.||+.||.|||++||+||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr 104 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVH 104 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 44556 6888888877 2334677889987 66999999752 4568999999999999999999999999999
Q ss_pred CCCCCcEEECCCC-------------------cEEEEecCCccccccc-----------------CCCCCCCCCCcccCc
Q 015556 309 DLKPENVLIDQEF-------------------HLKIADFGIACEEVYC-----------------DALSDDPGTYRWMAP 352 (405)
Q Consensus 309 DIkp~NILl~~~~-------------------~vkL~DFG~a~~~~~~-----------------~~~~~~~gt~~y~aP 352 (405)
||||+||||+..+ .+||+|||++...... .......||+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 9999999996544 4556666655321100 000113578899999
Q ss_pred cccccccCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 353 EMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 353 E~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
|++.+..|+.++|||||||+||||++|..||..
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 999999999999999999999999999998864
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=192.45 Aligned_cols=178 Identities=13% Similarity=0.133 Sum_probs=135.6
Q ss_pred CCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHH-HHHHHHHHHHHHHHhcCCCCeeEEeeEeecC--
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAA-RLEKQFNREVALLSRLHNPNVIKFVAACKKP-- 254 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-- 254 (405)
-.+|.+.+.||.|+||.||+....+..+|||+++......+..... .....+.+|+..+.+|.|++|..+..++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 4789999999999999999987777899999997554433221110 0123478999999999999999988876533
Q ss_pred ------CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEec
Q 015556 255 ------PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF 328 (405)
Q Consensus 255 ------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DF 328 (405)
+..+|||||++|.+|.++.. +++ ..+.+++.+|..||+.|++|||+||.||+++.++ ++|+||
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 35789999999999988732 232 2466999999999999999999999999999988 999999
Q ss_pred CCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHH
Q 015556 329 GIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMV 377 (405)
Q Consensus 329 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ell 377 (405)
|........... ..++....|+.++|+|+||+++..+.
T Consensus 179 g~~~~~~e~~a~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 987433211111 11334456778999999999887653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=184.16 Aligned_cols=144 Identities=19% Similarity=0.189 Sum_probs=108.4
Q ss_pred cceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHH------------------HHHHHHHHHHHHHHHHHhcCCCCe
Q 015556 184 GLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENET------------------LAARLEKQFNREVALLSRLHNPNV 244 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~------------------~~~~~~~~~~~Ei~il~~l~HpnI 244 (405)
.+.||+|++|.||+|... |+.||||+++......... ...........|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 357899999999999985 8999999998643211100 000112344569999999987776
Q ss_pred eEEeeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCcEEECCCCcE
Q 015556 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI-HSQGVIHRDLKPENVLIDQEFHL 323 (405)
Q Consensus 245 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~gIiHrDIkp~NILl~~~~~v 323 (405)
.......... .+|||||++++++...+.. ...+++..+..++.|++.+|.|| |+.||+||||||+|||++ ++.+
T Consensus 82 ~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 82 PCPEPILLKS--HVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCcEEEecC--CEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence 4333222222 3799999988777655332 35788999999999999999999 799999999999999998 4789
Q ss_pred EEEecCCcc
Q 015556 324 KIADFGIAC 332 (405)
Q Consensus 324 kL~DFG~a~ 332 (405)
+|+|||+|.
T Consensus 157 ~LiDFG~a~ 165 (190)
T cd05147 157 YIIDVSQSV 165 (190)
T ss_pred EEEEccccc
Confidence 999999984
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=178.06 Aligned_cols=185 Identities=14% Similarity=0.061 Sum_probs=136.8
Q ss_pred ecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeecCCeeEEEE
Q 015556 183 LGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPVYCVIT 261 (405)
Q Consensus 183 ~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~ 261 (405)
+...|+.|+||+||.+...+.+++.+.+.....- ...-....+.+|+++|++|. |++|.+++++ ...+++|
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~----~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWW----LRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhh----hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 4567899999999988877888887777532221 11112346889999999996 5889999886 3458999
Q ss_pred eecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCcEEECCCCcEEEEecCCcccccccCCC
Q 015556 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDL-KPENVLIDQEFHLKIADFGIACEEVYCDAL 340 (405)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDI-kp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 340 (405)
||+.|.+|.+.+.. ....++.|++.+|.+||++||+|||| ||+|||++.++.++|+|||++.........
T Consensus 78 eyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 78 SYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 99999998754321 11357889999999999999999999 799999999999999999999643221110
Q ss_pred --------------CCCCCCCcccCccccccc-cCC-chhhHHHHHHHHHHHHhCCCCCC
Q 015556 341 --------------SDDPGTYRWMAPEMIKHK-SYG-RKVDVYSFGLILWEMVAGTIPYE 384 (405)
Q Consensus 341 --------------~~~~gt~~y~aPE~~~~~-~~~-~k~DVwSlGvll~elltG~~Pf~ 384 (405)
.-...++.|+.|+...-- ..+ ...+.++.|+-+|.++|++.|+-
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 001257777777744221 222 56789999999999999988864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.7e-22 Score=176.01 Aligned_cols=111 Identities=29% Similarity=0.412 Sum_probs=97.3
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCCCCCCCCC
Q 015556 267 GSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT 346 (405)
Q Consensus 267 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt 346 (405)
|+|.+++... ...+++..++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ...||
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~ 67 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVD 67 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCc
Confidence 6899999763 456999999999999999999999998 999999999999999 9998654332 23689
Q ss_pred CcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 015556 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390 (405)
Q Consensus 347 ~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e 390 (405)
+.|||||++.+..++.++|||||||++|||++|..||.......
T Consensus 68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~ 111 (176)
T smart00750 68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS 111 (176)
T ss_pred ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc
Confidence 99999999999999999999999999999999999998765443
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=176.25 Aligned_cols=144 Identities=20% Similarity=0.196 Sum_probs=110.2
Q ss_pred cceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHH------------------HHHHHHHHHHHHHHHHHhcCCCCe
Q 015556 184 GLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENET------------------LAARLEKQFNREVALLSRLHNPNV 244 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~------------------~~~~~~~~~~~Ei~il~~l~HpnI 244 (405)
.+.||+|++|.||+|.+. |+.||||+++......... ........+..|...+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999985 8999999998653221000 001112335689999999999987
Q ss_pred eEEeeEeecCCeeEEEEeecCCCCHHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEECCCCc
Q 015556 245 IKFVAACKKPPVYCVITEYLSEGSLRAY-LHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFH 322 (405)
Q Consensus 245 v~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDIkp~NILl~~~~~ 322 (405)
.....+.... .+|||||++|+++... +.. ..++......++.|++.+|.+||. +||+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 5443333322 3799999988755433 432 467788899999999999999999 9999999999999998 789
Q ss_pred EEEEecCCccc
Q 015556 323 LKIADFGIACE 333 (405)
Q Consensus 323 vkL~DFG~a~~ 333 (405)
++|+|||++..
T Consensus 156 ~~liDFG~a~~ 166 (190)
T cd05145 156 PYIIDVSQAVE 166 (190)
T ss_pred EEEEEccccee
Confidence 99999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.6e-23 Score=187.28 Aligned_cols=212 Identities=27% Similarity=0.575 Sum_probs=176.7
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
...-||.+++.+..+|.+.-.|.+|+|++.|..+++|++...+. ..+..+.|..|.-.|+-+.||||+.++|+|
T Consensus 183 r~~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~------t~risrdfneefp~lrifshpnilpvlgac 256 (448)
T KOG0195|consen 183 RYTGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREV------TARISRDFNEEFPALRIFSHPNILPVLGAC 256 (448)
T ss_pred cccCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhc------chhhcchhhhhCcceeeecCCchhhhhhhc
Confidence 34467888889999999999999999999999999999976443 344567899999999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEECCCCcEEEE--e
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLIDQEFHLKIA--D 327 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IiHrDIkp~NILl~~~~~vkL~--D 327 (405)
..+..+.++..||+.|+|+..|+....-.++-.++.++++++++|++|||+.. |.---|....++||++.+.+|. |
T Consensus 257 nsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad 336 (448)
T KOG0195|consen 257 NSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMAD 336 (448)
T ss_pred cCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheeccc
Confidence 99999999999999999999999866666777899999999999999999875 4444688899999999877664 3
Q ss_pred cCCcccccccCCCCCCCCCCcccCccccccccCC---chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015556 328 FGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYG---RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395 (405)
Q Consensus 328 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i 395 (405)
--++.. . ......+.||+||.+..++-+ ..+|+|||++++|||.|...||.+..++|-..+|
T Consensus 337 ~kfsfq---e---~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki 401 (448)
T KOG0195|consen 337 TKFSFQ---E---VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI 401 (448)
T ss_pred ceeeee---c---cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh
Confidence 222211 1 122357889999999876643 5799999999999999999999999999876655
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-22 Score=204.85 Aligned_cols=194 Identities=25% Similarity=0.405 Sum_probs=164.1
Q ss_pred eeeeeeEEEEEEE-----ECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeecCCeeEEE
Q 015556 187 FAHGAHSRLYHGI-----YKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPVYCVI 260 (405)
Q Consensus 187 lG~G~~g~Vy~~~-----~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV 260 (405)
+|+|+||.|+++. +.+..+|+|+.+........ ......|..++..++ ||.+|++.-+++.+...+++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~------~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ 75 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRD------RTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLI 75 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccc------ccccccHHHHHhhccCCCceeeeeeeeccccchhHh
Confidence 5899999999764 34688999988754433221 114457888888887 99999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCCC
Q 015556 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL 340 (405)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 340 (405)
++|..+|.|...+.+ ...+++.....+...++-+++++|+.+|+|||+|++||+++.+|++++.|||++......+..
T Consensus 76 ld~~rgg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred hhhcccchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 999999999887765 456777788889999999999999999999999999999999999999999999776654433
Q ss_pred CCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 341 ~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
+||..|||||++. .....+|.||||++++||++|..||.. +....|.+
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~ 201 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK 201 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh
Confidence 8999999999998 667889999999999999999999998 55555554
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-20 Score=171.73 Aligned_cols=134 Identities=18% Similarity=0.304 Sum_probs=103.6
Q ss_pred cceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-----CCCCeeEEeeEeecCC---
Q 015556 184 GLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-----HNPNVIKFVAACKKPP--- 255 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~g~~~~~~--- 255 (405)
...||+|+||.||.-. .....+||++....... .+.+.+|+.+++.+ .||||++++|+++.+.
T Consensus 7 ~~~LG~G~~~~Vy~hp-~~~~k~IKv~~~~~~~~--------~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 7 QSPLGTGRHRKCYAHP-EDAQRCIKIVYHRGDGG--------DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred cceecCCCceEEEECC-CCcCeEEEEEeccccch--------HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 3578999999999622 23334789887543221 35688999999999 5799999999998863
Q ss_pred e-eEEEEee--cCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHHCCceecCCCCCcEEECC----CCcEEEEe
Q 015556 256 V-YCVITEY--LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGM-EYIHSQGVIHRDLKPENVLIDQ----EFHLKIAD 327 (405)
Q Consensus 256 ~-~~lV~E~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL-~yLH~~gIiHrDIkp~NILl~~----~~~vkL~D 327 (405)
. +.+|||| +.+++|.+++.+ ..+++. ..++.+++.++ +|||+++|+||||||+|||++. ++.++|+|
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 3 4478999 557899999965 345555 35678888887 9999999999999999999964 34899999
Q ss_pred cCCc
Q 015556 328 FGIA 331 (405)
Q Consensus 328 FG~a 331 (405)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4e-20 Score=169.33 Aligned_cols=142 Identities=20% Similarity=0.304 Sum_probs=117.0
Q ss_pred ceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEeec
Q 015556 185 LRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 264 (405)
+.||+|++|.||+|.+.+..|+||+...................+.+|+.++..+.|++|.....++.+....++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 46899999999999999999999987643322211111222456889999999999999887777777777888999999
Q ss_pred CCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 265 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
+|++|.+++.... . ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999986521 1 7888999999999999999999999999999999 78999999998854
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.7e-20 Score=167.41 Aligned_cols=137 Identities=22% Similarity=0.291 Sum_probs=109.3
Q ss_pred eeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEeecCC
Q 015556 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE 266 (405)
Q Consensus 187 lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 266 (405)
||+|++|.||+|.+.+..|+||....................+.+|++++..+.|+++.....++......++||||++|
T Consensus 2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g 81 (199)
T TIGR03724 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG 81 (199)
T ss_pred CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence 79999999999999999999999764322211111122246788999999999988765544455556667899999999
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 267 GSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 267 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
++|.+++.... . .++.+++.+|.+||+.|++|||++|.|||++ ++.++++|||++..
T Consensus 82 ~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 82 KPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999876511 0 7899999999999999999999999999999 88999999999854
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-21 Score=205.34 Aligned_cols=202 Identities=27% Similarity=0.381 Sum_probs=159.9
Q ss_pred eecceeeeeeeEEEEEEEEC--CccEEEEEEec---CCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 182 FLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRI---PDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 182 ~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~---~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
..+..+|.|++|.|+..... .+.++.|.++. +...+ ..+...+..|+.+-..|.|+|++..+..+.+...
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~-----~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESE-----RKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccH-----HHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 45678999999977776653 34455554432 11111 1122237789999999999999988887777666
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
..-+||||++ +|+.++.. ...++...+..++.|++.|+.|||++||.|||+|++|+|+..+|.+||+|||.+.....
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred chhhhhcccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeecc
Confidence 5566999999 99999986 35788889999999999999999999999999999999999999999999998843222
Q ss_pred c-----CCCCCCCCCCcccCccccccccCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 015556 337 C-----DALSDDPGTYRWMAPEMIKHKSYGR-KVDVYSFGLILWEMVAGTIPYEEMNPIQA 391 (405)
Q Consensus 337 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~-k~DVwSlGvll~elltG~~Pf~~~~~~e~ 391 (405)
. ......+|+..|+|||.+.+..|++ ..||||.|++++.|++|+.||......+.
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN 533 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence 1 2345667999999999999999964 69999999999999999999987655543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-20 Score=201.48 Aligned_cols=198 Identities=20% Similarity=0.310 Sum_probs=162.1
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC---CCCeeE
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---NPNVIK 246 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~ 246 (405)
..+..+....|.|-+.||+|+||.||+|... ++.||||+-+.+..-+ |.=-.+++.+|+ -+.|+.
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-----------fYI~~q~~~RLk~~~~~~~~~ 758 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-----------FYICLQVMERLKPQMLPSIMH 758 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-----------eeehHHHHHhhchhhhcchHH
Confidence 3455666788899999999999999999875 6999999977655432 222344455555 255666
Q ss_pred EeeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEC-------C
Q 015556 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-------Q 319 (405)
Q Consensus 247 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~-------~ 319 (405)
+..++.-.+.-+||+||.+.|+|.+++.. .+..++...+.+..|+++.++.||..+|||+||||+|+||. +
T Consensus 759 ~~~a~~~~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~ 836 (974)
T KOG1166|consen 759 ISSAHVFQNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSD 836 (974)
T ss_pred HHHHHccCCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCc
Confidence 66666666677899999999999999984 67889999999999999999999999999999999999993 2
Q ss_pred CCcEEEEecCCccccc---ccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCC
Q 015556 320 EFHLKIADFGIACEEV---YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI 381 (405)
Q Consensus 320 ~~~vkL~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~ 381 (405)
..-++|+|||.+.... .+..+...++|-.+-.+|+..+++.+..+|.|.|+-+++-||.|+.
T Consensus 837 ~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 837 SKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 3459999999996533 3345567789999999999999999999999999999999999864
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-20 Score=179.52 Aligned_cols=205 Identities=22% Similarity=0.401 Sum_probs=150.1
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEECC--c-----------------------------------cEEEEEEecCCCC
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKD--E-----------------------------------PVAVKIIRIPDDD 216 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~--~-----------------------------------~vAVK~~~~~~~~ 216 (405)
..+.+++|.+|+-||+|....||.+...+ . +.|||++..-+..
T Consensus 152 skFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~ 231 (598)
T KOG4158|consen 152 SKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD 231 (598)
T ss_pred cccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC
Confidence 35667899999999999999999887532 0 6788988765544
Q ss_pred hhHHHHHHHHHHHHHHHH------H--------HH-------h-cCCCCeeEEeeEeecC--------------------
Q 015556 217 ENETLAARLEKQFNREVA------L--------LS-------R-LHNPNVIKFVAACKKP-------------------- 254 (405)
Q Consensus 217 ~~~~~~~~~~~~~~~Ei~------i--------l~-------~-l~HpnIv~l~g~~~~~-------------------- 254 (405)
.... .+.+...+|+- . .+ + -+|||||++.++|.+.
T Consensus 232 s~~~---~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~ 308 (598)
T KOG4158|consen 232 SGDA---HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWY 308 (598)
T ss_pred CchH---HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceec
Confidence 3321 12223323310 1 11 1 2599999998877432
Q ss_pred -------CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE--CCCC--cE
Q 015556 255 -------PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI--DQEF--HL 323 (405)
Q Consensus 255 -------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl--~~~~--~v 323 (405)
..+|+||..++ .+|++|+-. ...+.....-++.|+++|+.|||++||.|||+|.+|||| |+++ .+
T Consensus 309 p~g~g~~~tlylvMkrY~-~tLr~yl~~---~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~L 384 (598)
T KOG4158|consen 309 PSGAGEPKTLYLVMKRYR-QTLREYLWT---RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQL 384 (598)
T ss_pred ccccCCCceEEEehhcch-hhHHHHHhc---CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEE
Confidence 35889999885 499999976 445555777799999999999999999999999999999 4443 58
Q ss_pred EEEecCCccccc-------ccCCCCCCCCCCcccCccccccccC------CchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 324 KIADFGIACEEV-------YCDALSDDPGTYRWMAPEMIKHKSY------GRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 324 kL~DFG~a~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~------~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
.|+|||++.-.. +.....+..|.-..||||+....+- -.++|.|+.|.+.||+++...||..
T Consensus 385 VvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 385 VVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred EEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 999999873211 1122234457888999999854331 2589999999999999999999977
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=172.85 Aligned_cols=200 Identities=20% Similarity=0.328 Sum_probs=130.4
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC----------CCeeEE
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN----------PNVIKF 247 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H----------pnIv~l 247 (405)
.+..+..||.|+++.||.+.+. ++.+|||++.......... .+++.+|......+.+ -.++-.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~-----~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANE-----YEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTH-----HHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHH-----HHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 4567889999999999999997 5999999998777433222 4556666544444322 112211
Q ss_pred eeEe---------ecC---C-----eeEEEEeecCCCCHHHHHHHh---cCC--CCCHHHHHHHHHHHHHHHHHHHHCCc
Q 015556 248 VAAC---------KKP---P-----VYCVITEYLSEGSLRAYLHKL---EHK--TLPLPKLIAIALDIARGMEYIHSQGV 305 (405)
Q Consensus 248 ~g~~---------~~~---~-----~~~lV~E~~~~gsL~~~l~~~---~~~--~l~~~~~~~i~~qi~~aL~yLH~~gI 305 (405)
++.. ... . ..+++|+-+ .++|.+++.-. ... .+.....+.+..|+++.+++||..|+
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl 166 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL 166 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence 1211 111 1 236778877 56888876532 111 12233456677999999999999999
Q ss_pred eecCCCCCcEEECCCCcEEEEecCCcccccccCCCCCCCCCCcccCcccccc--------ccCCchhhHHHHHHHHHHHH
Q 015556 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKH--------KSYGRKVDVYSFGLILWEMV 377 (405)
Q Consensus 306 iHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~DVwSlGvll~ell 377 (405)
+|+||+|+|+|++.+|.++|+||+........... ...+..|.+||.... -.++.+.|.|+||+++|.|.
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999999876443221111 334577999997743 25788999999999999999
Q ss_pred hCCCCCCCCC
Q 015556 378 AGTIPYEEMN 387 (405)
Q Consensus 378 tG~~Pf~~~~ 387 (405)
||+.||....
T Consensus 245 C~~lPf~~~~ 254 (288)
T PF14531_consen 245 CGRLPFGLSS 254 (288)
T ss_dssp HSS-STCCCG
T ss_pred HccCCCCCCC
Confidence 9999998543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-19 Score=186.68 Aligned_cols=141 Identities=19% Similarity=0.241 Sum_probs=115.1
Q ss_pred eecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEE
Q 015556 182 FLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261 (405)
Q Consensus 182 ~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 261 (405)
...+.||+|+||.||+|.+.+..+++|....................+.+|++++..++|++++..+.++.+....++||
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred CccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 45789999999999999998877777765432211111111122456889999999999999998888777777788999
Q ss_pred eecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
||+++++|.+++. ....++.+++.+|.|||+.||+||||||+|||+ .++.++|+|||++..
T Consensus 416 E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 416 EYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999886 346789999999999999999999999999999 678999999999854
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=169.53 Aligned_cols=146 Identities=21% Similarity=0.240 Sum_probs=110.9
Q ss_pred CeeecceeeeeeeEEEEEEE-E--CCccEEEEEEecCCCChhH----------------HHHHHHHHHHHHHHHHHHhcC
Q 015556 180 QLFLGLRFAHGAHSRLYHGI-Y--KDEPVAVKIIRIPDDDENE----------------TLAARLEKQFNREVALLSRLH 240 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~-~--~~~~vAVK~~~~~~~~~~~----------------~~~~~~~~~~~~Ei~il~~l~ 240 (405)
-|.+.+.||+|++|.||+|. . .|+.||||+++........ .........+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 35678899999999999998 2 4799999999864321100 001112345678999999997
Q ss_pred CCC--eeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCcEEE
Q 015556 241 NPN--VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG-VIHRDLKPENVLI 317 (405)
Q Consensus 241 Hpn--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g-IiHrDIkp~NILl 317 (405)
+.+ +.+++++ ...++||||+++++|..+... ...+....+..++.||+.+|.+||++| |+||||||+||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 633 3444443 234799999999888765432 244566677899999999999999999 9999999999999
Q ss_pred CCCCcEEEEecCCcc
Q 015556 318 DQEFHLKIADFGIAC 332 (405)
Q Consensus 318 ~~~~~vkL~DFG~a~ 332 (405)
+ ++.++|+|||.+.
T Consensus 183 ~-~~~i~LiDFg~a~ 196 (237)
T smart00090 183 H-DGKVVIIDVSQSV 196 (237)
T ss_pred E-CCCEEEEEChhhh
Confidence 9 8899999999874
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.2e-20 Score=195.96 Aligned_cols=197 Identities=19% Similarity=0.229 Sum_probs=153.7
Q ss_pred CeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEE
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV 259 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 259 (405)
++...+.||.+-|=+|.+|++..-.|+||++...++.-.-.- -++...|+. ...++|||++.+.-+-..+...||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~----~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRP----FKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchH----HHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHH
Confidence 677888999999999999999876799999987775433211 233334444 556689999999988888888889
Q ss_pred EEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc---
Q 015556 260 ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY--- 336 (405)
Q Consensus 260 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~--- 336 (405)
|-+|+. .+|+|.|.. ...+...+...|+.|++.||..||..||+|||||.+||||+.-+.+.|+||..-+....
T Consensus 99 vRqyvk-hnLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 99 VRQYVK-HNLYDRLST--RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHHh-hhhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 999984 499998865 45567788889999999999999999999999999999999999999999975422110
Q ss_pred -----cCCCCCCCCCCcccCccccccc----------c-CCchhhHHHHHHHHHHHHh-CCCCCC
Q 015556 337 -----CDALSDDPGTYRWMAPEMIKHK----------S-YGRKVDVYSFGLILWEMVA-GTIPYE 384 (405)
Q Consensus 337 -----~~~~~~~~gt~~y~aPE~~~~~----------~-~~~k~DVwSlGvll~ellt-G~~Pf~ 384 (405)
.-.+.....-..|.|||.+... . .+++.||||+||+++||++ |++||.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 0011122234569999987431 2 5688999999999999999 899985
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=157.10 Aligned_cols=140 Identities=22% Similarity=0.224 Sum_probs=107.6
Q ss_pred eeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhH-----H---------HHHHHHHHHHHHHHHHHhcCCCC--
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENE-----T---------LAARLEKQFNREVALLSRLHNPN-- 243 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~-----~---------~~~~~~~~~~~Ei~il~~l~Hpn-- 243 (405)
|.+++.||.|+||.||++... ++.||||++......... . ........+..|+.++..+.|.+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 567788999999999999884 799999998754311100 0 00112334678999999998774
Q ss_pred eeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcE
Q 015556 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323 (405)
Q Consensus 244 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~v 323 (405)
+...++. ...++||||++|++|...... .....++.+++.++.++|+.||+||||+|+||++++++.+
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 4444442 345899999999998765321 2456788999999999999999999999999999999999
Q ss_pred EEEecCCcc
Q 015556 324 KIADFGIAC 332 (405)
Q Consensus 324 kL~DFG~a~ 332 (405)
+|+|||++.
T Consensus 165 ~liDfg~~~ 173 (198)
T cd05144 165 YIIDWPQMV 173 (198)
T ss_pred EEEECCccc
Confidence 999999984
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.7e-17 Score=155.48 Aligned_cols=141 Identities=17% Similarity=0.141 Sum_probs=106.8
Q ss_pred ceee-eeeeEEEEEEEECCccEEEEEEecCCCC----hhHH-HHHHHHHHHHHHHHHHHhcCCCCe--eEEeeEeecC-C
Q 015556 185 LRFA-HGAHSRLYHGIYKDEPVAVKIIRIPDDD----ENET-LAARLEKQFNREVALLSRLHNPNV--IKFVAACKKP-P 255 (405)
Q Consensus 185 ~~lG-~G~~g~Vy~~~~~~~~vAVK~~~~~~~~----~~~~-~~~~~~~~~~~Ei~il~~l~HpnI--v~l~g~~~~~-~ 255 (405)
..|| .||.|+||.+...+..++||.+.....- .... ........+.+|+.++.+|.|++| +..+++.... .
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4577 8899999999888999999998643210 0000 001124567899999999998774 6777764432 2
Q ss_pred e---eEEEEeecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 256 V---YCVITEYLSE-GSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 256 ~---~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
. .++|||+++| .+|.+++.. ..+++. .+.+|+.+|.+||++||+||||||.|||++.++.++|+|||.+
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 2599999997 689988865 345543 3678999999999999999999999999999899999999987
Q ss_pred c
Q 015556 332 C 332 (405)
Q Consensus 332 ~ 332 (405)
.
T Consensus 190 ~ 190 (239)
T PRK01723 190 E 190 (239)
T ss_pred c
Confidence 4
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.9e-18 Score=180.13 Aligned_cols=173 Identities=32% Similarity=0.520 Sum_probs=128.9
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|..++.|-.|+||.||..+++ .+++|+|+-+. + .+.+. |+.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq-------~-------lilRn--ilt~a~npfvv----------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-------N-------LILRN--ILTFAGNPFVV----------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhccccc-------c-------hhhhc--cccccCCccee-----------
Confidence 34556788999999999999887 68999955331 0 11111 33444445444
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
|+-...+.. -+.++. +++.+++|||..||+|||+||+|.||..-|++|+.|||+......
T Consensus 136 ----------gDc~tllk~--~g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 ----------GDCATLLKN--IGPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred ----------chhhhhccc--CCCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 343444443 233433 227889999999999999999999999999999999998743211
Q ss_pred c----------------CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 337 C----------------DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 337 ~----------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
. -.....+||+.|.|||++..+.|+..+|.|++|+|+||.+-|..||.+..|.+.+..++.-
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd 273 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 273 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh
Confidence 1 0112447999999999999999999999999999999999999999999888877776653
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.7e-17 Score=145.54 Aligned_cols=140 Identities=24% Similarity=0.257 Sum_probs=98.6
Q ss_pred cceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHH----------------HHHHHHHHHHHHHHHhcCCCC--e
Q 015556 184 GLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLA----------------ARLEKQFNREVALLSRLHNPN--V 244 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~----------------~~~~~~~~~Ei~il~~l~Hpn--I 244 (405)
++.||+|+||+||+|... ++.||||+++........... .........|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 567899999999999987 799999998754322111000 000111245677777775443 4
Q ss_pred eEEeeEeecCCeeEEEEeecCCCCHHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEECCCCc
Q 015556 245 IKFVAACKKPPVYCVITEYLSEGSLRA-YLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFH 322 (405)
Q Consensus 245 v~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDIkp~NILl~~~~~ 322 (405)
.+.+++. ..++||||++++.+.. .+.... .. ..+..++.+++.++.++|. +||+||||||+||+++ ++.
T Consensus 82 ~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 82 PKPIDLN----RHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CceEecC----CCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 4555432 3589999999854321 121110 11 5678899999999999999 9999999999999999 899
Q ss_pred EEEEecCCcc
Q 015556 323 LKIADFGIAC 332 (405)
Q Consensus 323 vkL~DFG~a~ 332 (405)
++|+|||.+.
T Consensus 153 ~~liDfg~a~ 162 (187)
T cd05119 153 VYIIDVPQAV 162 (187)
T ss_pred EEEEECcccc
Confidence 9999999984
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=135.58 Aligned_cols=130 Identities=26% Similarity=0.263 Sum_probs=111.2
Q ss_pred cceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC--CCeeEEeeEeecCCeeEEEE
Q 015556 184 GLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN--PNVIKFVAACKKPPVYCVIT 261 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~lV~ 261 (405)
.+.||.|.++.||++...+..++||....... ...+.+|+.++..+.| .++.++++++...+..+++|
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~ 72 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLM 72 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc----------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEE
Confidence 46789999999999999889999999864332 2457789999999976 58999999998888899999
Q ss_pred eecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ---GVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
||+.++.+..+ +......++.+++.+|.+||.. +++|+|++|+|||++..+.++++|||.+.
T Consensus 73 e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 73 EWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred EecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 99988777543 4556777899999999999985 69999999999999998999999999873
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.6e-17 Score=162.54 Aligned_cols=121 Identities=32% Similarity=0.583 Sum_probs=107.6
Q ss_pred CeeEEEEeecCCCCHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
..+|+.|++|...+|.+||... .....++...+.++.|++.+++| +|.+|||+||.||++..+.++||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 4578999999999999999743 34456778899999999999999 9999999999999999999999999999865
Q ss_pred ccccC-------CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh
Q 015556 334 EVYCD-------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378 (405)
Q Consensus 334 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt 378 (405)
..... ..+..+||..||+||.+.+..|+.++|||+||+||+||+.
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 44444 5567789999999999999999999999999999999998
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.7e-16 Score=158.55 Aligned_cols=149 Identities=32% Similarity=0.536 Sum_probs=125.9
Q ss_pred HHhcCCCCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-eecCCCCCc
Q 015556 236 LSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV-IHRDLKPEN 314 (405)
Q Consensus 236 l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gI-iHrDIkp~N 314 (405)
|+.+.|.|+.+|+|.+.+++..++|.+||..|+|.|.+.. ....+++.....++++|+.||+|||.-.| .|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 4568899999999999999999999999999999999987 45678888999999999999999998766 999999999
Q ss_pred EEECCCCcEEEEecCCcccccc---cCCCCCCCCCCcccCcccccccc-------CCchhhHHHHHHHHHHHHhCCCCCC
Q 015556 315 VLIDQEFHLKIADFGIACEEVY---CDALSDDPGTYRWMAPEMIKHKS-------YGRKVDVYSFGLILWEMVAGTIPYE 384 (405)
Q Consensus 315 ILl~~~~~vkL~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~-------~~~k~DVwSlGvll~elltG~~Pf~ 384 (405)
+++|..+.+||+|||+...... ........-..-|.|||++.... .+.+.||||||++++|+++...||+
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 9999999999999999754321 01111222455699999986531 4677999999999999999999997
Q ss_pred C
Q 015556 385 E 385 (405)
Q Consensus 385 ~ 385 (405)
.
T Consensus 160 ~ 160 (484)
T KOG1023|consen 160 L 160 (484)
T ss_pred c
Confidence 6
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=8.3e-17 Score=168.64 Aligned_cols=205 Identities=28% Similarity=0.460 Sum_probs=165.2
Q ss_pred CeeecceeeeeeeEEEEEEEEC---CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeecCC
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK---DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPP 255 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~---~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~ 255 (405)
.|.+.+-||+|+|+.|-..... ...+|+|.+........ .......|..+-..+. |.|++.+++...+..
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~------~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~ 94 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSED------SSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR 94 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccc------hhhhcCccccccccccccccccccCCccCCCc
Confidence 4445566899999999887764 35677777665542221 2455667888888887 999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCcEEECCCC-cEEEEecCCccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH-SQGVIHRDLKPENVLIDQEF-HLKIADFGIACE 333 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~gIiHrDIkp~NILl~~~~-~vkL~DFG~a~~ 333 (405)
..+++++|..++++.+.+........+...+-.++.|+..++.|+| ..++.||||||+|.+++..+ .+++.|||+|..
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999999999998884222225666778889999999999999 99999999999999999999 999999999965
Q ss_pred ccc----cCCCCCCCC-CCcccCccccccccC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 015556 334 EVY----CDALSDDPG-TYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390 (405)
Q Consensus 334 ~~~----~~~~~~~~g-t~~y~aPE~~~~~~~-~~k~DVwSlGvll~elltG~~Pf~~~~~~e 390 (405)
... .......+| ++.|+|||...+..| ....|+||.|+++.-+++|..||......+
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 433 223345568 999999999987544 788999999999999999999998755544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.8e-14 Score=143.25 Aligned_cols=145 Identities=22% Similarity=0.252 Sum_probs=98.0
Q ss_pred ceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChh--------------------------HHHHHHHHH------HHHH
Q 015556 185 LRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDEN--------------------------ETLAARLEK------QFNR 231 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~--------------------------~~~~~~~~~------~~~~ 231 (405)
+.||.|++|+||+|++. |+.||||+.+......- ..+...+.. .|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 46899999999999985 79999999864321110 001111111 3555
Q ss_pred HHHHHHhcC----CCCeeEEeeEee-cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHHHHCCc
Q 015556 232 EVALLSRLH----NPNVIKFVAACK-KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR-GMEYIHSQGV 305 (405)
Q Consensus 232 Ei~il~~l~----HpnIv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~-aL~yLH~~gI 305 (405)
|...+.++. |.+-+.+-..+. .....+|||||++|++|.++..... ...+ ...++..++. .+..+|..|+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 666666663 333333333332 2344689999999999988765421 1222 3345666665 4788999999
Q ss_pred eecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 306 IHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 306 iHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
+|+|+||.||+++.++.++|+|||++..
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 9999999999999999999999999854
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.2e-13 Score=122.10 Aligned_cols=142 Identities=15% Similarity=0.186 Sum_probs=100.8
Q ss_pred cceeeeeeeEEEEEEEEC--------CccEEEEEEecCCCChh---HHH--H---------HHHHHHHH----HHHHHHH
Q 015556 184 GLRFAHGAHSRLYHGIYK--------DEPVAVKIIRIPDDDEN---ETL--A---------ARLEKQFN----REVALLS 237 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~--------~~~vAVK~~~~~~~~~~---~~~--~---------~~~~~~~~----~Ei~il~ 237 (405)
...||.|-.+.||.|... +..+|||+++.....-. .-+ . ..-.+.+. +|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 456899999999999865 26999999875421100 000 0 01123344 8999999
Q ss_pred hcCC--CCeeEEeeEeecCCeeEEEEeecCCCCHHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCC
Q 015556 238 RLHN--PNVIKFVAACKKPPVYCVITEYLSEGSLRA-YLHKLEHKTLPLPKLIAIALDIARGMEYI-HSQGVIHRDLKPE 313 (405)
Q Consensus 238 ~l~H--pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~gIiHrDIkp~ 313 (405)
+|.. -++...+++ ..-+|||||+.++.+.. .+.. ..++......++.+++.+|..| |+.||||+||++.
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 9964 455666654 34479999997654422 2222 3455566778889999999999 8999999999999
Q ss_pred cEEECCCCcEEEEecCCccc
Q 015556 314 NVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 314 NILl~~~~~vkL~DFG~a~~ 333 (405)
|||++ ++.+.|+|||.+..
T Consensus 155 NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred HEEEE-CCcEEEEECCCcee
Confidence 99997 46899999998854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.4e-13 Score=121.22 Aligned_cols=126 Identities=19% Similarity=0.148 Sum_probs=95.2
Q ss_pred ceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee-EEeeEeecCCeeEEEEee
Q 015556 185 LRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI-KFVAACKKPPVYCVITEY 263 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~g~~~~~~~~~lV~E~ 263 (405)
+.|+.|.++.||++...++.|+||+....... ...+..|+.++..+.+.+++ +++.+.. ...++||||
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~---------~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~ 72 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL---------LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEF 72 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCccc---------ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEe
Confidence 46789999999999999999999997543211 12356889999988765544 4554433 234799999
Q ss_pred cCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV-----IHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 264 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gI-----iHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
++|.++.+. .. ....++.+++.+|..||..++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 73 i~G~~l~~~-------~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 73 IEGSELLTE-------DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cCCCccccc-------cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 999877542 01 123457899999999999985 9999999999999 6789999999873
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.2e-12 Score=114.89 Aligned_cols=148 Identities=17% Similarity=0.225 Sum_probs=113.0
Q ss_pred cceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHH-HHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEe
Q 015556 184 GLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAAR-LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 262 (405)
...|-+|+.++|+++.+.|+.++||.=. +.......+..+ ..++..+|+.+|.++.--.|.--.-++.+...-+|+||
T Consensus 12 l~likQGAEArv~~~~~~Ge~~iIK~Rf-~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFSGEAAIIKERF-SKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeeccCCceeEEeecc-cccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 4567899999999999999988888643 222222233233 35677899999999986666544445556666679999
Q ss_pred ecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCC---cEEEEecCCcc
Q 015556 263 YLSE-GSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF---HLKIADFGIAC 332 (405)
Q Consensus 263 ~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~---~vkL~DFG~a~ 332 (405)
|++| -++.+|+..........+....++..|=..+.-||..+|||+||..+||++..++ .+.++|||++.
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 9976 4899999876555555555678999999999999999999999999999995443 35899999974
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=7e-14 Score=144.19 Aligned_cols=141 Identities=16% Similarity=0.193 Sum_probs=89.1
Q ss_pred ceeeeeeeEEEEEEEEC--CccEEEEEEecCCCC--------------------------hhHHHHHHHHHHHHH-----
Q 015556 185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDD--------------------------ENETLAARLEKQFNR----- 231 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~--------------------------~~~~~~~~~~~~~~~----- 231 (405)
+.||.|++|+||+|++. |+.||||+.+..-.. +...+...+.+.+.+
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 57899999999999985 799999999743111 011122233344444
Q ss_pred -HHHHHHhcC----CCCeeEEeeEeec-CCeeEEEEeecCCCCHHHHHHHhcCCCCC-----HHHHHHHHHHHHHHHHHH
Q 015556 232 -EVALLSRLH----NPNVIKFVAACKK-PPVYCVITEYLSEGSLRAYLHKLEHKTLP-----LPKLIAIALDIARGMEYI 300 (405)
Q Consensus 232 -Ei~il~~l~----HpnIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~-----~~~~~~i~~qi~~aL~yL 300 (405)
|+..+.+++ +.+.+.+-..+.+ ....+|||||+.|+.+.++-.- .....+ ...+..++.| +
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~~Q-------i 276 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFFTQ-------V 276 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHHHH-------H
Confidence 444444442 3333333333322 3345799999999999874321 112222 2222333333 4
Q ss_pred HHCCceecCCCCCcEEECCCC----cEEEEecCCccc
Q 015556 301 HSQGVIHRDLKPENVLIDQEF----HLKIADFGIACE 333 (405)
Q Consensus 301 H~~gIiHrDIkp~NILl~~~~----~vkL~DFG~a~~ 333 (405)
...|++|+|+||.||+++.++ +++++|||++..
T Consensus 277 f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~ 313 (537)
T PRK04750 277 FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGS 313 (537)
T ss_pred HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence 468999999999999999888 999999998743
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.1e-12 Score=115.56 Aligned_cols=136 Identities=22% Similarity=0.364 Sum_probs=107.2
Q ss_pred eeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHH-HHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEeec
Q 015556 186 RFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARL-EKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264 (405)
Q Consensus 186 ~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 264 (405)
.+++|+-+.+|.+.+.|.++++| .+.+.......+..++ ...-.+|..++.+++--.|.--+-+..+.....|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K-~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVK-ERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEE-eecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 56899999999998888775555 5566666655555554 445678999999998766655555556666667999999
Q ss_pred CCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 265 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
+|..|.+++... ...++..+=.-+.-||..||+|+||.++||++..++ +.++|||++.
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence 999999999773 245667777778889999999999999999997765 9999999984
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=9.1e-12 Score=127.58 Aligned_cols=161 Identities=17% Similarity=0.308 Sum_probs=123.0
Q ss_pred CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCC
Q 015556 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTL 281 (405)
Q Consensus 202 ~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l 281 (405)
+.+|.|..+..... +. .....+.+.-|+.|+||||++++..++..+..|||+|.+. .|..++...
T Consensus 37 ~~~vsVF~~~~~~~-~~-------~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----- 101 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNG-EV-------TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----- 101 (690)
T ss_pred CCceEEEEEeCCCc-hh-------hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----
Confidence 67899988886554 22 2345577888999999999999999999999999999873 788888763
Q ss_pred CHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCcEEECCCCcEEEEecCCcccccccCC-CCCCCCCCcccCcccccccc
Q 015556 282 PLPKLIAIALDIARGMEYIH-SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA-LSDDPGTYRWMAPEMIKHKS 359 (405)
Q Consensus 282 ~~~~~~~i~~qi~~aL~yLH-~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~ 359 (405)
........+.||+.||.+|| +.+++|++|....|+|++.|.+||.+|.++........ ......-..|..|+.+....
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence 35677778999999999997 66899999999999999999999999988743222111 11111122345555443222
Q ss_pred CCchhhHHHHHHHHHHHHhC
Q 015556 360 YGRKVDVYSFGLILWEMVAG 379 (405)
Q Consensus 360 ~~~k~DVwSlGvll~elltG 379 (405)
-..|.|-|||+++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 347999999999999999
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.4e-10 Score=110.34 Aligned_cols=141 Identities=21% Similarity=0.151 Sum_probs=99.4
Q ss_pred eEEEEEEEECCccEEEEEEecCCCChh-HHHHH--HHHHHHHHHHHHHHhcCCCC--eeEEeeEeec-----CCeeEEEE
Q 015556 192 HSRLYHGIYKDEPVAVKIIRIPDDDEN-ETLAA--RLEKQFNREVALLSRLHNPN--VIKFVAACKK-----PPVYCVIT 261 (405)
Q Consensus 192 ~g~Vy~~~~~~~~vAVK~~~~~~~~~~-~~~~~--~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~~~~-----~~~~~lV~ 261 (405)
...|+++...|+.|.||........+- ..+.. .-...+.+|...+.+|...+ +...+++.+. ....+|||
T Consensus 35 ~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 35 GRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred CceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 344777888889999998743221110 00000 00113678999998885433 3344444432 23467999
Q ss_pred eecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC-------CCcEEEEecCCcc
Q 015556 262 EYLSEG-SLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-------EFHLKIADFGIAC 332 (405)
Q Consensus 262 E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~-------~~~vkL~DFG~a~ 332 (405)
|++++. +|.+++........+......++.+++..+.-||+.||+|+|+++.|||++. ++.+.|+||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999876 8999986433345566777889999999999999999999999999999975 5789999999873
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.1e-12 Score=129.60 Aligned_cols=196 Identities=21% Similarity=0.303 Sum_probs=153.9
Q ss_pred Ceeecceeee--eeeEEEEEEEE----CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEee
Q 015556 180 QLFLGLRFAH--GAHSRLYHGIY----KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACK 252 (405)
Q Consensus 180 ~~~~~~~lG~--G~~g~Vy~~~~----~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~ 252 (405)
.+.+...+|. |.+|.||.+.. .+..+|+|.=+.+...... .+.=.+|+...+.++ |+|.++.+..+.
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~------~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD------SKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc------cccccchhhcccccCccccccccCcccc
Confidence 3445667899 99999999887 2578999985444332211 112236777777775 999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHHCCceecCCCCCcEEECCC-CcEEEEe
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR----GMEYIHSQGVIHRDLKPENVLIDQE-FHLKIAD 327 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~----aL~yLH~~gIiHrDIkp~NILl~~~-~~vkL~D 327 (405)
..+..++-+|+| +.+|.++.+. ....++...++.++.+... ||.++|..+++|-|+||.||++..+ ...+++|
T Consensus 189 ~~~~lfiqtE~~-~~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 189 GSGILFIQTELC-GESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred cCCcceeeeccc-cchhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCC
Confidence 999999999998 5789888876 3345777888888999998 9999999999999999999999988 8899999
Q ss_pred cCCcccccccCC------CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCC
Q 015556 328 FGIACEEVYCDA------LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384 (405)
Q Consensus 328 FG~a~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~ 384 (405)
||+......... .....|...|++||..+ ..++...|+|+||.++.+..+|..++.
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhccccc
Confidence 998765443321 12225788899999987 567889999999999999999866553
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.8e-11 Score=110.92 Aligned_cols=138 Identities=21% Similarity=0.239 Sum_probs=102.8
Q ss_pred ceeeeeeeEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC--CCeeEEeeEeecC---CeeE
Q 015556 185 LRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN--PNVIKFVAACKKP---PVYC 258 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~~-~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~---~~~~ 258 (405)
+.|+.|..+.||++...+ +.++||+........ ...++..|+.++..+.+ .++.+++.++... +..+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~-------~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~ 76 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLP-------SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPF 76 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCc-------ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCce
Confidence 457999999999998876 899999986543211 13457799999999976 3456777777654 3668
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 015556 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS------------------------------------ 302 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~------------------------------------ 302 (405)
+||||++|.++.+.+.. ..++......++.+++.+|.+||+
T Consensus 77 ~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 77 YVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred EEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 99999999877664421 245556666667777777777763
Q ss_pred --------------------CCceecCCCCCcEEECC--CCcEEEEecCCcc
Q 015556 303 --------------------QGVIHRDLKPENVLIDQ--EFHLKIADFGIAC 332 (405)
Q Consensus 303 --------------------~gIiHrDIkp~NILl~~--~~~vkL~DFG~a~ 332 (405)
..++|+|+++.|||++. ++.+.|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23699999999999988 6778999999873
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.7e-10 Score=111.25 Aligned_cols=193 Identities=15% Similarity=0.204 Sum_probs=136.7
Q ss_pred eeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeE--------EeeEe
Q 015556 181 LFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIK--------FVAAC 251 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~--------l~g~~ 251 (405)
+..|..||+|+.+.+|-.-.-+ ..+-|++..+...-.. +-+..|... .||-+-. |+|.-
T Consensus 13 i~~gr~LgqGgea~ly~l~e~~-d~VAKIYh~Pppa~~a-----------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~ 80 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEVR-DQVAKIYHAPPPAAQA-----------QKVAELAATPDAPLLNYRVAWPQATLHGGR 80 (637)
T ss_pred cCCCccccCCccceeeecchhh-chhheeecCCCchHHH-----------HHHHHhccCCCCcchhhhhcccHHHhhCCC
Confidence 3467889999999999643333 3456888766543321 223334443 4554332 22211
Q ss_pred ecCCeeEEEEeecCCC-CHHHHHH----HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEE
Q 015556 252 KKPPVYCVITEYLSEG-SLRAYLH----KLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA 326 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~g-sL~~~l~----~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~ 326 (405)
....+.+.|..+++. -+.+++. +.......|..++..++.++.+.+.||..|.+-+|+.++|||+++++.+.|.
T Consensus 81 -~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LV 159 (637)
T COG4248 81 -RGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLV 159 (637)
T ss_pred -ccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEE
Confidence 223377888888764 2333332 1123457899999999999999999999999999999999999999999999
Q ss_pred ecCCcccccccCCCCCCCCCCcccCccccc-----cccCCchhhHHHHHHHHHHHHhC-CCCCCCC
Q 015556 327 DFGIACEEVYCDALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAG-TIPYEEM 386 (405)
Q Consensus 327 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DVwSlGvll~elltG-~~Pf~~~ 386 (405)
|-+.-.....+......+|...|.+||+.. +...+...|.|.||++++++|.| ++||.+.
T Consensus 160 dsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 160 DSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred cccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 876543334444555667999999999764 44557889999999999999995 9999764
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.3e-10 Score=103.04 Aligned_cols=131 Identities=26% Similarity=0.326 Sum_probs=83.4
Q ss_pred EEEEEEEC-CccEEEEEEecCCCChh------------------HHHHHHHHHHHHHHHHHHHhcCCC--CeeEEeeEee
Q 015556 194 RLYHGIYK-DEPVAVKIIRIPDDDEN------------------ETLAARLEKQFNREVALLSRLHNP--NVIKFVAACK 252 (405)
Q Consensus 194 ~Vy~~~~~-~~~vAVK~~~~~~~~~~------------------~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~~~ 252 (405)
.||.|... |..+|||+.+.....-. ............+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999985 78999999875321100 011122345678899999999875 455666443
Q ss_pred cCCeeEEEEeecC--CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 253 KPPVYCVITEYLS--EGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEY-IHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 253 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~y-LH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
..+|||||+. |..+..+... .++.+....++.+++..+.. +|..||+|+||.+.|||++++ .+.|+|||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~ 151 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFG 151 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GT
T ss_pred ---CCEEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecC
Confidence 2269999998 5555443322 11234556678888885555 579999999999999999887 99999999
Q ss_pred Cccc
Q 015556 330 IACE 333 (405)
Q Consensus 330 ~a~~ 333 (405)
.+..
T Consensus 152 qav~ 155 (188)
T PF01163_consen 152 QAVD 155 (188)
T ss_dssp TEEE
T ss_pred ccee
Confidence 8854
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.5e-11 Score=123.04 Aligned_cols=194 Identities=21% Similarity=0.205 Sum_probs=145.5
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC---CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeec
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK---DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKK 253 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~---~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~ 253 (405)
..++.+...||.|.|+.||....+ +..|++|.....-.....++ .-..|+.+...+. |.++++++..+..
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di------~sl~ev~l~~~l~~~~~~~g~~~~W~~ 337 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI------FSLGEVILEAILGSHLPSVGKNSSWSQ 337 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh------cchhhhhHhhHhhcccccCCCCCCccc
Confidence 367778889999999999987754 57888888764333322211 1235666666664 8888888777777
Q ss_pred CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC-CcEEEEecCCcc
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE-FHLKIADFGIAC 332 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~-~~vkL~DFG~a~ 332 (405)
....|+--|||.++++...+.- ...+++...+.+..|++.++.++|+..++|+|++|.||++..+ +..++.|||++.
T Consensus 338 ~r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 338 LRQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccc
Confidence 7777799999999988776632 3567788899999999999999999999999999999999775 888999999875
Q ss_pred cccccCCCCCCCCCCccc--CccccccccCCchhhHHHHHHHHHHHHhCCC
Q 015556 333 EEVYCDALSDDPGTYRWM--APEMIKHKSYGRKVDVYSFGLILWEMVAGTI 381 (405)
Q Consensus 333 ~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~k~DVwSlGvll~elltG~~ 381 (405)
.... .. ......-+++ +++......+..+.|+++||.-+.+.++|..
T Consensus 416 ~~~~-~~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 416 RLAF-SS-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred ccce-ec-ccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 4111 11 1222333444 5666677778899999999999999888744
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2e-11 Score=130.04 Aligned_cols=217 Identities=21% Similarity=0.285 Sum_probs=160.3
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
....+.+.+.+-+-.|+++.++.+.-. +...+.|+......-.. ........+-.++-..++|.++...--+.
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~-----~~~~s~r~~s~~~i~p~~P~v~~~~~s~~ 874 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT-----NDYESIRSKSNILITPRSPAVVRSFPSFP 874 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhcc-----ccccccCCccCccccCCCCceecccCCCC
Confidence 345567777788889999999987754 34445554432111000 00112234444444456677777665555
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
.....+||++|+.+++|...|+. .+..+.+.+...+..+..+++|||...+.|+|++|.|+|+..+++.++.|||...
T Consensus 875 ~rsP~~L~~~~~~~~~~~Skl~~--~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 875 CRSPLPLVGHYLNGGDLPSKLHN--SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred CCCCcchhhHHhccCCchhhhhc--CCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccc
Confidence 55667899999999999999987 3456777778888899999999999999999999999999999999999998321
Q ss_pred ccc--------------------------------ccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCC
Q 015556 333 EEV--------------------------------YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT 380 (405)
Q Consensus 333 ~~~--------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~ 380 (405)
... .........||+.|.+||.+.+......+|.|++|++++|.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 100 001122345899999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhc
Q 015556 381 IPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 381 ~Pf~~~~~~e~~~~i~~~ 398 (405)
.||....+.+....+.+.
T Consensus 1033 pp~na~tpq~~f~ni~~~ 1050 (1205)
T KOG0606|consen 1033 PPFNAETPQQIFENILNR 1050 (1205)
T ss_pred CCCCCcchhhhhhccccC
Confidence 999999998887666654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.8e-10 Score=106.94 Aligned_cols=149 Identities=26% Similarity=0.348 Sum_probs=115.9
Q ss_pred HHHHhcCCCCeeEEeeEeecC-----CeeEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Q 015556 234 ALLSRLHNPNVIKFVAACKKP-----PVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQG-- 304 (405)
Q Consensus 234 ~il~~l~HpnIv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g-- 304 (405)
.-|-++-|-|||+++.|+.+. ....+++|||..|+|.+||++. .+..+......+++-||+.||.|||+..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 335566799999999998754 3577899999999999999875 3456777788889999999999999874
Q ss_pred ceecCCCCCcEEECCCCcEEEEecCCcc-----cccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhC
Q 015556 305 VIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG 379 (405)
Q Consensus 305 IiHrDIkp~NILl~~~~~vkL~DFG~a~-----~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG 379 (405)
|+|+++..+-|++..+|-+||.--.-.. ............+.++|.+||.=.....+-.+|||+||....+|..|
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9999999999999999888875321110 00111122344578899999987777778899999999999999887
Q ss_pred CCC
Q 015556 380 TIP 382 (405)
Q Consensus 380 ~~P 382 (405)
..-
T Consensus 279 Eiq 281 (458)
T KOG1266|consen 279 EIQ 281 (458)
T ss_pred eec
Confidence 654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.00 E-value=6.4e-09 Score=95.27 Aligned_cols=105 Identities=27% Similarity=0.339 Sum_probs=82.5
Q ss_pred HHHHHHHHHHHHhcCCC--CeeEEeeEeecC----CeeEEEEeecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Q 015556 226 EKQFNREVALLSRLHNP--NVIKFVAACKKP----PVYCVITEYLSEG-SLRAYLHKLEHKTLPLPKLIAIALDIARGME 298 (405)
Q Consensus 226 ~~~~~~Ei~il~~l~Hp--nIv~l~g~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~ 298 (405)
.....+|...+..|... .+...+++.+.. ...+||||++++. +|.+++..... .+......++.+++..+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 34567888888888543 344555555542 2457999999884 79999876322 566677889999999999
Q ss_pred HHHHCCceecCCCCCcEEECCCC---cEEEEecCCcc
Q 015556 299 YIHSQGVIHRDLKPENVLIDQEF---HLKIADFGIAC 332 (405)
Q Consensus 299 yLH~~gIiHrDIkp~NILl~~~~---~vkL~DFG~a~ 332 (405)
-||++||+|+|+++.|||++.++ .+.++||+.+.
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 99999999999999999998887 89999999763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.1e-09 Score=99.17 Aligned_cols=141 Identities=23% Similarity=0.246 Sum_probs=102.0
Q ss_pred eeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChh--------------HHHHHHHHHHHHHHHHHHHhcCCC--C
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDEN--------------ETLAARLEKQFNREVALLSRLHNP--N 243 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~--------------~~~~~~~~~~~~~Ei~il~~l~Hp--n 243 (405)
..+|..||-|.-+.||.|.+. |.++|||.-+.....-. ..-..-......+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 357889999999999999996 89999999754311100 000011234567899999999754 5
Q ss_pred eeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcE
Q 015556 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323 (405)
Q Consensus 244 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~v 323 (405)
|.+.+++ +..++||||++|-.|... .++.+..-.|+..|+.-+.-+-..||||+|+.+=|||++++|.+
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~-------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRL-------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecc-------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCE
Confidence 6666553 344699999988666442 12334455566677777776778999999999999999999999
Q ss_pred EEEecCCcc
Q 015556 324 KIADFGIAC 332 (405)
Q Consensus 324 kL~DFG~a~ 332 (405)
.++||-.+.
T Consensus 242 ~vIDwPQ~v 250 (304)
T COG0478 242 VVIDWPQAV 250 (304)
T ss_pred EEEeCcccc
Confidence 999998763
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.3e-08 Score=101.92 Aligned_cols=167 Identities=17% Similarity=0.232 Sum_probs=124.7
Q ss_pred eeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee----cCCeeEEEEeec
Q 015556 191 AHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK----KPPVYCVITEYL 264 (405)
Q Consensus 191 ~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~----~~~~~~lV~E~~ 264 (405)
-..+.|++... |..|++|++........ ..-..-+++++++.|.|||+|..++. .+..+++|++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--------nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYy 359 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST--------NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYY 359 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc--------ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecC
Confidence 45578888764 78999999943222111 11225688999999999999988775 356789999999
Q ss_pred CC-CCHHHHHHHh-------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 265 SE-GSLRAYLHKL-------------EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 265 ~~-gsL~~~l~~~-------------~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
++ ++|.++-... .+..+++..+|.++.|+..||.++|+.|+..+-|.+.+||++.+.+++|+..|+
T Consensus 360 P~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i 439 (655)
T KOG3741|consen 360 PSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGI 439 (655)
T ss_pred CCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccc
Confidence 86 4787765432 234577899999999999999999999999999999999999998999988877
Q ss_pred cccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCC
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI 381 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~ 381 (405)
........ + |.+.. -.+-|.=.||.+++.|.||..
T Consensus 440 ~Dvl~~d~------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 440 MDVLQEDP------T-------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred eeeecCCC------C-------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 53322211 0 11211 246799999999999999843
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.6e-08 Score=92.13 Aligned_cols=143 Identities=15% Similarity=0.020 Sum_probs=103.1
Q ss_pred eeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC--eeEEeeEee--c--CCeeEEEE
Q 015556 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN--VIKFVAACK--K--PPVYCVIT 261 (405)
Q Consensus 188 G~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~~~--~--~~~~~lV~ 261 (405)
|.||.+-|++..+.|+.+-||.-..--..... ...-+..|.+|+..|.+|..-+ +.+.+.+.. . ....+||+
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r--~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVR--YPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCccccccc--CCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 77999999999988888888875310000000 0112467889999999996422 444442211 1 12467999
Q ss_pred eecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCc--EEEEecCCcc
Q 015556 262 EYLSE-GSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH--LKIADFGIAC 332 (405)
Q Consensus 262 E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~--vkL~DFG~a~ 332 (405)
|-+.| -+|.+++....-...+......++.+++..+.-||+.|+.|+|+.+.|||++.++. ++++||.-+.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 98864 48999987643345577777899999999999999999999999999999986666 9999998653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.3e-07 Score=86.55 Aligned_cols=142 Identities=15% Similarity=0.204 Sum_probs=93.5
Q ss_pred CCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHH-HHHHHHHHHHHHhcCC---CCeeEEeeEeec-
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARL-EKQFNREVALLSRLHN---PNVIKFVAACKK- 253 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~-~~~~~~Ei~il~~l~H---pnIv~l~g~~~~- 253 (405)
.+|.+.+.+-......|.+-...++.+++|..+....-.+.....-+ -....+++..+.++.. .....++.+.+.
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk 110 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK 110 (229)
T ss_pred CCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence 56677777777788888888888999999998754432221110000 0112344444445433 233333433332
Q ss_pred ----CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 254 ----PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 254 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
....++||||++|..|.++.. +++ .++..++.++.-||+.|++|+|.+|.|++++.++ ++++||+
T Consensus 111 ~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 111 IFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred eccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECc
Confidence 234568999999988766432 222 2456677889999999999999999999998654 9999998
Q ss_pred Cc
Q 015556 330 IA 331 (405)
Q Consensus 330 ~a 331 (405)
..
T Consensus 180 ~k 181 (229)
T PF06176_consen 180 GK 181 (229)
T ss_pred cc
Confidence 65
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.64 E-value=3.7e-07 Score=84.88 Aligned_cols=135 Identities=14% Similarity=0.140 Sum_probs=83.5
Q ss_pred ceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC--eeEEeeEeecCCeeEEEEe
Q 015556 185 LRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN--VIKFVAACKKPPVYCVITE 262 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~~~~~~~~~lV~E 262 (405)
..||.|..+.||+. .+..+++|....... .....+|.+++..+..-+ +.+.++++.+.+..++|||
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~----------~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e 74 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFD----------KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYE 74 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCCC----------HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeee
Confidence 46799999999984 356788898763221 123468999999986443 4677888888888889999
Q ss_pred ecCCCC-HH--------------HHHHH----hc---CCCCCHHHHHH-HHH----------HHHH-HHHHHHH----CC
Q 015556 263 YLSEGS-LR--------------AYLHK----LE---HKTLPLPKLIA-IAL----------DIAR-GMEYIHS----QG 304 (405)
Q Consensus 263 ~~~~gs-L~--------------~~l~~----~~---~~~l~~~~~~~-i~~----------qi~~-aL~yLH~----~g 304 (405)
+++|.. +. ..+.. .. ........... +.. .+.. ...+|.. ..
T Consensus 75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 998853 11 11111 00 01111111111 100 0111 1222221 24
Q ss_pred ceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 305 VIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 305 IiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
++|+|+.|.||++++++ +.|+||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 78999999999999888 9999999873
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.1e-07 Score=95.98 Aligned_cols=143 Identities=20% Similarity=0.290 Sum_probs=91.1
Q ss_pred ceeeeeeeEEEEEEEEC-CccEEEEEEecCCC--------------------------ChhHHHHHHHHH------HHHH
Q 015556 185 LRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDD--------------------------DENETLAARLEK------QFNR 231 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~--------------------------~~~~~~~~~~~~------~~~~ 231 (405)
.-||.++-|+||+|++. |+.||||+.+..-. -+...+...+.+ .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 45799999999999998 89999999752210 111122222223 3455
Q ss_pred HHHHHHhcC-----CCCeeEEeeEe-ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHH-HHHHHHCC
Q 015556 232 EVALLSRLH-----NPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARG-MEYIHSQG 304 (405)
Q Consensus 232 Ei~il~~l~-----HpnIv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~a-L~yLH~~g 304 (405)
|..-+.+++ .++|. +-..| +-...-.|+|||++|..+.+...... ..++...+.. .++.+ +..+=..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~-VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~---~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVY-VPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAE---LLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeE-eceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHH---HHHHHHHHHHHhcC
Confidence 555555553 23332 22222 22344579999999998888743322 4455333322 22222 23333479
Q ss_pred ceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 305 VIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 305 IiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
++|.|.+|.||+++.+|++.+.|||+..
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g 313 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVG 313 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCccee
Confidence 9999999999999999999999999874
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.58 E-value=5.2e-07 Score=81.64 Aligned_cols=133 Identities=22% Similarity=0.388 Sum_probs=95.5
Q ss_pred CCeeecceeeeeee-EEEEEEEECCccEEEEEEec---CCCC-------hhH---HHHHHHHHHHHHHHHHHHhcC---C
Q 015556 179 SQLFLGLRFAHGAH-SRLYHGIYKDEPVAVKIIRI---PDDD-------ENE---TLAARLEKQFNREVALLSRLH---N 241 (405)
Q Consensus 179 ~~~~~~~~lG~G~~-g~Vy~~~~~~~~vAVK~~~~---~~~~-------~~~---~~~~~~~~~~~~Ei~il~~l~---H 241 (405)
.++++.+.||.|.. |.||++...|+.+|||+++. .... ... ........-|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 56778899999999 99999999999999999322 1111 000 001123446889999988886 3
Q ss_pred CCe--eEEeeEeecC------------------CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 015556 242 PNV--IKFVAACKKP------------------PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301 (405)
Q Consensus 242 pnI--v~l~g~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH 301 (405)
.++ |+++||..-. ....||.||++... .+ ...-+.+|.+-|..+|
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~----~~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PL----QIRDIPQMLRDLKILH 181 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------cc----chhHHHHHHHHHHHHH
Confidence 556 8999987211 23568888886533 12 2233567778888999
Q ss_pred HCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 302 ~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
..||+-+|+++.|.. .-+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999997 4589999965
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.52 E-value=9.5e-07 Score=81.86 Aligned_cols=141 Identities=21% Similarity=0.221 Sum_probs=94.6
Q ss_pred ceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHH----------------HHHHHHHHHHHHHHHHHhcC--CCCee
Q 015556 185 LRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENET----------------LAARLEKQFNREVALLSRLH--NPNVI 245 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~----------------~~~~~~~~~~~Ei~il~~l~--HpnIv 245 (405)
..|..|--+.||+|... +..+|||+++........- .......=..+|..-|+++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 36788999999999875 7899999997654332110 00000111356777777774 33444
Q ss_pred EEeeEeecCCeeEEEEeecCCCCHH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEECCCCcE
Q 015556 246 KFVAACKKPPVYCVITEYLSEGSLR-AYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHL 323 (405)
Q Consensus 246 ~l~g~~~~~~~~~lV~E~~~~gsL~-~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDIkp~NILl~~~~~v 323 (405)
+-+++... .|||||+....+. -.| ..-.+..+++..+..++++.+.-|-. .++||+||..=|||+. ++.+
T Consensus 134 ~Pi~~~~n----VLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 134 EPIAFRNN----VLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CceeecCC----eEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 55544432 4999999553110 011 11233344677888999999998876 8999999999999999 8899
Q ss_pred EEEecCCccc
Q 015556 324 KIADFGIACE 333 (405)
Q Consensus 324 kL~DFG~a~~ 333 (405)
.|+|||.|..
T Consensus 206 ~iID~~QaV~ 215 (268)
T COG1718 206 YIIDVSQAVT 215 (268)
T ss_pred EEEECccccc
Confidence 9999998843
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=6.4e-07 Score=78.81 Aligned_cols=128 Identities=20% Similarity=0.238 Sum_probs=94.4
Q ss_pred eecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee-EEeeEeecCCeeEEE
Q 015556 182 FLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI-KFVAACKKPPVYCVI 260 (405)
Q Consensus 182 ~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~g~~~~~~~~~lV 260 (405)
...+.||+|.+|.||+|.+.|..+|+|+=+.++. ...+..|.++|..+.-.++. ++|.+..+. +.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~----------r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~ 90 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP----------RRNLEKEAKILEILAGEGVTPEVYFYGEDF----IR 90 (201)
T ss_pred hhhhhhhcccccEEEEeeccCceEEEEEecCCcc----------hhhHHHHHHHHHHhhhcCCCceEEEechhh----hh
Confidence 3456789999999999999999999999775443 34577999999999887765 455555444 55
Q ss_pred EeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC-CCcEEECCCCcEEEEecCCcc
Q 015556 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLK-PENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIk-p~NILl~~~~~vkL~DFG~a~ 332 (405)
|||+.|-.|.++-... +- +-+..++..-.-|-..||-|+.|. |..++|-.++.+.|+||..|.
T Consensus 91 me~i~G~~L~~~~~~~-----~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 91 MEYIDGRPLGKLEIGG-----DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhcCcchhhhhhcc-----cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 9999887887755431 22 234456666666778899999998 544444445599999999885
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=3.2e-08 Score=102.29 Aligned_cols=108 Identities=18% Similarity=0.342 Sum_probs=80.2
Q ss_pred HHHHHHHHHHHHHC-CceecCCCCCcEEECCCCcEEEEecCCcccccc-----cCCCCC-----CCCCCcccCccccccc
Q 015556 290 ALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-----CDALSD-----DPGTYRWMAPEMIKHK 358 (405)
Q Consensus 290 ~~qi~~aL~yLH~~-gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~-----~~~~~~-----~~gt~~y~aPE~~~~~ 358 (405)
+.+++.|+.|+|.. ++||+.|.|++|.++.++.+||+.|+++..... ....+. ..-...|.|||++.+.
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 34555999999965 899999999999999999999999998743222 111111 1145569999999988
Q ss_pred cCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015556 359 SYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 359 ~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~ 397 (405)
..+.++|+|||||++|.+.. |..-+...+.........+
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~ 224 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN 224 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc
Confidence 88999999999999999994 6666665544444333333
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.42 E-value=3.6e-06 Score=77.25 Aligned_cols=137 Identities=23% Similarity=0.309 Sum_probs=83.1
Q ss_pred ceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC--eeEEeeEee---cCCeeEE
Q 015556 185 LRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN--VIKFVAACK---KPPVYCV 259 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~~~---~~~~~~l 259 (405)
+.|+.|..+.||+....+..++||..... .....+.+|..++..|.... +.+++.++. .....++
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~ 72 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP----------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYL 72 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH----------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC----------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceE
Confidence 56899999999999998889999997632 12456778999988886332 455665443 3345789
Q ss_pred EEeecCCCCHHH----------------HHHHh---c--CCCCCHHH---------HHHH------------HHHHHH-H
Q 015556 260 ITEYLSEGSLRA----------------YLHKL---E--HKTLPLPK---------LIAI------------ALDIAR-G 296 (405)
Q Consensus 260 V~E~~~~gsL~~----------------~l~~~---~--~~~l~~~~---------~~~i------------~~qi~~-a 296 (405)
+|++++|..+.. ++... . ...+.... .... +..+.. .
T Consensus 73 ~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (239)
T PF01636_consen 73 LMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERL 152 (239)
T ss_dssp EEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred EEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHH
Confidence 999999987776 22111 0 01111100 0000 112222 3
Q ss_pred HHHHHH-------CCceecCCCCCcEEEC-CCCcEEEEecCCc
Q 015556 297 MEYIHS-------QGVIHRDLKPENVLID-QEFHLKIADFGIA 331 (405)
Q Consensus 297 L~yLH~-------~gIiHrDIkp~NILl~-~~~~vkL~DFG~a 331 (405)
+..+++ ..++|+|+.+.|||++ .++.+-|+||+.+
T Consensus 153 ~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a 195 (239)
T PF01636_consen 153 LQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDA 195 (239)
T ss_dssp HHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred HHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccc
Confidence 334432 3599999999999999 6677789999976
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.4e-06 Score=78.21 Aligned_cols=135 Identities=16% Similarity=0.107 Sum_probs=83.1
Q ss_pred eeeeee-EEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeecCCeeEEEEeec
Q 015556 187 FAHGAH-SRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPVYCVITEYL 264 (405)
Q Consensus 187 lG~G~~-g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~ 264 (405)
|..|.. ..||+....+..++||+..... ...+.+|+.++..+. +--+.++++++...+..++|||++
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 74 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP-----------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAV 74 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc-----------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEee
Confidence 444555 7889987777788889875332 123457888888884 334557788777766778999999
Q ss_pred CCCCHHHHH----------------HHh---cCC--CCCH--HHHHHHHH--------------------HHHHHHHHHH
Q 015556 265 SEGSLRAYL----------------HKL---EHK--TLPL--PKLIAIAL--------------------DIARGMEYIH 301 (405)
Q Consensus 265 ~~gsL~~~l----------------~~~---~~~--~l~~--~~~~~i~~--------------------qi~~aL~yLH 301 (405)
+|.+|.... .+. ... .+.. ........ .+...+..|-
T Consensus 75 ~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 154 (244)
T cd05150 75 PGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELE 154 (244)
T ss_pred CCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHH
Confidence 987665431 111 000 1110 00000000 0111122221
Q ss_pred -------HCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 302 -------SQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 302 -------~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 155 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 155 ATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred hhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 1248999999999999998888999999873
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.28 E-value=9.8e-08 Score=97.89 Aligned_cols=181 Identities=19% Similarity=0.216 Sum_probs=133.0
Q ss_pred ceeeeeeeEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC-eeEEeeEeecCCeeEEEEe
Q 015556 185 LRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN-VIKFVAACKKPPVYCVITE 262 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~~-~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~lV~E 262 (405)
+-+++|+++.+++.+... +...++.+... -...-++++|.+++||| .+..++-++.+...+++|+
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-------------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-------------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 345899999999988753 34446665432 12336889999999999 7788888888888999999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCCCC
Q 015556 263 YLSEG-SLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALS 341 (405)
Q Consensus 263 ~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 341 (405)
++.++ +...-.. ...-.+...+...+.+.-++++++||+.--+|+| |||..+ +..+..||+............
T Consensus 315 i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~ 388 (829)
T KOG0576|consen 315 ICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPR 388 (829)
T ss_pred hhcCCccccccCC-hhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccccc
Confidence 99877 2111100 0112233445566777888899999988778998 777655 678999999876544443456
Q ss_pred CCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCC
Q 015556 342 DDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384 (405)
Q Consensus 342 ~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~ 384 (405)
...+++.|+|||+.....++...|+|++|+-..+|.-|..|-.
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 6679999999999999999999999999987777777766643
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.23 E-value=3.6e-06 Score=86.73 Aligned_cols=144 Identities=17% Similarity=0.218 Sum_probs=85.3
Q ss_pred ceeeeeeeEEEEEEEEC-CccEEEEEEecCCCCh-----------------------hHHHHHHHHHH------HHHHHH
Q 015556 185 LRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDE-----------------------NETLAARLEKQ------FNREVA 234 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~-----------------------~~~~~~~~~~~------~~~Ei~ 234 (405)
+-||.-+.|+||+|+++ |+.||||+=+..-... ..-+.....+. |.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 45799999999999997 6889999954211000 01111222233 333433
Q ss_pred HHHh----cCCCC---eeEEeeEeec-CCeeEEEEeecCCCCHHHH--HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 015556 235 LLSR----LHNPN---VIKFVAACKK-PPVYCVITEYLSEGSLRAY--LHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304 (405)
Q Consensus 235 il~~----l~Hpn---Iv~l~g~~~~-~~~~~lV~E~~~~gsL~~~--l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g 304 (405)
-..+ +.|-+ -|.+-..+.+ .....|+||||+|..+.|. |.+ ..++...+..-+.+...-+ +=..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~---~gi~~~~i~~~l~~~~~~q--If~~G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK---RGISPHDILNKLVEAYLEQ--IFKTG 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH---cCCCHHHHHHHHHHHHHHH--HHhcC
Confidence 3333 33444 1222222222 2345799999999865543 443 4555554443333322222 22458
Q ss_pred ceecCCCCCcEEEC----CCCcEEEEecCCccc
Q 015556 305 VIHRDLKPENVLID----QEFHLKIADFGIACE 333 (405)
Q Consensus 305 IiHrDIkp~NILl~----~~~~vkL~DFG~a~~ 333 (405)
.+|+|-+|.||++. .++.+.+.|||+...
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 99999999999998 367899999999743
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.18 E-value=3.3e-05 Score=70.21 Aligned_cols=135 Identities=19% Similarity=0.328 Sum_probs=93.3
Q ss_pred ceeeeeeeEEEEEEEECCccEEEEEEecCCCChhH--------HHHHHHHHHHHHHHHHHHhcC------CCCeeEEeeE
Q 015556 185 LRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENE--------TLAARLEKQFNREVALLSRLH------NPNVIKFVAA 250 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~--------~~~~~~~~~~~~Ei~il~~l~------HpnIv~l~g~ 250 (405)
..||+|+.-.||.-- .+....||+.......+.. .......+++.+|+.....+. +..|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 467999999999532 3567889998765400000 000011356667777666666 6889999999
Q ss_pred eecCCeeEEEEeecCC--C----CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC---C
Q 015556 251 CKKPPVYCVITEYLSE--G----SLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE---F 321 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~--g----sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~---~ 321 (405)
.+.+....+|+|.+.+ | +|.+++.. ..++. .+ ...+-+-..||-+.+|+.+|++|.||++... .
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 9999999999998743 2 68888865 45555 33 3344455678889999999999999999432 2
Q ss_pred -cEEEEe
Q 015556 322 -HLKIAD 327 (405)
Q Consensus 322 -~vkL~D 327 (405)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.17 E-value=5.1e-06 Score=74.95 Aligned_cols=96 Identities=24% Similarity=0.343 Sum_probs=78.5
Q ss_pred HHHHHHHhcCC-CCeeEEeeEeecCCeeEEEEeecCCCCHHHH---HHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---C
Q 015556 231 REVALLSRLHN-PNVIKFVAACKKPPVYCVITEYLSEGSLRAY---LHKLEHKTLPLPKLIAIALDIARGMEYIHS---Q 303 (405)
Q Consensus 231 ~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~---l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~ 303 (405)
.|.-+|+.+.+ +++.+++|+|.+ ++|+||...+++... +.. -...+|..+.+|+.++++.+++|+. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 58889999976 699999999943 478999976655321 111 1346899999999999999999987 3
Q ss_pred CceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 304 GVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 304 gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
.+...|++++||-+++++++|++|.+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 58889999999999999999999998763
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.7e-05 Score=87.35 Aligned_cols=78 Identities=18% Similarity=0.190 Sum_probs=55.4
Q ss_pred cceeeeeeeEEEEEEEECC----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCe--eEEeeEeecC--
Q 015556 184 GLRFAHGAHSRLYHGIYKD----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNV--IKFVAACKKP-- 254 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~~----~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnI--v~l~g~~~~~-- 254 (405)
...|+.|.+..+|+....+ ..+++|+......... ...+.+|+.+|+.|. |.+| .+++.+|.+.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~-------~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS-------AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc-------HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 3567999999999987764 4677776532221111 235779999999995 6664 7888888764
Q ss_pred -CeeEEEEeecCCCC
Q 015556 255 -PVYCVITEYLSEGS 268 (405)
Q Consensus 255 -~~~~lV~E~~~~gs 268 (405)
+..|+||||++|..
T Consensus 116 ~G~~flVME~v~G~~ 130 (822)
T PLN02876 116 IGTAFYIMEYLEGRI 130 (822)
T ss_pred CCCceEEEEecCCcc
Confidence 46789999998754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.05 E-value=2.2e-05 Score=73.17 Aligned_cols=28 Identities=32% Similarity=0.472 Sum_probs=24.7
Q ss_pred CceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 304 GVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 304 gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
+++|+|+.+.|||++.++..-|+||+.+
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a 192 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCL 192 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCccc
Confidence 4899999999999987766679999986
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00021 Score=69.23 Aligned_cols=76 Identities=13% Similarity=-0.018 Sum_probs=56.1
Q ss_pred cceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC---CCeeEEeeEeec---CCee
Q 015556 184 GLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN---PNVIKFVAACKK---PPVY 257 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~g~~~~---~~~~ 257 (405)
.+.||.|..+.||+....+..++||..+.... ...|..|...|+.|.. -.|.+++++|.. .+..
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~----------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~ 88 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGNPMPLMARSFST----------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD 88 (297)
T ss_pred eeecCCccceeEEEEEcCCCCEEEEEeccccc----------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence 35689999999999887666788888542111 2357789999988853 357788887754 3668
Q ss_pred EEEEeecCCCCH
Q 015556 258 CVITEYLSEGSL 269 (405)
Q Consensus 258 ~lV~E~~~~gsL 269 (405)
+||||+++++++
T Consensus 89 ~LVmE~i~G~~~ 100 (297)
T PRK10593 89 VLLLERLRGVSV 100 (297)
T ss_pred EEEEeccCCEec
Confidence 999999988654
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00032 Score=68.12 Aligned_cols=142 Identities=22% Similarity=0.258 Sum_probs=83.1
Q ss_pred eeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCC--CeeEEeeEe------e
Q 015556 181 LFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP--NVIKFVAAC------K 252 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~~------~ 252 (405)
..-...++.|....+|+....+..+++|+....... ..+..|++++..|... .+.+++... .
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~~----------~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~ 93 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRVKA----------EELPFFLALTTHLAARGLPVPKPVKSRDGRQLST 93 (307)
T ss_pred ceeccccCCccccceEEEEeCCCcEEEEEecCCCCH----------HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehh
Confidence 334456677878899998776778999987542111 2234566777777432 234444322 2
Q ss_pred cCCeeEEEEeecCCCCHH-----------HH---HHHhcCC---C-------CCHHHHH------------HHHHHHHHH
Q 015556 253 KPPVYCVITEYLSEGSLR-----------AY---LHKLEHK---T-------LPLPKLI------------AIALDIARG 296 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~-----------~~---l~~~~~~---~-------l~~~~~~------------~i~~qi~~a 296 (405)
..+..+++|+|++|..+. .. ++..... . ..|.... .....+...
T Consensus 94 ~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~ 173 (307)
T TIGR00938 94 LAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKE 173 (307)
T ss_pred cCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHH
Confidence 245678999999884321 11 1211110 0 0111100 011223345
Q ss_pred HHHHHH-------CCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 297 MEYIHS-------QGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 297 L~yLH~-------~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
++++.. .+++|+|+++.||+++.++...|+||+.+.
T Consensus 174 ~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 174 LDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 555542 579999999999999988877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00015 Score=69.70 Aligned_cols=138 Identities=21% Similarity=0.230 Sum_probs=83.7
Q ss_pred cceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC--eeEEeeE------eecCC
Q 015556 184 GLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN--VIKFVAA------CKKPP 255 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~------~~~~~ 255 (405)
.+.|..|....+|+....+..+++|+... . . ...+..|+.++..|.+.+ +.+++.. ...++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~-~-~---------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~ 87 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK-V-S---------AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG 87 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC-C-C---------hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence 34567788889999887778899998763 1 1 123556888888875332 4444332 12345
Q ss_pred eeEEEEeecCCCCHHH-----------H---HHHhcCC---------CCCHHHHH----------HHHHHHHHHHHHHHH
Q 015556 256 VYCVITEYLSEGSLRA-----------Y---LHKLEHK---------TLPLPKLI----------AIALDIARGMEYIHS 302 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~-----------~---l~~~~~~---------~l~~~~~~----------~i~~qi~~aL~yLH~ 302 (405)
..++|++|++|..+.. . ++..... ...|.... .....+..++.++.+
T Consensus 88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~ 167 (296)
T cd05153 88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA 167 (296)
T ss_pred ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence 5689999998855311 1 1111000 01111110 011223344555543
Q ss_pred -------CCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 303 -------QGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 303 -------~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 369999999999999998778999999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00018 Score=66.79 Aligned_cols=72 Identities=21% Similarity=0.264 Sum_probs=45.8
Q ss_pred ceeeeeeeEEEEEEEEC---CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe-eEEeeEeecCCeeEEE
Q 015556 185 LRFAHGAHSRLYHGIYK---DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV-IKFVAACKKPPVYCVI 260 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~---~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV 260 (405)
+.|..|-...+|+.... ++.|++|+....... .-...+|+.++..+...++ .++++.+. + .+|
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---------~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l 70 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---------IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLI 70 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---------eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEE
Confidence 45677888899998875 468999976532111 0112368888888854333 44544433 2 389
Q ss_pred EeecCCCCH
Q 015556 261 TEYLSEGSL 269 (405)
Q Consensus 261 ~E~~~~gsL 269 (405)
|||++|.++
T Consensus 71 ~e~i~G~~l 79 (235)
T cd05157 71 YEFIPGRTL 79 (235)
T ss_pred EEeeCCCcC
Confidence 999988654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.76 E-value=2.3e-05 Score=75.37 Aligned_cols=137 Identities=20% Similarity=0.237 Sum_probs=95.9
Q ss_pred CeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCC-----------------hhHHHHHHHHHHHHHHHHHHHhcC-
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDD-----------------ENETLAARLEKQFNREVALLSRLH- 240 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~-----------------~~~~~~~~~~~~~~~Ei~il~~l~- 240 (405)
-+.+|+.||-|.-+.||.+-+. |++.++|.-+..... .|..+ .+-...+|...|+.|.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyL---SRlaa~kEfafmkaL~e 169 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYL---SRLAATKEFAFMKALYE 169 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhh---HHHHHHHHHHHHHHHHH
Confidence 3568999999999999999987 899999986432211 11111 1223467888888885
Q ss_pred CCC-eeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC
Q 015556 241 NPN-VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319 (405)
Q Consensus 241 Hpn-Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~ 319 (405)
|-. |.+.+++ ...|+|||++.|-.|.+.-+- . ..-.+...+..-+--|..+|+||+|..-=||+|++
T Consensus 170 ~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-----~---d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 170 RGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-----E---DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKD 237 (465)
T ss_pred cCCCCCCcccc----cceeeHHHhhcccceeeeeec-----C---ChHHHHHHHHHHHHHHHHcCceecccchheeEEec
Confidence 322 3334433 345799999988777653321 1 22334455566667788899999999999999999
Q ss_pred CCcEEEEecCCc
Q 015556 320 EFHLKIADFGIA 331 (405)
Q Consensus 320 ~~~vkL~DFG~a 331 (405)
++.++++||-..
T Consensus 238 d~~i~vIDFPQm 249 (465)
T KOG2268|consen 238 DDKIVVIDFPQM 249 (465)
T ss_pred CCCEEEeechHh
Confidence 999999999754
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00091 Score=65.14 Aligned_cols=138 Identities=19% Similarity=0.224 Sum_probs=76.3
Q ss_pred ceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC--eeEEee------EeecCCe
Q 015556 185 LRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN--VIKFVA------ACKKPPV 256 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g------~~~~~~~ 256 (405)
+.|+.|....+|+....+..+++|++. .. . ...+..|+.++..|...+ +.+.+. +....+.
T Consensus 28 ~~l~~G~~n~~y~v~t~~g~~vLK~~~-~~-~---------~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~ 96 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQGEYVLTLFE-RL-T---------AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGK 96 (319)
T ss_pred chhccccccceEEEEeCCCcEEEEEec-cC-C---------hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCE
Confidence 456778888999988777789999875 11 1 112234556665553211 223222 1123456
Q ss_pred eEEEEeecCCCCH-----------HHHHHH---hcCC---------CCCH-HHHHH------------HHHH-HHHHHHH
Q 015556 257 YCVITEYLSEGSL-----------RAYLHK---LEHK---------TLPL-PKLIA------------IALD-IARGMEY 299 (405)
Q Consensus 257 ~~lV~E~~~~gsL-----------~~~l~~---~~~~---------~l~~-~~~~~------------i~~q-i~~aL~y 299 (405)
.+++++|++|..+ .+.|.+ .... .+.+ ..... .+.+ +...+..
T Consensus 97 ~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 176 (319)
T PRK05231 97 PAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAF 176 (319)
T ss_pred EEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHh
Confidence 7899999988632 112211 1100 1111 11111 1111 1112233
Q ss_pred HH-------HCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 300 IH-------SQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 300 LH-------~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
+. ..++||+|+++.|||++.+...-|+||+.++.
T Consensus 177 ~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 177 LASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred hhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 32 23799999999999998766668999998743
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00051 Score=64.77 Aligned_cols=134 Identities=19% Similarity=0.200 Sum_probs=76.9
Q ss_pred eeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe-eEEeeEeecCCeeEEEEeecC
Q 015556 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV-IKFVAACKKPPVYCVITEYLS 265 (405)
Q Consensus 187 lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~E~~~ 265 (405)
+..|-.+.+|+....++.++||+.......- .-...+|..+++.+...++ .++++.+. -++||||++
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~--------~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~ 71 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKAL--------GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLE 71 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccc--------cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEecc
Confidence 4567788899888778889999754321110 0123478888888864333 23444332 268999998
Q ss_pred CCCHHH--------------HHHHh---c--CCCCCHH-HHHHHHHHH---------HHHHHHHHHC--------Cceec
Q 015556 266 EGSLRA--------------YLHKL---E--HKTLPLP-KLIAIALDI---------ARGMEYIHSQ--------GVIHR 308 (405)
Q Consensus 266 ~gsL~~--------------~l~~~---~--~~~l~~~-~~~~i~~qi---------~~aL~yLH~~--------gIiHr 308 (405)
|..+.. .+.+. . ...++.. .+..+..++ ...+..+-.. .++|+
T Consensus 72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~ 151 (256)
T TIGR02721 72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM 151 (256)
T ss_pred CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence 865421 11111 1 1112221 111211111 1222222221 48999
Q ss_pred CCCCCcEEECCCCcEEEEecCCccc
Q 015556 309 DLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 309 DIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
|+.|.|||+++++ +.|+||..+..
T Consensus 152 Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 152 DVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CCCcCcEEEeCCC-CEEEeccccCc
Confidence 9999999999877 78999998743
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.45 E-value=2.2e-05 Score=87.68 Aligned_cols=182 Identities=13% Similarity=0.037 Sum_probs=129.9
Q ss_pred EEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec--CCeeEEEEeecCCCCHHHHHHHhcCC--C
Q 015556 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK--PPVYCVITEYLSEGSLRAYLHKLEHK--T 280 (405)
Q Consensus 205 vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~--~ 280 (405)
+-+|+++..+ -+.+..-+.+....|...++.+.|+++...+.-... ....+.+++|+.+|.+++.|-+.... .
T Consensus 1255 Fk~~I~ke~d---~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ 1331 (2724)
T KOG1826|consen 1255 FKFSIYKEYD---FENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPD 1331 (2724)
T ss_pred eEEEeehhhh---HHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCc
Confidence 4555554322 233444456667777777788899998876664432 34567899999999999998875322 2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCcEEECCCCcEEEEecCCcc-cccccCCCCCCCCCCcccCccc
Q 015556 281 LPLPKLIAIALDIARGMEYIHSQG-----VIHRDLKPENVLIDQEFHLKIADFGIAC-EEVYCDALSDDPGTYRWMAPEM 354 (405)
Q Consensus 281 l~~~~~~~i~~qi~~aL~yLH~~g-----IiHrDIkp~NILl~~~~~vkL~DFG~a~-~~~~~~~~~~~~gt~~y~aPE~ 354 (405)
++..-......+.+....-+|.+. .+|+++|+-|.+|..+..+|+.++|+.+ ............+++.|+.+++
T Consensus 1332 ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli 1411 (2724)
T KOG1826|consen 1332 LDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLI 1411 (2724)
T ss_pred chhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHH
Confidence 333333333333366666666542 6899999999999999999999999987 3333334445568889999999
Q ss_pred cccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 015556 355 IKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI 389 (405)
Q Consensus 355 ~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~ 389 (405)
...-.++.++|+|..|+.+|+.-.|..+|-.....
T Consensus 1412 ~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~ 1446 (2724)
T KOG1826|consen 1412 KNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQP 1446 (2724)
T ss_pred HHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHHHH
Confidence 98888998999999999999998898887554443
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.00092 Score=65.57 Aligned_cols=145 Identities=19% Similarity=0.228 Sum_probs=92.7
Q ss_pred ecceeeeeeeEEEEEEEEC-CccEEEEEEecCC-----CChh-------------HHHHHHHHHHHHHHHHHHHhcCCCC
Q 015556 183 LGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPD-----DDEN-------------ETLAARLEKQFNREVALLSRLHNPN 243 (405)
Q Consensus 183 ~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~-----~~~~-------------~~~~~~~~~~~~~Ei~il~~l~Hpn 243 (405)
+-..|..|--+.||++... |..+|||+++..- .+.. ..-.....-=...|+.-|.+|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 3346789999999999876 6889999986431 1100 0001111112346788888887544
Q ss_pred eeEEeeEeecCCeeEEEEeecCCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCcEEECCCC
Q 015556 244 VIKFVAACKKPPVYCVITEYLSEGS-LRAYLHKLEHKTLPLPKLIAIALDIARGMEYI-HSQGVIHRDLKPENVLIDQEF 321 (405)
Q Consensus 244 Iv~l~g~~~~~~~~~lV~E~~~~gs-L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~gIiHrDIkp~NILl~~~~ 321 (405)
|.-.--+.. ....|||+|+.... ..-.| ....++...+..+-.+++.-|.-| |.+++||.||.-=|+|+ .+|
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG 301 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDG 301 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECC
Confidence 321100111 12259999994321 11112 235566677888888888888888 67799999999999998 457
Q ss_pred cEEEEecCCccc
Q 015556 322 HLKIADFGIACE 333 (405)
Q Consensus 322 ~vkL~DFG~a~~ 333 (405)
.+.|+|.+.+..
T Consensus 302 ~lyiIDVSQSVE 313 (520)
T KOG2270|consen 302 KLYIIDVSQSVE 313 (520)
T ss_pred EEEEEEcccccc
Confidence 899999998743
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00084 Score=73.92 Aligned_cols=153 Identities=22% Similarity=0.244 Sum_probs=113.0
Q ss_pred HHHHHHHHHHhcCCCCeeEEeeEeecCCe----eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 015556 228 QFNREVALLSRLHNPNVIKFVAACKKPPV----YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303 (405)
Q Consensus 228 ~~~~Ei~il~~l~HpnIv~l~g~~~~~~~----~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 303 (405)
....|+..+....|+|++.+++|-.+... ..+..++|...++...+.. -..++....+.+..++..||.|+|+.
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~--v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS--VGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh--ccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 34467777888899999999988765432 3345678888888888876 46788889999999999999999999
Q ss_pred CceecCCCCC---cEEECCCCcEEEE--ecCCcccccccCCCCCCCCCCcccCccccccccCCc--hhhHHHHHHHHHHH
Q 015556 304 GVIHRDLKPE---NVLIDQEFHLKIA--DFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGR--KVDVYSFGLILWEM 376 (405)
Q Consensus 304 gIiHrDIkp~---NILl~~~~~vkL~--DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--k~DVwSlGvll~el 376 (405)
...|.-+... +..++..+.+.+. ||+................+..|.++|......++. ..|+|.+|.++..+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence 6655544444 4444556667766 888876555444444445666788888887666654 47999999999999
Q ss_pred HhCCCC
Q 015556 377 VAGTIP 382 (405)
Q Consensus 377 ltG~~P 382 (405)
..|..+
T Consensus 386 ~~~~~i 391 (1351)
T KOG1035|consen 386 SQGEDI 391 (1351)
T ss_pred hhcCcc
Confidence 987654
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0024 Score=64.19 Aligned_cols=80 Identities=15% Similarity=-0.027 Sum_probs=50.6
Q ss_pred ceeeeeeeEEEEEEEECC--ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC---CCCeeEEeeEeecCCeeEE
Q 015556 185 LRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---NPNVIKFVAACKKPPVYCV 259 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~~--~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~l 259 (405)
+.||.|....||++...+ +.|+||.-......... .......++..|.+.|..+. ...+.+++.+.. ...++
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~-~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l 108 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGE-SWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT 108 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccc-cccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence 467999999999999875 48999985321110000 00001345566777777763 245667776643 44679
Q ss_pred EEeecCCC
Q 015556 260 ITEYLSEG 267 (405)
Q Consensus 260 V~E~~~~g 267 (405)
||||+++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99999764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0038 Score=60.40 Aligned_cols=29 Identities=24% Similarity=0.480 Sum_probs=25.3
Q ss_pred CCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 303 QGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 303 ~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
.+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999663
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0033 Score=60.72 Aligned_cols=71 Identities=17% Similarity=0.259 Sum_probs=45.2
Q ss_pred eeeeeeeEEEEEEEEC--------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe-eEEeeEeecCCe
Q 015556 186 RFAHGAHSRLYHGIYK--------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV-IKFVAACKKPPV 256 (405)
Q Consensus 186 ~lG~G~~g~Vy~~~~~--------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~ 256 (405)
.|..|-...+|+.... ++.+++|+....... .....+|..++..+...++ .++++++..
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~---------~~~r~~E~~~~~~l~~~g~~P~~~~~~~~--- 72 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL---------LIDRERELVVFARLSERNLGPKLYGIFPN--- 72 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc---------eechHHHHHHHHHHHhCCCCCceEEEeCC---
Confidence 4556777788888765 378999997643211 1234478888888864333 345555542
Q ss_pred eEEEEeecCCCCH
Q 015556 257 YCVITEYLSEGSL 269 (405)
Q Consensus 257 ~~lV~E~~~~gsL 269 (405)
.+|+||++|..+
T Consensus 73 -~~v~e~i~G~~l 84 (302)
T cd05156 73 -GRIEEFIPSRTL 84 (302)
T ss_pred -CchhheeCCCcC
Confidence 368999988654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.014 Score=57.38 Aligned_cols=135 Identities=23% Similarity=0.309 Sum_probs=82.6
Q ss_pred eeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC------eeEEee----EeecCCe
Q 015556 187 FAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN------VIKFVA----ACKKPPV 256 (405)
Q Consensus 187 lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~g----~~~~~~~ 256 (405)
|+. .-..+|+....+..++||+.... .. ..++..|+..|..|.-.+ +..+-| ....+..
T Consensus 34 l~s-~eN~~f~~~~~~g~~iLki~~~~-~~---------~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r 102 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRYILKIYRPG-WT---------RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPR 102 (331)
T ss_pred ccc-ccCceEEEEecCCCeEEEEecCC-CC---------HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCce
Confidence 444 66788999888878899998854 22 245567888888884322 222222 2222237
Q ss_pred eEEEEeecCCCCHHH------------HHHHh----c-----C----CCCCHH-------------HHHHHHHHHHHHHH
Q 015556 257 YCVITEYLSEGSLRA------------YLHKL----E-----H----KTLPLP-------------KLIAIALDIARGME 298 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~------------~l~~~----~-----~----~~l~~~-------------~~~~i~~qi~~aL~ 298 (405)
.+-|++|++|..+.. ++-+. . + ....|. .-.....++...+.
T Consensus 103 ~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~ 182 (331)
T COG2334 103 PAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALD 182 (331)
T ss_pred eEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHH
Confidence 778999999876651 11110 0 0 012222 01113344444455
Q ss_pred HHHHC--------C--ceecCCCCCcEEECCCCc-EEEEecCCcc
Q 015556 299 YIHSQ--------G--VIHRDLKPENVLIDQEFH-LKIADFGIAC 332 (405)
Q Consensus 299 yLH~~--------g--IiHrDIkp~NILl~~~~~-vkL~DFG~a~ 332 (405)
.+.+. + +||+|+.|.|||++.+.. +-++||+-++
T Consensus 183 ~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 183 RLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 55432 3 999999999999998885 9999999874
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.027 Score=54.75 Aligned_cols=29 Identities=21% Similarity=0.208 Sum_probs=27.0
Q ss_pred CceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 304 GVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 304 gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
+++|+|+.+.|||++.++.+.|+||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 69999999999999999999999999874
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.012 Score=56.35 Aligned_cols=30 Identities=30% Similarity=0.492 Sum_probs=24.9
Q ss_pred CceecCCCCCcEEECCCCc-EEEEecCCccc
Q 015556 304 GVIHRDLKPENVLIDQEFH-LKIADFGIACE 333 (405)
Q Consensus 304 gIiHrDIkp~NILl~~~~~-vkL~DFG~a~~ 333 (405)
.++|+|+++.|||+++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3899999999999987555 56999998743
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.033 Score=54.79 Aligned_cols=134 Identities=18% Similarity=0.235 Sum_probs=75.4
Q ss_pred eeeeeeeEEEEEEEECC-----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee-EEeeEeecCCeeEE
Q 015556 186 RFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI-KFVAACKKPPVYCV 259 (405)
Q Consensus 186 ~lG~G~~g~Vy~~~~~~-----~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~g~~~~~~~~~l 259 (405)
.|..|-...+|+....+ ..|+||+.......- -...+|..+++.+..-++- ++++++. ++ +
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~---------IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~ 87 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV---------IDRERELQAIKYLSAAGFGAKLLGVFG-NG---M 87 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE---------echHHHHHHHHHHHhcCCCCceeEEeC-Cc---E
Confidence 34447778889887553 278899875422110 1123788888888755543 4565553 32 5
Q ss_pred EEeecCCCCHHH--------------HHHHhcCCC------C-CHHHHHHHHHH----------------------HHHH
Q 015556 260 ITEYLSEGSLRA--------------YLHKLEHKT------L-PLPKLIAIALD----------------------IARG 296 (405)
Q Consensus 260 V~E~~~~gsL~~--------------~l~~~~~~~------l-~~~~~~~i~~q----------------------i~~a 296 (405)
|.+|+++..|.. .+.+..... . -+..+..++.+ +..-
T Consensus 88 i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 167 (330)
T PLN02421 88 IQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDE 167 (330)
T ss_pred eehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHH
Confidence 889987654311 111111111 1 12222222211 1222
Q ss_pred HHHHH----HCC----ceecCCCCCcEEECC-CCcEEEEecCCcc
Q 015556 297 MEYIH----SQG----VIHRDLKPENVLIDQ-EFHLKIADFGIAC 332 (405)
Q Consensus 297 L~yLH----~~g----IiHrDIkp~NILl~~-~~~vkL~DFG~a~ 332 (405)
+..+. ..+ .+|.|+.+.|||+++ ++.++++||..|.
T Consensus 168 ~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 168 IVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 22222 112 699999999999974 5789999999884
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.046 Score=55.09 Aligned_cols=77 Identities=10% Similarity=-0.028 Sum_probs=49.5
Q ss_pred cceeeeeeeEEEEEEEECCccEEEEEEecCCC---ChhHHHHHHHHHHHHHHHHHHHhcC---CCCeeEEeeEeecCCee
Q 015556 184 GLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDD---DENETLAARLEKQFNREVALLSRLH---NPNVIKFVAACKKPPVY 257 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~---~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~ 257 (405)
.+.||.|....||+....+..++||.-..... ..+.. ...+-..|...|+.+. ...+.+++.++.+. .
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl----~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~ 110 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPM----TKERAYFEATALREHGRLCPDHVPEVYHFDRTM--A 110 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccC----CccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--C
Confidence 35679999999999888777899998641111 00000 0112224566665553 35788899888844 4
Q ss_pred EEEEeecCC
Q 015556 258 CVITEYLSE 266 (405)
Q Consensus 258 ~lV~E~~~~ 266 (405)
+++|||+++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 688999976
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.028 Score=55.58 Aligned_cols=134 Identities=16% Similarity=0.235 Sum_probs=76.5
Q ss_pred eeeeeeeEEEEEEEEC------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee-EEeeEeecCCeeE
Q 015556 186 RFAHGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI-KFVAACKKPPVYC 258 (405)
Q Consensus 186 ~lG~G~~g~Vy~~~~~------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~g~~~~~~~~~ 258 (405)
.|-.|-...+|+.... ++.|++|+.......- -...+|..++..+..-++. ++++.+..+
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~---------idR~~E~~~~~~l~~~gl~P~~~~~~~~g---- 109 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF---------FDRDDEIRTFECMSRHGQGPRLLGRFPNG---- 109 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee---------echHHHHHHHHHHHHcCCCCceEEEECCc----
Confidence 4445888899988653 2578899875432111 0124788888888654443 455655433
Q ss_pred EEEeecCCCCHHHH-----------------HHHhc--CC--CCCHHHHHHHHHH-----------------HHHHHHHH
Q 015556 259 VITEYLSEGSLRAY-----------------LHKLE--HK--TLPLPKLIAIALD-----------------IARGMEYI 300 (405)
Q Consensus 259 lV~E~~~~gsL~~~-----------------l~~~~--~~--~l~~~~~~~i~~q-----------------i~~aL~yL 300 (405)
.|++|+++.+|... +|... .. ...+..+..++.+ +...+..|
T Consensus 110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L 189 (344)
T PLN02236 110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL 189 (344)
T ss_pred eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence 57999977554311 11111 00 1112222222211 11222222
Q ss_pred H--------HCCceecCCCCCcEEECC-CCcEEEEecCCcc
Q 015556 301 H--------SQGVIHRDLKPENVLIDQ-EFHLKIADFGIAC 332 (405)
Q Consensus 301 H--------~~gIiHrDIkp~NILl~~-~~~vkL~DFG~a~ 332 (405)
. ...++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 2 124899999999999976 4789999999874
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.036 Score=54.94 Aligned_cols=82 Identities=17% Similarity=0.076 Sum_probs=47.2
Q ss_pred eeeeeeeEEEEEEEECC--ccEEEEEEecCCC---ChhHHHHHHHHHHHHHHHHHHHhcC--CC-CeeEEeeEeecCCee
Q 015556 186 RFAHGAHSRLYHGIYKD--EPVAVKIIRIPDD---DENETLAARLEKQFNREVALLSRLH--NP-NVIKFVAACKKPPVY 257 (405)
Q Consensus 186 ~lG~G~~g~Vy~~~~~~--~~vAVK~~~~~~~---~~~~~~~~~~~~~~~~Ei~il~~l~--Hp-nIv~l~g~~~~~~~~ 257 (405)
.||.|--..||++...+ +.|+||.-..... ..+.. ...+..-|...|+... -| .+.++|.+ +....
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl----~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~ 75 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPL----TLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMA 75 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCC----CccHHHHHHHHHHHhhccCccccCeEEEE--ccccc
Confidence 36889999999999864 5799998531111 01000 0223346777776664 24 34455543 33444
Q ss_pred EEEEeecCCC-CHHHHH
Q 015556 258 CVITEYLSEG-SLRAYL 273 (405)
Q Consensus 258 ~lV~E~~~~g-sL~~~l 273 (405)
.+|||+++.. .|++.|
T Consensus 76 ~~vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 76 VTVMEDLSHHKIARKGL 92 (370)
T ss_pred eehHhhCccchHHHHHH
Confidence 6999999653 343443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.014 Score=57.49 Aligned_cols=161 Identities=15% Similarity=0.096 Sum_probs=91.1
Q ss_pred eecccccccccccCCCeeecceeeeeeeEEEEEEEEC--------------CccEEEEEEecCCCChhHHHHHHHHHHHH
Q 015556 165 VNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--------------DEPVAVKIIRIPDDDENETLAARLEKQFN 230 (405)
Q Consensus 165 ~~~~~~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--------------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~ 230 (405)
.++.+..+.....+.+....+.++.+.-+.+.+|.+. .+.+.+|.+...+...-.....-+.-.-.
T Consensus 192 ~n~~d~d~~nl~QI~q~~dvk~fan~~~v~~vlgl~~~ln~~~s~qlssn~~q~~i~kkvs~g~~~~~~~d~~fls~~el 271 (488)
T COG5072 192 GNAQDADVLNLVQILQWCDVKGFANLHQVVVVLGLYPSLNLEESDQLSSNNWQENICKKVSLGSTQDYTVDCLFLSLTEL 271 (488)
T ss_pred CCccccchHHHHHHHHHhhhhhhccccceeEEecccccccchhhhHHhhhcchheeecccccccchhhhhhhhhhhcccc
Confidence 3344444444455555556667777777777776543 24567775544333221110000000000
Q ss_pred HHHHH--HHhcCCCCeeEEeeEe-ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-Cce
Q 015556 231 REVAL--LSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVI 306 (405)
Q Consensus 231 ~Ei~i--l~~l~HpnIv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIi 306 (405)
.+.++ ++..-.++..+.+-+- .+....|++|++- |++|.- + ....+++++.|+.+-+..+.-+... ..-
T Consensus 272 e~l~L~qw~~~g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lekkf~fe 344 (488)
T COG5072 272 EHLELRQWRECGSVFLETLKVVSLDETLYLYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEKKFPFE 344 (488)
T ss_pred chhhhhhhhhccchhhhcceEEecCCceEEEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhhcCCcc
Confidence 11111 1112223333322222 2334566777763 555432 1 2346778888998888877777654 689
Q ss_pred ecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 307 HRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 307 HrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
|||+.-.||||+ +|+|.|+||-+++.
T Consensus 345 hrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 345 HRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred cccccccceeee-cCceEEEEeeeeec
Confidence 999999999999 99999999999864
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.045 Score=53.38 Aligned_cols=141 Identities=15% Similarity=0.186 Sum_probs=81.3
Q ss_pred eeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC--CCeeEEeeEeecCC--eeEEEE
Q 015556 186 RFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN--PNVIKFVAACKKPP--VYCVIT 261 (405)
Q Consensus 186 ~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~--~~~lV~ 261 (405)
.+-.|....+|.....++.++|. .......- .......+|..+|..+.- --+-..+++|.++. ..+.||
T Consensus 32 ~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~------~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 32 EISGGWSNDTFRLGDTGQKYVLR-KPPRGDPV------ESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred eccCCcccceEEEecCCceEEEe-cCCccccc------hhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 33445555666666668888888 21111111 113445578888888754 23445677777665 779999
Q ss_pred eecCCCC---------HH---------HHHHHhc----------C--CCCCHHHHHHHHH--------------HHHHHH
Q 015556 262 EYLSEGS---------LR---------AYLHKLE----------H--KTLPLPKLIAIAL--------------DIARGM 297 (405)
Q Consensus 262 E~~~~gs---------L~---------~~l~~~~----------~--~~l~~~~~~~i~~--------------qi~~aL 297 (405)
+|+.|.. +. ++|.... . ......++..... ....-.
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 9998821 11 2221110 0 0000011111111 122335
Q ss_pred HHHHHC--------CceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 298 EYIHSQ--------GVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 298 ~yLH~~--------gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
.||+.+ .++|+|+.+.||+++.++-+=|+||+.+..
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 566543 389999999999999998899999998843
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.12 Score=50.78 Aligned_cols=70 Identities=16% Similarity=0.095 Sum_probs=41.2
Q ss_pred eeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCC--CeeE---Eee--EeecCCeeEEE
Q 015556 189 HGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP--NVIK---FVA--ACKKPPVYCVI 260 (405)
Q Consensus 189 ~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~---l~g--~~~~~~~~~lV 260 (405)
.+....||+.... +..++||+.+..... ..++..|++++..|... .++. .-| ....++..+.|
T Consensus 35 ~s~eN~vy~v~~~~~~~~vlKv~r~~~~~---------~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l 105 (325)
T PRK11768 35 NSYENRVYQFGDEDGRRVVAKFYRPERWS---------DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFAL 105 (325)
T ss_pred ccccceEEEEecCCCCEEEEEEcCcccCC---------HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEE
Confidence 3556688988775 567999988632211 23455677777766421 1222 111 12234567889
Q ss_pred EeecCCC
Q 015556 261 TEYLSEG 267 (405)
Q Consensus 261 ~E~~~~g 267 (405)
+++++|.
T Consensus 106 ~~~~~G~ 112 (325)
T PRK11768 106 FPRRGGR 112 (325)
T ss_pred EeeeCCC
Confidence 9999775
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.0076 Score=58.09 Aligned_cols=74 Identities=19% Similarity=0.090 Sum_probs=47.8
Q ss_pred ecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC---CCCeeEEeeEeecCCeeEE
Q 015556 183 LGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---NPNVIKFVAACKKPPVYCV 259 (405)
Q Consensus 183 ~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~l 259 (405)
-.+.++-|....+|+....++.+.||+-.... ...|..|.+-|+.|. --.+.+.+++.......+|
T Consensus 21 ~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~-----------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fL 89 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLDTDGGSYFVKVNSESG-----------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFL 89 (288)
T ss_dssp EEEEE--SSSSEEEEEETTS-EEEEEEEEGGG-----------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEE
T ss_pred eeEecCCCChhheEEEECCCccEEEEecChhh-----------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceE
Confidence 34567889999999988778999999987211 245778888888884 3456688888776666799
Q ss_pred EEeecCCC
Q 015556 260 ITEYLSEG 267 (405)
Q Consensus 260 V~E~~~~g 267 (405)
||||++.+
T Consensus 90 lle~l~~~ 97 (288)
T PF03881_consen 90 LLEFLEMG 97 (288)
T ss_dssp EEE-----
T ss_pred EEEeecCC
Confidence 99999765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.12 Score=58.53 Aligned_cols=30 Identities=37% Similarity=0.584 Sum_probs=25.6
Q ss_pred CCceecCCCCCcEEECCCC--cEE-EEecCCcc
Q 015556 303 QGVIHRDLKPENVLIDQEF--HLK-IADFGIAC 332 (405)
Q Consensus 303 ~gIiHrDIkp~NILl~~~~--~vk-L~DFG~a~ 332 (405)
.++||+|+.+.|||++.++ ++. |+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4699999999999998775 565 99999873
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.1 Score=52.42 Aligned_cols=29 Identities=28% Similarity=0.166 Sum_probs=24.1
Q ss_pred CCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 303 QGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 303 ~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
...+|.|+.+.|||.++ ..++++||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 35799999999999765 469999998874
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.058 Score=54.12 Aligned_cols=77 Identities=19% Similarity=0.140 Sum_probs=47.5
Q ss_pred cceeeeeeeEEEEEEEEC--CccEEEEEEecC--CCChhHHHHHHHHHHHHHHHHHHHhcC--CC-CeeEEeeEeecCCe
Q 015556 184 GLRFAHGAHSRLYHGIYK--DEPVAVKIIRIP--DDDENETLAARLEKQFNREVALLSRLH--NP-NVIKFVAACKKPPV 256 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~--~~~~~~~~~~~~~~~~~~Ei~il~~l~--Hp-nIv~l~g~~~~~~~ 256 (405)
...||.|--..||++.+. ++.|+||.-... ...++.- -..+..-|.++|+.+. -| .+.++|.+- ...
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL----~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D--~e~ 107 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKL----STNRIRIESDVLQLEEELAPGLVPKVYLFD--SVM 107 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCC----ChHHHHHHHHHHHHHHhhCCCcCCeEEEEC--cHH
Confidence 356799999999999985 578999985321 1111110 1234456777777664 34 455565443 344
Q ss_pred eEEEEeecCC
Q 015556 257 YCVITEYLSE 266 (405)
Q Consensus 257 ~~lV~E~~~~ 266 (405)
..+|||+++.
T Consensus 108 ~~~vMEdL~~ 117 (409)
T PRK12396 108 NCCVMEDLSD 117 (409)
T ss_pred hhHHHHhCcc
Confidence 4689999965
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.059 Score=49.69 Aligned_cols=116 Identities=23% Similarity=0.215 Sum_probs=73.6
Q ss_pred eeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEeecCCCCH
Q 015556 190 GAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSL 269 (405)
Q Consensus 190 G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 269 (405)
|+-+++-.+..+=-+..+|.+..-...-. ...|..+..++.++. .|+++..- +...+.++.|+|-...
T Consensus 73 ~gNsTl~~~kt~iG~L~lKKi~slp~~~~-------~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~- 140 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGPLFLKKIRSLPCCIN-------DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK- 140 (308)
T ss_pred CCceEEEEeccccchhhhhhccCCCcccc-------hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-
Confidence 44555555544434667777764333312 234567788888764 56776632 4556789999984311
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 270 RAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS--QGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 270 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
..+ .-.|. .=+.+|.-.|+ .+.+|+|..|+||+-|..|-+||.|-+.-
T Consensus 141 ----------i~~---~N~i~-agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 141 ----------INF---SNFIT-AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred ----------cch---hHHHH-HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 111 11111 11456777784 36999999999999999999999999864
|
The function of this family is unknown. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.072 Score=50.83 Aligned_cols=43 Identities=26% Similarity=0.371 Sum_probs=32.1
Q ss_pred HHHHHHHHHHHHHC--CceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 290 ALDIARGMEYIHSQ--GVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 290 ~~qi~~aL~yLH~~--gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
+..+-..+.-++.. -++|+|+.|+|+|+++.+.++|+||..|.
T Consensus 138 ~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 138 LKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence 33333334333333 48999999999999999999999998874
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.086 Score=48.04 Aligned_cols=29 Identities=38% Similarity=0.603 Sum_probs=20.8
Q ss_pred CceecCCCCCcEEE-CCCCcEEEEecCCcc
Q 015556 304 GVIHRDLKPENVLI-DQEFHLKIADFGIAC 332 (405)
Q Consensus 304 gIiHrDIkp~NILl-~~~~~vkL~DFG~a~ 332 (405)
-++|.|+.+.|||+ +.++.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 47999999999999 888999999999874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.18 Score=51.59 Aligned_cols=71 Identities=14% Similarity=0.129 Sum_probs=43.5
Q ss_pred cceeeeeeeEEEEEEEEC----------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee-EEeeEee
Q 015556 184 GLRFAHGAHSRLYHGIYK----------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI-KFVAACK 252 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~----------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~g~~~ 252 (405)
...|..|-.-.+|+.... ++.|.|++.-.....- . ....|..++..+...+|- ++++.+.
T Consensus 110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l--------I-dR~~E~~v~~~ls~~gi~P~l~~~f~ 180 (442)
T PTZ00296 110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL--------Y-NPISEFEVYKTMSKYRIAPQLLNTFS 180 (442)
T ss_pred EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce--------e-CHHHHHHHHHHHHHCCCCCceEEEeC
Confidence 345666777888888754 3578888875322110 0 123688888887654443 4555553
Q ss_pred cCCeeEEEEeecCCC
Q 015556 253 KPPVYCVITEYLSEG 267 (405)
Q Consensus 253 ~~~~~~lV~E~~~~g 267 (405)
+ +.|.||++|-
T Consensus 181 -g---g~I~efi~g~ 191 (442)
T PTZ00296 181 -G---GRIEEWLYGD 191 (442)
T ss_pred -C---CEEEEeeCCc
Confidence 2 3679999875
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.71 E-value=0.18 Score=46.76 Aligned_cols=73 Identities=22% Similarity=0.214 Sum_probs=53.7
Q ss_pred eeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC---CCCeeEEeeEeecCCeeEEEEe
Q 015556 186 RFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---NPNVIKFVAACKKPPVYCVITE 262 (405)
Q Consensus 186 ~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV~E 262 (405)
.+--|.--.-|+..+..+++.||+-. ......|..|+.-|..|. .-.|.+.+.+.......|+|||
T Consensus 23 ~v~gG~inea~~v~dg~~~~FvK~n~-----------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle 91 (286)
T COG3001 23 EVSGGDINEAWRLRDGTDPFFVKCNQ-----------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLE 91 (286)
T ss_pred ccCCccccceeEeecCCcceEEEecc-----------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEe
Confidence 34556666777777777999999854 222567788887777764 3557788888888899999999
Q ss_pred ecCCCCH
Q 015556 263 YLSEGSL 269 (405)
Q Consensus 263 ~~~~gsL 269 (405)
|++.+.+
T Consensus 92 ~L~~~~~ 98 (286)
T COG3001 92 YLPTGPL 98 (286)
T ss_pred eccCCCC
Confidence 9987543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 405 | ||||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-34 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-34 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-30 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-30 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-30 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-30 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-30 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-29 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-29 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-29 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-29 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-29 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-28 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-28 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-28 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-27 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-27 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-26 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-26 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-26 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-25 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-25 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-25 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-25 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-25 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-25 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-25 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-25 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-24 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-24 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-24 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-24 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-24 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-24 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-24 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-24 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-24 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-24 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-24 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-24 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-24 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-24 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-24 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-24 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-24 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-24 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-24 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-24 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-24 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-24 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-24 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-24 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-24 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-24 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-24 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-24 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-23 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-23 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-23 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-23 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-23 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-23 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-23 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-23 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-23 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-23 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-23 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-23 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-23 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-23 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-23 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-23 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-23 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-23 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-23 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-23 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-23 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-23 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-23 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-23 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-23 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-23 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-23 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-23 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-23 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-23 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-23 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-23 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-23 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-23 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-23 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-23 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-22 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-22 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-22 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-22 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-22 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-22 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-22 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-22 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-22 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-22 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-22 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-22 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-22 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-22 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-22 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-22 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-22 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-22 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-22 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-22 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-22 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-22 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-22 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-22 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-22 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-22 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-22 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-22 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-22 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-22 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-22 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-22 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-22 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-22 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-22 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-22 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-22 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-21 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-21 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-21 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-21 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-21 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-21 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-21 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-21 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-21 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-21 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-21 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-21 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-21 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-21 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-21 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-21 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-21 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-21 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-21 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-21 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-21 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-21 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-21 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-20 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-20 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-20 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-20 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-20 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-20 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-20 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-20 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-20 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-20 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-20 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-20 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-20 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-20 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-20 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-20 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-20 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-20 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-20 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-20 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-20 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-20 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-20 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-19 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-19 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-19 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-19 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-19 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-19 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-19 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-19 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-19 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-19 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-19 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-19 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-19 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-19 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-19 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-19 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-19 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-19 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-19 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-19 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-19 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-19 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-19 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-19 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-19 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-19 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-19 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-19 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-19 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-19 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-19 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-19 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-19 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-19 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-19 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-19 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-19 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-19 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-19 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-19 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-19 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-19 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-18 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-18 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-18 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-18 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-18 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-18 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-18 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-18 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-18 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-18 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-18 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-18 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-18 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-18 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-18 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-18 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-18 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-18 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-18 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-18 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-18 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-18 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-18 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-18 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-18 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-18 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-18 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-18 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-18 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-18 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-18 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-18 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-18 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-18 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-18 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-18 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-18 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-18 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-18 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-18 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-18 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-18 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-18 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-18 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-18 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-18 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-18 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-18 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-18 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-18 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-18 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-18 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-18 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-18 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-18 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-18 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-18 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-18 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-18 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-18 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-18 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-18 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-18 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-18 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-18 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-18 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-18 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-18 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-18 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-18 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-18 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-18 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-18 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-18 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-18 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-18 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-18 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-18 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-18 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-18 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-18 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-18 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-18 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-18 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-18 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-18 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-18 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-18 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-18 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-17 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-17 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-17 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-17 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-17 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-17 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-17 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-17 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-17 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-17 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-17 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-17 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-17 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-17 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-17 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-17 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-17 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-17 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-17 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-17 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-17 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-17 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-17 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-17 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-17 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-17 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-17 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-17 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-17 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-17 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-17 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-17 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-17 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-17 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-17 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-17 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-17 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-17 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-17 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-17 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-17 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-17 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-17 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-17 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-17 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-17 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-17 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-17 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-17 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-17 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-17 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-17 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-17 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-17 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-16 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-16 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-16 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-16 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-16 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-16 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-16 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-16 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-16 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-16 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-16 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-16 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-16 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-16 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-16 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-16 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-16 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-16 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-15 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-15 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-15 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-15 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-15 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-15 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-15 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-15 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-15 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-15 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-15 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-15 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-15 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-15 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-15 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-15 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-15 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-15 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-15 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-15 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-15 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-15 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-15 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-15 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-15 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-15 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-14 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-14 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-14 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-14 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-14 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-14 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-14 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-14 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-14 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-14 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-14 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-14 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-14 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-14 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-14 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-14 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-13 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-13 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-13 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-13 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-13 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-13 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-13 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-13 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-13 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-13 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-13 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-13 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-13 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-13 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-13 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-13 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-13 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-13 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-13 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-13 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-13 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-13 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-13 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-13 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-13 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-13 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-13 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-13 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-13 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-13 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-13 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-13 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-12 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-12 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-12 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-12 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-12 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-12 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-12 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 7e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-11 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-11 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-11 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-10 |
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = e-108
Identities = 78/232 (33%), Positives = 128/232 (55%), Gaps = 10/232 (4%)
Query: 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFN 230
D+ + L + + G+ ++ + VAVKI+ D +F
Sbjct: 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAE------RVNEFL 82
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE-HKTLPLPKLIAI 289
REVA++ RL +PN++ F+ A +PP ++TEYLS GSL LHK + L + +++
Sbjct: 83 REVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM 142
Query: 290 ALDIARGMEYIHSQG--VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-GT 346
A D+A+GM Y+H++ ++HR+LK N+L+D+++ +K+ DFG++ + S GT
Sbjct: 143 AYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGT 202
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
WMAPE+++ + K DVYSFG+ILWE+ P+ +NP Q AV K
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 254
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 313 bits (805), Expect = e-106
Identities = 74/234 (31%), Positives = 119/234 (50%), Gaps = 19/234 (8%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
+D ++L L G ++Y + + VAVK R D++ ++ + +E L
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDED----ISQTIENVRQEAKL 59
Query: 236 LSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR 295
+ L +PN+I C K P C++ E+ G L L K +P L+ A+ IAR
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIAR 116
Query: 296 GMEYIHSQG---VIHRDLKPENVLIDQEFH--------LKIADFGIACEEVYCDALSDDP 344
GM Y+H + +IHRDLK N+LI Q+ LKI DFG+A E +S
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-A 175
Query: 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
G Y WMAPE+I+ + + DV+S+G++LWE++ G +P+ ++ + A+ V
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN 229
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 309 bits (795), Expect = e-104
Identities = 73/236 (30%), Positives = 125/236 (52%), Gaps = 15/236 (6%)
Query: 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQ 228
DAAD+ + Q+ +G R G+ +Y G + + VAVK++ + + +
Sbjct: 14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTP------QQLQA 66
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
F EV +L + + N++ F+ P ++T++ SL +LH E K + KLI
Sbjct: 67 FKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETK-FEMKKLID 124
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC---DALSDDPG 345
IA ARGM+Y+H++ +IHRDLK N+ + ++ +KI DFG+A E+ G
Sbjct: 125 IARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184
Query: 346 TYRWMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
+ WMAPE+I+ + Y + DVY+FG++L+E++ G +PY +N +V +
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 240
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 304 bits (781), Expect = e-103
Identities = 55/230 (23%), Positives = 107/230 (46%), Gaps = 17/230 (7%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
+D QL + L+ G ++ + VK++++ D R + FN E
Sbjct: 7 IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWST------RKSRDFNEECPR 60
Query: 236 LSRLHNPNVIKFVAACKKPPV--YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDI 293
L +PNV+ + AC+ PP +IT ++ GSL LH+ + + + + ALD+
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 294 ARGMEYIHSQG--VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
ARGM ++H+ + L +V+ID++ +I+ + + W+A
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM----YAPAWVA 176
Query: 352 PEMIKHKSYG---RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
PE ++ K R D++SF ++LWE+V +P+ +++ ++ V +
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE 226
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 298 bits (764), Expect = 2e-99
Identities = 65/241 (26%), Positives = 110/241 (45%), Gaps = 24/241 (9%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
E + QL +G G ++YHG + E VA+++I I D+E++ K F R
Sbjct: 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE-VAIRLIDIERDNEDQ------LKAFKR 78
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
EV + + NV+ F+ AC PP +IT +L + + + L + K IA
Sbjct: 79 EVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQ 137
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC------DALSDDPG 345
+I +GM Y+H++G++H+DLK +NV D + I DFG+ D L G
Sbjct: 138 EIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 346 TYRWMAPEMIKH---------KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396
+APE+I+ + + DV++ G I +E+ A P++ + +
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256
Query: 397 N 397
Sbjct: 257 T 257
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 296 bits (761), Expect = 2e-99
Identities = 63/251 (25%), Positives = 123/251 (49%), Gaps = 19/251 (7%)
Query: 161 GGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDEN 218
G + + + T+ +++ + G ++ G VA+K + + D +
Sbjct: 1 GAMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE 60
Query: 219 ETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH 278
+ + + +F REV ++S L++PN++K PP ++ E++ G L L +
Sbjct: 61 TEMIEKFQ-EFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD-KA 116
Query: 279 KTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLIDQ-----EFHLKIADFGIA 331
+ + + LDIA G+EY+ +Q ++HRDL+ N+ + K+ADFG++
Sbjct: 117 HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176
Query: 332 CEEVYCDALSDDPGTYRWMAPEMI--KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI 389
+ V+ +S G ++WMAPE I + +SY K D YSF +IL+ ++ G P++E +
Sbjct: 177 QQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234
Query: 390 QAAF--AVVNK 398
+ F + +
Sbjct: 235 KIKFINMIREE 245
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 3e-97
Identities = 67/244 (27%), Positives = 109/244 (44%), Gaps = 22/244 (9%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
S L G G + +++ + + + DE ++ F +
Sbjct: 3 PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET------QRTFLK 56
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
EV ++ L +PNV+KF+ K ITEY+ G+LR + ++ + P + ++ A
Sbjct: 57 EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAK 115
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP------- 344
DIA GM Y+HS +IHRDL N L+ + ++ +ADFG+A V +
Sbjct: 116 DIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 345 --------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVV 396
G WMAPEMI +SY KVDV+SFG++L E++ + P F +
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN 235
Query: 397 NKVN 400
+
Sbjct: 236 VRGF 239
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 3e-97
Identities = 71/232 (30%), Positives = 117/232 (50%), Gaps = 20/232 (8%)
Query: 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNRE 232
H +D ++ + GA + ++ + VA+K I + K F E
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESE----------RKAFIVE 51
Query: 233 VALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIAL 291
+ LSR+++PN++K AC P C++ EY GSL LH E ++ L
Sbjct: 52 LRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 109
Query: 292 DIARGMEYIHS---QGVIHRDLKPENVLIDQEF-HLKIADFGIACEEVYCDALSDDPGTY 347
++G+ Y+HS + +IHRDLKP N+L+ LKI DFG AC+ ++++ G+
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--QTHMTNNKGSA 167
Query: 348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN-PIQAAFAVVNK 398
WMAPE+ + +Y K DV+S+G+ILWE++ P++E+ P V+
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN 219
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 2e-83
Identities = 67/255 (26%), Positives = 107/255 (41%), Gaps = 49/255 (19%)
Query: 180 QLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNRE--VALLS 237
+ L G + ++ G ++ E VAVKI D EK + RE +
Sbjct: 9 DITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----------EKSWFRETELYNTV 57
Query: 238 RLHNPNVIKFVAACKK----PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDI 293
L + N++ F+A+ +IT Y GSL YL TL + I L I
Sbjct: 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSI 114
Query: 294 ARGMEYIHSQ--------GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP- 344
A G+ ++H + + HRDLK +N+L+ + IAD G+A D
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 345 ----GTYRWMAPEMIKHK------SYGRKVDVYSFGLILWEMVAGT----------IPYE 384
GT R+MAPE++ ++VD+++FGL+LWE+ P+
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234
Query: 385 EMNPIQAAFAVVNKV 399
++ P +F + KV
Sbjct: 235 DVVPNDPSFEDMRKV 249
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 4e-82
Identities = 61/260 (23%), Positives = 109/260 (41%), Gaps = 45/260 (17%)
Query: 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNRE 232
Q+ + + G + ++ G ++ E VAVK+ ++ E
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEAS---------WFRETE 81
Query: 233 VALLSRLHNPNVIKFVAACKKPPV----YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
+ + + N++ F+AA K +IT+Y GSL YL TL ++
Sbjct: 82 IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLK 138
Query: 289 IALDIARGMEYIHSQ--------GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL 340
+A G+ ++H++ + HRDLK +N+L+ + IAD G+A + +
Sbjct: 139 LAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE 198
Query: 341 SDDP-----GTYRWMAPEMI------KHKSYGRKVDVYSFGLILWEMVAGT--------- 380
D P GT R+M PE++ H D+YSFGLILWE+
Sbjct: 199 VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258
Query: 381 -IPYEEMNPIQAAFAVVNKV 399
+PY ++ P ++ + ++
Sbjct: 259 QLPYHDLVPSDPSYEDMREI 278
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 1e-79
Identities = 62/266 (23%), Positives = 108/266 (40%), Gaps = 54/266 (20%)
Query: 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDE--NETLAARLEKQFN 230
+ L G ++ G ++ E VAVKI ++ E
Sbjct: 36 VQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE----------- 84
Query: 231 REVALLSRLHNPNVIKFVAACKK----PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
E+ L + N++ F+AA K ++++Y GSL YL++ T+ + +
Sbjct: 85 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGM 141
Query: 287 IAIALDIARGMEYIHSQ--------GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338
I +AL A G+ ++H + + HRDLK +N+L+ + IAD G+A
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 201
Query: 339 ALSDDP-----GTYRWMAPEMI------KHKSYGRKVDVYSFGLILWEMVAGT------- 380
D GT R+MAPE++ KH ++ D+Y+ GL+ WE+
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261
Query: 381 ---IPYEEMNPIQAAF-----AVVNK 398
+PY ++ P + V +
Sbjct: 262 DYQLPYYDLVPSDPSVEEMRKVVCEQ 287
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 3e-72
Identities = 65/260 (25%), Positives = 108/260 (41%), Gaps = 49/260 (18%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQF 229
AA E ++DL L L G + +Y G + PVAVK+ + + F
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----------RQNF 52
Query: 230 NRE--VALLSRLHNPNVIKFVAACKKPPV-----YCVITEYLSEGSLRAYLHKLEHKTLP 282
E + + + + N+ +F+ ++ Y ++ EY GSL YL T
Sbjct: 53 INEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSD 109
Query: 283 LPKLIAIALDIARGMEYIHSQ---------GVIHRDLKPENVLIDQEFHLKIADFGIACE 333
+A + RG+ Y+H++ + HRDL NVL+ + I+DFG++
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 334 EVYCDALSDDP---------GTYRWMAPEMIK-------HKSYGRKVDVYSFGLILWEMV 377
+ GT R+MAPE+++ +S ++VD+Y+ GLI WE+
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 378 AGT---IPYEEMNPIQAAFA 394
P E + Q AF
Sbjct: 230 MRCTDLFPGESVPEYQMAFQ 249
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 1e-66
Identities = 62/241 (25%), Positives = 101/241 (41%), Gaps = 38/241 (15%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
+ L L A G ++ +E VAVKI I D Q
Sbjct: 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQS---------WQNEY 67
Query: 232 EVALLSRLHNPNVIKFVAACKKPP----VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLI 287
EV L + + N+++F+ A K+ +IT + +GSL +L + +L
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELC 124
Query: 288 AIALDIARGMEYIHSQ----------GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337
IA +ARG+ Y+H + HRD+K +NVL+ IADFG+A +
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL--KFE 182
Query: 338 DALSDDP-----GTYRWMAPEMIKH-----KSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
S GT R+MAPE+++ + ++D+Y+ GL+LWE+ + +
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 388 P 388
Sbjct: 243 D 243
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 7e-54
Identities = 66/230 (28%), Positives = 115/230 (50%), Gaps = 20/230 (8%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
+++ +L L G + G Y+ VAVK I+ + T + F E ++
Sbjct: 18 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK-----NDAT-----AQAFLAEASV 67
Query: 236 LSRLHNPNVIKFVAAC--KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDI 293
+++L + N+++ + +K +Y ++TEY+++GSL YL L L+ +LD+
Sbjct: 68 MTQLRHSNLVQLLGVIVEEKGGLY-IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126
Query: 294 ARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPE 353
MEY+ +HRDL NVL+ ++ K++DFG+ E P +W APE
Sbjct: 127 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--VKWTAPE 184
Query: 354 MIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVNFG 402
++ K + K DV+SFG++LWE+ + G +PY + VV +V G
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVEKG 230
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-53
Identities = 68/247 (27%), Positives = 117/247 (47%), Gaps = 20/247 (8%)
Query: 159 DHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDEN 218
G V +++ +L L G + G Y+ VAVK I+ +
Sbjct: 173 MEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK-----ND 227
Query: 219 ETLAARLEKQFNREVALLSRLHNPNVIKFVAAC--KKPPVYCVITEYLSEGSLRAYLHKL 276
T + F E +++++L + N+++ + +K +Y ++TEY+++GSL YL
Sbjct: 228 AT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY-IVTEYMAKGSLVDYLRSR 281
Query: 277 EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336
L L+ +LD+ MEY+ +HRDL NVL+ ++ K++DFG+ E
Sbjct: 282 GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341
Query: 337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV 395
P +W APE ++ K + K DV+SFG++LWE+ + G +PY + V
Sbjct: 342 TQDTGKLP--VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----V 395
Query: 396 VNKVNFG 402
V +V G
Sbjct: 396 VPRVEKG 402
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-52
Identities = 73/236 (30%), Positives = 112/236 (47%), Gaps = 20/236 (8%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQFN 230
DE V L L R G ++ G Y VAVK ++ + F
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---------FL 56
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
E L+ +L + +++ A + P+Y +ITEY+ GSL +L L + KL+ +A
Sbjct: 57 AEANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---Y 347
IA GM +I + IHRDL+ N+L+ KIADFG+A + + + G
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEYTAREGAKFPI 174
Query: 348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVNFG 402
+W APE I + ++ K DV+SFG++L E+V G IPY M + V+ + G
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----VIQNLERG 226
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-52
Identities = 59/223 (26%), Positives = 105/223 (47%), Gaps = 35/223 (15%)
Query: 196 YHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249
Y G++ E PVA+K +R K+ E +++ + NP+V + +
Sbjct: 32 YKGLWIPEGEKVKIPVAIKELR-EATSPKA------NKEILDEAYVMASVDNPHVCRLLG 84
Query: 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
C V +IT+ + G L Y+ + + + L+ + IA+GM Y+ + ++HRD
Sbjct: 85 ICLTSTVQ-LITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRRLVHRD 142
Query: 310 LKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---------RWMAPEMIKHKSY 360
L NVL+ H+KI DFG+A L + Y +WMA E I H+ Y
Sbjct: 143 LAARNVLVKTPQHVKITDFGLA------KLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 361 GRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVNFG 402
+ DV+S+G+ +WE++ G+ PY+ + + + + + G
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKG 235
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 171 bits (437), Expect = 4e-51
Identities = 55/245 (22%), Positives = 109/245 (44%), Gaps = 29/245 (11%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-----PVAVKIIRIPDDDENETLAAR 224
++ + + L G +Y G+Y + VAVK + +
Sbjct: 3 GGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-------KDCTLD 55
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
+++F E ++ L +P+++K + ++ P + +I E G L YL + ++ L +
Sbjct: 56 NKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNS-LKVL 113
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALS 341
L+ +L I + M Y+ S +HRD+ N+L+ +K+ DFG++ +E Y A
Sbjct: 114 TLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS- 172
Query: 342 DDPGT---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
T +WM+PE I + + DV+ F + +WE+++ G P+ + V+
Sbjct: 173 ---VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VIG 225
Query: 398 KVNFG 402
+ G
Sbjct: 226 VLEKG 230
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 8e-51
Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 19/218 (8%)
Query: 190 GAHSRLYHGIYKDE--PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
G+ +Y G+ + VA ++ ++E ++F E +L L +PN+++F
Sbjct: 37 GSFKTVYKGLDTETTVEVAWCELQDRKLTKSE------RQRFKEEAEMLKGLQHPNIVRF 90
Query: 248 ----VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
+ K ++TE ++ G+L+ YL + K + + L + I +G++++H++
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 304 G--VIHRDLKPENVLIDQEF-HLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY 360
+IHRDLK +N+ I +KI D G+A + A + GT +MAPEM + K Y
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMYEEK-Y 206
Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
VDVY+FG+ + EM PY E + V
Sbjct: 207 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 244
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 8e-51
Identities = 71/239 (29%), Positives = 117/239 (48%), Gaps = 22/239 (9%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKIIRIPDDDENETLAARLEKQF 229
D+ ++ L LG + G ++ G + + VAVK R ETL L+ +F
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-------ETLPPDLKAKF 159
Query: 230 NREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
+E +L + +PN+++ + C +K P+Y ++ E + G +L E L + L+
Sbjct: 160 LQEARILKQYSHPNIVRLIGVCTQKQPIY-IVMELVQGGDFLTFLRT-EGARLRVKTLLQ 217
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT-- 346
+ D A GMEY+ S+ IHRDL N L+ ++ LKI+DFG++ E + G
Sbjct: 218 MVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS-REEADGVYAASGGLRQ 276
Query: 347 --YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVNFG 402
+W APE + + Y + DV+SFG++LWE + G PY ++ Q V G
Sbjct: 277 VPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ----TREFVEKG 331
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-50
Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 20/212 (9%)
Query: 196 YHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254
+ Y VAVK ++ F E ++ L + ++K A K
Sbjct: 205 WMATYNKHTKVAVKTMKPGSMSVEA---------FLAEANVMKTLQHDKLVKLHAVVTKE 255
Query: 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314
P+Y +ITE++++GSL +L E PLPKLI + IA GM +I + IHRDL+ N
Sbjct: 256 PIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAAN 314
Query: 315 VLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFGL 371
+L+ KIADFG+A + + + G +W APE I S+ K DV+SFG+
Sbjct: 315 ILVSASLVCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGI 373
Query: 372 ILWEMVA-GTIPYEEMNPIQAAFAVVNKVNFG 402
+L E+V G IPY M+ + V+ + G
Sbjct: 374 LLMEIVTYGRIPYPGMSNPE----VIRALERG 401
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-50
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 30/207 (14%)
Query: 196 YHGIYKDE----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251
G Y+ + VAVKI++ NE L+ + E ++ +L NP +++ + C
Sbjct: 34 KKGYYQMKKVVKTVAVKILK------NEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 87
Query: 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLK 311
+ ++ E G L YL + ++ + +I + ++ GM+Y+ +HRDL
Sbjct: 88 EAESWM-LVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA 144
Query: 312 PENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYG 361
NVL+ + + KI+DFG++ AL D Y +W APE I + +
Sbjct: 145 ARNVLLVTQHYAKISDFGLS------KALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 362 RKVDVYSFGLILWEMVA-GTIPYEEMN 387
K DV+SFG+++WE + G PY M
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPYRGMK 225
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 3e-50
Identities = 64/247 (25%), Positives = 102/247 (41%), Gaps = 33/247 (13%)
Query: 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-----PVAVKIIRIPDDDENETLAA 223
+ + L L + G+ + G + VAVK ++ +
Sbjct: 8 LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK-----PDVLSQP 62
Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
F REV + L + N+I+ PP+ ++TE GSL L K + L
Sbjct: 63 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLL 120
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD 343
L A+ +A GM Y+ S+ IHRDL N+L+ +KI DFG+ AL +
Sbjct: 121 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM------RALPQN 174
Query: 344 PGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAA 392
Y W APE +K +++ D + FG+ LWEM G P+ +N Q
Sbjct: 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-- 232
Query: 393 FAVVNKV 399
+++K+
Sbjct: 233 --ILHKI 237
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 7e-50
Identities = 67/237 (28%), Positives = 115/237 (48%), Gaps = 18/237 (7%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQ 228
A D + L L ++ G ++ G + VA+K ++
Sbjct: 175 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--------- 225
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
F +E ++ +L + +++ A + P+Y ++TEY+S+GSL +L K L LP+L+
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVD 284
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
+A IA GM Y+ +HRDL+ N+L+ + K+ADFG+A E+ A
Sbjct: 285 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVNFG 402
+W APE + + K DV+SFG++L E+ G +PY M + V+++V G
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVERG 397
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-49
Identities = 56/243 (23%), Positives = 112/243 (46%), Gaps = 25/243 (10%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-----PVAVKIIRIPDDDENETLAAR 224
+ ++ + ++ LG G ++ GIY VA+K + +
Sbjct: 6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-------NCTSDS 58
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP 284
+ ++F +E + + +P+++K + + PV+ +I E + G LR++L ++ L L
Sbjct: 59 VREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYS-LDLA 116
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG----IACEEVYCDAL 340
LI A ++ + Y+ S+ +HRD+ NVL+ +K+ DFG + Y +
Sbjct: 117 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 176
Query: 341 SDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399
P +WMAPE I + + DV+ FG+ +WE++ G P++ + V+ ++
Sbjct: 177 GKLP--IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRI 230
Query: 400 NFG 402
G
Sbjct: 231 ENG 233
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-49
Identities = 53/223 (23%), Positives = 100/223 (44%), Gaps = 35/223 (15%)
Query: 196 YHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249
+ G++ E PV +K+I + + + + + L + ++++ +
Sbjct: 30 HKGVWIPEGESIKIPVCIKVIE-------DKSGRQSFQAVTDHMLAIGSLDHAHIVRLLG 82
Query: 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
C + ++T+YL GSL ++ + L L+ + IA+GM Y+ G++HR+
Sbjct: 83 LCPGSSLQ-LVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYLEEHGMVHRN 140
Query: 310 LKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---------RWMAPEMIKHKSY 360
L NVL+ +++ADFG+A D L D +WMA E I Y
Sbjct: 141 LAARNVLLKSPSQVQVADFGVA------DLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 361 GRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVNFG 402
+ DV+S+G+ +WE++ G PY + + V + + G
Sbjct: 195 THQSDVWSYGVTVWELMTFGAEPYAGLRLAE----VPDLLEKG 233
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-49
Identities = 59/223 (26%), Positives = 105/223 (47%), Gaps = 35/223 (15%)
Query: 196 YHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249
Y G++ E PVA+K +R K+ E +++ + NP+V + +
Sbjct: 32 YKGLWIPEGEKVKIPVAIKELR-EATSPKA------NKEILDEAYVMASVDNPHVCRLLG 84
Query: 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
C V +IT+ + G L Y+ + + + L+ + IA+GM Y+ + ++HRD
Sbjct: 85 ICLTSTVQ-LITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRRLVHRD 142
Query: 310 LKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY---------RWMAPEMIKHKSY 360
L NVL+ H+KI DFG+A L + Y +WMA E I H+ Y
Sbjct: 143 LAARNVLVKTPQHVKITDFGLA------KLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 361 GRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVNFG 402
+ DV+S+G+ +WE++ G+ PY+ + + + + + G
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKG 235
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-49
Identities = 62/234 (26%), Positives = 119/234 (50%), Gaps = 22/234 (9%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDE--PVAVKIIRIPDDDENETLAARLEKQFNREV 233
++ + + + + G + +Y G++K VAVK ++ + E F +E
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---------FLKEA 60
Query: 234 ALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALD 292
A++ + +PN+++ + C ++PP Y +ITE+++ G+L YL + + + L+ +A
Sbjct: 61 AVMKEIKHPNLVQLLGVCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YRW 349
I+ MEY+ + IHRDL N L+ + +K+ADFG++ + D + G +W
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKW 178
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVNFG 402
APE + + + K DV++FG++LWE+ G PY ++ Q V +
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELLEKD 228
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 8e-49
Identities = 65/233 (27%), Positives = 112/233 (48%), Gaps = 22/233 (9%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQFNREVA 234
+D S+L G ++ G + ++ VA+K IR E + F E
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED---------FIEEAE 55
Query: 235 LLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDI 293
++ +L +P +++ C ++ P+ ++TE++ G L YL L+ + LD+
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQAPIC-LVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDV 113
Query: 294 ARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YRWM 350
GM Y+ VIHRDL N L+ + +K++DFG+ V D + GT +W
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWA 172
Query: 351 APEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVNFG 402
+PE+ Y K DV+SFG+++WE+ + G IPYE + + VV ++ G
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----VVEDISTG 221
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-48
Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 26/220 (11%)
Query: 196 YHGIYKDE-----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250
YHG Y D+ A+K + + + + F RE L+ L++PNV+ +
Sbjct: 38 YHGEYIDQAQNRIQCAIKSL-------SRITEMQQVEAFLREGLLMRGLNHPNVLALIGI 90
Query: 251 C--KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHR 308
+ + V+ Y+ G L ++ + + LI+ L +ARGMEY+ Q +HR
Sbjct: 91 MLPPEGLPH-VLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQKFVHR 148
Query: 309 DLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGTY--RWMAPEMIKHKSYGRK 363
DL N ++D+ F +K+ADFG+A + Y +W A E ++ + K
Sbjct: 149 DLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTK 208
Query: 364 VDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVNFG 402
DV+SFG++LWE++ G PY ++P + + + G
Sbjct: 209 SDVWSFGVLLWELLTRGAPPYRHIDPFD----LTHFLAQG 244
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-48
Identities = 70/213 (32%), Positives = 113/213 (53%), Gaps = 22/213 (10%)
Query: 196 YHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KK 253
G +K + VAVK+I+ E+E F +E + +L +P ++KF C K+
Sbjct: 25 KLGKWKGQYDVAVKMIKEGSMSEDE---------FFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPE 313
P+Y ++TEY+S G L YL K L +L+ + D+ GM ++ S IHRDL
Sbjct: 76 YPIY-IVTEYISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAAR 133
Query: 314 NVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFG 370
N L+D++ +K++DFG+ V D GT +W APE+ + Y K DV++FG
Sbjct: 134 NCLVDRDLCVKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFG 192
Query: 371 LILWEMVA-GTIPYEEMNPIQAAFAVVNKVNFG 402
+++WE+ + G +PY+ + VV KV+ G
Sbjct: 193 ILMWEVFSLGKMPYDLYTNSE----VVLKVSQG 221
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-48
Identities = 63/253 (24%), Positives = 101/253 (39%), Gaps = 51/253 (20%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAA 223
+D + L + G + Y E VAVK ++ ++
Sbjct: 1 GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR---- 56
Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACKKP---PVYCVITEYLSEGSLRAYLHKLEHKT 280
F RE+ +L L + N++K+ C + +I EYL GSLR YL K + +
Sbjct: 57 ----DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKER- 110
Query: 281 LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDAL 340
+ KL+ I +GMEY+ ++ IHRDL N+L++ E +KI DFG+ L
Sbjct: 111 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT------KVL 164
Query: 341 SDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMV------------- 377
D + W APE + + DV+SFG++L+E+
Sbjct: 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 224
Query: 378 ---AGTIPYEEMN 387
G +M
Sbjct: 225 MRMIGNDKQGQMI 237
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-48
Identities = 56/213 (26%), Positives = 111/213 (52%), Gaps = 22/213 (10%)
Query: 196 YHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KK 253
+G ++ + VA+K+I+ E+E F E ++ L + +++ C K+
Sbjct: 41 KYGKWRGQYDVAIKMIKEGSMSEDE---------FIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPE 313
P++ +ITEY++ G L YL ++ H+ +L+ + D+ MEY+ S+ +HRDL
Sbjct: 92 RPIF-IITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAAR 149
Query: 314 NVLIDQEFHLKIADFGIACEEVYCDALSDDPGT---YRWMAPEMIKHKSYGRKVDVYSFG 370
N L++ + +K++DFG++ V D + G+ RW PE++ + + K D+++FG
Sbjct: 150 NCLVNDQGVVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFG 208
Query: 371 LILWEMVA-GTIPYEEMNPIQAAFAVVNKVNFG 402
+++WE+ + G +PYE + + G
Sbjct: 209 VLMWEIYSLGKMPYERFTNSE----TAEHIAQG 237
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-48
Identities = 50/207 (24%), Positives = 102/207 (49%), Gaps = 30/207 (14%)
Query: 196 YHGIYKDE----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251
G+Y+ VA+K+++ ++ + ++ RE ++ +L NP +++ + C
Sbjct: 27 RQGVYRMRKKQIDVAIKVLK-QGTEKAD------TEEMMREAQIMHQLDNPYIVRLIGVC 79
Query: 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLK 311
+ + ++ E G L +L + + +P+ + + ++ GM+Y+ + +HRDL
Sbjct: 80 QAEALM-LVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA 137
Query: 312 PENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYG 361
NVL+ + KI+DFG++ AL D Y +W APE I + +
Sbjct: 138 ARNVLLVNRHYAKISDFGLS------KALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 362 RKVDVYSFGLILWEMVA-GTIPYEEMN 387
+ DV+S+G+ +WE ++ G PY++M
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPYKKMK 218
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 3e-48
Identities = 67/238 (28%), Positives = 115/238 (48%), Gaps = 20/238 (8%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-PVAVKIIRIPDDDENETLAARLEKQ 228
A D + L L ++ G ++ G + VA+K ++
Sbjct: 258 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--------- 308
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
F +E ++ +L + +++ A + P+Y ++TEY+S+GSL +L K L LP+L+
Sbjct: 309 FLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVD 367
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPG 345
+A IA GM Y+ +HRDL+ N+L+ + K+ADFG+A + Y A
Sbjct: 368 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKF 426
Query: 346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVNFG 402
+W APE + + K DV+SFG++L E+ G +PY M + V+++V G
Sbjct: 427 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVERG 480
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 3e-48
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 32/209 (15%)
Query: 196 YHGIYKDE-----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250
+G + PVA+K ++ E + + F E +++ + +PN+I+
Sbjct: 66 CYGRLRVPGQRDVPVAIKALK-AGYTERQ------RRDFLSEASIMGQFDHPNIIRLEGV 118
Query: 251 C-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
+ ++TEY+ GSL +L + + + +L+ + + GM Y+ G +HRD
Sbjct: 119 VTRGRLAM-IVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYLSDLGYVHRD 176
Query: 310 LKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY----------RWMAPEMIKHKS 359
L NVL+D K++DFG++ L DDP RW APE I ++
Sbjct: 177 LAARNVLVDSNLVCKVSDFGLSRV------LEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 360 YGRKVDVYSFGLILWEMVA-GTIPYEEMN 387
+ DV+SFG+++WE++A G PY M
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPYWNMT 259
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-48
Identities = 69/324 (21%), Positives = 125/324 (38%), Gaps = 40/324 (12%)
Query: 99 HPRRKESDKGLVGKFLYKQPQQETKASSNSYSTSPLRHLGSLRVTERYKSRKESAWTKYF 158
H + P+ L +E + + T +
Sbjct: 9 HHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGAN--TVHI 66
Query: 159 DHGGVRVNAVDAADEHTVDLSQLFLGL--RFAHGAHSRLYHGIYKDE-----PVAVKIIR 211
D + V A + S L + G +YHG D AVK +
Sbjct: 67 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 126
Query: 212 IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC--KKPPVYCVITEYLSEGSL 269
+ + F E ++ +PNV+ + C + V+ Y+ G L
Sbjct: 127 -----RITDIGEVSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDL 178
Query: 270 RAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329
R ++ H + LI L +A+GM+++ S+ +HRDL N ++D++F +K+ADFG
Sbjct: 179 RNFIRNETHN-PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG 237
Query: 330 IACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA- 378
+A ++Y + + +WMA E ++ + + K DV+SFG++LWE++
Sbjct: 238 LA-RDMY----DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 292
Query: 379 GTIPYEEMNPIQAAFAVVNKVNFG 402
G PY ++N + + G
Sbjct: 293 GAPPYPDVNTFD----ITVYLLQG 312
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-48
Identities = 61/213 (28%), Positives = 109/213 (51%), Gaps = 20/213 (9%)
Query: 196 YHGIYKDE--PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-K 252
Y G++K VAVK ++ D E E F +E A++ + +PN+++ + C +
Sbjct: 237 YEGVWKKYSLTVAVKTLK-EDTMEVEE--------FLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKP 312
+PP Y +ITE+++ G+L YL + + + L+ +A I+ MEY+ + IHR+L
Sbjct: 288 EPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAA 346
Query: 313 ENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFG 370
N L+ + +K+ADFG++ A + +W APE + + + K DV++FG
Sbjct: 347 RNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 406
Query: 371 LILWEMVA-GTIPYEEMNPIQAAFAVVNKVNFG 402
++LWE+ G PY ++ Q V +
Sbjct: 407 VLLWEIATYGMSPYPGIDLSQ----VYELLEKD 435
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-48
Identities = 67/262 (25%), Positives = 116/262 (44%), Gaps = 30/262 (11%)
Query: 157 YFDHGGVRVNAVDAADEHTVDLSQLFLGL--RFAHGAHSRLYHGIYKDE-----PVAVKI 209
+ D + V A + S L + G +YHG D AVK
Sbjct: 1 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 60
Query: 210 IRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC--KKPPVYCVITEYLSEG 267
+ + + F E ++ +PNV+ + C + V+ Y+ G
Sbjct: 61 LN-----RITDIGEVSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHG 112
Query: 268 SLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327
LR ++ H + LI L +A+GM+Y+ S+ +HRDL N ++D++F +K+AD
Sbjct: 113 DLRNFIRNETHN-PTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVAD 171
Query: 328 FGIACEEVY-CDALSDDPGTY-----RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GT 380
FG+A ++Y + S T +WMA E ++ + + K DV+SFG++LWE++ G
Sbjct: 172 FGLA-RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 230
Query: 381 IPYEEMNPIQAAFAVVNKVNFG 402
PY ++N + + G
Sbjct: 231 PPYPDVNTFD----ITVYLLQG 248
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-48
Identities = 63/301 (20%), Positives = 128/301 (42%), Gaps = 28/301 (9%)
Query: 112 KFLYKQPQQETKASSNSYSTSPLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAA 171
+ +PQ+E + + S +R + + + + D + +
Sbjct: 326 QSFIIRPQKEGERALPSIPKLANNEKQGVR-SHTVSVSETDDYAEIIDEEDT--YTMPST 382
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-----PVAVKIIRIPDDDENETLAARLE 226
++ + ++ LG G ++ GIY VA+K + + + R +
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-----NCTSDSVREK 437
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
F +E + + +P+++K + + PV+ +I E + G LR++L + L L L
Sbjct: 438 --FLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFS-LDLASL 493
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG----IACEEVYCDALSD 342
I A ++ + Y+ S+ +HRD+ NVL+ +K+ DFG + Y +
Sbjct: 494 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 343 DPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVNF 401
P +WMAPE I + + DV+ FG+ +WE++ G P++ + V+ ++
Sbjct: 554 LP--IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRIEN 607
Query: 402 G 402
G
Sbjct: 608 G 608
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-47
Identities = 68/263 (25%), Positives = 107/263 (40%), Gaps = 51/263 (19%)
Query: 159 DHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD------EPVAVKIIRI 212
HG + V D L G ++ Y E VAVK ++
Sbjct: 11 HHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK- 69
Query: 213 PDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC---KKPPVYCVITEYLSEGSL 269
D + +E+ +L L++ ++IK+ C + ++ EY+ GSL
Sbjct: 70 ADAGPQH------RSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ-LVMEYVPLGSL 122
Query: 270 RAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329
R YL + ++ L +L+ A I GM Y+H+Q IHRDL NVL+D + +KI DFG
Sbjct: 123 RDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG 179
Query: 330 IACEEVYCDALSDDPGTYR----------WMAPEMIKHKSYGRKVDVYSFGLILWEMV-- 377
+A A+ + YR W APE +K + DV+SFG+ L+E++
Sbjct: 180 LA------KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 233
Query: 378 -------------AGTIPYEEMN 387
I +M
Sbjct: 234 CDSSQSPPTKFLELIGIAQGQMT 256
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-47
Identities = 62/245 (25%), Positives = 113/245 (46%), Gaps = 37/245 (15%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQF 229
+ S + G +Y G+ K PVA+K ++ + F
Sbjct: 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-------AGYTEKQRVDF 93
Query: 230 NREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
E ++ + + N+I+ K P+ +ITEY+ G+L +L + + + + +L+
Sbjct: 94 LGEAGIMGQFSHHNIIRLEGVISKYKPMM-IITEYMENGALDKFLREKDGE-FSVLQLVG 151
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY- 347
+ IA GM+Y+ + +HRDL N+L++ K++DFG++ L DDP
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV------LEDDPEATY 205
Query: 348 ---------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
RW APE I ++ + DV+SFG+++WE++ G PY E++ + V+
Sbjct: 206 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----VMK 261
Query: 398 KVNFG 402
+N G
Sbjct: 262 AINDG 266
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-47
Identities = 68/270 (25%), Positives = 116/270 (42%), Gaps = 43/270 (15%)
Query: 159 DHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-----PVAVKIIRIP 213
D G+ + ++ + Q LG G + K E VAVK+++
Sbjct: 3 DSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKAD 62
Query: 214 DDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC------KKPPVYCVITEYLSEG 267
++ ++F RE A + +P+V K V + P+ VI ++ G
Sbjct: 63 IIASSD------IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHG 116
Query: 268 SLRAYL----HKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323
L A+L LPL L+ +DIA GMEY+ S+ IHRDL N ++ ++ +
Sbjct: 117 DLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176
Query: 324 KIADFGIACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLIL 373
+ADFG++ ++Y S D Y +W+A E + Y DV++FG+ +
Sbjct: 177 CVADFGLS-RKIY----SGD--YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTM 229
Query: 374 WEMVA-GTIPYEEMNPIQAAFAVVNKVNFG 402
WE++ G PY + + + N + G
Sbjct: 230 WEIMTRGQTPYAGIENAE----IYNYLIGG 255
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-47
Identities = 67/256 (26%), Positives = 118/256 (46%), Gaps = 42/256 (16%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-----PVAVKIIRIPDDDENETLAARLE 226
++ +D + L LG G + G K E VAVK +++ + + E
Sbjct: 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE------I 80
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKK-----PPVYCVITEYLSEGSLRAYL----HKLE 277
++F E A + +PNVI+ + C + P VI ++ G L YL +
Sbjct: 81 EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG 140
Query: 278 HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337
K +PL L+ +DIA GMEY+ ++ +HRDL N ++ + + +ADFG++ +++Y
Sbjct: 141 PKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS-KKIY- 198
Query: 338 DALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM 386
S D Y +W+A E + + Y K DV++FG+ +WE+ G PY +
Sbjct: 199 ---SGD--YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV 253
Query: 387 NPIQAAFAVVNKVNFG 402
+ + + + G
Sbjct: 254 QNHE----MYDYLLHG 265
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-47
Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 34/225 (15%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIPDDDENETLAARL 225
D + L G ++ Y E VAVK ++ P+ N
Sbjct: 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-PESGGNH------ 66
Query: 226 EKQFNREVALLSRLHNPNVIKFVAACKKP---PVYCVITEYLSEGSLRAYLHKLEHKTLP 282
+E+ +L L++ N++K+ C + + +I E+L GSL+ YL K ++K +
Sbjct: 67 IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK-LIMEFLPSGSLKEYLPKNKNK-IN 124
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
L + + A+ I +GM+Y+ S+ +HRDL NVL++ E +KI DFG+ A+
Sbjct: 125 LKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT------KAIET 178
Query: 343 DPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMV 377
D Y W APE + + DV+SFG+ L E++
Sbjct: 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-47
Identities = 67/244 (27%), Positives = 116/244 (47%), Gaps = 36/244 (14%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDE-----PVAVKIIRIPDDDENETLAARLEKQFN 230
+D + + + G + G K VA+K ++ T R + F
Sbjct: 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-----VGYTEKQRRD--FL 94
Query: 231 REVALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
E +++ + +PN+I+ K PV ++TEY+ GSL ++L K + + + +L+ +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSKPVM-IVTEYMENGSLDSFLRKHDAQ-FTVIQLVGM 152
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY-- 347
IA GM+Y+ G +HRDL N+LI+ K++DFG+ L DDP
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV------LEDDPEAAYT 206
Query: 348 --------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398
RW +PE I ++ + DV+S+G++LWE+++ G PY EM+ V+
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----VIKA 262
Query: 399 VNFG 402
V+ G
Sbjct: 263 VDEG 266
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-47
Identities = 62/244 (25%), Positives = 103/244 (42%), Gaps = 36/244 (14%)
Query: 160 HGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIP 213
H D + L + G + Y VAVK ++
Sbjct: 4 HHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS 63
Query: 214 DDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC---KKPPVYCVITEYLSEGSLR 270
D+ ++ F RE+ +L LH+ ++K+ + + ++ EYL G LR
Sbjct: 64 GPDQ--------QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR-LVMEYLPSGCLR 114
Query: 271 AYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330
+L + + L +L+ + I +GMEY+ S+ +HRDL N+L++ E H+KIADFG+
Sbjct: 115 DFLQRHRAR-LDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGL 173
Query: 331 ACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-G 379
A L D Y W APE + + R+ DV+SFG++L+E+
Sbjct: 174 A------KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYC 227
Query: 380 TIPY 383
Sbjct: 228 DKSC 231
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 4e-47
Identities = 66/261 (25%), Positives = 105/261 (40%), Gaps = 51/261 (19%)
Query: 162 GVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK------DEPVAVKIIRIPDD 215
G +A + D + L + G + Y E VAVK ++ +
Sbjct: 24 GAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE 83
Query: 216 DENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC---KKPPVYCVITEYLSEGSLRAY 272
+ F RE+ +L L + N++K+ C + + +I EYL GSLR Y
Sbjct: 84 EHLR--------DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDY 134
Query: 273 LHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332
L K + + + KL+ I +GMEY+ ++ IHRDL N+L++ E +KI DFG+
Sbjct: 135 LQKHKER-IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT- 192
Query: 333 EEVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMV----- 377
L D Y W APE + + DV+SFG++L+E+
Sbjct: 193 -----KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 247
Query: 378 -----------AGTIPYEEMN 387
G +M
Sbjct: 248 SKSPPAEFMRMIGNDKQGQMI 268
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-46
Identities = 61/289 (21%), Positives = 110/289 (38%), Gaps = 35/289 (12%)
Query: 126 SNSYSTSPLRHLGSLRVTERYKSRKESAW-TKYFDHGGVRVNAVDAADEHTVDLS----- 179
S S S+ L SL T S K + D+ GV + ++
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61
Query: 180 -QLFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALL 236
Q +G G+ ++ K AVK +R+ E+
Sbjct: 62 HQPRVG----RGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-------------EELVAC 104
Query: 237 SRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARG 296
+ L +P ++ A ++ P + E L GSL + + LP + + G
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEG 162
Query: 297 MEYIHSQGVIHRDLKPENVLIDQE-FHLKIADFGIA---CEEVYCDALSDDP---GTYRW 349
+EY+H++ ++H D+K +NVL+ + + DFG A + +L GT
Sbjct: 163 LEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
MAPE++ K KVD++S ++ M+ G P+ + + ++
Sbjct: 223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE 271
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 8e-46
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 28/201 (13%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF----------------V 248
+K ++ NE REV L++L + N++ +
Sbjct: 39 YVIKRVKY----NNEKAE--------REVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86
Query: 249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHR 308
++ K + E+ +G+L ++ K + L + + I +G++YIHS+ +I+R
Sbjct: 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINR 146
Query: 309 DLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYS 368
DLKP N+ + +KI DFG+ + GT R+M+PE I + YG++VD+Y+
Sbjct: 147 DLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYA 206
Query: 369 FGLILWEMVAGTIPYEEMNPI 389
GLIL E++ E +
Sbjct: 207 LGLILAELLHVCDTAFETSKF 227
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 9e-46
Identities = 56/234 (23%), Positives = 99/234 (42%), Gaps = 40/234 (17%)
Query: 189 HGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNPNVI 245
G S+++ + + + A+K + + + D + E+A L++L H+ +I
Sbjct: 19 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL------DSYRNEIAYLNKLQQHSDKII 72
Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
+ ++ E L ++L K K++ + + ++ + IH G+
Sbjct: 73 RLYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGI 129
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP---------GTYRWMAPEMIK 356
+H DLKP N LI LK+ DFGIA + + D GT +M PE IK
Sbjct: 130 VHSDLKPANFLIVDG-MLKLIDFGIA------NQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 357 HKS-----------YGRKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVVNK 398
S K DV+S G IL+ M G P++++ N I A+++
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 9e-46
Identities = 66/245 (26%), Positives = 103/245 (42%), Gaps = 48/245 (19%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDE-------PVAVKIIRIPDDDENETLAARLEKQ 228
+ LS + ++Y G VA+K ++ + R E
Sbjct: 6 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-----DKAEGPLREE-- 58
Query: 229 FNREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHK------------ 275
F E L +RL +PNV+ + K P+ +I Y S G L +L
Sbjct: 59 FRHEAMLRARLQHPNVVCLLGVVTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDD 117
Query: 276 --LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333
L P + + IA GMEY+ S V+H+DL NVL+ + ++KI+D G+
Sbjct: 118 DRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF-R 176
Query: 334 EVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIP 382
EVY + D Y RWMAPE I + + D++S+G++LWE+ + G P
Sbjct: 177 EVY----AAD--YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
Query: 383 YEEMN 387
Y +
Sbjct: 231 YCGYS 235
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-45
Identities = 39/194 (20%), Positives = 96/194 (49%), Gaps = 7/194 (3%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYL 264
+K I I E +R REVA+L+ + +PN++++ + ++ ++ +Y
Sbjct: 52 YVIKEINISRMSSKEREESR------REVAVLANMKHPNIVQYRESFEENGSLYIVMDYC 105
Query: 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
G L ++ + +++ + I ++++H + ++HRD+K +N+ + ++ ++
Sbjct: 106 EGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQ 165
Query: 325 IADFGIACE-EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
+ DFGIA + GT +++PE+ ++K Y K D+++ G +L+E+ +
Sbjct: 166 LGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF 225
Query: 384 EEMNPIQAAFAVVN 397
E + +++
Sbjct: 226 EAGSMKNLVLKIIS 239
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-45
Identities = 56/234 (23%), Positives = 99/234 (42%), Gaps = 40/234 (17%)
Query: 189 HGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNPNVI 245
G S+++ + + + A+K + + + D + E+A L++L H+ +I
Sbjct: 38 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL------DSYRNEIAYLNKLQQHSDKII 91
Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
+ ++ E L ++L K K++ + + ++ + IH G+
Sbjct: 92 RLYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGI 148
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP---------GTYRWMAPEMIK 356
+H DLKP N LI LK+ DFGIA + + D GT +M PE IK
Sbjct: 149 VHSDLKPANFLIVDG-MLKLIDFGIA------NQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 357 HKS-----------YGRKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVVNK 398
S K DV+S G IL+ M G P++++ N I A+++
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 255
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-45
Identities = 68/258 (26%), Positives = 118/258 (45%), Gaps = 46/258 (17%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-------PVAVKIIRIPDDDENETLAAR 224
DE V ++ + G+ +Y G+ K VA+K + E ++ R
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-----EAASMRER 72
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKT--- 280
+E F E +++ + +V++ + + P VI E ++ G L++YL L
Sbjct: 73 IE--FLNEASVMKEFNCHHVVRLLGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPAMANN 129
Query: 281 -----LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335
L K+I +A +IA GM Y+++ +HRDL N ++ ++F +KI DFG+ ++
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT-RDI 188
Query: 336 YCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYE 384
Y D Y RWM+PE +K + DV+SFG++LWE+ PY+
Sbjct: 189 Y----ETD--YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242
Query: 385 EMNPIQAAFAVVNKVNFG 402
++ Q V+ V G
Sbjct: 243 GLSNEQ----VLRFVMEG 256
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 8e-45
Identities = 68/252 (26%), Positives = 108/252 (42%), Gaps = 49/252 (19%)
Query: 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETL 221
+ + L GA +++ + VAVK ++ P
Sbjct: 5 SGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA---- 60
Query: 222 AARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYL------- 273
K F RE LL+ L + +++KF C P+ ++ EY+ G L +L
Sbjct: 61 ----RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDA 115
Query: 274 -------HKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA 326
+ L L +++ IA IA GM Y+ SQ +HRDL N L+ +KI
Sbjct: 116 MILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIG 175
Query: 327 DFGIACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
DFG++ +VY S D Y RWM PE I ++ + + DV+SFG+ILWE+
Sbjct: 176 DFGMS-RDVY----STD--YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 228
Query: 377 VA-GTIPYEEMN 387
G P+ +++
Sbjct: 229 FTYGKQPWFQLS 240
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-44
Identities = 74/313 (23%), Positives = 129/313 (41%), Gaps = 61/313 (19%)
Query: 114 LYKQPQQETKASSNSYSTSPLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADE 173
L +Q ++SS+ S +PL + + + + +
Sbjct: 26 LRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYE----------LPEDPK 75
Query: 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDE---------PVAVKIIRIPDDDENETLAAR 224
+L LG G ++ VAVK+++ ++ T
Sbjct: 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-----DDATEKDL 130
Query: 225 LEKQFNREVALLSRLHN-PNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYL--------- 273
+ E+ ++ + N+I + AC + P+Y VI EY S+G+LR YL
Sbjct: 131 SD--LVSEMEMMKMIGKHKNIINLLGACTQDGPLY-VIVEYASKGNLREYLRARRPPGME 187
Query: 274 -----HKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF 328
+++ + + L++ +ARGMEY+ SQ IHRDL NVL+ + +KIADF
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 247
Query: 329 GIACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
G+A ++ Y +WMAPE + + Y + DV+SFG+++WE+
Sbjct: 248 GLA-RDINNI------DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
Query: 379 -GTIPYEEMNPIQ 390
G PY + +
Sbjct: 301 LGGSPYPGIPVEE 313
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-44
Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 40/233 (17%)
Query: 190 GAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNPNVIK 246
G S+++ + + + A+K + + + D + E+A L++L H+ +I+
Sbjct: 67 GGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL------DSYRNEIAYLNKLQQHSDKIIR 120
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
++ E L ++L K K++ + + ++ + IH G++
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIV 177
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP---------GTYRWMAPEMIKH 357
H DLKP N LI LK+ DFGIA + + D G +M PE IK
Sbjct: 178 HSDLKPANFLIVDG-MLKLIDFGIA------NQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 358 KS-----------YGRKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVVNK 398
S K DV+S G IL+ M G P++++ N I A+++
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 3e-44
Identities = 49/207 (23%), Positives = 99/207 (47%), Gaps = 30/207 (14%)
Query: 196 YHGIYKDE----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251
G+Y+ VA+K+++ + ++ RE ++ +L NP +++ + C
Sbjct: 353 RQGVYRMRKKQIDVAIKVLK-------QGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC 405
Query: 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLK 311
+ + ++ E G L +L + +P+ + + ++ GM+Y+ + +HR+L
Sbjct: 406 QAEALM-LVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKNFVHRNLA 463
Query: 312 PENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYG 361
NVL+ + KI+DFG++ AL D Y +W APE I + +
Sbjct: 464 ARNVLLVNRHYAKISDFGLS------KALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 362 RKVDVYSFGLILWEMVA-GTIPYEEMN 387
+ DV+S+G+ +WE ++ G PY++M
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPYKKMK 544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-44
Identities = 65/269 (24%), Positives = 116/269 (43%), Gaps = 52/269 (19%)
Query: 166 NAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-------PVAVKIIRIPDDDEN 218
A H + + L GA +++ + VAVK ++ +
Sbjct: 28 QYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA- 86
Query: 219 ETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYL---- 273
+ F RE LL+ L + ++++F C + P+ ++ EY+ G L +L
Sbjct: 87 -------RQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL-MVFEYMRHGDLNRFLRSHG 138
Query: 274 ---------HKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324
+ L L +L+A+A +A GM Y+ +HRDL N L+ Q +K
Sbjct: 139 PDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVK 198
Query: 325 IADFGIACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILW 374
I DFG++ ++Y S D Y RWM PE I ++ + + DV+SFG++LW
Sbjct: 199 IGDFGMS-RDIY----STD--YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLW 251
Query: 375 EMVA-GTIPYEEMNPIQAAFAVVNKVNFG 402
E+ G P+ +++ + ++ + G
Sbjct: 252 EIFTYGKQPWYQLSNTE----AIDCITQG 276
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-44
Identities = 47/205 (22%), Positives = 83/205 (40%), Gaps = 10/205 (4%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
HG++ ++ K+ AVK P + E + +P ++
Sbjct: 67 HGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAE-----VGSHEKVGQHPCCVR 121
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
A ++ + + TE SL+ + +LP ++ D + ++HSQG++
Sbjct: 122 LEQAWEEGGILYLQTEL-CGPSLQQHCEA-WGASLPEAQVWGYLRDTLLALAHLHSQGLV 179
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDV 366
H D+KP N+ + K+ DFG+ E A G R+MAPE+++ YG DV
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS-YGTAADV 238
Query: 367 YSFGLILWEMVAGTIPYEEMNPIQA 391
+S GL + E+ Q
Sbjct: 239 FSLGLTILEVACNMELPHGGEGWQQ 263
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 6e-44
Identities = 69/258 (26%), Positives = 112/258 (43%), Gaps = 53/258 (20%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDE----PVAVKIIRIPDDDENETLAARLEKQFNR 231
+D + + G ++ K + A+K ++ E + + F
Sbjct: 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-----EYASKDDHRD--FAG 74
Query: 232 EVALLSRL-HNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHK-------------- 275
E+ +L +L H+PN+I + AC + +Y + EY G+L +L K
Sbjct: 75 ELEVLCKLGHHPNIINLLGACEHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133
Query: 276 LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335
TL +L+ A D+ARGM+Y+ + IHRDL N+L+ + + KIADFG
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG------ 187
Query: 336 YCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYE 384
LS Y RWMA E + + Y DV+S+G++LWE+V+ G PY
Sbjct: 188 ----LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243
Query: 385 EMNPIQAAFAVVNKVNFG 402
M + + K+ G
Sbjct: 244 GMTCAE----LYEKLPQG 257
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 6e-44
Identities = 65/270 (24%), Positives = 108/270 (40%), Gaps = 40/270 (14%)
Query: 145 RYKSRKESAWTKYFDHGGVRVNAVDAA-----DEHTVDLSQLFLGLRFAHGAHSRLYHGI 199
+ K + + W + G +D ++ + L G GA ++
Sbjct: 7 KQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEAT 66
Query: 200 YKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFVAAC 251
VAVK+++ + E+ ++S L N++ + AC
Sbjct: 67 AFGLGKEDAVLKVAVKMLK-----STAHADEKEA--LMSELKIMSHLGQHENIVNLLGAC 119
Query: 252 -KKPPVYCVITEYLSEGSLRAYLHK------------LEHKTLPLPKLIAIALDIARGME 298
PV VITEY G L +L + + + T L+ + +A+GM
Sbjct: 120 THGGPVL-VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMA 178
Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFG----IACEEVYCDALSDDPGTYRWMAPEM 354
++ S+ IHRD+ NVL+ KI DFG I + Y + +WMAPE
Sbjct: 179 FLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI-VKGNARLPVKWMAPES 237
Query: 355 IKHKSYGRKVDVYSFGLILWEMVA-GTIPY 383
I Y + DV+S+G++LWE+ + G PY
Sbjct: 238 IFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-43
Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 45/222 (20%)
Query: 196 YHGIYKDE---PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFVAAC 251
+G+ K + VAVK+++ + L R E+ +LS L N N++ + AC
Sbjct: 44 AYGLIKSDAAMTVAVKMLK-----PSAHLTEREA--LMSELKVLSYLGNHMNIVNLLGAC 96
Query: 252 KKPPVYCVITEYLSEGSLRAYL----------------HKLEHKTLPLPKLIAIALDIAR 295
VITEY G L +L + + L L L++ + +A+
Sbjct: 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK 156
Query: 296 GMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY-------- 347
GM ++ S+ IHRDL N+L+ KI DFG+A ++ D Y
Sbjct: 157 GMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA-RDIKND------SNYVVKGNARL 209
Query: 348 --RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM 386
+WMAPE I + Y + DV+S+G+ LWE+ + G+ PY M
Sbjct: 210 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-43
Identities = 69/251 (27%), Positives = 110/251 (43%), Gaps = 50/251 (19%)
Query: 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAA 223
A + +L LG GA ++ VAVK+++ E T +
Sbjct: 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-----EGATHSE 73
Query: 224 RLEKQFNREVALLSRLHN-PNVIKFVAAC--KKPPVYCVITEYLSEGSLRAYLHKLEH-- 278
E+ +L + + NV+ + AC P+ VI E+ G+L YL +
Sbjct: 74 HRA--LMSELKILIHIGHHLNVVNLLGACTKPGGPLM-VIVEFCKFGNLSTYLRSKRNEF 130
Query: 279 ------------KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA 326
L L LI + +A+GME++ S+ IHRDL N+L+ ++ +KI
Sbjct: 131 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 190
Query: 327 DFGIACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEM 376
DFG+A ++Y D Y +WMAPE I + Y + DV+SFG++LWE+
Sbjct: 191 DFGLA-RDIYKD------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
Query: 377 VA-GTIPYEEM 386
+ G PY +
Sbjct: 244 FSLGASPYPGV 254
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-43
Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 45/227 (19%)
Query: 195 LYHGIYKDE-----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFV 248
GI KD+ VAVK+++ ++ T + E+ ++ + N+I +
Sbjct: 55 EAVGIDKDKPKEAVTVAVKMLK-----DDATEKDLSD--LVSEMEMMKMIGKHKNIINLL 107
Query: 249 AACKKPPVYCVITEYLSEGSLRAYL--------------HKLEHKTLPLPKLIAIALDIA 294
AC + VI EY S+G+LR YL +++ + + L++ +A
Sbjct: 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA 167
Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY------- 347
RGMEY+ SQ IHRDL NVL+ + +KIADFG+A ++ Y
Sbjct: 168 RGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA-RDINNI------DYYKKTTNGR 220
Query: 348 ---RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQ 390
+WMAPE + + Y + DV+SFG+++WE+ G PY + +
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-43
Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 28/213 (13%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G +Y K +A+K++ + + A +E Q REV + S L +PN+++
Sbjct: 19 KGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNILR 73
Query: 247 ---FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
+ + VY ++ EY G++ L K + ++A + Y HS+
Sbjct: 74 LYGYFHDATR--VYLIL-EYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK 128
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP------GTYRWMAPEMIKH 357
VIHRD+KPEN+L+ LKIADFG + + GT ++ PEMI+
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYLPPEMIEG 181
Query: 358 KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390
+ + KVD++S G++ +E + G P+E +
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-43
Identities = 63/232 (27%), Positives = 109/232 (46%), Gaps = 52/232 (22%)
Query: 196 YHGIYKDE---PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC- 251
+ VAVK+++ EN + + + E +L ++++P+VIK AC
Sbjct: 44 AFHLKGRAGYTTVAVKMLK-----ENASPSELRD--LLSEFNVLKQVNHPHVIKLYGACS 96
Query: 252 KKPPVYCVITEYLSEGSLRAYL----------------------HKLEHKTLPLPKLIAI 289
+ P+ +I EY GSLR +L + + L + LI+
Sbjct: 97 QDGPLL-LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISF 155
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY-- 347
A I++GM+Y+ ++HRDL N+L+ + +KI+DFG++ +VY + +Y
Sbjct: 156 AWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS-RDVYEE------DSYVK 208
Query: 348 --------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQ 390
+WMA E + Y + DV+SFG++LWE+V G PY + P +
Sbjct: 209 RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-43
Identities = 45/234 (19%), Positives = 99/234 (42%), Gaps = 33/234 (14%)
Query: 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDE---------PVAVKIIRIPDDDENETLAAR 224
H + L G ++++ G+ ++ V +K++ N
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD--KAHRNY----- 55
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL 283
+ F +++S+L + +++ C ++ E++ GSL YL K ++ + +
Sbjct: 56 -SESFFEAASMMSKLSHKHLVLNYGVCVCGDENI-LVQEFVKFGSLDTYLKKNKNC-INI 112
Query: 284 PKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL--------KIADFGIACEEV 335
+ +A +A M ++ +IH ++ +N+L+ +E K++D GI+ V
Sbjct: 113 LWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-ITV 171
Query: 336 YCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVA-GTIPYEEMN 387
+ + W+ PE I++ K+ D +SFG LWE+ + G P ++
Sbjct: 172 LPKDILQER--IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-43
Identities = 64/257 (24%), Positives = 106/257 (41%), Gaps = 56/257 (21%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAAR 224
+ + GA R++ VAVK+++ E + +
Sbjct: 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-----EEASADMQ 94
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYL---------- 273
+ F RE AL++ NPN++K + C P+ ++ EY++ G L +L
Sbjct: 95 AD--FQREAALMAEFDNPNIVKLLGVCAVGKPMC-LLFEYMAYGDLNEFLRSMSPHTVCS 151
Query: 274 ------------HKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
L + + IA +A GM Y+ + +HRDL N L+ +
Sbjct: 152 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM 211
Query: 322 HLKIADFGIACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGL 371
+KIADFG++ +Y S D Y RWM PE I + Y + DV+++G+
Sbjct: 212 VVKIADFGLS-RNIY----SAD--YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 264
Query: 372 ILWEMVA-GTIPYEEMN 387
+LWE+ + G PY M
Sbjct: 265 VLWEIFSYGLQPYYGMA 281
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-43
Identities = 63/264 (23%), Positives = 110/264 (41%), Gaps = 46/264 (17%)
Query: 166 NAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDE-------PVAVKIIRIPDDDEN 218
+D V + L HGA +Y G VAVK + E
Sbjct: 17 KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-----EV 71
Query: 219 ETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYL---- 273
+ L+ F E ++S+ ++ N+++ + + P + ++ E ++ G L+++L
Sbjct: 72 CSEQDELD--FLMEALIISKFNHQNIVRCIGVSLQSLPRF-ILMELMAGGDLKSFLRETR 128
Query: 274 -HKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE---FHLKIADFG 329
+ +L + L+ +A DIA G +Y+ IHRD+ N L+ KI DFG
Sbjct: 129 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 330 IACEEVYCDALSDDPGTY----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA- 378
+A ++Y Y +WM PE + K D +SFG++LWE+ +
Sbjct: 189 MA-RDIYRA------SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 241
Query: 379 GTIPYEEMNPIQAAFAVVNKVNFG 402
G +PY + + V+ V G
Sbjct: 242 GYMPYPSKSNQE----VLEFVTSG 261
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 9e-43
Identities = 53/228 (23%), Positives = 100/228 (43%), Gaps = 24/228 (10%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA + ++ G +K + A+K+ N R RE +L +L++ N++K
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVF-------NNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 247 F--VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
+ +I E+ GSL L + + LP + + + D+ GM ++
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 304 GVIHRDLKPENVLI----DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIK--- 356
G++HR++KP N++ D + K+ DFG A E + GT ++ P+M +
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV 191
Query: 357 -----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399
K YG VD++S G+ + G++P+ + V+ K+
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-42
Identities = 72/307 (23%), Positives = 123/307 (40%), Gaps = 54/307 (17%)
Query: 123 KASSNSYSTSPLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDLSQLF 182
+ + S SP L LR + T Y + +D V +
Sbjct: 23 QGAMGSELQSPEYKLSKLRTSTIM--------TDYNPNYCFAGKTSSISDLKEVPRKNIT 74
Query: 183 LGLRFAHGAHSRLYHGIYKDE-------PVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
L HGA +Y G VAVK + E + L+ F E +
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-----EVCSEQDELD--FLMEALI 127
Query: 236 LSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYL-----HKLEHKTLPLPKLIAI 289
+S+ ++ N+++ + + P + ++ E ++ G L+++L + +L + L+ +
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLID---QEFHLKIADFGIACEEVYCDALSDDPGT 346
A DIA G +Y+ IHRD+ N L+ KI DFG+A ++Y G
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RDIYRA------GY 239
Query: 347 Y----------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV 395
Y +WM PE + K D +SFG++LWE+ + G +PY + + V
Sbjct: 240 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----V 295
Query: 396 VNKVNFG 402
+ V G
Sbjct: 296 LEFVTSG 302
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-42
Identities = 59/234 (25%), Positives = 96/234 (41%), Gaps = 47/234 (20%)
Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
GA ++ A+K IR ++ + L EV LL+ L++ V+++
Sbjct: 17 GAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL---------SEVMLLASLNHQYVVRY 67
Query: 248 -------------VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA--IALD 292
+ A KK + EY G+L +H + L + +
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQ 124
Query: 293 IARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------- 344
I + YIHSQG+IHRDLKP N+ ID+ ++KI DFG+A +
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 345 -------GTYRWMAPEMIKHKS-YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390
GT ++A E++ Y K+D+YS G+I +EM+ M +
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVN 236
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-42
Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 18/217 (8%)
Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
G + +Y G +A+K I D + + E+AL L + N++++
Sbjct: 33 GTYGIVYAGRDLSNQVRIAIKEIPERDSRY--------SQPLHEEIALHKHLKHKNIVQY 84
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP-KLIA-IALDIARGMEYIHSQGV 305
+ + + + E + GSL A L + + L + I I G++Y+H +
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 306 IHRDLKPENVLIDQEF-HLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIKHKS--YG 361
+HRD+K +NVLI+ LKI+DFG + GT ++MAPE+I YG
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYG 203
Query: 362 RKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVVN 397
+ D++S G + EM G P+ E+ P A F V
Sbjct: 204 KAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM 240
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 6e-42
Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 33/201 (16%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC---------- 251
D A+K IR+P+ + ++ REV L++L +P ++++ A
Sbjct: 30 DCNYAIKRIRLPNRELAR-------EKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82
Query: 252 --KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA-IALDIARGMEYIHSQGVIHR 308
+ + + +L+ +++ + I L IA +E++HS+G++HR
Sbjct: 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHR 142
Query: 309 DLKPENVLIDQEFHLKIADFGIAC-------------EEVYCDALSDDPGTYRWMAPEMI 355
DLKP N+ + +K+ DFG+ + GT +M+PE I
Sbjct: 143 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI 202
Query: 356 KHKSYGRKVDVYSFGLILWEM 376
SY KVD++S GLIL+E+
Sbjct: 203 HGNSYSHKVDIFSLGLILFEL 223
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-41
Identities = 69/227 (30%), Positives = 110/227 (48%), Gaps = 47/227 (20%)
Query: 196 YHGIYKDEP-----VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFVA 249
G+ KD+P VAVK+++ + T + E+ ++ + N+I +
Sbjct: 90 AIGLDKDKPNRVTKVAVKMLK-----SDATEKDLSD--LISEMEMMKMIGKHKNIINLLG 142
Query: 250 AC-KKPPVYCVITEYLSEGSLRAYL--------------HKLEHKTLPLPKLIAIALDIA 294
AC + P+Y VI EY S+G+LR YL + L L++ A +A
Sbjct: 143 ACTQDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVA 201
Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY------- 347
RGMEY+ S+ IHRDL NVL+ ++ +KIADFG+A +++ Y
Sbjct: 202 RGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA-RDIHHI------DYYKKTTNGR 254
Query: 348 ---RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQ 390
+WMAPE + + Y + DV+SFG++LWE+ G PY + +
Sbjct: 255 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-41
Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 28/213 (13%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G +Y K +A+K++ +++ +E Q RE+ + S L +PN+++
Sbjct: 24 KGKFGNVYLAREKQNKFIMALKVL-----FKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78
Query: 247 ---FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
+ K+ +Y ++ E+ G L L K H + ++A + Y H +
Sbjct: 79 MYNYFHDRKR--IY-LMLEFAPRGELYKELQK--HGRFDEQRSATFMEELADALHYCHER 133
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP------GTYRWMAPEMIKH 357
VIHRD+KPEN+L+ + LKIADFG + + GT ++ PEMI+
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRTMCGTLDYLPPEMIEG 186
Query: 358 KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390
K++ KVD++ G++ +E + G P++ + +
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-41
Identities = 53/228 (23%), Positives = 100/228 (43%), Gaps = 24/228 (10%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA + ++ G +K + A+K+ N R RE +L +L++ N++K
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVF-------NNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 247 F--VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQ 303
+ +I E+ GSL L + + LP + + + D+ GM ++
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 304 GVIHRDLKPENVLI----DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIK--- 356
G++HR++KP N++ D + K+ DFG A E + GT ++ P+M +
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV 191
Query: 357 -----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399
K YG VD++S G+ + G++P+ + V+ K+
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-41
Identities = 50/202 (24%), Positives = 88/202 (43%), Gaps = 27/202 (13%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV----YCVI 260
A+K I + + E RE + ++PN+++ VA C + ++
Sbjct: 57 YALKRILCHEQQDREEA--------QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108
Query: 261 TEYLSEGSLRAYL--HKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318
+ G+L + K + L +++ + L I RG+E IH++G HRDLKP N+L+
Sbjct: 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG 168
Query: 319 QEFHLKIADFGIACEEVY-------CDALSDDP---GTYRWMAPEMIKHKSY---GRKVD 365
E + D G + L D T + APE+ +S+ + D
Sbjct: 169 DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTD 228
Query: 366 VYSFGLILWEMVAGTIPYEEMN 387
V+S G +L+ M+ G PY+ +
Sbjct: 229 VWSLGCVLYAMMFGEGPYDMVF 250
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-41
Identities = 62/228 (27%), Positives = 100/228 (43%), Gaps = 52/228 (22%)
Query: 196 YHGIYKDE---PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFVAAC 251
+GI K VAVK+++ E + R E+ ++++L + N++ + AC
Sbjct: 66 AYGISKTGVSIQVAVKMLK-----EKADSSEREA--LMSELKMMTQLGSHENIVNLLGAC 118
Query: 252 -KKPPVYCVITEYLSEGSLRAYLHKL---------------------EHKTLPLPKLIAI 289
P+Y +I EY G L YL + L L+
Sbjct: 119 TLSGPIY-LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCF 177
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY-- 347
A +A+GME++ + +HRDL NVL+ +KI DFG+A ++ D Y
Sbjct: 178 AYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA-RDIMSD------SNYVV 230
Query: 348 --------RWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEM 386
+WMAPE + Y K DV+S+G++LWE+ + G PY +
Sbjct: 231 RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-41
Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 21/223 (9%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G + I++D E VA+K + L+ + +++ E+ ++ +L++PNV+
Sbjct: 24 TGGFGYVLRWIHQDTGEQVAIKQC-------RQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 247 FVA------ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL--DIARGME 298
+ + EY G LR YL++ E+ L + L DI+ +
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC-GLKEGPIRTLLSDISSALR 135
Query: 299 YIHSQGVIHRDLKPENVLID---QEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI 355
Y+H +IHRDLKPEN+++ Q KI D G A E + ++ GT +++APE++
Sbjct: 136 YLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL 195
Query: 356 KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
+ K Y VD +SFG + +E + G P+ V +
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 144 bits (367), Expect = 8e-41
Identities = 54/232 (23%), Positives = 101/232 (43%), Gaps = 32/232 (13%)
Query: 182 FLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL 239
LG G+ + +Y VA+K+I D+ A + ++ EV + +L
Sbjct: 18 LLG----KGSFAGVYRAESIHTGLEVAIKMI-----DKKAMYKAGMVQRVQNEVKIHCQL 68
Query: 240 HNPNVIKF--VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGM 297
+P++++ VY ++ E G + YL K + I GM
Sbjct: 69 KHPSILELYNYFEDSNY-VY-LVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGM 125
Query: 298 EYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP--------GTYRW 349
Y+HS G++HRDL N+L+ + ++KIADFG+A P GT +
Sbjct: 126 LYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA-------TQLKMPHEKHYTLCGTPNY 178
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNF 401
++PE+ ++G + DV+S G + + ++ G P++ ++ V ++
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT-VKNTLNKVVLADY 229
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-40
Identities = 48/240 (20%), Positives = 95/240 (39%), Gaps = 37/240 (15%)
Query: 189 HGAHSRLYHGIYKDEPVAVKIIR---------IPDDDENETLAARLEKQFNREVALLSRL 239
G +++ ++ A+K + ++ F E+ +++ +
Sbjct: 41 QGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100
Query: 240 HNPNVIK---FVAACKKPPVYCVITEYLSEGSLRAYLHK------LEHKTLPLPKLIAIA 290
N + + + VY +I EY+ S+ + +P+ + I
Sbjct: 101 KNEYCLTCEGIITNYDE--VY-IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 291 LDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP----- 344
+ YIH++ + HRD+KP N+L+D+ +K++DFG + D
Sbjct: 158 KSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES-------EYMVDKKIKGS 210
Query: 345 -GTYRWMAPEMIKHKS--YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNF 401
GTY +M PE ++S G KVD++S G+ L+ M +P+ + F + N
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI 270
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 14/217 (6%)
Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDD-DENETLAARLEKQFNREVALLSRLHNPNVIK 246
G S +Y PVA+K ++I D D +E+ LL +L++PNVIK
Sbjct: 43 GQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI------KEIDLLKQLNHPNVIK 96
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP--KLIAIALDIARGMEYIHSQG 304
+ A+ + ++ E G L + + + +P + + + +E++HS+
Sbjct: 97 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR 156
Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIKHKSYGRK 363
V+HRD+KP NV I +K+ D G+ A GT +M+PE I Y K
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 216
Query: 364 VDVYSFGLILWEMVAGTIPY--EEMNPIQAAFAVVNK 398
D++S G +L+EM A P+ ++MN +
Sbjct: 217 SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC 253
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-40
Identities = 57/214 (26%), Positives = 108/214 (50%), Gaps = 26/214 (12%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA +Y + + VA++ + + + E + E+ ++ NPN++
Sbjct: 30 QGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII--------NEILVMRENKNPNIVN 81
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
++ + V+ EYL+ GSL + + ++ A+ + + +E++HS VI
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------GTYRWMAPEMIKHKS 359
HRD+K +N+L+ + +K+ DFG +C ++ + GT WMAPE++ K+
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFG------FCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 360 YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393
YG KVD++S G++ EM+ G PY NP++A +
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-39
Identities = 42/230 (18%), Positives = 84/230 (36%), Gaps = 40/230 (17%)
Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIK 246
G ++ + + A+K + P + A REV + L + +V++
Sbjct: 22 GEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNAL------REVYAHAVLGQHSHVVR 75
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLP--KLIAIALDIARGMEYIHSQG 304
+ +A + + EY + GSL + + +L + L + RG+ YIHS
Sbjct: 76 YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 135
Query: 305 VIHRDLKPENVLIDQE-------------------FHLKIADFGIACEEVYCDALSDDP- 344
++H D+KP N+ I + KI D G +S
Sbjct: 136 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV------TRISSPQV 189
Query: 345 --GTYRWMAPEMIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQA 391
G R++A E+++ + ++ K D+++ L + +
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE 239
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 74/238 (31%), Positives = 120/238 (50%), Gaps = 28/238 (11%)
Query: 167 AVDAADEHTVDLSQLFLGL-RFAHGAHSRLYHGIYKD--EPVAVKIIRI-PDDDENETLA 222
+ D +LF L + G+ ++ GI + VA+KII + +DE E +
Sbjct: 9 GLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ 68
Query: 223 ARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLP 282
+E+ +LS+ +P V K+ + K +I EYL GS L LE L
Sbjct: 69 --------QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA---LDLLEPGPLD 117
Query: 283 LPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSD 342
++ I +I +G++Y+HS+ IHRD+K NVL+ + +K+ADFG+A + L+D
Sbjct: 118 ETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ------LTD 171
Query: 343 DP-------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393
GT WMAPE+IK +Y K D++S G+ E+ G P+ E++P++ F
Sbjct: 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF 229
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 23/205 (11%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK-FVAACKKPPVYCVI 260
+ VA+K I E E R F REV S+L + N++ + Y V+
Sbjct: 36 NIKVAIKAIF-IPPREKEETLKR----FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90
Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
EY+ +L Y+ H L + I I G+++ H ++HRD+KP+N+LID
Sbjct: 91 -EYIEGPTLSEYIE--SHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN 147
Query: 321 FHLKIADFGIACEEVYCDALSDDP--------GTYRWMAPEMIKHKSYGRKVDVYSFGLI 372
LKI DFGIA ALS+ GT ++ +PE K ++ D+YS G++
Sbjct: 148 KTLKIFDFGIA------KALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIV 201
Query: 373 LWEMVAGTIPYEEMNPIQAAFAVVN 397
L+EM+ G P+ + A +
Sbjct: 202 LYEMLVGEPPFNGETAVSIAIKHIQ 226
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 28/216 (12%)
Query: 182 FLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL 239
FLG G ++ + D E A KI+ ++ L ++ + E+++ L
Sbjct: 22 FLG----KGGFAKCFEISDADTKEVFAGKIV-----PKSLLLKPHQREKMSMEISIHRSL 72
Query: 240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEY 299
+ +V+ F + V+ E SL + K L P+ I G +Y
Sbjct: 73 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQY 130
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR--------WMA 351
+H VIHRDLK N+ ++++ +KI DFG+A + G + ++A
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKVLCGTPNYIA 183
Query: 352 PEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
PE++ K + +VDV+S G I++ ++ G P+E
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-39
Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
G+ + K VAVK++ + E L EV ++ + NV++
Sbjct: 56 GSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF--------NEVVIMRDYQHFNVVEM 107
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
+ V+ E+L G+L + L ++ + + + + Y+H+QGVIH
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQGVIH 164
Query: 308 RDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------GTYRWMAPEMIKHKSY 360
RD+K +++L+ + +K++DFG +C +S D GT WMAPE+I Y
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFG------FCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393
+VD++S G+++ EMV G PY +P+QA
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 251
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-39
Identities = 48/203 (23%), Positives = 87/203 (42%), Gaps = 16/203 (7%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA--CKKPPVYCVITE 262
+ K + E E EV LL L +PN++++ + ++ E
Sbjct: 34 LVWKELDYGSMTEAEKQMLV------SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 87
Query: 263 YLSEGSLRAYLHKLEHKTLPLP--KLIAIALDIARGMEYIHSQG-----VIHRDLKPENV 315
Y G L + + K + L ++ + + ++ H + V+HRDLKP NV
Sbjct: 88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANV 147
Query: 316 LIDQEFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILW 374
+D + ++K+ DFG+A GT +M+PE + SY K D++S G +L+
Sbjct: 148 FLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLY 207
Query: 375 EMVAGTIPYEEMNPIQAAFAVVN 397
E+ A P+ + + A +
Sbjct: 208 ELCALMPPFTAFSQKELAGKIRE 230
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-38
Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 32/218 (14%)
Query: 182 FLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL 239
FLG G ++ + D E A KI+ ++ L ++ + E+++ L
Sbjct: 48 FLG----KGGFAKCFEISDADTKEVFAGKIV-----PKSLLLKPHQREKMSMEISIHRSL 98
Query: 240 HNPNVIKF--VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGM 297
+ +V+ F V+ V+ E SL + K L P+ I G
Sbjct: 99 AHQHVVGFHGFFEDNDF-VF-VVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGC 154
Query: 298 EYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYR--------W 349
+Y+H VIHRDLK N+ ++++ +KI DFG+A + G + +
Sbjct: 155 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKVLCGTPNY 207
Query: 350 MAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387
+APE++ K + +VDV+S G I++ ++ G P+E
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 63/215 (29%), Positives = 114/215 (53%), Gaps = 26/215 (12%)
Query: 188 AHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI 245
G++ +Y I+K+ + VA+K + + D ++ +E++++ + +P+V+
Sbjct: 38 GEGSYGSVYKAIHKETGQIVAIKQVPVESD----------LQEIIKEISIMQQCDSPHVV 87
Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
K+ + K ++ EY GS+ + +L +KTL ++ I +G+EY+H
Sbjct: 88 KYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------GTYRWMAPEMIKHK 358
IHRD+K N+L++ E H K+ADFG+A + L+D GT WMAPE+I+
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQ------LTDTMAKRNTVIGTPFWMAPEVIQEI 200
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393
Y D++S G+ EM G PY +++P++A F
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF 235
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 6e-38
Identities = 42/210 (20%), Positives = 86/210 (40%), Gaps = 18/210 (8%)
Query: 196 YHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253
YK E V V+ I + + NE + E+ + ++PN++ + A
Sbjct: 44 NLARYKPTGEYVTVRRINL-EACSNEMV-----TFLQGELHVSKLFNHPNIVPYRATFIA 97
Query: 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPE 313
V+T +++ GS + + + + I + + ++YIH G +HR +K
Sbjct: 98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKAS 157
Query: 314 NVLIDQEFHLKIADFGIACE--------EVYCDALSDDPGTYRWMAPEMIKH--KSYGRK 363
++LI + + ++ V D W++PE+++ + Y K
Sbjct: 158 HILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK 217
Query: 364 VDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393
D+YS G+ E+ G +P+++M Q
Sbjct: 218 SDIYSVGITACELANGHVPFKDMPATQMLL 247
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 59/186 (31%), Positives = 100/186 (53%), Gaps = 9/186 (4%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
VA+KII + L ++ REV ++ L++PN++K + +I E
Sbjct: 41 REVAIKII------DKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 94
Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
Y S G + YL + H + + + I ++Y H + ++HRDLK EN+L+D + +
Sbjct: 95 YASGGEVFDYL--VAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN 152
Query: 323 LKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTI 381
+KIADFG + E L G + APE+ + K Y G +VDV+S G+IL+ +V+G++
Sbjct: 153 IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 212
Query: 382 PYEEMN 387
P++ N
Sbjct: 213 PFDGQN 218
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 60/221 (27%), Positives = 108/221 (48%), Gaps = 24/221 (10%)
Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRI-PDDDENETLAARLEKQFNREVALLSRLHNPNVI 245
GA + + E VA+K I + + L +E+ +S+ H+PN++
Sbjct: 25 SGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELL--------KEIQAMSQCHHPNIV 76
Query: 246 KFVAACKKPPVYCVITEYLSEGSL----RAYLHKLEHKTLPLP-KLIAIAL-DIARGMEY 299
+ + ++ + LS GS+ + + K EHK+ L IA L ++ G+EY
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP------GTYRWMAPE 353
+H G IHRD+K N+L+ ++ ++IADFG++ ++ + GT WMAPE
Sbjct: 137 LHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 354 MIK-HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393
+++ + Y K D++SFG+ E+ G PY + P++
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM 237
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 196 YHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255
Y G + VAVK + D E L++QF++E+ ++++ + N+++ +
Sbjct: 48 YKGYVNNTTVAVKKLAAMVDITTE----ELKQQFDQEIKVMAKCQHENLVELLGFSSDGD 103
Query: 256 VYCVITEYLSEGSLRAYLHKLE-HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314
C++ Y+ GSL L L+ L IA A G+ ++H IHRD+K N
Sbjct: 104 DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSAN 163
Query: 315 VLIDQEFHLKIADFGIACEEVYCDALSDDP--------GTYRWMAPE-MIKHKSYGRKVD 365
+L+D+ F KI+DFG+A + GT +MAPE + + K D
Sbjct: 164 ILLDEAFTAKISDFGLA-----RASEKFAQTVMTSRIVGTTAYMAPEALRGEITP--KSD 216
Query: 366 VYSFGLILWEMVAGTIPYEEMNPIQ 390
+YSFG++L E++ G +E Q
Sbjct: 217 IYSFGVVLLEIITGLPAVDEHREPQ 241
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-37
Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA ++Y K+ A K+I ++E E E+ +L+ +P ++K
Sbjct: 29 DGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI--------VEIEILATCDHPYIVK 80
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+ A ++ E+ G++ A + +L+ + L P++ + + + ++HS+ +I
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRII 139
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------GTYRWMAPEMI---- 355
HRDLK NVL+ E +++ADFG++ + GT WMAPE++
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAK------NLKTLQKRDSFIGTPYWMAPEVVMCET 193
Query: 356 -KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393
K Y K D++S G+ L EM P+ E+NP++
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL 232
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-37
Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 29/211 (13%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK-----FVAACKKPPV 256
VAVK++R D + + R F RE + L++P ++ P
Sbjct: 37 HRDVAVKVLR-ADLARDPSFYLR----FRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316
Y V+ EY+ +LR +H + + I + D + + + H G+IHRD+KP N++
Sbjct: 92 YIVM-EYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIM 148
Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDP----------GTYRWMAPEMIKHKSYGRKVDV 366
I +K+ DFGIA A++D GT ++++PE + S + DV
Sbjct: 149 ISATNAVKVMDFGIA------RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV 202
Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
YS G +L+E++ G P+ +P+ A+ V
Sbjct: 203 YSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 233
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-37
Identities = 49/214 (22%), Positives = 96/214 (44%), Gaps = 37/214 (17%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPP-------- 255
A+K + ++++N + +EV + +L +PN+++F +A
Sbjct: 56 YALKRLLSNEEEKNRAII--------QEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107
Query: 256 VYCVITEYLSEGSLRAYLHKLEHKT-LPLPKLIAIALDIARGMEYIHSQG--VIHRDLKP 312
+ ++TE +G L +L K+E + L ++ I R ++++H Q +IHRDLK
Sbjct: 108 EFLLLTEL-CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKV 166
Query: 313 ENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------------GTYRWMAPEMI---K 356
EN+L+ + +K+ DFG A + S T + PE+I
Sbjct: 167 ENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS 226
Query: 357 HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390
+ G K D+++ G IL+ + P+E+ ++
Sbjct: 227 NFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-36
Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 56/222 (25%)
Query: 196 YHGIYKD-EPVAVKIIRIPDDDENETLAARL-------EKQFNREVALLSRLHNPNVIKF 247
Y G+ +D VA+K R ++F E+ LS +P+++
Sbjct: 56 YKGVLRDGAKVALK---------------RRTPESSQGIEEFETEIETLSFCRHPHLVSL 100
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPL--PKLIAIALDIARGMEYIHSQGV 305
+ C + +I +Y+ G+L+ +L+ + T+ + + + I + ARG+ Y+H++ +
Sbjct: 101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP--------GTYRWMAPEMIKH 357
IHRD+K N+L+D+ F KI DFGI+ D GT ++ PE
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGIS-----KKGTELDQTHLSTVVKGTLGYIDPE---- 211
Query: 358 KSYGR------KVDVYSFGLILWEMVAG------TIPYEEMN 387
Y K DVYSFG++L+E++ ++P E +N
Sbjct: 212 --YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-36
Identities = 39/297 (13%), Positives = 88/297 (29%), Gaps = 47/297 (15%)
Query: 134 LRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDLSQL-FLGLRFAHGAH 192
+ +E +S +S + + G E L + LG
Sbjct: 31 IPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLG----QEDP 86
Query: 193 SRLYHGIYKD--EPVAVKIIRIP--------DDDENETLAARLEKQFNREVALLSRLHNP 242
++ E V + + E L RL + + L
Sbjct: 87 YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146
Query: 243 NVIKFVAACKKPPVYC-------------VITEYLSEGSLRAYLHKL-----EHKTLPLP 284
V +K + + +L+ + L HK+L
Sbjct: 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHH 206
Query: 285 KLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP 344
+ + L + R + +H G++H L+P ++++DQ + + F + A
Sbjct: 207 ARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD---GARVVSS 263
Query: 345 GTYRWMAPEMIKHKS-----------YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390
+ + PE+ ++ D ++ GL+++ + +P + +
Sbjct: 264 VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALG 320
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-36
Identities = 49/204 (24%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G ++ +K +A K+I + + Q RE+ +L ++P ++
Sbjct: 43 AGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-------IRNQIIRELQVLHECNSPYIVG 95
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG-V 305
F A + E++ GSL L K +P L +++ + +G+ Y+ + +
Sbjct: 96 FYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKI 153
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMIKHKSYGRKV 364
+HRD+KP N+L++ +K+ DFG++ + + D++++ GT +M+PE ++ Y +
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSVQS 211
Query: 365 DVYSFGLILWEMVAGTIPYEEMNP 388
D++S GL L EM G P +
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPPPDA 235
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 18/220 (8%)
Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVI 245
GA+ + ++K + +AVK IR DE E +KQ ++ ++ R + P ++
Sbjct: 32 RGAYGSVNKMVHKPSGQIMAVKRIRS-TVDEKE------QKQLLMDLDVVMRSSDCPYIV 84
Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAY--LHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
+F A + + E +S + Y ++ + +P L I L + + ++
Sbjct: 85 QFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 304 G-VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIK----HK 358
+IHRD+KP N+L+D+ ++K+ DFGI+ + V A + D G +MAPE I +
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQ 204
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAA-FAVVN 397
Y + DV+S G+ L+E+ G PY + N + VV
Sbjct: 205 GYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 31/226 (13%)
Query: 189 HGAHSRLYHG--IYKDEPVAVKII------------------RIPDDDENETLAARLEKQ 228
G++ + + A+K++ +Q
Sbjct: 23 KGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82
Query: 229 FNREVALLSRLHNPNVIKFV---AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPK 285
+E+A+L +L +PNV+K V + +Y V E +++G + + K L +
Sbjct: 83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVF-ELVNQGPV---MEVPTLKPLSEDQ 138
Query: 286 LIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA-LSDDP 344
D+ +G+EY+H Q +IHRD+KP N+L+ ++ H+KIADFG++ E DA LS+
Sbjct: 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV 198
Query: 345 GTYRWMAPEMI--KHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMN 387
GT +MAPE + K + G+ +DV++ G+ L+ V G P+ +
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 59/231 (25%), Positives = 107/231 (46%), Gaps = 36/231 (15%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVI 245
+G + ++Y G + + A+K++ + D+E E +E+ +L + H+ N+
Sbjct: 34 NGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE---------IKQEINMLKKYSHHRNIA 84
Query: 246 KFVAACKKPPVYC------VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEY 299
+ A K ++ E+ GS+ + + TL + I +I RG+ +
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------GTYRWMAP 352
+H VIHRD+K +NVL+ + +K+ DFG++ + L GT WMAP
Sbjct: 145 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ------LDRTVGRRNTFIGTPYWMAP 198
Query: 353 EMIKHK-----SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
E+I +Y K D++S G+ EM G P +M+P++A F +
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 249
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 57/186 (30%), Positives = 100/186 (53%), Gaps = 8/186 (4%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
VAVKI+ + + + + + RE+ L +P++IK P + ++ E
Sbjct: 37 HKVAVKIL-----NRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91
Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
Y+S G L Y+ +H + + + I ++Y H V+HRDLKPENVL+D +
Sbjct: 92 YVSGGELFDYI--CKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN 149
Query: 323 LKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTI 381
KIADFG++ + L G+ + APE+I + Y G +VD++S G+IL+ ++ GT+
Sbjct: 150 AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTL 209
Query: 382 PYEEMN 387
P+++ +
Sbjct: 210 PFDDEH 215
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 29/228 (12%)
Query: 189 HGAHSRLYH-GIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIK 246
HGA + + G++ + VAVK I +REV LL PNVI+
Sbjct: 34 HGAEGTIVYRGMFDNRDVAVKRILP-----------ECFSFADREVQLLRESDEHPNVIR 82
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+ K + E +L+ Y+ + + + I + G+ ++HS ++
Sbjct: 83 YFCTEKDRQFQYIAIELC-AATLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140
Query: 307 HRDLKPENVLI-----DQEFHLKIADFGIAC----EEVYCDALSDDPGTYRWMAPEMIK- 356
HRDLKP N+LI + I+DFG+ S PGT W+APEM+
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 357 --HKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVNF 401
++ VD++S G + + +++ G+ P+ + Q A ++ +
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-ANILLGACSL 247
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-35
Identities = 54/215 (25%), Positives = 101/215 (46%), Gaps = 20/215 (9%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA ++ + K+ + V VK I+ E+ + + E+A+LSR+ + N+IK
Sbjct: 34 SGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIK 93
Query: 247 FVAACKKPPVYCVITEYLSEGS-LRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
+ + + ++ E G L A++ H L P I + + Y+ + +
Sbjct: 94 VLDIFENQGFFQLVMEKHGSGLDLFAFI--DRHPRLDEPLASYIFRQLVSAVGYLRLKDI 151
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACE-------EVYCDALSDDPGTYRWMAPEMIKHK 358
IHRD+K EN++I ++F +K+ DFG A +C GT + APE++
Sbjct: 152 IHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC-------GTIEYCAPEVLMGN 204
Query: 359 SY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAA 392
Y G +++++S G+ L+ +V P+ E+ A
Sbjct: 205 PYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA 239
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 132 bits (332), Expect = 4e-35
Identities = 38/219 (17%), Positives = 83/219 (37%), Gaps = 32/219 (14%)
Query: 189 HGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN 241
GA +++Y D + +K+ + + E + + L
Sbjct: 75 EGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG--------TQLMERLKPSMQ 126
Query: 242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH---KTLPLPKLIAIALDIARGME 298
+KF +A ++ E S G+L ++ ++ K +P +I+ A+ + +E
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIE 186
Query: 299 YIHSQGVIHRDLKPENVLI-----------DQEFHLKIADFGIACEEVYCD---ALSDDP 344
+H +IH D+KP+N ++ D L + D G + + +
Sbjct: 187 QVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC 246
Query: 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY 383
T + EM+ +K + ++D + ++ M+ GT
Sbjct: 247 ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 54/194 (27%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF--VAACKKPPVYCVI 260
AVKI+ + E +E+ LL RL + NVI+ V ++ ++
Sbjct: 31 CRRAVKIL----KKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV 86
Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
EY ++ L + K P+ + + G+EY+HSQG++H+D+KP N+L+
Sbjct: 87 MEYCV-CGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG 145
Query: 321 FHLKIADFGIACEEVYCDALSDDP-----GTYRWMAPEMIK-HKSY-GRKVDVYSFGLIL 373
LKI+ G+A E +DD G+ + PE+ ++ G KVD++S G+ L
Sbjct: 146 GTLKISALGVA--EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203
Query: 374 WEMVAGTIPYEEMN 387
+ + G P+E N
Sbjct: 204 YNITTGLYPFEGDN 217
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 5e-35
Identities = 39/199 (19%), Positives = 82/199 (41%), Gaps = 14/199 (7%)
Query: 192 HSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251
++ L K + +I + + + + ++ + N + +
Sbjct: 71 NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130
Query: 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLI-AIALDIARGMEYIHSQGVIHRDL 310
+ + + +L+ ++++ + I + IA +E++HS+G++HRDL
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDL 190
Query: 311 KPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-------------GTYRWMAPEMIKH 357
KP N+ + +K+ DFG+ + GT +M+PE I
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG 250
Query: 358 KSYGRKVDVYSFGLILWEM 376
+Y KVD++S GLIL+E+
Sbjct: 251 NNYSHKVDIFSLGLILFEL 269
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-35
Identities = 49/201 (24%), Positives = 82/201 (40%), Gaps = 39/201 (19%)
Query: 201 KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV- 259
++ VA+K++ + R RE RL P+V+ P++
Sbjct: 58 RERIVALKLMS-ETLSSDPVFRTR----MQREARTAGRLQEPHVV---------PIHDFG 103
Query: 260 --------ITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLK 311
++ L A L L P+ +AI I ++ H+ G HRD+K
Sbjct: 104 EIDGQLYVDMRLINGVDLAAMLR--RQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVK 161
Query: 312 PENVLIDQEFHLKIADFGIACEEVYCDALSDDP--------GTYRWMAPEMIKHKSYGRK 363
PEN+L+ + + DFGIA A +D+ GT +MAPE +
Sbjct: 162 PENILVSADDFAYLVDFGIA------SATTDEKLTQLGNTVGTLYYMAPERFSESHATYR 215
Query: 364 VDVYSFGLILWEMVAGTIPYE 384
D+Y+ +L+E + G+ PY+
Sbjct: 216 ADIYALTCVLYECLTGSPPYQ 236
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-35
Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 19/220 (8%)
Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVI 245
G +++ ++ +AVK +R ++ E K+ ++ ++ + H+ P ++
Sbjct: 35 SGTCGQVWKMRFRKTGHVIAVKQMRR-SGNKEE------NKRILMDLDVVLKSHDCPYIV 87
Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-G 304
+ + E + + + K +P L + + I + + Y+ + G
Sbjct: 88 QCFGTFITNTDVFIAMELMGTCAEKLK--KRMQGPIPERILGKMTVAIVKALYYLKEKHG 145
Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIK-----HKS 359
VIHRD+KP N+L+D+ +K+ DFGI+ V A G +MAPE I
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPD 205
Query: 360 YGRKVDVYSFGLILWEMVAGTIPYEEMNPI-QAAFAVVNK 398
Y + DV+S G+ L E+ G PY+ + V+ +
Sbjct: 206 YDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE 245
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 49/220 (22%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA+ + + + E VAVKI+ + A + +E+ + L++ NV+K
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIV-------DMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 247 F--VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR--------G 296
F + + EY S G L + +P A+ G
Sbjct: 70 FYGHRREGN--IQYLFLEYCSGGELFDRI--EPDIGMPE--------PDAQRFFHQLMAG 117
Query: 297 MEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWM------ 350
+ Y+H G+ HRD+KPEN+L+D+ +LKI+DFG+A + R +
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA-------TVFRYNNRERLLNKMCGT 170
Query: 351 ----APEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEE 385
APE++K + + VDV+S G++L M+AG +P+++
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 19/220 (8%)
Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVI 245
GA+ + + + +AVK IR + E +K+ ++ + R + P +
Sbjct: 17 RGAYGVVEKMRHVPSGQIMAVKRIRA-TVNSQE------QKRLLMDLDISMRTVDCPFTV 69
Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQ 303
F A + + E + + SL + ++ + +T+P L IA+ I + +E++HS+
Sbjct: 70 TFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 304 G-VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIK----HK 358
VIHRD+KP NVLI+ +K+ DFGI+ V A D G +MAPE I K
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQK 188
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVVN 397
Y K D++S G+ + E+ PY+ P Q VV
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE 228
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-34
Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 37/212 (17%)
Query: 196 YHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254
Y G D VAVK + E E QF EV ++S + N+++ C P
Sbjct: 47 YKGRLADGTLVAVKRL-------KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99
Query: 255 P----VYCVITEYLSEGSLRAYLHKLEHKTLPL--PKLIAIALDIARGMEYIHSQG---V 305
VY Y++ GS+ + L + PL PK IAL ARG+ Y+H +
Sbjct: 100 TERLLVY----PYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 155
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP---------GTYRWMAPEMIK 356
IHRD+K N+L+D+EF + DFG+A L D GT +APE +
Sbjct: 156 IHRDVKAANILLDEEFEAVVGDFGLA-------KLMDYKDTHVTTAVRGTIGHIAPEYLS 208
Query: 357 HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP 388
K DV+ +G++L E++ G ++
Sbjct: 209 TGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 69/286 (24%), Positives = 112/286 (39%), Gaps = 31/286 (10%)
Query: 114 LYKQPQQETKASSNSYSTSPLRHLGSLRVTERYKSRKESAWTKYFDHGGVRVNAVDAADE 173
Y + + + + R S K+ + F
Sbjct: 3 YYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKD------------ 50
Query: 174 HTVDLSQLFLGL-RFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFN 230
D +LF L HG+ +Y E VA+K + NE +
Sbjct: 51 ---DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW-----QDII 102
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
+EV L +L +PN I++ + ++ EY GS L ++ K L ++ A+
Sbjct: 103 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAVT 160
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWM 350
+G+ Y+HS +IHRD+K N+L+ + +K+ DFG A ++ GT WM
Sbjct: 161 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV---GTPYWM 217
Query: 351 APEMI---KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393
APE+I Y KVDV+S G+ E+ P MN + A +
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 263
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-34
Identities = 57/186 (30%), Positives = 96/186 (51%), Gaps = 9/186 (4%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
+ VA+K I + + + RE++ L L +P++IK P ++ E
Sbjct: 35 QKVALKFI-----SRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89
Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
Y G L Y+ +E K + + I +EY H ++HRDLKPEN+L+D +
Sbjct: 90 YAG-GELFDYI--VEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN 146
Query: 323 LKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTI 381
+KIADFG++ + L G+ + APE+I K Y G +VDV+S G++L+ M+ G +
Sbjct: 147 VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRL 206
Query: 382 PYEEMN 387
P+++
Sbjct: 207 PFDDEF 212
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 49/220 (22%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA+ + + + E VAVKI+ + A + +E+ + L++ NV+K
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIV-------DMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 247 F--VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR--------G 296
F + + EY S G L + +P A+ G
Sbjct: 70 FYGHRREGN--IQYLFLEYCSGGELFDRI--EPDIGMPE--------PDAQRFFHQLMAG 117
Query: 297 MEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWM------ 350
+ Y+H G+ HRD+KPEN+L+D+ +LKI+DFG+A + R +
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA-------TVFRYNNRERLLNKMCGT 170
Query: 351 ----APEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEE 385
APE++K + + VDV+S G++L M+AG +P+++
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-33
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 12/208 (5%)
Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
GA + + + VA++II A E+ +L +L++P +IK
Sbjct: 146 GACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 205
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
Y ++ E + G L + + +K L + ++Y+H G+IH
Sbjct: 206 KNFFDAEDYY-IVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 262
Query: 308 RDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI---KHKSYG 361
RDLKPENVL+ +++ +KI DFG + + GT ++APE++ Y
Sbjct: 263 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYN 322
Query: 362 RKVDVYSFGLILWEMVAGTIP-YEEMNP 388
R VD +S G+IL+ ++G P E
Sbjct: 323 RAVDCWSLGVILFICLSGYPPFSEHRTQ 350
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 14/212 (6%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN--PNV 244
G +Y GI PVA+K + D ++ + EV LL ++ + V
Sbjct: 53 SGGFGSVYSGIRVSDNLPVAIKHV--EKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 245 IKFVAACKKPPVYCVITEYLS-EGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
I+ + ++P + +I E L ++ E L + + + + H+
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHNC 168
Query: 304 GVIHRDLKPENVLIDQE-FHLKIADFGIACEEVYCDALSDDP-GTYRWMAPEMIKHKSY- 360
GV+HRD+K EN+LID LK+ DFG + D + D GT + PE I++ Y
Sbjct: 169 GVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 226
Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAA 392
GR V+S G++L++MV G IP+E I
Sbjct: 227 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 258
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 6e-33
Identities = 26/237 (10%), Positives = 68/237 (28%), Gaps = 41/237 (17%)
Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
G S ++ + E A+K+ + + ++ + +RL + +
Sbjct: 73 GDRSVVFLVRDVERLEDFALKVFTMG-----AENSRSELERLHEATFAAARLLGESPEEA 127
Query: 248 VAACK------------KPPVYCVITEY-------------LSEGSLRAYLHKL-----E 277
+ +PP + + L L
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 278 HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337
+ L + + R + S+G++H P+N+ I + L + D +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV--G 245
Query: 338 DALSDDPGTYRWMAPEMIKHKS--YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAA 392
+ E + + + ++ + GL ++ + +P+ + P
Sbjct: 246 TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-33
Identities = 50/238 (21%), Positives = 98/238 (41%), Gaps = 45/238 (18%)
Query: 189 HGAHSRLYH-GIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIK 246
+G+ + G ++ PVAVK + I E+ LL+ + PNVI+
Sbjct: 25 YGSSGTVVFQGSFQGRPVAVKRMLI-----------DFCDIALMEIKLLTESDDHPNVIR 73
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHK-----LEHKTLPLPKLIAIALDIARGMEYIH 301
+ + + E +L+ + K I++ IA G+ ++H
Sbjct: 74 YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 302 SQGVIHRDLKPENVLID-------------QEFHLKIADFGIAC-----EEVYCDALSDD 343
S +IHRDLKP+N+L+ + + I+DFG+ + + L++
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 344 PGTYRWMAPEMIK-------HKSYGRKVDVYSFGLILWEMV-AGTIPYEEMNPIQAAF 393
GT W APE+++ + R +D++S G + + ++ G P+ + ++
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 58/186 (31%), Positives = 100/186 (53%), Gaps = 8/186 (4%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
VAVKI+ + + + + + RE+ L +P++IK P ++ E
Sbjct: 42 HKVAVKIL-----NRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96
Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
Y+S G L Y+ ++ L + + I G++Y H V+HRDLKPENVL+D +
Sbjct: 97 YVSGGELFDYI--CKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN 154
Query: 323 LKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTI 381
KIADFG++ + L G+ + APE+I + Y G +VD++S G+IL+ ++ GT+
Sbjct: 155 AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTL 214
Query: 382 PYEEMN 387
P+++ +
Sbjct: 215 PFDDDH 220
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 59/245 (24%), Positives = 109/245 (44%), Gaps = 15/245 (6%)
Query: 145 RYKSRKESAWTKYFDHGGVRVNAVDAADEHTVDLSQLF-LGLRFAHGAHSRLYHGIYK-- 201
+ S + G ++ LS+++ + GA+ + K
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
A+KIIR +++ + EVA+L L +PN++K + Y ++
Sbjct: 62 HVERAIKIIRK------TSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115
Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---D 318
E G L + + I + G+ Y+H ++HRDLKPEN+L+ +
Sbjct: 116 ECYKGGELFDEI--IHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE 173
Query: 319 QEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
++ +KI DFG++ + + GT ++APE+++ K Y K DV+S G+IL+ ++A
Sbjct: 174 KDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLA 232
Query: 379 GTIPY 383
G P+
Sbjct: 233 GYPPF 237
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 68/337 (20%), Positives = 136/337 (40%), Gaps = 48/337 (14%)
Query: 57 NSSQSQQNPAANKPRSVSPLPETVLPDTFKEARSATKRFSTPHPRRKESDKGLVGKFLYK 116
+ S + NK R + LP+ +E R A R P + + K
Sbjct: 5 HHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDA 64
Query: 117 QPQQETKASSNSYSTSPLRHLGSL--RVTERYKSRKESAWTKYFDHGGVRVNAVDAADEH 174
QP+ S + ++Y +
Sbjct: 65 QPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDV----------------------- 101
Query: 175 TVDLSQLFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNRE 232
+G G S + +++ AVKI+ + + + + + RE
Sbjct: 102 --------IG----RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRE 149
Query: 233 VALLSRLHN-PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
+L ++ P++I + + + ++ + + +G L YL E L + +I
Sbjct: 150 THILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL--TEKVALSEKETRSIMR 207
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
+ + ++H+ ++HRDLKPEN+L+D ++++DFG +C + L + GT ++A
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLA 267
Query: 352 PEMIK------HKSYGRKVDVYSFGLILWEMVAGTIP 382
PE++K H YG++VD+++ G+IL+ ++AG+ P
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 35/258 (13%), Positives = 73/258 (28%), Gaps = 41/258 (15%)
Query: 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDD--------ENETLAARLEKQF 229
L G + E V + + + E L RL +
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYL---------------- 273
+ L V +K + V + L +
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 274 --HKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331
H HK+L + + L + R + +H G++H L+P ++++DQ + + F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 258
Query: 332 CEEVYCDALSDDPGTYRWMAPEMI----------KHKSYGRKVDVYSFGLILWEMVAGTI 381
+ A + P + PE D ++ GL ++ + +
Sbjct: 259 VRD---GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 382 PYEEMNPIQAAFAVVNKV 399
P + + + +
Sbjct: 316 PNTDDAALGGSEWIFRSC 333
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 57/217 (26%), Positives = 88/217 (40%), Gaps = 22/217 (10%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKII---RIPDDDENETLAARLEKQFNREVALLSRLHN-- 241
G ++ G VA+K+I R+ EVALL ++
Sbjct: 41 KGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSV-TCP----LEVALLWKVGAGG 95
Query: 242 --PNVIKFVAACKKPPVYCVITEYLSEGS-LRAYLHKLEHKTLPLPKLIAIALDIARGME 298
P VI+ + + + ++ E L Y+ E L + ++
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI--TEKGPLGEGPSRCFFGQVVAAIQ 153
Query: 299 YIHSQGVIHRDLKPENVLIDQE-FHLKIADFGIACEEVYCDALSDDP-GTYRWMAPEMIK 356
+ HS+GV+HRD+K EN+LID K+ DFG + D D GT + PE I
Sbjct: 154 HCHSRGVVHRDIKDENILIDLRRGCAKLIDFG--SGALLHDEPYTDFDGTRVYSPPEWIS 211
Query: 357 HKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAA 392
Y V+S G++L++MV G IP+E I A
Sbjct: 212 RHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEA 248
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 189 HGAHSRLYHGIYK--DEPVAVKIIR-----IPDDDENETLAARLEKQFNREVALLSRLHN 241
GA+ + K A+K+I+ ++ + ++ E++LL L +
Sbjct: 46 SGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH 105
Query: 242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
PN+IK + + ++TE+ G L + + I I G+ Y+H
Sbjct: 106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI--INRHKFDECDAANIMKQILSGICYLH 163
Query: 302 SQGVIHRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK 358
++HRD+KPEN+L+ + ++KI DFG++ L D GT ++APE++K K
Sbjct: 164 KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-K 222
Query: 359 SYGRKVDVYSFGLILWEMVAGTIP 382
Y K DV+S G+I++ ++ G P
Sbjct: 223 KYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 52/200 (26%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G+ + K + AVK+I + ++ REV LL +L +PN++K
Sbjct: 36 KGSFGEVILCKDKITGQECAVKVISK-----RQVKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+ + ++ E + G L + + K I + G+ Y+H ++
Sbjct: 91 LYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQVLSGITYMHKNKIV 148
Query: 307 HRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRK 363
HRDLKPEN+L+ ++ +++I DFG++ + D GT ++APE++ +Y K
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-GTYDEK 207
Query: 364 VDVYSFGLILWEMVAGTIPY 383
DV+S G+IL+ +++G P+
Sbjct: 208 CDVWSTGVILYILLSGCPPF 227
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 59/196 (30%), Positives = 85/196 (43%), Gaps = 30/196 (15%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
E VAVK I E +++ RE+ L +PN+++F P +I E
Sbjct: 46 ELVAVKYI------ERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96
Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR--------GMEYIHSQGVIHRDLKPEN 314
Y S G L + D AR G+ Y HS + HRDLK EN
Sbjct: 97 YASGGELYERI--CNAGRFSE--------DEARFFFQQLLSGVSYCHSMQICHRDLKLEN 146
Query: 315 VLIDQEF--HLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGL 371
L+D LKI DFG + V GT ++APE++ + Y G+ DV+S G+
Sbjct: 147 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGV 206
Query: 372 ILWEMVAGTIPYEEMN 387
L+ M+ G P+E+
Sbjct: 207 TLYVMLVGAYPFEDPE 222
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 58/204 (28%), Positives = 107/204 (52%), Gaps = 12/204 (5%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRI-PDDDENETLAARLEKQFNREVALLSRLHN-PNV 244
G S + I+K + AVKII + + L + +EV +L ++ PN+
Sbjct: 27 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304
I+ + + ++ + + +G L YL E TL + I + + +H
Sbjct: 87 IQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIK------HK 358
++HRDLKPEN+L+D + ++K+ DFG +C+ + L + GT ++APE+I+ H
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP 204
Query: 359 SYGRKVDVYSFGLILWEMVAGTIP 382
YG++VD++S G+I++ ++AG+ P
Sbjct: 205 GYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 53/199 (26%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G+ + + + AVK+I + + REV LL +L +PN++K
Sbjct: 32 KGSFGEVLKCKDRITQQEYAVKVINK------ASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+ + ++ E + G L + ++ K I + G+ Y+H ++
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMHKHNIV 143
Query: 307 HRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRK 363
HRDLKPEN+L+ +++ +KI DFG++ + D GT ++APE+++ +Y K
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTYDEK 202
Query: 364 VDVYSFGLILWEMVAGTIP 382
DV+S G+IL+ +++GT P
Sbjct: 203 CDVWSAGVILYILLSGTPP 221
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 49/183 (26%), Positives = 94/183 (51%), Gaps = 13/183 (7%)
Query: 206 AVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
A K + E L EKQ +L ++++ V+ A + C++
Sbjct: 213 ACKKLEKKRIKKRKGEAMALN---EKQ------ILEKVNSRFVVSLAYAYETKDALCLVL 263
Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
++ G L+ +++ + P + + A +I G+E +H + +++RDLKPEN+L+D
Sbjct: 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG 323
Query: 322 HLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI 381
H++I+D G+A + GT +MAPE++K++ Y D ++ G +L+EM+AG
Sbjct: 324 HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383
Query: 382 PYE 384
P++
Sbjct: 384 PFQ 386
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 53/193 (27%), Positives = 88/193 (45%), Gaps = 10/193 (5%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
+ VA+KII A E+ +L +L++P +IK Y ++ E
Sbjct: 36 KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYY-IVLE 94
Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---DQ 319
+ G L + + +K L + ++Y+H G+IHRDLKPENVL+ ++
Sbjct: 95 LMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE 152
Query: 320 EFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI---KHKSYGRKVDVYSFGLILWEM 376
+ +KI DFG + + GT ++APE++ Y R VD +S G+IL+
Sbjct: 153 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 212
Query: 377 VAGTIP-YEEMNP 388
++G P E
Sbjct: 213 LSGYPPFSEHRTQ 225
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 48/169 (28%), Positives = 85/169 (50%), Gaps = 15/169 (8%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL--- 286
RE ++SRL +P +K + Y G L Y+ K+ +
Sbjct: 78 TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137
Query: 287 -IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP- 344
I AL EY+H +G+IHRDLKPEN+L++++ H++I DFG + + ++
Sbjct: 138 EIVSAL------EYLHGKGIIHRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARAN 190
Query: 345 ---GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390
GT ++++PE++ KS + D+++ G I++++VAG P+ N
Sbjct: 191 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-30
Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 21/204 (10%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKII---RIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
GA ++ + +K I R E Q E+ +L L +PN
Sbjct: 32 SGAFGDVHLVEERSSGLERVIKTINKDRSQVPME----------QIEAEIEVLKSLDHPN 81
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL--DIARGMEYIH 301
+IK + ++ E G L + + + L + L + + Y H
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 302 SQGVIHRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK 358
SQ V+H+DLKPEN+L +KI DFG+A + ++ GT +MAPE+ K +
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-R 200
Query: 359 SYGRKVDVYSFGLILWEMVAGTIP 382
K D++S G++++ ++ G +P
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 48/193 (24%), Positives = 93/193 (48%), Gaps = 30/193 (15%)
Query: 206 AVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
A K + + EK+ +L+++H+ ++ A + C++
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMV---EKK------ILAKVHSRFIVSLAYAFETKTDLCLVM 264
Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAI--ALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
++ G +R +++ ++ + AI I G+E++H + +I+RDLKPENVL+D
Sbjct: 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDD 324
Query: 320 EFHLKIADFGIACEEV--------YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGL 371
+ +++I+D G+A E Y GT +MAPE++ + Y VD ++ G+
Sbjct: 325 DGNVRISDLGLAVELKAGQTKTKGYA-------GTPGFMAPELLLGEEYDFSVDYFALGV 377
Query: 372 ILWEMVAGTIPYE 384
L+EM+A P+
Sbjct: 378 TLYEMIAARGPFR 390
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-30
Identities = 30/191 (15%), Positives = 78/191 (40%), Gaps = 18/191 (9%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G ++ + + K +++ D+ +E+++L+ + N++
Sbjct: 15 RGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL---------VKKEISILNIARHRNILH 65
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL--DIARGMEYIHSQG 304
+ + +I E++S + ++ L + ++ + ++++HS
Sbjct: 66 LHESFESMEELVMIFEFISGLDI---FERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 305 VIHRDLKPENVLI--DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGR 362
+ H D++PEN++ + +KI +FG A + D + APE+ +H
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 363 KVDVYSFGLIL 373
D++S G ++
Sbjct: 183 ATDMWSLGTLV 193
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 51/242 (21%), Positives = 97/242 (40%), Gaps = 52/242 (21%)
Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
G++ + I A+KI+ + + + ++ EV L+ +LH+PN+ +
Sbjct: 37 GSYGVVRVAIENQTRAIRAIKIMNKN---KIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLI-------------------- 287
+ C++ E G L L+ + +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 288 ------------------AIALDIARGMEYIHSQGVIHRDLKPENVLI--DQEFHLKIAD 327
I I + Y+H+QG+ HRD+KPEN L ++ F +K+ D
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVD 213
Query: 328 FGIA-----CEEVYCDALSDDPGTYRWMAPEMIK--HKSYGRKVDVYSFGLILWEMVAGT 380
FG++ ++ GT ++APE++ ++SYG K D +S G++L ++ G
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
Query: 381 IP 382
+P
Sbjct: 274 VP 275
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-29
Identities = 50/190 (26%), Positives = 96/190 (50%), Gaps = 13/190 (6%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA S + ++K A KII + L+AR ++ RE + +L +PN+++
Sbjct: 16 KGAFSVVRRCVHKTTGLEFAAKIINT------KKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+ ++ + ++ + ++ G L + + + I + Y HS G++
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESIAYCHSNGIV 127
Query: 307 HRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRK 363
HR+LKPEN+L+ + +K+ADFG+A E +A GT +++PE++K Y +
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 187
Query: 364 VDVYSFGLIL 373
VD+++ G+IL
Sbjct: 188 VDIWACGVIL 197
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 47/217 (21%), Positives = 85/217 (39%), Gaps = 44/217 (20%)
Query: 186 RFAHGAHSRLYHGIYKDE-----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
AHG +Y D PV +K + D E A E L+ +
Sbjct: 87 CIAHGGLGWIYLA--LDRNVNGRPVVLKGLVHSGDAE---AQAM----AMAERQFLAEVV 137
Query: 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAY----------LHKLEHKTLPLPKLIAIA 290
+P++++ ++ + G Y L + + + LP+ + IA
Sbjct: 138 HPSIVQ---------IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYL 188
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP---GTY 347
L+I + Y+HS G+++ DLKPEN+++ +E LK+ D G ++ GT
Sbjct: 189 LEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAV------SRINSFGYLYGTP 241
Query: 348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384
+ APE+++ D+Y+ G L +
Sbjct: 242 GFQAPEIVRTGPTVAT-DIYTVGRTLAALTLDLPTRN 277
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-29
Identities = 53/200 (26%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G+ + + + AVK+I + + REV LL +L +PN++K
Sbjct: 32 KGSFGEVLKCKDRITQQEYAVKVINK------ASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHK-LEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
+ + ++ E + G L + ++ K I + G+ Y+H +
Sbjct: 86 LFEILEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 306 IHRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGR 362
+HRDLKPEN+L+ +++ +KI DFG++ + D GT ++APE+++ +Y
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTYDE 201
Query: 363 KVDVYSFGLILWEMVAGTIP 382
K DV+S G+IL+ +++GT P
Sbjct: 202 KCDVWSAGVILYILLSGTPP 221
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-29
Identities = 47/176 (26%), Positives = 85/176 (48%), Gaps = 10/176 (5%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
+ A K I+ + +R ++ REV +L + +PN+I + +I E
Sbjct: 31 KEYAAKFIKKRRLSSSRRGVSR--EEIEREVNILREIRHPNIITLHDIFENKTDVVLILE 88
Query: 263 YLSEGSLRAYLHKL-EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---- 317
+S G L L E ++L + I G+ Y+HS+ + H DLKPEN+++
Sbjct: 89 LVSGGEL---FDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKN 145
Query: 318 DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
+K+ DFGIA + + + GT ++APE++ ++ G + D++S G+I
Sbjct: 146 VPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-29
Identities = 46/194 (23%), Positives = 88/194 (45%), Gaps = 13/194 (6%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G S + I ++ + AVKI+ + + L+ + RE ++ L +P++++
Sbjct: 34 KGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLS---TEDLKREASICHMLKHPHIVE 90
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL--DIARGMEYIHSQG 304
+ + ++ E++ L + K + +A I + Y H
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150
Query: 305 VIHRDLKPENVLI---DQEFHLKIADFGIACEEVYCD--ALSDDPGTYRWMAPEMIKHKS 359
+IHRD+KP VL+ + +K+ FG+A ++ GT +MAPE++K +
Sbjct: 151 IIHRDVKPHCVLLASKENSAPVKLGGFGVAI-QLGESGLVAGGRVGTPHFMAPEVVKREP 209
Query: 360 YGRKVDVYSFGLIL 373
YG+ VDV+ G+IL
Sbjct: 210 YGKPVDVWGCGVIL 223
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-29
Identities = 44/200 (22%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA ++ + A K + P + + E +E+ +S L +P ++
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTPHESDKE--------TVRKEIQTMSVLRHPTLVN 218
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL--DIARGMEYIHSQG 304
A + +I E++S G L K+ + + + A+ + +G+ ++H
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 305 VIHRDLKPENVLI--DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGR 362
+H DLKPEN++ + LK+ DFG+ ++ GT + APE+ + K G
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 335
Query: 363 KVDVYSFGLILWEMVAGTIP 382
D++S G++ + +++G P
Sbjct: 336 YTDMWSVGVLSYILLSGLSP 355
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 56/197 (28%), Positives = 104/197 (52%), Gaps = 37/197 (18%)
Query: 206 AVKIIR---IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
A+K+++ + D T E+ +L +++P ++K A + +I +
Sbjct: 56 AMKVLKKATLKVRDRVRTKM---ERD------ILVEVNHPFIVKLHYAFQTEGKLYLILD 106
Query: 263 YLSEGSLRAYLHKLEHKTLPLPKL----IAIALDIARGMEYIHSQGVIHRDLKPENVLID 318
+L G L L K T K +A+AL +++HS G+I+RDLKPEN+L+D
Sbjct: 107 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL------DHLHSLGIIYRDLKPENILLD 160
Query: 319 QEFHLKIADFGIACEEV--------YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFG 370
+E H+K+ DFG++ E + +C GT +MAPE++ + + + D +SFG
Sbjct: 161 EEGHIKLTDFGLSKESIDHEKKAYSFC-------GTVEYMAPEVVNRRGHTQSADWWSFG 213
Query: 371 LILWEMVAGTIPYEEMN 387
++++EM+ GT+P++ +
Sbjct: 214 VLMFEMLTGTLPFQGKD 230
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 39/181 (21%), Positives = 73/181 (40%), Gaps = 22/181 (12%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVIT 261
+ A K ++ + E+A+L P VI + +I
Sbjct: 55 QEYAAKFLKKR------RRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL 108
Query: 262 EYLSEGSL------RAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV 315
EY + G + E+ I + I G+ Y+H ++H DLKP+N+
Sbjct: 109 EYAAGGEIFSLCLPELAEMVSENDV------IRLIKQILEGVYYLHQNNIVHLDLKPQNI 162
Query: 316 LI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLI 372
L+ +KI DFG++ + + L + GT ++APE++ + D+++ G+I
Sbjct: 163 LLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGII 222
Query: 373 L 373
Sbjct: 223 A 223
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 35/198 (17%)
Query: 206 AVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
A+K+++ + T E+ +LS + +P +I+ + +I
Sbjct: 35 AMKVLKKEIVVRLKQVEHTND---ERL------MLSIVTHPFIIRMWGTFQDAQQIFMIM 85
Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKL----IAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
+Y+ G L + L K + P+ K + +AL EY+HS+ +I+RDLKPEN+L+
Sbjct: 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL------EYLHSKDIIYRDLKPENILL 139
Query: 318 DQEFHLKIADFGIACEEV-----YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLI 372
D+ H+KI DFG A C GT ++APE++ K Y + +D +SFG++
Sbjct: 140 DKNGHIKITDFGFAKYVPDVTYTLC-------GTPDYIAPEVVSTKPYNKSIDWWSFGIL 192
Query: 373 LWEMVAGTIPYEEMNPIQ 390
++EM+AG P+ + N ++
Sbjct: 193 IYEMLAGYTPFYDSNTMK 210
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 46/194 (23%), Positives = 86/194 (44%), Gaps = 24/194 (12%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA S ++ + + A+K I+ A + E+A+L ++ + N++
Sbjct: 19 SGAFSEVFLVKQRLTGKLFALKCIK--------KSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 247 FVAACKKPPVYCVITEYLSEGSL----RAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
+ Y ++ + +S G L E + + ++Y+H
Sbjct: 71 LEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDA------SLVIQQVLSAVKYLHE 124
Query: 303 QGVIHRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKS 359
G++HRDLKPEN+L ++ + I DFG++ E +S GT ++APE++ K
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-NGIMSTACGTPGYVAPEVLAQKP 183
Query: 360 YGRKVDVYSFGLIL 373
Y + VD +S G+I
Sbjct: 184 YSKAVDCWSIGVIT 197
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 50/190 (26%), Positives = 96/190 (50%), Gaps = 13/190 (6%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA S + ++K A KII + L+AR ++ RE + +L +PN+++
Sbjct: 39 KGAFSVVRRCVHKTTGLEFAAKIINT------KKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+ ++ + ++ + ++ G L + + + I + Y HS G++
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESIAYCHSNGIV 150
Query: 307 HRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRK 363
HR+LKPEN+L+ + +K+ADFG+A E +A GT +++PE++K Y +
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 210
Query: 364 VDVYSFGLIL 373
VD+++ G+IL
Sbjct: 211 VDIWACGVIL 220
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 47/175 (26%), Positives = 86/175 (49%), Gaps = 8/175 (4%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
A K I+ + +R ++ REV++L ++ + NVI + +I E
Sbjct: 38 LEYAAKFIKKRQSRASRRGVSR--EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILE 95
Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI----D 318
+S G L +L + E L + + I G+ Y+H++ + H DLKPEN+++
Sbjct: 96 LVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI 153
Query: 319 QEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
H+K+ DFG+A E + GT ++APE++ ++ G + D++S G+I
Sbjct: 154 PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-28
Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 45/212 (21%)
Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVI 245
G +S ++ I +E V VKI++ P +K+ RE+ +L L PN+I
Sbjct: 46 RGKYSEVFEAINITNNEKVVVKILK-PVK----------KKKIKREIKILENLRGGPNII 94
Query: 246 K----FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL-DIARGMEYI 300
+ P + E+++ + L I + +I + ++Y
Sbjct: 95 TLADIVKDPVSRTPAL--VFEHVNNTDFKQLYQTLT------DYDIRFYMYEILKALDYC 146
Query: 301 HSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVYCDALSDDPGTY-------RWM-A 351
HS G++HRD+KP NV+ID E L++ D+G+A E Y PG R+
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA--EFY------HPGQEYNVRVASRYFKG 198
Query: 352 PE-MIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
PE ++ ++ Y +D++S G +L M+ P
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 47/175 (26%), Positives = 86/175 (49%), Gaps = 8/175 (4%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
A K I+ + R ++ REV++L ++ +PN+I + +I E
Sbjct: 38 LEYAAKFIKKRQSRASRRGVCR--EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILE 95
Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI----D 318
+S G L +L + E L + + I G+ Y+H++ + H DLKPEN+++
Sbjct: 96 LVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI 153
Query: 319 QEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
H+K+ DFG+A E + GT ++APE++ ++ G + D++S G+I
Sbjct: 154 PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 31/196 (15%)
Query: 206 AVKIIR---IPDDDENE-TLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
A+KI+ + + E TL E +L ++ P ++K + K ++
Sbjct: 70 AMKILDKQKVVKLKQIEHTLN---------EKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIA--IALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319
EY++ G + ++L ++ + P + A I L EY+HS +I+RDLKPEN+LIDQ
Sbjct: 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLHSLDLIYRDLKPENLLIDQ 176
Query: 320 EFHLKIADFGIACEEV-----YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILW 374
+ ++++ DFG A C GT +APE+I K Y + VD ++ G++++
Sbjct: 177 QGYIQVTDFGFAKRVKGRTWTLC-------GTPEALAPEIILSKGYNKAVDWWALGVLIY 229
Query: 375 EMVAGTIPYEEMNPIQ 390
EM AG P+ PIQ
Sbjct: 230 EMAAGYPPFFADQPIQ 245
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-28
Identities = 44/199 (22%), Positives = 83/199 (41%), Gaps = 16/199 (8%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G+ + + K A K I +F +E+ ++ L +PN+I+
Sbjct: 19 RGSWGEVKIAVQKGTRIRRAAKKIP--------KYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+ ++ E + G L + + + I D+ + Y H V
Sbjct: 71 LYETFEDNTDIYLVMELCTGGELFERV--VHKRVFRESDAARIMKDVLSAVAYCHKLNVA 128
Query: 307 HRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRK 363
HRDLKPEN L + LK+ DFG+A + GT +++P++++ YG +
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE-GLYGPE 187
Query: 364 VDVYSFGLILWEMVAGTIP 382
D +S G++++ ++ G P
Sbjct: 188 CDEWSAGVMMYVLLCGYPP 206
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 46/162 (28%), Positives = 81/162 (50%), Gaps = 13/162 (8%)
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL--- 286
+E+ ++ L +P ++ + + ++ + L G LR +L + H KL
Sbjct: 63 FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC 122
Query: 287 -IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPG 345
+ +AL +Y+ +Q +IHRD+KP+N+L+D+ H+ I DF IA ++ G
Sbjct: 123 ELVMAL------DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAG 176
Query: 346 TYRWMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYE 384
T +MAPEM + Y VD +S G+ +E++ G PY
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH 218
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 47/176 (26%), Positives = 85/176 (48%), Gaps = 10/176 (5%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
A K I+ + +R + REV++L + +PNVI + +I E
Sbjct: 37 LQYAAKFIKKRRTKSSRRGVSR--EDIEREVSILKEIQHPNVITLHEVYENKTDVILILE 94
Query: 263 YLSEGSLRAYLHKL-EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---- 317
++ G L L E ++L + I G+ Y+HS + H DLKPEN+++
Sbjct: 95 LVAGGEL---FDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN 151
Query: 318 DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
+ +KI DFG+A + + + + GT ++APE++ ++ G + D++S G+I
Sbjct: 152 VPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 56/196 (28%), Positives = 92/196 (46%), Gaps = 29/196 (14%)
Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA S +Y K +P A+K+++ D +K E+ +L RL +PN+IK
Sbjct: 63 RGATSIVYRCKQKGTQKPYALKVLKKTVD----------KKIVRTEIGVLLRLSHPNIIK 112
Query: 247 FVAACKKPPVYCVITEYLSEGSL------RAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
+ P ++ E ++ G L + Y E I + Y+
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGYYS--ERDA------ADAVKQILEAVAYL 164
Query: 301 HSQGVIHRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKH 357
H G++HRDLKPEN+L + LKIADFG++ + + GT + APE+++
Sbjct: 165 HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG 224
Query: 358 KSYGRKVDVYSFGLIL 373
+YG +VD++S G+I
Sbjct: 225 CAYGPEVDMWSVGIIT 240
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 42/199 (21%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
GA ++ + K K I P + E++++++LH+P +I
Sbjct: 62 GAFGVVHRCVEKATGRVFVAKFINTPYPLDKY--------TVKNEISIMNQLHHPKLINL 113
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL--DIARGMEYIHSQGV 305
A + +I E+LS G L ++ + + + I G++++H +
Sbjct: 114 HDAFEDKYEMVLILEFLSGGEL---FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 170
Query: 306 IHRDLKPENVLI--DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRK 363
+H D+KPEN++ + +KI DFG+A + + + T + APE++ + G
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFY 230
Query: 364 VDVYSFGLILWEMVAGTIP 382
D+++ G++ + +++G P
Sbjct: 231 TDMWAIGVLGYVLLSGLSP 249
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 65/291 (22%), Positives = 119/291 (40%), Gaps = 32/291 (10%)
Query: 99 HPRRKESDKGLVGKFLYKQPQQET---KASSNSYSTSPLRHLGSLRVTERYKSRKESAWT 155
H S L + LY Q + + + S + L KS++ SA
Sbjct: 4 HHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALA 63
Query: 156 KY-------FDHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD--EPVA 206
FDH V +TV +++ LG G +++ +A
Sbjct: 64 VDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEI-LG----GGRFGQVHKCEETATGLKLA 118
Query: 207 VKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSE 266
KII+ + E + E++++++L + N+I+ A + ++ EY+
Sbjct: 119 AKIIKTRGMKDKE--------EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170
Query: 267 GSLRAYLHKLEHKTLPLPKLIAIAL--DIARGMEYIHSQGVIHRDLKPENVLI--DQEFH 322
G L ++ ++ L +L I I G+ ++H ++H DLKPEN+L
Sbjct: 171 GEL---FDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQ 227
Query: 323 LKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
+KI DFG+A + L + GT ++APE++ + D++S G+I
Sbjct: 228 IKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 3e-27
Identities = 54/191 (28%), Positives = 97/191 (50%), Gaps = 29/191 (15%)
Query: 206 AVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
A+K ++ + DDD T+ EK+ L +P + + +
Sbjct: 46 AIKALKKDVVLMDDDVECTMV---EKR-----VLSLAWEHPFLTHMFCTFQTKENLFFVM 97
Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
EYL+ G L ++ L + A +I G++++HS+G+++RDLK +N+L+D++
Sbjct: 98 EYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG 155
Query: 322 HLKIADFGIACEEV--------YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
H+KIADFG+ E + +C GT ++APE++ + Y VD +SFG++L
Sbjct: 156 HIKIADFGMCKENMLGDAKTNTFC-------GTPDYIAPEILLGQKYNHSVDWWSFGVLL 208
Query: 374 WEMVAGTIPYE 384
+EM+ G P+
Sbjct: 209 YEMLIGQSPFH 219
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 26/219 (11%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQF 229
+ +DL LG G+ S ++K + AVKII + R+E
Sbjct: 8 QHYDLDLKDKPLG----EGSFSICRKCVHKKSNQAFAVKII-----------SKRMEANT 52
Query: 230 NREVALLSRL-HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK-LEHKTLPLPKLI 287
+E+ L +PN++K ++ E L+ G L + + K +
Sbjct: 53 QKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL---FERIKKKKHFSETEAS 109
Query: 288 AIALDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIACE-EVYCDALSDD 343
I + + ++H GV+HRDLKPEN+L + +KI DFG A L
Sbjct: 110 YIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP 169
Query: 344 PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
T + APE++ Y D++S G+IL+ M++G +P
Sbjct: 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 52/191 (27%), Positives = 95/191 (49%), Gaps = 30/191 (15%)
Query: 206 AVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
A+KI+R I D+ T+ E + +L +P + A + C +
Sbjct: 34 AMKILRKEVIIAKDEVAHTVT---ESR------VLQNTRHPFLTALKYAFQTHDRLCFVM 84
Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
EY + G L +L + + + +I +EY+HS+ V++RD+K EN+++D++
Sbjct: 85 EYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG 142
Query: 322 HLKIADFGIACEEVY--------CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
H+KI DFG+ E + C GT ++APE+++ YGR VD + G+++
Sbjct: 143 HIKITDFGLCKEGISDGATMKTFC-------GTPEYLAPEVLEDNDYGRAVDWWGLGVVM 195
Query: 374 WEMVAGTIPYE 384
+EM+ G +P+
Sbjct: 196 YEMMCGRLPFY 206
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 21/185 (11%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP------- 255
VA+K ++ +N+T A R RE+ L+ +++ N+I +
Sbjct: 51 RNVAIK--KLSRPFQNQTHAKRAY----RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104
Query: 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV 315
VY V E + A L ++ L ++ + + G++++HS G+IHRDLKP N+
Sbjct: 105 VYIV-MELMD-----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 158
Query: 316 LIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWM-APEMIKHKSYGRKVDVYSFGLILW 374
++ + LKI DFG+A ++ T R+ APE+I Y VD++S G I+
Sbjct: 159 VVKSDCTLKILDFGLARTAGTSFMMTPYVVT-RYYRAPEVILGMGYKENVDIWSVGCIMG 217
Query: 375 EMVAG 379
EM+ G
Sbjct: 218 EMIKG 222
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 4e-27
Identities = 45/133 (33%), Positives = 70/133 (52%), Gaps = 4/133 (3%)
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
V + LS+ L L L LI + +A+GME++ S+ IHRDL N+L+
Sbjct: 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 226
Query: 318 DQEFHLKIADFGIA---CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILW 374
++ +KI DFG+A ++ D +WMAPE I + Y + DV+SFG++LW
Sbjct: 227 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 286
Query: 375 EMVA-GTIPYEEM 386
E+ + G PY +
Sbjct: 287 EIFSLGASPYPGV 299
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 35/163 (21%), Positives = 59/163 (36%), Gaps = 22/163 (13%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQ 228
+L LG GA ++ VAVK+++ +E +
Sbjct: 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEH------RA 71
Query: 229 FNREVALLSRL-HNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL 286
E+ +L + H+ NV+ + AC K VI E+ G+L YL ++ +P
Sbjct: 72 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 131
Query: 287 IAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329
A +G +Y+ + I DLK I + F
Sbjct: 132 GA---RFRQGKDYVGA---IPVDLKRRLDSITSSQSSASSGFV 168
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 57/194 (29%), Positives = 100/194 (51%), Gaps = 29/194 (14%)
Query: 206 AVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
AVK+++ + DDD T+ EK+ + L+R H P + + + P +
Sbjct: 52 AVKVLKKDVILQDDDVECTMT---EKR----ILSLARNH-PFLTQLFCCFQTPDRLFFVM 103
Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
E+++ G L ++ K + + A +I + ++H +G+I+RDLK +NVL+D E
Sbjct: 104 EFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG 161
Query: 322 HLKIADFGIACEEVY--------CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
H K+ADFG+ E + C GT ++APE+++ YG VD ++ G++L
Sbjct: 162 HCKLADFGMCKEGICNGVTTATFC-------GTPDYIAPEILQEMLYGPAVDWWAMGVLL 214
Query: 374 WEMVAGTIPYEEMN 387
+EM+ G P+E N
Sbjct: 215 YEMLCGHAPFEAEN 228
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 48/138 (34%), Positives = 83/138 (60%), Gaps = 17/138 (12%)
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
+ EY++ G L ++ + P + A +IA G+ ++ S+G+I+RDLK +NV++
Sbjct: 97 YFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 154
Query: 318 DQEFHLKIADFGIACEEVY--------CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSF 369
D E H+KIADFG+ E ++ C GT ++APE+I ++ YG+ VD ++F
Sbjct: 155 DSEGHIKIADFGMCKENIWDGVTTKTFC-------GTPDYIAPEIIAYQPYGKSVDWWAF 207
Query: 370 GLILWEMVAGTIPYEEMN 387
G++L+EM+AG P+E +
Sbjct: 208 GVLLYEMLAGQAPFEGED 225
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-27
Identities = 50/237 (21%), Positives = 106/237 (44%), Gaps = 30/237 (12%)
Query: 177 DLSQLFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVA 234
LS+ LG G + ++ ++ + A+K++ D + +EV
Sbjct: 31 QLSKQVLG----LGVNGKVLECFHRRTGQKCALKLL----YDS---------PKARQEVD 73
Query: 235 LLSRLHN-PNVIKFVAAC-----KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
+ P+++ + K + +I E + G L + + + + +
Sbjct: 74 HHWQASGGPHIVCILDVYENMHHGKRCLL-IIMECMEGGELFSRIQERGDQAFTEREAAE 132
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPG 345
I DI ++++HS + HRD+KPEN+L +++ LK+ DFG A +E +AL
Sbjct: 133 IMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA-KETTQNALQTPCY 191
Query: 346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNFG 402
T ++APE++ + Y + D++S G+I++ ++ G P+ + + ++ G
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG 248
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 52/197 (26%), Positives = 92/197 (46%), Gaps = 26/197 (13%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA S + + + A II + L+AR ++ RE + L +PN+++
Sbjct: 21 KGAFSVVRRCVKVLAGQEYAAMIINT------KKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 247 FVAACKKPPVYCVITEYLSEGSL------RAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
+ + + +I + ++ G L R Y E I + +
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS--EADA------SHCIQQILEAVLHC 126
Query: 301 HSQGVIHRDLKPENVLI---DQEFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIK 356
H GV+HR+LKPEN+L+ + +K+ADFG+A E E A GT +++PE+++
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 357 HKSYGRKVDVYSFGLIL 373
YG+ VD+++ G+IL
Sbjct: 187 KDPYGKPVDLWACGVIL 203
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 26/202 (12%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA+ + I K E VA+K ++ ++E A R RE+ LL + + NVI
Sbjct: 34 SGAYGSVCSAIDKRSGEKVAIK--KLSRPFQSEIFAKRAY----RELLLLKHMQHENVIG 87
Query: 247 FVAACKKPP-------VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEY 299
+ Y V ++ L K+ K+ + + +G++Y
Sbjct: 88 LLDVFTPASSLRNFYDFYLV-MPFMQ-----TDLQKIMGLKFSEEKIQYLVYQMLKGLKY 141
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW-MAPE-MIKH 357
IHS GV+HRDLKP N+ ++++ LKI DFG+A ++ T RW APE ++
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLA--RHADAEMTGYVVT-RWYRAPEVILSW 198
Query: 358 KSYGRKVDVYSFGLILWEMVAG 379
Y + VD++S G I+ EM+ G
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTG 220
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 11/181 (6%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
D VA+K ++ +N+T A R RE+ L+ +++ N+I +
Sbjct: 87 DRNVAIK--KLSRPFQNQTHAKRAY----RELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140
Query: 262 E-YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
+ YL + A L ++ L ++ + + G++++HS G+IHRDLKP N+++ +
Sbjct: 141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
Query: 321 FHLKIADFGIACEEVYCDALSDDPGT--YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378
LKI DFG+A ++ T YR APE+I Y VD++S G I+ EMV
Sbjct: 201 CTLKILDFGLARTAGTSFMMTPYVVTRYYR--APEVILGMGYKENVDIWSVGCIMGEMVR 258
Query: 379 G 379
Sbjct: 259 H 259
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 22/201 (10%)
Query: 190 GAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIK 246
G++S I+K AVKII + ++ E+ +L R +PN+I
Sbjct: 33 GSYSVCKRCIHKATNMEFAVKII------------DKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
V+TE + G L + L K + A+ I + +EY+H+QGV+
Sbjct: 81 LKDVYDDGKYVYVVTELMKGGELLDKI--LRQKFFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 307 HRDLKPENVLI----DQEFHLKIADFGIACEEVYCDALSDDP-GTYRWMAPEMIKHKSYG 361
HRDLKP N+L ++I DFG A + + L P T ++APE+++ + Y
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYD 198
Query: 362 RKVDVYSFGLILWEMVAGTIP 382
D++S G++L+ M+ G P
Sbjct: 199 AACDIWSLGVLLYTMLTGYTP 219
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 48/190 (25%), Positives = 97/190 (51%), Gaps = 29/190 (15%)
Query: 206 AVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
A+K+++ D+D + EK ++P ++ + + +
Sbjct: 38 AMKVVKKELVNDDEDIDWVQT---EKH-----VFEQASNHPFLVGLHSCFQTESRLFFVI 89
Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
EY++ G L ++ + + LP + +I+ + Y+H +G+I+RDLK +NVL+D E
Sbjct: 90 EYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG 147
Query: 322 HLKIADFGIACEEV--------YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
H+K+ D+G+ E + +C GT ++APE+++ + YG VD ++ G+++
Sbjct: 148 HIKLTDYGMCKEGLRPGDTTSTFC-------GTPNYIAPEILRGEDYGFSVDWWALGVLM 200
Query: 374 WEMVAGTIPY 383
+EM+AG P+
Sbjct: 201 FEMMAGRSPF 210
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 42/135 (31%), Positives = 74/135 (54%), Gaps = 11/135 (8%)
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKL----IAIALDIARGMEYIHSQGVIHRDLKPE 313
+I EYLS G L L + I++AL ++H +G+I+RDLKPE
Sbjct: 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMAL------GHLHQKGIIYRDLKPE 150
Query: 314 NVLIDQEFHLKIADFGIACEEVYCDALSDDP-GTYRWMAPEMIKHKSYGRKVDVYSFGLI 372
N++++ + H+K+ DFG+ E ++ ++ GT +MAPE++ + R VD +S G +
Sbjct: 151 NIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGAL 210
Query: 373 LWEMVAGTIPYEEMN 387
+++M+ G P+ N
Sbjct: 211 MYDMLTGAPPFTGEN 225
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 3e-26
Identities = 61/191 (31%), Positives = 103/191 (53%), Gaps = 29/191 (15%)
Query: 206 AVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
AVKI++ I DDD T+ EK+ L P + + + + +
Sbjct: 370 AVKILKKDVVIQDDDVECTMV---EKR-----VLALPGKPPFLTQLHSCFQTMDRLYFVM 421
Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
EY++ G L ++ + P + A +IA G+ ++ S+G+I+RDLK +NV++D E
Sbjct: 422 EYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG 479
Query: 322 HLKIADFGIACEEV--------YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLIL 373
H+KIADFG+ E + +C GT ++APE+I ++ YG+ VD ++FG++L
Sbjct: 480 HIKIADFGMCKENIWDGVTTKTFC-------GTPDYIAPEIIAYQPYGKSVDWWAFGVLL 532
Query: 374 WEMVAGTIPYE 384
+EM+AG P+E
Sbjct: 533 YEMLAGQAPFE 543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 37/201 (18%)
Query: 206 AVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
AVK+++ + +E ++ E+ LL + +P ++ + + +
Sbjct: 67 AVKVLQKKAILKKKEEKHIMS---ERNV-----LLKNVKHPFLVGLHFSFQTADKLYFVL 118
Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKL----IAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
+Y++ G L +L + P + IA AL Y+HS +++RDLKPEN+L+
Sbjct: 119 DYINGGELFYHLQRERCFLEPRARFYAAEIASAL------GYLHSLNIVYRDLKPENILL 172
Query: 318 DQEFHLKIADFGIACEEVY--------CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSF 369
D + H+ + DFG+ E + C GT ++APE++ + Y R VD +
Sbjct: 173 DSQGHIVLTDFGLCKENIEHNSTTSTFC-------GTPEYLAPEVLHKQPYDRTVDWWCL 225
Query: 370 GLILWEMVAGTIPYEEMNPIQ 390
G +L+EM+ G P+ N +
Sbjct: 226 GAVLYEMLYGLPPFYSRNTAE 246
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 39/195 (20%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK-----FVAACKKPPVY 257
E VA+K ++ D + NRE+ ++ +L + N+++ + + KK VY
Sbjct: 80 ELVAIK--KVLQDKRFK----------NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127
Query: 258 -CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL---DIARGMEYIHSQGVIHRDLKPE 313
++ +Y+ E ++ LP +I + L + R + YIHS G+ HRD+KP+
Sbjct: 128 LNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQ 185
Query: 314 NVLIDQEFH-LKIADFGIACEEVYCDALSDDPGT-------YRWMAPE-MIKHKSYGRKV 364
N+L+D + LK+ DFG A + V +P YR APE + Y +
Sbjct: 186 NLLLDPDTAVLKLCDFGSAKQLV-----RGEPNVSYICSRYYR--APELIFGATDYTSSI 238
Query: 365 DVYSFGLILWEMVAG 379
DV+S G +L E++ G
Sbjct: 239 DVWSAGCVLAELLLG 253
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 41/134 (30%), Positives = 78/134 (58%), Gaps = 17/134 (12%)
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
+ EY++ G L ++ + + LP + +I+ + Y+H +G+I+RDLK +NVL+
Sbjct: 129 FFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL 186
Query: 318 DQEFHLKIADFGIACEEV--------YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSF 369
D E H+K+ D+G+ E + +C GT ++APE+++ + YG VD ++
Sbjct: 187 DSEGHIKLTDYGMCKEGLRPGDTTSTFC-------GTPNYIAPEILRGEDYGFSVDWWAL 239
Query: 370 GLILWEMVAGTIPY 383
G++++EM+AG P+
Sbjct: 240 GVLMFEMMAGRSPF 253
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 48/194 (24%), Positives = 91/194 (46%), Gaps = 26/194 (13%)
Query: 206 AVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
A+K + E L E+ ++L+S P ++ A P I
Sbjct: 218 AMKCLDKKRIKMKQGETLALN---ERIM---LSLVSTGDCPFIVCMSYAFHTPDKLSFIL 271
Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
+ ++ G L +L + H + A +I G+E++H++ V++RDLKP N+L+D+
Sbjct: 272 DLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG 329
Query: 322 HLKIADFGIACEEV------YCDALSDDPGTYRWMAPEMIKHKS-YGRKVDVYSFGLILW 374
H++I+D G+AC+ GT+ +MAPE+++ Y D +S G +L+
Sbjct: 330 HVRISDLGLACDFSKKKPHASV-------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 382
Query: 375 EMVAGTIPYEEMNP 388
+++ G P+ +
Sbjct: 383 KLLRGHSPFRQHKT 396
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-25
Identities = 49/188 (26%), Positives = 87/188 (46%), Gaps = 24/188 (12%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK-KPPVYCVI 260
+ VA+K +DD A RE+ +L +L +PN++ + + K ++ V
Sbjct: 28 GQIVAIKKFLESEDDPVIKKIAL------REIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81
Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
EY + ++ L + +P + +I + + + H IHRD+KPEN+LI +
Sbjct: 82 -EYC-DHTVLHEL-DRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH 138
Query: 321 FHLKIADFGIACEEVYCDALSDDPGTY------RWM-APEMI-KHKSYGRKVDVYSFGLI 372
+K+ DFG A L+ Y RW +PE++ YG VDV++ G +
Sbjct: 139 SVIKLCDFGFA------RLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCV 192
Query: 373 LWEMVAGT 380
E+++G
Sbjct: 193 FAELLSGV 200
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 50/185 (27%), Positives = 95/185 (51%), Gaps = 17/185 (9%)
Query: 206 AVKIIR----IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
A+KI++ + D+ TL E + +L +P + + + C +
Sbjct: 177 AMKILKKEVIVAKDEVAHTLT---ENR------VLQNSRHPFLTALKYSFQTHDRLCFVM 227
Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQE 320
EY + G L +L + + + +I ++Y+HS+ V++RDLK EN+++D++
Sbjct: 228 EYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD 285
Query: 321 FHLKIADFGIACEEVYCDALSDD-PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG 379
H+KI DFG+ E + A GT ++APE+++ YGR VD + G++++EM+ G
Sbjct: 286 GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345
Query: 380 TIPYE 384
+P+
Sbjct: 346 RLPFY 350
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 57/197 (28%), Positives = 87/197 (44%), Gaps = 34/197 (17%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFN----REVALLSRLHN---PNVIKF--VAACK 252
VA+K +R+P+ REVALL RL PNV++ V A
Sbjct: 34 GHFVALKSVRVPNGGGGGG-------GLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86
Query: 253 KPPVYCVIT---EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
+ +T E++ + LR YL K LP + + RG++++H+ ++HRD
Sbjct: 87 RTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRD 145
Query: 310 LKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY------RWM-APEMIKHKSYGR 362
LKPEN+L+ +K+ADFG+A W APE++ +Y
Sbjct: 146 LKPENILVTSGGTVKLADFGLARI-------YSYQMALTPVVVTLWYRAPEVLLQSTYAT 198
Query: 363 KVDVYSFGLILWEMVAG 379
VD++S G I EM
Sbjct: 199 PVDMWSVGCIFAEMFRR 215
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 49/193 (25%), Positives = 83/193 (43%), Gaps = 21/193 (10%)
Query: 201 KDEPVAVKIIRIPDDDENETLAARLEKQFN-----REVALLSRLHNPNVIKFVAACKKPP 255
+ PVA+K R+ + + L F RE+ LL+ H+PN++
Sbjct: 45 EGIPVAIK--RVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFE 102
Query: 256 ------VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
+Y V TE + L +H + + + I G+ +H GV+HRD
Sbjct: 103 EPAMHKLYLV-TELM-RTDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRD 159
Query: 310 LKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGT--YRWMAPE-MIKHKSYGRKVDV 366
L P N+L+ + I DF +A E+ + YR APE +++ K + + VD+
Sbjct: 160 LHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYR--APELVMQFKGFTKLVDM 217
Query: 367 YSFGLILWEMVAG 379
+S G ++ EM
Sbjct: 218 WSAGCVMAEMFNR 230
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 24/186 (12%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK-KPPVYCVIT 261
VA+K DDD+ A RE+ LL +L + N++ + CK K Y V
Sbjct: 51 RIVAIKKFLESDDDKMVKKIAM------REIKLLKQLRHENLVNLLEVCKKKKRWYLVF- 103
Query: 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF 321
E++ + ++ L + L + I G+ + HS +IHRD+KPEN+L+ Q
Sbjct: 104 EFV-DHTILDDLELFPNG-LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG 161
Query: 322 HLKIADFGIACEEVYCDALSDDPGTY------RWM-APEMI-KHKSYGRKVDVYSFGLIL 373
+K+ DFG A L+ Y RW APE++ YG+ VDV++ G ++
Sbjct: 162 VVKLCDFGFA------RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLV 215
Query: 374 WEMVAG 379
EM G
Sbjct: 216 TEMFMG 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 53/186 (28%), Positives = 89/186 (47%), Gaps = 23/186 (12%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP------- 255
VA+K ++ ++E A R RE+ LL + + NVI +
Sbjct: 51 AKVAIK--KLYRPFQSELFAKRAY----RELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104
Query: 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV 315
Y V ++ L + H+ L ++ + + +G+ YIH+ G+IHRDLKP N+
Sbjct: 105 FYLV-MPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNL 159
Query: 316 LIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWM-APE-MIKHKSYGRKVDVYSFGLIL 373
++++ LKI DFG+A ++ T RW APE ++ Y + VD++S G I+
Sbjct: 160 AVNEDCELKILDFGLA--RQADSEMTGYVVT-RWYRAPEVILNWMRYTQTVDIWSVGCIM 216
Query: 374 WEMVAG 379
EM+ G
Sbjct: 217 AEMITG 222
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 37/227 (16%)
Query: 177 DLSQLFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVA 234
L + LG GAH+R+ I + AVKII E + + REV
Sbjct: 15 QLQEDVLG----EGAHARVQTCINLITSQEYAVKII--------EKQPGHIRSRVFREVE 62
Query: 235 LLSRLHN-PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA--IAL 291
+L + NV++ + ++ + ++ E + GS+ +++HK H +L A +
Sbjct: 63 MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN----ELEASVVVQ 118
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIA--------CEEVYCDAL 340
D+A ++++H++G+ HRDLKPEN+L +Q +KI DF + C + L
Sbjct: 119 DVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 341 SDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIP 382
G+ +MAPE+++ Y ++ D++S G+IL+ +++G P
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 46/198 (23%), Positives = 86/198 (43%), Gaps = 23/198 (11%)
Query: 206 AVKIIR---IPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262
A+KI+ + E F E +L + + A + ++ E
Sbjct: 90 AMKIMNKWDMLKRGEVS--------CFREERDVLVNGDRRWITQLHFAFQDENYLYLVME 141
Query: 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH 322
Y G L L K + +P +I ++ +H G +HRD+KP+N+L+D+ H
Sbjct: 142 YYVGGDLLTLLSKFGER-IPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH 200
Query: 323 LKIADFGIACEEVYCDALSDDP---GTYRWMAPEMIK-------HKSYGRKVDVYSFGLI 372
+++ADFG C ++ D GT +++PE+++ SYG + D ++ G+
Sbjct: 201 IRLADFGS-CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVF 259
Query: 373 LWEMVAGTIPYEEMNPIQ 390
+EM G P+ + +
Sbjct: 260 AYEMFYGQTPFYADSTAE 277
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 25/205 (12%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVI 245
G + ++ K E A+K++ D + REV L R P+++
Sbjct: 72 LGINGKVLQIFNKRTQEKFALKML----QDC---------PKARREVELHWRASQCPHIV 118
Query: 246 KFVAAC-----KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
+ V + + ++ E L G L + + + + I I ++Y+
Sbjct: 119 RIVDVYENLYAGRKCLL-IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 301 HSQGVIHRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKH 357
HS + HRD+KPEN+L LK+ DFG A E ++L+ T ++APE++
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 237
Query: 358 KSYGRKVDVYSFGLILWEMVAGTIP 382
+ Y + D++S G+I++ ++ G P
Sbjct: 238 EKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 37/141 (26%), Positives = 72/141 (51%), Gaps = 10/141 (7%)
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
++ +Y G L L K E + LP ++ ++ +H +HRD+KP+N+L+
Sbjct: 150 YLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 208
Query: 318 DQEFHLKIADFGIACEEVYCDALSDDP---GTYRWMAPEMIK-----HKSYGRKVDVYSF 369
D H+++ADFG C ++ D GT +++PE+++ YG + D +S
Sbjct: 209 DMNGHIRLADFGS-CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267
Query: 370 GLILWEMVAGTIPYEEMNPIQ 390
G+ ++EM+ G P+ + ++
Sbjct: 268 GVCMYEMLYGETPFYAESLVE 288
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 49/192 (25%), Positives = 87/192 (45%), Gaps = 37/192 (19%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK-----FVAACKKPPVY-C 258
VA+K + +N RE+ ++ + +PNV+ + KK V+
Sbjct: 67 VAIKKVLQDKRFKN------------RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114
Query: 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLI--AIALDIARGMEYIHSQGVIHRDLKPENVL 316
++ EY+ E ++ +P L+ + R + YIHS G+ HRD+KP+N+L
Sbjct: 115 LVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLL 173
Query: 317 IDQEFH-LKIADFGIACEEVYCDALSDDPGT-------YRWMAPE-MIKHKSYGRKVDVY 367
+D LK+ DFG A + + +P YR APE + +Y +D++
Sbjct: 174 LDPPSGVLKLIDFGSAKILI-----AGEPNVSYICSRYYR--APELIFGATNYTTNIDIW 226
Query: 368 SFGLILWEMVAG 379
S G ++ E++ G
Sbjct: 227 STGCVMAELMQG 238
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 37/197 (18%)
Query: 202 DEPVAVKIIRIPDDDE---NETLAARLEKQFNREVALLSRLHN---PNVIK------FVA 249
VA+K +R+ +E T+ REVA+L L PNV++
Sbjct: 37 GRFVALKRVRVQTGEEGMPLSTI---------REVAVLRHLETFEHPNVVRLFDVCTVSR 87
Query: 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
++ + V E++ + L YL K+ +P + + + RG++++HS V+HRD
Sbjct: 88 TDRETKLTLV-FEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRD 145
Query: 310 LKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY------RWM-APEMIKHKSYGR 362
LKP+N+L+ +K+ADFG+A W APE++ SY
Sbjct: 146 LKPQNILVTSSGQIKLADFGLARI-------YSFQMALTSVVVTLWYRAPEVLLQSSYAT 198
Query: 363 KVDVYSFGLILWEMVAG 379
VD++S G I EM
Sbjct: 199 PVDLWSVGCIFAEMFRR 215
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 29/222 (13%), Positives = 55/222 (24%), Gaps = 41/222 (18%)
Query: 183 LGLRFAHGAHSRLYHGIYKDE----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSR 238
L + + + D VA+ + P + + LSR
Sbjct: 35 LLIFHGGVPPLQFWQA--LDTALDRQVALTFVD-PQGVLPDDVLQE----TLSRTLRLSR 87
Query: 239 LHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
+ P V + + V+ E++ GSL+ + I +A +
Sbjct: 88 IDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAAD 143
Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK 358
H GV P V + + + +A M
Sbjct: 144 AAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT-------------------MPDA----- 179
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400
+ D+ G L+ ++ P E
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA 219
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 50/192 (26%), Positives = 98/192 (51%), Gaps = 16/192 (8%)
Query: 206 AVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLS 265
A+K++ E + F E +++ ++P V++ A + ++ EY+
Sbjct: 98 AMKLLSK-----FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 152
Query: 266 EGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI 325
G L ++ + + +P ++ ++ IHS G IHRD+KP+N+L+D+ HLK+
Sbjct: 153 GGDL---VNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKL 209
Query: 326 ADFGIACEEVYCDALSDDP---GTYRWMAPEMIKHK----SYGRKVDVYSFGLILWEMVA 378
ADFG C ++ + + GT +++PE++K + YGR+ D +S G+ L+EM+
Sbjct: 210 ADFGT-CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268
Query: 379 GTIPYEEMNPIQ 390
G P+ + +
Sbjct: 269 GDTPFYADSLVG 280
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 54/203 (26%), Positives = 79/203 (38%), Gaps = 46/203 (22%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP------V 256
E VA+K I + A R RE+ +L + N+I + V
Sbjct: 37 EIVAIKKIEP---FDKPLFALRTL----REIKILKHFKHENIITIFNIQRPDSFENFNEV 89
Query: 257 YCVITEYLSEGSLRAYLHKL--------EHKTLPLPKLIAIALDIARGMEYIHSQGVIHR 308
Y + E + LH++ +H R ++ +H VIHR
Sbjct: 90 YII-QELMQ-----TDLHRVISTQMLSDDHIQY-------FIYQTLRAVKVLHGSNVIHR 136
Query: 309 DLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY----------RWM-APE-MIK 356
DLKP N+LI+ LK+ DFG+A A + +P RW APE M+
Sbjct: 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196
Query: 357 HKSYGRKVDVYSFGLILWEMVAG 379
Y R +DV+S G IL E+
Sbjct: 197 SAKYSRAMDVWSCGCILAELFLR 219
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 27/203 (13%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA+ + VAVK + P ++ A R RE+ LL + + NVI
Sbjct: 39 SGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTY----RELRLLKHMKHENVIG 92
Query: 247 FVAACKKPP-------VYCVITEYLSEGSLRAYLHK-LEHKTLPLPKLIAIALDIARGME 298
+ VY V T + A L+ ++ + L + + I RG++
Sbjct: 93 LLDVFTPARSLEEFNDVYLV-THLMG-----ADLNNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRW-MAPE-MIK 356
YIHS +IHRDLKP N+ ++++ LKI DFG+A D ++ T RW APE M+
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTADEMTGYVAT-RWYRAPEIMLN 203
Query: 357 HKSYGRKVDVYSFGLILWEMVAG 379
Y + VD++S G I+ E++ G
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTG 226
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 49/212 (23%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP------V 256
VA+K +I E+ R+ RE+A+L+RL++ +V+K + +
Sbjct: 79 RVVAIK--KILRVFEDLIDCKRIL----REIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA--IALDIARGMEYIHSQGVIHRDLKPEN 314
Y V E + KL + L +L + ++ G++Y+HS G++HRDLKP N
Sbjct: 133 YVV-LEIAD-----SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPAN 186
Query: 315 VLIDQEFHLKIADFGIA------------------CEEVYCDALSDDPGTYRWM------ 350
L++Q+ +K+ DFG+A +++ R +
Sbjct: 187 CLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVT 246
Query: 351 ----APE-MIKHKSYGRKVDVYSFGLILWEMV 377
APE ++ ++Y +DV+S G I E++
Sbjct: 247 RWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 48/218 (22%), Positives = 90/218 (41%), Gaps = 44/218 (20%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP------V 256
+ VA+K ++ E+ R+ RE+ +L+RL + +I+ +
Sbjct: 52 KNVAIK--KVNRMFEDLIDCKRIL----REITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105
Query: 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPK--LIAIALDIARGMEYIHSQGVIHRDLKPEN 314
Y V E + L KL + L + + I ++ G +IH G+IHRDLKP N
Sbjct: 106 YIV-LEIAD-----SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPAN 159
Query: 315 VLIDQEFHLKIADFGIA-------------CEEVYCDALSDDPGTYRWM----------A 351
L++Q+ +K+ DFG+A E + + + + A
Sbjct: 160 CLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRA 219
Query: 352 PE-MIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP 388
PE ++ ++Y + +D++S G I E++ +
Sbjct: 220 PELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA+ + VA+K I E++T R RE+ +L R + N+I
Sbjct: 37 EGAYGMVCSAYDNLNKVRVAIKKI---SPFEHQTYCQRTL----REIKILLRFRHENIIG 89
Query: 247 FVAACKKPP------VYCVITEYLSEGSLRAYLHK-LEHKTLPLPKLIAIALDIARGMEY 299
+ P VY V + + L+K L+ + L + I RG++Y
Sbjct: 90 INDIIRAPTIEQMKDVYIV-QDLME-----TDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIA----CEEVYCDALSDDPGT--YRWMAPE 353
IHS V+HRDLKP N+L++ LKI DFG+A + + L++ T YR APE
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR--APE 201
Query: 354 -MIKHKSYGRKVDVYSFGLILWEMVAG 379
M+ K Y + +D++S G IL EM++
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSN 228
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 41/142 (28%), Positives = 76/142 (53%), Gaps = 28/142 (19%)
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKL----IAIALDIARGMEYIHSQGVIHRDLKPE 313
+I +Y++ G L +L + E T ++ I +AL E++H G+I+RD+K E
Sbjct: 135 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL------EHLHKLGIIYRDIKLE 188
Query: 314 NVLIDQEFHLKIADFGIACEEV---------YCDALSDDPGTYRWMAPEMIKHKSYG--R 362
N+L+D H+ + DFG++ E V +C GT +MAP++++ G +
Sbjct: 189 NILLDSNGHVVLTDFGLSKEFVADETERAYDFC-------GTIEYMAPDIVRGGDSGHDK 241
Query: 363 KVDVYSFGLILWEMVAGTIPYE 384
VD +S G++++E++ G P+
Sbjct: 242 AVDWWSLGVLMYELLTGASPFT 263
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-23
Identities = 61/196 (31%), Positives = 90/196 (45%), Gaps = 40/196 (20%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261
E A+K IR+ +DE RE+++L L + N++K +Y VI
Sbjct: 26 GETFALKKIRLEKEDEGIPSTTI------REISILKELKHSNIVK---------LYDVIH 70
Query: 262 ---------EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKP 312
E+L + L+ L E L + L + G+ Y H + V+HRDLKP
Sbjct: 71 TKKRLVLVFEHL-DQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKP 128
Query: 313 ENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY------RWM-APE-MIKHKSYGRKV 364
+N+LI++E LKIADFG+A A Y W AP+ ++ K Y +
Sbjct: 129 QNLLINREGELKIADFGLAR------AFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 365 DVYSFGLILWEMVAGT 380
D++S G I EMV GT
Sbjct: 183 DIWSVGCIFAEMVNGT 198
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 4e-23
Identities = 52/194 (26%), Positives = 86/194 (44%), Gaps = 30/194 (15%)
Query: 202 DEPVAVKIIRIPDDDE---NETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVY 257
E VA+K +R+ DDDE + L RE+ LL L + N+++ +
Sbjct: 27 HEIVALKRVRLDDDDEGVPSSAL---------REICLLKELKHKNIVRLHDVLHSDKKLT 77
Query: 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI 317
V E+ + L+ Y L + + + +G+ + HS+ V+HRDLKP+N+LI
Sbjct: 78 LVF-EFC-DQDLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI 134
Query: 318 DQEFHLKIADFGIACEEVYCDALSDDPGTY------RWM-APE-MIKHKSYGRKVDVYSF 369
++ LK+A+FG+A A Y W P+ + K Y +D++S
Sbjct: 135 NRNGELKLANFGLAR------AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 188
Query: 370 GLILWEMVAGTIPY 383
G I E+ P
Sbjct: 189 GCIFAELANAGRPL 202
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-23
Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 30/197 (15%)
Query: 202 DEPVAVKIIRIPDDDENETLAAR-LEKQFNREVALLSRLHNPNVIK----FVAACKKPPV 256
D+ VA+K I + + L RE+ ++ RL + N++K + +
Sbjct: 36 DKRVAIKKIVL----TDPQSVKHAL-----REIKIIRRLDHDNIVKVFEILGPSGSQLTD 86
Query: 257 YCVITE-----YLSEGSLRAYLHK-LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDL 310
Y+ + + L LE L + RG++YIHS V+HRDL
Sbjct: 87 DVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDL 146
Query: 311 KPENVLIDQEF-HLKIADFGIA----CEEVYCDALSDDPGT--YRWMAPE-MIKHKSYGR 362
KP N+ I+ E LKI DFG+A + LS+ T YR +P ++ +Y +
Sbjct: 147 KPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR--SPRLLLSPNNYTK 204
Query: 363 KVDVYSFGLILWEMVAG 379
+D+++ G I EM+ G
Sbjct: 205 AIDMWAAGCIFAEMLTG 221
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-23
Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 56/213 (26%)
Query: 203 EPVAVKIIRIPDDDENETLAAR-LEKQFNREVALLSRLHN-PNVIKFVAACKKPP---VY 257
E VAVK +I D +N T A R RE+ +L+ L N++ + + VY
Sbjct: 35 EVVAVK--KIFDAFQNSTDAQRTF-----REIMILTELSGHENIVNLLNVLRADNDRDVY 87
Query: 258 CVITEYLSEGSLRAYLHKL--------EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309
V +Y+ LH + HK + + + ++Y+HS G++HRD
Sbjct: 88 LV-FDYME-----TDLHAVIRANILEPVHKQY-------VVYQLIKVIKYLHSGGLLHRD 134
Query: 310 LKPENVLIDQEFHLKIADFGIA------------CEEVYCDALSDDPGTYRWM------- 350
+KP N+L++ E H+K+ADFG++ + + +
Sbjct: 135 MKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATR 194
Query: 351 ---APE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
APE ++ Y + +D++S G IL E++ G
Sbjct: 195 WYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 5e-23
Identities = 57/192 (29%), Positives = 90/192 (46%), Gaps = 32/192 (16%)
Query: 202 DEPVAVKIIRIPDDDE--NETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYC 258
VA+K IR+ +DE T RE++LL LH+PN++ + + +
Sbjct: 45 GRIVALKRIRLDAEDEGIPSTAI--------REISLLKELHHPNIVSLIDVIHSERCLTL 96
Query: 259 VITEYLSEGSLRAYLHKLEHKTLPL-PKLI-AIALDIARGMEYIHSQGVIHRDLKPENVL 316
V E++ E L+ L + L I + RG+ + H ++HRDLKP+N+L
Sbjct: 97 VF-EFM-EKDLKKVL---DENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLL 151
Query: 317 IDQEFHLKIADFGIACEEVYCDALSDDPGTY------RWM-APE-MIKHKSYGRKVDVYS 368
I+ + LK+ADFG+A A +Y W AP+ ++ K Y VD++S
Sbjct: 152 INSDGALKLADFGLAR------AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWS 205
Query: 369 FGLILWEMVAGT 380
G I EM+ G
Sbjct: 206 IGCIFAEMITGK 217
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 7e-23
Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 37/196 (18%)
Query: 202 DEPVAVKIIRIPDDDENE------TLAARLEKQFNREVALLSRLHNPNVIKFV-AACKKP 254
++ VA+K I++ E + L RE+ LL L +PN+I + A K
Sbjct: 35 NQIVAIKKIKLGHRSEAKDGINRTAL---------REIKLLQELSHPNIIGLLDAFGHKS 85
Query: 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPL-PKLI-AIALDIARGMEYIHSQGVIHRDLKP 312
+ V +++ E L + + +L L P I A L +G+EY+H ++HRDLKP
Sbjct: 86 NISLV-FDFM-ETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKP 140
Query: 313 ENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY------RWM-APEMIKH-KSYGRKV 364
N+L+D+ LK+ADFG+A + Y RW APE++ + YG V
Sbjct: 141 NNLLLDENGVLKLADFGLAK------SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 194
Query: 365 DVYSFGLILWEMVAGT 380
D+++ G IL E++
Sbjct: 195 DMWAVGCILAELLLRV 210
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 9e-23
Identities = 51/195 (26%), Positives = 87/195 (44%), Gaps = 28/195 (14%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK---------FVAACK 252
+ VA+K + + ++ E + A RE+ +L L + NV+
Sbjct: 42 GQKVALKKVLMENEKEGFPITAL------REIKILQLLKHENVVNLIEICRTKASPYNRC 95
Query: 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKP 312
K +Y V ++ E L L + K L ++ + + G+ YIH ++HRD+K
Sbjct: 96 KGSIYLV-FDFC-EHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKA 152
Query: 313 ENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY------RWM-APEMI-KHKSYGRKV 364
NVLI ++ LK+ADFG+A + A + P Y W PE++ + YG +
Sbjct: 153 ANVLITRDGVLKLADFGLA--RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPI 210
Query: 365 DVYSFGLILWEMVAG 379
D++ G I+ EM
Sbjct: 211 DLWGAGCIMAEMWTR 225
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-22
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 43/210 (20%)
Query: 190 GAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
G ++ +Y G K D VA+K IR+ + +E A REV+LL L + N++
Sbjct: 13 GTYATVYKGKSKLTDNLVALKEIRL-EHEEGAPCTAI------REVSLLKDLKHANIVT- 64
Query: 248 VAACKKPPVYCVIT---------EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
++ +I EYL + L+ YL + + + + + RG+
Sbjct: 65 --------LHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNI-INMHNVKLFLFQLLRGLA 114
Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY------RWM-A 351
Y H Q V+HRDLKP+N+LI++ LK+ADFG+A A S TY W
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFGLAR------AKSIPTKTYDNEVVTLWYRP 168
Query: 352 PE-MIKHKSYGRKVDVYSFGLILWEMVAGT 380
P+ ++ Y ++D++ G I +EM G
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 43/200 (21%)
Query: 203 EPVAVKIIRIPDD--DENETLAARLEKQFNREVALLSRLHNPNVIK----FVAACKKPP- 255
VA+K ++ D N L + + L+ LH+PN+++ F ++
Sbjct: 49 MSVAIK--KVIQDPRFRNREL---------QIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97
Query: 256 -VY-CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL---DIARGMEYIH--SQGVIHR 308
+Y V+ EY+ + +L + + P I I + + R + +H S V HR
Sbjct: 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP-PILIKVFLFQLIRSIGCLHLPSVNVCHR 155
Query: 309 DLKPENVLIDQEFH-LKIADFGIACEEVYCDALSDDPGT-------YRWMAPE-MIKHKS 359
D+KP NVL+++ LK+ DFG A + +P YR APE + ++
Sbjct: 156 DIKPHNVLVNEADGTLKLCDFGSAKKLS-----PSEPNVAYICSRYYR--APELIFGNQH 208
Query: 360 YGRKVDVYSFGLILWEMVAG 379
Y VD++S G I EM+ G
Sbjct: 209 YTTAVDIWSVGCIFAEMMLG 228
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 9e-22
Identities = 45/198 (22%), Positives = 89/198 (44%), Gaps = 40/198 (20%)
Query: 202 DEPVAVKIIRIPDDDENE------TLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKP 254
VA+K +++ ++E + RE++L+ L + N+++ +
Sbjct: 30 GVYVALKEVKL----DSEEGTPSTAI---------REISLMKELKHENIVRLYDVIHTEN 76
Query: 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA----IALDIARGMEYIHSQGVIHRDL 310
+ V E++ + L+ Y+ P + + +G+ + H ++HRDL
Sbjct: 77 KLTLVF-EFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDL 134
Query: 311 KPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTY------RWM-APE-MIKHKSYGR 362
KP+N+LI++ LK+ DFG+A A T+ W AP+ ++ ++Y
Sbjct: 135 KPQNLLINKRGQLKLGDFGLAR------AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYST 188
Query: 363 KVDVYSFGLILWEMVAGT 380
+D++S G IL EM+ G
Sbjct: 189 SIDIWSCGCILAEMITGK 206
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 52/193 (26%), Positives = 88/193 (45%), Gaps = 30/193 (15%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPPVYCVI 260
+E VA+K IR+ ++E A REV+LL L + N+I+ + ++ +
Sbjct: 59 NETVAIKRIRLEHEEEGVPGTAI------REVSLLKELQHRNIIELKSVIHHNHRLHLIF 112
Query: 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320
EY E L+ Y+ K + + + + + + G+ + HS+ +HRDLKP+N+L+
Sbjct: 113 -EYA-ENDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVS 168
Query: 321 F-----HLKIADFGIACEEVYCDALSDDPGTY------RWM-APE-MIKHKSYGRKVDVY 367
LKI DFG+A A + W PE ++ + Y VD++
Sbjct: 169 DASETPVLKIGDFGLAR------AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIW 222
Query: 368 SFGLILWEMVAGT 380
S I EM+ T
Sbjct: 223 SIACIWAEMLMKT 235
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 40/205 (19%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP-----------NVIK---- 246
+ VA+KI+R + E+ LL R+++ +++K
Sbjct: 44 NTHVAMKIVR------G---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GV 305
F ++ E L E +L A + K EH+ +PL + I+ + G++Y+H + G+
Sbjct: 95 FNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGI 153
Query: 306 IHRDLKPENVLIDQE------FHLKIADFGIAC---EEVYCDALSDDPGTYRWMAPEMIK 356
IH D+KPENVL++ +KIAD G AC E + YR +PE++
Sbjct: 154 IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR---EYR--SPEVLL 208
Query: 357 HKSYGRKVDVYSFGLILWEMVAGTI 381
+G D++S +++E++ G
Sbjct: 209 GAPWGCGADIWSTACLIFELITGDF 233
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 48/228 (21%), Positives = 87/228 (38%), Gaps = 73/228 (32%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQF-NREVALLSRLHNPNVIK--------------- 246
+ A+K ++ D ++ NRE+ ++ L + N+IK
Sbjct: 33 KRFALK--KVLQD-----------PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79
Query: 247 -----------------FVAACKKPP-------VYCVITEYLSEGSLRAYLHKLEHKTLP 282
+ VI EY+ + +L L
Sbjct: 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN-VIMEYVPD-TLHKVLKSFIRSGRS 137
Query: 283 LPKLIA--IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-LKIADFGIACEEVYCDA 339
+P + + R + +IHS G+ HRD+KP+N+L++ + + LK+ DFG A + +
Sbjct: 138 IPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI---- 193
Query: 340 LSDDPGT-------YRWMAPE-MIKHKSYGRKVDVYSFGLILWEMVAG 379
+P YR APE M+ Y +D++S G + E++ G
Sbjct: 194 -PSEPSVAYICSRFYR--APELMLGATEYTPSIDLWSIGCVFGELILG 238
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-20
Identities = 44/222 (19%), Positives = 86/222 (38%), Gaps = 46/222 (20%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVI 245
G + ++ K E A+K++ D + REV L R P+++
Sbjct: 28 LGINGKVLQIFNKRTQEKFALKML----QDC---------PKARREVELHWRASQCPHIV 74
Query: 246 KFVAAC-----KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
+ V + + ++ E L G L + + + + I I ++Y+
Sbjct: 75 RIVDVYENLYAGRKCLL-IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 301 HSQGVIHRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKH 357
HS + HRD+KPEN+L LK+ DFG A E
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKETTG- 172
Query: 358 KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399
+ Y + D++S G+I++ ++ G P+ + + + + ++
Sbjct: 173 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 214
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 55/194 (28%), Positives = 89/194 (45%), Gaps = 32/194 (16%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNPNVIKFVAACKKPPVY-- 257
+ VA+K++R NE R +Q E+ +L L + + V + +
Sbjct: 122 HQHVALKMVR------NEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172
Query: 258 --CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV 315
C+ E LS +L + K + + LP + A I + ++ +H +IH DLKPEN+
Sbjct: 173 HICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI 231
Query: 316 LIDQEFH--LKIADFGIACEEVYCDALSDDPGT------YRWMAPEMIKHKSYGRKVDVY 367
L+ Q+ +K+ DFG +C E T YR APE+I YG +D++
Sbjct: 232 LLKQQGRSGIKVIDFGSSCYE------HQRVYTYIQSRFYR--APEVILGARYGMPIDMW 283
Query: 368 SFGLILWEMVAGTI 381
S G IL E++ G
Sbjct: 284 SLGCILAELLTGYP 297
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 43/225 (19%)
Query: 182 FLGLRFAHGAHSRLYHGIYKD----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLS 237
+ G + G + +Y KD + A+K I +++A RE+ALL
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE----GTGISMSAC------REIALLR 73
Query: 238 RLHNPNVIKF---VAACKKPPVYCVITEYLSEGSLRAYLH-----KLEHKTLPLPKLI-- 287
L +PNVI + V+ + +Y E L + K K + LP+ +
Sbjct: 74 ELKHPNVISLQKVFLSHADRKVWLLF-DYA-EHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 288 AIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF----HLKIADFGIACE-EVYCDALSD 342
++ I G+ Y+H+ V+HRDLKP N+L+ E +KIAD G A L+D
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191
Query: 343 DPGT-----YRWMAPEMI---KHKSYGRKVDVYSFGLILWEMVAG 379
YR APE++ +H Y + +D+++ G I E++
Sbjct: 192 LDPVVVTFWYR--APELLLGARH--YTKAIDIWAIGCIFAELLTS 232
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 9e-19
Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 34/196 (17%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNPNVIKFVAACKKPPVY-- 257
E VA+KII+ N+ Q EV LL + H+ + ++ K+ ++
Sbjct: 79 QEWVAIKIIK------NKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129
Query: 258 --CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ--GVIHRDLKPE 313
C++ E LS +L L + + L A + + ++ + +IH DLKPE
Sbjct: 130 HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPE 188
Query: 314 NVLIDQEFH--LKIADFGIACEEVYCDALSDDPGT------YRWMAPEMIKHKSYGRKVD 365
N+L+ +KI DFG +C+ YR +PE++ Y +D
Sbjct: 189 NILLCNPKRSAIKIVDFGSSCQL------GQRIYQYIQSRFYR--SPEVLLGMPYDLAID 240
Query: 366 VYSFGLILWEMVAGTI 381
++S G IL EM G
Sbjct: 241 MWSLGCILVEMHTGEP 256
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 51/219 (23%), Positives = 83/219 (37%), Gaps = 65/219 (29%)
Query: 200 YKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNP----NVIK----FVA 249
VAVKI++ + + AAR E+ +L L +P ++ F
Sbjct: 38 AGGRHVAVKIVK---NVDRYCEAARS------EIQVLEHLNTTDPNSTFRCVQMLEWF-- 86
Query: 250 ACKKPPVY----CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
+ C++ E L S ++ + L + +A I + + ++HS +
Sbjct: 87 ------EHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKL 139
Query: 306 IHRDLKPENVLIDQEFH-------------------LKIADFGIACEEVYCDALSDDPGT 346
H DLKPEN+L Q + +K+ DFG A + + T
Sbjct: 140 THTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD------DEHHST 193
Query: 347 ------YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG 379
YR APE+I + + DV+S G IL E G
Sbjct: 194 LVSTRHYR--APEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 46/218 (21%), Positives = 80/218 (36%), Gaps = 65/218 (29%)
Query: 203 EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNP----NVIK----FVAACK 252
VA+KIIR N + + E+ +L ++ + + F
Sbjct: 46 SQVALKIIR------NVG---KYREAARLEINVLKKIKEKDKENKFLCVLMSDWF----- 91
Query: 253 KPPVY----CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHR 308
+ C+ E L + + +L + + PLP + +A + + ++H + H
Sbjct: 92 ---NFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHT 147
Query: 309 DLKPENVLIDQEFH-------------------LKIADFGIACEEVYCDALSDDPGT--- 346
DLKPEN+L +++ADFG A + + T
Sbjct: 148 DLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD------HEHHTTIVA 201
Query: 347 ---YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI 381
YR PE+I + + DV+S G IL+E G
Sbjct: 202 TRHYR--PPEVILELGWAQPCDVWSIGCILFEYYRGFT 237
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 6e-14
Identities = 47/237 (19%), Positives = 85/237 (35%), Gaps = 74/237 (31%)
Query: 205 VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI----KFVAACK-----KPP 255
VA+K+++ E+ T A E+ LL + N + + V
Sbjct: 65 VAMKVVK---SAEHYTETAL------DEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115
Query: 256 V---YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLK 311
C++ E L L ++ K ++ LPLP + I + +G++Y+H++ +IH D+K
Sbjct: 116 NGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIK 174
Query: 312 PENVLI-------------------------------------------------DQEFH 322
PEN+L+ ++
Sbjct: 175 PENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLK 234
Query: 323 LKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG 379
+KIAD G AC YR + E++ Y D++S + +E+ G
Sbjct: 235 VKIADLGNACWVHKHFTEDIQTRQYR--SLEVLIGSGYNTPADIWSTACMAFELATG 289
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 6e-14
Identities = 51/222 (22%), Positives = 92/222 (41%), Gaps = 70/222 (31%)
Query: 202 DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-----HNPNVIK----FVAACK 252
+ AVK++R + + T +A++E +L ++ +N N++K F+
Sbjct: 60 KKYYAVKVVR---NIKKYTRSAKIE------ADILKKIQNDDINNNNIVKYHGKFM---- 106
Query: 253 KPPVY----CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHR 308
Y C+I E L SL + + + + + ++I + + Y+ + H
Sbjct: 107 ----YYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHT 161
Query: 309 DLKPENVLIDQEFH-------------------------LKIADFGIACEEVYCDALSDD 343
DLKPEN+L+D + +K+ DFG A + SD
Sbjct: 162 DLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK------SDY 215
Query: 344 PGT------YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG 379
G+ YR APE+I + + D++SFG +L E+ G
Sbjct: 216 HGSIINTRQYR--APEVILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 32/218 (14%)
Query: 183 LGLRFAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
+G + G L G +Y +E VA+K+ E + +R Q + E +L
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKL---------EPMKSR-APQLHLEYRFYKQLG 62
Query: 241 N-PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEY 299
+ + + ++ E L SL L L +T L ++ IA+ + MEY
Sbjct: 63 SGDGIPQVYYFGPCGKYNAMVLELLGP-SL-EDLFDLCDRTFSLKTVLMIAIQLISRMEY 120
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLK-----IADFGIACEEVYCDALSDDP---------- 344
+HS+ +I+RD+KPEN LI + + I DF +A E Y D +
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE--YIDPETKKHIPYREHKSLT 178
Query: 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
GT R+M+ K R+ D+ + G + + G++P
Sbjct: 179 GTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 7e-13
Identities = 44/189 (23%), Positives = 78/189 (41%), Gaps = 24/189 (12%)
Query: 218 NETLAARLEK------QFNREVALLSRLHN-PNVIKFVAACKKPPVYCVITEYLSEGSLR 270
E +A +LE Q + E + + + + ++ E L SL
Sbjct: 34 GEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SL- 91
Query: 271 AYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIAD 327
L + L ++ +A + +EYIHS+ IHRD+KP+N L+ + + I D
Sbjct: 92 EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIID 151
Query: 328 FGIACEEVYCDALSDDP----------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMV 377
FG+A + Y DA + GT R+ + R+ D+ S G +L
Sbjct: 152 FGLAKK--YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN 209
Query: 378 AGTIPYEEM 386
G++P++ +
Sbjct: 210 LGSLPWQGL 218
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.7 bits (159), Expect = 5e-12
Identities = 29/180 (16%), Positives = 51/180 (28%), Gaps = 43/180 (23%)
Query: 190 GAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-------- 241
G ++ I PVA+KII I D + ++ E+ + L
Sbjct: 31 GVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNR 90
Query: 242 -PNVIKFVAAC----KKPPVYC--------------------------VITEYLSEGSLR 270
I + PP+ ++ E+ G
Sbjct: 91 TEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGID- 149
Query: 271 AYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFG 329
L ++ K L +I + + + HRDL NVL+ + K+
Sbjct: 150 --LEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTL 207
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 6e-12
Identities = 33/189 (17%), Positives = 67/189 (35%), Gaps = 31/189 (16%)
Query: 227 KQFNREVALLSRLHNPNVIKFVAACKK------PPVYCVITEYLSEGSLRA--------- 271
E+ R P I+ +K P + + S R
Sbjct: 78 GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSD 137
Query: 272 --YLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID--QEFHLKIAD 327
+++ K ++ ++L I +EYIH +H D+K N+L++ + + D
Sbjct: 138 LQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVD 197
Query: 328 FGIACEEVYCDALSDDP----------GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMV 377
+G+A YC GT + + + + R+ D+ G + + +
Sbjct: 198 YGLAYR--YCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWL 255
Query: 378 AGTIPYEEM 386
G +P+E+
Sbjct: 256 TGHLPWEDN 264
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 40/218 (18%), Positives = 82/218 (37%), Gaps = 32/218 (14%)
Query: 183 LGLRFAHGAHSRLYHG--IYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240
+G R G+ ++ G + ++ VA+K E + Q E L
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIK---------FEPRRSD-APQLRDEYRTYKLLA 63
Query: 241 N-PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEY 299
+ ++ ++ + L SL L L + + + A + ++
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDLLGP-SL-EDLLDLCGRKFSVKTVAMAAKQMLARVQS 121
Query: 300 IHSQGVIHRDLKPENVLIDQEFHLK-----IADFGIACEEVYCDALSDDP---------- 344
IH + +++RD+KP+N LI + + DFG+ Y D ++
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF--YRDPVTKQHIPYREKKNLS 179
Query: 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
GT R+M+ + R+ D+ + G + + G++P
Sbjct: 180 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 34/227 (14%), Positives = 82/227 (36%), Gaps = 40/227 (17%)
Query: 180 QLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQF------NREV 233
L+ + + + ++K+ + + E+ F +V
Sbjct: 57 ILYEAAP----TSTLTCDSGPQKQKFSLKL-------DAKDGRLFNEQNFFQRAAKPLQV 105
Query: 234 ALLSRLHN------PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLI 287
+L++ P + F K ++ L SL++ L L ++
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDK--YRFLVLPSLGR-SLQSALDVSPKHVLSERSVL 162
Query: 288 AIALDIARGMEYIHSQGVIHRDLKPENVLI--DQEFHLKIADFGIACEEVYCD-----AL 340
+A + +E++H +H ++ EN+ + + + + +A +G A YC A
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR--YCPSGKHVAY 220
Query: 341 SDDP-----GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP 382
+ G +++ ++ K R+ D+ S G + + + G +P
Sbjct: 221 VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 40/214 (18%), Positives = 77/214 (35%), Gaps = 37/214 (17%)
Query: 214 DDDENETLAARLEK-------QFNREVALLSRLHNPNVIKFVAACKK------PPVYCVI 260
++ E A + K E+ R+ + IK K+ P Y
Sbjct: 58 PTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG 117
Query: 261 TEYLSEGSLRAY--------LHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDL 310
S R L K+ ++ T ++ + + + +EYIH +H D+
Sbjct: 118 LTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDI 177
Query: 311 KPENVLIDQEFHLKI--ADFGIACEEVYCDALSDDP----------GTYRWMAPEMIKHK 358
K N+L+ + ++ AD+G++ YC + GT + + + K
Sbjct: 178 KAANLLLGYKNPDQVYLADYGLSYR--YCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV 235
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAA 392
+ R+ DV G + + G +P+E+ A
Sbjct: 236 ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 46/192 (23%), Positives = 78/192 (40%), Gaps = 30/192 (15%)
Query: 214 DDDENETLAARLEK------QFNREVALLSRLHN----PNVIKFVAACKKPPVYCVITEY 263
+ NE +A +LE Q E + L PNV F ++ +
Sbjct: 28 NIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDY---NVLVMDL 84
Query: 264 LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH- 322
L SL L + L L ++ +A + +E++HS+ +HRD+KP+N L+
Sbjct: 85 LGP-SL-EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142
Query: 323 --LKIADFGIACEEVYCDALSDDP----------GTYRWMAPEMIKHKSYGRKVDVYSFG 370
+ I DFG+A + Y D + GT R+ + R+ D+ S G
Sbjct: 143 NQVYIIDFGLAKK--YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLG 200
Query: 371 LILWEMVAGTIP 382
+L + G++P
Sbjct: 201 YVLMYFLRGSLP 212
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 1e-04
Identities = 51/342 (14%), Positives = 97/342 (28%), Gaps = 107/342 (31%)
Query: 13 KFSHTVCHRLDSSILASLPLNLPETISVL--KSRPGPASSNQ---------KSAPNSSQS 61
K+ L +L + P +S++ R G A+ + + SS +
Sbjct: 309 KYLDCRPQDLPREVLTTNPR----RLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN 364
Query: 62 QQNPAANK---------PRSVSPLPETVLP-----DTFKEARSATKRFSTPHPRRKESDK 107
PA + P S +P +L + +
Sbjct: 365 VLEPAEYRKMFDRLSVFPPSA-HIPTILLSLIWFDVIKSDVMVVVNKLH---------KY 414
Query: 108 GLVGKFLYKQPQQETKASSNSYS--------TSPLRHLGSL--RVTERYKSRKESAWTK- 156
L + KQP++ T S L + +L + + Y K
Sbjct: 415 SL----VEKQPKEST------ISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDL 464
Query: 157 -------YF-DHGGVRVNAVDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVK 208
YF H G + ++ + T+ +FL RF + K
Sbjct: 465 IPPYLDQYFYSHIGHHLKNIEHPERMTL-FRMVFLDFRF-----------------LEQK 506
Query: 209 IIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGS 268
I D + + + L +L ++ C P Y ++ +
Sbjct: 507 IRH---DSTAWNASGSI-------LNTLQQLKFYK--PYI--CDNDPKY---ERLVN--A 547
Query: 269 LRAYLHKLEHKTL--PLPKLIAIALDIARGMEYIHSQGVIHR 308
+ +L K+E + L+ IAL + + + R
Sbjct: 548 ILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQVQR 589
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 27/145 (18%), Positives = 52/145 (35%), Gaps = 14/145 (9%)
Query: 188 AHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR-EVALLSRLHNPNVIK 246
GA + + Y D V +K R+ +E L + K E L+ + + +
Sbjct: 345 GKGAEADIKRDSYLDFDVIIKE-RVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPA 403
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
++ Y++ + + + IA I + +H VI
Sbjct: 404 PYIFDVDLDNKRIMMSYINGKLAKDVIEDN----------LDIAYKIGEIVGKLHKNDVI 453
Query: 307 HRDLKPENVLIDQEFHLKIADFGIA 331
H DL N + D++ ++ DFG+
Sbjct: 454 HNDLTTSNFIFDKDLYI--IDFGLG 476
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 25/151 (16%), Positives = 48/151 (31%), Gaps = 25/151 (16%)
Query: 190 GAHSRLYHGIYKDE-PVAVKIIRIP------DDDENETLAARLEKQF----NREVALLSR 238
G S +++ + VK ++ ++ + E L +
Sbjct: 101 GKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160
Query: 239 LHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
L V K A V+ E + L + + + I +
Sbjct: 161 LQGLAVPKVYAWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVA 207
Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329
+ +G++H DL NVL+ +E + I DF
Sbjct: 208 KFYHRGIVHGDLSQYNVLVSEE-GIWIIDFP 237
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 40.8 bits (95), Expect = 3e-04
Identities = 31/170 (18%), Positives = 61/170 (35%), Gaps = 29/170 (17%)
Query: 183 LGLRFAHGAHSRLYHGI----YKDEPVAVKIIRIP-------------DDDENETLAARL 225
+G + G + +++ K +AVKI RI D+ + +
Sbjct: 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPK 110
Query: 226 EKQF---NREVALLSRLHNP--NVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT 280
EK F +E L R +V + K ++ E++ E L A +
Sbjct: 111 EKVFIWTEKEFRNLERAKEAGVSVPQPYTYMK----NVLLMEFIGEDELPAPTLVELGRE 166
Query: 281 LPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFG 329
L + I D+ ++ ++ + ++H DL N++ + D G
Sbjct: 167 LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMG 214
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 405 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.44 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.24 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.15 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.91 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.72 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.64 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.61 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.45 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.29 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.26 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.12 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.91 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.83 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.77 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.75 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.66 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.56 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.39 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.25 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.21 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.09 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.97 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.87 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.66 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.02 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.58 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.39 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 86.7 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.65 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.37 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.29 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 82.13 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=416.01 Aligned_cols=218 Identities=17% Similarity=0.345 Sum_probs=190.2
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
.+++|.+++.||+|+||+||+|++. |+.||||++........ ....|.+|+.+|++|+|||||++++++.++
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~------~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 95 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK------EREESRREVAVLANMKHPNIVQYRESFEEN 95 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHH------HHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHH------HHHHHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 4578999999999999999999986 79999999987654432 256789999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
+.+|||||||+||+|.++|.......+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|...
T Consensus 96 ~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 96 GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175 (350)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceee
Confidence 99999999999999999998766677899999999999999999999999999999999999999999999999999654
Q ss_pred ccc-CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 335 VYC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 335 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
... ......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.+++++..
T Consensus 176 ~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~ 242 (350)
T 4b9d_A 176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF 242 (350)
T ss_dssp CHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred cCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC
Confidence 322 122345699999999999999999999999999999999999999999999999999988753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-53 Score=406.78 Aligned_cols=219 Identities=30% Similarity=0.593 Sum_probs=186.4
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
...|+|+.+++.++++||+|+||+||+|++.+ .||||+++....... ..+.|.+|+.+|++++|||||+++|+
T Consensus 28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~------~~~~f~~E~~il~~l~HpNIV~l~g~ 100 (307)
T 3omv_A 28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPE------QFQAFRNEVAVLRKTRHVNILLFMGY 100 (307)
T ss_dssp -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHH------HHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHH------HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 35789999999999999999999999999866 599999976554432 25689999999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
|.++ .+|||||||++|+|.++|+.. ...+++..++.|+.|||.||+|||+++||||||||+||||++++.+||+|||+
T Consensus 101 ~~~~-~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 178 (307)
T 3omv_A 101 MTKD-NLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGL 178 (307)
T ss_dssp ECSS-SCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred EECC-eEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccC
Confidence 8764 578999999999999999763 46799999999999999999999999999999999999999999999999999
Q ss_pred cccccc---cCCCCCCCCCCcccCcccccc---ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 331 ACEEVY---CDALSDDPGTYRWMAPEMIKH---KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 331 a~~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
|..... .......+||+.|||||++.+ ..|+.++|||||||+||||+||+.||.+.+..+.+..++..
T Consensus 179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~ 252 (307)
T 3omv_A 179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR 252 (307)
T ss_dssp CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT
T ss_pred ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc
Confidence 965322 223445689999999999864 46899999999999999999999999998877666665544
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=403.85 Aligned_cols=214 Identities=25% Similarity=0.397 Sum_probs=190.9
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+++.||+|+||+||+|++. ++.||||++..... ......+.+.+|+++|++|+|||||++++++.++..
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-----IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC-----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 57999999999999999999986 78999999974211 111224678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+|||||||+||+|.++|.+ .+.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|.....
T Consensus 107 ~yivmEy~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp EEEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999999999987 46799999999999999999999999999999999999999999999999999975432
Q ss_pred ---cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 337 ---CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 337 ---~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
.......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+...+|++..
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~ 250 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE 250 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 223456789999999999999999999999999999999999999999999998888887753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=407.45 Aligned_cols=210 Identities=26% Similarity=0.465 Sum_probs=190.8
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
+.|.++++||+|+||.||+|++. |+.||||++....... .+.+.+|+.+|++|+|||||+++++|.+++.
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~ 145 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--------RELLFNEVVIMRDYQHENVVEMYNSYLVGDE 145 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--------GGGGHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--------HHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 46889999999999999999986 7999999998654433 2457799999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+|||||||+||+|.+++.+ ..+++..+..++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|.....
T Consensus 146 ~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp EEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 9999999999999999976 5699999999999999999999999999999999999999999999999999976433
Q ss_pred -cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 337 -CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 337 -~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
.......+||+.|||||++.+..|+.++|||||||+||||++|..||.+.++.+.+..+.++.
T Consensus 223 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~ 286 (346)
T 4fih_A 223 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL 286 (346)
T ss_dssp SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS
T ss_pred CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC
Confidence 334567789999999999999999999999999999999999999999999999888887654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=403.29 Aligned_cols=219 Identities=27% Similarity=0.506 Sum_probs=190.9
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeE
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 246 (405)
+.|+.++|.++++||+|+||.||+|.+. ++.||||+++... . ...++|.+|+.+|++|+|||||+
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~------~~~~~f~~E~~il~~l~HpnIV~ 79 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--D------NARKDFHREAELLTNLQHEHIVK 79 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--H------HHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--h------HHHHHHHHHHHHHHhCCCCCCcc
Confidence 3577789999999999999999999874 5689999997432 1 12568999999999999999999
Q ss_pred EeeEeecCCeeEEEEeecCCCCHHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 015556 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLE-----------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV 315 (405)
Q Consensus 247 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NI 315 (405)
++|+|.+++.+|||||||++|+|.++|+... ...+++..++.|+.||+.||.|||+++||||||||+||
T Consensus 80 l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NI 159 (299)
T 4asz_A 80 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNC 159 (299)
T ss_dssp EEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhE
Confidence 9999999999999999999999999998632 35799999999999999999999999999999999999
Q ss_pred EECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 015556 316 LIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQA 391 (405)
Q Consensus 316 Ll~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~ 391 (405)
||+.++.+||+|||+|....... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.
T Consensus 160 Ll~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~ 239 (299)
T 4asz_A 160 LVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 239 (299)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred EECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999999996433222 1223458999999999999999999999999999999999 9999999999999
Q ss_pred HHHHHhccc
Q 015556 392 AFAVVNKVN 400 (405)
Q Consensus 392 ~~~i~~~~~ 400 (405)
+..+.++..
T Consensus 240 ~~~i~~~~~ 248 (299)
T 4asz_A 240 IECITQGRV 248 (299)
T ss_dssp HHHHHHTCC
T ss_pred HHHHHcCCC
Confidence 988887653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-52 Score=401.48 Aligned_cols=221 Identities=28% Similarity=0.503 Sum_probs=193.8
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI 245 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 245 (405)
...++.+++.++++||+|+||+||+|.+. ++.||||+++...... ..++|.+|+.+|++|+|||||
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~-------~~~~f~~E~~il~~l~HpNIV 92 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP-------LREEFRHEAMLRARLQHPNVV 92 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC--------CHHHHHHHHHHHHHCCCTTBC
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChH-------HHHHHHHHHHHHHhCCCCCCC
Confidence 34677888999999999999999999973 4789999997543322 146799999999999999999
Q ss_pred EEeeEeecCCeeEEEEeecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 015556 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLK 311 (405)
Q Consensus 246 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIk 311 (405)
+++|+|.+++.++||||||++|+|.++|.... ...+++..++.|+.|||.||+|||+++|||||||
T Consensus 93 ~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK 172 (308)
T 4gt4_A 93 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLA 172 (308)
T ss_dssp CEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 99999999999999999999999999997532 2468999999999999999999999999999999
Q ss_pred CCcEEECCCCcEEEEecCCccccccc---CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 015556 312 PENVLIDQEFHLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMN 387 (405)
Q Consensus 312 p~NILl~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~ 387 (405)
|+||||++++.+||+|||++...... .......||++|||||++.+..|+.++|||||||+||||+| |..||.+.+
T Consensus 173 ~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 173 TRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp GGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred ccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999654322 23445679999999999999999999999999999999999 999999999
Q ss_pred HHHHHHHHHhccc
Q 015556 388 PIQAAFAVVNKVN 400 (405)
Q Consensus 388 ~~e~~~~i~~~~~ 400 (405)
..+.+..+.++..
T Consensus 253 ~~~~~~~i~~~~~ 265 (308)
T 4gt4_A 253 NQDVVEMIRNRQV 265 (308)
T ss_dssp HHHHHHHHHTTCC
T ss_pred HHHHHHHHHcCCC
Confidence 9998888887654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=402.07 Aligned_cols=220 Identities=27% Similarity=0.516 Sum_probs=187.8
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI 245 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 245 (405)
.+.++.++|.+.++||+|+||+||+|.+. ++.||||+++..+ . ...++|.+|+.+|++|+|||||
T Consensus 35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~------~~~~~f~~E~~il~~l~HpnIV 106 (329)
T 4aoj_A 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--E------SARQDFQREAELLTMLQHQHIV 106 (329)
T ss_dssp SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--H------HHHHHHHHHHHHHTTCCCTTBC
T ss_pred hcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--H------HHHHHHHHHHHHHHhCCCCCCC
Confidence 45677789999999999999999999874 5789999996422 1 1256799999999999999999
Q ss_pred EEeeEeecCCeeEEEEeecCCCCHHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 015556 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLE-------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKP 312 (405)
Q Consensus 246 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp 312 (405)
+++|+|.++..+|||||||++|+|.++|+... ...+++..++.|+.||+.||.|||+++||||||||
T Consensus 107 ~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp 186 (329)
T 4aoj_A 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLAT 186 (329)
T ss_dssp CEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred cEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccH
Confidence 99999999999999999999999999998642 24689999999999999999999999999999999
Q ss_pred CcEEECCCCcEEEEecCCccccccc---CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 015556 313 ENVLIDQEFHLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNP 388 (405)
Q Consensus 313 ~NILl~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~ 388 (405)
+||||+.++.+||+|||+|...... .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+.
T Consensus 187 ~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~ 266 (329)
T 4aoj_A 187 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266 (329)
T ss_dssp GGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH
T ss_pred hhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999999999999654322 22245679999999999999999999999999999999999 9999999999
Q ss_pred HHHHHHHHhccc
Q 015556 389 IQAAFAVVNKVN 400 (405)
Q Consensus 389 ~e~~~~i~~~~~ 400 (405)
.+.+..+.++..
T Consensus 267 ~~~~~~i~~g~~ 278 (329)
T 4aoj_A 267 TEAIDCITQGRE 278 (329)
T ss_dssp HHHHHHHHHTCC
T ss_pred HHHHHHHHcCCC
Confidence 999888887643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=402.64 Aligned_cols=218 Identities=25% Similarity=0.415 Sum_probs=187.0
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 248 (405)
..+|.++|.+++.||+|+||+||+|+.. ++.||||++......... ..++.+|+.+|++|+|||||+++
T Consensus 19 ~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~------~~~~~~E~~il~~l~HpnIv~l~ 92 (304)
T 3ubd_A 19 EKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD------RVRTKMERDILVEVNHPFIVKLH 92 (304)
T ss_dssp CCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE------CC------CCCCCCCCTTEECEE
T ss_pred ccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH------HHHHHHHHHHHHHCCCCCCCeEE
Confidence 3567789999999999999999999872 578999999754322211 23567899999999999999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEec
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF 328 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DF 328 (405)
+++.+++.+|||||||+||+|.++|.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 93 ~~~~~~~~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DF 170 (304)
T 3ubd_A 93 YAFQTEGKLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDF 170 (304)
T ss_dssp EEEEETTEEEEEECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESS
T ss_pred EEEEECCEEEEEEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEeccc
Confidence 999999999999999999999999987 467999999999999999999999999999999999999999999999999
Q ss_pred CCcccccc-cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 329 GIACEEVY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 329 G~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
|+|..... .......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+....+.++.
T Consensus 171 Gla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~ 242 (304)
T 3ubd_A 171 GLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 242 (304)
T ss_dssp EEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred ccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC
Confidence 99975432 234456789999999999999999999999999999999999999999999999888887653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=389.87 Aligned_cols=214 Identities=27% Similarity=0.452 Sum_probs=174.1
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
+++|.+++.||+|+||+||+|.+. ++.||||++......+. .....+.+|+.+|++++|||||++++++.++.
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKS-----DMQGRIEREISYLRLLRHPHIIKLYDVIKSKD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCH-----HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 468999999999999999999985 79999999975443221 12467889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+|+||||| +|+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 87 ~~~ivmEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EEEEEEECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred EEEEEEeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 999999999 6899999987 4689999999999999999999999999999999999999999999999999997665
Q ss_pred ccCCCCCCCCCCcccCccccccccC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 336 YCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 336 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
........+||+.|||||++.+..| +.++|||||||++|+|++|+.||.+.+..+....+.++.
T Consensus 164 ~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~ 228 (275)
T 3hyh_A 164 DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV 228 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC
Confidence 5555667789999999999998887 589999999999999999999999988877777666543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=410.14 Aligned_cols=210 Identities=26% Similarity=0.465 Sum_probs=191.4
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
+.|.++++||+|+||.||+|++. |+.||||++....... .+.+.+|+.+|+.|+|||||+++++|.++..
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~ 222 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--------RELLFNEVVIMRDYQHENVVEMYNSYLVGDE 222 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--------GGGHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--------HHHHHHHHHHHHhCCCCCCCceEEEEEECCE
Confidence 56999999999999999999986 7999999998765443 2457799999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+|||||||+||+|.+++.. ..+++..+..|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|.....
T Consensus 223 ~~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp EEEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 9999999999999999976 5699999999999999999999999999999999999999999999999999975433
Q ss_pred -cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 337 -CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 337 -~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
.......+||+.|||||++.+..|+.++|||||||+||||++|..||.+.++.+.+..+.++.
T Consensus 300 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~ 363 (423)
T 4fie_A 300 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL 363 (423)
T ss_dssp SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC
Confidence 234556789999999999999999999999999999999999999999999999988887754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=400.52 Aligned_cols=210 Identities=23% Similarity=0.316 Sum_probs=184.5
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
..+.+.|.++++||+|+||.||+|++. |+.||||+++.... +.+|+.+|++|+|||||+++++|.
T Consensus 54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------------~~~E~~il~~l~HpnIV~l~~~~~ 120 (336)
T 4g3f_A 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------------RVEELVACAGLSSPRIVPLYGAVR 120 (336)
T ss_dssp CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------------CTHHHHTTTTCCCTTBCCEEEEEE
T ss_pred hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------------HHHHHHHHHhCCCCCCCcEEEEEE
Confidence 345577899999999999999999986 78999999985432 236999999999999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCC-cEEEEecCCc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-HLKIADFGIA 331 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~-~vkL~DFG~a 331 (405)
+++.+|||||||+||+|.++|.+ .+.+++..++.++.||+.||+|||++|||||||||+||||+.+| ++||+|||+|
T Consensus 121 ~~~~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla 198 (336)
T 4g3f_A 121 EGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHA 198 (336)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTC
T ss_pred ECCEEEEEEeccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCC
Confidence 99999999999999999999987 35799999999999999999999999999999999999999887 6999999999
Q ss_pred ccccccC------CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 332 CEEVYCD------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 332 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
....... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+...++.+..
T Consensus 199 ~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~ 272 (336)
T 4g3f_A 199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP 272 (336)
T ss_dssp EEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC
T ss_pred eEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC
Confidence 6543211 1233579999999999999999999999999999999999999999888877777777654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=387.12 Aligned_cols=209 Identities=27% Similarity=0.506 Sum_probs=179.8
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec----C
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK----P 254 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~ 254 (405)
|.+.++||+|+||+||+|.+. ++.||||++........ ..+.|.+|+.+|++|+|||||+++++|.+ .
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~------~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 101 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS------ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH------HHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH------HHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCC
Confidence 467788999999999999986 68999999976543332 24678999999999999999999999865 3
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEC-CCCcEEEEecCCc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLID-QEFHLKIADFGIA 331 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IiHrDIkp~NILl~-~~~~vkL~DFG~a 331 (405)
..+|||||||+||+|.++|.+ ...+++..+..++.||+.||+|||++| ||||||||+||||+ .++.+||+|||+|
T Consensus 102 ~~~~lvmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla 179 (290)
T 3fpq_A 102 KCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred cEEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence 568999999999999999987 467999999999999999999999998 99999999999997 4799999999999
Q ss_pred ccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 332 CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 332 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
..... ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+......+...+...
T Consensus 180 ~~~~~-~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~ 245 (290)
T 3fpq_A 180 TLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG 245 (290)
T ss_dssp GGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT
T ss_pred EeCCC-CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC
Confidence 64332 33455689999999999875 69999999999999999999999998877666666555443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=397.05 Aligned_cols=220 Identities=29% Similarity=0.494 Sum_probs=188.6
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC-CC
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PN 243 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pn 243 (405)
++|+|+.++|.+++.||+|+||.||+|.+.+ +.||||++....... ..+.|.+|+.+|.+++| ||
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~-------~~~~~~~E~~il~~l~hhpn 129 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-------EHRALMSELKILIHIGHHLN 129 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHH-------HHHHHHHHHHHHHHHCCCTT
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChH-------HHHHHHHHHHHHHHcCCCCc
Confidence 5689999999999999999999999999753 579999997543322 14678999999999975 99
Q ss_pred eeEEeeEeec-CCeeEEEEeecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 015556 244 VIKFVAACKK-PPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHR 308 (405)
Q Consensus 244 Iv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHr 308 (405)
||+++|+|.+ +..+|||||||++|+|.++|+... ...+++..++.++.|||.||+|||+++||||
T Consensus 130 IV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHR 209 (353)
T 4ase_A 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 209 (353)
T ss_dssp BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecC
Confidence 9999999976 457899999999999999998642 2458999999999999999999999999999
Q ss_pred CCCCCcEEECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCC
Q 015556 309 DLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYE 384 (405)
Q Consensus 309 DIkp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~ 384 (405)
||||+|||+++++.+||+|||+|....... ......||+.|||||++.+..|+.++|||||||+||||+| |..||.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 999999999999999999999996543222 2234568999999999999999999999999999999998 999999
Q ss_pred CCCHHHHHHHHHhc
Q 015556 385 EMNPIQAAFAVVNK 398 (405)
Q Consensus 385 ~~~~~e~~~~i~~~ 398 (405)
+.+..+.+.+++..
T Consensus 290 ~~~~~~~~~~~i~~ 303 (353)
T 4ase_A 290 GVKIDEEFCRRLKE 303 (353)
T ss_dssp TCCCSHHHHHHHHH
T ss_pred CCCHHHHHHHHHHc
Confidence 98766666555543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=374.75 Aligned_cols=198 Identities=27% Similarity=0.484 Sum_probs=162.2
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC-
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP- 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~- 255 (405)
++|.+++.||+|+||+||+|++. ++.||||++....... ..+.+.+|+.+|++|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-------~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 77 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL-------AREKVMREVKALAKLEHPGIVRYFNAWLEKNT 77 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHH-------HHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHH-------HHHHHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence 46889999999999999999986 7899999998654321 2467889999999999999999999987543
Q ss_pred -----------eeEEEEeecCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcE
Q 015556 256 -----------VYCVITEYLSEGSLRAYLHKLEH-KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323 (405)
Q Consensus 256 -----------~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~v 323 (405)
.+|+|||||++|+|.+++..... ...++..++.++.||+.||+|||++|||||||||+||||+.++.+
T Consensus 78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~v 157 (299)
T 4g31_A 78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV 157 (299)
T ss_dssp ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcE
Confidence 37899999999999999986322 234566788999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccC-------------CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 324 KIADFGIACEEVYCD-------------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 324 kL~DFG~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
||+|||+|....... .....+||+.|||||++.+..|+.++|||||||+||||++ ||...
T Consensus 158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence 999999996533211 1234579999999999999999999999999999999996 88754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=381.41 Aligned_cols=213 Identities=25% Similarity=0.361 Sum_probs=185.6
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec---
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK--- 253 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--- 253 (405)
++|.+++.||+|+||+||+|++. |+.||||++........ ..+.+.+|+.+|++|+|||||++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 127 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVT------NAKRTLRELKILKHFKHDNIIAIKDILRPTVP 127 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHH------HHHHHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchH------HHHHHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence 57999999999999999999986 79999999975543322 14678899999999999999999998764
Q ss_pred ---CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 254 ---PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 254 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
...+|||||||. |+|.+++.. .+.+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+
T Consensus 128 ~~~~~~~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 128 YGEFKSVYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred cccCCEEEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecce
Confidence 367899999995 689999976 56899999999999999999999999999999999999999999999999999
Q ss_pred cccccc-----cCCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 331 ACEEVY-----CDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 331 a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
|..... .......+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+..+.+..|++...
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g 280 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG 280 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence 965322 2334567899999999998875 469999999999999999999999999999999988877554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=373.83 Aligned_cols=193 Identities=28% Similarity=0.485 Sum_probs=161.5
Q ss_pred CCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC---
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP--- 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--- 255 (405)
.+|.++++||+|+||.||+|+++|+.||||++.... .. ...+..|+.++.+++|||||+++|+|.++.
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~------~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~ 73 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ER------SWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HH------HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hh------hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCc
Confidence 468899999999999999999999999999986321 10 123345677778899999999999998653
Q ss_pred -eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCcEEECCCCcEEEE
Q 015556 256 -VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ--------GVIHRDLKPENVLIDQEFHLKIA 326 (405)
Q Consensus 256 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------gIiHrDIkp~NILl~~~~~vkL~ 326 (405)
.+|||||||++|+|.++|+. ..++++.++.++.|++.||+|||++ +||||||||+||||+.++.+||+
T Consensus 74 ~~~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~ 150 (303)
T 3hmm_A 74 TQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred eEEEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence 57999999999999999987 5799999999999999999999987 99999999999999999999999
Q ss_pred ecCCcccccccC-----CCCCCCCCCcccCccccccc------cCCchhhHHHHHHHHHHHHhCCCCC
Q 015556 327 DFGIACEEVYCD-----ALSDDPGTYRWMAPEMIKHK------SYGRKVDVYSFGLILWEMVAGTIPY 383 (405)
Q Consensus 327 DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~------~~~~k~DVwSlGvll~elltG~~Pf 383 (405)
|||+|....... .....+||+.|||||++.+. .|+.++|||||||+||||+||..||
T Consensus 151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~ 218 (303)
T 3hmm_A 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218 (303)
T ss_dssp CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence 999986543221 22345799999999998654 4678999999999999999997654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=391.11 Aligned_cols=213 Identities=22% Similarity=0.375 Sum_probs=192.2
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
+++|.+++.||+|+||.||+|++. |+.||||++......+ .+.+.+|+.+|+.|+|||||+++++|.++.
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~--------~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 227 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--------KETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH--------HHHHHHHHHHHHHTCCTTBCCEEEEEECSS
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhh--------HHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 468999999999999999999986 7999999997543211 456789999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC--CcEEEEecCCccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE--FHLKIADFGIACE 333 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~--~~vkL~DFG~a~~ 333 (405)
.+|||||||+||+|.++|.. ....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|..
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEEEEEeecCCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 99999999999999999965 34579999999999999999999999999999999999999754 8999999999987
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
..........+||+.|||||++.+..|+.++|||||||+||||++|..||.+.+..+.+..+.+..
T Consensus 307 ~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~ 372 (573)
T 3uto_A 307 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD 372 (573)
T ss_dssp CCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred ccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCC
Confidence 665555566789999999999999999999999999999999999999999999999988887653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=364.89 Aligned_cols=204 Identities=21% Similarity=0.377 Sum_probs=173.5
Q ss_pred CCeeecceeeeeeeEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEee
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACK 252 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~ 252 (405)
+.|.++++||+|+||+||+|+++ ++.||||.+..... ..++.+|+++|+.+ +|||||++++++.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----------~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----------PIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----------HHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----------HHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 56999999999999999999863 57899999864332 23567899999998 6999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC-CcEEEEecCCc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE-FHLKIADFGIA 331 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~-~~vkL~DFG~a 331 (405)
+...+|+|||||++|+|.+++. .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 9999999999999999999984 48999999999999999999999999999999999999876 89999999999
Q ss_pred cccccc-----------------------------CCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCC
Q 015556 332 CEEVYC-----------------------------DALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTI 381 (405)
Q Consensus 332 ~~~~~~-----------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~ 381 (405)
...... ......+||+.|||||++.+. .|+.++||||+||++|||++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 532211 123445799999999999775 48999999999999999999999
Q ss_pred CCC-CCCHHHHHHHHHh
Q 015556 382 PYE-EMNPIQAAFAVVN 397 (405)
Q Consensus 382 Pf~-~~~~~e~~~~i~~ 397 (405)
||. +.+..+.+..|.+
T Consensus 246 Pf~~~~~~~~~l~~I~~ 262 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMT 262 (361)
T ss_dssp SSSCCSSHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHH
Confidence 994 5566666666654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=385.21 Aligned_cols=207 Identities=23% Similarity=0.387 Sum_probs=175.8
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
.+.+++|.+++.||+|+||.||+|+.. |+.||||++.......... .........++.+++.++|||||+++++|.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~--~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVSTGDCPFIVCMSYAFH 262 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTC--HHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhh--HHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence 456789999999999999999999986 7999999997421100000 001122234566777889999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
+...+|||||||+||+|.++|.+ .+.+++..+..++.||+.||+|||++|||||||||+||||+.+|++||+|||+|.
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ECCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999999999987 4679999999999999999999999999999999999999999999999999997
Q ss_pred cccccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 333 EEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 333 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
..... .....+||+.|||||++.. ..|+.++|||||||+||||++|..||.+.
T Consensus 341 ~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 341 DFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp ECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred ecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 65433 3456789999999999964 57999999999999999999999999753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=341.82 Aligned_cols=215 Identities=28% Similarity=0.453 Sum_probs=192.6
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 253 (405)
..+++|.+++.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.+|+.++||||+++++++..
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 85 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPT------SLQKLFREVRIMKILNHPNIVKLFEVIET 85 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH------HHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHH------HHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 44678999999999999999999984 79999999976543322 24678899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
...+|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 163 (328)
T 3fe3_A 86 EKTLYLIMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE 163 (328)
T ss_dssp SSEEEEEECCCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred CCEEEEEEECCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence 9999999999999999999977 35799999999999999999999999999999999999999999999999999976
Q ss_pred ccccCCCCCCCCCCcccCccccccccCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYG-RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
..........+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+....+..+
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 229 (328)
T 3fe3_A 164 FTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG 229 (328)
T ss_dssp GSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred cCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 6555566677899999999999888874 8999999999999999999999999988887777665
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=345.09 Aligned_cols=221 Identities=25% Similarity=0.399 Sum_probs=185.2
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEe
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFV 248 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 248 (405)
....+.+++|.+++.||+|+||.||+|++. ++.||||++.... .........+.+|+.++..+ +||||++++
T Consensus 16 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~-----~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~ 90 (353)
T 3txo_A 16 SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV-----ILQDDDVECTMTEKRILSLARNHPFLTQLF 90 (353)
T ss_dssp -------CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH-----HHHHTTHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred CcCCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHH-----hcchhHHHHHHHHHHHHHhccCCCceeeEE
Confidence 344677889999999999999999999986 6899999997421 11122245678999999998 699999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEec
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF 328 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DF 328 (405)
+++.+...+|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+||
T Consensus 91 ~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DF 168 (353)
T 3txo_A 91 CCFQTPDRLFFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADF 168 (353)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccc
Confidence 999999999999999999999999987 367999999999999999999999999999999999999999999999999
Q ss_pred CCccccc-ccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 329 GIACEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 329 G~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
|++.... ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....++++.
T Consensus 169 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~ 240 (353)
T 3txo_A 169 GMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE 240 (353)
T ss_dssp TTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred cceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 9986532 2233455679999999999999999999999999999999999999999999988888887654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=340.00 Aligned_cols=216 Identities=24% Similarity=0.400 Sum_probs=189.3
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 253 (405)
+.+++|.+++.||+|+||.||++... ++.||||++..... ........+.+|+.+|+.++||||+++++++.+
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 76 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-----IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh-----hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence 45688999999999999999999986 78999999974210 111124567899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
...+|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 77 ~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 154 (337)
T 1o6l_A 77 HDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhh
Confidence 9999999999999999999986 35789999999999999999999999999999999999999999999999999865
Q ss_pred cc-ccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 334 EV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 334 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.. ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+...
T Consensus 155 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~ 220 (337)
T 1o6l_A 155 GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220 (337)
T ss_dssp SCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred cccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 32 233445667999999999999999999999999999999999999999998887777766654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=332.20 Aligned_cols=221 Identities=34% Similarity=0.629 Sum_probs=184.4
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
.+.+.+..++|.+++.||+|+||.||+|.+.++.||||++........ ..+.+.+|+.++++++||||++++++
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~ 102 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAE------RVNEFLREVAIMKRLRHPNIVLFMGA 102 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHH------HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHH------HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 356678889999999999999999999999999999999976554332 14678899999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEECCCCcEEEEe
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLE-HKTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLIDQEFHLKIAD 327 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g--IiHrDIkp~NILl~~~~~vkL~D 327 (405)
+.+...+++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|
T Consensus 103 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp ECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred EEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECC
Confidence 999999999999999999999998632 123899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccccc-CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 328 FGIACEEVYC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 328 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 183 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~ 253 (309)
T 3p86_A 183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF 253 (309)
T ss_dssp CC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHH
T ss_pred CCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 9998643322 123445799999999999999999999999999999999999999999998887776643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=328.95 Aligned_cols=211 Identities=27% Similarity=0.504 Sum_probs=187.6
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++....... ...+.+|+.++++++||||+++++++....
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--------KELIINEILVMRENKNPNIVNYLDSYLVGD 90 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--------HHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--------HHHHHHHHHHHhcCCCCCCCeEeEEEEECC
Confidence 367889999999999999999874 7899999998655443 345779999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+++||||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 91 ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999999999999987 468999999999999999999999999999999999999999999999999986543
Q ss_pred cc-CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 336 YC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 336 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.++.+....+....
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 232 (297)
T 3fxz_A 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232 (297)
T ss_dssp STTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC
T ss_pred CcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 22 23345679999999999999999999999999999999999999999999888777766543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=337.29 Aligned_cols=212 Identities=23% Similarity=0.397 Sum_probs=189.1
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+++.||+|+||.||+|.+. ++.||||++........ ....+.+|+.++++++||||+++++++.+...
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 102 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR------DFQKLEREARICRKLQHPNIVRLHDSIQEESF 102 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHH------HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHH------HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 57889999999999999999986 78999999986554332 14578899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC---CcEEEEecCCccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE---FHLKIADFGIACE 333 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~---~~vkL~DFG~a~~ 333 (405)
.|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus 103 ~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp EEEEECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999999999999976 4678999999999999999999999999999999999999765 4599999999976
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.++
T Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~ 245 (362)
T 2bdw_A 181 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 245 (362)
T ss_dssp CTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred ecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence 65555556678999999999999989999999999999999999999999998888777776654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=332.68 Aligned_cols=214 Identities=28% Similarity=0.458 Sum_probs=189.5
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 253 (405)
+.+++|.+++.||+|+||.||++... ++.||||++..... ........+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 77 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-----VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD 77 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence 45688999999999999999999986 78999999974211 111124567899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
...+|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 78 ~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~ 155 (318)
T 1fot_A 78 AQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY 155 (318)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred CCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCccee
Confidence 9999999999999999999987 46789999999999999999999999999999999999999999999999999865
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+++.
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 218 (318)
T 1fot_A 156 VPD--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 218 (318)
T ss_dssp CSS--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC
T ss_pred cCC--ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 432 234567999999999999999999999999999999999999999999988888887765
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=327.24 Aligned_cols=214 Identities=29% Similarity=0.480 Sum_probs=185.0
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.++|.+++.||+|+||.||++.+. ++.||||++......... ..+.+.+|+.++.+++||||+++++++.+..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEE-----TLKRFEREVHNSSQLSHQNIVSMIDVDEEDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHH-----HHHHHHHHHHHHTTCCBTTBCCEEEEEECSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHH-----HHHHHHHHHHHHhcCCCCCCceEEEeeeeCC
Confidence 468999999999999999999986 689999999765544432 2567899999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+|+||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred eEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999999999987 3579999999999999999999999999999999999999999999999999986543
Q ss_pred cc--CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 336 YC--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 336 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.. .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+....+...+.+..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 227 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD 227 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc
Confidence 22 1223456999999999999999999999999999999999999999999988877766654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=337.97 Aligned_cols=216 Identities=23% Similarity=0.389 Sum_probs=190.2
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
+.|.+++.||+|+||.||++.+. |+.||||++.......... ......+.+|+.+|++++||||+++++++.+...
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR--GVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccc--hhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 56899999999999999999986 7899999998654322100 0013568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCC----cEEEEecCCcc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF----HLKIADFGIAC 332 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~----~vkL~DFG~a~ 332 (405)
+++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 90 ~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 9999999999999999975 46799999999999999999999999999999999999998776 79999999997
Q ss_pred cccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 333 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.+.
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~ 233 (361)
T 2yab_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233 (361)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred EcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 665555556778999999999999999999999999999999999999999998888877777654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=335.56 Aligned_cols=217 Identities=24% Similarity=0.430 Sum_probs=187.7
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEe
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAAC 251 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~ 251 (405)
.+..++|.+++.||+|+||.||+|.+. ++.||||++..... ........+..|..++..+ +||||+++++++
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~ 87 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-----LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 87 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh-----hhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence 456789999999999999999999986 68999999974210 0111234577899999887 899999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
.+...+|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 88 QTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 999999999999999999999987 357899999999999999999999999999999999999999999999999998
Q ss_pred ccccc-cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 332 CEEVY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 332 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
..... .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+...
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~ 233 (345)
T 1xjd_A 166 KENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 233 (345)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred hhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC
Confidence 65332 23345668999999999999999999999999999999999999999999888877777654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=336.64 Aligned_cols=217 Identities=27% Similarity=0.430 Sum_probs=188.5
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEe
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAAC 251 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~ 251 (405)
.+.+++|.+++.||+|+||.||+|.+. ++.||||++..... ........+..|..++..+ +||||+++++++
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~-----~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 90 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV-----IQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 90 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence 456789999999999999999999997 58899999974211 0111245677899999988 799999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
.+...+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a 168 (353)
T 2i0e_A 91 QTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168 (353)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence 9999999999999999999999863 57999999999999999999999999999999999999999999999999999
Q ss_pred cccc-ccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 332 CEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 332 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.... ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+++.
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~ 236 (353)
T 2i0e_A 169 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236 (353)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred cccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC
Confidence 7532 233445668999999999999999999999999999999999999999999988888777764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=347.04 Aligned_cols=218 Identities=24% Similarity=0.384 Sum_probs=189.0
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
+..+..++|.+++.||+|+||.||+|.+. ++.||||++.... .........+.+|+.++..++||||++++++
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~-----~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 137 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE-----MIKRSDSAFFWEERDIMAFANSPWVVQLFYA 137 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTCCCSTHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhh-----hhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 34566789999999999999999999986 6899999997311 0000112347789999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
|.+...+|+|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 138 ~~~~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 138 FQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccce
Confidence 9999999999999999999999976 4689999999999999999999999999999999999999999999999999
Q ss_pred cccccccC--CCCCCCCCCcccCcccccccc----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 331 ACEEVYCD--ALSDDPGTYRWMAPEMIKHKS----YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 331 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
+....... .....+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+....+++.
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 288 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 288 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhc
Confidence 96543322 234667999999999997665 789999999999999999999999999999988888765
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=348.25 Aligned_cols=219 Identities=22% Similarity=0.342 Sum_probs=188.9
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
..+..++|.+++.||+|+||+||+|.+. ++.||||++.... .........+.+|+.++..++||||++++++|
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE-----MLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH-----HHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHH-----hhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3455688999999999999999999986 5899999997311 01111123478999999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
.+...+|+|||||++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 9999999999999999999999763 467999999999999999999999999999999999999999999999999998
Q ss_pred ccccccC--CCCCCCCCCcccCccccc-----cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 332 CEEVYCD--ALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 332 ~~~~~~~--~~~~~~gt~~y~aPE~~~-----~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
....... .....+||+.|+|||++. ...|+.++|||||||++|||++|..||.+.+..+....+++.
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 296 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 296 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhc
Confidence 6543322 223467999999999986 567899999999999999999999999999999988888764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=332.16 Aligned_cols=218 Identities=22% Similarity=0.368 Sum_probs=180.8
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEE-----CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIY-----KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
.+..++|.+++.||+|+||.||++.. .++.||||++......... .....+.+|+.+|+.++||||+++++
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~ 88 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNA----KDTAHTKAERNILEEVKHPFIVDLIY 88 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC------------------HHHHHHHCCCTTBCCEEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhh----hHHHHHHHHHHHHHhCCCCCccceeE
Confidence 45668899999999999999999997 3689999999754322211 12456779999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
++.+...+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 166 (327)
T 3a62_A 89 AFQTGGKLYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFG 166 (327)
T ss_dssp EEECSSCEEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCC
Confidence 99999999999999999999999986 3578999999999999999999999999999999999999999999999999
Q ss_pred Ccccccc-cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 330 IACEEVY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 330 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.+.
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 236 (327)
T 3a62_A 167 LCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236 (327)
T ss_dssp CC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT
T ss_pred cccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence 9864322 22334567999999999999999999999999999999999999999999888877777654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=333.08 Aligned_cols=204 Identities=25% Similarity=0.455 Sum_probs=181.5
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEe
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAAC 251 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~ 251 (405)
.+.+++|.+++.||+|+||.||++++. ++.||||++......... ....+.+|+.++.++ +||||+++++++
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 79 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE-----DIDWVQTEKHVFEQASNHPFLVGLHSCF 79 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHH-----HHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchH-----HHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence 456788999999999999999999986 689999999865433322 245678999999998 899999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
.+...+|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a 157 (345)
T 3a8x_A 80 QTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157 (345)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccc
Confidence 999999999999999999999986 357999999999999999999999999999999999999999999999999998
Q ss_pred cccc-ccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 332 CEEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 332 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
.... ........+||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 158 KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp BCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 6532 23344566899999999999999999999999999999999999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=342.36 Aligned_cols=205 Identities=25% Similarity=0.445 Sum_probs=179.8
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeE
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAA 250 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~ 250 (405)
..+.+++|.+++.||+|+||.||++++. ++.||||+++........ ....+.+|..++.++ +||||++++++
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~-----~~~~~~~E~~il~~~~~hp~Iv~l~~~ 121 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE-----DIDWVQTEKHVFEQASNHPFLVGLHSC 121 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC---------CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHH-----HHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence 3566789999999999999999999986 689999999864332221 134577899999887 89999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
+.+...+|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 122 ~~~~~~~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGl 199 (396)
T 4dc2_A 122 FQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 199 (396)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecce
Confidence 9999999999999999999999987 35799999999999999999999999999999999999999999999999999
Q ss_pred ccc-ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 331 ACE-EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 331 a~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
+.. ..........+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 200 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 200 CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp CBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred eeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 975 3333445667899999999999999999999999999999999999999964
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=338.32 Aligned_cols=221 Identities=29% Similarity=0.507 Sum_probs=189.2
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEEC---------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-C
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK---------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-H 240 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~---------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~ 240 (405)
...|.+..++|.+++.||+|+||.||+|.+. +..||||++...... .....+.+|+.+|+++ +
T Consensus 73 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~~ 145 (370)
T 2psq_A 73 DPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-------KDLSDLVSEMEMMKMIGK 145 (370)
T ss_dssp CTTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH-------HHHHHHHHHHHHHHHSCC
T ss_pred cccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH-------HHHHHHHHHHHHHHHhcC
Confidence 3456778899999999999999999999873 246999999754321 1246788999999999 8
Q ss_pred CCCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 015556 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVI 306 (405)
Q Consensus 241 HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIi 306 (405)
||||++++++|.+...+|+||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+
T Consensus 146 hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 225 (370)
T 2psq_A 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI 225 (370)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred CCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 9999999999999999999999999999999998743 23588999999999999999999999999
Q ss_pred ecCCCCCcEEECCCCcEEEEecCCccccccc---CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCC
Q 015556 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIP 382 (405)
Q Consensus 307 HrDIkp~NILl~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~P 382 (405)
||||||+||||+.++.+||+|||++...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 226 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p 305 (370)
T 2psq_A 226 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305 (370)
T ss_dssp CSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999998643322 22334457889999999999999999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHhc
Q 015556 383 YEEMNPIQAAFAVVNK 398 (405)
Q Consensus 383 f~~~~~~e~~~~i~~~ 398 (405)
|.+....+....+.++
T Consensus 306 ~~~~~~~~~~~~~~~~ 321 (370)
T 2psq_A 306 YPGIPVEELFKLLKEG 321 (370)
T ss_dssp STTCCGGGHHHHHHTT
T ss_pred CCCCCHHHHHHHHhcC
Confidence 9998876666655554
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=332.21 Aligned_cols=211 Identities=16% Similarity=0.297 Sum_probs=187.6
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+++.||+|+||.||+|.+. ++.||+|++..... ....+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 75 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---------DQVLVKKEISILNIARHRNILHLHESFESMEE 75 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---------HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc---------cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCE
Confidence 68999999999999999999986 68999999974321 13467899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC--CCcEEEEecCCcccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ--EFHLKIADFGIACEE 334 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~--~~~vkL~DFG~a~~~ 334 (405)
+++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 76 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 76 LVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 9999999999999999975 2357999999999999999999999999999999999999987 789999999999765
Q ss_pred cccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 335 VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 335 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.++.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 219 (321)
T 1tki_A 155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE 219 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred CCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCC
Confidence 44444445569999999999998889999999999999999999999999998888887777654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=343.42 Aligned_cols=220 Identities=23% Similarity=0.333 Sum_probs=190.5
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
+..+..++|.+++.||+|+||.||+++.. ++.||||++.... .........+.+|..++..++||||++++++
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~-----~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD-----MLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-----HHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH-----hhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 44567789999999999999999999985 7999999997311 1111123457899999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
|.+...+|+||||+++|+|.+++.+. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechh
Confidence 99999999999999999999999863 34799999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC--CCCCCCCCcccCccccc-------cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 331 ACEEVYCDA--LSDDPGTYRWMAPEMIK-------HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 331 a~~~~~~~~--~~~~~gt~~y~aPE~~~-------~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
+........ ....+||+.|+|||++. ...|+.++|||||||++|||++|+.||...+..+...++++.
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 285 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 965433222 23457999999999997 457899999999999999999999999999999888888763
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=338.37 Aligned_cols=207 Identities=22% Similarity=0.398 Sum_probs=183.8
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
..+.+.+++|.+++.||+|+||.||++.+. ++.||||++.... .........+.+|+.+|+.++||||+++++
T Consensus 8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~-----~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 82 (384)
T 4fr4_A 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQK-----CVERNEVRNVFKELQIMQGLEHPFLVNLWY 82 (384)
T ss_dssp CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhh-----cccHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 456788899999999999999999999986 5889999997421 111112467889999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
+|.+...+|+||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 83 ~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG 160 (384)
T 4fr4_A 83 SFQDEEDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFN 160 (384)
T ss_dssp EEECSSEEEEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEeCCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccc
Confidence 99999999999999999999999986 4679999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCCcccCcccccc---ccCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 330 IACEEVYCDALSDDPGTYRWMAPEMIKH---KSYGRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 330 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
++............+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 161 ~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~ 219 (384)
T 4fr4_A 161 IAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219 (384)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCC
Confidence 9976655556677789999999999963 4589999999999999999999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=334.17 Aligned_cols=216 Identities=28% Similarity=0.381 Sum_probs=190.8
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
....+++|.+++.||+|+||.||++.+. ++.||||++..... ........+.+|+.+|+.++||||+++++++
T Consensus 36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 110 (350)
T 1rdq_E 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-----VKLKQIEHTLNEKRILQAVNFPFLVKLEFSF 110 (350)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh-----ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3456789999999999999999999986 78999999974211 1112245788999999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
.+...+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 111 ~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a 188 (350)
T 1rdq_E 111 KDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188 (350)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccc
Confidence 9999999999999999999999873 56999999999999999999999999999999999999999999999999998
Q ss_pred ccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 332 CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 332 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.++
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~ 253 (350)
T 1rdq_E 189 KRVKG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253 (350)
T ss_dssp EECSS--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred eeccC--CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 65432 234567999999999999999999999999999999999999999999988888887765
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=339.44 Aligned_cols=216 Identities=25% Similarity=0.419 Sum_probs=181.9
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHH-HHhcCCCCeeEEeeEee
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVAL-LSRLHNPNVIKFVAACK 252 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~g~~~ 252 (405)
+..++|.+++.||+|+||.||++++. ++.||||++......... ....+.+|..+ ++.++||||+++++++.
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~-----~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~ 109 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK-----EEKHIMSERNVLLKNVKHPFLVGLHFSFQ 109 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC------------------CCBCCCCCTTBCCEEEEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhH-----HHHHHHHHHHHHHHhCCCCCCCCEEEEEE
Confidence 44578999999999999999999986 588999999764432211 13456677776 56789999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
+...+|+||||+++|+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 110 ~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~ 187 (373)
T 2r5t_A 110 TADKLYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK 187 (373)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred eCCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccc
Confidence 99999999999999999999987 3578999999999999999999999999999999999999999999999999987
Q ss_pred ccc-ccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 333 EEV-YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 333 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
... ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....++++
T Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~ 254 (373)
T 2r5t_A 188 ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 254 (373)
T ss_dssp GGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS
T ss_pred ccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc
Confidence 532 233445667999999999999999999999999999999999999999999998888888765
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=344.12 Aligned_cols=217 Identities=27% Similarity=0.514 Sum_probs=190.6
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
...|.++.++|.+++.||+|+||.||+|.+.++.||||+++.... .+.|.+|+.+|++++||||++++++
T Consensus 185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~ 254 (450)
T 1k9a_A 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT----------AQAFLAEASVMTQLRHSNLVQLLGV 254 (450)
T ss_dssp HTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTT----------SHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchH----------HHHHHHHHHHHHhccCCCEEEEEEE
Confidence 467899999999999999999999999999999999999975431 3568899999999999999999999
Q ss_pred eecCC-eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 251 CKKPP-VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 251 ~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
+.+.. .+++||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 255 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG 334 (450)
T 1k9a_A 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 334 (450)
T ss_dssp EECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCC
Confidence 87654 78999999999999999998655568999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 330 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
++...... .....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.++.
T Consensus 335 ~a~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~ 403 (450)
T 1k9a_A 335 LTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 403 (450)
T ss_dssp TCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC
T ss_pred Cccccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 98654322 223467899999999999999999999999999999998 999999988777776666553
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=318.02 Aligned_cols=218 Identities=26% Similarity=0.538 Sum_probs=191.4
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
..|.++.++|.+++.||+|+||.||+|.+. ++.||||++...... .+++.+|+.++++++||||++++++
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~ 73 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGV 73 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC---------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC---------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 357889999999999999999999999985 688999999754433 2457899999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
+.+....++||||+++++|.+++.. ....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 152 (269)
T 4hcu_A 74 CLEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM 152 (269)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTG
T ss_pred EecCCceEEEEEeCCCCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccc
Confidence 9999999999999999999999976 345689999999999999999999999999999999999999999999999999
Q ss_pred ccccccc--CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 331 ACEEVYC--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 331 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
+...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~ 224 (269)
T 4hcu_A 153 TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 224 (269)
T ss_dssp GGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC
T ss_pred cccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc
Confidence 8643221 22344557889999999998999999999999999999999 999999999888887777653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=329.37 Aligned_cols=220 Identities=25% Similarity=0.530 Sum_probs=188.5
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 248 (405)
..+..++|.+++.||+|+||.||+|.+. +..||||++....... ..+.|.+|+.++++++||||++++
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~ 116 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER-------QRRDFLSEASIMGQFDHPNIIRLE 116 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHH-------HHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHH-------HHHHHHHHHHHHHhCCCCCCCcEE
Confidence 3566789999999999999999999984 3459999997543221 256788999999999999999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEec
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF 328 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DF 328 (405)
+++.+...+++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df 195 (325)
T 3kul_A 117 GVVTRGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDF 195 (325)
T ss_dssp EEECGGGCCEEEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEeCCccEEEeeCCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCC
Confidence 999999999999999999999999975 3457999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccC----CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccC
Q 015556 329 GIACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVNF 401 (405)
Q Consensus 329 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~~ 401 (405)
|++....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+..+...
T Consensus 196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~ 273 (325)
T 3kul_A 196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL 273 (325)
T ss_dssp SSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred CcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC
Confidence 9986533211 2223346788999999998899999999999999999999 99999999998888887776443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=324.63 Aligned_cols=205 Identities=32% Similarity=0.526 Sum_probs=180.2
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
.+.++.++|.+++.||+|+||.||+|.+. ++.||||.+...+. ...+.|.+|+.++++++||||++++++
T Consensus 4 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~--------~~~~~~~~E~~~l~~l~hp~iv~~~~~ 75 (310)
T 3s95_A 4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE--------ETQRTFLKEVKVMRCLEHPNVLKFIGV 75 (310)
T ss_dssp CEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCH--------HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCH--------HHHHHHHHHHHHHHhCCCcCcccEEEE
Confidence 45677889999999999999999999986 68999999854221 125678899999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
+.++...++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 154 (310)
T 3s95_A 76 LYKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGL 154 (310)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTT
T ss_pred EecCCeeEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeeccc
Confidence 99999999999999999999999873 46799999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC---------------CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 331 ACEEVYCDA---------------LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 331 a~~~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
+........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp CEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred ceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 864322211 11457999999999999999999999999999999999999999764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=326.10 Aligned_cols=216 Identities=24% Similarity=0.380 Sum_probs=188.8
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
+.|.+++.||+|+||.||++.+. ++.||||++.......... ......+.+|+.+|++++||||+++++++.+...
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR--GVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 56889999999999999999986 7899999998654322100 0013568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCC----cEEEEecCCcc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF----HLKIADFGIAC 332 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~----~vkL~DFG~a~ 332 (405)
+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 89 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 9999999999999999975 46799999999999999999999999999999999999998887 89999999997
Q ss_pred cccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 333 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
............||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+...
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 232 (326)
T 2y0a_A 167 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232 (326)
T ss_dssp ECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHT
T ss_pred ECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhc
Confidence 665555556678999999999999899999999999999999999999999998887777666543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=340.33 Aligned_cols=213 Identities=23% Similarity=0.344 Sum_probs=186.9
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+++.||+|+||.||+|.+. ++.||+|++........ ..+.+.+|+.++++++||||+++++++.+...
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 84 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSAR------DHQKLEREARICRLLKHPNIVRLHDSISEEGH 84 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHH------HHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHH------HHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence 57889999999999999999985 78999999986553322 24678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEC---CCCcEEEEecCCccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID---QEFHLKIADFGIACE 333 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~---~~~~vkL~DFG~a~~ 333 (405)
.|+||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 85 ~~lv~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp EEEEECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEEEEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999999999999999987 46799999999999999999999999999999999999998 568899999999965
Q ss_pred cccc-CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 334 EVYC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 334 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.++.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 229 (444)
T 3soa_A 163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA 229 (444)
T ss_dssp CCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred ecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC
Confidence 4332 23345679999999999999999999999999999999999999999999888887777653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=316.96 Aligned_cols=217 Identities=24% Similarity=0.499 Sum_probs=190.7
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
.+.+++++|.+++.||+|+||.||+|.+.++.||||++......... .+.+.+|+.++++++||||+++++++.
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRK------SRDFNEECPRLRIFSHPNVLPVLGACQ 77 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHH------HHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHH------HHHHHHHHHHHHhcCCCchhheEEEEc
Confidence 45678899999999999999999999999999999999876544322 467899999999999999999999998
Q ss_pred cC--CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEECCCCcEEEEec
Q 015556 253 KP--PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLIDQEFHLKIADF 328 (405)
Q Consensus 253 ~~--~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IiHrDIkp~NILl~~~~~vkL~DF 328 (405)
+. ..+++||||+++|+|.+++.......+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~ 157 (271)
T 3kmu_A 78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMA 157 (271)
T ss_dssp TTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred cCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEec
Confidence 87 78899999999999999998755556999999999999999999999999 999999999999999999999999
Q ss_pred CCcccccccCCCCCCCCCCcccCccccccccCCc---hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 329 GIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGR---KVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 329 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
|++... ......||+.|+|||++.+..++. ++||||||+++|+|++|..||.+.+..+....+....
T Consensus 158 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 227 (271)
T 3kmu_A 158 DVKFSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG 227 (271)
T ss_dssp GSCCTT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSC
T ss_pred cceeee----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcC
Confidence 987432 223456899999999998765544 8999999999999999999999999988877776553
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=334.04 Aligned_cols=219 Identities=19% Similarity=0.335 Sum_probs=189.1
Q ss_pred ccccCCCeeecceeeee--eeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 174 HTVDLSQLFLGLRFAHG--AHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G--~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
...+.++|.+++.||+| +||.||+|.+. ++.||||++........ ....+.+|+.++++++|||||++++
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~ 93 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE------MVTFLQGELHVSKLFNHPNIVPYRA 93 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHH------HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChH------HHHHHHHHHHHHHhCCCCCCCcEeE
Confidence 34567899999999999 99999999996 78999999986543322 2567889999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
++.+...+|+|||||++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg 173 (389)
T 3gni_B 94 TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLR 173 (389)
T ss_dssp EEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGG
T ss_pred EEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccc
Confidence 99999999999999999999999988666789999999999999999999999999999999999999999999999999
Q ss_pred Ccccccc--------cCCCCCCCCCCcccCcccccc--ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 330 IACEEVY--------CDALSDDPGTYRWMAPEMIKH--KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 330 ~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.+..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....++++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 252 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 252 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 8743211 112233478999999999987 57899999999999999999999999988777766655543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=331.67 Aligned_cols=223 Identities=30% Similarity=0.507 Sum_probs=193.1
Q ss_pred ccccccccCCCeeecceeeeeeeEEEEEEEECC---------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-
Q 015556 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD---------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL- 239 (405)
Q Consensus 170 ~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~---------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l- 239 (405)
....|.+..++|.+++.||+|+||.||+|.+.+ ..||||++....... ...++.+|+.+++++
T Consensus 60 ~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~ 132 (382)
T 3tt0_A 60 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-------DLSDLISEMEMMKMIG 132 (382)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHH-------HHHHHHHHHHHHHHHC
T ss_pred cCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHH-------HHHHHHHHHHHHHHhc
Confidence 346678888999999999999999999999742 579999997543221 246788999999999
Q ss_pred CCCCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 015556 240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGV 305 (405)
Q Consensus 240 ~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~gI 305 (405)
+||||++++++|.+....++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||
T Consensus 133 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 212 (382)
T 3tt0_A 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC 212 (382)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 89999999999999999999999999999999998753 2458999999999999999999999999
Q ss_pred eecCCCCCcEEECCCCcEEEEecCCccccccc---CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCC
Q 015556 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTI 381 (405)
Q Consensus 306 iHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~ 381 (405)
+||||||+||||+.++.+||+|||++...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 213 vH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~ 292 (382)
T 3tt0_A 213 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 292 (382)
T ss_dssp CCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998654322 22344567889999999999999999999999999999999 999
Q ss_pred CCCCCCHHHHHHHHHhcc
Q 015556 382 PYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 382 Pf~~~~~~e~~~~i~~~~ 399 (405)
||.+.+..+....+.++.
T Consensus 293 p~~~~~~~~~~~~~~~~~ 310 (382)
T 3tt0_A 293 PYPGVPVEELFKLLKEGH 310 (382)
T ss_dssp SSTTCCHHHHHHHHHTTC
T ss_pred CCCCCCHHHHHHHHHcCC
Confidence 999988887776666553
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=333.02 Aligned_cols=202 Identities=19% Similarity=0.314 Sum_probs=176.6
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEE-------ECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC---C
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGI-------YKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---N 241 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~-------~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~---H 241 (405)
.+..+..++|.+++.||+|+||.||+|. ..++.||||++.... ...+..|+.++..++ |
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~l~~~~~ 126 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----------PWEFYIGTQLMERLKPSMQ 126 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----------HHHHHHHHHHHHHSCGGGG
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----------hhHHHHHHHHHHHhhhhhh
Confidence 4455667889999999999999999994 247899999997432 245678888888887 8
Q ss_pred CCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEC
Q 015556 242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKL---EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID 318 (405)
Q Consensus 242 pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~ 318 (405)
+||+.+++++......|+|||||++|+|.+++... ....+++..++.|+.||+.||+|||++||+||||||+||||+
T Consensus 127 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~ 206 (365)
T 3e7e_A 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILG 206 (365)
T ss_dssp GGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC
T ss_pred hhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEec
Confidence 99999999999999999999999999999999854 346799999999999999999999999999999999999998
Q ss_pred C-----------CCcEEEEecCCccccc---ccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCC
Q 015556 319 Q-----------EFHLKIADFGIACEEV---YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384 (405)
Q Consensus 319 ~-----------~~~vkL~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~ 384 (405)
. ++.+||+|||++.... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence 8 8999999999995432 2334456679999999999999999999999999999999999999984
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=338.92 Aligned_cols=221 Identities=29% Similarity=0.508 Sum_probs=191.1
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 248 (405)
.+.|.++.++|.+++.||+|+||.||+|.+. ++.||||++...... .....|.+|+.+|++++||||++++
T Consensus 106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~hpniv~~~ 178 (377)
T 3cbl_A 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPP-------DLKAKFLQEARILKQYSHPNIVRLI 178 (377)
T ss_dssp CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCH-------HHHTTTTHHHHHHTTCCCTTBCCEE
T ss_pred ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCH-------HHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 4678999999999999999999999999996 789999998743221 1245788999999999999999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEec
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF 328 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DF 328 (405)
++|.+...+++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 179 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~Df 257 (377)
T 3cbl_A 179 GVCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDF 257 (377)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCG
T ss_pred EEEecCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcC
Confidence 9999999999999999999999999863 346899999999999999999999999999999999999999999999999
Q ss_pred CCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 329 GIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 329 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
|++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.++.
T Consensus 258 G~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 332 (377)
T 3cbl_A 258 GMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG 332 (377)
T ss_dssp GGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC
T ss_pred CCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9986432211 1112235778999999998899999999999999999998 999999999887776665543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=327.07 Aligned_cols=216 Identities=25% Similarity=0.429 Sum_probs=181.4
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.++|.+++.||+|+||.||++.+. ++.||||++......+. .....+.+|+.++.+++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP-----SFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSH-----HHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCH-----HHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence 367999999999999999999974 68999999986544332 22567889999999999999999999987654
Q ss_pred e----eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 256 V----YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 256 ~----~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
. .|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 86 PAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp TTEEEEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred CCCcccEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 3 4999999999999999986 357899999999999999999999999999999999999999999999999998
Q ss_pred cccccc----CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 332 CEEVYC----DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 332 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.++.+....++....
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 236 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 236 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC
Confidence 643321 122334689999999999999999999999999999999999999999999888877776543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=323.74 Aligned_cols=212 Identities=25% Similarity=0.424 Sum_probs=179.9
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++....... .....+.+|+.++++++||||+++++++.+...
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE------GIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccc------hhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 478999999999999999999985 6899999997543222 124678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc-
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV- 335 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~- 335 (405)
+++||||++ ++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 94 ~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 94 LTLVFEFME-KDLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EEEEEECCS-EEHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EEEEEcCCC-CCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 999999997 488888876 34569999999999999999999999999999999999999999999999999996543
Q ss_pred ccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 336 YCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 336 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+.+
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 234 (311)
T 3niz_A 172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS 234 (311)
T ss_dssp CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHH
T ss_pred CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 2233445678999999999876 5689999999999999999999999998777776666655
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=327.41 Aligned_cols=219 Identities=28% Similarity=0.543 Sum_probs=189.3
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeE
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 246 (405)
+.+..++|.+++.||+|+||.||+|.+.+ +.||||++...... .....+.+|+.++++++||||++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~ 114 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-------DMQADFQREAALMAEFDNPNIVK 114 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-------HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH-------HHHHHHHHHHHHHHhCCCCCEEE
Confidence 45667889999999999999999999864 78999999754321 12567899999999999999999
Q ss_pred EeeEeecCCeeEEEEeecCCCCHHHHHHHhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 015556 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLE----------------------HKTLPLPKLIAIALDIARGMEYIHSQG 304 (405)
Q Consensus 247 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~yLH~~g 304 (405)
++++|.+...+++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++|
T Consensus 115 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 194 (343)
T 1luf_A 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 194 (343)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999998742 157899999999999999999999999
Q ss_pred ceecCCCCCcEEECCCCcEEEEecCCccccccc---CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CC
Q 015556 305 VIHRDLKPENVLIDQEFHLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GT 380 (405)
Q Consensus 305 IiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~ 380 (405)
|+||||||+|||++.++.+||+|||++...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 999999999999999999999999998643222 22334568899999999998899999999999999999999 99
Q ss_pred CCCCCCCHHHHHHHHHhcc
Q 015556 381 IPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 381 ~Pf~~~~~~e~~~~i~~~~ 399 (405)
.||.+....+....+.++.
T Consensus 275 ~p~~~~~~~~~~~~~~~~~ 293 (343)
T 1luf_A 275 QPYYGMAHEEVIYYVRDGN 293 (343)
T ss_dssp CTTTTSCHHHHHHHHHTTC
T ss_pred CcCCCCChHHHHHHHhCCC
Confidence 9999999888777776654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=317.48 Aligned_cols=214 Identities=23% Similarity=0.390 Sum_probs=183.2
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
+++|.+++.||+|+||+||+|.+. ++.||||++......... ...+.+|+.++++++||||+++++++.++.
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 74 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV------PSSALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTH------HHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCc------chHHHHHHHHHhcCCCCCEeeEEeEEEeCC
Confidence 368999999999999999999985 689999999876544332 456779999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+++||||+++ +|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 75 ~~~lv~e~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 75 KLTLVFEFCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEEEEECCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEecCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence 99999999975 67666655 34679999999999999999999999999999999999999999999999999996543
Q ss_pred -ccCCCCCCCCCCcccCcccccccc-CCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhcc
Q 015556 336 -YCDALSDDPGTYRWMAPEMIKHKS-YGRKVDVYSFGLILWEMVAGTIP-YEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 336 -~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DVwSlGvll~elltG~~P-f~~~~~~e~~~~i~~~~ 399 (405)
.........||+.|+|||++.+.. ++.++|||||||++|+|++|..| |...+..+....+.+..
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~ 219 (292)
T 3o0g_A 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219 (292)
T ss_dssp SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH
T ss_pred CccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence 223345567899999999997765 79999999999999999987776 67777777777776543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=342.70 Aligned_cols=219 Identities=23% Similarity=0.383 Sum_probs=180.3
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
.+.+..++|.+++.||+|+||.||+|.+. ++.||||++...... .......+.+|+.+++.++||||++++++
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~l~~~ 216 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-----AKDEVAHTLTENRVLQNSRHPFLTALKYS 216 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC------------------CCCCCSCTTSCCEEEE
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh-----hhHHHHHHHHHHHHHHhCCCCeEeeEEEE
Confidence 34566788999999999999999999986 689999999742111 11124567789999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEECCCCcEEEEecC
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
|.+...+|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ +||+||||||+||||+.++.+||+|||
T Consensus 217 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG 294 (446)
T 4ejn_A 217 FQTHDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFG 294 (446)
T ss_dssp EEETTEEEEEECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCC
T ss_pred EeeCCEEEEEEeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCC
Confidence 9999999999999999999999987 3578999999999999999999998 999999999999999999999999999
Q ss_pred Ccccc-cccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 330 IACEE-VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 330 ~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
++... .........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+...
T Consensus 295 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~ 364 (446)
T 4ejn_A 295 LCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 364 (446)
T ss_dssp CCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred CceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC
Confidence 98653 2233445678999999999999999999999999999999999999999998888777766554
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=320.22 Aligned_cols=213 Identities=26% Similarity=0.422 Sum_probs=181.1
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
+++|.+++.||+|+||.||+|.+. ++.||||++........ ....+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG------IPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGC------CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred CccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccc------cchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence 368999999999999999999986 78999999976543221 13567799999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+++||||+++ +|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 75 ~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 75 LVLVFEHLDQ-DLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp EEEEEECCSE-EHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred EEEEEEecCC-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 9999999975 99999876 346789999999999999999999999999999999999999999999999999864322
Q ss_pred -cCCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 337 -CDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 337 -~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.+.
T Consensus 153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 216 (288)
T 1ob3_A 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred cccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 2233455789999999999764 5899999999999999999999999999988888777654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=322.98 Aligned_cols=213 Identities=23% Similarity=0.441 Sum_probs=171.9
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++........ ...+.+|+.++++++||||+++++++.+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 76 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT-------PSTAIREISLMKELKHENIVRLYDVIHTEN 76 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCS-------CHHHHHHHHHHTTCCBTTBCCEEEEECCTT
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccccc-------HHHHHHHHHHHHhcCCCCcceEEEEEEECC
Confidence 467889999999999999999875 78999999986543322 245678999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLE----HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
.+++||||++ ++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 77 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 77 KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA 155 (317)
T ss_dssp EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccc
Confidence 9999999997 59999997642 245899999999999999999999999999999999999999999999999998
Q ss_pred ccccc-cCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 332 CEEVY-CDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 332 ~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.+.
T Consensus 156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 224 (317)
T 2pmi_A 156 RAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI 224 (317)
T ss_dssp EETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred eecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 65432 233445679999999999976 46899999999999999999999999999998888777664
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=331.77 Aligned_cols=215 Identities=25% Similarity=0.430 Sum_probs=175.9
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeecC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKP 254 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~ 254 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++........ ....+.+|+.++.++. ||||+++++++...
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 81 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST------DAQRTFREIMILTELSGHENIVNLLNVLRAD 81 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHH------HHHHHHHHHHHHHHTTTCTTBCCEEEEEECT
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChH------HHHHHHHHHHHHHhccCCCCCCeeeeEEecC
Confidence 468999999999999999999986 78999999965433322 1456779999999997 99999999999754
Q ss_pred --CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 255 --PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 255 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
..+|+|||||. ++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 82 ~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 82 NDRDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp TSSCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred CCCEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 37899999996 599999976 578999999999999999999999999999999999999999999999999986
Q ss_pred cccc----------------------cCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 015556 333 EEVY----------------------CDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI 389 (405)
Q Consensus 333 ~~~~----------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~ 389 (405)
.... .......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 4321 122344579999999999976 67899999999999999999999999999999
Q ss_pred HHHHHHHhcccCC
Q 015556 390 QAAFAVVNKVNFG 402 (405)
Q Consensus 390 e~~~~i~~~~~~~ 402 (405)
+.+..++....++
T Consensus 238 ~~~~~i~~~~~~p 250 (388)
T 3oz6_A 238 NQLERIIGVIDFP 250 (388)
T ss_dssp HHHHHHHHHHCCC
T ss_pred HHHHHHHHhcCCC
Confidence 9999888766554
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=342.39 Aligned_cols=213 Identities=25% Similarity=0.359 Sum_probs=181.2
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC-
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP- 254 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~- 254 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++....... ...+++.+|+.+|+.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 134 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ------THAKRAYRELVLMKCVNHKNIISLLNVFTPQK 134 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSH------HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccCh------HHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence 578999999999999999999986 6899999997543222 1256788999999999999999999999654
Q ss_pred -----CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 255 -----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 255 -----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
..+|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 135 ~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 135 TLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred ccccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEE
Confidence 457999999965 57776643 58999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Q 015556 330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNF 401 (405)
Q Consensus 330 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~~ 401 (405)
++............+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+++..+.
T Consensus 210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~ 281 (464)
T 3ttj_A 210 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281 (464)
T ss_dssp CC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred eeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 997765555566778999999999999999999999999999999999999999999999999988876543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=328.10 Aligned_cols=203 Identities=28% Similarity=0.496 Sum_probs=178.9
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
.+++|.+++.||+|+||.||+|.+. ++.||||++..... ........+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 81 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL-----KKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP 81 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHc-----cchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 3578999999999999999999984 78999999973110 0111235688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
..+++||||+ +|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~~lv~E~~-~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 82 TDIVMVIEYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp SEEEEEECCC-CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred CEEEEEEECC-CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 9999999999 7899999876 357999999999999999999999999999999999999999999999999999766
Q ss_pred cccCCCCCCCCCCcccCccccccccC-CchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 335 VYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 335 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
.........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+..
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 212 (336)
T 3h4j_B 159 TDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212 (336)
T ss_dssp TTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS
T ss_pred cCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc
Confidence 66556667789999999999988876 789999999999999999999997643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=313.07 Aligned_cols=213 Identities=23% Similarity=0.393 Sum_probs=189.3
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+++.||+|+||.||+|.+. ++.||||++........ ....+.+|+.++++++||||+++++++.+...
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR------DFQKLEREARICRKLQHPNIVRLHDSIQEESF 79 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHH------HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHH------HHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCE
Confidence 67899999999999999999986 68999999986544332 14678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCc---EEEEecCCccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH---LKIADFGIACE 333 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~---vkL~DFG~a~~ 333 (405)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999999999998873 57899999999999999999999999999999999999976655 99999999976
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
...........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+..+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 223 (284)
T 3kk8_A 158 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 223 (284)
T ss_dssp CCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred cccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcc
Confidence 655555566789999999999999999999999999999999999999999988887777666543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=341.73 Aligned_cols=220 Identities=31% Similarity=0.498 Sum_probs=192.5
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
.+.|.+..++|.+++.||+|+||.||+|.+. +..||||+++..... .+.|.+|+.+|++++||||+++++
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~iv~l~~ 250 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---------VEAFLAEANVMKTLQHDKLVKLHA 250 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---------HHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---------HHHHHHHHHHHhhCCCCCEeeEEE
Confidence 4678999999999999999999999999997 578999999753321 357889999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
++. ...+++||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 251 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG 329 (454)
T 1qcf_A 251 VVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG 329 (454)
T ss_dssp EEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred EEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCC
Confidence 987 5568899999999999999986544578999999999999999999999999999999999999999999999999
Q ss_pred Cccccccc--CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 015556 330 IACEEVYC--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 330 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
++...... .......++..|+|||++....++.++|||||||+||||++ |..||.+.+..+....+.++..
T Consensus 330 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~ 403 (454)
T 1qcf_A 330 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR 403 (454)
T ss_dssp GGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC
T ss_pred CceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99653321 12233456789999999998899999999999999999999 9999999999888887776544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=315.38 Aligned_cols=219 Identities=24% Similarity=0.505 Sum_probs=189.6
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
..|.++.++|.+++.||+|+||.||++.+.+ ..||||++...... .+++.+|+.++.+++||||++++++
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~ 87 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMNLSHEKLVQLYGV 87 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC---------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC---------HHHHHHHHHHHhcCCCCCEeeEEEE
Confidence 4678888999999999999999999999875 68999999754433 2457799999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
+.+...+++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 166 (283)
T 3gen_A 88 CTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGL 166 (283)
T ss_dssp ECSSSSEEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred EecCCCeEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccc
Confidence 99999999999999999999999763 35699999999999999999999999999999999999999999999999999
Q ss_pred ccccccc--CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 015556 331 ACEEVYC--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 331 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
+...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+.++..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~ 239 (283)
T 3gen_A 167 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR 239 (283)
T ss_dssp GGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred cccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC
Confidence 8643221 22334457888999999998899999999999999999998 9999999999888888776643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=333.80 Aligned_cols=211 Identities=21% Similarity=0.369 Sum_probs=186.3
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
+.|.+++.||+|+||.||+|.+. ++.||+|++......+ ...+.+|+.+|+.++||||+++++++.+...
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~--------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 122 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--------KYTVKNEISIMNQLHHPKLINLHDAFEDKYE 122 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH--------HHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhh--------HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence 67999999999999999999986 6899999997543211 3468899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC--CCcEEEEecCCcccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ--EFHLKIADFGIACEE 334 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~--~~~vkL~DFG~a~~~ 334 (405)
+++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 123 ~~lv~E~~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EEEEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence 9999999999999999875 2357899999999999999999999999999999999999974 578999999999765
Q ss_pred cccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 335 VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 335 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.+.
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~ 265 (387)
T 1kob_A 202 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC 265 (387)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC
T ss_pred CCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 4444444557999999999999999999999999999999999999999999888877776654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=312.44 Aligned_cols=218 Identities=28% Similarity=0.529 Sum_probs=190.3
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
.+.+..++|.+++.||+|+||.||+|.+.+ ..||||++...... .+++.+|+.++.+++||||+++++++
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~ 72 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---------EDEFFQEAQTMMKLSHPKLVKFYGVC 72 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC---------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc---------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 356677899999999999999999999875 58999999754433 24578999999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
.+....++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 151 (268)
T 3sxs_A 73 SKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151 (268)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred ccCCceEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccc
Confidence 9999999999999999999999873 346899999999999999999999999999999999999999999999999998
Q ss_pred ccccccC--CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 015556 332 CEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 332 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
....... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+.++..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 223 (268)
T 3sxs_A 152 RYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR 223 (268)
T ss_dssp EECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred eecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC
Confidence 6433221 2234456788999999998889999999999999999999 9999999998888777766543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=314.59 Aligned_cols=217 Identities=34% Similarity=0.649 Sum_probs=177.9
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
.++.++|.+++.||+|+||.||+|.+.++.||||++........ ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDI----SQTIENVRQEAKLFAMLKHPNIIALRGVCLKE 78 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC--------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccH----HHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 35678999999999999999999999999999999875433221 12246788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCcEEECC--------CCcE
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG---VIHRDLKPENVLIDQ--------EFHL 323 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IiHrDIkp~NILl~~--------~~~v 323 (405)
...++||||+++++|.+++.. ..+++..++.++.|++.||.|||++| |+||||||+|||++. ++.+
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp --CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred CceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence 999999999999999999864 67999999999999999999999999 999999999999986 7789
Q ss_pred EEEecCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 324 KIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 324 kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
||+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+....
T Consensus 156 kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 230 (271)
T 3dtc_A 156 KITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230 (271)
T ss_dssp EECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC
T ss_pred EEccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC
Confidence 999999986543322 234579999999999998899999999999999999999999999998888777666543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=325.07 Aligned_cols=214 Identities=24% Similarity=0.434 Sum_probs=182.1
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++........ ...+.+|+.++++++||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-------VDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-------HHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch-------HHHHHHHHHHHHhcCCCCcceEEEEeecCC
Confidence 467899999999999999999997 78999999975332221 355679999999999999999999998755
Q ss_pred --eeEEEEeecCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE----CCCCcEEEEec
Q 015556 256 --VYCVITEYLSEGSLRAYLHKLEH-KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI----DQEFHLKIADF 328 (405)
Q Consensus 256 --~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl----~~~~~vkL~DF 328 (405)
.+++||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Df 160 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccC
Confidence 78999999999999999986432 349999999999999999999999999999999999999 78888999999
Q ss_pred CCcccccccCCCCCCCCCCcccCccccc--------cccCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHH
Q 015556 329 GIACEEVYCDALSDDPGTYRWMAPEMIK--------HKSYGRKVDVYSFGLILWEMVAGTIPYEEMN----PIQAAFAVV 396 (405)
Q Consensus 329 G~a~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~k~DVwSlGvll~elltG~~Pf~~~~----~~e~~~~i~ 396 (405)
|++.............||+.|+|||++. +..++.++|||||||++|||++|..||.... ..+...+++
T Consensus 161 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred CCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 9997665555556677999999999986 5678999999999999999999999997433 344555555
Q ss_pred hc
Q 015556 397 NK 398 (405)
Q Consensus 397 ~~ 398 (405)
.+
T Consensus 241 ~~ 242 (319)
T 4euu_A 241 TG 242 (319)
T ss_dssp HH
T ss_pred cC
Confidence 44
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=319.91 Aligned_cols=207 Identities=26% Similarity=0.448 Sum_probs=184.0
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeE
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC 258 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 258 (405)
|...+.||+|+||.||+|.+. |+.||||++....... ...+.+|+.++++++||||+++++++......+
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR--------RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELW 118 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS--------HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH--------HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEE
Confidence 566778999999999999985 7999999998655433 346779999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc-
Q 015556 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC- 337 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~- 337 (405)
+||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 119 lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 195 (321)
T 2c30_A 119 VLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 195 (321)
T ss_dssp EEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred EEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc
Confidence 99999999999999865 57999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 338 DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 338 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+...
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 256 (321)
T 2c30_A 196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS 256 (321)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence 2334567999999999999999999999999999999999999999999888877766654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=326.72 Aligned_cols=203 Identities=30% Similarity=0.519 Sum_probs=176.1
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++......+ ..+.+.+|+.+++.++||||+++++++.++.
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-------CPENIKKEICINKMLNHENVVKFYGHRREGN 78 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc-------hHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 468999999999999999999986 6899999997544322 1356789999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
..|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred eEEEEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 99999999999999999865 4569999999999999999999999999999999999999999999999999996432
Q ss_pred c---cCCCCCCCCCCcccCccccccccC-CchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 015556 336 Y---CDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPI 389 (405)
Q Consensus 336 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DVwSlGvll~elltG~~Pf~~~~~~ 389 (405)
. ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||......
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 214 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT
T ss_pred cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH
Confidence 2 223345679999999999987776 78999999999999999999999876554
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=326.98 Aligned_cols=222 Identities=26% Similarity=0.478 Sum_probs=187.2
Q ss_pred ccccccccCCCeeecceeeeeeeEEEEEEEE-------CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CC
Q 015556 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIY-------KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HN 241 (405)
Q Consensus 170 ~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~H 241 (405)
...+|.++.++|.+++.||+|+||.||+|.+ .++.||||++....... ....+.+|+.++.++ +|
T Consensus 36 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~~h 108 (344)
T 1rjb_A 36 YDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-------EREALMSELKMMTQLGSH 108 (344)
T ss_dssp CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCC
T ss_pred cCcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHH-------HHHHHHHHHHHHHhhcCC
Confidence 3457888999999999999999999999997 24689999997433221 246788999999999 89
Q ss_pred CCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHH
Q 015556 242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH---------------------KTLPLPKLIAIALDIARGMEYI 300 (405)
Q Consensus 242 pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~aL~yL 300 (405)
|||+++++++.+.+.+++||||+++|+|.+++..... ..+++..++.++.||+.||.||
T Consensus 109 p~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 188 (344)
T 1rjb_A 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL 188 (344)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHH
T ss_pred CCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999986432 2378999999999999999999
Q ss_pred HHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCC---CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHH
Q 015556 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMV 377 (405)
Q Consensus 301 H~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ell 377 (405)
|++||+||||||+|||++.++.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 189 H~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 268 (344)
T 1rjb_A 189 EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268 (344)
T ss_dssp HHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred HhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHH
Confidence 999999999999999999999999999999865433221 22334678899999999889999999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhc
Q 015556 378 A-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 378 t-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
+ |..||.+....+....++..
T Consensus 269 t~g~~p~~~~~~~~~~~~~~~~ 290 (344)
T 1rjb_A 269 SLGVNPYPGIPVDANFYKLIQN 290 (344)
T ss_dssp TTSCCSSTTCCCSHHHHHHHHT
T ss_pred cCCCCCcccCCcHHHHHHHHhc
Confidence 8 99999988766666655554
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=311.48 Aligned_cols=210 Identities=21% Similarity=0.367 Sum_probs=187.4
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||+|+||.||+|.+. +..||+|.+....... ...+.+|+.++++++||||+++++++.+...
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--------VDRFKQEIEIMKSLDHPNIIRLYETFEDNTD 80 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--------HHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--------HHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence 56889999999999999999987 4689999997644333 3567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---CCCCcEEEEecCCccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIACE 333 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl---~~~~~vkL~DFG~a~~ 333 (405)
.++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp EEEEEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 9999999999999999987 3568999999999999999999999999999999999999 7889999999999976
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
...........||+.|+|||++.+. ++.++||||||+++|+|++|..||......+....+.++.
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 223 (277)
T 3f3z_A 159 FKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT 223 (277)
T ss_dssp CCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred ccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence 6555555677899999999998754 8999999999999999999999999998888877776653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=326.48 Aligned_cols=204 Identities=28% Similarity=0.456 Sum_probs=165.4
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
+.|.+.+.||+|+||.||+|.+. ++.||||++..... .+.+.+|+.+|++++||||++++++|.+...
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 122 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD----------KKIVRTEIGVLLRLSHPNIIKLKEIFETPTE 122 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------------CHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh----------HHHHHHHHHHHHhCCCCCCcceeeeEecCCe
Confidence 56889999999999999999996 57899999985321 3457789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC---CCcEEEEecCCccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ---EFHLKIADFGIACE 333 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~---~~~vkL~DFG~a~~ 333 (405)
+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 123 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp EEEEECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EEEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 9999999999999999976 456899999999999999999999999999999999999975 88999999999876
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFA 394 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~ 394 (405)
...........||+.|+|||++.+..++.++|||||||++|||++|..||.+....+....
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 261 (349)
T 2w4o_A 201 VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFR 261 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHH
T ss_pred cCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHH
Confidence 5444444566799999999999998999999999999999999999999987766554443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=320.11 Aligned_cols=223 Identities=27% Similarity=0.465 Sum_probs=190.4
Q ss_pred cccccccccCCCeeecceeeeeeeEEEEEEEE-------CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-C
Q 015556 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIY-------KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-H 240 (405)
Q Consensus 169 ~~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~ 240 (405)
.....|.+..++|.+++.||+|+||.||+|.+ .++.||||++....... ....+.+|+.+++++ +
T Consensus 13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~~ 85 (313)
T 1t46_A 13 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT-------EREALMSELKVLSYLGN 85 (313)
T ss_dssp CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-------HHHHHHHHHHHHHHHCC
T ss_pred CCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHH-------HHHHHHHHHHHHhhccc
Confidence 34567888889999999999999999999986 24789999997543221 146788999999999 8
Q ss_pred CCCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 015556 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH----------------KTLPLPKLIAIALDIARGMEYIHSQG 304 (405)
Q Consensus 241 HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~g 304 (405)
||||+++++++.+....++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++|
T Consensus 86 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 165 (313)
T 1t46_A 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN 165 (313)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999999999999999999999999999999987432 24899999999999999999999999
Q ss_pred ceecCCCCCcEEECCCCcEEEEecCCcccccccCC---CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CC
Q 015556 305 VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GT 380 (405)
Q Consensus 305 IiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~ 380 (405)
|+||||||+|||++.++.+||+|||++........ .....+|+.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 166 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 245 (313)
T 1t46_A 166 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245 (313)
T ss_dssp CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999865433221 223446788999999998899999999999999999999 99
Q ss_pred CCCCCCCHHHHHHHHHhc
Q 015556 381 IPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 381 ~Pf~~~~~~e~~~~i~~~ 398 (405)
.||......+....++..
T Consensus 246 ~p~~~~~~~~~~~~~~~~ 263 (313)
T 1t46_A 246 SPYPGMPVDSKFYKMIKE 263 (313)
T ss_dssp CSSTTCCSSHHHHHHHHH
T ss_pred CCCCcccchhHHHHHhcc
Confidence 999987766555555543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=329.55 Aligned_cols=220 Identities=30% Similarity=0.515 Sum_probs=184.6
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCC
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPN 243 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~Hpn 243 (405)
..|.+..++|.+++.||+|+||.||+|.+. ++.||||++....... ..+.+.+|+.++.++ +|||
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~~hpn 87 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-------EHRALMSELKILIHIGHHLN 87 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-------HHHHHHHHHHHHHHHCCCTT
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHH-------HHHHHHHHHHHHHhhcCCcc
Confidence 467888899999999999999999999853 3789999997543222 146788999999999 7899
Q ss_pred eeEEeeEeecCC-eeEEEEeecCCCCHHHHHHHhcC--------------------------------------------
Q 015556 244 VIKFVAACKKPP-VYCVITEYLSEGSLRAYLHKLEH-------------------------------------------- 278 (405)
Q Consensus 244 Iv~l~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------- 278 (405)
|++++++|.+.. .+++||||+++|+|.+++.....
T Consensus 88 iv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 999999998755 48999999999999999986432
Q ss_pred --------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccC
Q 015556 279 --------------------KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338 (405)
Q Consensus 279 --------------------~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~ 338 (405)
..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 128899999999999999999999999999999999999999999999999986432211
Q ss_pred ---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 339 ---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 339 ---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
......||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.....+..
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 311 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 311 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc
Confidence 2234457889999999999999999999999999999998 99999987755555544443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=322.88 Aligned_cols=216 Identities=22% Similarity=0.375 Sum_probs=179.9
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.+.|.+++.||+|+||.||+|.+. ++.||||++......... ......+.+|+.+++.++||||+++++++.+..
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 99 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP---GLSTEDLKREASICHMLKHPHIVELLETYSSDG 99 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSS---SCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccc---cchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 367899999999999999999986 689999999632100000 001356889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCc---EEEEecCC
Q 015556 256 VYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH---LKIADFGI 330 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~---vkL~DFG~ 330 (405)
.+|+|||||++++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999999988754 2346899999999999999999999999999999999999976554 99999999
Q ss_pred cccccccC-CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 331 ACEEVYCD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 331 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ..+....+.+
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~ 246 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIK 246 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHH
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHc
Confidence 96544322 234567999999999999999999999999999999999999999874 3344444443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=344.54 Aligned_cols=210 Identities=23% Similarity=0.401 Sum_probs=185.8
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
...+..++|.+++.||+|+||.||+|.+. ++.||||++..... ........+.+|+.+|..++||||++++++
T Consensus 178 ~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 252 (576)
T 2acx_A 178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-----KKRKGEAMALNEKQILEKVNSRFVVSLAYA 252 (576)
T ss_dssp TSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhh-----hhhHHHHHHHHHHHHHHHcCCCCEeeEEEE
Confidence 44577789999999999999999999985 78999999974211 011124567899999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
+.+...+|+||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 253 ~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGl 332 (576)
T 2acx_A 253 YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL 332 (576)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred EeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccc
Confidence 99999999999999999999999875556699999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
+............+||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 333 a~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 333 AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp CEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred ceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 976555444556689999999999999999999999999999999999999998753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=330.22 Aligned_cols=209 Identities=22% Similarity=0.321 Sum_probs=180.3
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeE
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYC 258 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 258 (405)
+...+.||+|+||.||+|.+. ++.||||++...... ....+.+|+.+|++++||||++++++|.+...++
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 162 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK--------DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV 162 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHH--------HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc--------cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 344678999999999999985 789999999854321 1457889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE--CCCCcEEEEecCCcccccc
Q 015556 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI--DQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl--~~~~~vkL~DFG~a~~~~~ 336 (405)
|||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 163 lv~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 163 LVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp EEEECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 999999999999999762 3568999999999999999999999999999999999999 6778999999999976655
Q ss_pred cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 337 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+++.
T Consensus 242 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 303 (373)
T 2x4f_A 242 REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC 303 (373)
T ss_dssp TCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT
T ss_pred ccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 55556667999999999999889999999999999999999999999999988888877764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=331.69 Aligned_cols=218 Identities=27% Similarity=0.522 Sum_probs=178.4
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
.++.++|.+++.||+|+||.||+|.+. +..||||++...... ...+.|.+|+.++++++||||+++++
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~ 113 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE-------KQRRDFLGEASIMGQFDHPNIIRLEG 113 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH-------HHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH-------HHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 566788999999999999999999874 578999999754321 12567899999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
+|.+...+++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 114 ~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 192 (373)
T 2qol_A 114 VVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFG 192 (373)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred EEeeCCceEEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCc
Confidence 99999999999999999999999976 34578999999999999999999999999999999999999999999999999
Q ss_pred CcccccccC----CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 015556 330 IACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 330 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
++....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||...+..+....+.++..
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~ 268 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR 268 (373)
T ss_dssp ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE
T ss_pred cccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 986533221 1122235778999999998999999999999999999998 9999999998887777766543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=341.20 Aligned_cols=220 Identities=29% Similarity=0.492 Sum_probs=192.7
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
...+..++|.+++.||+|+||.||+|.+. |+.||||++..... ........+.+|+.+++.++||||++++++
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~-----~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~ 84 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI-----RSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH-----HHTTTHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc-----cCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 34556789999999999999999999986 79999999973211 011124578899999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
+.+...+|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~ 162 (476)
T 2y94_A 85 ISTPSDIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGL 162 (476)
T ss_dssp EECSSEEEEEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred EEECCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccc
Confidence 9999999999999999999999975 46799999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccCccccccccC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
+............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.++.
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 232 (476)
T 2y94_A 163 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI 232 (476)
T ss_dssp CEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC
T ss_pred hhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC
Confidence 976655555667789999999999988776 789999999999999999999999988777777776553
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=309.31 Aligned_cols=217 Identities=27% Similarity=0.542 Sum_probs=190.8
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
+|.++.++|.+++.||+|+||.||++.+. ++.||||++...... .+.+.+|+.++++++||||+++++++
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~ 72 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGVC 72 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC---------HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC---------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 57889999999999999999999999985 578999999754432 24678999999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
.+....++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 151 (267)
T 3t9t_A 73 LEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 151 (267)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred ccCCCeEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccc
Confidence 9999999999999999999999863 356899999999999999999999999999999999999999999999999998
Q ss_pred cccccc--CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 332 CEEVYC--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 332 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
...... .......++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+.++.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~ 222 (267)
T 3t9t_A 152 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 222 (267)
T ss_dssp GGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC
T ss_pred cccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Confidence 643221 12234567889999999998899999999999999999999 999999998888777776653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=322.23 Aligned_cols=225 Identities=26% Similarity=0.455 Sum_probs=176.1
Q ss_pred ccccccccCCCeeecceeeeeeeEEEEEEEECC-----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 015556 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244 (405)
Q Consensus 170 ~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI 244 (405)
..++..+..++|.+++.||+|+||.||+|.+.. ..||||++........ ..+.+.+|+.++++++||||
T Consensus 14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~i 87 (323)
T 3qup_A 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS------DIEEFLREAACMKEFDHPHV 87 (323)
T ss_dssp --CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CH------HHHHHHHHHHHHTTCCCTTB
T ss_pred HhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHH------HHHHHHHHHHHHHHCCCCce
Confidence 445667788899999999999999999998763 2799999975432222 25678899999999999999
Q ss_pred eEEeeEeecCCee------EEEEeecCCCCHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 015556 245 IKFVAACKKPPVY------CVITEYLSEGSLRAYLHKLEH----KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314 (405)
Q Consensus 245 v~l~g~~~~~~~~------~lV~E~~~~gsL~~~l~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~N 314 (405)
+++++++...... ++||||+.+|+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 88 v~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~N 167 (323)
T 3qup_A 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARN 167 (323)
T ss_dssp CCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcce
Confidence 9999999877654 899999999999999976432 258999999999999999999999999999999999
Q ss_pred EEECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 015556 315 VLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQ 390 (405)
Q Consensus 315 ILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e 390 (405)
||++.++.+||+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+
T Consensus 168 Ili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~ 247 (323)
T 3qup_A 168 CMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247 (323)
T ss_dssp EEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred EEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986543322 2223457788999999999999999999999999999999 999999988888
Q ss_pred HHHHHHhccc
Q 015556 391 AAFAVVNKVN 400 (405)
Q Consensus 391 ~~~~i~~~~~ 400 (405)
....+..+..
T Consensus 248 ~~~~~~~~~~ 257 (323)
T 3qup_A 248 IYNYLIGGNR 257 (323)
T ss_dssp HHHHHHTTCC
T ss_pred HHHHHhcCCC
Confidence 7777766543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=318.09 Aligned_cols=216 Identities=23% Similarity=0.377 Sum_probs=189.1
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
+.|.+++.||+|+||.||+|.+. ++.||||++.......... ......+.+|+.++++++||||+++++++.+...
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR--GVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEeccccccccc--chhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 56889999999999999999986 6899999998654332100 0013568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCC----cEEEEecCCcc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF----HLKIADFGIAC 332 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~----~vkL~DFG~a~ 332 (405)
+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 9999999999999999976 46789999999999999999999999999999999999999887 79999999997
Q ss_pred cccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 333 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
............||+.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+.+.
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 233 (321)
T 2a2a_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233 (321)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred ecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 655544556667999999999999999999999999999999999999999998887777666553
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=330.07 Aligned_cols=221 Identities=26% Similarity=0.425 Sum_probs=188.3
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI 244 (405)
+.+.+..++|.+++.||+|+||.||+|.+. ++.||||++....... ....+.+|+.++++++||||
T Consensus 64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~hpnI 136 (367)
T 3l9p_A 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ-------DELDFLMEALIISKFNHQNI 136 (367)
T ss_dssp GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHH-------HHHHHHHHHHHHHHCCCTTB
T ss_pred chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChh-------hHHHHHHHHHHHHhCCCCCC
Confidence 345667789999999999999999999954 4589999986433222 14568899999999999999
Q ss_pred eEEeeEeecCCeeEEEEeecCCCCHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC
Q 015556 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH-----KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319 (405)
Q Consensus 245 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~ 319 (405)
+++++++.+....++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 137 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 216 (367)
T 3l9p_A 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC 216 (367)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESC
T ss_pred CeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEec
Confidence 9999999999999999999999999999987532 45899999999999999999999999999999999999985
Q ss_pred CC---cEEEEecCCccccccc---CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 015556 320 EF---HLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAA 392 (405)
Q Consensus 320 ~~---~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~ 392 (405)
++ .+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|||++ |..||......+..
T Consensus 217 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~ 296 (367)
T 3l9p_A 217 PGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 296 (367)
T ss_dssp SSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred CCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 54 5999999998643222 22233457899999999998999999999999999999998 99999999988888
Q ss_pred HHHHhcc
Q 015556 393 FAVVNKV 399 (405)
Q Consensus 393 ~~i~~~~ 399 (405)
..+.++.
T Consensus 297 ~~i~~~~ 303 (367)
T 3l9p_A 297 EFVTSGG 303 (367)
T ss_dssp HHHHTTC
T ss_pred HHHHcCC
Confidence 7777654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=316.49 Aligned_cols=213 Identities=22% Similarity=0.395 Sum_probs=180.5
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
+++|.+++.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 75 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV------IKKIALREIRMLKQLKHPNLVNLLEVFRRKR 75 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HH------HHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchH------HHHHHHHHHHHHHhCCCCCccchhheeecCC
Confidence 368999999999999999999986 78999999976543322 2567889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 76 RLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp EEEEEEECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred eEEEEEEeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 99999999999999998875 4679999999999999999999999999999999999999999999999999986543
Q ss_pred -ccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 336 -YCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 336 -~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.........||..|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+.+.
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 218 (311)
T 4agu_A 154 GPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKT 218 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 2223345679999999999976 56799999999999999999999999999988877766543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=312.23 Aligned_cols=218 Identities=32% Similarity=0.503 Sum_probs=189.3
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
.++|.+..++|.+++.||+|+||.||+|.+.+ +.||||++...... .+.+.+|+.++++++||||+++++
T Consensus 5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~ 75 (279)
T 1qpc_A 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---------PDAFLAEANLMKQLQHQRLVRLYA 75 (279)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---------HHHHHHHHHHHHhCCCcCcceEEE
Confidence 46899999999999999999999999999875 68999999754332 346789999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
++.++ ..++||||+++++|.+++.......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 76 ~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg 154 (279)
T 1qpc_A 76 VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFG 154 (279)
T ss_dssp EECSS-SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEcCC-CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCc
Confidence 98754 57899999999999999976444479999999999999999999999999999999999999999999999999
Q ss_pred CcccccccC--CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 330 IACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 330 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
++....... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+.++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 226 (279)
T 1qpc_A 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226 (279)
T ss_dssp TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred ccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc
Confidence 986543221 2234457889999999998889999999999999999999 99999998888777666554
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=319.98 Aligned_cols=221 Identities=29% Similarity=0.431 Sum_probs=184.8
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC---CCCeeEEeeE
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---NPNVIKFVAA 250 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~ 250 (405)
+..++|.+++.||+|+||.||+|.+. ++.||||++.......... .....+.+|+.+++++. ||||++++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGG---GLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSS---CCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccccc---ccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 34578999999999999999999964 7899999997543221100 00134456777777664 9999999999
Q ss_pred eecCC-----eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEE
Q 015556 251 CKKPP-----VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI 325 (405)
Q Consensus 251 ~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL 325 (405)
|.... .+++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp EEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEE
T ss_pred eeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEE
Confidence 98755 5899999996 59999998865566999999999999999999999999999999999999999999999
Q ss_pred EecCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 326 ADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 326 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+++...
T Consensus 162 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (308)
T 3g33_A 162 ADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236 (308)
T ss_dssp CSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC
T ss_pred eeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999765554555566799999999999999999999999999999999999999999999998888877543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=327.98 Aligned_cols=204 Identities=30% Similarity=0.458 Sum_probs=176.7
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
.+++.++.++|.+++.||+|+||.||+|.+.++.||||++..... ...++..|+.++.+++||||++++++
T Consensus 16 ~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~~~~~ 86 (322)
T 3soc_A 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDK---------QSWQNEYEVYSLPGMKHENILQFIGA 86 (322)
T ss_dssp CCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGH---------HHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred ccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCch---------HHHHHHHHHHHHhcCCCCCchhhcce
Confidence 456778899999999999999999999999999999999964221 13345669999999999999999999
Q ss_pred eecCC----eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----------CceecCCCCCcEE
Q 015556 251 CKKPP----VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ----------GVIHRDLKPENVL 316 (405)
Q Consensus 251 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----------gIiHrDIkp~NIL 316 (405)
+.+.. .+++||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||
T Consensus 87 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nil 163 (322)
T 3soc_A 87 EKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL 163 (322)
T ss_dssp EEEECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEE
T ss_pred eccCCCCCceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEE
Confidence 98744 47999999999999999987 5699999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCcccccc-----ccCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 317 IDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKH-----KSYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 317 l~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.
T Consensus 164 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 164 LKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp ECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred ECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999996533222 2334579999999999976 35677899999999999999999999753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=319.36 Aligned_cols=221 Identities=29% Similarity=0.500 Sum_probs=189.5
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn 243 (405)
...|.+..++|.+++.||+|+||.||+|.+. ++.||||++....... ..+.+.+|+.++++++|||
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~hp~ 87 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS-------ELRDLLSEFNVLKQVNHPH 87 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHH-------HHHHHHHHHHHHTTCCCTT
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHH-------HHHHHHHHHHHHhhCCCCc
Confidence 4677888899999999999999999999872 3789999997443211 2467889999999999999
Q ss_pred eeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHH
Q 015556 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH----------------------KTLPLPKLIAIALDIARGMEYIH 301 (405)
Q Consensus 244 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~aL~yLH 301 (405)
|+++++++.+...+++||||+++++|.+++..... ..+++..++.++.||+.||.|||
T Consensus 88 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH 167 (314)
T 2ivs_A 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA 167 (314)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH
T ss_pred eeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999987432 34889999999999999999999
Q ss_pred HCCceecCCCCCcEEECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh
Q 015556 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA 378 (405)
Q Consensus 302 ~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt 378 (405)
++||+||||||+|||++.++.+||+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++
T Consensus 168 ~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 247 (314)
T 2ivs_A 168 EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247 (314)
T ss_dssp HTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred HCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHh
Confidence 9999999999999999999999999999986433221 2234457889999999998899999999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHhc
Q 015556 379 -GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 379 -G~~Pf~~~~~~e~~~~i~~~ 398 (405)
|..||.+....+....+..+
T Consensus 248 ~g~~p~~~~~~~~~~~~~~~~ 268 (314)
T 2ivs_A 248 LGGNPYPGIPPERLFNLLKTG 268 (314)
T ss_dssp TSCCSSTTCCGGGHHHHHHTT
T ss_pred CCCCCCCCCCHHHHHHHhhcC
Confidence 99999988776655555443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=316.25 Aligned_cols=220 Identities=31% Similarity=0.631 Sum_probs=177.7
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
+.+.+..++|.++++||+|+||.||+|.+.+ .||||+++........ .+.|.+|+.++++++||||+++++++
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQ------LQAFKNEVGVLRKTRHVNILLFMGYS 89 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHH------HHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHH------HHHHHHHHHHHHhCCCCcEEEEEeec
Confidence 5667888999999999999999999998765 4999999866544322 46788999999999999999999966
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
. ....++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 90 ~-~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 167 (289)
T 3og7_A 90 T-APQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167 (289)
T ss_dssp C-SSSCEEEEECCCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred c-CCccEEEEEecCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceec
Confidence 4 5567899999999999999965 3467899999999999999999999999999999999999999999999999998
Q ss_pred ccccc---cCCCCCCCCCCcccCccccc---cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 332 CEEVY---CDALSDDPGTYRWMAPEMIK---HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 332 ~~~~~---~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
..... ........||+.|+|||++. +..++.++||||||+++|+|++|..||.+....+....++....
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 242 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS 242 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTS
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccc
Confidence 64322 22334456999999999986 56788999999999999999999999998777776666665443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=317.91 Aligned_cols=222 Identities=27% Similarity=0.411 Sum_probs=179.0
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHH------------------HHHHHHHHHHHH
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETL------------------AARLEKQFNREV 233 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~------------------~~~~~~~~~~Ei 233 (405)
..+.+++|.+++.||+|+||.||+|.+. ++.||||++........... .....+.+.+|+
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 87 (298)
T 2zv2_A 8 DCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEI 87 (298)
T ss_dssp --CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHH
T ss_pred CceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHH
Confidence 3456689999999999999999999985 68999999976543221100 011235688999
Q ss_pred HHHHhcCCCCeeEEeeEeec--CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 015556 234 ALLSRLHNPNVIKFVAACKK--PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLK 311 (405)
Q Consensus 234 ~il~~l~HpnIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIk 311 (405)
.+|++++||||+++++++.+ ...+++||||+++++|.+++. ...+++..++.++.||+.||.|||++||+|||||
T Consensus 88 ~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 164 (298)
T 2zv2_A 88 AILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIK 164 (298)
T ss_dssp HHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 99999999999999999986 568999999999999987653 3679999999999999999999999999999999
Q ss_pred CCcEEECCCCcEEEEecCCccccccc-CCCCCCCCCCcccCcccccccc---CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 312 PENVLIDQEFHLKIADFGIACEEVYC-DALSDDPGTYRWMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 312 p~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~---~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
|+|||++.++.+||+|||++...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 99999999999999999998654322 2234567999999999997655 3789999999999999999999999988
Q ss_pred HHHHHHHHHhc
Q 015556 388 PIQAAFAVVNK 398 (405)
Q Consensus 388 ~~e~~~~i~~~ 398 (405)
..+....+...
T Consensus 245 ~~~~~~~~~~~ 255 (298)
T 2zv2_A 245 IMCLHSKIKSQ 255 (298)
T ss_dssp HHHHHHHHHHC
T ss_pred HHHHHHHHhcc
Confidence 77666555543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=323.33 Aligned_cols=218 Identities=23% Similarity=0.473 Sum_probs=191.4
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecCC
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPP 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 255 (405)
++|.+++.||.|+||.||+|.+. |+.||||++..................+.+|+.++.++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 56889999999999999999986 78999999987553322233344567889999999999 7999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 99999999999999999986 3578999999999999999999999999999999999999999999999999987665
Q ss_pred ccCCCCCCCCCCcccCcccccc------ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 336 YCDALSDDPGTYRWMAPEMIKH------KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 336 ~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.++
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~ 320 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG 320 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence 5555567789999999999853 35889999999999999999999999998888777766654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=329.56 Aligned_cols=203 Identities=29% Similarity=0.403 Sum_probs=167.4
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
..+.++|.+++.||+|+||.||++.+. ++.||||++....... ..+.+|+.+++.++||||+++++++.
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~E~~~l~~l~hpniv~~~~~~~ 86 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---------ENVQREIINHRSLRHPNIVRFKEVIL 86 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---------HHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---------HHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 345678999999999999999999996 6899999997644332 34679999999999999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCc--EEEEecCC
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH--LKIADFGI 330 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~--vkL~DFG~ 330 (405)
+...+++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~ 164 (361)
T 3uc3_A 87 TPTHLAIIMEYASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY 164 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCC
T ss_pred eCCEEEEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCc
Confidence 99999999999999999999976 357999999999999999999999999999999999999987765 99999999
Q ss_pred cccccccCCCCCCCCCCcccCccccccccCCch-hhHHHHHHHHHHHHhCCCCCCCCCH
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRK-VDVYSFGLILWEMVAGTIPYEEMNP 388 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-~DVwSlGvll~elltG~~Pf~~~~~ 388 (405)
+.............||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+...
T Consensus 165 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 165 SKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp C---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred cccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 875444444556679999999999988887655 8999999999999999999987554
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=320.74 Aligned_cols=225 Identities=29% Similarity=0.501 Sum_probs=192.0
Q ss_pred ccccccccccCCCeeecceeeeeeeEEEEEEEEC---------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHh
Q 015556 168 VDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK---------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR 238 (405)
Q Consensus 168 ~~~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~---------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~ 238 (405)
....+.|.+..++|.+++.||+|+||.||+|.+. ++.||||++....... ....+.+|+.++++
T Consensus 24 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~ 96 (334)
T 2pvf_A 24 LPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-------DLSDLVSEMEMMKM 96 (334)
T ss_dssp CCCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHH-------HHHHHHHHHHHHHH
T ss_pred CCCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHH-------HHHHHHHHHHHHHH
Confidence 3445778888999999999999999999999974 4679999987543211 24678899999999
Q ss_pred c-CCCCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHC
Q 015556 239 L-HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH--------------KTLPLPKLIAIALDIARGMEYIHSQ 303 (405)
Q Consensus 239 l-~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~ 303 (405)
+ +||||++++++|.+...+++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++
T Consensus 97 l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 176 (334)
T 2pvf_A 97 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ 176 (334)
T ss_dssp HCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9 899999999999999999999999999999999986432 2489999999999999999999999
Q ss_pred CceecCCCCCcEEECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-C
Q 015556 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-G 379 (405)
Q Consensus 304 gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G 379 (405)
||+||||||+|||++.++.+||+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |
T Consensus 177 ~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 256 (334)
T 2pvf_A 177 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256 (334)
T ss_dssp TEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred CeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986543221 2334457889999999988889999999999999999999 9
Q ss_pred CCCCCCCCHHHHHHHHHhcc
Q 015556 380 TIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 380 ~~Pf~~~~~~e~~~~i~~~~ 399 (405)
..||.+....+....+.++.
T Consensus 257 ~~p~~~~~~~~~~~~~~~~~ 276 (334)
T 2pvf_A 257 GSPYPGIPVEELFKLLKEGH 276 (334)
T ss_dssp CCSSTTCCHHHHHHHHHHTC
T ss_pred CCCcCcCCHHHHHHHHhcCC
Confidence 99999988877666665543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=311.20 Aligned_cols=214 Identities=29% Similarity=0.451 Sum_probs=183.7
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 253 (405)
+.+++|.+++.||+|+||.||+|.+. ++.||||++.... .........+.+|+.++++++||||+++++++.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-----LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 80 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccc-----cchhhHHHHHHHHHHHHHcCCCCCCcchhheEec
Confidence 45578999999999999999999987 4789999996321 1112235678899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
....++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH 158 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEecccccc
Confidence 99999999999999999999873 5689999999999999999999999999999999999999999999999998854
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
... .......|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+..
T Consensus 159 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 221 (279)
T 3fdn_A 159 APS-SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 221 (279)
T ss_dssp C---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred CCc-ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh
Confidence 333 223455799999999999999999999999999999999999999999888777666554
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=315.27 Aligned_cols=219 Identities=24% Similarity=0.462 Sum_probs=177.2
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeE
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 246 (405)
.++.+..++|.+++.||+|+||.||+|.+. +..||||++...... .....+.+|+.++++++||||++
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~ 80 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-------SVREKFLQEALTMRQFDHPHIVK 80 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH-------HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCH-------HHHHHHHHHHHHHHhCCCCccce
Confidence 467788899999999999999999999985 246999988643321 12567889999999999999999
Q ss_pred EeeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEE
Q 015556 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA 326 (405)
Q Consensus 247 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~ 326 (405)
+++++.+ +..++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+
T Consensus 81 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 158 (281)
T 1mp8_A 81 LIGVITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLG 158 (281)
T ss_dssp EEEEECS-SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred EEEEEcc-CccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEEC
Confidence 9999854 5678999999999999999863 3568999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccccC--CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 327 DFGIACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 327 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
|||++....... ......+++.|+|||++.+..++.++||||||+++|||++ |..||.+....+....+.++.
T Consensus 159 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~ 234 (281)
T 1mp8_A 159 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 234 (281)
T ss_dssp C-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred ccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC
Confidence 999986543322 1233457789999999998899999999999999999997 999999988777776666554
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=343.77 Aligned_cols=219 Identities=26% Similarity=0.541 Sum_probs=192.3
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 248 (405)
.+.|.+..++|.+++.||+|+||.||+|.+. ++.||||++...... .+.|.+|+.+|++++||||++++
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~hpniv~l~ 282 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---------VEEFLKEAAVMKEIKHPNLVQLL 282 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---------hHHHHHHHHHHHhcCCCCEeeEE
Confidence 3678899999999999999999999999997 689999998754322 35688999999999999999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEec
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF 328 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DF 328 (405)
++|.+...+++||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+||
T Consensus 283 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DF 362 (495)
T 1opk_A 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADF 362 (495)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCT
T ss_pred EEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeec
Confidence 99999999999999999999999998866677999999999999999999999999999999999999999999999999
Q ss_pred CCccccccc--CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 329 GIACEEVYC--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 329 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
|++...... .......++..|+|||++.+..++.++|||||||+||||++ |..||.+.+..+....+.++
T Consensus 363 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 435 (495)
T 1opk_A 363 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 435 (495)
T ss_dssp TCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred ccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 998653321 12233456789999999998899999999999999999999 99999998877666555544
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=340.57 Aligned_cols=219 Identities=22% Similarity=0.365 Sum_probs=186.7
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
..+..++|.+.+.||+|+||.||++.+. ++.||||++..... ........+.+|+.+|.+++||||+++++++
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 254 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL-----KKRKGYQGAMVEKKILAKVHSRFIVSLAYAF 254 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh-----hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 4466789999999999999999999985 79999999973211 0111245688999999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLE--HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
.+...+|+||||++||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFG 334 (543)
T 3c4z_A 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLG 334 (543)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecc
Confidence 99999999999999999999998643 4569999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCC-CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHh
Q 015556 330 IACEEVYCDA-LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM----NPIQAAFAVVN 397 (405)
Q Consensus 330 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~----~~~e~~~~i~~ 397 (405)
++........ ....+||+.|+|||++.+..|+.++|||||||++|||++|..||... ...+....+.+
T Consensus 335 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~ 407 (543)
T 3c4z_A 335 LAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE 407 (543)
T ss_dssp TCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH
T ss_pred eeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh
Confidence 9976443332 23458999999999999999999999999999999999999999875 33444444443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=336.94 Aligned_cols=220 Identities=28% Similarity=0.481 Sum_probs=188.5
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
.+.|.+..++|.+++.||+|+||.||+|.+.+ ..||||+++..... .+.|.+|+.+|++++||||+++++
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~hp~iv~~~~ 246 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYA 246 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---------HHHHHHHHHHHHhCCCCCEeeEEE
Confidence 46788999999999999999999999999985 67999999754322 246889999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
++.+ ..+++||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 247 ~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG 325 (452)
T 1fmk_A 247 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 325 (452)
T ss_dssp EECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred EEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCc
Confidence 9987 668899999999999999986555679999999999999999999999999999999999999999999999999
Q ss_pred CcccccccC--CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 015556 330 IACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 330 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.++..
T Consensus 326 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~ 399 (452)
T 1fmk_A 326 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 399 (452)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred cceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 996543221 1223457789999999998899999999999999999999 9999999999888877766543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=324.46 Aligned_cols=212 Identities=24% Similarity=0.376 Sum_probs=176.1
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 97 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT------HAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 97 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHH------HHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChH------HHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence 478999999999999999999985 68999999986543322 2467889999999999999999999997654
Q ss_pred ------eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 256 ------VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 256 ------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
.+|+||||++ ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 98 ~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 98 SLEEFQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp STTTCCEEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccccccceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEee
Confidence 7899999996 58888885 358999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 330 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
++.............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+++...
T Consensus 173 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 243 (371)
T 2xrw_A 173 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 243 (371)
T ss_dssp C----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CC
T ss_pred cccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99765544445566799999999999999999999999999999999999999999999998888877543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=319.33 Aligned_cols=223 Identities=27% Similarity=0.503 Sum_probs=192.1
Q ss_pred ccccccccCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCC
Q 015556 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP 242 (405)
Q Consensus 170 ~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp 242 (405)
..++|.+..++|.+++.||+|+||.||+|.+. ++.||||++....... ....+.+|+.+++.++||
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~ 88 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-------ERIEFLNEASVMKEFNCH 88 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH-------HHHHHHHHHHHGGGCCCT
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHH-------HHHHHHHHHHHHHhcCCC
Confidence 45688888899999999999999999999865 4789999987433221 245688999999999999
Q ss_pred CeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 015556 243 NVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314 (405)
Q Consensus 243 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~N 314 (405)
||+++++++.+....++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 89 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~N 168 (322)
T 1p4o_A 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 168 (322)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGG
T ss_pred CEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccce
Confidence 99999999999999999999999999999998642 1467899999999999999999999999999999999
Q ss_pred EEECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 015556 315 VLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQ 390 (405)
Q Consensus 315 ILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e 390 (405)
||++.++.+||+|||++....... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+
T Consensus 169 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 248 (322)
T 1p4o_A 169 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248 (322)
T ss_dssp EEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred EEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH
Confidence 999999999999999986433221 1223456889999999998899999999999999999999 899999998888
Q ss_pred HHHHHHhcc
Q 015556 391 AAFAVVNKV 399 (405)
Q Consensus 391 ~~~~i~~~~ 399 (405)
....+.++.
T Consensus 249 ~~~~~~~~~ 257 (322)
T 1p4o_A 249 VLRFVMEGG 257 (322)
T ss_dssp HHHHHHTTC
T ss_pred HHHHHHcCC
Confidence 777776654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=319.79 Aligned_cols=197 Identities=24% Similarity=0.363 Sum_probs=174.7
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKP 254 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~ 254 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++...... ..+.+|+.++++| +||||+++++++.+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 77 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----------PQLHLEYRFYKQLGSGDGIPQVYYFGPCG 77 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----------CCHHHHHHHHHHHCSCTTSCCEEEEEEET
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----------HHHHHHHHHHHHhhCCCCCCEEEEEEecC
Confidence 468999999999999999999974 789999999765432 2466899999999 899999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCc-----EEEEecC
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-----LKIADFG 329 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~-----vkL~DFG 329 (405)
...++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 78 KYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred CccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 9999999999 99999999874 468999999999999999999999999999999999999998887 9999999
Q ss_pred CcccccccCC--------CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 330 IACEEVYCDA--------LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 330 ~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~ 220 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccc
Confidence 9965432221 24567999999999999999999999999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=351.80 Aligned_cols=220 Identities=27% Similarity=0.413 Sum_probs=189.6
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEee
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVA 249 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g 249 (405)
...+.+++|.+++.||+|+||.||+|.+. ++.||||++..... ........+..|..+|..+ +||||+.+++
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~-----~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~ 409 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV-----IQDDDVECTMVEKRVLALPGKPPFLTQLHS 409 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH-----HHTTTTHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc-----ccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 34567889999999999999999999986 57899999974210 1111235677899999988 6999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
++.+...+||||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus 410 ~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFG 487 (674)
T 3pfq_A 410 CFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 487 (674)
T ss_dssp ECBCSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCT
T ss_pred EEEeCCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecc
Confidence 999999999999999999999999873 579999999999999999999999999999999999999999999999999
Q ss_pred Ccccc-cccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 330 IACEE-VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 330 ~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
++... .........+||+.|+|||++.+..|+.++|||||||+||||++|..||.+.+..+....|++..
T Consensus 488 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 558 (674)
T 3pfq_A 488 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 558 (674)
T ss_dssp TCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC
T ss_pred eeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC
Confidence 99753 23334556789999999999999999999999999999999999999999999988888887653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=321.33 Aligned_cols=211 Identities=22% Similarity=0.360 Sum_probs=185.4
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-----CCCeeEE
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-----NPNVIKF 247 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l 247 (405)
.+-.++|.+++.||+|+||.||+|.+. ++.||||++.... .....+..|+.++..+. ||||+++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK---------KYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH---------HHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch---------hhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 344578999999999999999999994 6899999996311 12456678999999997 9999999
Q ss_pred eeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC--------
Q 015556 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-------- 319 (405)
Q Consensus 248 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~-------- 319 (405)
++++......++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccccc
Confidence 99999999999999999 899999999866667999999999999999999999999999999999999975
Q ss_pred -----------------CCcEEEEecCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCC
Q 015556 320 -----------------EFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIP 382 (405)
Q Consensus 320 -----------------~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~P 382 (405)
++.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 258 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred chhcccccccccccccCCCCEEEEeccCceecC--CCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence 7899999999996533 233456799999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHh
Q 015556 383 YEEMNPIQAAFAVVN 397 (405)
Q Consensus 383 f~~~~~~e~~~~i~~ 397 (405)
|...+..+....+..
T Consensus 259 f~~~~~~~~~~~~~~ 273 (360)
T 3llt_A 259 FRTHEHMEHLAMMES 273 (360)
T ss_dssp CCCSSHHHHHHHHHH
T ss_pred CCCCcHHHHHHHHHH
Confidence 999888877766554
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=321.76 Aligned_cols=216 Identities=25% Similarity=0.429 Sum_probs=177.7
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
.+++|.+++.||+|+||.||+|.+. ++.||||++....... .....+.+|+.++++++||||+++++++.++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE------GVPGTAIREVSLLKELQHRNIIELKSVIHHN 105 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc------ccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 3468999999999999999999875 6899999997554322 1245677999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE-----CCCCcEEEEecC
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI-----DQEFHLKIADFG 329 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl-----~~~~~vkL~DFG 329 (405)
..+++||||+. |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 106 ~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 106 HRLHLIFEYAE-NDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp TEEEEEEECCS-EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred CEEEEEEecCC-CCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 99999999997 599999987 4579999999999999999999999999999999999999 455669999999
Q ss_pred Cccccc-ccCCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Q 015556 330 IACEEV-YCDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNF 401 (405)
Q Consensus 330 ~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~~ 401 (405)
++.... .........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+.+..+++....
T Consensus 183 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 256 (329)
T 3gbz_A 183 LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL 256 (329)
T ss_dssp HHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred CccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCC
Confidence 986432 22333455689999999999774 4899999999999999999999999999999999888876543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=329.87 Aligned_cols=197 Identities=24% Similarity=0.418 Sum_probs=162.9
Q ss_pred CCeeec-ceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHh-cCCCCeeEEeeEeec-
Q 015556 179 SQLFLG-LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR-LHNPNVIKFVAACKK- 253 (405)
Q Consensus 179 ~~~~~~-~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~g~~~~- 253 (405)
++|.+. +.||.|+||+||++.+. ++.||||++.. ...+.+|+.++.+ ++||||++++++|..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~ 127 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------------CPKARREVELHWRASQCPHIVRIVDVYENL 127 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------------chhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence 456665 68999999999999986 68999999962 1245578888755 479999999998875
Q ss_pred ---CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC---CCcEEEEe
Q 015556 254 ---PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ---EFHLKIAD 327 (405)
Q Consensus 254 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~---~~~vkL~D 327 (405)
...+|||||||++|+|.+++.......+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence 567899999999999999998755557999999999999999999999999999999999999987 78999999
Q ss_pred cCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 015556 328 FGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP 388 (405)
Q Consensus 328 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~ 388 (405)
||++............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 208 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp CTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred cccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 9999765554555667899999999999999999999999999999999999999976543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=309.62 Aligned_cols=219 Identities=25% Similarity=0.411 Sum_probs=188.6
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
+...+..++|.+++.||+|+||.||+|.+. ++.||||++..... ........+.+|+.++++++||||+++++
T Consensus 7 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 81 (284)
T 2vgo_A 7 PKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL-----EKEGVEHQLRREIEIQSHLRHPNILRMYN 81 (284)
T ss_dssp ---CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccccc-----chHHHHHHHHHHHHHHhcCCCCCEeeEEE
Confidence 344566789999999999999999999986 57899999974211 01112467889999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
++.+...+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg 159 (284)
T 2vgo_A 82 YFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 159 (284)
T ss_dssp EEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEEcCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEeccc
Confidence 999999999999999999999999873 568999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 330 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
++..... .......|++.|+|||++.+..++.++||||||+++|+|++|..||......+....+.+.
T Consensus 160 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 227 (284)
T 2vgo_A 160 WSVHAPS-LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV 227 (284)
T ss_dssp TCEECSS-SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT
T ss_pred ccccCcc-cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc
Confidence 9854432 2234567999999999999999999999999999999999999999998887777666553
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=308.89 Aligned_cols=214 Identities=23% Similarity=0.343 Sum_probs=187.7
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.++|.+++.||+|+||.||++.+. ++.||+|++........ .....+.+|+.+++.++||||+++++++.+..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP-----HQREKMSMEISIHRSLAHQHVVGFHGFFEDND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSH-----HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCH-----HHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 467999999999999999999996 68999999976543322 12567889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999999999876 3578999999999999999999999999999999999999999999999999986543
Q ss_pred -ccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 336 -YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 336 -~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.........||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+.+.
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 230 (294)
T 2rku_A 167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 230 (294)
T ss_dssp STTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT
T ss_pred cCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc
Confidence 223334567999999999999888999999999999999999999999998887776665543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=310.43 Aligned_cols=211 Identities=23% Similarity=0.361 Sum_probs=178.8
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||+|+||.||++.+. ++.||||++........ .+.+.+|+.++++++||||+++++++.+...
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 94 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-------MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN 94 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC-------HHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh-------HHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence 57889999999999999999986 68999999986543322 3568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---CCCCcEEEEecCCc
Q 015556 257 YCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIA 331 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl---~~~~~vkL~DFG~a 331 (405)
.++||||+++|+|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 99999999999999998753 34679999999999999999999999999999999999999 55688999999999
Q ss_pred ccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 332 CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 332 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+....+..
T Consensus 175 ~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~ 239 (285)
T 3is5_A 175 ELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY 239 (285)
T ss_dssp CC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc
Confidence 7655444556677999999999986 5689999999999999999999999999887776655443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=342.30 Aligned_cols=220 Identities=28% Similarity=0.477 Sum_probs=192.4
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
.+.|.++.++|.+++.||+|+||.||+|.+.+ ..||||+++..... .+.|.+|+.+|++|+||||+++++
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~hpniv~~~~ 329 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYA 329 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---------HHHHHHHHHHHHhCCCCCEeeEEE
Confidence 46788999999999999999999999999985 67999999754422 246889999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
++.+ ..+||||||+.+|+|.++|.......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 330 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG 408 (535)
T 2h8h_A 330 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 408 (535)
T ss_dssp EECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTT
T ss_pred EEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccc
Confidence 9987 668899999999999999986555679999999999999999999999999999999999999999999999999
Q ss_pred Cccccccc--CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 015556 330 IACEEVYC--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 330 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
++...... .......++..|+|||++....++.++|||||||+||||++ |..||.+....+....+.++..
T Consensus 409 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~ 482 (535)
T 2h8h_A 409 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 482 (535)
T ss_dssp STTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred cceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99653321 12233457889999999998899999999999999999999 9999999998888877766543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=324.04 Aligned_cols=211 Identities=23% Similarity=0.389 Sum_probs=181.7
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec-
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK- 253 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~- 253 (405)
..++|.+++.||+|+||.||+|.+. ++.||||++....... .+|+.+|+.++||||++++++|..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~------------~~E~~il~~l~hpnIv~l~~~~~~~ 72 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK------------NRELDIMKVLDHVNIIKLVDYFYTT 72 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSC------------CHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchH------------HHHHHHHHHcCCCCccchhheeeec
Confidence 4568999999999999999999985 7999999997543322 279999999999999999999843
Q ss_pred -------------------------------------CCeeEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHH
Q 015556 254 -------------------------------------PPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIA 294 (405)
Q Consensus 254 -------------------------------------~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~ 294 (405)
...+++||||++ ++|.+++... ....+++..+..++.||+
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~ 151 (383)
T 3eb0_A 73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLF 151 (383)
T ss_dssp -------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence 345889999997 5888877642 457899999999999999
Q ss_pred HHHHHHHHCCceecCCCCCcEEEC-CCCcEEEEecCCcccccccCCCCCCCCCCcccCccccccc-cCCchhhHHHHHHH
Q 015556 295 RGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLI 372 (405)
Q Consensus 295 ~aL~yLH~~gIiHrDIkp~NILl~-~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvl 372 (405)
.||.|||++||+||||||+|||++ .++.+||+|||++.............||..|+|||++.+. .++.++|||||||+
T Consensus 152 ~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 152 RAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 999999999999999999999997 6899999999999766555566677899999999998765 48999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 373 LWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 373 l~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
+|||++|+.||.+.+..+.+..+++...
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g 259 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMG 259 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999999999999999999988886543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=316.09 Aligned_cols=214 Identities=23% Similarity=0.343 Sum_probs=187.4
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.++|.+++.||+|+||.||++.+. ++.||+|++........ .....+.+|+.+++.++||||+++++++.+..
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP-----HQREKMSMEISIHRSLAHQHVVGFHGFFEDND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSH-----HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 367889999999999999999986 58999999975443322 12567889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999999999876 3578999999999999999999999999999999999999999999999999986543
Q ss_pred -ccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 336 -YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 336 -~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.........||..|+|||++.+..++.++||||||+++|+|++|..||......+....+.+.
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 256 (335)
T 2owb_A 193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 256 (335)
T ss_dssp STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT
T ss_pred cCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC
Confidence 223334567999999999999888999999999999999999999999998877776665543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=318.19 Aligned_cols=199 Identities=26% Similarity=0.463 Sum_probs=169.0
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC-
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP- 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~- 255 (405)
++|.+++.||+|+||.||+|.+. ++.||||++........ .+.+.+|+.+|++++||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-------REKVMREVKALAKLEHPGIVRYFNAWLETPP 78 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTH-------HHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhH-------HHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence 57889999999999999999986 78999999986553322 467889999999999999999999986543
Q ss_pred --------------------------------------------------------eeEEEEeecCCCCHHHHHHHhcC-
Q 015556 256 --------------------------------------------------------VYCVITEYLSEGSLRAYLHKLEH- 278 (405)
Q Consensus 256 --------------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~- 278 (405)
.+++|||||++++|.+++.....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 158 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence 37999999999999999987432
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc-------------CCCCCCCC
Q 015556 279 KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC-------------DALSDDPG 345 (405)
Q Consensus 279 ~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~-------------~~~~~~~g 345 (405)
...++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......|
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 23566678999999999999999999999999999999999999999999998654332 12234569
Q ss_pred CCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCC
Q 015556 346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384 (405)
Q Consensus 346 t~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~ 384 (405)
|+.|+|||++.+..++.++|||||||++|+|++|..|+.
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 999999999999999999999999999999999877753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=323.79 Aligned_cols=210 Identities=24% Similarity=0.413 Sum_probs=178.8
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC-
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP- 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~- 255 (405)
++|.+++.||+|+||.||+|.+. |+.||||++........ ..+.+.+|+.+|++++||||+++++++....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL------FAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHH------HHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHH------HHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 67999999999999999999985 78999999865443321 2567889999999999999999999997653
Q ss_pred -----eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 256 -----VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 256 -----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
.+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 99 LDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 8899999986 5789999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
+.... .......+|..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+++...
T Consensus 175 a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 243 (367)
T 1cm8_A 175 ARQAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243 (367)
T ss_dssp CEECC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred ccccc--cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 96543 23455679999999999876 6789999999999999999999999999999988888876443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=321.74 Aligned_cols=214 Identities=25% Similarity=0.457 Sum_probs=178.0
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
+++|.+++.||+|+||.||+|.+. ++.||||++........ ...+.+|+.++++++||||+++++++.+..
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-------PCTAIREVSLLKDLKHANIVTLHDIIHTEK 73 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc-------chhHHHHHHHHHhcCCCCCCeeeeEEeeCC
Confidence 368999999999999999999986 68999999975432211 224457999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+++||||++ |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 74 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 74 SLTLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKS 151 (324)
T ss_dssp CEEEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred EEEEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence 9999999996 5999998873 4568999999999999999999999999999999999999999999999999986433
Q ss_pred c-cCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 336 Y-CDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 336 ~-~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.+...
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 218 (324)
T 3mtl_A 152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILG 218 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 2 223345578999999999876 5689999999999999999999999999999888887776443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=314.02 Aligned_cols=216 Identities=27% Similarity=0.517 Sum_probs=180.6
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
...|.++.++|.+++.||+|+||.||++.+.++.||||++..... .+.+.+|+.++++++||||++++++
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~----------~~~~~~E~~~l~~l~h~~iv~~~~~ 82 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT----------AQAFLAEASVMTQLRHSNLVQLLGV 82 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------------HHHHHTHHHHTTCCCTTBCCEEEE
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhH----------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 456788999999999999999999999999999999999874321 3567899999999999999999998
Q ss_pred eecC-CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 251 CKKP-PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 251 ~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
+.+. ..+++||||+++++|.+++.......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg 162 (278)
T 1byg_A 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 162 (278)
T ss_dssp ECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred EEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecc
Confidence 7554 578999999999999999987544458899999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 330 IACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 330 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
++...... .....++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+.++
T Consensus 163 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~ 230 (278)
T 1byg_A 163 LTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 230 (278)
T ss_dssp C--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT
T ss_pred cccccccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence 98654322 233467889999999998899999999999999999998 99999987766665555443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=307.35 Aligned_cols=216 Identities=23% Similarity=0.392 Sum_probs=183.4
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+++.||+|+||.||++.+. ++.||||++.......... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRR--GVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhcccccccc--chHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 56889999999999999999996 6899999998654322100 0013568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCC----cEEEEecCCcc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF----HLKIADFGIAC 332 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~----~vkL~DFG~a~ 332 (405)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 9999999999999999976 35789999999999999999999999999999999999998877 89999999997
Q ss_pred cccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 333 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
............|++.|+|||++.+..++.++||||||+++|+|++|..||......+....+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 226 (283)
T 3bhy_A 161 KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 226 (283)
T ss_dssp ECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT
T ss_pred eccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhc
Confidence 655444455667999999999999899999999999999999999999999998887776665543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=320.32 Aligned_cols=222 Identities=27% Similarity=0.472 Sum_probs=189.1
Q ss_pred ccccccccCCCeeecceeeeeeeEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CC
Q 015556 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HN 241 (405)
Q Consensus 170 ~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~H 241 (405)
....+.+..++|.+++.||+|+||.||+|.+.+ +.||||++......+ ....+.+|+.+++++ +|
T Consensus 37 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~~h 109 (333)
T 2i1m_A 37 YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD-------EKEALMSELKIMSHLGQH 109 (333)
T ss_dssp CCGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHH-------HHHHHHHHHHHHHHHCCC
T ss_pred ccccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChH-------HHHHHHHHHHHHHhhcCC
Confidence 345688889999999999999999999999853 379999997544222 246788999999999 89
Q ss_pred CCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q 015556 242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRD 309 (405)
Q Consensus 242 pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrD 309 (405)
|||++++++|.+...+++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+|||
T Consensus 110 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~D 189 (333)
T 2i1m_A 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRD 189 (333)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred CCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCC
Confidence 999999999999999999999999999999998642 34689999999999999999999999999999
Q ss_pred CCCCcEEECCCCcEEEEecCCcccccccCC---CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 015556 310 LKPENVLIDQEFHLKIADFGIACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEE 385 (405)
Q Consensus 310 Ikp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~ 385 (405)
|||+|||++.++.+||+|||++........ .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+
T Consensus 190 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 269 (333)
T 2i1m_A 190 VAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269 (333)
T ss_dssp CSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999999999865432221 223446788999999998899999999999999999999 9999998
Q ss_pred CCHHHHHHHHHhc
Q 015556 386 MNPIQAAFAVVNK 398 (405)
Q Consensus 386 ~~~~e~~~~i~~~ 398 (405)
....+....++..
T Consensus 270 ~~~~~~~~~~~~~ 282 (333)
T 2i1m_A 270 ILVNSKFYKLVKD 282 (333)
T ss_dssp CCSSHHHHHHHHH
T ss_pred cchhHHHHHHHhc
Confidence 7766655555543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=336.54 Aligned_cols=212 Identities=26% Similarity=0.456 Sum_probs=184.0
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+++.||+|+||.||+|.+. ++.||||++........ ....+.+|+.+|++++||||+++++++.+...
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 95 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK------DTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch------HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence 57889999999999999999986 78999999964221111 13567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEC---CCCcEEEEecCCccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID---QEFHLKIADFGIACE 333 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~---~~~~vkL~DFG~a~~ 333 (405)
+|+|||||.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999999999999763 5799999999999999999999999999999999999994 556899999999976
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
...........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.++.
T Consensus 174 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 238 (486)
T 3mwu_A 174 FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK 238 (486)
T ss_dssp BCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred CCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 555555566789999999999975 59999999999999999999999999999988888777653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=316.94 Aligned_cols=219 Identities=26% Similarity=0.489 Sum_probs=184.3
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEECC------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEE
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKD------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 247 (405)
..++.++|.+++.||+|+||.||+|.+.. ..||||++....... ....+.+|+.++.+++||||+++
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~ 111 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-------QRVDFLGEAGIMGQFSHHNIIRL 111 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH-------HHHHHHHHHHHHHTCCCTTBCCE
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHH-------HHHHHHHHHHHHHhCCCCCCCcE
Confidence 46778899999999999999999998752 359999997543221 24578899999999999999999
Q ss_pred eeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEe
Q 015556 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327 (405)
Q Consensus 248 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~D 327 (405)
++++.+....++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 112 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~D 190 (333)
T 1mqb_A 112 EGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSD 190 (333)
T ss_dssp EEEECSSSSEEEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECC
T ss_pred EEEEecCCCcEEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECC
Confidence 9999999999999999999999999986 346799999999999999999999999999999999999999999999999
Q ss_pred cCCcccccccC----CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 015556 328 FGIACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 328 FG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
||++....... ......+|..|+|||++.+..++.++||||||+++|||++ |..||.+....+....+.++..
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~ 268 (333)
T 1mqb_A 191 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR 268 (333)
T ss_dssp CCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred CCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc
Confidence 99986533211 1223346788999999998999999999999999999999 9999999998887777766543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=314.38 Aligned_cols=218 Identities=27% Similarity=0.551 Sum_probs=190.9
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
+.|.+..++|.+++.||+|+||.||+|.+. ++.||||++...... .+.+.+|+.++++++||||+++++
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~ 76 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---------VEEFLKEAAVMKEIKHPNLVQLLG 76 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH---------HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH---------HHHHHHHHHHHHhCCCCCEeeEEE
Confidence 578888999999999999999999999997 689999999743221 456889999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
++.+...+++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg 156 (288)
T 3kfa_A 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156 (288)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred EEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCc
Confidence 99999999999999999999999988666779999999999999999999999999999999999999999999999999
Q ss_pred CcccccccC--CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 330 IACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 330 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
++....... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~ 228 (288)
T 3kfa_A 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 228 (288)
T ss_dssp GGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred cceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc
Confidence 986533221 1223346788999999998899999999999999999999 99999988776665555544
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=335.58 Aligned_cols=212 Identities=26% Similarity=0.411 Sum_probs=182.3
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
+.|.+++.||+|+||.||+|.+. ++.||||++......... ...+.+|+.+++.++||||++++++|.+...
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 110 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS------NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN 110 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT------THHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH------HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 46889999999999999999986 689999999864422211 3567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC---CCcEEEEecCCccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ---EFHLKIADFGIACE 333 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~---~~~vkL~DFG~a~~ 333 (405)
+|+|||||.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999999998763 57899999999999999999999999999999999999976 45599999999976
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
...........||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+.++.
T Consensus 189 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 253 (494)
T 3lij_A 189 FENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK 253 (494)
T ss_dssp CBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred CCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 65555566778999999999986 569999999999999999999999999999988887776653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=317.23 Aligned_cols=211 Identities=28% Similarity=0.431 Sum_probs=184.7
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
+.|.+.+.||+|+||.||+|.+. ++.||||++......... ....+.+|+.++++++||||++++++|.+...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-----KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHH-----HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCe
Confidence 45788899999999999999974 789999999865443322 24678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
.++||||+. |+|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 129 ~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 999999996 6888888653 46799999999999999999999999999999999999999999999999999865432
Q ss_pred cCCCCCCCCCCcccCccccc---cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 337 CDALSDDPGTYRWMAPEMIK---HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 337 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
.....||+.|+|||++. ...++.++|||||||++|||++|..||.+.+..+....+..+.
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~ 269 (348)
T 1u5q_A 207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 269 (348)
T ss_dssp ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Confidence 24567999999999984 5678999999999999999999999999999988888777654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=306.63 Aligned_cols=219 Identities=28% Similarity=0.477 Sum_probs=179.5
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
...+..++|.+++.||+|+||.||+|.+. ++.||||++..... ........+.+|+.+++.++||||++++++
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 79 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-----RSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc-----cchhHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence 34556789999999999999999999986 78999999973211 011124578899999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
+.+...+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~ 157 (276)
T 2h6d_A 80 ISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGL 157 (276)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCG
T ss_pred EecCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccc
Confidence 99999999999999999999999873 5689999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccCccccccccC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
+.............|++.|+|||++.+..+ +.++||||||+++|+|++|..||......+....+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 226 (276)
T 2h6d_A 158 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG 226 (276)
T ss_dssp GGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred ccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence 876554444455679999999999987766 68999999999999999999999998877766665543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=313.91 Aligned_cols=200 Identities=25% Similarity=0.332 Sum_probs=168.7
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecCC
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPP 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 255 (405)
++|.++++||+|+||+||+|.+. ++.||||++......... ...+..|+..+.++ +||||++++++|.+..
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD------RARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH------HHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH------HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 67889999999999999999996 789999998765444322 23444566655555 8999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 999999999 77999998774 4579999999999999999999999999999999999999999999999999987655
Q ss_pred ccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 336 YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 336 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
.........||+.|+|||++.+ .++.++|||||||++|||++|..||....
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~ 259 (311)
T 3p1a_A 209 TAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE 259 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH
T ss_pred cCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 5455556679999999999875 78999999999999999999977665533
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=336.39 Aligned_cols=213 Identities=25% Similarity=0.432 Sum_probs=187.9
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+++.||+|+||.||+|.+. ++.||||++.......... ...+.+|+.++++++||||+++++++.+...
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 100 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD-----KESLLREVQLLKQLDHPNIMKLYEFFEDKGY 100 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSC-----HHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 57889999999999999999986 7899999997654332111 3568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---CCCCcEEEEecCCccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIACE 333 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl---~~~~~vkL~DFG~a~~ 333 (405)
+++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 101 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EEEEECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999999999999976 4679999999999999999999999999999999999999 5678999999999866
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
...........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.++.
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 243 (484)
T 3nyv_A 179 FEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK 243 (484)
T ss_dssp BCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred cccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC
Confidence 544444445579999999999975 68999999999999999999999999999988888877654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=316.68 Aligned_cols=217 Identities=25% Similarity=0.385 Sum_probs=185.2
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
....+++|.+++.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.++++++||||+++++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~ 93 (331)
T 4aaa_A 20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM------VKKIAMREIKLLKQLRHENLVNLLEVC 93 (331)
T ss_dssp CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHH------HHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchH------HHHHHHHHHHHHhhCCCCCEeeEEEEe
Confidence 3445689999999999999999999996 68999999976554332 246678999999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
.+...+++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 171 (331)
T 4aaa_A 94 KKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA 171 (331)
T ss_dssp EETTEEEEEEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecCCEEEEEEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCc
Confidence 999999999999999888887664 457999999999999999999999999999999999999999999999999998
Q ss_pred ccccc-cCCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 332 CEEVY-CDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 332 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
..... ........||..|+|||++.+. .++.++|||||||++|+|++|..||......+....++..
T Consensus 172 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 240 (331)
T 4aaa_A 172 RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMC 240 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred eeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 65332 2333456799999999999775 6899999999999999999999999999998888777643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=305.79 Aligned_cols=220 Identities=26% Similarity=0.458 Sum_probs=190.8
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChh-HHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeec
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDEN-ETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKK 253 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~-~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~ 253 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++........ ..........+.+|+.++.++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468899999999999999999985 68999999986542211 1122334678899999999996 9999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
....++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 9999999999999999999986 35789999999999999999999999999999999999999999999999999976
Q ss_pred ccccCCCCCCCCCCcccCccccc------cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIK------HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
...........|++.|+|||++. ...++.++||||||+++|+|++|..||...+..+....+.++.
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 245 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC
Confidence 55555556677999999999985 4567899999999999999999999999988887777666543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=320.25 Aligned_cols=205 Identities=28% Similarity=0.439 Sum_probs=175.8
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecCC
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPP 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 255 (405)
++|.+++.||+|+||.||++.+. ++.||||++...... +.+|++++.++ +||||+++++++.+..
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------------~~~E~~~l~~~~~hp~iv~~~~~~~~~~ 89 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------------PTEEIEILLRYGQHPNIITLKDVYDDGK 89 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------------CHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------------hHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence 67889999999999999999986 689999999764432 23688888888 7999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC----CcEEEEecCCc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE----FHLKIADFGIA 331 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~----~~vkL~DFG~a 331 (405)
.+|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+..+ +.+||+|||++
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 99999999999999999976 4679999999999999999999999999999999999998433 35999999999
Q ss_pred cccccc-CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHh
Q 015556 332 CEEVYC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE---MNPIQAAFAVVN 397 (405)
Q Consensus 332 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~---~~~~e~~~~i~~ 397 (405)
...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.. ....+....+..
T Consensus 168 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 237 (342)
T 2qr7_A 168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS 237 (342)
T ss_dssp EECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH
T ss_pred ccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc
Confidence 654332 234456799999999999988899999999999999999999999986 344455545444
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=330.61 Aligned_cols=200 Identities=26% Similarity=0.392 Sum_probs=158.9
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec---
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK--- 253 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--- 253 (405)
++|.+++.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.+|++++|||||++++++..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLI------DCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHH------HHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHH------HHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 67999999999999999999886 68999999975433322 14678899999999999999999999943
Q ss_pred --CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 254 --PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 254 --~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
...+|+||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 127 EKFDELYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp TTCCCEEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ccCceEEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccc
Confidence 35789999998 5799999975 467999999999999999999999999999999999999999999999999999
Q ss_pred cccccc----------------------------CCCCCCCCCCcccCcccc-ccccCCchhhHHHHHHHHHHHHh----
Q 015556 332 CEEVYC----------------------------DALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVA---- 378 (405)
Q Consensus 332 ~~~~~~----------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~DVwSlGvll~ellt---- 378 (405)
...... ......+||+.|+|||++ ....|+.++|||||||+||||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 653211 123445789999999976 56679999999999999999999
Q ss_pred -------CCCCCCCCC
Q 015556 379 -------GTIPYEEMN 387 (405)
Q Consensus 379 -------G~~Pf~~~~ 387 (405)
|..+|++.+
T Consensus 284 ~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSS 299 (458)
T ss_dssp TCSSGGGCCCSCC---
T ss_pred cccccccccccCCCCc
Confidence 778887754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=333.46 Aligned_cols=218 Identities=27% Similarity=0.451 Sum_probs=185.5
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChh-----HHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDEN-----ETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~-----~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
++|.+++.||+|+||.||+|.+. ++.||||++........ ..........+.+|+.+|++++||||++++++|
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 67899999999999999999986 58999999976442211 001112356788999999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCC---cEEEEec
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF---HLKIADF 328 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~---~vkL~DF 328 (405)
.+...+|+|||||++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EcCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 999999999999999999999976 35799999999999999999999999999999999999998775 6999999
Q ss_pred CCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 329 GIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 329 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
|++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+.++.
T Consensus 194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 263 (504)
T 3q5i_A 194 GLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK 263 (504)
T ss_dssp TTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred CCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 9997665555566778999999999987 568999999999999999999999999999888887777654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=327.21 Aligned_cols=208 Identities=24% Similarity=0.358 Sum_probs=177.5
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec---
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK--- 253 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--- 253 (405)
.+|.+++.||+|+||.||+|.+. ++.||||++...... +.+|+++|++++|||||+++++|..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~------------~~~E~~il~~l~hpniv~l~~~~~~~~~ 121 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------------KNRELQIMRKLDHCNIVRLRYFFYSSGE 121 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS------------CCHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh------------HHHHHHHHHHcCCCCccceeeEEeccCC
Confidence 46889999999999999999995 789999999753322 2379999999999999999998843
Q ss_pred ---CCeeEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC-CcEEEEe
Q 015556 254 ---PPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE-FHLKIAD 327 (405)
Q Consensus 254 ---~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~-~~vkL~D 327 (405)
...+++||||+++ +|.+++... ....+++..+..++.||+.||.|||++||+||||||+||||+.+ +.+||+|
T Consensus 122 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~D 200 (420)
T 1j1b_A 122 KKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCD 200 (420)
T ss_dssp TTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred CCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEecc
Confidence 2246799999975 677766542 35679999999999999999999999999999999999999855 6789999
Q ss_pred cCCcccccccCCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 328 FGIACEEVYCDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 328 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
||++.............||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.+..+.+.++++..
T Consensus 201 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~l 273 (420)
T 1j1b_A 201 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 273 (420)
T ss_dssp CTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred chhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999765555555667899999999999764 78999999999999999999999999999998888887643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=310.83 Aligned_cols=214 Identities=20% Similarity=0.407 Sum_probs=179.7
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEECC---------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYKD---------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI 245 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~---------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 245 (405)
.+..++|.+++.||+|+||.||+|.+.. ..||||++...... ..+.+.+|+.++++++||||+
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv 75 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN--------YSESFFEAASMMSKLSHKHLV 75 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG--------GHHHHHHHHHHHHTSCCTTBC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH--------HHHHHHHHHHHHHhCCCCCEe
Confidence 4667899999999999999999998763 46999999643221 146788999999999999999
Q ss_pred EEeeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCc---
Q 015556 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH--- 322 (405)
Q Consensus 246 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~--- 322 (405)
++++++.++...++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 76 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 154 (289)
T 4fvq_A 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKT 154 (289)
T ss_dssp CEEEEECCTTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGG
T ss_pred EEEEEEEeCCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccc
Confidence 9999999999999999999999999999873 344899999999999999999999999999999999999988877
Q ss_pred -----EEEEecCCcccccccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 015556 323 -----LKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAV 395 (405)
Q Consensus 323 -----vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i 395 (405)
+||+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|+|++ |..||............
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~ 231 (289)
T 4fvq_A 155 GNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231 (289)
T ss_dssp TBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred cccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence 999999998543221 12347889999999987 678999999999999999999 56677777766655544
Q ss_pred Hhccc
Q 015556 396 VNKVN 400 (405)
Q Consensus 396 ~~~~~ 400 (405)
.....
T Consensus 232 ~~~~~ 236 (289)
T 4fvq_A 232 EDRHQ 236 (289)
T ss_dssp HTTCC
T ss_pred hccCC
Confidence 44333
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=308.14 Aligned_cols=210 Identities=30% Similarity=0.526 Sum_probs=186.5
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
+.|.+++.||+|+||.||+|.+. ++.||||++........ .+.+.+|+.++++++||||+++++++.+...
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 94 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-------IEDIQQEITVLSQCDSPYVTKYYGSYLKDTK 94 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTT-------HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHH-------HHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 45889999999999999999985 68999999986654332 4568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 95 LWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp EEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred EEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 9999999999999999865 6799999999999999999999999999999999999999999999999999865433
Q ss_pred c-CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 337 C-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 337 ~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
. .......|++.|+|||++.+..++.++||||||+++|+|++|..||......+....+.++
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN 234 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC
Confidence 2 2234557999999999999999999999999999999999999999999888877666544
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=316.95 Aligned_cols=218 Identities=28% Similarity=0.505 Sum_probs=184.5
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC--Cc--cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEe
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DE--PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFV 248 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~--~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 248 (405)
-.+++++|.+++.||+|+||.||+|.+. +. .||||.+....... ....+.+|+.++.++ +||||++++
T Consensus 20 p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~-------~~~~~~~E~~~l~~l~~hp~iv~~~ 92 (327)
T 1fvr_A 20 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-------DHRDFAGELEVLCKLGHHPNIINLL 92 (327)
T ss_dssp SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCCEE
T ss_pred ccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchH-------HHHHHHHHHHHHHhccCCCchhhhc
Confidence 3567789999999999999999999875 44 45999987433221 145688999999999 899999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPEN 314 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~N 314 (405)
+++.+...+++||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 172 (327)
T 1fvr_A 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 172 (327)
T ss_dssp EEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred eeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccce
Confidence 99999999999999999999999998632 2478999999999999999999999999999999999
Q ss_pred EEECCCCcEEEEecCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 015556 315 VLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAF 393 (405)
Q Consensus 315 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~ 393 (405)
||++.++.+||+|||++.............+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....+...
T Consensus 173 Il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~ 252 (327)
T 1fvr_A 173 ILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 252 (327)
T ss_dssp EEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred EEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH
Confidence 9999999999999999865444344445567889999999988889999999999999999998 999999998877766
Q ss_pred HHHhc
Q 015556 394 AVVNK 398 (405)
Q Consensus 394 ~i~~~ 398 (405)
.+..+
T Consensus 253 ~~~~~ 257 (327)
T 1fvr_A 253 KLPQG 257 (327)
T ss_dssp HGGGT
T ss_pred HhhcC
Confidence 66554
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=309.06 Aligned_cols=217 Identities=23% Similarity=0.514 Sum_probs=185.0
Q ss_pred cccccCCCeeecc-eeeeeeeEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEE
Q 015556 173 EHTVDLSQLFLGL-RFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247 (405)
Q Consensus 173 ~~~i~~~~~~~~~-~lG~G~~g~Vy~~~~~----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 247 (405)
++.++.++|.+.+ .||+|+||.||+|.+. ++.||||++....... ..+.+.+|+.++++++||||+++
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~ 75 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-------DTEEMMREAQIMHQLDNPYIVRL 75 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHH-------HHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchh-------HHHHHHHHHHHHHhCCCCCEeEE
Confidence 4567778888887 9999999999999863 5789999997543221 25678899999999999999999
Q ss_pred eeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEe
Q 015556 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327 (405)
Q Consensus 248 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~D 327 (405)
++++. ...+++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 76 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~D 153 (287)
T 1u59_A 76 IGVCQ-AEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISD 153 (287)
T ss_dssp EEEEE-SSSEEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECC
T ss_pred EEEec-CCCcEEEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECc
Confidence 99994 5568999999999999999975 345699999999999999999999999999999999999999999999999
Q ss_pred cCCccccccc----CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 328 FGIACEEVYC----DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 328 FG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
||++...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+.++
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~ 229 (287)
T 1u59_A 154 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 229 (287)
T ss_dssp CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT
T ss_pred ccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC
Confidence 9998654322 12233457899999999988889999999999999999998 99999998887777666554
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=313.20 Aligned_cols=203 Identities=29% Similarity=0.480 Sum_probs=172.0
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEE------CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEE
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIY------KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 247 (405)
..+..++|.+++.||+|+||.||+|.+ .++.||||++..... ...+.+.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~ 76 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--------EHLRDFEREIEILKSLQHDNIVKY 76 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH--------HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH--------HHHHHHHHHHHHHHhCCCCCEeeE
Confidence 356678999999999999999999985 368999999974321 124678899999999999999999
Q ss_pred eeEeec--CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEE
Q 015556 248 VAACKK--PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI 325 (405)
Q Consensus 248 ~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL 325 (405)
+++|.. ...+++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 77 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl 155 (295)
T 3ugc_A 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 155 (295)
T ss_dssp EEEECHHHHTSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEE
T ss_pred EEEEecCCCCceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEE
Confidence 999864 45689999999999999999873 345899999999999999999999999999999999999999999999
Q ss_pred EecCCccccccc----CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 326 ADFGIACEEVYC----DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 326 ~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
+|||++...... .......++..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 156 GDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp CCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred ccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 999998654322 122344577889999999999999999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=317.22 Aligned_cols=216 Identities=26% Similarity=0.500 Sum_probs=176.7
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--Cc----cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DE----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~----~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 248 (405)
.+..++|.+++.||+|+||.||+|.+. ++ .||+|.+...... ...+.|.+|+.++++++||||++++
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~ 83 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-------KANKEILDEAYVMASVDNPHVCRLL 83 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------------CHHHHHHHHHHHHHCCBTTBCCEE
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCH-------HHHHHHHHHHHHHHhCCCCCEeEEE
Confidence 345578999999999999999999974 34 3577777532221 2246788999999999999999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEec
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF 328 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DF 328 (405)
++|.++. .++||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 84 ~~~~~~~-~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Df 161 (327)
T 3poz_A 84 GICLTST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp EEEESSS-EEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCT
T ss_pred EEEecCC-eEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccC
Confidence 9998765 67899999999999999873 467999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 329 GIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 329 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
|++....... ......+|..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+..+.
T Consensus 162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 236 (327)
T 3poz_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236 (327)
T ss_dssp THHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred cceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC
Confidence 9986432221 2233456889999999999999999999999999999999 999999887766655555443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=315.41 Aligned_cols=191 Identities=28% Similarity=0.474 Sum_probs=150.7
Q ss_pred cceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeecCCeeEEE
Q 015556 184 GLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPVYCVI 260 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV 260 (405)
++.||+|+||.||+|.+. ++.||||++... ....+.+|+.+++.+. ||||+++++++.+....|+|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 467999999999999986 689999999632 1356678999999997 99999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCC---cEEEEecCCcccccc-
Q 015556 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF---HLKIADFGIACEEVY- 336 (405)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~---~vkL~DFG~a~~~~~- 336 (405)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 85 MELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp ECCCCSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred EEccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 999999999999987 46799999999999999999999999999999999999997665 899999999864322
Q ss_pred cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 337 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
........||+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 163 NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 233345678999999999999999999999999999999999999998754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=307.93 Aligned_cols=218 Identities=23% Similarity=0.432 Sum_probs=182.2
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEECC-----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeE
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 246 (405)
..+.+..++|.+++.||+|+||.||+|.+.+ ..||||++......+ ....+.+|+.++++++||||++
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~ 77 (281)
T 3cc6_A 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD-------NKEKFMSEAVIMKNLDHPHIVK 77 (281)
T ss_dssp CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHH-------HHHHHHHHHHHHHHHCCTTBCC
T ss_pred ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCch-------HHHHHHHHHHHHHhCCCCCcce
Confidence 3466778899999999999999999998753 359999987543221 2467889999999999999999
Q ss_pred EeeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEE
Q 015556 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA 326 (405)
Q Consensus 247 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~ 326 (405)
+++++.++ ..++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+
T Consensus 78 ~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 155 (281)
T 3cc6_A 78 LIGIIEEE-PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLG 155 (281)
T ss_dssp EEEEECSS-SCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEEC
T ss_pred EEEEEcCC-CCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeC
Confidence 99998765 458999999999999999763 4568999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccccC--CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 327 DFGIACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 327 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+.++
T Consensus 156 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~ 230 (281)
T 3cc6_A 156 DFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG 230 (281)
T ss_dssp CCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT
T ss_pred ccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC
Confidence 999986543222 2234457889999999998899999999999999999998 99999877766665555444
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=309.39 Aligned_cols=218 Identities=27% Similarity=0.514 Sum_probs=182.2
Q ss_pred ccccccCCCeeecc-eeeeeeeEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeE
Q 015556 172 DEHTVDLSQLFLGL-RFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246 (405)
Q Consensus 172 ~~~~i~~~~~~~~~-~lG~G~~g~Vy~~~~~----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 246 (405)
.+..++.++|.+.+ .||+|+||.||+|.+. ++.||||++....... ...+.+.+|+.+++.++||||++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~ 82 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP------ALKDELLAEANVMQQLDNPYIVR 82 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C------HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCH------HHHHHHHHHHHHHHhCCCCCEEE
Confidence 45567788999998 9999999999999763 4789999997543322 22567889999999999999999
Q ss_pred EeeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEE
Q 015556 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA 326 (405)
Q Consensus 247 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~ 326 (405)
+++++ +...+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 83 ~~~~~-~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~ 159 (291)
T 1xbb_A 83 MIGIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKIS 159 (291)
T ss_dssp EEEEE-ESSSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred EEEEE-CCCCcEEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEc
Confidence 99999 55677899999999999999987 4569999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccccC----CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 327 DFGIACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 327 DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+.++
T Consensus 160 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~ 236 (291)
T 1xbb_A 160 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236 (291)
T ss_dssp CCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred cCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 999986433221 1223446789999999988889999999999999999999 99999998887776666554
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=318.39 Aligned_cols=218 Identities=26% Similarity=0.441 Sum_probs=179.8
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+++.||+|+||.||+|.+. ++.||||++....... ......+.+.+|+.++++++||||+++++++.+...
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ---INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcc---cCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 67889999999999999999986 5789999997421100 011225678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhc--------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 015556 257 YCVITEYLSEGSLRAYLHKLE--------------------------------------HKTLPLPKLIAIALDIARGME 298 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~qi~~aL~ 298 (405)
.++||||+++|+|.+++.... ...+++..++.++.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 999999999999999985210 112356778899999999999
Q ss_pred HHHHCCceecCCCCCcEEECCCC--cEEEEecCCcccccccC-----CCCCCCCCCcccCcccccc--ccCCchhhHHHH
Q 015556 299 YIHSQGVIHRDLKPENVLIDQEF--HLKIADFGIACEEVYCD-----ALSDDPGTYRWMAPEMIKH--KSYGRKVDVYSF 369 (405)
Q Consensus 299 yLH~~gIiHrDIkp~NILl~~~~--~vkL~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~k~DVwSl 369 (405)
|||++||+||||||+|||++.++ .+||+|||++....... ......||+.|+|||++.+ ..++.++|||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 99999999999999999998776 89999999986432211 2345679999999999965 678999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 370 GLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 370 Gvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
||++|+|++|..||.+....+....++++.
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~ 292 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKK 292 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcc
Confidence 999999999999999999988888877654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=312.65 Aligned_cols=214 Identities=27% Similarity=0.456 Sum_probs=185.2
Q ss_pred CCeeecceeeeeeeEEEEEEEEC---CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc---CCCCeeEEeeEee
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK---DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL---HNPNVIKFVAACK 252 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~---~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~ 252 (405)
++|.+++.||+|+||.||+|.+. ++.||||++......... ...+.+|+.+++.+ +||||++++++|.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 84 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------PLSTIREVAVLRHLETFEHPNVVRLFDVCT 84 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC------BCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC------CchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence 68999999999999999999983 588999999754332211 12345677777766 8999999999987
Q ss_pred -----cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEe
Q 015556 253 -----KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327 (405)
Q Consensus 253 -----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~D 327 (405)
....+++||||+. |+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 85 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp EEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred ecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEec
Confidence 5678899999997 6999999886666799999999999999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 328 FGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 328 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
||++.............||..|+|||++.+..++.++||||||+++|+|++|..||.+....+.+..+++..
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (326)
T 1blx_A 164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235 (326)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred CcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHc
Confidence 999976554445566789999999999998999999999999999999999999999999988888887643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=316.62 Aligned_cols=214 Identities=21% Similarity=0.347 Sum_probs=182.0
Q ss_pred CCeeec-ceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeecC
Q 015556 179 SQLFLG-LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKP 254 (405)
Q Consensus 179 ~~~~~~-~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~ 254 (405)
+.|.+. +.||+|+||.||+|.+. ++.||||++......... ...+.+|+.++..+. ||||+++++++.+.
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC------RAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEEC------HHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHH------HHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 345555 88999999999999986 789999999865433321 356789999999995 69999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC---CCcEEEEecCCc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ---EFHLKIADFGIA 331 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~---~~~vkL~DFG~a 331 (405)
..+++||||+.+|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a 181 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence 99999999999999999987655578999999999999999999999999999999999999987 789999999999
Q ss_pred ccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 332 CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 332 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.............||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.+.
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 248 (327)
T 3lm5_A 182 RKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV 248 (327)
T ss_dssp EEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred cccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc
Confidence 7655544455667999999999999999999999999999999999999999999888877766553
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=332.43 Aligned_cols=209 Identities=26% Similarity=0.401 Sum_probs=166.0
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++..................+.+|+.+|++++||||+++++++...
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~- 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 478999999999999999999986 58999999975432211111111234578999999999999999999998654
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC---CcEEEEecCCcc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE---FHLKIADFGIAC 332 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~---~~vkL~DFG~a~ 332 (405)
.+++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred ceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 57899999999999998865 4679999999999999999999999999999999999999654 459999999997
Q ss_pred cccccCCCCCCCCCCcccCcccccc---ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 015556 333 EEVYCDALSDDPGTYRWMAPEMIKH---KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI 389 (405)
Q Consensus 333 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~ 389 (405)
............||+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~ 350 (419)
T 3i6u_A 291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 350 (419)
T ss_dssp SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS
T ss_pred ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch
Confidence 6655555556789999999999853 56788999999999999999999999875543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=322.35 Aligned_cols=208 Identities=18% Similarity=0.273 Sum_probs=170.0
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHH---HHHHHHHHHHHHHHHHhcCCCCeeE
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETL---AARLEKQFNREVALLSRLHNPNVIK 246 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~ 246 (405)
..++|.+++.||+|+||.||+|.+. ++.||||++.........+. .......+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 3468999999999999999999885 37899999975432111110 0001123456777788889999999
Q ss_pred EeeEeecC----CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEC--CC
Q 015556 247 FVAACKKP----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID--QE 320 (405)
Q Consensus 247 l~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~--~~ 320 (405)
+++++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||||+ .+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 99998764 4589999999 9999999987 346799999999999999999999999999999999999998 88
Q ss_pred CcEEEEecCCcccccccC--------CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 321 FHLKIADFGIACEEVYCD--------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 321 ~~vkL~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
+.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 999999999995432221 113445999999999999999999999999999999999999999863
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=314.97 Aligned_cols=213 Identities=25% Similarity=0.417 Sum_probs=176.2
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC--CCeeEEeeEe
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN--PNVIKFVAAC 251 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~ 251 (405)
.+...+|.+++.||+|+||.||++.+. ++.||||++........ ..+.+.+|+.+|.+++| +||+++++++
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 78 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ------TLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHH------HHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchH------HHHHHHHHHHHHHhhhhcCCceEEEeeeE
Confidence 345578999999999999999999886 58899999987654432 24678899999999986 9999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
.+...+++|||+ .+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++
T Consensus 79 ~~~~~~~lv~e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a 154 (343)
T 3dbq_A 79 ITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA 154 (343)
T ss_dssp ECSSEEEEEECC-CSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred eeCCEEEEEEeC-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccc
Confidence 999999999994 58899999987 46789999999999999999999999999999999999997 578999999999
Q ss_pred ccccccC---CCCCCCCCCcccCcccccc-----------ccCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHH
Q 015556 332 CEEVYCD---ALSDDPGTYRWMAPEMIKH-----------KSYGRKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVV 396 (405)
Q Consensus 332 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DVwSlGvll~elltG~~Pf~~~-~~~e~~~~i~ 396 (405)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... +.......++
T Consensus 155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 234 (343)
T 3dbq_A 155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234 (343)
T ss_dssp CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence 6543222 2235579999999999864 67899999999999999999999999874 4445555554
Q ss_pred h
Q 015556 397 N 397 (405)
Q Consensus 397 ~ 397 (405)
.
T Consensus 235 ~ 235 (343)
T 3dbq_A 235 D 235 (343)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=304.45 Aligned_cols=200 Identities=19% Similarity=0.279 Sum_probs=175.4
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEe
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAAC 251 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~ 251 (405)
.+-.++|.+++.||+|+||.||+|.+. ++.||||++...... ..+.+|+.++..+ +|+|++++++++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~e~~~~~~l~~~~~i~~~~~~~ 75 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----------PQLRDEYRTYKLLAGCTGIPNVYYFG 75 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----------CCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----------HHHHHHHHHHHHHhcCCCCCeEEeec
Confidence 344578999999999999999999964 799999999754432 2466899999999 799999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCc-----EEEE
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH-----LKIA 326 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~-----vkL~ 326 (405)
.+....++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+
T Consensus 76 ~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~ 153 (298)
T 1csn_A 76 QEGLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVV 153 (298)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred CCCceeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEE
Confidence 9999999999999 99999999863 356999999999999999999999999999999999999987766 9999
Q ss_pred ecCCcccccccC--------CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 327 DFGIACEEVYCD--------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 327 DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 221 (298)
T 1csn_A 154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221 (298)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchh
Confidence 999986543321 234556999999999999999999999999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=318.03 Aligned_cols=218 Identities=25% Similarity=0.376 Sum_probs=180.1
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++......... ......+.+|+.+++.++||||+++++++.+..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAK---DGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhh---hhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 467899999999999999999986 689999999754322211 112346789999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
..++||||+.+ +|.+++.. ....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred ceEEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 99999999975 89988875 34568899999999999999999999999999999999999999999999999986543
Q ss_pred c-cCCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 336 Y-CDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 336 ~-~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
. ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+++...
T Consensus 164 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~ 230 (346)
T 1ua2_A 164 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 230 (346)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred CCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcC
Confidence 2 2334556799999999999654 589999999999999999999999999999998888877543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=317.51 Aligned_cols=215 Identities=24% Similarity=0.445 Sum_probs=178.6
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--Ccc----EEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEP----VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~----vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 248 (405)
.+..++|.+++.||+|+||.||+|.+. ++. ||+|.+........ ...+.+|+.++.+++||||++++
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~ 81 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS-------FQAVTDHMLAIGSLDHAHIVRLL 81 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSC-------BCSCCHHHHHHHTCCCTTBCCEE
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHH-------HHHHHHHHHHHhcCCCCCcCeEE
Confidence 456688999999999999999999985 344 78888754332221 23466899999999999999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEec
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF 328 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DF 328 (405)
++|.+ ...++||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~-~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Df 159 (325)
T 3kex_A 82 GLCPG-SSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADF 159 (325)
T ss_dssp EEECB-SSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSC
T ss_pred EEEcC-CccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCC
Confidence 99874 5578999999999999999763 357889999999999999999999999999999999999999999999999
Q ss_pred CCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 329 GIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 329 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
|++....... ......|+..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+.++
T Consensus 160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 233 (325)
T 3kex_A 160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG 233 (325)
T ss_dssp SGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT
T ss_pred CcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC
Confidence 9996543221 2344568889999999998999999999999999999999 99999988777666665554
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=327.29 Aligned_cols=215 Identities=24% Similarity=0.419 Sum_probs=182.7
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++........ ...+.+|+.++++++||||+++++++.+..
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-------VDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-------HHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch-------HHHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence 467899999999999999999997 78999999975332221 355678999999999999999999998755
Q ss_pred --eeEEEEeecCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE----CCCCcEEEEec
Q 015556 256 --VYCVITEYLSEGSLRAYLHKLE-HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI----DQEFHLKIADF 328 (405)
Q Consensus 256 --~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl----~~~~~vkL~DF 328 (405)
..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DF 160 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecC
Confidence 7899999999999999998643 2349999999999999999999999999999999999999 78888999999
Q ss_pred CCcccccccCCCCCCCCCCcccCcccccc--------ccCCchhhHHHHHHHHHHHHhCCCCCCC----CCHHHHHHHHH
Q 015556 329 GIACEEVYCDALSDDPGTYRWMAPEMIKH--------KSYGRKVDVYSFGLILWEMVAGTIPYEE----MNPIQAAFAVV 396 (405)
Q Consensus 329 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~DVwSlGvll~elltG~~Pf~~----~~~~e~~~~i~ 396 (405)
|++.............||+.|+|||++.+ ..++.++|||||||++|||++|..||.. ....+...+++
T Consensus 161 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp GGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred CCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 99976555555566779999999999865 5678899999999999999999999964 33455666666
Q ss_pred hcc
Q 015556 397 NKV 399 (405)
Q Consensus 397 ~~~ 399 (405)
.+.
T Consensus 241 ~~~ 243 (396)
T 4eut_A 241 TGK 243 (396)
T ss_dssp HSC
T ss_pred cCC
Confidence 543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=309.64 Aligned_cols=209 Identities=22% Similarity=0.413 Sum_probs=181.8
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+++.||+|+||.||++.+. ++.||||++....... ...+.+|+.++++++||||+++++++.+...
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR--------DSSLENEIAVLKKIKHENIVTLEDIYESTTH 80 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc--------hHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence 57889999999999999999986 7899999998543221 3467799999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---CCCCcEEEEecCCccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIACE 333 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl---~~~~~vkL~DFG~a~~ 333 (405)
+++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp EEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EEEEEEcCCCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 9999999999999999976 3578999999999999999999999999999999999999 7889999999999854
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+.++
T Consensus 159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 222 (304)
T 2jam_A 159 EQNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG 222 (304)
T ss_dssp CCCB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHC
T ss_pred cCCC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC
Confidence 3221 222335899999999999999999999999999999999999999998887777766654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=318.72 Aligned_cols=202 Identities=26% Similarity=0.484 Sum_probs=176.2
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++....... .+.+.+|+.+++.++||||++++++|.+...
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG--------IEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSH--------HHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred HhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHH--------HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 467889999999999999999986 6899999887544322 4568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLE--HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
.++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999999999987532 235899999999999999999999999999999999999999999999999998643
Q ss_pred ccc---CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 335 VYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 335 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~ 245 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence 221 12234458999999999988899999999999999999999999997644
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=305.44 Aligned_cols=218 Identities=28% Similarity=0.379 Sum_probs=170.3
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
.+..++|.+++.||+|+||.||++.+ .++.||||++........ ....+..+..+++.++||||+++++++.
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~~~~~~~~~~h~~iv~~~~~~~ 76 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE------QKRLLMDLDISMRTVDCPFTVTFYGALF 76 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHH------HHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHH------HHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence 45668999999999999999999998 478999999975432221 1344555666688889999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEECCCCcEEEEecC
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
+....++||||++ |+|.+++... ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 77 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T 3fme_A 77 REGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG 155 (290)
T ss_dssp CSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred ccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecC
Confidence 9999999999996 5888887653 456799999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccCCCCCCCCCCcccCcccc----ccccCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcc
Q 015556 330 IACEEVYCDALSDDPGTYRWMAPEMI----KHKSYGRKVDVYSFGLILWEMVAGTIPYEE-MNPIQAAFAVVNKV 399 (405)
Q Consensus 330 ~a~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~DVwSlGvll~elltG~~Pf~~-~~~~e~~~~i~~~~ 399 (405)
++.............||+.|+|||++ .+..++.++||||||+++|+|++|..||.. ..+.+.....+...
T Consensus 156 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 230 (290)
T 3fme_A 156 ISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP 230 (290)
T ss_dssp --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC
T ss_pred CcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC
Confidence 99765544444555799999999996 566789999999999999999999999987 45555555555443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=317.97 Aligned_cols=209 Identities=23% Similarity=0.389 Sum_probs=182.9
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
..+..++|.+++.||+|+||.||++.+. ++.||||++...... ...+.+.+|+.++++++||||+++++++
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 100 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-------AIRNQIIRELQVLHECNSPYIVGFYGAF 100 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCH-------HHHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCH-------HHHHHHHHHHHHHHHCCCCCEEEEeEEE
Confidence 3455678999999999999999999997 789999999865322 1256788999999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEECCCCcEEEEecCC
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
.++..+++||||+++++|.+++... ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 101 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 178 (360)
T 3eqc_A 101 YSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV 178 (360)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred EECCEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCC
Confidence 9999999999999999999999873 5789999999999999999999996 999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAA 392 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~ 392 (405)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+..
T Consensus 179 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 239 (360)
T 3eqc_A 179 SGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 239 (360)
T ss_dssp CHHHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHH
T ss_pred Ccccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 8644322 234557999999999999999999999999999999999999999987766543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=324.55 Aligned_cols=212 Identities=25% Similarity=0.382 Sum_probs=186.1
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc------CCCCeeEEee
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL------HNPNVIKFVA 249 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~g 249 (405)
..+|.+++.||+|+||.||+|.+. ++.||||++.... ....++.+|+.++..+ +|+||+++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~---------~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~ 166 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK---------RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE 166 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH---------HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc---------chHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence 367999999999999999999986 5899999997421 1245677888888887 5679999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCc--EEEEe
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH--LKIAD 327 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~--vkL~D 327 (405)
++.....+|+||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|
T Consensus 167 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 167 NFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp EEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECC
T ss_pred ecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEee
Confidence 9999999999999995 69999999866667999999999999999999999999999999999999999887 99999
Q ss_pred cCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Q 015556 328 FGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNF 401 (405)
Q Consensus 328 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~~ 401 (405)
||++.... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+++....
T Consensus 246 FG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~ 317 (429)
T 3kvw_A 246 FGSSCYEH--QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGM 317 (429)
T ss_dssp CTTCEETT--CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred cccceecC--CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99986533 2334567999999999999999999999999999999999999999999999988888765443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=309.48 Aligned_cols=213 Identities=27% Similarity=0.481 Sum_probs=179.0
Q ss_pred cCCCeeecceeeeeeeEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeec
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKK 253 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~ 253 (405)
..++|.+++.||+|+||.||+|.+ .++.||||++...... ...+.+|+.++.++ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---------EEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---------THHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---------HHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 347899999999999999999999 4789999999765433 24577999999999 79999999999976
Q ss_pred ------CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEe
Q 015556 254 ------PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327 (405)
Q Consensus 254 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~D 327 (405)
...+++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEee
Confidence 46889999999999999999876556899999999999999999999999999999999999999999999999
Q ss_pred cCCccccccc-CCCCCCCCCCcccCccccc-----cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 328 FGIACEEVYC-DALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 328 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
||++...... .......||+.|+|||++. +..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 249 (326)
T 2x7f_A 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 249 (326)
T ss_dssp CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence 9998653321 2233456999999999986 567899999999999999999999999999988887776654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=311.73 Aligned_cols=195 Identities=32% Similarity=0.533 Sum_probs=166.6
Q ss_pred CCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHh--cCCCCeeEEeeEeec--
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR--LHNPNVIKFVAACKK-- 253 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~~-- 253 (405)
.++|.+++.||+|+||.||+|.+.++.||||++.... ...+..|.+++.. ++||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG-----------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc-----------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 4688999999999999999999999999999986321 2445567777777 789999999998654
Q ss_pred --CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCcEEECCCCcE
Q 015556 254 --PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH--------SQGVIHRDLKPENVLIDQEFHL 323 (405)
Q Consensus 254 --~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~gIiHrDIkp~NILl~~~~~v 323 (405)
...+++||||+++|+|.+++.. ..+++..++.++.||+.||.||| ++||+||||||+|||++.++.+
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred CCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCE
Confidence 3568999999999999999964 57999999999999999999999 9999999999999999999999
Q ss_pred EEEecCCcccccccC-----CCCCCCCCCcccCccccccc------cCCchhhHHHHHHHHHHHHhC----------CCC
Q 015556 324 KIADFGIACEEVYCD-----ALSDDPGTYRWMAPEMIKHK------SYGRKVDVYSFGLILWEMVAG----------TIP 382 (405)
Q Consensus 324 kL~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~------~~~~k~DVwSlGvll~elltG----------~~P 382 (405)
||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|||++| ..|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 999999985433221 12344799999999999876 455799999999999999999 889
Q ss_pred CCCC
Q 015556 383 YEEM 386 (405)
Q Consensus 383 f~~~ 386 (405)
|...
T Consensus 233 f~~~ 236 (301)
T 3q4u_A 233 FYDV 236 (301)
T ss_dssp TTTT
T ss_pred cccc
Confidence 8653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=319.94 Aligned_cols=213 Identities=25% Similarity=0.410 Sum_probs=177.1
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC--CCCeeEEeeEee
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH--NPNVIKFVAACK 252 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~g~~~ 252 (405)
+....|.+++.||+|+||.||++.+. ++.||||++........ ....+.+|+.+|.+|. ||||+++++++.
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~ 126 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ------TLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 126 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHH------HHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHH------HHHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence 33456999999999999999999886 68899999987554332 2567889999999996 599999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
....+|+||| +.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.
T Consensus 127 ~~~~~~lv~E-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 127 TDQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 202 (390)
T ss_dssp CSSEEEEEEE-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred cCCEEEEEEe-cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccc
Confidence 9999999999 568899999987 45789999999999999999999999999999999999995 5899999999996
Q ss_pred cccccC---CCCCCCCCCcccCcccccc-----------ccCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHh
Q 015556 333 EEVYCD---ALSDDPGTYRWMAPEMIKH-----------KSYGRKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVVN 397 (405)
Q Consensus 333 ~~~~~~---~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DVwSlGvll~elltG~~Pf~~~-~~~e~~~~i~~ 397 (405)
...... .....+||+.|+|||++.+ ..++.++|||||||+||||++|..||... ...+.+..++.
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~ 282 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282 (390)
T ss_dssp CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence 543221 2345679999999999865 46899999999999999999999999875 44555555554
Q ss_pred c
Q 015556 398 K 398 (405)
Q Consensus 398 ~ 398 (405)
.
T Consensus 283 ~ 283 (390)
T 2zmd_A 283 P 283 (390)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=307.01 Aligned_cols=208 Identities=23% Similarity=0.430 Sum_probs=158.2
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
+++|.+++.||+|+||.||+|.+. ++.||||++..... ........+.+|+.++.+++||||+++++++.+..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM-----YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhh-----hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence 467999999999999999999984 78999999963211 11112467889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
..++||||+++++|.+++.. ....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999999999986 33678999999999999999999999999999999999999999999999999986543
Q ss_pred c-cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 015556 336 Y-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQA 391 (405)
Q Consensus 336 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~ 391 (405)
. ........||+.|+|||++.+..++.++||||||+++|+|++|..||......+.
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 220 (278)
T 3cok_A 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT 220 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--
T ss_pred CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH
Confidence 2 1222345689999999999988899999999999999999999999987654333
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=303.80 Aligned_cols=212 Identities=27% Similarity=0.502 Sum_probs=179.4
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec-
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK- 253 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~- 253 (405)
+...|.+++.||+|+||.||+|.+. +..||||++........ ..+.+.+|+.++++++||||+++++++..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 97 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS------ERQRFKEEAEMLKGLQHPNIVRFYDSWEST 97 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH------HHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHH------HHHHHHHHHHHHHhCCCCCeeeeeeeeccc
Confidence 3456888999999999999999986 57899999986544332 25678899999999999999999998865
Q ss_pred ---CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEC-CCCcEEEEe
Q 015556 254 ---PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLID-QEFHLKIAD 327 (405)
Q Consensus 254 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IiHrDIkp~NILl~-~~~~vkL~D 327 (405)
...+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~D 175 (290)
T 1t4h_A 98 VKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD 175 (290)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred cCCCceEEEEEEecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEee
Confidence 4568999999999999999987 367899999999999999999999999 99999999999997 789999999
Q ss_pred cCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 328 FGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 328 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
||++..... .......||+.|+|||++. ..++.++||||||+++|+|++|..||............+..
T Consensus 176 fg~~~~~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 244 (290)
T 1t4h_A 176 LGLATLKRA-SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 244 (290)
T ss_dssp TTGGGGCCT-TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT
T ss_pred CCCcccccc-cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc
Confidence 999854332 2233456999999999887 45899999999999999999999999986665555544443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=309.03 Aligned_cols=204 Identities=24% Similarity=0.420 Sum_probs=177.3
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeec-
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKK- 253 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~- 253 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++.... .+.+.+|+.++++++ ||||+++++++.+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 103 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNIITLADIVKDP 103 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----------hHHHHHHHHHHHHcCCCCCEEEeeeeeccC
Confidence 478999999999999999999885 6899999997322 356789999999997 9999999999987
Q ss_pred -CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCC-cEEEEecCCc
Q 015556 254 -PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-HLKIADFGIA 331 (405)
Q Consensus 254 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~-~vkL~DFG~a 331 (405)
....++||||+.+++|.+++.. +++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 104 ~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 104 VSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178 (330)
T ss_dssp TTCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CCCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence 6678999999999999998853 88999999999999999999999999999999999999776 8999999999
Q ss_pred ccccccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHh
Q 015556 332 CEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYE-EMNPIQAAFAVVN 397 (405)
Q Consensus 332 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~-~~~~~e~~~~i~~ 397 (405)
.............|+..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+.+
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~ 246 (330)
T 3nsz_A 179 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 246 (330)
T ss_dssp EECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH
T ss_pred eEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHH
Confidence 76555555566789999999999977 678999999999999999999999994 4455555554443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=316.24 Aligned_cols=214 Identities=21% Similarity=0.364 Sum_probs=181.8
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec-
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK- 253 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~- 253 (405)
..++|.+++.||+|+||.||+|.+. ++.||||++......... ...+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 88 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF------PITALREIKILQLLKHENVVNLIEICRTK 88 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS------CHHHHHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc------hHHHHHHHHHHHhccCCCcccHhheeecc
Confidence 4578999999999999999999985 689999998765443321 3456789999999999999999999987
Q ss_pred -------CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEE
Q 015556 254 -------PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA 326 (405)
Q Consensus 254 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~ 326 (405)
.+.+++||||+.+ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~ 166 (351)
T 3mi9_A 89 ASPYNRCKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLA 166 (351)
T ss_dssp --------CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEEC
T ss_pred ccccccCCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEc
Confidence 4568999999965 888887653 3569999999999999999999999999999999999999999999999
Q ss_pred ecCCccccc-----ccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 327 DFGIACEEV-----YCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 327 DFG~a~~~~-----~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
|||++.... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.+.
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 244 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 999986432 1223345578999999999876 45799999999999999999999999999888877776653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=320.52 Aligned_cols=208 Identities=23% Similarity=0.352 Sum_probs=177.3
Q ss_pred CCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC--
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP-- 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-- 255 (405)
.+|.+++.||+|+||.||+|.+. +..||||.+....... .+|+.+|+.++||||++++++|....
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~------------~~E~~il~~l~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK------------NRELQIMRIVKHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSC------------CHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchH------------HHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence 57999999999999999999985 4669999887543322 26999999999999999999985433
Q ss_pred ----eeEEEEeecCCCCHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEC-CCCcEEEEec
Q 015556 256 ----VYCVITEYLSEGSLRAYLHK--LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADF 328 (405)
Q Consensus 256 ----~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~-~~~~vkL~DF 328 (405)
.+++||||++++ +.+.+.. .....+++..+..++.||+.||.|||++||+||||||+||||+ .++.+||+||
T Consensus 108 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp SSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 388999999764 4444332 1356799999999999999999999999999999999999998 7999999999
Q ss_pred CCcccccccCCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 329 GIACEEVYCDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 329 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
|++.............||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+++..
T Consensus 187 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~ 258 (394)
T 4e7w_A 187 GSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL 258 (394)
T ss_dssp TTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred CCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999766555555667899999999998765 58999999999999999999999999999999988888754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=324.56 Aligned_cols=206 Identities=25% Similarity=0.420 Sum_probs=177.0
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+++.||+|+||.||+|.+. ++.||||++..................+.+|+.++++++||||+++++++.+...
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 57889999999999999999875 6899999998654322100000012346689999999999999999999999999
Q ss_pred eEEEEeecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 257 YCVITEYLSEG-SLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 257 ~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
+++||||+.+| +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 99999999776 99999986 4579999999999999999999999999999999999999999999999999997655
Q ss_pred ccCCCCCCCCCCcccCccccccccC-CchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 336 YCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 336 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
.........||+.|+|||++.+..+ +.++|||||||++|+|++|..||...
T Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 5444555679999999999988877 88999999999999999999999763
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=321.08 Aligned_cols=210 Identities=26% Similarity=0.382 Sum_probs=166.6
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC--
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-- 254 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-- 254 (405)
++|.+++.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.+|+.++||||+++++++...
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII------HAKRTYRELRLLKHMKHENVIGLLDVFTPARS 102 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHH------HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHH------HHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence 78999999999999999999875 78999999875443321 246788999999999999999999998654
Q ss_pred ----CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 255 ----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 255 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
..+|+|||++ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 103 LEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp GGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred cccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5689999999 7899998875 5799999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
+..... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+++...
T Consensus 179 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 247 (367)
T 2fst_X 179 ARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 865432 2345679999999999876 6789999999999999999999999999999888888776443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=309.61 Aligned_cols=223 Identities=26% Similarity=0.489 Sum_probs=180.7
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI 245 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 245 (405)
..+..++.++|.+++.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.++++++||||+
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv 99 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR------EIEEFLSEAACMKDFSHPNVI 99 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHH------HHHHHHHHHHHHHTCCCTTBC
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchh------HHHHHHHHHHHHhcCCCCCee
Confidence 4566788899999999999999999999874 24799999976544332 146788999999999999999
Q ss_pred EEeeEeecCC-----eeEEEEeecCCCCHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEE
Q 015556 246 KFVAACKKPP-----VYCVITEYLSEGSLRAYLHKL----EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVL 316 (405)
Q Consensus 246 ~l~g~~~~~~-----~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NIL 316 (405)
++++++.+.. ..++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 100 ~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIl 179 (313)
T 3brb_A 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCM 179 (313)
T ss_dssp CCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEE
T ss_pred eeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEE
Confidence 9999998754 359999999999999999642 3456999999999999999999999999999999999999
Q ss_pred ECCCCcEEEEecCCccccccc---CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 015556 317 IDQEFHLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAA 392 (405)
Q Consensus 317 l~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~ 392 (405)
++.++.+||+|||++...... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+..
T Consensus 180 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 259 (313)
T 3brb_A 180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259 (313)
T ss_dssp ECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred EcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH
Confidence 999999999999998654322 12233457889999999999999999999999999999999 99999998887777
Q ss_pred HHHHhcc
Q 015556 393 FAVVNKV 399 (405)
Q Consensus 393 ~~i~~~~ 399 (405)
..+.++.
T Consensus 260 ~~~~~~~ 266 (313)
T 3brb_A 260 DYLLHGH 266 (313)
T ss_dssp HHHHTTC
T ss_pred HHHHcCC
Confidence 6666553
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=322.03 Aligned_cols=194 Identities=25% Similarity=0.390 Sum_probs=165.1
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC-
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP- 254 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~- 254 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.+|++++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI------DCKRILREITILNRLKSDYIIRLYDLIIPDD 98 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHH------HHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChH------HHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 378999999999999999999986 68899999975433321 246788999999999999999999999766
Q ss_pred ----CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 255 ----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 255 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
..+|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 99 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 99 LLKFDELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CCcCCeEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 57899999985 699999976 46799999999999999999999999999999999999999999999999999
Q ss_pred ccccccc-----------------------CCCCCCCCCCcccCcccc-ccccCCchhhHHHHHHHHHHHHhCC
Q 015556 331 ACEEVYC-----------------------DALSDDPGTYRWMAPEMI-KHKSYGRKVDVYSFGLILWEMVAGT 380 (405)
Q Consensus 331 a~~~~~~-----------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~DVwSlGvll~elltG~ 380 (405)
+...... ......+||+.|+|||++ ....++.++|||||||++|||++|.
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~ 249 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence 9654322 123567899999999986 5667999999999999999999843
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=309.99 Aligned_cols=206 Identities=24% Similarity=0.391 Sum_probs=170.9
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
+++|.+++.||+|+||.||+|.+. ++.||||++......+ ....+.+.+|+.++++++||||+++++++.++.
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD-----PVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGS-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccC-----HHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 578999999999999999999985 6899999987543222 223577889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred eEEEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999999999987 3578999999999999999999999999999999999999999999999999986433
Q ss_pred cc--CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 015556 336 YC--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390 (405)
Q Consensus 336 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e 390 (405)
.. .......|++.|+|||++.+..++.++||||||+++|+|++|..||...+...
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 242 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV 242 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH
Confidence 22 22234569999999999998999999999999999999999999999876553
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=309.57 Aligned_cols=199 Identities=35% Similarity=0.664 Sum_probs=168.7
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 253 (405)
..++.++|.+++.||+|+||.||+|.+.++.||||++.... ..+.|.+|+.++++++||||+++++++.+
T Consensus 3 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 72 (307)
T 2eva_A 3 HMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES----------ERKAFIVELRQLSRVNHPNIVKLYGACLN 72 (307)
T ss_dssp CBCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTT----------HHHHHHHHHHHHHHCCCTTBCCEEEBCTT
T ss_pred CcCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChh----------HHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 35678899999999999999999999999999999986321 14578899999999999999999999874
Q ss_pred CCeeEEEEeecCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCCCcEEECCCCc-EEEEec
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKLEH-KTLPLPKLIAIALDIARGMEYIHS---QGVIHRDLKPENVLIDQEFH-LKIADF 328 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~gIiHrDIkp~NILl~~~~~-vkL~DF 328 (405)
. .++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+ +||+||||||+|||++.++. +||+||
T Consensus 73 ~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Df 150 (307)
T 2eva_A 73 P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF 150 (307)
T ss_dssp T--TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCC
T ss_pred C--cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccc
Confidence 4 7899999999999999986432 247889999999999999999999 89999999999999988876 799999
Q ss_pred CCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 329 GIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 329 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
|++..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 151 g~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 151 GTACDIQT--HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp CC--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred cccccccc--ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 99864332 223456999999999999999999999999999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=310.18 Aligned_cols=204 Identities=29% Similarity=0.490 Sum_probs=175.0
Q ss_pred CeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEE
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCV 259 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 259 (405)
.|..++.||+|+||.||+|.+.++.||||++......... ...+.+.+|+.++++++||||+++++++.+....++
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 107 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE----ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCL 107 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTT----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchH----HHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEE
Confidence 3456789999999999999999999999999754322211 125678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc-
Q 015556 260 ITEYLSEGSLRAYLHKLE-HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC- 337 (405)
Q Consensus 260 V~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~- 337 (405)
||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 187 (307)
T 2nru_A 108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187 (307)
T ss_dssp EEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS
T ss_pred EEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccc
Confidence 999999999999997543 456899999999999999999999999999999999999999999999999998643321
Q ss_pred --CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 015556 338 --DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP 388 (405)
Q Consensus 338 --~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~ 388 (405)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..||.....
T Consensus 188 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 188 QTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp SCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred ccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 11234569999999999875 588999999999999999999999987543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=315.50 Aligned_cols=222 Identities=23% Similarity=0.330 Sum_probs=178.2
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChh---HHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDEN---ETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~---~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
-.++|.+++.||+|+||.||+|.+. ++.||||++........ ........+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 3478999999999999999999875 68999999965433211 0011223578899999999999999999999984
Q ss_pred c-----CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEe
Q 015556 253 K-----PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327 (405)
Q Consensus 253 ~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~D 327 (405)
. ...+|+||||+. |+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 3 346899999997 689888875 345799999999999999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 328 FGIACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 328 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+++...
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 251 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251 (362)
T ss_dssp TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 999976555455556679999999999876 6789999999999999999999999999998888888776443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=308.03 Aligned_cols=199 Identities=27% Similarity=0.463 Sum_probs=167.7
Q ss_pred CCeee-cceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecC
Q 015556 179 SQLFL-GLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKP 254 (405)
Q Consensus 179 ~~~~~-~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~ 254 (405)
+.|.+ ++.||+|+||.||+|.+. ++.||||++....... ...+.+|+.++.++ +||||+++++++.+.
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~ 83 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI--------RSRVFREVEMLYQCQGHRNVLELIEFFEEE 83 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC--------HHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh--------HHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 45666 478999999999999874 7899999997654332 35677999999995 799999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCc---EEEEecCCc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH---LKIADFGIA 331 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~---vkL~DFG~a 331 (405)
..+++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred CEEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 9999999999999999999873 57899999999999999999999999999999999999988766 999999998
Q ss_pred cccccc--------CCCCCCCCCCcccCcccccc-----ccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 332 CEEVYC--------DALSDDPGTYRWMAPEMIKH-----KSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 332 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 543211 12234469999999999875 568899999999999999999999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=339.07 Aligned_cols=218 Identities=23% Similarity=0.521 Sum_probs=182.1
Q ss_pred cccccCCCeeecc-eeeeeeeEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEE
Q 015556 173 EHTVDLSQLFLGL-RFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247 (405)
Q Consensus 173 ~~~i~~~~~~~~~-~lG~G~~g~Vy~~~~~----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 247 (405)
.+.+..+++.+.+ .||+|+||.||+|.+. +..||||+++....... .+.|.+|+.+|++++|||||++
T Consensus 329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~-------~~~~~~E~~il~~l~hpniv~l 401 (613)
T 2ozo_A 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-------TEEMMREAQIMHQLDNPYIVRL 401 (613)
T ss_dssp CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTT-------HHHHHHHHHHHTTCCCTTBCCE
T ss_pred ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHH-------HHHHHHHHHHHHhCCCCCEeeE
Confidence 3455666777776 8999999999999874 45799999976533322 4678899999999999999999
Q ss_pred eeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEe
Q 015556 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327 (405)
Q Consensus 248 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~D 327 (405)
+++|.+ ..+++|||||++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|
T Consensus 402 ~~~~~~-~~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~D 479 (613)
T 2ozo_A 402 IGVCQA-EALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISD 479 (613)
T ss_dssp EEEEES-SSEEEEEECCTTCBHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred EEEecc-CCeEEEEEeCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEee
Confidence 999987 458999999999999999975 346799999999999999999999999999999999999999999999999
Q ss_pred cCCcccccccC----CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 328 FGIACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 328 FG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
||++....... ......+++.|+|||++.+..++.++|||||||+||||++ |..||.+.+..+....+.++.
T Consensus 480 FGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~ 556 (613)
T 2ozo_A 480 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 556 (613)
T ss_dssp CSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC
T ss_pred ccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence 99996543221 1122346689999999998999999999999999999998 999999999888777776654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=312.15 Aligned_cols=218 Identities=30% Similarity=0.517 Sum_probs=182.3
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCC
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPN 243 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~Hpn 243 (405)
..|.+..++|.+++.||+|+||.||+|.+. ++.||||++....... ....+.+|+.++.++ +|||
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~~hp~ 92 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-------EHRALMSELKILIHIGHHLN 92 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-------HHHHHHHHHHHHHHHCCCTT
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcH-------HHHHHHHHHHHHHhcccCCC
Confidence 356777889999999999999999999852 4789999997543221 145788999999999 6899
Q ss_pred eeEEeeEeecCC-eeEEEEeecCCCCHHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 015556 244 VIKFVAACKKPP-VYCVITEYLSEGSLRAYLHKLEH--------------KTLPLPKLIAIALDIARGMEYIHSQGVIHR 308 (405)
Q Consensus 244 Iv~l~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~gIiHr 308 (405)
|+++++++...+ .+++||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||
T Consensus 93 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~ 172 (316)
T 2xir_A 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 172 (316)
T ss_dssp BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 999999987754 58999999999999999987432 128899999999999999999999999999
Q ss_pred CCCCCcEEECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCC
Q 015556 309 DLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYE 384 (405)
Q Consensus 309 DIkp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~ 384 (405)
||||+|||++.++.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 999999999999999999999986433221 1223447889999999998999999999999999999998 999998
Q ss_pred CCCHHHHHHHHH
Q 015556 385 EMNPIQAAFAVV 396 (405)
Q Consensus 385 ~~~~~e~~~~i~ 396 (405)
+....+.....+
T Consensus 253 ~~~~~~~~~~~~ 264 (316)
T 2xir_A 253 GVKIDEEFCRRL 264 (316)
T ss_dssp TCCCSHHHHHHH
T ss_pred ccchhHHHHHHh
Confidence 876554444443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=304.28 Aligned_cols=216 Identities=24% Similarity=0.338 Sum_probs=182.8
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee--c
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK--K 253 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~ 253 (405)
.++|.+++.||+|+||.||++.+. ++.||||++........ ..+.+.+|+.++++++||||+++++++. .
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA------EKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 78 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHH------HHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHH------HHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence 468899999999999999999985 68999999986554332 2567889999999999999999999874 4
Q ss_pred CCeeEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCcEEECCCCcEEEE
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQG-----VIHRDLKPENVLIDQEFHLKIA 326 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g-----IiHrDIkp~NILl~~~~~vkL~ 326 (405)
...+++||||+++++|.+++... ....+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~ 158 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence 67899999999999999999864 2345999999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccccC-CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 327 DFGIACEEVYCD-ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 327 DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
|||++....... ......|+..|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.++.
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~ 232 (279)
T 2w5a_A 159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 232 (279)
T ss_dssp CCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred cCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc
Confidence 999985432211 1122358999999999998899999999999999999999999999998877776666543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=316.99 Aligned_cols=205 Identities=29% Similarity=0.511 Sum_probs=176.6
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
+..+..++|.+.+.||+|+||.||+|.+. ++.||||++........ ...+.+|+.+++.++||||++++++|
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG-------ELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C-------CCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH-------HHHHHHHHHHHHhccCCCccceEEEE
Confidence 34455678999999999999999999875 78999999875432221 23578999999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCcEEECCCCcEEEE
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLE--HKTLPLPKLIAIALDIARGMEYIHSQ---GVIHRDLKPENVLIDQEFHLKIA 326 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---gIiHrDIkp~NILl~~~~~vkL~ 326 (405)
.+....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999998643 23499999999999999999999999 99999999999999999999999
Q ss_pred ecCCcccccc--cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCC
Q 015556 327 DFGIACEEVY--CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384 (405)
Q Consensus 327 DFG~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~ 384 (405)
|||++..... ........||+.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 9999865332 222344569999999999988889999999999999999999999995
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=339.71 Aligned_cols=220 Identities=26% Similarity=0.503 Sum_probs=182.5
Q ss_pred ccccccCCCeeecc-eeeeeeeEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeE
Q 015556 172 DEHTVDLSQLFLGL-RFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246 (405)
Q Consensus 172 ~~~~i~~~~~~~~~-~lG~G~~g~Vy~~~~~----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 246 (405)
.++.++...+.+.. .||+|+||.||+|.+. ++.||||+++....... ..++|.+|+.+|++++|||||+
T Consensus 361 ~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~------~~~~~~~E~~il~~l~hpnIv~ 434 (635)
T 4fl3_A 361 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA------LKDELLAEANVMQQLDNPYIVR 434 (635)
T ss_dssp SSSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGG------GHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHH------HHHHHHHHHHHHHhCCCCCEee
Confidence 34556666666644 7999999999999763 47899999975433221 2467889999999999999999
Q ss_pred EeeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEE
Q 015556 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA 326 (405)
Q Consensus 247 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~ 326 (405)
++++|.++ .+++|||||++|+|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 435 l~~~~~~~-~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~ 511 (635)
T 4fl3_A 435 MIGICEAE-SWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKIS 511 (635)
T ss_dssp EEEEEESS-SEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred EEEEEecC-CEEEEEEccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEE
Confidence 99999754 57899999999999999976 5679999999999999999999999999999999999999999999999
Q ss_pred ecCCccccccc----CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 015556 327 DFGIACEEVYC----DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 327 DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
|||++...... .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+.+..+....+.++..
T Consensus 512 DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~ 590 (635)
T 4fl3_A 512 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER 590 (635)
T ss_dssp CTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred EcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99998643322 12233457789999999998999999999999999999998 9999999999887777766543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=304.97 Aligned_cols=210 Identities=29% Similarity=0.507 Sum_probs=180.8
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++..... ...+.+|+.++.+++||||+++++++.+..
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----------LQEIIKEISIMQQCDSPHVVKYYGSYFKNT 97 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----------CHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----------HHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence 467889999999999999999986 78999999986432 245778999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred EEEEEeecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 99999999999999999974 34679999999999999999999999999999999999999999999999999986543
Q ss_pred cc-CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 336 YC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 336 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
.. .......|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+...
T Consensus 177 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 240 (314)
T 3com_A 177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN 240 (314)
T ss_dssp TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC
Confidence 22 2234557999999999999989999999999999999999999999998888777665544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=323.83 Aligned_cols=206 Identities=22% Similarity=0.390 Sum_probs=173.1
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEE-----CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEE
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIY-----KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKF 247 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l 247 (405)
..+.+++|.+++.||+|+||.||++.. .++.||||++......... .....+.+|+.+|.++ +||||+++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~ 124 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA----KTTEHTRTERQVLEHIRQSPFLVTL 124 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE----SSGGGCCCHHHHHHHHHTCTTBCCE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhh----hHHHHHHHHHHHHHHccCCCceeEE
Confidence 355678999999999999999999998 4789999998643211000 0023456899999999 69999999
Q ss_pred eeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEe
Q 015556 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327 (405)
Q Consensus 248 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~D 327 (405)
++++.....+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|
T Consensus 125 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D 202 (355)
T 1vzo_A 125 HYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTD 202 (355)
T ss_dssp EEEEEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESC
T ss_pred EEEEeeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEee
Confidence 99999999999999999999999999873 5789999999999999999999999999999999999999999999999
Q ss_pred cCCcccccc--cCCCCCCCCCCcccCcccccc--ccCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 328 FGIACEEVY--CDALSDDPGTYRWMAPEMIKH--KSYGRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 328 FG~a~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
||++..... ........||+.|+|||++.+ ..++.++|||||||+||||++|..||..
T Consensus 203 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 264 (355)
T 1vzo_A 203 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264 (355)
T ss_dssp SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred CCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 999864322 122234569999999999985 3478999999999999999999999974
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=315.97 Aligned_cols=207 Identities=27% Similarity=0.414 Sum_probs=168.5
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+++.||+|+||.||+|.+. ++.||||++..................+.+|+.+|++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 57889999999999999999986 589999999754322111111122456789999999999999999999998765
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCc---EEEEecCCccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH---LKIADFGIACE 333 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~---vkL~DFG~a~~ 333 (405)
+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 89 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 7899999999999999875 467999999999999999999999999999999999999987654 99999999865
Q ss_pred ccccCCCCCCCCCCcccCccccc---cccCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIK---HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP 388 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~ 388 (405)
...........||+.|+|||++. ...++.++|||||||++|+|++|..||.....
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp CCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred cccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 43322223345899999999973 56789999999999999999999999986543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=307.10 Aligned_cols=203 Identities=27% Similarity=0.444 Sum_probs=173.0
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEE------CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEE
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIY------KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 247 (405)
..++...|.+++.||+|+||.||+|.+ .++.||||++........ ...+.+|+.+++.++||||+++
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~ 88 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH-------IADLKKEIEILRNLYHENIVKY 88 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CC-------HHHHHHHHHHHHTCCCTTBCCE
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchh-------HHHHHHHHHHHHhCCCCCeeee
Confidence 345567799999999999999999985 368999999975432221 4568899999999999999999
Q ss_pred eeEeecC--CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEE
Q 015556 248 VAACKKP--PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI 325 (405)
Q Consensus 248 ~g~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL 325 (405)
++++.+. ..+++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 89 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl 167 (302)
T 4e5w_A 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKI 167 (302)
T ss_dssp EEEEEC---CCEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred eeEEecCCCceEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEE
Confidence 9999876 6789999999999999999663 456999999999999999999999999999999999999999999999
Q ss_pred EecCCccccccc----CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCC
Q 015556 326 ADFGIACEEVYC----DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384 (405)
Q Consensus 326 ~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~ 384 (405)
+|||++...... .......||..|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 168 GDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred CcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 999998654322 22345568889999999998899999999999999999999998764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=311.38 Aligned_cols=219 Identities=26% Similarity=0.430 Sum_probs=182.2
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI 245 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 245 (405)
...+..++|.+++.||+|+||.||+|.+. ++.||||++....... ...++.+|+.++++++||||+
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv 96 (327)
T 2yfx_A 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ-------DELDFLMEALIISKFNHQNIV 96 (327)
T ss_dssp SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHH-------HHHHHHHHHHHHHHCCCTTBC
T ss_pred cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchh-------hHHHHHHHHHHHhhCCCCCCC
Confidence 34566788999999999999999999842 5689999996433221 145788999999999999999
Q ss_pred EEeeEeecCCeeEEEEeecCCCCHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC-
Q 015556 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH-----KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ- 319 (405)
Q Consensus 246 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~- 319 (405)
++++++.+....++||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 97 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~ 176 (327)
T 2yfx_A 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCP 176 (327)
T ss_dssp CEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS
T ss_pred eEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecC
Confidence 999999999999999999999999999987532 35889999999999999999999999999999999999984
Q ss_pred --CCcEEEEecCCccccccc---CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 015556 320 --EFHLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAF 393 (405)
Q Consensus 320 --~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~ 393 (405)
+..+||+|||++...... .......|++.|+|||++.+..++.++||||||+++|+|++ |..||......+...
T Consensus 177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 256 (327)
T 2yfx_A 177 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 256 (327)
T ss_dssp STTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred CCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHH
Confidence 456999999998543221 12223457889999999988899999999999999999998 999999988877776
Q ss_pred HHHhc
Q 015556 394 AVVNK 398 (405)
Q Consensus 394 ~i~~~ 398 (405)
.+..+
T Consensus 257 ~~~~~ 261 (327)
T 2yfx_A 257 FVTSG 261 (327)
T ss_dssp HHHTT
T ss_pred HHhcC
Confidence 66654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=303.24 Aligned_cols=202 Identities=30% Similarity=0.518 Sum_probs=177.4
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+++.||+|+||.||+|.+. ++.||||++........ ...+.+|+.+++.++||||+++++++.+...
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-------PENIKKEICINKMLNHENVVKFYGHRREGNI 79 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTH-------HHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhh-------hHHHHHHHHHHHhcCCCCceeeeeEEEcCCE
Confidence 57889999999999999999986 78999999975443321 4568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
.++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp EEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EEEEEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 9999999999999998865 45789999999999999999999999999999999999999999999999999864322
Q ss_pred ---cCCCCCCCCCCcccCccccccccC-CchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 015556 337 ---CDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPI 389 (405)
Q Consensus 337 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DVwSlGvll~elltG~~Pf~~~~~~ 389 (405)
........|++.|+|||++.+..+ +.++||||||+++|+|++|..||......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 214 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Confidence 123345679999999999987765 78999999999999999999999876543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=313.92 Aligned_cols=209 Identities=25% Similarity=0.374 Sum_probs=179.8
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC--
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-- 254 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-- 254 (405)
++|.+++.||+|+||.||+|.+. ++.||||++....... ....+.+|+.++.+++||||+++++++...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT-------YCQRTLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHH-------HHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcH-------HHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 58999999999999999999986 6889999997433211 246788999999999999999999999754
Q ss_pred ---CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 255 ---PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 255 ---~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
...++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 100 EQMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cccceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcce
Confidence 46899999996 599999976 56999999999999999999999999999999999999999999999999998
Q ss_pred ccccccC----CCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 332 CEEVYCD----ALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 332 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+++.
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 247 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 247 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHH
Confidence 6543221 2345579999999998754 45899999999999999999999999998888877777643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=311.82 Aligned_cols=219 Identities=25% Similarity=0.465 Sum_probs=167.9
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeE
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAA 250 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 250 (405)
.|.++.++|.+++.||+|+||.||+|.+ .++.||||++....... ....+.+|+.++.+++||||++++++
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~ 81 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT-------SMDELLKEIQAMSQCHHPNIVSYYTS 81 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------------CCCCCCCTTBCCEEEE
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcch-------hHHHHHHHHHHHhhcCCCCEeeEEEE
Confidence 4677889999999999999999999987 47899999986433211 24568899999999999999999999
Q ss_pred eecCCeeEEEEeecCCCCHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEE
Q 015556 251 CKKPPVYCVITEYLSEGSLRAYLHKL------EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLK 324 (405)
Q Consensus 251 ~~~~~~~~lV~E~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vk 324 (405)
+......++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k 161 (303)
T 2vwi_A 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQ 161 (303)
T ss_dssp EESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEE
T ss_pred EeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEE
Confidence 99999999999999999999999752 245689999999999999999999999999999999999999999999
Q ss_pred EEecCCccccccc------CCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 325 IADFGIACEEVYC------DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 325 L~DFG~a~~~~~~------~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
|+|||++...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||......+.......
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 241 (303)
T 2vwi_A 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ 241 (303)
T ss_dssp ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT
T ss_pred EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc
Confidence 9999988543221 11234469999999999876 5689999999999999999999999998877666655544
Q ss_pred c
Q 015556 398 K 398 (405)
Q Consensus 398 ~ 398 (405)
.
T Consensus 242 ~ 242 (303)
T 2vwi_A 242 N 242 (303)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=300.17 Aligned_cols=201 Identities=20% Similarity=0.323 Sum_probs=173.8
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecCC
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPP 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 255 (405)
++|.+++.||+|+||.||+|.+. ++.||||++......... ..++.+|+.++..+ +||||+++++++.+..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD------EQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHH------HHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHH------HHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 57889999999999999999996 799999999865444332 45678999999999 8999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC--------------
Q 015556 256 VYCVITEYLSEGSLRAYLHKLE--HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-------------- 319 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~-------------- 319 (405)
.+++||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 9999999999999999998642 267899999999999999999999999999999999999984
Q ss_pred -----CCcEEEEecCCcccccccCCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 015556 320 -----EFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNP 388 (405)
Q Consensus 320 -----~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~ 388 (405)
...+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|..|+.....
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 236 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236 (289)
T ss_dssp -----CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH
T ss_pred cccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH
Confidence 447999999998654332 344699999999999765 567899999999999999999988766543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=303.85 Aligned_cols=208 Identities=29% Similarity=0.560 Sum_probs=176.9
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
.+..++|.+.+.||+|+||.||+|.+. ++.||||++........... ....+.+.+|+.++++++||||+++++++.
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEM-IEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHH-HCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhH-HHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 456688999999999999999999985 68999999976554433221 111267889999999999999999999997
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEECCCCc-----EEE
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLIDQEFH-----LKI 325 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IiHrDIkp~NILl~~~~~-----vkL 325 (405)
+.. ++||||+++++|.+++.. ....+++..++.++.|++.||.|||++| |+||||||+|||++.++. +||
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred CCC--eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 765 699999999999999876 3457999999999999999999999999 999999999999988776 999
Q ss_pred EecCCcccccccCCCCCCCCCCcccCcccc--ccccCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 015556 326 ADFGIACEEVYCDALSDDPGTYRWMAPEMI--KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP 388 (405)
Q Consensus 326 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~ 388 (405)
+|||++..... ......||+.|+|||++ ....++.++|||||||++|+|++|..||.....
T Consensus 171 ~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 233 (287)
T 4f0f_A 171 ADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233 (287)
T ss_dssp CCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence 99999864332 33456799999999998 445678999999999999999999999987553
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=303.38 Aligned_cols=195 Identities=25% Similarity=0.452 Sum_probs=174.5
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec---
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK--- 253 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--- 253 (405)
.+|.+++.||+|+||.||+|.+. ++.||||++.... ..+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------------EKAEREVKALAKLDHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------------HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence 57889999999999999999996 7999999997543 234589999999999999999998864
Q ss_pred -------------CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC
Q 015556 254 -------------PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE 320 (405)
Q Consensus 254 -------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~ 320 (405)
...+++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence 4458999999999999999987666789999999999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 321 FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 321 ~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
+.+||+|||++.............||+.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred CCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 99999999998765554445566799999999999989999999999999999999999998853
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=304.13 Aligned_cols=213 Identities=26% Similarity=0.479 Sum_probs=180.3
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++....... ...+.+|+.++..++||||+++++++.+..
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 89 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--------LEDYIVEIEILATCDHPYIVKLLGAYYHDG 89 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC--------HHHHHHHHHHHHHCCCTTBCCEEEEEECC-
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH--------HHHHHHHHHHHhcCCCCCEeeeeeeeeeCC
Confidence 478999999999999999999996 6899999987543322 356789999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 90 ~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 90 KLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp CEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred eEEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999999998763 4669999999999999999999999999999999999999999999999999874322
Q ss_pred c-cCCCCCCCCCCcccCcccc-----ccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 336 Y-CDALSDDPGTYRWMAPEMI-----KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 336 ~-~~~~~~~~gt~~y~aPE~~-----~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
. ........||..|+|||++ .+..++.++||||||+++|+|++|..||...+..+....+.+..
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (302)
T 2j7t_A 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD 238 (302)
T ss_dssp HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC
Confidence 1 1222345699999999998 46678999999999999999999999999999888777776553
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=313.28 Aligned_cols=209 Identities=26% Similarity=0.436 Sum_probs=179.8
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+++.||+|+||.||+|.+. ++.||||++......+. ..+.+.+|+.+++.++||||+++++++.....
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI------FAKRAYRELLLLKHMQHENVIGLLDVFTPASS 115 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHH------HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchh------HHHHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence 68999999999999999999986 78999999976543322 25678899999999999999999999987765
Q ss_pred e------EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 257 Y------CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 257 ~------~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
. ++||||+. ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 116 ~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 116 LRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp STTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred cccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 4 99999996 68888774 4599999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+++...
T Consensus 191 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 259 (371)
T 4exu_A 191 ARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 259 (371)
T ss_dssp C----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 865432 3345678999999999987 6789999999999999999999999999999988888876443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=306.00 Aligned_cols=209 Identities=24% Similarity=0.349 Sum_probs=181.4
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEE---CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCC------CeeE
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIY---KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP------NVIK 246 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~---~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp------nIv~ 246 (405)
+-.++|.+++.||+|+||.||+|.+ .++.||||++.... .....+.+|+.++..++|+ +|++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~ 81 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD---------RYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH---------HHHHHHHHHHHHHHHHHHHCTTCTTCBCC
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC---------chhHHHHHHHHHHHHhhhcCCCCceeeEe
Confidence 3457899999999999999999987 36899999996321 1246678899999998765 4999
Q ss_pred EeeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC-------
Q 015556 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ------- 319 (405)
Q Consensus 247 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~------- 319 (405)
+++++.+.+.+++||||+ +++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 82 MLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccccc
Confidence 999999999999999999 889999998865567899999999999999999999999999999999999987
Q ss_pred ------------CCcEEEEecCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 320 ------------EFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 320 ------------~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
++.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|..||...+
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred CCccccccccccCCCceEeeCcccccCc--cccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 6689999999986533 23345679999999999999999999999999999999999999999988
Q ss_pred HHHHHHHHH
Q 015556 388 PIQAAFAVV 396 (405)
Q Consensus 388 ~~e~~~~i~ 396 (405)
..+....+.
T Consensus 239 ~~~~~~~~~ 247 (339)
T 1z57_A 239 SKEHLAMME 247 (339)
T ss_dssp HHHHHHHHH
T ss_pred hHHHHHHHH
Confidence 877665543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=303.87 Aligned_cols=213 Identities=28% Similarity=0.534 Sum_probs=176.9
Q ss_pred CCeeecceeeeeeeEEEEEEEECC-----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee-
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK- 252 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~- 252 (405)
.+|.+++.||+|+||.||+|.+.+ ..||||.+....... ..+.+.+|+.++++++||||++++++|.
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-------EVSQFLTEGIIMKDFSHPNVLSLLGICLR 97 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHH-------HHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHH-------HHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence 467889999999999999999742 258888886533221 2467889999999999999999999864
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
.+...++||||+++|+|.+++.. ....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 98 ~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 98 SEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred CCCceEEEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccc
Confidence 56688999999999999999975 34668999999999999999999999999999999999999999999999999986
Q ss_pred ccccc-----CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 333 EEVYC-----DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 333 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
..... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.++.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~ 249 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 249 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC
Confidence 43221 12234457889999999998999999999999999999999 788888877766666665544
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=309.41 Aligned_cols=216 Identities=26% Similarity=0.486 Sum_probs=177.0
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--Ccc----EEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEP----VAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~----vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 248 (405)
.+..++|.+++.||+|+||.||+|.+. ++. ||+|.+........ .+.+.+|+.++++++||||++++
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~-------~~~~~~E~~~l~~l~hp~iv~~~ 83 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-------NKEILDEAYVMASVDNPHVCRLL 83 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCC-------HHHHHHHHHHHTTCCBTTBCCCC
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHH-------HHHHHHHHHHHHhCCCCCeeEEE
Confidence 355688999999999999999999985 444 57777754333222 45788999999999999999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEec
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF 328 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DF 328 (405)
++|..+. .++||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 84 ~~~~~~~-~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~Df 161 (327)
T 3lzb_A 84 GICLTST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp EEEESSS-EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCT
T ss_pred EEEecCC-ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccC
Confidence 9998765 67999999999999999873 457899999999999999999999999999999999999999999999999
Q ss_pred CCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 329 GIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 329 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
|++....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+..+.
T Consensus 162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 236 (327)
T 3lzb_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236 (327)
T ss_dssp TC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred cceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence 9996532221 2233456888999999999999999999999999999999 999999988777666555544
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=312.48 Aligned_cols=199 Identities=30% Similarity=0.521 Sum_probs=162.8
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHH--HHhcCCCCeeEEee
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL--LSRLHNPNVIKFVA 249 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~i--l~~l~HpnIv~l~g 249 (405)
.+..+++++|.+++.||+|+||.||+|.+.++.||||++.... ...+..|.++ +..++||||+++++
T Consensus 6 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~~~h~~i~~~~~ 74 (336)
T 3g2f_A 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----------RQNFINEKNIYRVPLMEHDNIARFIV 74 (336)
T ss_dssp ---CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----------HHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred cCCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----------hhhHHHHHHHHHHHhccCcchhhhee
Confidence 3556788999999999999999999999999999999997422 1223334444 55589999999998
Q ss_pred Eee-----cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCcE
Q 015556 250 ACK-----KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ---------GVIHRDLKPENV 315 (405)
Q Consensus 250 ~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---------gIiHrDIkp~NI 315 (405)
.+. ....+++||||+++|+|.+++.. ...++..++.++.||+.||.|||++ ||+||||||+||
T Consensus 75 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Ni 151 (336)
T 3g2f_A 75 GDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNV 151 (336)
T ss_dssp EEEEECTTSCEEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGE
T ss_pred cccccccCCCceEEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceE
Confidence 553 23467899999999999999976 4558899999999999999999999 999999999999
Q ss_pred EECCCCcEEEEecCCcccccc---------cCCCCCCCCCCcccCcccccc-------ccCCchhhHHHHHHHHHHHHhC
Q 015556 316 LIDQEFHLKIADFGIACEEVY---------CDALSDDPGTYRWMAPEMIKH-------KSYGRKVDVYSFGLILWEMVAG 379 (405)
Q Consensus 316 Ll~~~~~vkL~DFG~a~~~~~---------~~~~~~~~gt~~y~aPE~~~~-------~~~~~k~DVwSlGvll~elltG 379 (405)
||+.++.+||+|||++..... ........||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 152 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g 231 (336)
T 3g2f_A 152 LVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231 (336)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhc
Confidence 999999999999999964322 122234569999999999976 4567899999999999999999
Q ss_pred CCCCC
Q 015556 380 TIPYE 384 (405)
Q Consensus 380 ~~Pf~ 384 (405)
..||.
T Consensus 232 ~~p~~ 236 (336)
T 3g2f_A 232 CTDLF 236 (336)
T ss_dssp BGGGS
T ss_pred CCcCC
Confidence 77653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=308.40 Aligned_cols=202 Identities=29% Similarity=0.478 Sum_probs=173.5
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEE------CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIY------KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 248 (405)
.++...|.+++.||+|+||.||++.+ .++.||||++....... ....+.+|+.++++++||||++++
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~ 99 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ-------HRSGWKQEIDILRTLYHEHIIKYK 99 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHH-------HHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChH-------HHHHHHHHHHHHHhCCCcchhhEE
Confidence 44445568999999999999999876 36889999997543221 256788999999999999999999
Q ss_pred eEeec--CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEE
Q 015556 249 AACKK--PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA 326 (405)
Q Consensus 249 g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~ 326 (405)
+++.+ ...+++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~ 176 (318)
T 3lxp_A 100 GCCEDAGAASLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIG 176 (318)
T ss_dssp EEEEETTTTEEEEEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEecCCCceEEEEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEEC
Confidence 99987 4678999999999999999976 459999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccccC----CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 327 DFGIACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 327 DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
|||++....... ......+|..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 177 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 177 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp CGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred CccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 999986543321 233456888999999999889999999999999999999999999763
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=308.42 Aligned_cols=209 Identities=25% Similarity=0.334 Sum_probs=178.3
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC--
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-- 254 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-- 254 (405)
++|.+++.||+|+||.||+|.+. ++.||||++...... .....+.+|+.++++++||||+++++++...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP-------LFALRTLREIKILKHFKHENIITIFNIQRPDSF 83 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSH-------HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccc-------hHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence 68999999999999999999986 789999999643221 1245678999999999999999999988754
Q ss_pred ---CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 255 ---PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 255 ---~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
...++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 84 ENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred CccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 67899999996 699999976 57999999999999999999999999999999999999999999999999998
Q ss_pred ccccccC-----------CCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 332 CEEVYCD-----------ALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 332 ~~~~~~~-----------~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 238 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 6432211 1234568999999998754 67899999999999999999999999999887777666543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=300.82 Aligned_cols=212 Identities=28% Similarity=0.531 Sum_probs=177.2
Q ss_pred CeeecceeeeeeeEEEEEEEEC--C---ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--D---EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~---~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
.|.+++.||+|+||.||+|.+. + ..||||++....... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ-------QVEAFLREGLLMRGLNHPNVLALIGIMLPP 94 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHH-------HHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHH-------HHHHHHHHHHHHHhCCCCCeeeEEEEEecC
Confidence 4556799999999999999873 2 269999986433221 246788999999999999999999999876
Q ss_pred Cee-EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 255 PVY-CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 255 ~~~-~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
... ++||||+.+++|.+++.. ....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 95 ~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 95 EGLPHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp SSCCEEEECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred CCCcEEEEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 554 899999999999999976 346789999999999999999999999999999999999999999999999999864
Q ss_pred ccc-----cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 334 EVY-----CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 334 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...++.+....+.+..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~ 245 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR 245 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC
Confidence 322 223344568899999999999999999999999999999999 566677777766666555544
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=326.35 Aligned_cols=207 Identities=16% Similarity=0.260 Sum_probs=164.6
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHH---HHHHhcCCCCeeEEe-
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREV---ALLSRLHNPNVIKFV- 248 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei---~il~~l~HpnIv~l~- 248 (405)
....++|.+++.||+|+||.||+|.+. ++.||||++......... ..+.+.+|+ .+|++++|||||+++
T Consensus 69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~~l~hpniv~~~~ 143 (377)
T 3byv_A 69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN-----AIKQMKEEVLRLRLLRGIKNQKQAKVHL 143 (377)
T ss_dssp SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTT-----HHHHHHHHHHGGGGSTTCCSHHHHHHHH
T ss_pred CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchH-----HHHHHHHHHHHHHhccccCCHHHHHHHh
Confidence 334578999999999999999999964 799999999854333221 146788999 555566899999998
Q ss_pred ------eEeecCC-----------------eeEEEEeecCCCCHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHH
Q 015556 249 ------AACKKPP-----------------VYCVITEYLSEGSLRAYLHKLEH-----KTLPLPKLIAIALDIARGMEYI 300 (405)
Q Consensus 249 ------g~~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~yL 300 (405)
+++.+.+ ..|+||||+ +|+|.+++..... ..+++..++.|+.||+.||+||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 222 (377)
T 3byv_A 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 222 (377)
T ss_dssp CBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 6665543 278999999 6899999986421 1233478888999999999999
Q ss_pred HHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCCCCCCCCCCcccCccccccc-----------cCCchhhHHHH
Q 015556 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK-----------SYGRKVDVYSF 369 (405)
Q Consensus 301 H~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~k~DVwSl 369 (405)
|++||+||||||+||||+.++.+||+|||++.... .......| +.|+|||++.+. .++.++|||||
T Consensus 223 H~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl 299 (377)
T 3byv_A 223 HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299 (377)
T ss_dssp HHTTEECSCCCGGGEEECTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred HhCCeecCCCCHHHEEEcCCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence 99999999999999999999999999999997532 23345567 999999999887 89999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHH
Q 015556 370 GLILWEMVAGTIPYEEMNPIQ 390 (405)
Q Consensus 370 Gvll~elltG~~Pf~~~~~~e 390 (405)
||++|||++|..||.+....+
T Consensus 300 G~il~elltg~~Pf~~~~~~~ 320 (377)
T 3byv_A 300 GLVIYWIWCADLPITKDAALG 320 (377)
T ss_dssp HHHHHHHHHSSCCC------C
T ss_pred HHHHHHHHHCCCCCccccccc
Confidence 999999999999998765433
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=301.62 Aligned_cols=211 Identities=27% Similarity=0.467 Sum_probs=183.4
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+++.||+|+||.||+|.+. ++.||||++......... ...+.+|+.++++++||||+++++++.+...
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD------TSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSC------HHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHH------HHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 67889999999999999999985 789999999754332211 3567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC---CcEEEEecCCccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE---FHLKIADFGIACE 333 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~---~~vkL~DFG~a~~ 333 (405)
+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 99999999999999998763 578999999999999999999999999999999999999654 4799999999865
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
...........|++.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+.++
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (287)
T 2wei_A 174 FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG 237 (287)
T ss_dssp BCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred ecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 544444444568999999999875 4899999999999999999999999998888877776654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=305.00 Aligned_cols=216 Identities=25% Similarity=0.406 Sum_probs=179.1
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe--ec
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC--KK 253 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~--~~ 253 (405)
.++|.+++.||+|+||.||++.+. ++.||||++....... .......+.+|+.++++++||||+++++++ .+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR----IPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE 79 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH----STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc----cchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 368899999999999999999985 6899999997421100 011256788999999999999999999998 45
Q ss_pred CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
....++||||+.++ |.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 80 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 80 KQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp --CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 56889999999775 88888876677899999999999999999999999999999999999999999999999999865
Q ss_pred ccc---cCCCCCCCCCCcccCcccccccc--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 334 EVY---CDALSDDPGTYRWMAPEMIKHKS--YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 334 ~~~---~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
... ........||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+..+....+.++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~ 228 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG 228 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC
Confidence 321 22234556999999999997644 378999999999999999999999998877766665543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=312.38 Aligned_cols=221 Identities=29% Similarity=0.515 Sum_probs=185.8
Q ss_pred ccccccccCCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 170 ~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
...+|.++.++|.+++.||+|+||.||+|.+.+ .||||++......... .+.+.+|+.++++++||||+++++
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~ 96 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQ------LKAFKREVMAYRQTRHENVVLFMG 96 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCC------CCCCCTTGGGGTTCCCTTBCCCCE
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHH------HHHHHHHHHHHhcCCCCCEeEEEE
Confidence 346788999999999999999999999999876 5999999765433221 245668999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
++.+...+++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||
T Consensus 97 ~~~~~~~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 97 ACMSPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp EEECSSCEEEECBCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCS
T ss_pred EEecCCceEEEeecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecC
Confidence 99999999999999999999999976 334689999999999999999999999999999999999998 6799999999
Q ss_pred Cccccc------ccCCCCCCCCCCcccCcccccc---------ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015556 330 IACEEV------YCDALSDDPGTYRWMAPEMIKH---------KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFA 394 (405)
Q Consensus 330 ~a~~~~------~~~~~~~~~gt~~y~aPE~~~~---------~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~ 394 (405)
++.... .........|++.|+|||++.. ..++.++||||||+++|+|++|..||......+....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 254 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 875421 1122334568999999999864 4578999999999999999999999999988887777
Q ss_pred HHhcc
Q 015556 395 VVNKV 399 (405)
Q Consensus 395 i~~~~ 399 (405)
+..+.
T Consensus 255 ~~~~~ 259 (319)
T 2y4i_B 255 MGTGM 259 (319)
T ss_dssp HHTTC
T ss_pred hccCC
Confidence 66553
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=314.52 Aligned_cols=206 Identities=18% Similarity=0.269 Sum_probs=167.9
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC-----CccEEEEEEecCCCChhHHH---HHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETL---AARLEKQFNREVALLSRLHNPNVIKFV 248 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vAVK~~~~~~~~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~ 248 (405)
..++|.+++.||+|+||.||+|.+. +..||||++.........+. .......+.+|+.++..++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 3478999999999999999999984 47999999986543221111 111123477899999999999999999
Q ss_pred eEeec----CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCC--c
Q 015556 249 AACKK----PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF--H 322 (405)
Q Consensus 249 g~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~--~ 322 (405)
+++.. ...+|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTS
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCc
Confidence 99987 77899999999 99999999763 3799999999999999999999999999999999999998877 9
Q ss_pred EEEEecCCcccccccC--------CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 323 LKIADFGIACEEVYCD--------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 323 vkL~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9999999996432211 11345799999999999998999999999999999999999999965
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=300.46 Aligned_cols=205 Identities=27% Similarity=0.438 Sum_probs=167.8
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
.+++|.+++.||+|+||.||+|... ++.||||++......+. .....+.+|+.++++++||||+++++++.+.
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 104 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDA-----KARADCIKEIDLLKQLNHPNVIKYYASFIED 104 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCH-----HHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 4568999999999999999999974 78999999986443332 1256788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
...++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 184 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence 9999999999999999999753 35678999999999999999999999999999999999999999999999999986
Q ss_pred ccccc-CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 333 EEVYC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 333 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
..... .......|+..|+|||++.+..++.++||||||+++|+|++|..||.+.
T Consensus 185 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 185 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred eecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 43322 2223456899999999999899999999999999999999999999753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=308.70 Aligned_cols=215 Identities=23% Similarity=0.314 Sum_probs=171.6
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
...+++|.+++.||+|+||.||+|.+. ++.||||++....... ..+.+|+..+..++||||++++++|.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~~l~~l~h~niv~~~~~~~ 89 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---------NRELQIMQDLAVLHHPNIVQLQSYFY 89 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---------CHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---------HHHHHHHHHHHhcCCCCcccHHHhhh
Confidence 344578999999999999999999986 7899999987543332 23457888889999999999999986
Q ss_pred cCCe-------eEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCcEEECC-C
Q 015556 253 KPPV-------YCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIH--SQGVIHRDLKPENVLIDQ-E 320 (405)
Q Consensus 253 ~~~~-------~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH--~~gIiHrDIkp~NILl~~-~ 320 (405)
.... +++||||+++ +|.+.+... ....+++..+..++.|++.||.||| ++||+||||||+|||++. +
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~ 168 (360)
T 3e3p_A 90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEAD 168 (360)
T ss_dssp EECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTT
T ss_pred ccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCC
Confidence 5332 7899999976 665555432 3567899999999999999999999 999999999999999986 8
Q ss_pred CcEEEEecCCcccccccCCCCCCCCCCcccCcccccccc-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 321 FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKS-YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 321 ~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
+.+||+|||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+++..
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp TEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred CcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 999999999997665555556677999999999986654 8999999999999999999999999999998888887644
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=311.53 Aligned_cols=198 Identities=24% Similarity=0.418 Sum_probs=172.8
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC--------CCCeeEE
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH--------NPNVIKF 247 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~--------HpnIv~l 247 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++... ......+.+|+.+++.++ |+||+++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~ 106 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---------EHYTETALDEIRLLKSVRNSDPNDPNREMVVQL 106 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---------CcchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence 478999999999999999999885 689999999632 112466789999999995 7889999
Q ss_pred eeEee----cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEECCCC-
Q 015556 248 VAACK----KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEF- 321 (405)
Q Consensus 248 ~g~~~----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDIkp~NILl~~~~- 321 (405)
++++. +...+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+||||+.++
T Consensus 107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHH
T ss_pred ecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccch
Confidence 99987 566899999999 67888888775556799999999999999999999998 999999999999998775
Q ss_pred ------------------------------------------------cEEEEecCCcccccccCCCCCCCCCCcccCcc
Q 015556 322 ------------------------------------------------HLKIADFGIACEEVYCDALSDDPGTYRWMAPE 353 (405)
Q Consensus 322 ------------------------------------------------~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE 353 (405)
.+||+|||++..... ......||+.|+|||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE 263 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHH
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCCh
Confidence 799999999865433 345567999999999
Q ss_pred ccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 354 MIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 354 ~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
++.+..++.++|||||||+||||++|..||...+
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 9999999999999999999999999999998654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=317.16 Aligned_cols=212 Identities=25% Similarity=0.356 Sum_probs=162.0
Q ss_pred Ceee-cceeeeeeeEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee--
Q 015556 180 QLFL-GLRFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK-- 252 (405)
Q Consensus 180 ~~~~-~~~lG~G~~g~Vy~~~~~----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~-- 252 (405)
.|.+ +++||+|+||.||+|.+. ++.||||++...... ..+.+|+.+|++|+||||+++++++.
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----------MSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----------HHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----------HHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 3444 668999999999999975 579999999754332 34668999999999999999999994
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE----CCCC
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLE-------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI----DQEF 321 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl----~~~~ 321 (405)
....+|+||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||| +.++
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT
T ss_pred CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC
Confidence 4778999999996 58888886421 2248999999999999999999999999999999999999 7789
Q ss_pred cEEEEecCCccccccc----CCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------
Q 015556 322 HLKIADFGIACEEVYC----DALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNP-------- 388 (405)
Q Consensus 322 ~vkL~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~-------- 388 (405)
.+||+|||++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.....
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 9999999999654321 233456799999999999874 589999999999999999999999976554
Q ss_pred -HHHHHHHHhcccCC
Q 015556 389 -IQAAFAVVNKVNFG 402 (405)
Q Consensus 389 -~e~~~~i~~~~~~~ 402 (405)
.+.+..+++...++
T Consensus 250 ~~~~l~~i~~~~g~p 264 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFP 264 (405)
T ss_dssp CHHHHHHHHHHHCCC
T ss_pred hHHHHHHHHHhhCCC
Confidence 35555665544433
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=308.89 Aligned_cols=204 Identities=27% Similarity=0.461 Sum_probs=176.5
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEE------CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEE
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIY------KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 247 (405)
..++.++|.+++.||+|+||.||++.+ .++.||||++..... ...+.+.+|+.++++++||||+++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~~~ 89 (327)
T 3lxl_A 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP--------DQQRDFQREIQILKALHSDFIVKY 89 (327)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH--------HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred hhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH--------HHHHHHHHHHHHHHhcCCCceeEE
Confidence 356678999999999999999999985 368999999975431 124678899999999999999999
Q ss_pred eeEee--cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEE
Q 015556 248 VAACK--KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI 325 (405)
Q Consensus 248 ~g~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL 325 (405)
++++. +...+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl 168 (327)
T 3lxl_A 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKI 168 (327)
T ss_dssp EEEEECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred EEEEecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEE
Confidence 99886 4567899999999999999998632 46899999999999999999999999999999999999999999999
Q ss_pred EecCCcccccccC----CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 326 ADFGIACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 326 ~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
+|||++....... ......||..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 169 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp CCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 9999986432221 234456888999999999888999999999999999999999998653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=303.43 Aligned_cols=210 Identities=25% Similarity=0.424 Sum_probs=173.5
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee---
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK--- 252 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--- 252 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++...+. ...+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP--------QSVKHALREIKIIRRLDHDNIVKVFEILGPSG 81 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSH--------HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh--------HHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence 368999999999999999999997 68999999975431 12467889999999999999999999874
Q ss_pred -----------cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEC-CC
Q 015556 253 -----------KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QE 320 (405)
Q Consensus 253 -----------~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~-~~ 320 (405)
+...+++||||+. |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED 157 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT
T ss_pred cccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC
Confidence 4467899999997 699999864 6789999999999999999999999999999999999997 56
Q ss_pred CcEEEEecCCccccccc----CCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015556 321 FHLKIADFGIACEEVYC----DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395 (405)
Q Consensus 321 ~~vkL~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i 395 (405)
+.+||+|||++...... .......+|..|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 79999999998653221 12233457899999998865 67899999999999999999999999999988888777
Q ss_pred Hhcc
Q 015556 396 VNKV 399 (405)
Q Consensus 396 ~~~~ 399 (405)
++..
T Consensus 238 ~~~~ 241 (320)
T 2i6l_A 238 LESI 241 (320)
T ss_dssp HHHS
T ss_pred HHhc
Confidence 6643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=318.58 Aligned_cols=212 Identities=28% Similarity=0.549 Sum_probs=170.3
Q ss_pred CeeecceeeeeeeEEEEEEEECC-----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec-
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK- 253 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~~-----~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~- 253 (405)
.|.+++.||+|+||.||+|.+.+ ..||||.+........ .++|.+|+.++++++||||++++++|.+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-------VSQFLTEGIIMKDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHH-------HHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHH-------HHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 46788999999999999998742 3689998865333221 4678899999999999999999998754
Q ss_pred CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
.+..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred CCCeEEEEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccc
Confidence 5678999999999999999975 345688999999999999999999999999999999999999999999999999864
Q ss_pred ccccC-----CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 334 EVYCD-----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 334 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
..... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~ 313 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 313 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC
Confidence 32211 1233457889999999999999999999999999999999 788998877666665555543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=305.99 Aligned_cols=194 Identities=30% Similarity=0.546 Sum_probs=164.4
Q ss_pred CCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc--CCCCeeEEeeEeecC--
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNPNVIKFVAACKKP-- 254 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~g~~~~~-- 254 (405)
++|.+++.||+|+||.||+|.+.++.||||++.... ...+..|.+++..+ +||||+++++++.+.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----------EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 578899999999999999999999999999996321 22344555665554 899999999999877
Q ss_pred --CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCcEEECCCCcEE
Q 015556 255 --PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ--------GVIHRDLKPENVLIDQEFHLK 324 (405)
Q Consensus 255 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------gIiHrDIkp~NILl~~~~~vk 324 (405)
..+++||||+++|+|.+++.. ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+|
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 789999999999999999976 4799999999999999999999999 999999999999999999999
Q ss_pred EEecCCcccccccCC-----CCCCCCCCcccCccccccccCCch------hhHHHHHHHHHHHHhC----------CCCC
Q 015556 325 IADFGIACEEVYCDA-----LSDDPGTYRWMAPEMIKHKSYGRK------VDVYSFGLILWEMVAG----------TIPY 383 (405)
Q Consensus 325 L~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~k------~DVwSlGvll~elltG----------~~Pf 383 (405)
|+|||++........ .....||+.|+|||++.+..+... +|||||||++|||++| ..||
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 999999854332211 124579999999999987766554 9999999999999999 7888
Q ss_pred CCC
Q 015556 384 EEM 386 (405)
Q Consensus 384 ~~~ 386 (405)
...
T Consensus 263 ~~~ 265 (337)
T 3mdy_A 263 HDL 265 (337)
T ss_dssp TTT
T ss_pred hhh
Confidence 654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=313.46 Aligned_cols=196 Identities=17% Similarity=0.256 Sum_probs=170.6
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC----------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeE-
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK----------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK- 246 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~----------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~- 246 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++... ..+.+|+.++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------------~~~~~E~~~l~~l~h~niv~~ 107 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------------GRLFNEQNFFQRAAKPLQVNK 107 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------------STHHHHHHHHHHHCCHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------------chHHHHHHHHHHhcccchhhh
Confidence 478999999999999999999985 589999999743 24668999999999999887
Q ss_pred --------------EeeEeec-CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 015556 247 --------------FVAACKK-PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLK 311 (405)
Q Consensus 247 --------------l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIk 311 (405)
+++++.. +..+++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+|||||
T Consensus 108 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dik 186 (352)
T 2jii_A 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVT 186 (352)
T ss_dssp HHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCC
T ss_pred hhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC
Confidence 6777765 77899999999 9999999997545789999999999999999999999999999999
Q ss_pred CCcEEECCCC--cEEEEecCCcccccccC--------CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCC
Q 015556 312 PENVLIDQEF--HLKIADFGIACEEVYCD--------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI 381 (405)
Q Consensus 312 p~NILl~~~~--~vkL~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~ 381 (405)
|+|||++.++ .+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 266 (352)
T 2jii_A 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL 266 (352)
T ss_dssp GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999998 99999999996433221 1234479999999999999899999999999999999999999
Q ss_pred CCCCCC
Q 015556 382 PYEEMN 387 (405)
Q Consensus 382 Pf~~~~ 387 (405)
||....
T Consensus 267 pf~~~~ 272 (352)
T 2jii_A 267 PWTNCL 272 (352)
T ss_dssp TTGGGT
T ss_pred CcccCC
Confidence 998764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=305.37 Aligned_cols=210 Identities=27% Similarity=0.432 Sum_probs=159.0
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHH-HHHhcCCCCeeEE
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVA-LLSRLHNPNVIKF 247 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l 247 (405)
...|.+..++|.+++.||+|+||.||+|.+. ++.||||++........ ..++..|+. +++.++||||+++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~e~~~~~~~~~h~niv~~ 86 (327)
T 3aln_A 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-------QKQLLMDLDVVMRSSDCPYIVQF 86 (327)
T ss_dssp CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHH-------HHHHHHHHHHHHSSCCCTTBCCE
T ss_pred HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchH-------HHHHHHHHHHHHHcCCCCcEeee
Confidence 4567888899999999999999999999996 78999999986543221 344555665 6777899999999
Q ss_pred eeEeecCCeeEEEEeecCCCCHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEECCCCcE
Q 015556 248 VAACKKPPVYCVITEYLSEGSLRAYLHKL---EHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHL 323 (405)
Q Consensus 248 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDIkp~NILl~~~~~v 323 (405)
++++.+.+..++||||+.+ +|.+++... ....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~ 165 (327)
T 3aln_A 87 YGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNI 165 (327)
T ss_dssp EEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEE
T ss_pred eeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCE
Confidence 9999999999999999975 888877642 356789999999999999999999999 99999999999999999999
Q ss_pred EEEecCCcccccccCCCCCCCCCCcccCcccc----ccccCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 015556 324 KIADFGIACEEVYCDALSDDPGTYRWMAPEMI----KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP 388 (405)
Q Consensus 324 kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~ 388 (405)
||+|||++.............||+.|+|||++ .+..++.++||||||+++|+|++|..||.....
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (327)
T 3aln_A 166 KLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234 (327)
T ss_dssp EECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--
T ss_pred EEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcch
Confidence 99999999765444444455799999999998 456789999999999999999999999987543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=310.25 Aligned_cols=225 Identities=21% Similarity=0.359 Sum_probs=187.1
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHH---------HHHHHHHHHHHHHHHHHhcCCC
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENET---------LAARLEKQFNREVALLSRLHNP 242 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~---------~~~~~~~~~~~Ei~il~~l~Hp 242 (405)
....+..++|.+++.||+|+||.||+|.+.++.||||++.......... ........+.+|+.++.+++||
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 103 (348)
T 2pml_X 24 KEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE 103 (348)
T ss_dssp SSSCEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred hhcccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence 3445557899999999999999999999999999999997422111000 0000016788999999999999
Q ss_pred CeeEEeeEeecCCeeEEEEeecCCCCHHHH------HHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcE
Q 015556 243 NVIKFVAACKKPPVYCVITEYLSEGSLRAY------LHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENV 315 (405)
Q Consensus 243 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDIkp~NI 315 (405)
||+++++++.+...+++||||+++++|.++ +.......+++..++.++.||+.||.|||+ +||+||||||+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 999999999999999999999999999998 655446789999999999999999999999 9999999999999
Q ss_pred EECCCCcEEEEecCCcccccccCCCCCCCCCCcccCccccccc-cCCc-hhhHHHHHHHHHHHHhCCCCCCCCCH-HHHH
Q 015556 316 LIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK-SYGR-KVDVYSFGLILWEMVAGTIPYEEMNP-IQAA 392 (405)
Q Consensus 316 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-k~DVwSlGvll~elltG~~Pf~~~~~-~e~~ 392 (405)
|++.++.+||+|||++...... ......|+..|+|||++.+. .++. ++||||||+++|+|++|..||..... .+..
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred EEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 9999999999999998654332 34556799999999999877 6666 99999999999999999999998776 4444
Q ss_pred HHHHh
Q 015556 393 FAVVN 397 (405)
Q Consensus 393 ~~i~~ 397 (405)
..+..
T Consensus 263 ~~i~~ 267 (348)
T 2pml_X 263 NNIRT 267 (348)
T ss_dssp HHHTS
T ss_pred HHHhc
Confidence 44433
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=301.05 Aligned_cols=218 Identities=28% Similarity=0.439 Sum_probs=175.4
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC---C--ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK---D--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~---~--~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 248 (405)
..+..++|.+++.||+|+||.||+|.+. + ..||||++........ ...+.+.+|+.++++++||||++++
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~ 87 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP-----EAMDDFIREVNAMHSLDHRNLIRLY 87 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------C-----HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCH-----HHHHHHHHHHHHHHhCCCCCcccEE
Confidence 3556688999999999999999999863 2 2689999875432221 1256788999999999999999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEec
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF 328 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DF 328 (405)
+++.+.. .++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 88 ~~~~~~~-~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Df 165 (291)
T 1u46_A 88 GVVLTPP-MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 165 (291)
T ss_dssp EEECSSS-CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred EEEccCC-ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccc
Confidence 9998765 78999999999999999864 356899999999999999999999999999999999999999999999999
Q ss_pred CCcccccccC----CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 015556 329 GIACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 329 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~ 398 (405)
|++....... ......+|..|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+.+.
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~ 240 (291)
T 1u46_A 166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 240 (291)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS
T ss_pred cccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc
Confidence 9986543221 1233457889999999998889999999999999999999 99999999988877777654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=306.73 Aligned_cols=210 Identities=24% Similarity=0.401 Sum_probs=158.6
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEE--CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEee
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVA 249 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g 249 (405)
...+...+|.+++.||+|+||.||+|.+ .++.||||++..... .....+.+|+.++.++. ||||+++++
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~~h~~iv~~~~ 93 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE--------EKNRAIIQEVCFMKKLSGHPNIVQFCS 93 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH--------HHHHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch--------HHHHHHHHHHHHHHHhccCCChhhccc
Confidence 3445556899999999999999999998 478999999864321 12457889999999996 999999999
Q ss_pred Eee--------cCCeeEEEEeecCCCCHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEC
Q 015556 250 ACK--------KPPVYCVITEYLSEGSLRAYLHKL-EHKTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLID 318 (405)
Q Consensus 250 ~~~--------~~~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IiHrDIkp~NILl~ 318 (405)
++. ....+++||||+. |+|.+++... ....+++..++.++.||+.||.|||++| |+||||||+|||++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~ 172 (337)
T 3ll6_A 94 AASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS 172 (337)
T ss_dssp EEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC
T ss_pred cccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC
Confidence 983 4456899999995 7999998763 3457999999999999999999999999 99999999999999
Q ss_pred CCCcEEEEecCCcccccccCC-------------CCCCCCCCcccCcccc---ccccCCchhhHHHHHHHHHHHHhCCCC
Q 015556 319 QEFHLKIADFGIACEEVYCDA-------------LSDDPGTYRWMAPEMI---KHKSYGRKVDVYSFGLILWEMVAGTIP 382 (405)
Q Consensus 319 ~~~~vkL~DFG~a~~~~~~~~-------------~~~~~gt~~y~aPE~~---~~~~~~~k~DVwSlGvll~elltG~~P 382 (405)
.++.+||+|||++........ .....||+.|+|||++ .+..++.++|||||||++|+|++|..|
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p 252 (337)
T 3ll6_A 173 NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252 (337)
T ss_dssp TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCC
T ss_pred CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence 999999999999865432211 1134589999999998 566789999999999999999999999
Q ss_pred CCCCCHHHH
Q 015556 383 YEEMNPIQA 391 (405)
Q Consensus 383 f~~~~~~e~ 391 (405)
|.+....+.
T Consensus 253 ~~~~~~~~~ 261 (337)
T 3ll6_A 253 FEDGAKLRI 261 (337)
T ss_dssp C--------
T ss_pred CcchhHHHh
Confidence 987655443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=311.47 Aligned_cols=212 Identities=23% Similarity=0.353 Sum_probs=184.5
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CC-----CeeEEee
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NP-----NVIKFVA 249 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~l~g 249 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++.... ....++..|+.++..++ |+ +|+++++
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK---------AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH---------HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH---------HHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 578999999999999999999986 6889999997321 12456778999988885 55 4999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCcEEEC--CCCcEEE
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH--SQGVIHRDLKPENVLID--QEFHLKI 325 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH--~~gIiHrDIkp~NILl~--~~~~vkL 325 (405)
++.....+|+||||+. ++|.+++.......+++..+..++.||+.||.||| +.||+||||||+||||+ .++.+||
T Consensus 124 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 124 HFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred eeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence 9999999999999995 59999999866567999999999999999999999 57999999999999994 5788999
Q ss_pred EecCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Q 015556 326 ADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNF 401 (405)
Q Consensus 326 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~~ 401 (405)
+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+++....
T Consensus 203 ~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 203 VDFGSSCQLG--QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp CCCTTCEETT--CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred EeccCceecc--cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999996543 2344567999999999999999999999999999999999999999999999998888875443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=316.73 Aligned_cols=202 Identities=14% Similarity=0.192 Sum_probs=156.2
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc--CCCCeeEEe----
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL--HNPNVIKFV---- 248 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~---- 248 (405)
...+|.+++.||+|+||.||+|.+. ++.||||++......... ....+.+|+.++..| +||||++++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~ 134 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRS-----ELERLHEATFAAARLLGESPEEARDRRRLL 134 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHH-----HHHHHHHHHHHHHHHHC----------CBC
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccccccc-----HHHHHHHHHHHHHHhcccChhhhhhceeEE
Confidence 3456899999999999999999985 689999999976543322 245677886555555 699988755
Q ss_pred ---eEeecC-----------------CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHH
Q 015556 249 ---AACKKP-----------------PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKL------IAIALDIARGMEYIHS 302 (405)
Q Consensus 249 ---g~~~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~qi~~aL~yLH~ 302 (405)
+++... ..+|+||||++ |+|.+++.... ..+++..+ +.++.||+.||+|||+
T Consensus 135 ~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~ 212 (371)
T 3q60_A 135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQS 212 (371)
T ss_dssp CCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 444332 33799999998 89999998742 23455555 6788999999999999
Q ss_pred CCceecCCCCCcEEECCCCcEEEEecCCcccccccCCCCCCCCCCcccCcccccc--ccCCchhhHHHHHHHHHHHHhCC
Q 015556 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKH--KSYGRKVDVYSFGLILWEMVAGT 380 (405)
Q Consensus 303 ~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DVwSlGvll~elltG~ 380 (405)
+||+||||||+||||+.++.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 213 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 213 KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp TTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CCCccCcCCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999998654322 114457799999999987 78999999999999999999999
Q ss_pred CCCCCCC
Q 015556 381 IPYEEMN 387 (405)
Q Consensus 381 ~Pf~~~~ 387 (405)
.||.+..
T Consensus 291 ~Pf~~~~ 297 (371)
T 3q60_A 291 LPFGLVT 297 (371)
T ss_dssp CSTTBCC
T ss_pred CCCCCcC
Confidence 9998763
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=305.32 Aligned_cols=206 Identities=24% Similarity=0.388 Sum_probs=172.5
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
+...++.++|.+++.||+|+||.||++... ++.||||++..... .....+.+|+.+++.++||||+++++
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~ 93 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ--------QDREEAQREADMHRLFNHPNILRLVA 93 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH--------HHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH--------HHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 345677789999999999999999999974 78999999875321 12467889999999999999999999
Q ss_pred Eee----cCCeeEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcE
Q 015556 250 ACK----KPPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323 (405)
Q Consensus 250 ~~~----~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~v 323 (405)
++. .....++||||+.+|+|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~ 173 (317)
T 2buj_A 94 YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQP 173 (317)
T ss_dssp EEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCE
T ss_pred EEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCE
Confidence 987 345789999999999999999864 34679999999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccC----------CCCCCCCCCcccCcccccccc---CCchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 324 KIADFGIACEEVYCD----------ALSDDPGTYRWMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 324 kL~DFG~a~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~---~~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
||+|||++....... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||..
T Consensus 174 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp EECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred EEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 999999875432110 011234799999999987543 68999999999999999999999954
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=298.49 Aligned_cols=207 Identities=26% Similarity=0.394 Sum_probs=173.8
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
+..+.+++.....||+|+||.||+|.+. ++.||||.+...+... .+.+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~~ 88 (295)
T 2clq_A 17 YDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY--------SQPLHEEIALHKHLKHKNIVQYLGSF 88 (295)
T ss_dssp EEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----------HHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHH--------HHHHHHHHHHHHhCCCCCEeeEeeEE
Confidence 3444556666678999999999999985 6899999998654321 45688999999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC-CCcEEEEecC
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLE-HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-EFHLKIADFG 329 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~-~~~vkL~DFG 329 (405)
.+....++||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg 168 (295)
T 2clq_A 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFG 168 (295)
T ss_dssp EETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTT
T ss_pred EeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecc
Confidence 99999999999999999999998743 235678889999999999999999999999999999999987 8999999999
Q ss_pred Cccccccc-CCCCCCCCCCcccCcccccccc--CCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 015556 330 IACEEVYC-DALSDDPGTYRWMAPEMIKHKS--YGRKVDVYSFGLILWEMVAGTIPYEEMNP 388 (405)
Q Consensus 330 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~k~DVwSlGvll~elltG~~Pf~~~~~ 388 (405)
++...... .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||.....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (295)
T 2clq_A 169 TSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230 (295)
T ss_dssp TCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS
T ss_pred cccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc
Confidence 98654321 2234557999999999997653 78999999999999999999999976543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=296.41 Aligned_cols=196 Identities=24% Similarity=0.375 Sum_probs=169.6
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe-ecCC
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPP 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~-~~~~ 255 (405)
++|.+++.||+|+||.||+|.+. ++.||||++...... .++.+|+.++..++|++++..+..+ .+..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----------PQLHIESKIYKMMQGGVGIPTIRWCGAEGD 78 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----------CHHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----------hHHHHHHHHHHHhhcCCCCCccccccCCCC
Confidence 68999999999999999999974 799999999765433 2467899999999988766655554 6678
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---CCCCcEEEEecCCcc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIAC 332 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl---~~~~~vkL~DFG~a~ 332 (405)
..++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 79 YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred ceEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 889999999 89999999753 4579999999999999999999999999999999999999 488999999999986
Q ss_pred cccccC--------CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 333 EEVYCD--------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 333 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence 543322 124557999999999999999999999999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=308.43 Aligned_cols=208 Identities=26% Similarity=0.445 Sum_probs=177.4
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+++.||+|+||.||+|.+. |+.||||++......+. ..+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 97 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI------FAKRAYRELLLLKHMQHENVIGLLDVFTPASS 97 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHH------HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchH------HHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence 67999999999999999999986 78999999976543322 25678899999999999999999999987654
Q ss_pred ------eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 257 ------YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 257 ------~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
+|+||||+. ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 98 LRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp GGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred cccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999996 58877664 3589999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+++..
T Consensus 173 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 240 (353)
T 3coi_A 173 ARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 240 (353)
T ss_dssp TTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHH
T ss_pred ccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 865332 2345578999999999876 678999999999999999999999999999888887776643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=304.37 Aligned_cols=194 Identities=30% Similarity=0.579 Sum_probs=169.6
Q ss_pred CCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHh--cCCCCeeEEeeEeecCC-
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSR--LHNPNVIKFVAACKKPP- 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~~~~- 255 (405)
++|.+++.||+|+||.||+|.+.++.||||++.... ...+.+|++++.. ++||||+++++++....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----------ERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG-----------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh-----------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 578899999999999999999999999999996321 3456789999988 78999999999998876
Q ss_pred ---eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCcEEECCCCcEE
Q 015556 256 ---VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH--------SQGVIHRDLKPENVLIDQEFHLK 324 (405)
Q Consensus 256 ---~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~gIiHrDIkp~NILl~~~~~vk 324 (405)
.+++||||+++|+|.+++.. ..+++..++.++.|++.||.||| +.||+||||||+|||++.++.+|
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred ccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence 78999999999999999976 46899999999999999999999 89999999999999999999999
Q ss_pred EEecCCcccccccC-----CCCCCCCCCcccCccccccc------cCCchhhHHHHHHHHHHHHhC----------CCCC
Q 015556 325 IADFGIACEEVYCD-----ALSDDPGTYRWMAPEMIKHK------SYGRKVDVYSFGLILWEMVAG----------TIPY 383 (405)
Q Consensus 325 L~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~------~~~~k~DVwSlGvll~elltG----------~~Pf 383 (405)
|+|||++....... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 99999986543322 23455799999999999765 334789999999999999999 8899
Q ss_pred CCC
Q 015556 384 EEM 386 (405)
Q Consensus 384 ~~~ 386 (405)
...
T Consensus 268 ~~~ 270 (342)
T 1b6c_B 268 YDL 270 (342)
T ss_dssp TTT
T ss_pred ccc
Confidence 765
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=300.17 Aligned_cols=219 Identities=22% Similarity=0.389 Sum_probs=166.2
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
..+.+.+++|.+++.||+|+||.||+|.+. ++.||||++........ ....+..+..+++.++||||+++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~~~~~~~~~~h~~i~~~~~ 91 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE------NKRILMDLDVVLKSHDCPYIVQCFG 91 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHH------HHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchH------HHHHHHHHHHHHHhcCCCceeeEEE
Confidence 456677899999999999999999999995 78999999986543221 1334555666788889999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEECCCCcEEEEec
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENVLIDQEFHLKIADF 328 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDIkp~NILl~~~~~vkL~DF 328 (405)
++.+...+++||||+ ++.+..++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+||
T Consensus 92 ~~~~~~~~~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~df 169 (318)
T 2dyl_A 92 TFITNTDVFIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDF 169 (318)
T ss_dssp EEECSSEEEEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCC
T ss_pred EEecCCcEEEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEEC
Confidence 999999999999999 5566555543 356799999999999999999999995 9999999999999999999999999
Q ss_pred CCcccccccCCCCCCCCCCcccCccccc-----cccCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhc
Q 015556 329 GIACEEVYCDALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIPYEEM-NPIQAAFAVVNK 398 (405)
Q Consensus 329 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DVwSlGvll~elltG~~Pf~~~-~~~e~~~~i~~~ 398 (405)
|++.............||+.|+|||++. ...++.++||||||+++|+|++|..||... ...+....+..+
T Consensus 170 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 245 (318)
T 2dyl_A 170 GISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE 245 (318)
T ss_dssp TTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS
T ss_pred CCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc
Confidence 9986654444445567999999999984 456889999999999999999999999874 455555555544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=296.61 Aligned_cols=197 Identities=24% Similarity=0.374 Sum_probs=167.0
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe-ecCC
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC-KKPP 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~-~~~~ 255 (405)
++|.+++.||+|+||.||+|.+. ++.||||++...... .++.+|+.++..++|++++..++.+ .+..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----------PQLHIESKIYKMMQGGVGIPTIRWCGAEGD 78 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----------CCHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----------hHHHHHHHHHHHhcCCCCCCeeeeecCCCC
Confidence 67899999999999999999974 689999997754432 2466899999999987766665554 6778
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---CCCCcEEEEecCCcc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIAC 332 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl---~~~~~vkL~DFG~a~ 332 (405)
..++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 79 YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred ceEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 889999999 99999999853 4579999999999999999999999999999999999999 788999999999986
Q ss_pred cccccC--------CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 333 EEVYCD--------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 333 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 543321 2235579999999999999999999999999999999999999998743
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=303.91 Aligned_cols=208 Identities=21% Similarity=0.363 Sum_probs=180.0
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--C-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC------eeEEe
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--D-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN------VIKFV 248 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~-~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~ 248 (405)
.++|.+++.||+|+||.||+|.+. + +.||||++.... .....+.+|+.+++.++|++ ++.++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG---------KYREAARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH---------HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc---------cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 478999999999999999999985 3 689999996321 12456778999999997755 99999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE-----------
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI----------- 317 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl----------- 317 (405)
+++...+.+++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccc
Confidence 9999999999999999 7788888887555679999999999999999999999999999999999999
Q ss_pred --------CCCCcEEEEecCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 015556 318 --------DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI 389 (405)
Q Consensus 318 --------~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~ 389 (405)
+.++.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|..||...+..
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccCCCcEEEeecCcccccc--ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 567899999999986533 2334567999999999999999999999999999999999999999998887
Q ss_pred HHHHHHHh
Q 015556 390 QAAFAVVN 397 (405)
Q Consensus 390 e~~~~i~~ 397 (405)
+....+.+
T Consensus 246 ~~~~~~~~ 253 (355)
T 2eu9_A 246 EHLVMMEK 253 (355)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 76655443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=303.03 Aligned_cols=205 Identities=29% Similarity=0.487 Sum_probs=174.3
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEE------CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIY------KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI 245 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 245 (405)
+...+..++|.+++.||+|+||.||++.+ .++.||||++...... ..+.+.+|+.++++++||||+
T Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv 105 (326)
T 2w1i_A 34 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--------HLRDFEREIEILKSLQHDNIV 105 (326)
T ss_dssp ---CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSH--------HHHHHHHHHHHHHTCCCTTBC
T ss_pred CccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHH--------HHHHHHHHHHHHHhCCCCCee
Confidence 34456678899999999999999999985 3689999999753321 146788999999999999999
Q ss_pred EEeeEeecCC--eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcE
Q 015556 246 KFVAACKKPP--VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323 (405)
Q Consensus 246 ~l~g~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~v 323 (405)
++++++.... .+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~ 184 (326)
T 2w1i_A 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 184 (326)
T ss_dssp CEEEEECC----CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEE
T ss_pred eEEEEEEecCCCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcE
Confidence 9999987644 789999999999999999873 3568999999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccC----CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 324 KIADFGIACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 324 kL~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
||+|||++....... ......++..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 185 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 185 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp EECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred EEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 999999986543221 12344578889999999988899999999999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=328.86 Aligned_cols=220 Identities=24% Similarity=0.460 Sum_probs=185.6
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEEC-----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeE
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 246 (405)
..+.+..++|.+++.||+|+||.||+|.+. +..||||.+...... .....+.+|+.++++++||||++
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~HpnIv~ 455 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD-------SVREKFLQEALTMRQFDHPHIVK 455 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH-------HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH-------HHHHHHHHHHHHHHhCCCCCCCe
Confidence 456777889999999999999999999985 246899987643321 12567889999999999999999
Q ss_pred EeeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEE
Q 015556 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA 326 (405)
Q Consensus 247 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~ 326 (405)
+++++.+ +..++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 456 l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~ 533 (656)
T 2j0j_A 456 LIGVITE-NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLG 533 (656)
T ss_dssp EEEEECS-SSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred EEEEEec-CceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEE
Confidence 9999965 5578999999999999999863 3568999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccccC--CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 015556 327 DFGIACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 327 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
|||++....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.++..
T Consensus 534 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~ 610 (656)
T 2j0j_A 534 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 610 (656)
T ss_dssp CCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC
T ss_pred ecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC
Confidence 999986543222 1223457789999999998899999999999999999997 9999999999888887776543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=314.95 Aligned_cols=198 Identities=22% Similarity=0.362 Sum_probs=172.1
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC-CCeeEEeeEeecC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFVAACKKP 254 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~ 254 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++....... ++.+|+.++..|.| ++|..+..++.+.
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----------~~~~E~~il~~L~~~~~i~~i~~~~~~~ 75 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----------QLLYESKIYRILQGGTGIPNVRWFGVEG 75 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----------CHHHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----------HHHHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence 368999999999999999999985 7899999987655432 35689999999987 5666777777888
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---CCCCcEEEEecCCc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLI---DQEFHLKIADFGIA 331 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl---~~~~~vkL~DFG~a 331 (405)
...+|||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||++
T Consensus 76 ~~~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 76 DYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred CEEEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 8999999999 99999999863 4679999999999999999999999999999999999999 68899999999999
Q ss_pred ccccccCC--------CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 332 CEEVYCDA--------LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 332 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
........ .....||..|+|||++.+..++.++|||||||+||||++|..||.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~ 217 (483)
T 3sv0_A 154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (483)
T ss_dssp EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 65433221 225679999999999999999999999999999999999999998754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=305.27 Aligned_cols=202 Identities=26% Similarity=0.453 Sum_probs=172.3
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-----------
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH----------- 240 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~----------- 240 (405)
..+..++|.+++.||+|+||.||+|.+. ++.||||++.... .....+.+|+.++.+++
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~~~~ 84 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---------VYTEAAEDEIKLLQRVNDADNTKEDSMG 84 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---------HHHHHHHHHHHHHHHHHHTCCSHHHHHH
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc---------cchhhhhHHHHHHHHhhcccccchhccc
Confidence 3455688999999999999999999974 7899999996311 12456778999999886
Q ss_pred CCCeeEEeeEeecCC----eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcE
Q 015556 241 NPNVIKFVAACKKPP----VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GVIHRDLKPENV 315 (405)
Q Consensus 241 HpnIv~l~g~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIiHrDIkp~NI 315 (405)
|+||+++++++.... .+++||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+||
T Consensus 85 ~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NI 163 (373)
T 1q8y_A 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV 163 (373)
T ss_dssp HTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGE
T ss_pred cchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHe
Confidence 799999999987654 789999999 88999999987667799999999999999999999998 999999999999
Q ss_pred EEC------CCCcEEEEecCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 316 LID------QEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 316 Ll~------~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
||+ ..+.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|..||...+
T Consensus 164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 164 LMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEeccCCCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 994 445899999999865432 3345679999999999999999999999999999999999999998654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=293.56 Aligned_cols=215 Identities=25% Similarity=0.398 Sum_probs=175.6
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC--CCCeeEEee
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH--NPNVIKFVA 249 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~g 249 (405)
...+..++|.+++.||+|+||.||++.+. ++.||||++........ ....+.+|+.++.+++ |+||+++++
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ------TLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHH------HHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccccc------chHHHHHHHHHHHhccccCCceEEEEE
Confidence 34455678999999999999999999886 68899999986554332 2467889999999997 599999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
++.+...+++||| +.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeecc
Confidence 9999999999999 568899999987 457899999999999999999999999999999999999964 899999999
Q ss_pred CcccccccC---CCCCCCCCCcccCcccccc-----------ccCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHH
Q 015556 330 IACEEVYCD---ALSDDPGTYRWMAPEMIKH-----------KSYGRKVDVYSFGLILWEMVAGTIPYEEMN-PIQAAFA 394 (405)
Q Consensus 330 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DVwSlGvll~elltG~~Pf~~~~-~~e~~~~ 394 (405)
++....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.... .......
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 251 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHH
Confidence 986543221 1234569999999999865 468899999999999999999999998753 4444444
Q ss_pred HHh
Q 015556 395 VVN 397 (405)
Q Consensus 395 i~~ 397 (405)
++.
T Consensus 252 ~~~ 254 (313)
T 3cek_A 252 IID 254 (313)
T ss_dssp HHC
T ss_pred HHh
Confidence 443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=303.34 Aligned_cols=200 Identities=22% Similarity=0.373 Sum_probs=146.2
Q ss_pred CCCeeecc-eeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec-
Q 015556 178 LSQLFLGL-RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK- 253 (405)
Q Consensus 178 ~~~~~~~~-~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~- 253 (405)
.++|.+.+ .||+|+||.||+|.+. ++.||||++.... .........+..+.||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 94 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------------KARQEVDHHWQASGGPHIVCILDVYENM 94 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------------HHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------------HHHHHHHHHHHhcCCCChHHHHHHHhhc
Confidence 36777754 6999999999999997 7899999996421 111123334566799999999999876
Q ss_pred ---CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC---CCcEEEEe
Q 015556 254 ---PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ---EFHLKIAD 327 (405)
Q Consensus 254 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~---~~~vkL~D 327 (405)
...+++||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEec
Confidence 456899999999999999998765567999999999999999999999999999999999999976 45699999
Q ss_pred cCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 015556 328 FGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390 (405)
Q Consensus 328 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e 390 (405)
||++..... .......||+.|+|||++.+..++.++||||||+++|+|++|..||......+
T Consensus 175 fg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 236 (336)
T 3fhr_A 175 FGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA 236 (336)
T ss_dssp CTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cccceeccc-cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchh
Confidence 999865433 23345678999999999988889999999999999999999999997765443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=293.34 Aligned_cols=195 Identities=31% Similarity=0.485 Sum_probs=161.9
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec---
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK--- 253 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--- 253 (405)
++|.+++.||+|+||.||+|.+. ++.||||++.... .....+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 76 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE---------EKLSTILSEVMLLASLNHQYVVRYYAAWLERRN 76 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH---------HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH---------HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence 56889999999999999999985 7899999996311 124678899999999999999999998865
Q ss_pred ----------CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcE
Q 015556 254 ----------PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHL 323 (405)
Q Consensus 254 ----------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~v 323 (405)
....++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~ 155 (303)
T 1zy4_A 77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNV 155 (303)
T ss_dssp CCC------CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCE
T ss_pred hhhhhcccccCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCE
Confidence 3568999999999999999986 34567888999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccc---------------cCCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 324 KIADFGIACEEVY---------------CDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 324 kL~DFG~a~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
||+|||++..... ........||..|+|||++.+. .++.++|||||||++|+|++ ||...
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~ 231 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence 9999999864321 1223345689999999999765 68999999999999999998 66543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=296.41 Aligned_cols=203 Identities=28% Similarity=0.399 Sum_probs=166.3
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc----CCCCeeEEeeEee
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL----HNPNVIKFVAACK 252 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l----~HpnIv~l~g~~~ 252 (405)
++|.+++.||+|+||.||+|.+. ++.||||++........... .....+.+|+.++.++ +|+||+++++++.
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPL--SDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC----------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccc--hhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 67889999999999999999884 68999999976543322111 1134566899999999 8999999999999
Q ss_pred cCCeeEEEEee-cCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEC-CCCcEEEEecCC
Q 015556 253 KPPVYCVITEY-LSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIADFGI 330 (405)
Q Consensus 253 ~~~~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~-~~~~vkL~DFG~ 330 (405)
+....++|||| +.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred cCCeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 99999999999 789999999987 35689999999999999999999999999999999999998 889999999999
Q ss_pred cccccccCCCCCCCCCCcccCccccccccC-CchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
+..... .......|+..|+|||++.+..+ +.++||||||+++|+|++|+.||...
T Consensus 187 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 187 GALLHD-EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp CEECCS-SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred hhhccc-CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 865443 33455679999999999977666 45899999999999999999999763
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=298.66 Aligned_cols=209 Identities=29% Similarity=0.437 Sum_probs=174.7
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC--CCCeeEEe
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH--NPNVIKFV 248 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~ 248 (405)
+...-.++|.+++.||+|+||.||+|.+. ++.||||++........... .....+.+|+.++++++ |+||++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--PNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEEC--TTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhh--hhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 33444678999999999999999999985 68999999976543221000 00234568999999996 59999999
Q ss_pred eEeecCCeeEEEEeecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEC-CCCcEEEE
Q 015556 249 AACKKPPVYCVITEYLSE-GSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID-QEFHLKIA 326 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~-~~~~vkL~ 326 (405)
+++.+...+++|||++.+ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence 999999999999999976 899999987 36789999999999999999999999999999999999998 78999999
Q ss_pred ecCCcccccccCCCCCCCCCCcccCccccccccC-CchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 327 DFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 327 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
|||++..... .......||+.|+|||++.+..+ +.++||||||+++|||++|..||...
T Consensus 193 Dfg~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 193 DFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp CCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred eCcccccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 9999865433 33445679999999999977666 68899999999999999999999764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=311.62 Aligned_cols=203 Identities=17% Similarity=0.174 Sum_probs=164.2
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC---------CCCee
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---------NPNVI 245 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~---------HpnIv 245 (405)
.+..++|.+++.||+|+||.||+|+++++.||||++................+.+.+|+.+|+.++ |||||
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 16 CLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp HSCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred hcccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 345678899999999999999999999999999999865432100000001356778888888886 77777
Q ss_pred EEeeEe-----------------ec-------------CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHH
Q 015556 246 KFVAAC-----------------KK-------------PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIAR 295 (405)
Q Consensus 246 ~l~g~~-----------------~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~ 295 (405)
++++.+ .+ ...+|+||||+++|++.+.+.+ ..+++..++.++.||+.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTA 172 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHH
Confidence 776653 22 6789999999999977666643 57899999999999999
Q ss_pred HHHHHH-HCCceecCCCCCcEEECCCC--------------------cEEEEecCCcccccccCCCCCCCCCCcccCccc
Q 015556 296 GMEYIH-SQGVIHRDLKPENVLIDQEF--------------------HLKIADFGIACEEVYCDALSDDPGTYRWMAPEM 354 (405)
Q Consensus 296 aL~yLH-~~gIiHrDIkp~NILl~~~~--------------------~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~ 354 (405)
||.||| ++||+||||||+||||+.++ .+||+|||+|..... ....||+.|+|||+
T Consensus 173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGG
T ss_pred HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhh
Confidence 999999 99999999999999999887 999999999975443 23469999999999
Q ss_pred cccccCCchhhHHHHHHH-HHHHHhCCCCCCC
Q 015556 355 IKHKSYGRKVDVYSFGLI-LWEMVAGTIPYEE 385 (405)
Q Consensus 355 ~~~~~~~~k~DVwSlGvl-l~elltG~~Pf~~ 385 (405)
+.+.. +.++||||||++ .+++++|..||.+
T Consensus 249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred hcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 98766 899999998776 7788889999965
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=305.89 Aligned_cols=202 Identities=28% Similarity=0.450 Sum_probs=161.6
Q ss_pred cccCCCeeecceeeeeeeEE-EEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEee
Q 015556 175 TVDLSQLFLGLRFAHGAHSR-LYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACK 252 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~-Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~ 252 (405)
.+...+|.+.+.||+|+||+ ||++...++.||||++...... .+.+|+.+|+.+ +|||||++++++.
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----------~~~~E~~~l~~l~~HpnIv~l~~~~~ 88 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----------FADREVQLLRESDEHPNVIRYFCTEK 88 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----------ECHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----------HHHHHHHHHHhccCCCCcCeEEEEEe
Confidence 34445688899999999998 5666667899999999643322 234899999999 7999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC-----CCcEEEEe
Q 015556 253 KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-----EFHLKIAD 327 (405)
Q Consensus 253 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~-----~~~vkL~D 327 (405)
+....|+|||||. |+|.+++.... ..+.+..++.++.||+.||.|||++||+||||||+||||+. ...+||+|
T Consensus 89 ~~~~~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~D 166 (432)
T 3p23_A 89 DRQFQYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISD 166 (432)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred cCCEEEEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEec
Confidence 9999999999995 69999998633 34455567889999999999999999999999999999943 33688999
Q ss_pred cCCccccccc----CCCCCCCCCCcccCccccc---cccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 015556 328 FGIACEEVYC----DALSDDPGTYRWMAPEMIK---HKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPI 389 (405)
Q Consensus 328 FG~a~~~~~~----~~~~~~~gt~~y~aPE~~~---~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~ 389 (405)
||++...... .......||+.|+|||++. ...++.++|||||||++|||++ |..||......
T Consensus 167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~ 236 (432)
T 3p23_A 167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR 236 (432)
T ss_dssp TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH
T ss_pred ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH
Confidence 9998654322 2234567999999999997 4567889999999999999999 99999765443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=305.27 Aligned_cols=197 Identities=25% Similarity=0.435 Sum_probs=154.8
Q ss_pred eeecceeeeeeeEEEEE-EEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecCCeeE
Q 015556 181 LFLGLRFAHGAHSRLYH-GIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYC 258 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~-~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~ 258 (405)
|.+.+.||+|+||+||. +...|+.||||++.... ...+.+|+.+|.++ +||||+++++++.+...+|
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 85 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY 85 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence 44567899999999965 44568999999997421 23567899999987 8999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHhcCCC-----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC-------------
Q 015556 259 VITEYLSEGSLRAYLHKLEHKT-----LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE------------- 320 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~-----l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~------------- 320 (405)
+|||||. |+|.+++....... .++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCc
Confidence 9999995 69999998632211 1233457899999999999999999999999999999654
Q ss_pred CcEEEEecCCcccccccC-----CCCCCCCCCcccCcccccc-------ccCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 015556 321 FHLKIADFGIACEEVYCD-----ALSDDPGTYRWMAPEMIKH-------KSYGRKVDVYSFGLILWEMVA-GTIPYEEMN 387 (405)
Q Consensus 321 ~~vkL~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~-------~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~ 387 (405)
+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+..
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 489999999986543321 1234579999999999965 568999999999999999999 999998754
Q ss_pred HH
Q 015556 388 PI 389 (405)
Q Consensus 388 ~~ 389 (405)
..
T Consensus 245 ~~ 246 (434)
T 2rio_A 245 SR 246 (434)
T ss_dssp TH
T ss_pred hh
Confidence 43
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.45 Aligned_cols=205 Identities=27% Similarity=0.427 Sum_probs=176.2
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec--
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK-- 253 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-- 253 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++...... .....+.+|+.++++++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~-------~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~ 85 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP-------KNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ 85 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCH-------HHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCH-------HHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence 368899999999999999999974 789999998754321 125678899999999999999999999865
Q ss_pred ----CCeeEEEEeecCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCc---EEE
Q 015556 254 ----PPVYCVITEYLSEGSLRAYLHKLE-HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFH---LKI 325 (405)
Q Consensus 254 ----~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~---vkL 325 (405)
....++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||
T Consensus 86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL 165 (676)
T 3qa8_A 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKI 165 (676)
T ss_dssp CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEE
Confidence 677899999999999999998743 236889999999999999999999999999999999999987664 999
Q ss_pred EecCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 015556 326 ADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPI 389 (405)
Q Consensus 326 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~ 389 (405)
+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 166 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~ 229 (676)
T 3qa8_A 166 IDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 229 (676)
T ss_dssp CSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH
T ss_pred cccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch
Confidence 9999997765555556678999999999999999999999999999999999999999875543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=320.58 Aligned_cols=195 Identities=24% Similarity=0.369 Sum_probs=166.1
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC---CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK---DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~---~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
.+-.++|.+++.||+|+||.||+|.+. ++.||||++......+ ....+.+|+.++.+++||||++++++|
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~hp~iv~~~~~~ 148 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAE-------AQAMAMAERQFLAEVVHPSIVQIFNFV 148 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHH-------HHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHH-------HHHHHHHHHHHHHhcCCCCcCeEeeeE
Confidence 344578999999999999999999984 6899999886533211 246788999999999999999999999
Q ss_pred ecCCe-----eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEE
Q 015556 252 KKPPV-----YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA 326 (405)
Q Consensus 252 ~~~~~-----~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~ 326 (405)
.+... .||||||+++++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+
T Consensus 149 ~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~ 223 (681)
T 2pzi_A 149 EHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLI 223 (681)
T ss_dssp EEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEEC
T ss_pred eecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEE
Confidence 87655 7999999999999987753 79999999999999999999999999999999999999885 89999
Q ss_pred ecCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCC
Q 015556 327 DFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEE 385 (405)
Q Consensus 327 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~ 385 (405)
|||++...... ....||+.|+|||++.+. ++.++|||||||+||+|++|..||.+
T Consensus 224 DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 224 DLGAVSRINSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp CCTTCEETTCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred ecccchhcccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcc
Confidence 99998654332 456799999999998755 48999999999999999999998864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=281.79 Aligned_cols=176 Identities=16% Similarity=0.180 Sum_probs=154.0
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.++|.+++.||+|+||.||+|.+. ++.||||++......... ....+.+|+.++.+++||||+++++++.+.+
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 104 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDD-----VLQETLSRTLRLSRIDKPGVARVLDVVHTRA 104 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHH-----HHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHH-----HHHHHHHHHHHHhcCCCCCcceeeEEEEECC
Confidence 367889999999999999999997 789999999865544322 2567889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
..|+||||++|++|.+++.. + .....+..++.||+.||.|||++||+||||||+|||++.++.+||++++.
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~----- 175 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT----- 175 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC-----
T ss_pred cEEEEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc-----
Confidence 99999999999999999954 2 35567889999999999999999999999999999999999999985543
Q ss_pred ccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 015556 336 YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP 388 (405)
Q Consensus 336 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~ 388 (405)
++ .++.++|||||||++|||++|+.||.+.+.
T Consensus 176 --------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 176 --------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp --------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred --------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 23 378999999999999999999999987543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=277.80 Aligned_cols=178 Identities=24% Similarity=0.429 Sum_probs=151.4
Q ss_pred CCeeec-ceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHH-HhcCCCCeeEEeeEeec-
Q 015556 179 SQLFLG-LRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALL-SRLHNPNVIKFVAACKK- 253 (405)
Q Consensus 179 ~~~~~~-~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~g~~~~- 253 (405)
++|.+. +.||+|+||.||++.+. ++.||||++.. ...+.+|+.++ +.++||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------------CPKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------------cHHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 456665 77999999999999985 68999999963 13455888888 55689999999999876
Q ss_pred ---CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC---CCcEEEEe
Q 015556 254 ---PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ---EFHLKIAD 327 (405)
Q Consensus 254 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~---~~~vkL~D 327 (405)
...+++||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 678899999999999999999865567999999999999999999999999999999999999988 78999999
Q ss_pred cCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 015556 328 FGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQ 390 (405)
Q Consensus 328 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e 390 (405)
||++... .+..++.++|||||||++|+|++|..||.+....+
T Consensus 164 fg~a~~~---------------------~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 205 (299)
T 3m2w_A 164 FGFAKET---------------------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 205 (299)
T ss_dssp CTTCEEC---------------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----
T ss_pred ccccccc---------------------ccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh
Confidence 9988432 12557889999999999999999999997765433
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=297.18 Aligned_cols=206 Identities=17% Similarity=0.233 Sum_probs=159.5
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC-CCee------
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVI------ 245 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv------ 245 (405)
......|.+++.||+|+||.||+|.+. ++.||||++........ ...+.|.+|+.++..+.| .|..
T Consensus 74 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~-----~~~~~~~~E~~~~~~l~~~~~~~~~~~~~ 148 (413)
T 3dzo_A 74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS-----NAIKQMKEEVLRLRLLRGIKNQKQAKVHL 148 (413)
T ss_dssp SSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC---------CCHHHHHHHHGGGGSTTCCSHHHHHHHT
T ss_pred CCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccH-----HHHHHHHHHHHHHHhhccCCCHHHHHHhc
Confidence 334456889999999999999999987 79999999884443322 124668899999999987 2211
Q ss_pred ---------E------EeeEeec-----CCeeEEEEeecCCCCHHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHH
Q 015556 246 ---------K------FVAACKK-----PPVYCVITEYLSEGSLRAYLHKL-----EHKTLPLPKLIAIALDIARGMEYI 300 (405)
Q Consensus 246 ---------~------l~g~~~~-----~~~~~lV~E~~~~gsL~~~l~~~-----~~~~l~~~~~~~i~~qi~~aL~yL 300 (405)
. +..++.. ...++++|+++ +++|.+++... ....+++..++.++.||+.||.||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 227 (413)
T 3dzo_A 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 227 (413)
T ss_dssp CBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 1 1111111 22466777765 68999998632 234577889999999999999999
Q ss_pred HHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCCCCCCCCCCcccCcccc----------ccccCCchhhHHHHH
Q 015556 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI----------KHKSYGRKVDVYSFG 370 (405)
Q Consensus 301 H~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~k~DVwSlG 370 (405)
|++||+||||||+||||+.++.+||+|||++...... ....+| +.|+|||++ ....++.++||||||
T Consensus 228 H~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 228 HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp HHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred HhCCcccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 9999999999999999999999999999998654332 445567 999999999 566688999999999
Q ss_pred HHHHHHHhCCCCCCCCCHH
Q 015556 371 LILWEMVAGTIPYEEMNPI 389 (405)
Q Consensus 371 vll~elltG~~Pf~~~~~~ 389 (405)
|++|||++|+.||...+..
T Consensus 305 vil~elltg~~Pf~~~~~~ 323 (413)
T 3dzo_A 305 LAIYWIWCADLPNTDDAAL 323 (413)
T ss_dssp HHHHHHHHSSCCCCTTGGG
T ss_pred HHHHHHHHCCCCCCCcchh
Confidence 9999999999999876543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-33 Score=292.87 Aligned_cols=190 Identities=15% Similarity=0.142 Sum_probs=132.5
Q ss_pred eeeeeeeEEEEEEE--ECCccEEEEEEecCCCC--hhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeecCCeeEEE
Q 015556 186 RFAHGAHSRLYHGI--YKDEPVAVKIIRIPDDD--ENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVI 260 (405)
Q Consensus 186 ~lG~G~~g~Vy~~~--~~~~~vAVK~~~~~~~~--~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 260 (405)
..+.|+.|.+..++ +.|+.||||++...... ..........++|.+|+++|+++ .|+||+++++++++++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 34566666555443 34899999999764321 12233344567899999999999 699999999999999999999
Q ss_pred EeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc-cCC
Q 015556 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDA 339 (405)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~-~~~ 339 (405)
|||++|++|.++|.. .+.+++. .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|..... ...
T Consensus 321 MEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC
T ss_pred EecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc
Confidence 999999999999986 4567654 4889999999999999999999999999999999999999999864332 223
Q ss_pred CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCC
Q 015556 340 LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI 381 (405)
Q Consensus 340 ~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~ 381 (405)
....+||+.|||||++.+ .+...+|+|++|+++++|+++..
T Consensus 396 ~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp SHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 334569999999999975 46778999999999887755533
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-30 Score=269.30 Aligned_cols=190 Identities=18% Similarity=0.154 Sum_probs=151.5
Q ss_pred ecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEEe
Q 015556 183 LGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITE 262 (405)
Q Consensus 183 ~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 262 (405)
..+.||+|+||.||+|...++.+++|..................+++.+|+.+|++++||||+++..++......|||||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 35689999999999998889999999987644333322223346779999999999999999966666667777799999
Q ss_pred ecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCC---
Q 015556 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA--- 339 (405)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~--- 339 (405)
|+++++|.+++.. ++.++.|++.||.|||++||+||||||+|||++. .+||+|||++........
T Consensus 420 ~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 420 YINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp CCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred CCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 9999999999865 5679999999999999999999999999999998 999999999965433211
Q ss_pred -----CCCCCCCCcccCcccccc--ccCCchhhHHHHHHHHHHHHhCCCCCC
Q 015556 340 -----LSDDPGTYRWMAPEMIKH--KSYGRKVDVYSFGLILWEMVAGTIPYE 384 (405)
Q Consensus 340 -----~~~~~gt~~y~aPE~~~~--~~~~~k~DVwSlGvll~elltG~~Pf~ 384 (405)
.....||+.|||||++.. ..|+..+|+|+..+-..+.+.++-+|.
T Consensus 488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 124469999999999977 668888999999999999888888775
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.7e-26 Score=216.23 Aligned_cols=152 Identities=16% Similarity=0.154 Sum_probs=117.4
Q ss_pred CCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChh-----H-----HHHHHHHHHHHHHHHHHHhcCCCCeeEE
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDEN-----E-----TLAARLEKQFNREVALLSRLHNPNVIKF 247 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~-----~-----~~~~~~~~~~~~Ei~il~~l~HpnIv~l 247 (405)
..|.+++.||+|+||.||+|.+. ++.||||+++....... . .........+.+|+.+|++++ | +++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 34557799999999999999995 78999999964322110 0 000123567889999999999 5 666
Q ss_pred eeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEe
Q 015556 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327 (405)
Q Consensus 248 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~D 327 (405)
++++.. +..|+||||++|++|.+ +. ......++.|++.||.|||++||+||||||+|||++ ++.+||+|
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~--------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VR--------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CC--------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cc--------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 665544 45689999999999987 31 123457999999999999999999999999999999 99999999
Q ss_pred cCCcccccccCCCCCCCCCCcccCccccc
Q 015556 328 FGIACEEVYCDALSDDPGTYRWMAPEMIK 356 (405)
Q Consensus 328 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~ 356 (405)
||++. .+..++|||++.
T Consensus 236 FG~a~------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSV------------EVGEEGWREILE 252 (282)
T ss_dssp CTTCE------------ETTSTTHHHHHH
T ss_pred CCCCe------------ECCCCCHHHHHH
Confidence 99984 234578999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.7e-21 Score=181.75 Aligned_cols=142 Identities=18% Similarity=0.234 Sum_probs=107.1
Q ss_pred eeecceeeeeeeEEEEEEEE--CCcc--EEEEEEecCCCChhH----------------HHHHHHHHHHHHHHHHHHhcC
Q 015556 181 LFLGLRFAHGAHSRLYHGIY--KDEP--VAVKIIRIPDDDENE----------------TLAARLEKQFNREVALLSRLH 240 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~--~~~~--vAVK~~~~~~~~~~~----------------~~~~~~~~~~~~Ei~il~~l~ 240 (405)
|.+++.||+|+||.||+|.+ .|+. ||||+++........ .........+.+|+.+|.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56889999999999999998 6888 999998654211000 001122346889999999998
Q ss_pred CCCe--eEEeeEeecCCeeEEEEeecCC-C----CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCC
Q 015556 241 NPNV--IKFVAACKKPPVYCVITEYLSE-G----SLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH-SQGVIHRDLKP 312 (405)
Q Consensus 241 HpnI--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~gIiHrDIkp 312 (405)
|+++ ..++++ ...+|||||+.+ | .|.++... .++..+..++.|++.+|.||| ++||+||||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 8754 344432 245899999942 3 77776533 234567889999999999999 99999999999
Q ss_pred CcEEECCCCcEEEEecCCccc
Q 015556 313 ENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 313 ~NILl~~~~~vkL~DFG~a~~ 333 (405)
+|||++. .++|+|||+|..
T Consensus 200 ~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp TSEEESS--SEEECCCTTCEE
T ss_pred HHEEEcC--cEEEEECccccc
Confidence 9999988 999999999853
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.3e-18 Score=171.85 Aligned_cols=140 Identities=17% Similarity=0.180 Sum_probs=100.8
Q ss_pred eeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCC--------------hhHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDD--------------ENETLAARLEKQFNREVALLSRLHNPNVI 245 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~--------------~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 245 (405)
|.+++.||.|++|.||+|... |+.||||+++..... .........+....+|...|.+|.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 789999999999999999975 789999998642110 00011111122234678888888655442
Q ss_pred --EEeeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCC--
Q 015556 246 --KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-- 321 (405)
Q Consensus 246 --~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~-- 321 (405)
..+++. ..+|||||++|+.|.++. .......++.||+.+|.|||++|||||||||.|||+++++
T Consensus 177 vp~p~~~~----~~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 177 VPEPIAQS----RHTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CCCEEEEE----TTEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCeeeecc----CceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 233222 236999999988875432 1123467889999999999999999999999999998776
Q ss_pred --------cEEEEecCCcc
Q 015556 322 --------HLKIADFGIAC 332 (405)
Q Consensus 322 --------~vkL~DFG~a~ 332 (405)
.+.|+||+.+.
T Consensus 245 ~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp SCTTSEEEEEEECCCTTCE
T ss_pred ccccccccceEEEEeCCcc
Confidence 38999999873
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=2.1e-13 Score=127.30 Aligned_cols=139 Identities=13% Similarity=0.037 Sum_probs=109.5
Q ss_pred CCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeecCCee
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPVY 257 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~ 257 (405)
..|.+...++.|+.+.||+....++.++||+........ ...+.+|+.++..|. +..+.++++++.+.+..
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--------TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--------TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--------HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 346666777888889999998878999999987421111 124668999999995 67788899999988999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS----------------------------------- 302 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~----------------------------------- 302 (405)
|+||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 86 ~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 99999999999987531 112334678899999999998
Q ss_pred ------------------------CCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 303 ------------------------QGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 303 ------------------------~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
..++|+|+++.|||++++..+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876666799999763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.25 E-value=1.2e-11 Score=114.47 Aligned_cols=124 Identities=15% Similarity=0.085 Sum_probs=92.1
Q ss_pred eeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC--eeEEeeEeecCCeeEEEEeec
Q 015556 188 AHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN--VIKFVAACKKPPVYCVITEYL 264 (405)
Q Consensus 188 G~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~~~~~~~~~lV~E~~ 264 (405)
+.|..+.||++... |+.++||+..... ...+.+|+.+++.+.+.+ +.++++++..++..++||||+
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA-----------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT-----------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc-----------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 45566999998765 5789999976431 123568999999986544 556888888888889999999
Q ss_pred CCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC----------------------------------------
Q 015556 265 SEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG---------------------------------------- 304 (405)
Q Consensus 265 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---------------------------------------- 304 (405)
+|.+|. .. ..+ ...++.+++..|..||+..
T Consensus 98 ~G~~l~--~~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 98 PGQDLL--SS-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp SSEETT--TS-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred CCcccC--cC-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 998873 11 111 2245667777777777643
Q ss_pred ------------------ceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 305 ------------------VIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 305 ------------------IiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
++|+|++|.|||+++++.+.|+||+.+.
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999873
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.2e-11 Score=120.81 Aligned_cols=138 Identities=16% Similarity=0.221 Sum_probs=105.2
Q ss_pred cceeeeeeeEEEEEEEECCccEEEEEEe--cCCCChhHHHHHHHHHHHHHHHHHHHhcCC--CCeeEEeeEeecC---Ce
Q 015556 184 GLRFAHGAHSRLYHGIYKDEPVAVKIIR--IPDDDENETLAARLEKQFNREVALLSRLHN--PNVIKFVAACKKP---PV 256 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~~~~vAVK~~~--~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~---~~ 256 (405)
.+.|+.|.++.||+....+..++||+.. ...... ....+.+|+.+++.|.. ..+.+++.++.+. +.
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~-------~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLP-------SAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC-----------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCC-------cHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 4567999999999998888889999875 211100 12467789999999974 5578899988876 45
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS---------------------------------- 302 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---------------------------------- 302 (405)
.++||||++|..+.+. .-..++......++.+++..|..||+
T Consensus 116 ~~~vme~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp CEEEEECCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred eEEEEEecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 8899999998776431 12346778888899999999999997
Q ss_pred ------------------------CCceecCCCCCcEEECCCCc--EEEEecCCcc
Q 015556 303 ------------------------QGVIHRDLKPENVLIDQEFH--LKIADFGIAC 332 (405)
Q Consensus 303 ------------------------~gIiHrDIkp~NILl~~~~~--vkL~DFG~a~ 332 (405)
..++|+|+++.|||++.++. +.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 35899999999999987653 6999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.15 E-value=8.2e-11 Score=112.35 Aligned_cols=182 Identities=20% Similarity=0.206 Sum_probs=119.9
Q ss_pred ceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCC--eeEEeeEeecCC---eeE
Q 015556 185 LRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPN--VIKFVAACKKPP---VYC 258 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-Hpn--Iv~l~g~~~~~~---~~~ 258 (405)
+.++.|....||+. ++.++||+.... .....+.+|..+|..+. +.. +.+++..+.... ..|
T Consensus 26 ~~~~~G~~n~v~~v---~~~~vlR~~~~~----------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~ 92 (304)
T 3sg8_A 26 EISGEGNDCIAYEI---NRDFIFKFPKHS----------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSF 92 (304)
T ss_dssp CEEEECSSEEEEES---TTSEEEEEESSH----------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSC
T ss_pred EecCCCCcceEEEE---CCEEEEEecCCc----------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcce
Confidence 45799999999986 367999986521 12456889999999884 322 345555544333 457
Q ss_pred EEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 015556 259 VITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS------------------------------------ 302 (405)
Q Consensus 259 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~------------------------------------ 302 (405)
+||++++|..|.+... ..++......++.+++..|..||+
T Consensus 93 ~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (304)
T 3sg8_A 93 AGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP 168 (304)
T ss_dssp EEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred EEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence 8999999988765433 246677777888888888888886
Q ss_pred ----------------------CCceecCCCCCcEEECC--CCcEEEEecCCcccccccCCCCCCCCCCcccCcccccc-
Q 015556 303 ----------------------QGVIHRDLKPENVLIDQ--EFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKH- 357 (405)
Q Consensus 303 ----------------------~gIiHrDIkp~NILl~~--~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~- 357 (405)
..++|+|+++.|||+++ ...+.|+||+.+.................-..|+....
T Consensus 169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHH
T ss_pred cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHH
Confidence 13699999999999988 56689999998754321110000000000022222110
Q ss_pred ---cc----------CCchhhHHHHHHHHHHHHhCCCCC
Q 015556 358 ---KS----------YGRKVDVYSFGLILWEMVAGTIPY 383 (405)
Q Consensus 358 ---~~----------~~~k~DVwSlGvll~elltG~~Pf 383 (405)
-. .....+.|+++.++|.+.+|..+|
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00 112368999999999999998876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.72 E-value=2e-07 Score=89.04 Aligned_cols=132 Identities=21% Similarity=0.186 Sum_probs=90.2
Q ss_pred ceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCC---CeeEEeeEee-cCCeeEEE
Q 015556 185 LRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP---NVIKFVAACK-KPPVYCVI 260 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~g~~~-~~~~~~lV 260 (405)
..++.|....||+. ++.++||+... . .....+.+|..+|..|.+. .|.+.+.++. ..+..++|
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~~----~------~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v 91 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPKS----Q------QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVG 91 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEESS----H------HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEE
T ss_pred eecCCCcceeEEEE---CCEEEEEecCC----c------hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEE
Confidence 45688888999987 78899998531 1 1245788999999999752 2456666664 45567899
Q ss_pred EeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-------------------------------------
Q 015556 261 TEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ------------------------------------- 303 (405)
Q Consensus 261 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~------------------------------------- 303 (405)
|||++|..|.+... ..++......++.++...|..||+.
T Consensus 92 ~e~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~ 167 (306)
T 3tdw_A 92 YRKVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES 167 (306)
T ss_dssp EECCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred EeccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence 99999987765321 1233344444444444444444432
Q ss_pred -----------------------CceecCCCCCcEEECC---CCc-EEEEecCCccc
Q 015556 304 -----------------------GVIHRDLKPENVLIDQ---EFH-LKIADFGIACE 333 (405)
Q Consensus 304 -----------------------gIiHrDIkp~NILl~~---~~~-vkL~DFG~a~~ 333 (405)
.++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999987 455 58999998743
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=3.2e-07 Score=85.29 Aligned_cols=129 Identities=16% Similarity=0.104 Sum_probs=91.3
Q ss_pred eeeeeeE-EEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeecCCeeEEEEe
Q 015556 187 FAHGAHS-RLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPVYCVITE 262 (405)
Q Consensus 187 lG~G~~g-~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E 262 (405)
+..|..+ .||+.... +..++||+-... ....+.+|..+|+.|. +--|.++++++.+++..++|||
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme 100 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT 100 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH-----------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence 3445554 68887654 468999987521 1345778999999885 3336678888998899999999
Q ss_pred ecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------
Q 015556 263 YLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ--------------------------------------- 303 (405)
Q Consensus 263 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------------------------------------- 303 (405)
+++|.++.+..... ......++.+++..|..||..
T Consensus 101 ~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW 174 (272)
T ss_dssp CCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred eeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence 99998887765431 112233455555555555531
Q ss_pred -------------------CceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 304 -------------------GVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 304 -------------------gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
.++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 16899999999999988777899999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=5.4e-07 Score=87.44 Aligned_cols=79 Identities=6% Similarity=0.008 Sum_probs=52.8
Q ss_pred ccee-eeeeeEEEEEEEEC--------CccEEEEEEecCCC--ChhHHHHHHHHHHHHHHHHHHHhcC-C--CCeeEEee
Q 015556 184 GLRF-AHGAHSRLYHGIYK--------DEPVAVKIIRIPDD--DENETLAARLEKQFNREVALLSRLH-N--PNVIKFVA 249 (405)
Q Consensus 184 ~~~l-G~G~~g~Vy~~~~~--------~~~vAVK~~~~~~~--~~~~~~~~~~~~~~~~Ei~il~~l~-H--pnIv~l~g 249 (405)
.+.| +.|....+|+.... ++.+++|+...... ... ...+.+|+.++..|. + -.+.++++
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~-------~~~~~~E~~~l~~L~~~~~vpvP~v~~ 97 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP-------TYRLDHQFEVIRLVGELTDVPVPRVRW 97 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS-------CCCHHHHHHHHHHHHHHCCSCCCCEEE
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc-------hhHHHHHHHHHHHHhhcCCCCCCcEEE
Confidence 3567 78889999988765 67899997643210 000 023457888888874 2 34667888
Q ss_pred EeecC---CeeEEEEeecCCCCH
Q 015556 250 ACKKP---PVYCVITEYLSEGSL 269 (405)
Q Consensus 250 ~~~~~---~~~~lV~E~~~~gsL 269 (405)
++.+. +..++||||++|..+
T Consensus 98 ~~~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 98 IETTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp EECSSTTTSSCEEEEECCCCBCC
T ss_pred EccCCCccCCceEEEEecCCCCh
Confidence 77665 456899999987553
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.26 E-value=7.9e-06 Score=78.12 Aligned_cols=135 Identities=15% Similarity=0.162 Sum_probs=77.6
Q ss_pred eeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-----CCCeeEEe-e--EeecCCee
Q 015556 186 RFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-----NPNVIKFV-A--ACKKPPVY 257 (405)
Q Consensus 186 ~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~-g--~~~~~~~~ 257 (405)
.|+.|..+.||+....+..++||+.... . ..+..|+.++..|. .|.++... | +....+..
T Consensus 39 ~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~ 106 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSGAVCLKRIHRP---E---------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFL 106 (346)
T ss_dssp ECC----CEEEEEEETTEEEEEEEECSC---H---------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEE
T ss_pred eccccccCcEEEEEeCCCCEEEEecCCC---H---------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEE
Confidence 4566778899999887777999998741 1 12224455555443 24444311 1 12345678
Q ss_pred EEEEeecCCCCHH--------------HHHHHhcC-C--C---------CCHHH--------------------------
Q 015556 258 CVITEYLSEGSLR--------------AYLHKLEH-K--T---------LPLPK-------------------------- 285 (405)
Q Consensus 258 ~lV~E~~~~gsL~--------------~~l~~~~~-~--~---------l~~~~-------------------------- 285 (405)
++||+|++|..+. ..++.... . . ..|..
T Consensus 107 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 186 (346)
T 2q83_A 107 FVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQ 186 (346)
T ss_dssp EEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHH
T ss_pred EEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHH
Confidence 8999999885431 11222111 0 0 11211
Q ss_pred -----HHHHHHHHHHHHHHHHH-------------CCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 286 -----LIAIALDIARGMEYIHS-------------QGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 286 -----~~~i~~qi~~aL~yLH~-------------~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
+..+...+..++.+|++ ..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 187 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 187 LYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 01111223445666653 479999999999999888899999999873
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=6.1e-06 Score=81.31 Aligned_cols=80 Identities=15% Similarity=0.073 Sum_probs=47.4
Q ss_pred cceeeeeeeEEEEEEEE--CCccEEEEEEecCCC-ChhHHHHHHHHHHHHHHHHHHHhcCC--CC-eeEEeeEeecCCee
Q 015556 184 GLRFAHGAHSRLYHGIY--KDEPVAVKIIRIPDD-DENETLAARLEKQFNREVALLSRLHN--PN-VIKFVAACKKPPVY 257 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~--~~~~vAVK~~~~~~~-~~~~~~~~~~~~~~~~Ei~il~~l~H--pn-Iv~l~g~~~~~~~~ 257 (405)
.+.||.|..+.||++.. .++.|+||....... ... . .......+..|.++|..+.. +. +.+++.+. ....
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~-~-~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGE-S-WPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC---------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCC-C-CcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCcc
Confidence 35689999999999964 468899998653211 000 0 00002345678888887742 33 34555443 3445
Q ss_pred EEEEeecCCC
Q 015556 258 CVITEYLSEG 267 (405)
Q Consensus 258 ~lV~E~~~~g 267 (405)
++||||+++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 7999999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.91 E-value=3.5e-05 Score=73.82 Aligned_cols=74 Identities=18% Similarity=0.100 Sum_probs=59.3
Q ss_pred cceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC---CCCeeEEeeEeecCCeeEEE
Q 015556 184 GLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH---NPNVIKFVAACKKPPVYCVI 260 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV 260 (405)
.+.|+.|....+|+....+..++||+..... ...+..|...|+.|. ...+.++++++...+..++|
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~-----------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lv 109 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERSY-----------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLL 109 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGGG-----------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEE
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCccc-----------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEE
Confidence 3568999999999998778899999876311 346778999888884 35677888888888889999
Q ss_pred EeecCCCC
Q 015556 261 TEYLSEGS 268 (405)
Q Consensus 261 ~E~~~~gs 268 (405)
|||+++..
T Consensus 110 me~l~G~~ 117 (312)
T 3jr1_A 110 LEALNKSK 117 (312)
T ss_dssp EECCCCCC
T ss_pred EEeccCCC
Confidence 99998864
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.83 E-value=4e-05 Score=76.21 Aligned_cols=77 Identities=14% Similarity=0.107 Sum_probs=44.7
Q ss_pred HCCceecCCCCCcEEECCCCcEEEEecCCcccccccCCCCCCC--CCCcccCcccccccc---CCchhhHHHHHHHHHHH
Q 015556 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP--GTYRWMAPEMIKHKS---YGRKVDVYSFGLILWEM 376 (405)
Q Consensus 302 ~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~--gt~~y~aPE~~~~~~---~~~k~DVwSlGvll~el 376 (405)
...++|+|+++.|||++.++ +.|+||+.+............. -...|++|+...... .....++..+...+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 45699999999999998876 9999999875432111100000 012355555443111 11234555667777766
Q ss_pred HhC
Q 015556 377 VAG 379 (405)
Q Consensus 377 ltG 379 (405)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.77 E-value=8.6e-05 Score=70.16 Aligned_cols=70 Identities=10% Similarity=0.117 Sum_probs=43.3
Q ss_pred cceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe-eEEeeEeecCCeeEEEEe
Q 015556 184 GLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV-IKFVAACKKPPVYCVITE 262 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~E 262 (405)
.+.|+.|....+|+. +.++||+........ -...+|+.++..+...++ .++++.+.+ .-++|+|
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~---------~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e 87 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEY---------INRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTR 87 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----C---------CCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccce---------eCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEe
Confidence 467888999999998 679999886421110 012357777777753233 355554433 2368999
Q ss_pred ec-CCCC
Q 015556 263 YL-SEGS 268 (405)
Q Consensus 263 ~~-~~gs 268 (405)
|+ +|.+
T Consensus 88 ~i~~g~~ 94 (301)
T 3dxq_A 88 YIAGAQT 94 (301)
T ss_dssp CCTTCEE
T ss_pred ecCCCcc
Confidence 99 5543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00014 Score=69.62 Aligned_cols=135 Identities=17% Similarity=0.100 Sum_probs=71.4
Q ss_pred eeeeeeeEE-EEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC--CCeeEEeeEeecCCeeEEEE
Q 015556 186 RFAHGAHSR-LYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN--PNVIKFVAACKKPPVYCVIT 261 (405)
Q Consensus 186 ~lG~G~~g~-Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~lV~ 261 (405)
.|+.|+... +|+.... ++.+++|........ .+..|+.++..|.. -.+.+++.+..+.+ ++||
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~~-----------~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~ 91 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEGG-----------DTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLI 91 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTTC-----------CSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEE
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCCc-----------cccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEE
Confidence 455565555 6677664 677877754322101 22356777776642 23455666654444 6899
Q ss_pred eecCCCCHHHHHHHhc---------------------C---CCCCHHHHH-------H-H------------HHHHHHHH
Q 015556 262 EYLSEGSLRAYLHKLE---------------------H---KTLPLPKLI-------A-I------------ALDIARGM 297 (405)
Q Consensus 262 E~~~~gsL~~~l~~~~---------------------~---~~l~~~~~~-------~-i------------~~qi~~aL 297 (405)
|++.+..+.+++.... . ..++..... . + ...+...+
T Consensus 92 e~l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~ 171 (333)
T 3csv_A 92 EDLGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRF 171 (333)
T ss_dssp CCCCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHH
T ss_pred eeCCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 9997777765543210 0 112211110 0 0 01112223
Q ss_pred HHHH------HCCceecCCCCCcEEECCC----CcEEEEecCCccc
Q 015556 298 EYIH------SQGVIHRDLKPENVLIDQE----FHLKIADFGIACE 333 (405)
Q Consensus 298 ~yLH------~~gIiHrDIkp~NILl~~~----~~vkL~DFG~a~~ 333 (405)
..|. ...++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 172 ~~l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 172 AQILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHHHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3331 2369999999999999874 6899999998743
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00033 Score=66.44 Aligned_cols=139 Identities=18% Similarity=0.223 Sum_probs=79.3
Q ss_pred cceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC--eeEEeeE------eecCC
Q 015556 184 GLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN--VIKFVAA------CKKPP 255 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~------~~~~~ 255 (405)
.+.|+.|....+|+....+..+++|+...... ...+..|+.++..|...+ +.+++.. ....+
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~----------~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g 96 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKDPLILTLYEKRVE----------KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 96 (322)
T ss_dssp EEEECC---EEEEEEEESSCCEEEEEECC-------------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred eeccCCCcccceEEEEeCCccEEEEEeCCCCC----------HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECC
Confidence 45677888899999988777899999874211 123446777777774222 2233321 12235
Q ss_pred eeEEEEeecCCCCHH-----------H---HHHHhcCC---C----CC---HHHHHH------------HHHHHHHHHHH
Q 015556 256 VYCVITEYLSEGSLR-----------A---YLHKLEHK---T----LP---LPKLIA------------IALDIARGMEY 299 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~-----------~---~l~~~~~~---~----l~---~~~~~~------------i~~qi~~aL~y 299 (405)
..++||+|++|..+. + .++..... . .. |..... +...+...+.+
T Consensus 97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 176 (322)
T 2ppq_A 97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 176 (322)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence 678999999875321 1 12221100 0 11 111000 01123445566
Q ss_pred HHH-------CCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 300 IHS-------QGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 300 LH~-------~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
|.. .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 177 l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 177 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 653 369999999999999887666899999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.0002 Score=67.09 Aligned_cols=76 Identities=17% Similarity=0.112 Sum_probs=52.3
Q ss_pred eeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC---CCeeEEeeEeecCCe
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN---PNVIKFVAACKKPPV 256 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~g~~~~~~~ 256 (405)
+.-...+|.|..+.||+.... |+.|+||+........ ...|..|...|+.|.. --+.+++++..
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--------~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~---- 84 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--------DGLFRAEALGLDWLGRSFGSPVPQVAGWDD---- 84 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--------TTHHHHHHHHHHHHTCSTTCCSCCEEEEET----
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--------hhHHHHHHHHHHHHHhhCCCCcceEEeccC----
Confidence 344567899999999999986 6899999865333221 2356789999998852 22445555432
Q ss_pred eEEEEeecCCCC
Q 015556 257 YCVITEYLSEGS 268 (405)
Q Consensus 257 ~~lV~E~~~~gs 268 (405)
-++||||++++.
T Consensus 85 ~~lv~e~l~~~~ 96 (288)
T 3f7w_A 85 RTLAMEWVDERP 96 (288)
T ss_dssp TEEEEECCCCCC
T ss_pred ceEEEEeecccC
Confidence 368999997753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00018 Score=71.86 Aligned_cols=68 Identities=16% Similarity=0.262 Sum_probs=46.4
Q ss_pred ceeeeeeeEEEEEEEEC---------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe-eEEeeEeecC
Q 015556 185 LRFAHGAHSRLYHGIYK---------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV-IKFVAACKKP 254 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~---------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~ 254 (405)
..|+.|....||+.... ++.++||+..... . ...+.+|..++..|...++ .++++.+.+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---------~~~li~E~~~l~~L~~~g~~P~l~~~~~~- 147 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---------ESHLVAESVIFTLLSERHLGPKLYGIFSG- 147 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---------HHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---------HHHHHHHHHHHHHHHhCCCCCcEEEEeCC-
Confidence 56788888999999875 3689999984321 1 0123368888888853333 566776643
Q ss_pred CeeEEEEeecCC
Q 015556 255 PVYCVITEYLSE 266 (405)
Q Consensus 255 ~~~~lV~E~~~~ 266 (405)
.+||||++|
T Consensus 148 ---g~v~e~l~G 156 (429)
T 1nw1_A 148 ---GRLEEYIPS 156 (429)
T ss_dssp ---EEEECCCCE
T ss_pred ---CEEEEEeCC
Confidence 389999976
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0019 Score=61.29 Aligned_cols=136 Identities=17% Similarity=0.150 Sum_probs=76.4
Q ss_pred eeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC--eeEEeeE-----eecCCee
Q 015556 186 RFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN--VIKFVAA-----CKKPPVY 257 (405)
Q Consensus 186 ~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~-----~~~~~~~ 257 (405)
.|+ |....||+.... |+.++||+....... ..++..|..++..|.... +.+++.. ....+..
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~---------~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~ 102 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWT---------ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFY 102 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSC---------HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEE
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCC---------HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEE
Confidence 345 788899987764 568999998632221 234556778877774222 3444433 1224566
Q ss_pred EEEEeecCCCCH-----HH------H---HHHhcC-------CCCCHHHH----HHHH---------------HHHHHHH
Q 015556 258 CVITEYLSEGSL-----RA------Y---LHKLEH-------KTLPLPKL----IAIA---------------LDIARGM 297 (405)
Q Consensus 258 ~lV~E~~~~gsL-----~~------~---l~~~~~-------~~l~~~~~----~~i~---------------~qi~~aL 297 (405)
++||+|++|..+ .. . ++.... ...++... ..++ ..+-..+
T Consensus 103 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 182 (328)
T 1zyl_A 103 FAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELI 182 (328)
T ss_dssp EEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHH
T ss_pred EEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHH
Confidence 789999987432 11 1 221110 11222111 0011 0111123
Q ss_pred HHHH-------HCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 298 EYIH-------SQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 298 ~yLH-------~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
+.+. ...++|+|+++.|||++ + .+.|+||+.+..
T Consensus 183 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 183 AAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 3332 23489999999999998 4 899999987743
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0004 Score=67.54 Aligned_cols=70 Identities=17% Similarity=0.170 Sum_probs=41.6
Q ss_pred ceeeeeeeEEEEEEEECC----------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC-eeEEeeEeec
Q 015556 185 LRFAHGAHSRLYHGIYKD----------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN-VIKFVAACKK 253 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~~----------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~ 253 (405)
..|+.|....+|+....+ +.+++|+...... . . .....|..++..|...+ +.++++..
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~---~-----~~~~~E~~~l~~L~~~g~~P~~~~~~-- 107 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-E---L-----YNTISEFEVYKTMSKYKIAPQLLNTF-- 107 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-G---T-----SCHHHHHHHHHHHHHTTSSCCEEEEE--
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-c---e-----ecHHHHHHHHHHHHhcCCCCceEEec--
Confidence 456788889999998764 6788888653211 0 0 01246888888775333 33566544
Q ss_pred CCeeEEEEeecCCC
Q 015556 254 PPVYCVITEYLSEG 267 (405)
Q Consensus 254 ~~~~~lV~E~~~~g 267 (405)
.+ ++||||++|.
T Consensus 108 ~~--~~v~e~i~G~ 119 (369)
T 3c5i_A 108 NG--GRIEEWLYGD 119 (369)
T ss_dssp TT--EEEEECCCSE
T ss_pred CC--cEEEEEecCC
Confidence 22 6899999874
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.09 E-value=0.00085 Score=65.87 Aligned_cols=135 Identities=16% Similarity=0.209 Sum_probs=78.0
Q ss_pred ceeeeeeeEEEEEEEEC---------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC-eeEEeeEeecC
Q 015556 185 LRFAHGAHSRLYHGIYK---------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN-VIKFVAACKKP 254 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~---------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~ 254 (405)
+.|..|-...+|+.... ++.|+||+.... ... ...+.+|..+++.|..-+ ..++++++.+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~--------~~~~~rE~~vl~~L~~~gv~P~ll~~~~~- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQG--------VDSLVLESVMFAILAERSLGPQLYGVFPE- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CC--------HHHHHHHHHHHHHHHHTTSSCCEEEEETT-
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cch--------HHHHHHHHHHHHHHHhcCCCCeEEEEcCC-
Confidence 45677888899998863 367999985321 111 123448989888885322 3556766654
Q ss_pred CeeEEEEeecCCCCHH--------------HHH---HHhc---CCCCC--HHHHHHHHHHHH------------------
Q 015556 255 PVYCVITEYLSEGSLR--------------AYL---HKLE---HKTLP--LPKLIAIALDIA------------------ 294 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~--------------~~l---~~~~---~~~l~--~~~~~~i~~qi~------------------ 294 (405)
.+||||++|.+|. +.| +... ..... +..+..++.++.
T Consensus 126 ---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 202 (379)
T 3feg_A 126 ---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL 202 (379)
T ss_dssp ---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred ---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence 2999999874431 111 1111 11112 334444443332
Q ss_pred -HHHHHHH----HC----CceecCCCCCcEEECCC----CcEEEEecCCcc
Q 015556 295 -RGMEYIH----SQ----GVIHRDLKPENVLIDQE----FHLKIADFGIAC 332 (405)
Q Consensus 295 -~aL~yLH----~~----gIiHrDIkp~NILl~~~----~~vkL~DFG~a~ 332 (405)
..+..|. .. .++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2233443 22 48999999999999876 789999999874
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0072 Score=60.73 Aligned_cols=71 Identities=15% Similarity=0.053 Sum_probs=47.0
Q ss_pred cceeeeeeeEEEEEEEECC--ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe-eEEeeEeecCCeeEEE
Q 015556 184 GLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV-IKFVAACKKPPVYCVI 260 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~~--~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV 260 (405)
...|+.|-...+|+....+ ..+++|+.......-. ...+|..++..|...++ .++++++. + .+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i---------dR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v 179 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII---------NREREKKISCILYNKNIAKKIYVFFT-N---GRI 179 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS---------CHHHHHHHHHHHTTSSSBCCEEEEET-T---EEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc---------CHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEE
Confidence 3567889999999999876 7899998743211100 01379999999975554 46777763 2 259
Q ss_pred EeecCCC
Q 015556 261 TEYLSEG 267 (405)
Q Consensus 261 ~E~~~~g 267 (405)
|||++|.
T Consensus 180 ~e~I~G~ 186 (458)
T 2qg7_A 180 EEFMDGY 186 (458)
T ss_dssp EECCCSE
T ss_pred EEeeCCc
Confidence 9999873
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0038 Score=60.04 Aligned_cols=30 Identities=27% Similarity=0.352 Sum_probs=26.8
Q ss_pred CceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 304 GVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 304 gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
.++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 589999999999999888899999987743
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.02 E-value=0.0085 Score=59.60 Aligned_cols=71 Identities=14% Similarity=0.121 Sum_probs=45.2
Q ss_pred ceeeeeeeEEEEEEEEC---------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC-eeEEeeEeecC
Q 015556 185 LRFAHGAHSRLYHGIYK---------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN-VIKFVAACKKP 254 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~---------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~ 254 (405)
+.|..|....+|+.... ++.|+|++.......- -...+|..+++.|...+ ..++++.+.
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~---------idR~~E~~~l~~L~~~gi~P~l~~~~~-- 144 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF---------YDSKVELDVFRYLSNINIAPNIIADFP-- 144 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC---------CCHHHHHHHHHHHHHTTSSCCEEEEET--
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh---------cCHHHHHHHHHHHHhcCCCCCEEEEcC--
Confidence 45677888899999876 5789999864321110 01236888888875323 345555432
Q ss_pred CeeEEEEeecCCCC
Q 015556 255 PVYCVITEYLSEGS 268 (405)
Q Consensus 255 ~~~~lV~E~~~~gs 268 (405)
+ ++||||++|..
T Consensus 145 ~--~~I~efI~G~~ 156 (424)
T 3mes_A 145 E--GRIEEFIDGEP 156 (424)
T ss_dssp T--EEEEECCCSEE
T ss_pred C--CEEEEEeCCcc
Confidence 2 68999998854
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.58 E-value=0.064 Score=48.21 Aligned_cols=116 Identities=13% Similarity=0.106 Sum_probs=74.8
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEECCCCcEEEEecCCcccccccCCCCCCCC
Q 015556 267 GSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPG 345 (405)
Q Consensus 267 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~g 345 (405)
.+|.+.|.. .+.++++++++.++.|.+.+|.-+-. +.-..+=+.|..|+|..+|.|.+.+ +.+. ..
T Consensus 33 vSL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~ 99 (229)
T 2yle_A 33 LSLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AG 99 (229)
T ss_dssp EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred ccHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cc
Confidence 379998876 46899999999999999999877622 1212333447899999999988774 2211 12
Q ss_pred CCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCC---CCCHHHHHHHHH
Q 015556 346 TYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYE---EMNPIQAAFAVV 396 (405)
Q Consensus 346 t~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~---~~~~~e~~~~i~ 396 (405)
...+.+||... ...+.+.=|||||+++|..+- |-.+=. -..+.+.+...|
T Consensus 100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~eE~eLS~~LE~LL~~M 153 (229)
T 2yle_A 100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLIDHM 153 (229)
T ss_dssp -------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTEEECCCHHHHHHHHHH
T ss_pred ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcccchhhCHHHHHHHHHH
Confidence 23456888764 345688899999999999998 544332 234555555444
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.39 E-value=0.09 Score=51.53 Aligned_cols=28 Identities=25% Similarity=0.475 Sum_probs=24.5
Q ss_pred ceecCCCCCcEEE------CCCCcEEEEecCCcc
Q 015556 305 VIHRDLKPENVLI------DQEFHLKIADFGIAC 332 (405)
Q Consensus 305 IiHrDIkp~NILl------~~~~~vkL~DFG~a~ 332 (405)
++|+|+.+.|||+ +++..+.++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6799999999999 456789999999884
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=86.70 E-value=13 Score=38.25 Aligned_cols=86 Identities=13% Similarity=0.113 Sum_probs=49.3
Q ss_pred eEEeeEeecCCeeEEEEeecCCCC----------HHHHHHHhcCCC-----CCHHHHHHHHHHHHHHHHHHHHCCceecC
Q 015556 245 IKFVAACKKPPVYCVITEYLSEGS----------LRAYLHKLEHKT-----LPLPKLIAIALDIARGMEYIHSQGVIHRD 309 (405)
Q Consensus 245 v~l~g~~~~~~~~~lV~E~~~~gs----------L~~~l~~~~~~~-----l~~~~~~~i~~qi~~aL~yLH~~gIiHrD 309 (405)
+..|.+..-.....+ .|++++.+ +.+|+.+..... ..+.....++..+|.---..+=.|| +|
T Consensus 402 i~~Y~Vipls~~~Gl-IE~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YILGi--gD 478 (614)
T 3ls8_A 402 LTPYKVLATSTKHGF-MQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGV--GD 478 (614)
T ss_dssp CCCCCEEESSSSEEE-EECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHHHTC--CC
T ss_pred eeccEEEEecCCCce-EEEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhheeeec--cC
Confidence 344444444444444 46776544 444444432111 1233444455554443222233444 68
Q ss_pred CCCCcEEECCCCcEEEEecCCccc
Q 015556 310 LKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 310 Ikp~NILl~~~~~vkL~DFG~a~~ 333 (405)
=+++||||+.+|++.=+|||....
T Consensus 479 RH~~NILld~tG~v~HIDFG~~f~ 502 (614)
T 3ls8_A 479 RHLDNLLLTKTGKLFHIDFGYILG 502 (614)
T ss_dssp CCTTSEEECTTSCEEECCCSSCTT
T ss_pred CCCcceeEcCCCCEeeeehHHhhc
Confidence 899999999999999999998743
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.65 E-value=0.038 Score=55.50 Aligned_cols=62 Identities=11% Similarity=-0.058 Sum_probs=18.5
Q ss_pred eecceeeeeeeEEEEEEEECC--ccEEE------EEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEee
Q 015556 182 FLGLRFAHGAHSRLYHGIYKD--EPVAV------KIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACK 252 (405)
Q Consensus 182 ~~~~~lG~G~~g~Vy~~~~~~--~~vAV------K~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 252 (405)
.+.+.|| ||.||+|.+.+ .+||| |..+.... .......|.+|..++..++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~------~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV------SEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccc------cccccccccccccccccccccccCCCcceEE
Confidence 4667787 99999999975 58888 66543221 1222356788999999999999999877653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.37 E-value=0.82 Score=40.76 Aligned_cols=116 Identities=9% Similarity=0.081 Sum_probs=74.7
Q ss_pred CCCCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC
Q 015556 240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ 319 (405)
Q Consensus 240 ~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~ 319 (405)
.||+++.. .+-.+.+.+.+.++.-+.+.=+..+ ...+....++++..|+....+++. =+|=-|+|+||+++.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~~~--r~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVNRT--RYTFVLAPDELFFTR 114 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGGGS--SEECCCSGGGEEECT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHhcC--ceEEEEecceEEEcC
Confidence 57888876 4455555665655543322211223 346778899999999988755543 367789999999999
Q ss_pred CCcEEEEecCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCC
Q 015556 320 EFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384 (405)
Q Consensus 320 ~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~ 384 (405)
++.++|.--|+... ++|. ..+...=+-.+=+++..+++++..|+
T Consensus 115 ~~~p~i~~RGik~~----------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 115 DGLPIAKTRGLQNV----------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp TSCEEESCCEETTT----------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CCCEEEEEccCccC----------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999998776311 2221 12222223346778888888877774
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.29 E-value=2.3 Score=37.93 Aligned_cols=83 Identities=13% Similarity=0.063 Sum_probs=57.9
Q ss_pred CCCCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH-HHHHCCceecCCCCCcEEEC
Q 015556 240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME-YIHSQGVIHRDLKPENVLID 318 (405)
Q Consensus 240 ~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~-yLH~~gIiHrDIkp~NILl~ 318 (405)
.||++ . ..+-.+.+.+.+.++.-+++.-+..++ ..+....++++..|+.... +++ .-+|--|+|+||+++
T Consensus 48 ~~~~f-~-~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~--~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 48 VDPCI-V-RDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSA--RRLIFIVCPENLMFN 118 (219)
T ss_dssp SCSSS-E-EEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCS--SSEECCCCGGGEEEC
T ss_pred cCCCC-C-eEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhh--CceeEEEeCceEEEe
Confidence 57777 2 333355666666666544443333443 4678889998888888666 454 346778899999999
Q ss_pred CCCcEEEEecCCc
Q 015556 319 QEFHLKIADFGIA 331 (405)
Q Consensus 319 ~~~~vkL~DFG~a 331 (405)
.++.++|.-.|+-
T Consensus 119 ~~~~p~i~hRGi~ 131 (219)
T 4ano_A 119 RALEPFFLHVGVK 131 (219)
T ss_dssp TTCCEEESCCEET
T ss_pred CCCcEEEEEcCCc
Confidence 9999999988863
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=82.13 E-value=18 Score=37.77 Aligned_cols=45 Identities=22% Similarity=0.128 Sum_probs=30.8
Q ss_pred HHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 286 LIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 286 ~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
+..++..+|.---..+=.|| +|-+++||||+..|++.=+|||.+.
T Consensus 531 r~nF~~SlA~~Svv~YILGl--GDRH~~NILid~tG~v~HIDFG~~f 575 (696)
T 2x6h_A 531 MDTYIKSCAGYCVITYLLGV--GDRHLDNLLLTTNGKLFHIDFGYIL 575 (696)
T ss_dssp HHHHHHHHHHHHHHHHHHTC--CCCCTTTEEECTTSCEEECCCCSCT
T ss_pred HHHHHHHHHHHHHHHHHccC--CCCCCcceEEeCCCCEEEEeehhhh
Confidence 34444444433222222343 6899999999999999999999874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 405 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-52 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-50 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-50 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-50 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-49 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-46 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-44 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-42 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-19 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 2e-63
Identities = 68/233 (29%), Positives = 122/233 (52%), Gaps = 15/233 (6%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNR 231
D+ + Q+ +G R G+ +Y G + + VAVK++ + + + F
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQ------LQAFKN 53
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
EV +L + + N++ F+ P + ++T++ SL +LH +E K + KLI IA
Sbjct: 54 EVGVLRKTRHVNILLFMGYSTAPQLA-IVTQWCEGSSLYHHLHIIETK-FEMIKLIDIAR 111
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC---EEVYCDALSDDPGTYR 348
A+GM+Y+H++ +IHRDLK N+ + ++ +KI DFG+A G+
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 349 WMAPEMIKHKS---YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
WMAPE+I+ + Y + DVY+FG++L+E++ G +PY +N +V +
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 224
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 1e-56
Identities = 59/224 (26%), Positives = 106/224 (47%), Gaps = 14/224 (6%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVAL 235
+++ +L L G + G Y+ VAVK I+ + F E ++
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT----------AQAFLAEASV 53
Query: 236 LSRLHNPNVIKFVAAC-KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIA 294
+++L + N+++ + ++ ++TEY+++GSL YL L L+ +LD+
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEM 354
MEY+ +HRDL NVL+ ++ K++DFG+ E +W APE
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEA 171
Query: 355 IKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
++ K + K DV+SFG++LWE+ + G +PY + V
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 215
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-56
Identities = 49/215 (22%), Positives = 97/215 (45%), Gaps = 13/215 (6%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G ++ +K +A K+I + + Q RE+ +L ++P ++
Sbjct: 16 AGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-------IRNQIIRELQVLHECNSPYIVG 68
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ-GV 305
F A + E++ GSL L K +P L +++ + +G+ Y+ + +
Sbjct: 69 FYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVD 365
+HRD+KP N+L++ +K+ DFG++ + + + GT +M+PE ++ Y + D
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 366 VYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400
++S GL L EM G P + + +V
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 220
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-55
Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 10/211 (4%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G +Y K +A+K++ ++ +E Q REV + S L +PN+++
Sbjct: 16 KGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-----VEHQLRREVEIQSHLRHPNILR 70
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+I EY G++ L K + ++A + Y HS+ VI
Sbjct: 71 LYGYFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKRVI 128
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDV 366
HRD+KPEN+L+ LKIADFG + + GT ++ PEMI+ + + KVD+
Sbjct: 129 HRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 187
Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
+S G++ +E + G P+E + +
Sbjct: 188 WSLGVLCYEFLVGKPPFEANTYQETYKRISR 218
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-54
Identities = 56/218 (25%), Positives = 102/218 (46%), Gaps = 17/218 (7%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA ++Y K+ A K+I ++E E + E+ +L+ +PN++K
Sbjct: 22 DGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE--------DYMVEIDILASCDHPNIVK 73
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+ A ++ E+ + G++ A + +L + L ++ + + Y+H +I
Sbjct: 74 LLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKII 132
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEV-YCDALSDDPGTYRWMAPEMI-----KHKSY 360
HRDLK N+L + +K+ADFG++ + GT WMAPE++ K + Y
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 192
Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
K DV+S G+ L EM P+ E+NP++ +
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS 230
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-52
Identities = 55/213 (25%), Positives = 107/213 (50%), Gaps = 14/213 (6%)
Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA +Y + + VA++ + + + ++ E+ ++ NPN++
Sbjct: 30 QGASGTVYTAMDVATGQEVAIRQMNLQQQPK--------KELIINEILVMRENKNPNIVN 81
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
++ + V+ EYL+ GSL + + + ++ A+ + + +E++HS VI
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-GTYRWMAPEMIKHKSYGRKVD 365
HRD+K +N+L+ + +K+ DFG + + GT WMAPE++ K+YG KVD
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 366 VYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
++S G++ EM+ G PY NP++A + +
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (445), Expect = 2e-52
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 15/215 (6%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
HG+ +Y E VA+K + NE + +EV L +L +PN I+
Sbjct: 25 HGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW-----QDIIKEVRFLQKLRHPNTIQ 79
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+ + ++ EY + L ++ K L ++ A+ +G+ Y+HS +I
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI---KHKSYGRK 363
HRD+K N+L+ + +K+ DFG A + GT WMAPE+I Y K
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 364 VDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
VDV+S G+ E+ P MN + A + +
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 4e-52
Identities = 52/221 (23%), Positives = 96/221 (43%), Gaps = 18/221 (8%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G++ R K + + K + E E ++ EV LL L +PN+++
Sbjct: 14 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE------KQMLVSEVNLLRELKHPNIVR 67
Query: 247 FVAAC--KKPPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHS 302
+ + ++ EY G L + + K E + L ++ + + ++ H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 303 QG-----VIHRDLKPENVLIDQEFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIK 356
+ V+HRDLKP NV +D + ++K+ DFG+A GT +M+PE +
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN 187
Query: 357 HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
SY K D++S G +L+E+ A P+ + + A +
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 228
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 4e-52
Identities = 71/230 (30%), Positives = 106/230 (46%), Gaps = 14/230 (6%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFN 230
DE V L L R G ++ G Y VAVK ++ F
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---------DAFL 56
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
E L+ +L + +++ A + P+Y + TEY+ GSL +L L + KL+ +A
Sbjct: 57 AEANLMKQLQHQRLVRLYAVVTQEPIYII-TEYMENGSLVDFLKTPSGIKLTINKLLDMA 115
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGTYR 348
IA GM +I + IHRDL+ N+L+ KIADFG+A E+ A +
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
W APE I + ++ K DV+SFG++L E+V G IPY M + +
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 172 bits (437), Expect = 6e-51
Identities = 45/213 (21%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA ++ + A K + P + + ++ +E+ +S L +P ++
Sbjct: 36 TGAFGVVHRVTERATGNNFAAKFVMTPHESD--------KETVRKEIQTMSVLRHPTLVN 87
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
A + +I E++S G L + EH + + + + +G+ ++H +
Sbjct: 88 LHDAFEDDNEMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYV 146
Query: 307 HRDLKPENVLIDQEF--HLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKV 364
H DLKPEN++ + LK+ DFG+ ++ GT + APE+ + K G
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 206
Query: 365 DVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
D++S G++ + +++G P+ N + V +
Sbjct: 207 DMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 239
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-50
Identities = 59/216 (27%), Positives = 111/216 (51%), Gaps = 15/216 (6%)
Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA+ + + + +E VAVKI+ + + + +E+ + L++ NV+K
Sbjct: 15 EGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-------ENIKKEICINKMLNHENVVK 67
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
F ++ + + EY S G L + +P P + G+ Y+H G+
Sbjct: 68 FYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGIT 125
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSY-GR 362
HRD+KPEN+L+D+ +LKI+DFG+A Y + L+ GT ++APE++K + +
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 363 KVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
VDV+S G++L M+AG +P+++ + ++ +
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 221
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 169 bits (429), Expect = 2e-50
Identities = 57/220 (25%), Positives = 111/220 (50%), Gaps = 12/220 (5%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRI-PDDDENETLAARLEKQFNREVALLSRLHN-PNV 244
G S + I+K + AVKII + + L + +EV +L ++ PN+
Sbjct: 13 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 72
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304
I+ + + ++ + + +G L YL + TL + I + + +H
Sbjct: 73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLN 130
Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI------KHK 358
++HRDLKPEN+L+D + ++K+ DFG +C+ + L + GT ++APE+I H
Sbjct: 131 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP 190
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
YG++VD++S G+I++ ++AG+ P+ + +++
Sbjct: 191 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 3e-50
Identities = 54/226 (23%), Positives = 106/226 (46%), Gaps = 14/226 (6%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVA 234
+D L G + +G ++ VA+K+I+ + E +F E
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK---------EGSMSEDEFIEEAK 51
Query: 235 LLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIA 294
++ L + +++ C K +ITEY++ G L YL + +L+ + D+
Sbjct: 52 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVC 110
Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD--PGTYRWMAP 352
MEY+ S+ +HRDL N L++ + +K++DFG++ + + S RW P
Sbjct: 111 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170
Query: 353 EMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
E++ + + K D+++FG+++WE+ + G +PYE + A +
Sbjct: 171 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 3e-50
Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 19/219 (8%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G+ +Y G+ + VA ++ ++E ++F E +L L +PN+++
Sbjct: 19 RGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE------RQRFKEEAEMLKGLQHPNIVR 72
Query: 247 FVAAC----KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
F + K ++TE ++ G+L+ YL + K + + L + I +G++++H+
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 303 QG--VIHRDLKPENVLIDQE-FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKS 359
+ +IHRDLK +N+ I +KI D G+A GT +MAPEM + K
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFMAPEMYEEK- 188
Query: 360 YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
Y VDVY+FG+ + EM PY E + V
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 227
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-49
Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 18/218 (8%)
Query: 189 HGAHSRLYHGIYKD----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
G + G Y+ + VAVKI++ +D L+ + E ++ +L NP +
Sbjct: 17 SGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA------LKDELLAEANVMQQLDNPYI 70
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304
++ + C+ V E G L YL + ++ + +I + ++ GM+Y+
Sbjct: 71 VRMIGICEAESWMLV-MEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIAC----EEVYCDALSDDPGTYRWMAPEMIKHKSY 360
+HRDL NVL+ + + KI+DFG++ +E Y A + +W APE I + +
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 361 GRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
K DV+SFG+++WE + G PY M + +
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-49
Identities = 66/232 (28%), Positives = 110/232 (47%), Gaps = 14/232 (6%)
Query: 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQ 228
A D + L L ++ G ++ G + VA+K ++ +
Sbjct: 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---------EA 58
Query: 229 FNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIA 288
F +E ++ +L + +++ A + P+Y V TEY+S+GSL +L K L LP+L+
Sbjct: 59 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIV-TEYMSKGSLLDFLKGETGKYLRLPQLVD 117
Query: 289 IALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA--CEEVYCDALSDDPGT 346
+A IA GM Y+ +HRDL+ N+L+ + K+ADFG+A E+ A
Sbjct: 118 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 177
Query: 347 YRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
+W APE + + K DV+SFG++L E+ G +PY M + V
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 229
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 167 bits (423), Expect = 2e-49
Identities = 55/231 (23%), Positives = 115/231 (49%), Gaps = 13/231 (5%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQF 229
D+ ++ + + + + G + +Y G++K VAVK ++ ++F
Sbjct: 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---------EDTMEVEEF 60
Query: 230 NREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAI 289
+E A++ + +PN+++ + C + P + +ITE+++ G+L YL + + + L+ +
Sbjct: 61 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 120
Query: 290 ALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC--EEVYCDALSDDPGTY 347
A I+ MEY+ + IHRDL N L+ + +K+ADFG++ A +
Sbjct: 121 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 348 RWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
+W APE + + + K DV++FG++LWE+ + + + ++ K
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 231
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 4e-49
Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 14/226 (6%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVA 234
+D S+L G ++ G + + + VA+K IR A E+ F E
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR---------EGAMSEEDFIEEAE 52
Query: 235 LLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIA 294
++ +L +P +++ C + C++ E++ G L YL + L+ + LD+
Sbjct: 53 VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVC 111
Query: 295 RGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD--PGTYRWMAP 352
GM Y+ VIHRDL N L+ + +K++DFG+ + S +W +P
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171
Query: 353 EMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
E+ Y K DV+SFG+++WE+ + G IPYE + + +
Sbjct: 172 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 217
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 5e-49
Identities = 50/218 (22%), Positives = 106/218 (48%), Gaps = 18/218 (8%)
Query: 189 HGAHSRLYHGIYKD----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV 244
G + G+Y+ VA+K+++ + + ++ RE ++ +L NP +
Sbjct: 19 CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-------EEMMREAQIMHQLDNPYI 71
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304
++ + C+ + ++ E G L +L + + +P+ + + ++ GM+Y+ +
Sbjct: 72 VRLIGVCQAEALM-LVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN 129
Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIAC----EEVYCDALSDDPGTYRWMAPEMIKHKSY 360
+HRDL NVL+ + KI+DFG++ ++ Y A S +W APE I + +
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189
Query: 361 GRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
+ DV+S+G+ +WE ++ G PY++M + +
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 166 bits (422), Expect = 1e-48
Identities = 44/213 (20%), Positives = 97/213 (45%), Gaps = 13/213 (6%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA ++ + K K I P + + E++++++LH+P +I
Sbjct: 39 SGAFGVVHRCVEKATGRVFVAKFINTPYPLD--------KYTVKNEISIMNQLHHPKLIN 90
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
A + +I E+LS G L + E + ++I G++++H ++
Sbjct: 91 LHDAFEDKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIV 149
Query: 307 HRDLKPENVLID--QEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKV 364
H D+KPEN++ + + +KI DFG+A + + + T + APE++ + G
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 365 DVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
D+++ G++ + +++G P+ + ++ V
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 242
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 4e-48
Identities = 34/213 (15%), Positives = 89/213 (41%), Gaps = 14/213 (6%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G ++ + + K +++ D+ +E+++L+ + N++
Sbjct: 15 RGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---------VLVKKEISILNIARHRNILH 65
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+ + +I E++S + ++ L ++++ + ++++HS +
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 307 HRDLKPENVLIDQ--EFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKV 364
H D++PEN++ +KI +FG A + D + APE+ +H
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 365 DVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
D++S G +++ +++G P+ Q ++N
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-47
Identities = 59/256 (23%), Positives = 100/256 (39%), Gaps = 40/256 (15%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQ 228
L G GA ++ + VAVK+++ D +
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER-------EA 86
Query: 229 FNREVALLSRLHN-PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK-------- 279
E+ ++++L + N++ + AC +I EY G L YL K
Sbjct: 87 LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 146
Query: 280 -------------TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA 326
L L+ A +A+GME++ + +HRDL NVL+ +KI
Sbjct: 147 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKIC 206
Query: 327 DFGIACEEVYCDALSDD---PGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIP 382
DFG+A + + +WMAPE + Y K DV+S+G++LWE+ + G P
Sbjct: 207 DFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266
Query: 383 YEEMNPIQAAFAVVNK 398
Y + + ++
Sbjct: 267 YPGIPVDANFYKLIQN 282
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (408), Expect = 4e-47
Identities = 55/234 (23%), Positives = 107/234 (45%), Gaps = 20/234 (8%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFN 230
+D+S + + G + G K VA+K ++ ++ + F
Sbjct: 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR-------RDFL 75
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
E +++ + +PNVI K +ITE++ GSL ++L + + +L+ +
Sbjct: 76 SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ-NDGQFTVIQLVGML 134
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC------EEVYCDALSDDP 344
IA GM+Y+ +HRDL N+L++ K++DFG++ + +
Sbjct: 135 RGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194
Query: 345 GTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
RW APE I+++ + DV+S+G+++WE+++ G PY +M A+
Sbjct: 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ 248
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-46
Identities = 52/213 (24%), Positives = 107/213 (50%), Gaps = 9/213 (4%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G+ +++ +K + A+K ++ ++ +E + L +P +
Sbjct: 12 KGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD----DVECTMVEKRVLSLAWEHPFLTH 67
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+ + EYL+ G L ++ L + A +I G++++HS+G++
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKGIV 125
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-GTYRWMAPEMIKHKSYGRKVD 365
+RDLK +N+L+D++ H+KIADFG+ E + DA ++ GT ++APE++ + Y VD
Sbjct: 126 YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVD 185
Query: 366 VYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
+SFG++L+EM+ G P+ + + ++
Sbjct: 186 WWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 218
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (405), Expect = 1e-46
Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 14/215 (6%)
Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA S + K + VA+K I + E E+A+L ++ +PN++
Sbjct: 19 TGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-------GSMENEIAVLHKIKHPNIVA 71
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+ +I + +S G L + + + + ++Y+H G++
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIV 129
Query: 307 HRDLKPENVLI---DQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRK 363
HRDLKPEN+L D++ + I+DFG++ E LS GT ++APE++ K Y +
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 189
Query: 364 VDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
VD +S G+I + ++ G P+ + N + ++
Sbjct: 190 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA 224
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-46
Identities = 61/220 (27%), Positives = 92/220 (41%), Gaps = 17/220 (7%)
Query: 189 HGAHSRLYHGIYKDE-----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
G+ + G + VAVK ++ + E + F REV + L + N
Sbjct: 18 DGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM-----DDFIREVNAMHSLDHRN 72
Query: 244 VIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
+I+ PP+ V TE GSL L K L L A+ +A GM Y+ S+
Sbjct: 73 LIRLYGVVLTPPMKMV-TELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD----ALSDDPGTYRWMAPEMIKHKS 359
IHRDL N+L+ +KI DFG+ D + W APE +K ++
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 360 YGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNK 398
+ D + FG+ LWEM G P+ +N Q + +
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 230
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-46
Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 12/214 (5%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G+ S + A+KI+ + + RE ++SRL +P +K
Sbjct: 18 EGSFSTVVLARELATSREYAIKILEKRHIIKENKV-----PYVTRERDVMSRLDHPFFVK 72
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+ Y G L Y+ K + +I +EY+H +G+I
Sbjct: 73 LYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGII 130
Query: 307 HRDLKPENVLIDQEFHLKIADFGIA---CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRK 363
HRDLKPEN+L++++ H++I DFG A E + GT ++++PE++ KS +
Sbjct: 131 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS 190
Query: 364 VDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
D+++ G I++++VAG P+ N ++
Sbjct: 191 SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 224
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 5e-46
Identities = 62/240 (25%), Positives = 106/240 (44%), Gaps = 23/240 (9%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREV 233
+D + + G ++ K + I R+ + + + F E+
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-----HRDFAGEL 61
Query: 234 ALLSRL-HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH-------------- 278
+L +L H+PN+I + AC+ + EY G+L +L K
Sbjct: 62 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 279 KTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCD 338
TL +L+ A D+ARGM+Y+ + IHRDL N+L+ + + KIADFG++ +
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 339 ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
+ RWMA E + + Y DV+S+G++LWE+V+ G PY M + +
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 7e-46
Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 189 HGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248
G ++ G ++ E VAVKI ++ E+ L + N++ F+
Sbjct: 13 KGRFGEVWRGKWRGEEVAVKIFSSREERS---------WFREAEIYQTVMLRHENILGFI 63
Query: 249 AACKKP----PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ- 303
AA K ++++Y GSL YL++ T+ + +I +AL A G+ ++H +
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 304 -------GVIHRDLKPENVLIDQEFHLKIADFGIAC-----EEVYCDALSDDPGTYRWMA 351
+ HRDLK +N+L+ + IAD G+A + A + GT R+MA
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 352 PEMI------KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393
PE++ KH ++ D+Y+ GL+ WE+ Q +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (398), Expect = 9e-46
Identities = 63/243 (25%), Positives = 107/243 (44%), Gaps = 40/243 (16%)
Query: 189 HGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN 241
GA R++ VAVK+++ + ++ F RE AL++ N
Sbjct: 23 EGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-------MQADFQREAALMAEFDN 75
Query: 242 PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKT--------------------- 280
PN++K + C C++ EY++ G L +L + T
Sbjct: 76 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 135
Query: 281 -LPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA---CEEVY 336
L + + IA +A GM Y+ + +HRDL N L+ + +KIADFG++ Y
Sbjct: 136 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 195
Query: 337 CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI-PYEEMNPIQAAFAV 395
A +D RWM PE I + Y + DV+++G++LWE+ + + PY M + + V
Sbjct: 196 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV 255
Query: 396 VNK 398
+
Sbjct: 256 RDG 258
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 3e-45
Identities = 49/224 (21%), Positives = 98/224 (43%), Gaps = 23/224 (10%)
Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVI 245
G + ++ K E A+K+++ + REV L R P+++
Sbjct: 22 LGINGKVLQIFNKRTQEKFALKMLQD-------------CPKARREVELHWRASQCPHIV 68
Query: 246 KFVAACK----KPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
+ V + ++ E L G L + + + + I I ++Y+H
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 302 SQGVIHRDLKPENVLID---QEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK 358
S + HRD+KPEN+L LK+ DFG A E ++L+ T ++APE++ +
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNFG 402
Y + D++S G+I++ ++ G P+ + + + + ++ G
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 232
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 154 bits (389), Expect = 9e-45
Identities = 53/220 (24%), Positives = 98/220 (44%), Gaps = 17/220 (7%)
Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G S ++ VAVK++R + +F RE + L++P ++
Sbjct: 17 FGGMSEVHLARDLRLHRDVAVKVLRADLARDPS-----FYLRFRREAQNAAALNHPAIVA 71
Query: 247 FVAAC----KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
P+ ++ EY+ +LR +H + + I + D + + + H
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQ 129
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIAC----EEVYCDALSDDPGTYRWMAPEMIKHK 358
G+IHRD+KP N++I +K+ DFGIA + GT ++++PE +
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
S + DVYS G +L+E++ G P+ +P+ A+ V +
Sbjct: 190 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 229
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-44
Identities = 53/230 (23%), Positives = 102/230 (44%), Gaps = 17/230 (7%)
Query: 176 VDLSQLFLGLRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFN 230
+ ++ LG G ++ GIY VA+K + D + ++F
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS-------VREKFL 56
Query: 231 REVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIA 290
+E + + +P+++K + + PV+ + E + G LR++L +L L LI A
Sbjct: 57 QEALTMRQFDHPHIVKLIGVITENPVWII-MELCTLGELRSFLQV-RKYSLDLASLILYA 114
Query: 291 LDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP--GTYR 348
++ + Y+ S+ +HRD+ NVL+ +K+ DFG++ +
Sbjct: 115 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 349 WMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
WMAPE I + + DV+ FG+ +WE++ G P++ + + N
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 224
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 5e-44
Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 10/215 (4%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G + + K A K I+ + +R + REV++L + +PNVI
Sbjct: 20 SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR--EDIEREVSILKEIQHPNVIT 77
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+ +I E ++ G L +L + ++L + I G+ Y+HS +
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIA 135
Query: 307 HRDLKPENVLIDQE----FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGR 362
H DLKPEN+++ +KI DFG+A + + + + GT ++APE++ ++ G
Sbjct: 136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL 195
Query: 363 KVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
+ D++S G+I + +++G P+ + V
Sbjct: 196 EADMWSIGVITYILLSGASPFLGDTKQETLANVSA 230
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-43
Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 19/219 (8%)
Query: 189 HGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP 242
GA +Y G++ E PVA+K +R + K+ E +++ + NP
Sbjct: 19 SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-------KEILDEAYVMASVDNP 71
Query: 243 NVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
+V + + C V IT+ + G L Y+ + + L+ + IA+GM Y+
Sbjct: 72 HVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIAC---EEVYCDALSDDPGTYRWMAPEMIKHKS 359
+ ++HRDL NVL+ H+KI DFG+A E +WMA E I H+
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 360 YGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
Y + DV+S+G+ +WE++ G+ PY+ + + + +
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 228
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 151 bits (383), Expect = 2e-43
Identities = 59/211 (27%), Positives = 112/211 (53%), Gaps = 11/211 (5%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G+ R++ + A+K+++ + + + + N E +LS + +P +I+
Sbjct: 14 TGSFGRVHLIRSRHNGRYYAMKVLK-----KEIVVRLKQVEHTNDERLMLSIVTHPFIIR 68
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+ +I +Y+ G L + L K + P+ K A ++ +EY+HS+ +I
Sbjct: 69 MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA--EVCLALEYLHSKDII 126
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDV 366
+RDLKPEN+L+D+ H+KI DFG A D GT ++APE++ K Y + +D
Sbjct: 127 YRDLKPENILLDKNGHIKITDFGFAKY--VPDVTYTLCGTPDYIAPEVVSTKPYNKSIDW 184
Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
+SFG++++EM+AG P+ + N ++ ++N
Sbjct: 185 WSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-43
Identities = 51/220 (23%), Positives = 96/220 (43%), Gaps = 18/220 (8%)
Query: 189 HGAHSRLYHGIYKDE------PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNP 242
G +Y G+ K PVA+K ++ ++ F E ++ + +
Sbjct: 17 AGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-------VDFLGEAGIMGQFSHH 69
Query: 243 NVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
N+I+ K +ITEY+ G+L +L + + + +L+ + IA GM+Y+ +
Sbjct: 70 NIIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLAN 128
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIAC----EEVYCDALSDDPGTYRWMAPEMIKHK 358
+HRDL N+L++ K++DFG++ + S RW APE I ++
Sbjct: 129 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 188
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
+ DV+SFG+++WE++ +N
Sbjct: 189 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 228
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 151 bits (382), Expect = 1e-42
Identities = 49/203 (24%), Positives = 95/203 (46%), Gaps = 8/203 (3%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G +Y D + A+K + + L ++L+S P ++
Sbjct: 14 RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPFIVC 71
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
A P I + ++ G L +L + H + A +I G+E++H++ V+
Sbjct: 72 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRFVV 129
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVD 365
+RDLKP N+L+D+ H++I+D G+AC + GT+ +MAPE+++ +Y D
Sbjct: 130 YRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSAD 188
Query: 366 VYSFGLILWEMVAGTIPYEEMNP 388
+S G +L++++ G P+ +
Sbjct: 189 WFSLGCMLFKLLRGHSPFRQHKT 211
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-42
Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 20/221 (9%)
Query: 189 HGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN 243
G +YHG D AVK + D QF E ++ +PN
Sbjct: 37 RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-------SQFLTEGIIMKDFSHPN 89
Query: 244 VIKFVAACKKPP-VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
V+ + C + V+ Y+ G LR ++ E + LI L +A+GM+++ S
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLAS 148
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDD-----PGTYRWMAPEMIKH 357
+ +HRDL N ++D++F +K+ADFG+A + + S +WMA E ++
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 358 KSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVN 397
+ + K DV+SFG++LWE++ G PY ++N ++
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-42
Identities = 62/249 (24%), Positives = 102/249 (40%), Gaps = 34/249 (13%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAAR 224
+ ++L G GA ++ VAVK+++ P E
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTE----- 69
Query: 225 LEKQFNREVALLSRLHN-PNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHK-------- 275
+ E+ +LS L N N++ + AC VITEY G L +L +
Sbjct: 70 -REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 276 --------LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327
+ L L L++ + +A+GM ++ S+ IHRDL N+L+ KI D
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188
Query: 328 FGIAC---EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384
FG+A + + +WMAPE I + Y + DV+S+G+ LWE+ +
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248
Query: 385 EMNPIQAAF 393
P+ + F
Sbjct: 249 PGMPVDSKF 257
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-42
Identities = 56/221 (25%), Positives = 100/221 (45%), Gaps = 16/221 (7%)
Query: 189 HGAHSRLYHGIYK---DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL---HNP 242
GA+ +++ VA+K +R+ +E REVA+L L +P
Sbjct: 17 EGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------PLSTIREVAVLRHLETFEHP 70
Query: 243 NVIKFVAACKKPP----VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
NV++ C + + L YL K+ +P + + + RG++
Sbjct: 71 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 130
Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK 358
++HS V+HRDLKP+N+L+ +K+ADFG+A + AL+ T + APE++
Sbjct: 131 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 190
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399
SY VD++S G I EM + + + +++ +
Sbjct: 191 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 6e-42
Identities = 61/246 (24%), Positives = 108/246 (43%), Gaps = 26/246 (10%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAAR 224
DE V ++ + G+ +Y G+ K + VA+K +
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER----- 67
Query: 225 LEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHK----- 279
+F E +++ + +V++ + + VI E ++ G L++YL L
Sbjct: 68 --IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 125
Query: 280 ---TLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC---E 333
L K+I +A +IA GM Y+++ +HRDL N ++ ++F +KI DFG+ E
Sbjct: 126 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 185
Query: 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGT-IPYEEMNPIQAA 392
Y RWM+PE +K + DV+SFG++LWE+ PY+ ++ Q
Sbjct: 186 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245
Query: 393 FAVVNK 398
V+
Sbjct: 246 RFVMEG 251
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-41
Identities = 51/213 (23%), Positives = 100/213 (46%), Gaps = 10/213 (4%)
Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G ++ K A+KI+R + + E +L +P +
Sbjct: 15 KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEV-----AHTVTESRVLQNTRHPFLTA 69
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
A + C + EY + G L +L + + + +I +EY+HS+ V+
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDP-GTYRWMAPEMIKHKSYGRKVD 365
+RD+K EN+++D++ H+KI DFG+ E + A GT ++APE+++ YGR VD
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 187
Query: 366 VYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398
+ G++++EM+ G +P+ + + ++ +
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 8e-41
Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 10/207 (4%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN--PNV 244
G +Y GI PVA+K + + L + EV LL ++ + V
Sbjct: 14 SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG--TRVPMEVVLLKKVSSGFSGV 71
Query: 245 IKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG 304
I+ + ++P + +I E E L + + + + H+ G
Sbjct: 72 IRLLDWFERPDSFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 305 VIHRDLKPENVLIDQE-FHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY-GR 362
V+HRD+K EN+LID LK+ DFG + +D GT + PE I++ Y GR
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 189
Query: 363 KVDVYSFGLILWEMVAGTIPYEEMNPI 389
V+S G++L++MV G IP+E I
Sbjct: 190 SAAVWSLGILLYDMVCGDIPFEHDEEI 216
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 3e-40
Identities = 66/254 (25%), Positives = 112/254 (44%), Gaps = 34/254 (13%)
Query: 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD---------EPVAVKIIRIPDDDENETLA 222
+ +L LG GA ++ VAVK+++ +++
Sbjct: 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL--- 62
Query: 223 ARLEKQFNREVALLSRL-HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLH------- 274
E+ ++ + + N+I + AC + VI EY S+G+LR YL
Sbjct: 63 ----SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118
Query: 275 -------KLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327
+ L L++ A +ARGMEY+ S+ IHRDL NVL+ ++ +KIAD
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 178
Query: 328 FGIAC---EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384
FG+A Y ++ +WMAPE + + Y + DV+SFG++LWE+
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238
Query: 385 EMNPIQAAFAVVNK 398
P++ F ++ +
Sbjct: 239 PGVPVEELFKLLKE 252
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 3e-40
Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 9/215 (4%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G + +Y K+ + VA+K I++ E + + + RE+ LL L +PN+I
Sbjct: 8 EGQFATVYKARDKNTNQIVAIKKIKLGHRSEAK---DGINRTALREIKLLQELSHPNIIG 64
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+ A ++ +++ L + A L +G+EY+H ++
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIK-HKSYGRKV 364
HRDLKP N+L+D+ LK+ADFG+A A + T + APE++ + YG V
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182
Query: 365 DVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399
D+++ G IL E++ + + + +
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 217
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (357), Expect = 2e-39
Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 11/211 (5%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G+ R+ +K+ A+KI+ + + + + E +L ++ P ++K
Sbjct: 51 TGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-----EHTLNEKRILQAVNFPFLVK 105
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+ K ++ EY++ G + ++L + P A I EY+HS +I
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDV 366
+RDLKPEN+LIDQ+ ++++ DFG A GT +APE+I K Y + VD
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGYNKAVDW 221
Query: 367 YSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
++ G++++EM AG P+ PIQ +V+
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (352), Expect = 3e-39
Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 11/213 (5%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G + +Y K E VA+K IR+ + E + RE++LL L++PN++K
Sbjct: 12 EGTYGVVYKARNKLTGEVVALKKIRLDTETEG------VPSTAIREISLLKELNHPNIVK 65
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+ ++ E+L + + ++ +PLP + + + +G+ + HS V+
Sbjct: 66 LLDVIHTENKLYLVFEFLHQDLKK-FMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACE-EVYCDALSDDPGTYRWMAPEMIKHKSY-GRKV 364
HRDLKP+N+LI+ E +K+ADFG+A V + + T + APE++ Y V
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 365 DVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
D++S G I EMV + + I F +
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 5e-39
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 15/217 (6%)
Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA+ + VA+K I + ++ RE+ +L R + N+I
Sbjct: 18 EGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC-------QRTLREIKILLRFRHENIIG 70
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHK-LEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
+ P + + YL + A L+K L+ + L + I RG++YIHS V
Sbjct: 71 INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 130
Query: 306 IHRDLKPENVLIDQEFHLKIADFGIAC----EEVYCDALSDDPGTYRWMAPEMIKHK-SY 360
+HRDLKP N+L++ LKI DFG+A + + L++ T + APE++ + Y
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
+ +D++S G IL EM++ + + + ++
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 227
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 2e-38
Identities = 66/254 (25%), Positives = 106/254 (41%), Gaps = 32/254 (12%)
Query: 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAA 223
A + +L LG GA ++ VAVK+++
Sbjct: 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH---- 60
Query: 224 RLEKQFNREVALLSRLHNPNVIKFVAACKKPP-VYCVITEYLSEGSLRAYLHK------- 275
+ L+ H+ NV+ + AC KP VI E+ G+L YL
Sbjct: 61 --RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 118
Query: 276 -------LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF 328
L L L LI + +A+GME++ S+ IHRDL N+L+ ++ +KI DF
Sbjct: 119 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 178
Query: 329 GIAC---EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTI-PYE 384
G+A ++ D +WMAPE I + Y + DV+SFG++LWE+ + PY
Sbjct: 179 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238
Query: 385 EMNPIQAAFAVVNK 398
+ + + +
Sbjct: 239 GVKIDEEFCRRLKE 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (346), Expect = 3e-38
Identities = 47/222 (21%), Positives = 83/222 (37%), Gaps = 24/222 (10%)
Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G+ +Y G E VA+K+ + Q + E + + I
Sbjct: 17 SGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----------QLHIESKIYKMMQGGVGIP 66
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
+ C Y V+ L SL L + L ++ +A + +EYIHS+ I
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLE-DLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 125
Query: 307 HRDLKPENVLI---DQEFHLKIADFGIAC--------EEVYCDALSDDPGTYRWMAPEMI 355
HRD+KP+N L+ + + I DFG+A + + + GT R+ +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 356 KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
R+ D+ S G +L G++P++ +
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 227
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 136 bits (343), Expect = 8e-38
Identities = 35/223 (15%), Positives = 79/223 (35%), Gaps = 28/223 (12%)
Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVI 245
G+ ++ G ++ VA+K D Q E L +
Sbjct: 15 EGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP----------QLRDEYRTYKLLAGCTGIP 64
Query: 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGV 305
++ ++ + L G L L + + + A + ++ IH + +
Sbjct: 65 NVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 122
Query: 306 IHRDLKPENVLIDQEFH-----LKIADFGIAC--------EEVYCDALSDDPGTYRWMAP 352
++RD+KP+N LI + + + DFG+ + + + GT R+M+
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 353 EMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAV 395
+ R+ D+ + G + + G++P++ +
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 225
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-37
Identities = 52/220 (23%), Positives = 98/220 (44%), Gaps = 23/220 (10%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
+G+ +Y D E VA+K + + ++ NRE+ ++ +L + N+++
Sbjct: 30 NGSFGVVYQAKLCDSGELVAIKKVL------------QDKRFKNRELQIMRKLDHCNIVR 77
Query: 247 FVAAC------KKPPVYCVITEYLSEGSLRAYLHKLEHK-TLPLPKLIAIALDIARGMEY 299
K ++ +Y+ E R H K TLP+ + + R + Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 300 IHSQGVIHRDLKPENVLIDQE-FHLKIADFGIACEEVYCDALSDDPGTYRWMAP-EMIKH 357
IHS G+ HRD+KP+N+L+D + LK+ DFG A + V + + + AP +
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 358 KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
Y +DV+S G +L E++ G + + + ++
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 134 bits (338), Expect = 3e-37
Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 11/212 (5%)
Query: 189 HGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247
G + +Y E A+K IR+ +DE + RE+++L L + N++K
Sbjct: 12 EGTYGVVYKAQNNYGETFALKKIRLEKEDEG------IPSTTIREISILKELKHSNIVKL 65
Query: 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIH 307
++ E+L + + L + L + G+ Y H + V+H
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 308 RDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI--KHKSYGRKVD 365
RDLKP+N+LI++E LKIADFG+A W + K Y +D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 366 VYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
++S G I EMV GT + ++ +
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 3e-36
Identities = 43/225 (19%), Positives = 91/225 (40%), Gaps = 24/225 (10%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G ++ ++ + VA+K + + ++ E RE+ +L L + NV+
Sbjct: 20 QGTFGEVFKARHRKTGQKVALKKVLMENEKEGF------PITALREIKILQLLKHENVVN 73
Query: 247 FVAACKKPPVY--------CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGME 298
+ C+ ++ ++ + L L ++ + + G+
Sbjct: 74 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLLNGLY 131
Query: 299 YIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA-----CEEVYCDALSDDPGTYRWMAPE 353
YIH ++HRD+K NVLI ++ LK+ADFG+A + + ++ T + PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 354 MI-KHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
++ + YG +D++ G I+ EM + + +
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 4e-36
Identities = 43/221 (19%), Positives = 102/221 (46%), Gaps = 16/221 (7%)
Query: 189 HGAHSRLYHGIYK-----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNP 242
GA+ +++ + A+K+++ + + + E +L + +P
Sbjct: 34 TGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA----KTTEHTRTERQVLEHIRQSP 89
Query: 243 NVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS 302
++ A + +I +Y++ G L +L + + ++ +I +E++H
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHK 147
Query: 303 QGVIHRDLKPENVLIDQEFHLKIADFGIACE--EVYCDALSDDPGTYRWMAPEMI--KHK 358
G+I+RD+K EN+L+D H+ + DFG++ E + D GT +MAP+++
Sbjct: 148 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDS 207
Query: 359 SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399
+ + VD +S G++++E++ G P+ + + ++
Sbjct: 208 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 248
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 8e-36
Identities = 48/215 (22%), Positives = 91/215 (42%), Gaps = 12/215 (5%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
G + ++ ++ E VA+K +R+ DDDE + RE+ LL L + N+++
Sbjct: 12 EGTYGTVFKAKNRETHEIVALKRVRLDDDDEG------VPSSALREICLLKELKHKNIVR 65
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVI 306
++ E+ + + L + + + +G+ + HS+ V+
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQDLK--KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123
Query: 307 HRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAP--EMIKHKSYGRKV 364
HRDLKP+N+LI++ LK+A+FG+A W P + K Y +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 365 DVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399
D++S G I E+ P N + + ++
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-34
Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 13/214 (6%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA+ + + VA+K + P E K+ RE+ LL + + NVI
Sbjct: 28 SGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE------LFAKRAYRELRLLKHMRHENVIG 81
Query: 247 FVAACKKPPVYCVITEYLSEGSLRAYLHK--LEHKTLPLPKLIAIALDIARGMEYIHSQG 304
+ T++ ++H+ L ++ + + +G+ YIH+ G
Sbjct: 82 LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG 141
Query: 305 VIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMI-KHKSYGRK 363
+IHRDLKP N+ ++++ LKI DFG+A + ++ T + APE+I Y +
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVILNWMRYTQT 199
Query: 364 VDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
VD++S G I+ EM+ G ++ + + ++
Sbjct: 200 VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (313), Expect = 5e-33
Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 19/217 (8%)
Query: 189 HGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA + D VA+K + P ++ K+ RE+ L+ +++ N+I
Sbjct: 27 SGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH------AKRAYRELVLMKCVNHKNIIS 80
Query: 247 FVAACKKPPV------YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYI 300
+ ++ E + + +L+H+ ++ + + G++++
Sbjct: 81 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHL 135
Query: 301 HSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSY 360
HS G+IHRDLKP N+++ + LKI DFG+A ++ T + APE+I Y
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 361 GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
VD++S G I+ EMV I + + I V+
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 121 bits (305), Expect = 4e-32
Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 23/218 (10%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVI 245
G +S ++ I E V VKI++ +K+ RE+ +L L PN+I
Sbjct: 45 RGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNII 93
Query: 246 KFVAACKKPP--VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQ 303
K P ++ E+++ + ++TL + +I + ++Y HS
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQL-----YQTLTDYDIRFYMYEILKALDYCHSM 148
Query: 304 GVIHRDLKPENVLIDQEF-HLKIADFGIACEEVYCDALSDDPGTYRWMAPE-MIKHKSYG 361
G++HRD+KP NV+ID E L++ D+G+A + + + PE ++ ++ Y
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 362 RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399
+D++S G +L M+ P+ + + KV
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 2e-30
Identities = 49/216 (22%), Positives = 87/216 (40%), Gaps = 17/216 (7%)
Query: 189 HGAHSRLYHGIYKD--EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIK 246
GA+ + VAVK + P K+ RE+ LL + + NVI
Sbjct: 28 SGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH------AKRTYRELRLLKHMKHENVIG 81
Query: 247 FVAACKKPP-----VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH 301
+ + +L + ++ + L + + I RG++YIH
Sbjct: 82 LLDVFTPARSLEEFNDVYLVTHLMGAD---LNNIVKCQKLTDDHVQFLIYQILRGLKYIH 138
Query: 302 SQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYG 361
S +IHRDLKP N+ ++++ LKI DFG+A + + M+ Y
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTGYVATRWYRAPEIMLNWMHYN 197
Query: 362 RKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397
+ VD++S G I+ E++ G + + I ++
Sbjct: 198 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (256), Expect = 4e-25
Identities = 53/240 (22%), Positives = 103/240 (42%), Gaps = 40/240 (16%)
Query: 174 HTVDLSQLFLGLRF------AHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARL 225
H + + R+ G S ++ + VA+KI+R
Sbjct: 2 HPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---------GDKVY 52
Query: 226 EKQFNREVALLSRLHNPNVIKFVAACKKPPV--------------YCVITEYLSEGSLRA 271
+ E+ LL R+++ + K + + + V+ + +L A
Sbjct: 53 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLA 112
Query: 272 YLHKLEHKTLPLPKLIAIALDIARGMEYIH-SQGVIHRDLKPENVLIDQE------FHLK 324
+ K EH+ +PL + I+ + G++Y+H G+IH D+KPENVL++ +K
Sbjct: 113 LIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 172
Query: 325 IADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE 384
IAD G AC Y + ++ T + +PE++ +G D++S +++E++ G +E
Sbjct: 173 IADLGNACW--YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.9 bits (204), Expect = 3e-19
Identities = 32/207 (15%), Positives = 63/207 (30%), Gaps = 47/207 (22%)
Query: 183 LGLRFAHGAHSRLYHGIYKD-EPVAVKIIRI----------PDDDENETLAARLEKQFNR 231
+G G S +++ + VK ++ D + + +
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 232 EVALLSRLHNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIAL 291
E L +L V K A V+ E + E + + +
Sbjct: 64 EFRALQKLQGLAVPKVYAWEG----NAVLMELIDAK---------ELYRVRVENPDEVLD 110
Query: 292 DIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMA 351
I + + +G++H DL NVL+ E + I DF + E
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE------------VGEEGW 157
Query: 352 PEMIKH----------KSYGRKVDVYS 368
E+++ ++Y + D+ S
Sbjct: 158 REILERDVRNIITYFSRTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 405 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.53 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.94 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.52 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.46 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.06 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.88 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-51 Score=386.89 Aligned_cols=219 Identities=30% Similarity=0.610 Sum_probs=186.2
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
++|+|+.++|.+++.||+|+||+||+|++++ .||||+++........ .+.|.+|+.+|++++|||||++++++
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~------~~~~~~E~~~l~~l~HpnIv~~~~~~ 73 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQ------LQAFKNEVGVLRKTRHVNILLFMGYS 73 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTH------HHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHH------HHHHHHHHHHHHhCCCCCEeeeeEEE
Confidence 5799999999999999999999999998765 5999999765544332 46789999999999999999999988
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
.+ +.+++|||||++|+|.+++.. ....+++..++.|+.||+.||+|||+++||||||||+||||+.++.+||+|||+|
T Consensus 74 ~~-~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla 151 (276)
T d1uwha_ 74 TA-PQLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA 151 (276)
T ss_dssp CS-SSCEEEEECCCEEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCS
T ss_pred ec-cEEEEEEecCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccce
Confidence 65 457899999999999999976 3457999999999999999999999999999999999999999999999999998
Q ss_pred ccccc---cCCCCCCCCCCcccCcccccc---ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 332 CEEVY---CDALSDDPGTYRWMAPEMIKH---KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 332 ~~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
..... ........||+.|||||++.+ ..|+.++|||||||+||||+||+.||.+.++.+.+..++.+.
T Consensus 152 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~ 225 (276)
T d1uwha_ 152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG 225 (276)
T ss_dssp CC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHT
T ss_pred eeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcC
Confidence 65432 223345679999999999864 358999999999999999999999999988777766665543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=379.40 Aligned_cols=214 Identities=28% Similarity=0.430 Sum_probs=189.8
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
+++|.+++.||+|+||+||+|++. ++.||||++..... ........+.+|+.+|++++|||||++++++.++.
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHc-----cChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence 468999999999999999999986 68999999973211 11123567889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+|+|||||++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred EEEEEEeecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC
Confidence 99999999999999999986 3579999999999999999999999999999999999999999999999999996544
Q ss_pred ccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 336 YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 336 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
. .......||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+....+.+..
T Consensus 158 ~-~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 220 (263)
T d2j4za1 158 S-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 220 (263)
T ss_dssp C-CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC
T ss_pred C-CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 3 23345679999999999999999999999999999999999999999999888887776654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-50 Score=381.64 Aligned_cols=211 Identities=27% Similarity=0.509 Sum_probs=190.4
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+.+.||+|+||+||+|.+. |+.||||++....... .+.+.+|+.+|++++|||||++++++.++..
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 91 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--------KELIINEILVMRENKNPNIVNYLDSYLVGDE 91 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--------HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--------HHHHHHHHHHHHhCCCCCEeeEeEEEEECCE
Confidence 46899999999999999999975 7999999998654433 3567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+|+|||||++|+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 92 ~~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp EEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 9999999999999998876 5799999999999999999999999999999999999999999999999999976433
Q ss_pred -cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 337 -CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 337 -~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....++++..
T Consensus 169 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~ 233 (293)
T d1yhwa1 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT 233 (293)
T ss_dssp TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS
T ss_pred ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC
Confidence 2344566799999999999999999999999999999999999999999999998888876643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=379.74 Aligned_cols=207 Identities=29% Similarity=0.513 Sum_probs=178.8
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.++|.+++.||+|+||+||+|++. |+.||||++......+ ..+.+.+|+.+|++++|||||++++++.++.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-------~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~ 76 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-------CPENIKKEICINKMLNHENVVKFYGHRREGN 76 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-------HHHHHHHHHHHHHhCCCCCEeeEeeeeccCc
Confidence 357999999999999999999986 7899999997644322 1356889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+|+|||||++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 77 ~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 77 IQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp EEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred eeEEEEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeec
Confidence 99999999999999999865 5679999999999999999999999999999999999999999999999999996543
Q ss_pred c---cCCCCCCCCCCcccCccccccccC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015556 336 Y---CDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393 (405)
Q Consensus 336 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~ 393 (405)
. .......+||+.|||||++.+..+ +.++|||||||+||||++|+.||..........
T Consensus 155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~ 216 (271)
T d1nvra_ 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 216 (271)
T ss_dssp ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH
T ss_pred cCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH
Confidence 2 223456689999999999988876 578999999999999999999998765444333
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=378.52 Aligned_cols=215 Identities=25% Similarity=0.397 Sum_probs=187.7
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
.++|.+++.||+|+||+||+|.+. ++.||||++..... ......+.+.+|+.+|++++|||||++++++.++.
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 81 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-----IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 81 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc-----cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC
Confidence 367999999999999999999986 78999999974211 11122467889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+|+|||||++|+|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+|||+++++.+||+|||+|....
T Consensus 82 ~~~ivmEy~~gg~L~~~~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp EEEEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEccCCCCHHHhhhc--cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecc
Confidence 99999999999999999887 4679999999999999999999999999999999999999999999999999996543
Q ss_pred c---cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 336 Y---CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 336 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
. .......+||+.|||||++.+..|+.++|||||||+||||++|..||.+.+..+...++.+..
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~ 226 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 226 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC
T ss_pred cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC
Confidence 2 223345679999999999999999999999999999999999999999999998888887654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=373.26 Aligned_cols=221 Identities=31% Similarity=0.486 Sum_probs=192.1
Q ss_pred ccccccccCCCeeecceeeeeeeEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 015556 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248 (405)
Q Consensus 170 ~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 248 (405)
+.++|+|+.++|.+++.||+|+||.||+|.+++ +.||||++...... .+.|.+|+.+|.+++|||||+++
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---------~~~~~~E~~~l~~l~HpnIv~~~ 74 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---------PDAFLAEANLMKQLQHQRLVRLY 74 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---------HHHHHHHHHHHHhCCCCCEeEEE
Confidence 467899999999999999999999999999974 78999999754332 34688999999999999999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEec
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF 328 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DF 328 (405)
|++.++ .+++|||||++|+|.+++.......+++..++.|+.||+.||.|||+++|+||||||+||||+.++.+||+||
T Consensus 75 g~~~~~-~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DF 153 (272)
T d1qpca_ 75 AVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADF 153 (272)
T ss_dssp EEECSS-SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred eeeccC-CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccc
Confidence 988764 5689999999999999887655567999999999999999999999999999999999999999999999999
Q ss_pred CCccccccc--CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 015556 329 GIACEEVYC--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 329 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
|+|...... .......||+.|||||++.+..++.++|||||||++|||+| |..||...+..+....+.++..
T Consensus 154 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~ 228 (272)
T d1qpca_ 154 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR 228 (272)
T ss_dssp TTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred cceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC
Confidence 999654322 23345679999999999998999999999999999999999 5667777888777777766543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=378.53 Aligned_cols=212 Identities=25% Similarity=0.464 Sum_probs=187.9
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
+.|.+++.||+|+||.||+|++. ++.||||++....... .+.+.+|+++|++++|||||++++++.+++.
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--------~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 83 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE--------LEDYMVEIDILASCDHPNIVKLLDAFYYENN 83 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG--------GGGTHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH--------HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCe
Confidence 35889999999999999999986 6899999998654332 3567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
+|+|||||++|+|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 84 ~~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 99999999999999998763 46799999999999999999999999999999999999999999999999999865332
Q ss_pred c-CCCCCCCCCCcccCccccc-----cccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 337 C-DALSDDPGTYRWMAPEMIK-----HKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 337 ~-~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
. .......||+.|||||++. ...|+.++|||||||+||||++|+.||.+.++.+.+.++.++.
T Consensus 163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~ 231 (288)
T d2jfla1 163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE 231 (288)
T ss_dssp HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC
T ss_pred CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence 1 2334678999999999983 5568999999999999999999999999999999998888764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-49 Score=379.47 Aligned_cols=216 Identities=25% Similarity=0.542 Sum_probs=187.4
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
++|+++.++|.+++.||+|+||+||+|.+. ++.||||+++..... .++|.+|+.+|++++|||||+++|
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---------~~~~~~E~~il~~l~HpnIv~~~~ 80 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---------VEEFLKEAAVMKEIKHPNLVQLLG 80 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---------HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---------HHHHHHHHHHHHhCCCCCEecCCc
Confidence 578999999999999999999999999986 689999998643322 346889999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
+|.+++.+++|||||++|+|.+++.......+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus 81 ~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG 160 (287)
T d1opja_ 81 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 160 (287)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred cEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEcccc
Confidence 99999999999999999999999988777889999999999999999999999999999999999999999999999999
Q ss_pred CcccccccC--CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHh
Q 015556 330 IACEEVYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPY-EEMNPIQAAFAVVN 397 (405)
Q Consensus 330 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf-~~~~~~e~~~~i~~ 397 (405)
+|....... ......|++.|+|||++.+..|+.++|||||||++|||++|..|| .+.+..+ +.+++.
T Consensus 161 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~~i~ 230 (287)
T d1opja_ 161 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLE 230 (287)
T ss_dssp CTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHHH
T ss_pred ceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HHHHHh
Confidence 996543221 223345889999999999999999999999999999999966555 5555544 444443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=373.71 Aligned_cols=216 Identities=24% Similarity=0.349 Sum_probs=179.2
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec--
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK-- 253 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-- 253 (405)
.++|.+.+.||+|+||+||+|++. |+.||||++......+.. .+.+.+|+.+|++++|||||++++++.+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 76 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE------KQMLVSEVNLLRELKHPNIVRYYDRIIDRT 76 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHH------HHHHHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHH------HHHHHHHHHHHHHCCCCCEeeEEEEEEeCC
Confidence 367999999999999999999986 789999999866544322 4678899999999999999999999865
Q ss_pred CCeeEEEEeecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCcEEECCCCcEEEE
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKL--EHKTLPLPKLIAIALDIARGMEYIHSQG-----VIHRDLKPENVLIDQEFHLKIA 326 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g-----IiHrDIkp~NILl~~~~~vkL~ 326 (405)
+..+|+|||||++|+|.+++.+. ....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+
T Consensus 77 ~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~ 156 (269)
T d2java1 77 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 156 (269)
T ss_dssp --CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEEC
T ss_pred CCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEe
Confidence 46689999999999999999753 3567999999999999999999999976 9999999999999999999999
Q ss_pred ecCCccccccc-CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 327 DFGIACEEVYC-DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 327 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
|||+|...... .......||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.++.
T Consensus 157 DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~ 230 (269)
T d2java1 157 DFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 230 (269)
T ss_dssp CHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred eccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence 99999654332 23345679999999999999999999999999999999999999999999988888877654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=380.81 Aligned_cols=217 Identities=24% Similarity=0.396 Sum_probs=192.2
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 253 (405)
|.+++|.+++.||+|+||.||+|++. |+.||||++..... ......+++.+|+.+|++++|||||++++++.+
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~-----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-----IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhc-----cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence 56789999999999999999999985 79999999974211 111124678899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
...+|+|||||+||+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 77 ~~~~~iv~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~ 154 (337)
T d1o6la_ 77 HDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred ccccccceeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccc
Confidence 9999999999999999999987 46789999999999999999999999999999999999999999999999999976
Q ss_pred ccc-cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 334 EVY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 334 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
... .......+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+....+.++.
T Consensus 155 ~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~ 221 (337)
T d1o6la_ 155 GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221 (337)
T ss_dssp SCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred cccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC
Confidence 433 344456789999999999999999999999999999999999999999999888777666543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-49 Score=380.27 Aligned_cols=212 Identities=25% Similarity=0.392 Sum_probs=173.6
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
+.|.+++.||+|+||+||+|.+. ++.||||++........ ...+.+|+.+|++++|||||++++++.+++.
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-------~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 81 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-------EGSMENEIAVLHKIKHPNIVALDDIYESGGH 81 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------------CHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH-------HHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 45999999999999999999986 78999999985443221 3567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEC---CCCcEEEEecCCccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID---QEFHLKIADFGIACE 333 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~---~~~~vkL~DFG~a~~ 333 (405)
+|+|||||+||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+. +++.+||+|||+|..
T Consensus 82 ~~lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp EEEEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred EEEEEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 9999999999999999976 56899999999999999999999999999999999999994 578999999999976
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
..........+||+.|||||++.+..|+.++|||||||+||||++|..||.+.+..+....+.++.
T Consensus 160 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~ 225 (307)
T d1a06a_ 160 EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE 225 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTC
T ss_pred ccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccC
Confidence 655555566789999999999999999999999999999999999999999999988888887754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.8e-49 Score=383.63 Aligned_cols=213 Identities=22% Similarity=0.366 Sum_probs=190.4
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
+++|.+++.||+|+||.||+|++. |+.||||++...... ..+.+.+|+.+|++|+|||||++++++.+++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~--------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--------DKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH--------HHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh--------hHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 358999999999999999999986 789999999754321 1457889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEC--CCCcEEEEecCCccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID--QEFHLKIADFGIACE 333 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~--~~~~vkL~DFG~a~~ 333 (405)
.+|+|||||+||+|.+++.. ....+++..++.|+.||+.||.|||++|||||||||+|||++ .++.+||+|||++..
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 99999999999999999965 245799999999999999999999999999999999999995 468899999999976
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
...........||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+..+.+..
T Consensus 176 ~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 241 (350)
T d1koaa2 176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD 241 (350)
T ss_dssp CCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred cccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 655555556789999999999999999999999999999999999999999999998888887654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-48 Score=375.01 Aligned_cols=213 Identities=28% Similarity=0.458 Sum_probs=190.6
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
+++|.+++.||+|+||+||+|++. |+.||||++..... ......+.+.+|+.+|++++|||||++++++.++.
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 77 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-----VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 77 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc-----cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC
Confidence 578999999999999999999986 78999999973211 11122467889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+|+|||||.||+|..++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|....
T Consensus 78 ~~~ivmE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp EEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eeeeEeeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEec
Confidence 99999999999999999887 5678899999999999999999999999999999999999999999999999996543
Q ss_pred ccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 336 YCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 336 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
. .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+...++.++.
T Consensus 156 ~--~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~ 217 (316)
T d1fota_ 156 D--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE 217 (316)
T ss_dssp S--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC
T ss_pred c--ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC
Confidence 2 3346789999999999999999999999999999999999999999999999988888764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-48 Score=374.48 Aligned_cols=219 Identities=25% Similarity=0.495 Sum_probs=180.9
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--Cc---cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DE---PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~---~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
.++.++|.+++.||+|+||+||+|.+. ++ .||||.+....... ..+.|.+|+.+|++++|||||+++|
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~HpnIv~l~g 94 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-------QRRDFLSEASIMGQFDHPNVIHLEG 94 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHH-------HHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHH-------HHHHHHHHHHHHHhCCCCCCccEEE
Confidence 567789999999999999999999985 22 57888775433221 2467899999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
+|.+++.+++|||||++|+|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||
T Consensus 95 ~~~~~~~~~iv~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG 173 (299)
T d1jpaa_ 95 VVTKSTPVMIITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFG 173 (299)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred EEeeCCEEEEEEEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcc
Confidence 99999999999999999999999876 34579999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCC------CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccC
Q 015556 330 IACEEVYCDA------LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVNF 401 (405)
Q Consensus 330 ~a~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~~ 401 (405)
++........ .....||+.|||||++.+..|+.++|||||||+||||+| |..||.+....+....+.++...
T Consensus 174 la~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 252 (299)
T d1jpaa_ 174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL 252 (299)
T ss_dssp ----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred cceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9965332211 122357899999999999999999999999999999998 89999999999888888776543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=366.53 Aligned_cols=215 Identities=27% Similarity=0.546 Sum_probs=180.6
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
+|.++|.+++.||+|+||+||+|.+. ++.||||+++..... .++|.+|+.++++++|||||+++|+|.++
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---------HHHHHHHHHHHHhcCCCCcccccceeccC
Confidence 67789999999999999999999996 578999998753332 34688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
..+++|||||++|+|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++...
T Consensus 73 ~~~~lv~E~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 151 (263)
T d1sm2a_ 73 APICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 151 (263)
T ss_dssp SSCEEEEECCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred CceEEEEEecCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheec
Confidence 999999999999999999876 3467899999999999999999999999999999999999999999999999999654
Q ss_pred cccC--CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 015556 335 VYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 335 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
.... ......||+.|+|||++.+..|+.++|||||||++|||+| |..||...+..+....+.++..
T Consensus 152 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~ 220 (263)
T d1sm2a_ 152 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR 220 (263)
T ss_dssp -------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC
T ss_pred cCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC
Confidence 3322 2234568999999999999999999999999999999999 6788888888777777766543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=370.81 Aligned_cols=217 Identities=24% Similarity=0.375 Sum_probs=192.1
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
+.|.+++.||+|+||+||+|++. |+.||||++.......... ....+.|.+|+.+|++++|||||+++++|.++..
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR--GVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhh--hHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 46999999999999999999986 7899999997643322110 0114678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCC----cEEEEecCCcc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF----HLKIADFGIAC 332 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~----~vkL~DFG~a~ 332 (405)
+|+|||||++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 88 ~~iv~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 9999999999999999987 35799999999999999999999999999999999999998776 59999999997
Q ss_pred cccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 333 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
............||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.+..
T Consensus 166 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~ 232 (293)
T d1jksa_ 166 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 232 (293)
T ss_dssp ECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC
T ss_pred hcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcC
Confidence 7666566677789999999999999999999999999999999999999999999988888776653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-49 Score=381.09 Aligned_cols=201 Identities=24% Similarity=0.397 Sum_probs=178.8
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
-++|.+++.||+|+||+||+|++. |+.||||+++....... ..++.+|+.+|++++|||||+++++|.++.
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~-------~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 77 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI-------RNQIIRELQVLHECNSPYIVGFYGAFYSDG 77 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTH-------HHHHHHHGGGGGGCCCTTBCCEEEEEECSS
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHH-------HHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 367999999999999999999986 78999999986543322 467889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
.+|+|||||++|+|.+++.+ .+.+++..+..++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+|...
T Consensus 78 ~~~iVmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 78 EISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EEEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEEEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 99999999999999999987 3579999999999999999999997 59999999999999999999999999999754
Q ss_pred cccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 015556 335 VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNP 388 (405)
Q Consensus 335 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~ 388 (405)
... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.
T Consensus 156 ~~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 156 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp HHH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred CCC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 432 33456899999999999999999999999999999999999999987553
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-48 Score=372.18 Aligned_cols=211 Identities=27% Similarity=0.407 Sum_probs=187.5
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVY 257 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 257 (405)
.|.+.+.||+|+||.||+|++. ++.||||++......... ..+.+.+|+.+|++|+|||||++++++.++..+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-----KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHH-----HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHH-----HHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEE
Confidence 4888999999999999999985 688999999865544332 246788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccccc
Q 015556 258 CVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC 337 (405)
Q Consensus 258 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~ 337 (405)
|+|||||.+|+|..++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|.....
T Consensus 91 ~iv~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp EEEEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EEEEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 999999999999777665 46799999999999999999999999999999999999999999999999999965433
Q ss_pred CCCCCCCCCCcccCcccccc---ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 338 DALSDDPGTYRWMAPEMIKH---KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 338 ~~~~~~~gt~~y~aPE~~~~---~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
.....||+.|||||++.+ ..|+.++|||||||++|||++|..||.+.+..+.+..++++..
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~ 231 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 231 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 345679999999999854 4689999999999999999999999999999999988887643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2e-48 Score=381.40 Aligned_cols=212 Identities=21% Similarity=0.365 Sum_probs=190.7
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
++|.+++.||+|+||.||+|++. |+.||||++......+ ...+.+|+.+|++|+|||||++++++.++..
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--------~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~ 100 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--------KYTVKNEISIMNQLHHPKLINLHDAFEDKYE 100 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH--------HHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH--------HHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 57999999999999999999985 7999999997543211 3567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEC--CCCcEEEEecCCcccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID--QEFHLKIADFGIACEE 334 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~--~~~~vkL~DFG~a~~~ 334 (405)
+|+|||||+||+|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+|...
T Consensus 101 ~~ivmE~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceec
Confidence 9999999999999998765 345699999999999999999999999999999999999997 6789999999999776
Q ss_pred cccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 335 VYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 335 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
..........||+.|||||++.+..|+.++|||||||+||+|++|+.||.+.+..+.+..+.+..
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 244 (352)
T d1koba_ 180 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD 244 (352)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC
T ss_pred CCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 55555556789999999999999999999999999999999999999999999999888887754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=364.99 Aligned_cols=208 Identities=28% Similarity=0.524 Sum_probs=177.8
Q ss_pred eeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec----C
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK----P 254 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~ 254 (405)
|.+.++||+|+||+||+|.+. ++.||||.+......+.. .+.|.+|+++|++++|||||+++++|.+ .
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 84 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE------RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 84 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH------HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHH------HHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence 467788999999999999986 578999999865443322 4678899999999999999999999865 4
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEC-CCCcEEEEecCCc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQG--VIHRDLKPENVLID-QEFHLKIADFGIA 331 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IiHrDIkp~NILl~-~~~~vkL~DFG~a 331 (405)
..+|+|||||++|+|.+++.+ ...+++..++.++.||+.||+|||+++ |+||||||+||||+ +++.+||+|||+|
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred CEEEEEEeCCCCCcHHHHHhc--cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 568999999999999999987 367999999999999999999999998 99999999999996 5789999999999
Q ss_pred ccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 332 CEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 332 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
..... ......+||+.|||||++.+ .|+.++|||||||+||||++|+.||.+....+.+.+.+..
T Consensus 163 ~~~~~-~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~ 227 (270)
T d1t4ha_ 163 TLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 227 (270)
T ss_dssp GGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT
T ss_pred eeccC-CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc
Confidence 64332 23345679999999999875 5999999999999999999999999887666655555443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=379.54 Aligned_cols=224 Identities=26% Similarity=0.471 Sum_probs=190.4
Q ss_pred cccccccccCCCeeecceeeeeeeEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-C
Q 015556 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-H 240 (405)
Q Consensus 169 ~~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~ 240 (405)
.+...|+++.++|.+++.||+|+||+||+|++.+ ..||||.+....... ....+.+|+.+|.++ +
T Consensus 27 ~~~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~~ 99 (325)
T d1rjba_ 27 EYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-------EREALMSELKMMTQLGS 99 (325)
T ss_dssp CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCC
T ss_pred CCCccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHH-------HHHHHHHHHHHHHHhcC
Confidence 3456788999999999999999999999999753 269999986433222 245788999999998 8
Q ss_pred CCCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHH
Q 015556 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLEH---------------------KTLPLPKLIAIALDIARGMEY 299 (405)
Q Consensus 241 HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~aL~y 299 (405)
|||||+++++|.+.+.+++|||||++|+|.++|+.... ..+++..++.++.||+.||+|
T Consensus 100 HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~y 179 (325)
T d1rjba_ 100 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179 (325)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHH
T ss_pred CCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999986421 358999999999999999999
Q ss_pred HHHCCceecCCCCCcEEECCCCcEEEEecCCcccccccCC---CCCCCCCCcccCccccccccCCchhhHHHHHHHHHHH
Q 015556 300 IHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVYCDA---LSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEM 376 (405)
Q Consensus 300 LH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~el 376 (405)
||+++||||||||+|||++.++.+||+|||+|........ .....||+.|||||++.+..|+.++|||||||+||||
T Consensus 180 LH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~em 259 (325)
T d1rjba_ 180 LEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 259 (325)
T ss_dssp HHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHH
Confidence 9999999999999999999999999999999965433222 2244579999999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 377 VA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 377 lt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
++ |..||.+.+..+.+.+++++.
T Consensus 260 lt~g~~Pf~~~~~~~~~~~~~~~~ 283 (325)
T d1rjba_ 260 FSLGVNPYPGIPVDANFYKLIQNG 283 (325)
T ss_dssp TTTSCCSSTTCCCSHHHHHHHHTT
T ss_pred HhCCCCCCCCCCHHHHHHHHHhcC
Confidence 98 999999988877777777653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=359.81 Aligned_cols=215 Identities=25% Similarity=0.521 Sum_probs=190.7
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
+|.++|++++.||+|+||+||+|+++ ++.||||+++..... .++|.+|+.++++++||||++++|+|.++
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~ 71 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---------HHHHHHHHHHHHTCCCTTBCCEEEEECCS
T ss_pred CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC---------HHHHHHHHHHHHhcCCCceeeEEEEEeeC
Confidence 46789999999999999999999997 468999999865433 24688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
+.+++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 72 ~~~~iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~ 150 (258)
T d1k2pa_ 72 RPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 150 (258)
T ss_dssp SSEEEEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBC
T ss_pred CceEEEEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheec
Confidence 9999999999999999997763 457889999999999999999999999999999999999999999999999999653
Q ss_pred cccC--CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 015556 335 VYCD--ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 335 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
.... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+....+.++..
T Consensus 151 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 219 (258)
T d1k2pa_ 151 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR 219 (258)
T ss_dssp SSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred cCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC
Confidence 3322 2234568999999999999999999999999999999998 8999999999988888877644
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-48 Score=366.89 Aligned_cols=218 Identities=23% Similarity=0.502 Sum_probs=185.7
Q ss_pred ccccCCCeeecce-eeeeeeEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 015556 174 HTVDLSQLFLGLR-FAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248 (405)
Q Consensus 174 ~~i~~~~~~~~~~-lG~G~~g~Vy~~~~~----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 248 (405)
+.+..++|.+.+. ||+|+||.||+|.+. +..||||+++...... ..+.|.+|+.+|++++|||||+++
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~-------~~~~~~~E~~il~~l~HpnIv~l~ 75 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-------DTEEMMREAQIMHQLDNPYIVRLI 75 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHH-------HHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHH-------HHHHHHHHHHHHHhCCCCCEeeEe
Confidence 3455677888884 999999999999875 3479999997543221 246789999999999999999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEec
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF 328 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DF 328 (405)
|+|.++ .+|+|||||++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+||
T Consensus 76 g~~~~~-~~~lvmE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DF 153 (285)
T d1u59a_ 76 GVCQAE-ALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF 153 (285)
T ss_dssp EEEESS-SEEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCC
T ss_pred eeeccC-eEEEEEEeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccc
Confidence 999765 57899999999999999865 3467999999999999999999999999999999999999999999999999
Q ss_pred CCccccccc----CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 015556 329 GIACEEVYC----DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 329 G~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
|++...... .......||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..+....+.++..
T Consensus 154 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~ 230 (285)
T d1u59a_ 154 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR 230 (285)
T ss_dssp TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC
T ss_pred hhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999653322 22334568999999999999999999999999999999998 9999999998888777776543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.5e-47 Score=358.01 Aligned_cols=220 Identities=25% Similarity=0.447 Sum_probs=195.1
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChh-HHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeec
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDEN-ETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKK 253 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~-~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~ 253 (405)
.++|++++.||+|+||+||+|++. ++.||||++........ ........+.+.+|+.+|++|+ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999984 69999999987654332 1223445678999999999997 9999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
+..+|+|||||++|+|.++|.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CcceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 9999999999999999999986 45799999999999999999999999999999999999999999999999999977
Q ss_pred ccccCCCCCCCCCCcccCcccccc------ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKH------KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
...........||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.++.+....++++.
T Consensus 160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~ 231 (277)
T d1phka_ 160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 231 (277)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence 665556667789999999999853 356889999999999999999999999999998888888764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=364.79 Aligned_cols=220 Identities=28% Similarity=0.477 Sum_probs=186.2
Q ss_pred cccccccCCCeeecceeeeeeeEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 171 ADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 171 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
.++|+|+.++|.+++.||+|+||.||+|++++ +.||||++...... .+.|.+|+.+|++++|||||+++|
T Consensus 9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---------~~~~~~E~~~l~~l~h~nIv~~~g 79 (285)
T d1fmka3 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYA 79 (285)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---------HHHHHHHHHHHHhcccCCEeEEEE
Confidence 47899999999999999999999999999975 68999998754332 256889999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
+|.++ .+++|||||++|+|..++.......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus 80 ~~~~~-~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfG 158 (285)
T d1fmka3 80 VVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 158 (285)
T ss_dssp EECSS-SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred EEecC-CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccc
Confidence 99654 57899999999999999987666779999999999999999999999999999999999999999999999999
Q ss_pred Cccccccc--CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 015556 330 IACEEVYC--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 330 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
++...... .......||+.|+|||++.+..++.++|||||||+||||++ |..||.+....+.+..+.++..
T Consensus 159 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~ 232 (285)
T d1fmka3 159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 232 (285)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred hhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC
Confidence 99654322 22334569999999999999999999999999999999999 5666677777777777766543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-47 Score=373.54 Aligned_cols=215 Identities=28% Similarity=0.367 Sum_probs=191.4
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 253 (405)
..+++|.+++.||+|+||.||+|++. |+.||||++..... ........+.+|+.+|+.++|||||++++++.+
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 112 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-----VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc-----cCHHHHHHHHHHHHHHHHcCCCcEeeccccccc
Confidence 44578999999999999999999986 79999999963211 111224578899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 254 PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 254 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
...+++||||+.+|+|.+++.+ .+.+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+|..
T Consensus 113 ~~~~~~v~e~~~~g~l~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~ 190 (350)
T d1rdqe_ 113 NSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ccccccccccccccchhhhHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeee
Confidence 9999999999999999999987 35799999999999999999999999999999999999999999999999999965
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
... ......||+.|||||++.+..|+.++|||||||+||||++|+.||.+.++.+...++.++.
T Consensus 191 ~~~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~ 254 (350)
T d1rdqe_ 191 VKG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK 254 (350)
T ss_dssp CSS--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred ccc--ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC
Confidence 432 3345679999999999999999999999999999999999999999999999888887764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=363.89 Aligned_cols=212 Identities=26% Similarity=0.517 Sum_probs=177.4
Q ss_pred Ceeec-ceeeeeeeEEEEEEEEC----CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC
Q 015556 180 QLFLG-LRFAHGAHSRLYHGIYK----DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP 254 (405)
Q Consensus 180 ~~~~~-~~lG~G~~g~Vy~~~~~----~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 254 (405)
.+.+. ++||+|+||+||+|.+. ++.||||+++....+. ...++|.+|+.+|++++|||||+++|+|.++
T Consensus 7 ~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~------~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~ 80 (277)
T d1xbba_ 7 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP------ALKDELLAEANVMQQLDNPYIVRMIGICEAE 80 (277)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C------HHHHHHHHHHHHHHTCCCTTBCCEEEEEESS
T ss_pred hCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCH------HHHHHHHHHHHHHHhCCCCCCceEEEEeccC
Confidence 34443 36999999999999874 3679999996533222 2256799999999999999999999999765
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
.++||||||++|+|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...
T Consensus 81 -~~~lvmE~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 81 -SWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 157 (277)
T ss_dssp -SEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred -CEEEEEEcCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhc
Confidence 56899999999999999987 567999999999999999999999999999999999999999999999999999643
Q ss_pred ccc----CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 015556 335 VYC----DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 335 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
... .......||+.|||||++.+..++.++|||||||++|||++ |+.||.+.+..+....+.++..
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~ 228 (277)
T d1xbba_ 158 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER 228 (277)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred cccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 221 12234569999999999999999999999999999999998 9999999999888777776543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6e-47 Score=358.70 Aligned_cols=216 Identities=25% Similarity=0.440 Sum_probs=182.8
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC-
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP- 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~- 255 (405)
++|.+++.||+|+||.||+|.+. ++.||||++......+.. ....|.+|+.+|+.++|||||++++++....
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~-----~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPS-----FYLRFRREAQNAAALNHPAIVAVYDTGEAETP 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHH-----HHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHH-----HHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence 56999999999999999999986 799999999865443322 2567899999999999999999999987643
Q ss_pred ---eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 256 ---VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 256 ---~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
.+|+|||||+|++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+.
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred CCceEEEEEECCCCCEehhhhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhh
Confidence 48899999999999999877 4679999999999999999999999999999999999999999999999999875
Q ss_pred ccccc----CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Q 015556 333 EEVYC----DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNF 401 (405)
Q Consensus 333 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~~ 401 (405)
..... ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.++.+...++++....
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 232 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC
Confidence 43221 2334557999999999999999999999999999999999999999999999999988876543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=361.03 Aligned_cols=215 Identities=27% Similarity=0.521 Sum_probs=184.2
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK 253 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 253 (405)
|+++.++|.+++.||+|+||.||+|.++|+.||||+++.... .+.|.+|+.+|++++||||++++|+|.+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~----------~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 71 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT----------AQAFLAEASVMTQLRHSNLVQLLGVIVE 71 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------------HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHH----------HHHHHHHHHHHHhCCCCCEeeEEEEEEe
Confidence 889999999999999999999999999999999999964321 3568899999999999999999999865
Q ss_pred -CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 254 -PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 254 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
.+.+|+||||+++|+|.++|.......+++..++.|+.||+.||.|||+.+|+||||||+|||++.++.+||+|||++.
T Consensus 72 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 151 (262)
T ss_dssp C--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred cCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccce
Confidence 4668999999999999999987555568999999999999999999999999999999999999999999999999997
Q ss_pred cccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 015556 333 EEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 333 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
.... ......+|..|+|||++.+..++.++|||||||++|||+| |+.||...+..+....+.++..
T Consensus 152 ~~~~--~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~ 218 (262)
T d1byga_ 152 EASS--TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK 218 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC
T ss_pred ecCC--CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC
Confidence 5433 2344568999999999999999999999999999999998 8999999888888888766543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=367.85 Aligned_cols=212 Identities=16% Similarity=0.310 Sum_probs=189.0
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
+++|.+++.||+|+||+||+|.+. ++.||||+++....+ ...+.+|+.+|++++|||||++++++.+++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~---------~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 74 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---------QVLVKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH---------HHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc---------HHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 468999999999999999999986 689999999754311 345779999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC--CcEEEEecCCccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE--FHLKIADFGIACE 333 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~--~~vkL~DFG~a~~ 333 (405)
.+|+|||||+||+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhc
Confidence 99999999999999999976 23479999999999999999999999999999999999999754 5899999999976
Q ss_pred ccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 334 EVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 334 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
...........+|+.|+|||.+.+..|+.++|||||||++|+|++|..||.+.+..+....+.+..
T Consensus 154 ~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~ 219 (321)
T d1tkia_ 154 LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE 219 (321)
T ss_dssp CCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred cccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 555444555679999999999999999999999999999999999999999999998888887754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=360.53 Aligned_cols=219 Identities=24% Similarity=0.464 Sum_probs=180.0
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEECC-----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEE
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKF 247 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 247 (405)
+|+|+.++|.+++.||+|+||.||+|++.. ..||||.+...... ...+.|.+|+.+|++++|||||++
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~-------~~~~~~~~E~~~l~~l~HpnIv~l 73 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-------SVREKFLQEALTMRQFDHPHIVKL 73 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH-------HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH-------HHHHHHHHHHHHHHhCCCCCEeeE
Confidence 588999999999999999999999999852 34777776432221 125678999999999999999999
Q ss_pred eeEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEe
Q 015556 248 VAACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327 (405)
Q Consensus 248 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~D 327 (405)
+|+|.+ +.+++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|
T Consensus 74 ~~~~~~-~~~~iv~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~D 151 (273)
T d1mp8a_ 74 IGVITE-NPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD 151 (273)
T ss_dssp EEEECS-SSCEEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred EEEEec-CeEEEEEEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEcc
Confidence 999975 567899999999999998876 346789999999999999999999999999999999999999999999999
Q ss_pred cCCccccccc--CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 015556 328 FGIACEEVYC--DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 328 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
||+|...... .......||+.|+|||++.+..|+.++|||||||++|||++ |..||.+.+..+....+.++..
T Consensus 152 fG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~ 227 (273)
T d1mp8a_ 152 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 227 (273)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred chhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999654322 22344568999999999999999999999999999999998 9999999999988888887654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=364.04 Aligned_cols=215 Identities=25% Similarity=0.430 Sum_probs=185.9
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHH-hcCCCCeeEEeeEeecC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLS-RLHNPNVIKFVAACKKP 254 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~g~~~~~ 254 (405)
+++|.+++.||+|+||+||+|++. ++.||||++..... ........+..|+.++. .++|||||++++++.++
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~-----~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~ 75 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-----LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 75 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc-----cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC
Confidence 468999999999999999999995 79999999974210 01111334556666665 68999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccc
Q 015556 255 PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEE 334 (405)
Q Consensus 255 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~ 334 (405)
+.+|+|||||++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 76 ~~~yivmEy~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 76 ENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp SEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred CceeEEEeecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhc
Confidence 999999999999999999987 457899999999999999999999999999999999999999999999999999754
Q ss_pred cc-cCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 335 VY-CDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 335 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
.. ........||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.++.+...++.++.
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~ 219 (320)
T d1xjda_ 154 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN 219 (320)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred ccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 32 334455689999999999999999999999999999999999999999999988887776543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=358.36 Aligned_cols=218 Identities=26% Similarity=0.492 Sum_probs=181.2
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEECC------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYKD------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFV 248 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 248 (405)
+++.++|.+++.||+|+||.||+|.+.+ ..||||++....... ...+|.+|+.+|++++|||||+++
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~-------~~~~~~~E~~il~~l~H~nIv~~~ 75 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-------QRVDFLGEAGIMGQFSHHNIIRLE 75 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH-------HHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH-------HHHHHHHHHHHHHhcCCCCEeeee
Confidence 5677899999999999999999998753 369999997543322 145788999999999999999999
Q ss_pred eEeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEec
Q 015556 249 AACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADF 328 (405)
Q Consensus 249 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DF 328 (405)
|+|.+....++|||||.+++|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+||
T Consensus 76 g~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DF 154 (283)
T d1mqba_ 76 GVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDF 154 (283)
T ss_dssp EEECSSSSEEEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred EEEecCCceEEEEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEccc
Confidence 999999999999999999999998876 3467999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccC----CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 015556 329 GIACEEVYCD----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 329 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
|++....... ......||+.|||||++.+..++.++|||||||++|||++ |..||...+..+....+.++..
T Consensus 155 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~ 231 (283)
T d1mqba_ 155 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR 231 (283)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred chhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC
Confidence 9996533221 2233468999999999999999999999999999999999 5666677777777666666543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-47 Score=367.46 Aligned_cols=203 Identities=24% Similarity=0.409 Sum_probs=175.1
Q ss_pred CCCeeecc-eeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEeeEeec
Q 015556 178 LSQLFLGL-RFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVAACKK 253 (405)
Q Consensus 178 ~~~~~~~~-~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~ 253 (405)
+++|.+.+ .||+|+||+||+|++. ++.||||++.. ...+.+|+.++.++ +|||||+++++|.+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------------CPKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------------SHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------------cHHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 35787764 6999999999999985 68999999963 23466899987665 79999999999875
Q ss_pred ----CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC---CCcEEEE
Q 015556 254 ----PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ---EFHLKIA 326 (405)
Q Consensus 254 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~---~~~vkL~ 326 (405)
...+|+|||||+||+|.++|.......+++..+..|+.||+.||+|||++||+||||||+|||++. ++.+||+
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred cccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccc
Confidence 467899999999999999998755567999999999999999999999999999999999999975 5679999
Q ss_pred ecCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015556 327 DFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393 (405)
Q Consensus 327 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~ 393 (405)
|||+|.............||+.|||||++.+..|+.++|||||||+||+|+||+.||.+.+..+...
T Consensus 157 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~ 223 (335)
T d2ozaa1 157 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 223 (335)
T ss_dssp CCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----
T ss_pred ccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH
Confidence 9999977666666677789999999999999999999999999999999999999998765544433
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4e-46 Score=366.58 Aligned_cols=204 Identities=24% Similarity=0.383 Sum_probs=174.5
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHH---HHHHHHHhcCCCCeeEEeeEe
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFN---REVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~---~Ei~il~~l~HpnIv~l~g~~ 251 (405)
.+++|.+++.||+|+||.||+|++. |+.||||++...... .......+. .|+.+++.++|||||++++++
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~-----~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~ 76 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-----MKQGETLALNERIMLSLVSTGDCPFIVCMSYAF 76 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcc-----hhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE
Confidence 4678999999999999999999986 789999999632111 011122333 456777778899999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
.+.+.+|+|||||++|+|.++|.+ ...+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|
T Consensus 77 ~~~~~~~ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla 154 (364)
T d1omwa3 77 HTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 154 (364)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred EECCEEEEEEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeecee
Confidence 999999999999999999999987 467899999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 015556 332 CEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNP 388 (405)
Q Consensus 332 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~ 388 (405)
...... ......||+.|+|||++.. ..|+.++|||||||+||||++|+.||.+.+.
T Consensus 155 ~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 211 (364)
T d1omwa3 155 CDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211 (364)
T ss_dssp EECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred eecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence 755443 3455679999999999864 5689999999999999999999999987543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-46 Score=354.70 Aligned_cols=215 Identities=27% Similarity=0.475 Sum_probs=185.4
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
+++|.++++||+|+||+||+|++. ++.||||++......+ ....++.+|+.+|++++|||||++++++.++.
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~ 74 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE------GVPSTAIREISLLKELNHPNIVKLLDVIHTEN 74 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcCh------HHHHHHHHHHHHHHhCCCCcEEEecccccccc
Confidence 368999999999999999999986 7899999996543221 12467889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+|+||||+. +.+.+++.......+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+|....
T Consensus 75 ~~~iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 75 KLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153 (298)
T ss_dssp EEEEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred ceeEEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceecc
Confidence 9999999995 566777766566789999999999999999999999999999999999999999999999999996543
Q ss_pred c-cCCCCCCCCCCcccCccccccccC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 336 Y-CDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 336 ~-~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
. ........||+.|+|||++....+ +.++|||||||++|+|++|+.||.+.+..+.+..+.+..
T Consensus 154 ~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~ 219 (298)
T d1gz8a_ 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 219 (298)
T ss_dssp CCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred CCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhc
Confidence 2 334455679999999999876664 889999999999999999999999999999888887654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-46 Score=354.39 Aligned_cols=224 Identities=30% Similarity=0.511 Sum_probs=188.3
Q ss_pred ccccccccCCCeeecceeeeeeeEEEEEEEECC---------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-
Q 015556 170 AADEHTVDLSQLFLGLRFAHGAHSRLYHGIYKD---------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL- 239 (405)
Q Consensus 170 ~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~---------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l- 239 (405)
..++|.|+.++|.+++.||+|+||.||+|++.+ ..||||+++...... ...++.+|+.++.++
T Consensus 4 ~~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-------~~~~~~~e~~~l~~~~ 76 (299)
T d1fgka_ 4 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-------DLSDLISEMEMMKMIG 76 (299)
T ss_dssp CCTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHH-------HHHHHHHHHHHHHHHC
T ss_pred cCCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChH-------HHHHHHHHHHHHHHhc
Confidence 456799999999999999999999999998742 369999987533221 246788999999998
Q ss_pred CCCCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 015556 240 HNPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGV 305 (405)
Q Consensus 240 ~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~gI 305 (405)
+|||||+++++|.++..+++|||||++|+|.++|.... ...+++..++.++.||+.||.|||+++|
T Consensus 77 ~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~i 156 (299)
T d1fgka_ 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC 156 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCE
Confidence 79999999999999999999999999999999997643 2458999999999999999999999999
Q ss_pred eecCCCCCcEEECCCCcEEEEecCCcccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCC
Q 015556 306 IHRDLKPENVLIDQEFHLKIADFGIACEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTI 381 (405)
Q Consensus 306 iHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~ 381 (405)
|||||||+|||++.++.+||+|||++....... ......||+.|+|||.+.++.|+.++|||||||++|||++ |..
T Consensus 157 vHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~ 236 (299)
T d1fgka_ 157 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236 (299)
T ss_dssp CCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred EeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCC
Confidence 999999999999999999999999986543322 3344679999999999999999999999999999999998 799
Q ss_pred CCCCCCHHHHHHHHHhccc
Q 015556 382 PYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 382 Pf~~~~~~e~~~~i~~~~~ 400 (405)
||.+.+..+....+.++..
T Consensus 237 p~~~~~~~~~~~~i~~~~~ 255 (299)
T d1fgka_ 237 PYPGVPVEELFKLLKEGHR 255 (299)
T ss_dssp SSTTCCHHHHHHHHHTTCC
T ss_pred CCCCCCHHHHHHHHHcCCC
Confidence 9999888777666655543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-45 Score=353.38 Aligned_cols=221 Identities=28% Similarity=0.519 Sum_probs=189.6
Q ss_pred cccccCCCeeecceeeeeeeEEEEEEEECC-------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 015556 173 EHTVDLSQLFLGLRFAHGAHSRLYHGIYKD-------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVI 245 (405)
Q Consensus 173 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 245 (405)
++++..++|.+++.||+|+||+||+|++.+ +.||||++...... ...++|.+|+.+|++++||||+
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-------~~~~~~~~E~~il~~l~h~niv 79 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-------DMQADFQREAALMAEFDNPNIV 79 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-------HHHHHHHHHHHHHHTCCCTTBC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh-------HHHHHHHHHHHHHHhcCCCCcc
Confidence 355667889999999999999999999753 68999998643322 1257889999999999999999
Q ss_pred EEeeEeecCCeeEEEEeecCCCCHHHHHHHhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 015556 246 KFVAACKKPPVYCVITEYLSEGSLRAYLHKLE----------------------HKTLPLPKLIAIALDIARGMEYIHSQ 303 (405)
Q Consensus 246 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~yLH~~ 303 (405)
+++++|.+....++||||+++|+|.+++.... ...+++..++.|+.||+.||+|||++
T Consensus 80 ~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~ 159 (301)
T d1lufa_ 80 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 159 (301)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC
Confidence 99999999999999999999999999997532 23488999999999999999999999
Q ss_pred CceecCCCCCcEEECCCCcEEEEecCCccccccc---CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhC-
Q 015556 304 GVIHRDLKPENVLIDQEFHLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG- 379 (405)
Q Consensus 304 gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG- 379 (405)
+||||||||+||||+.++.+||+|||+|...... .......||+.|+|||++.+..|+.++|||||||++|||++|
T Consensus 160 ~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~ 239 (301)
T d1lufa_ 160 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239 (301)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccC
Confidence 9999999999999999999999999998643222 233455789999999999999999999999999999999997
Q ss_pred CCCCCCCCHHHHHHHHHhccc
Q 015556 380 TIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 380 ~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
..||.+.+..+....+.++..
T Consensus 240 ~~p~~~~~~~e~~~~v~~~~~ 260 (301)
T d1lufa_ 240 LQPYYGMAHEEVIYYVRDGNI 260 (301)
T ss_dssp CCTTTTSCHHHHHHHHHTTCC
T ss_pred CCCCCCCCHHHHHHHHHcCCC
Confidence 578999999999888887654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-46 Score=355.62 Aligned_cols=211 Identities=25% Similarity=0.372 Sum_probs=176.4
Q ss_pred cceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCeeEEEE
Q 015556 184 GLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPVYCVIT 261 (405)
Q Consensus 184 ~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 261 (405)
++.||+|+||+||+|++. |+.||||+++........ ....+.+.+|+.+|++++|||||++++++.++..+|+||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~---~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivm 79 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAK---DGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF 79 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhh---HHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehh
Confidence 468999999999999985 789999998754432211 122457889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc-cCCC
Q 015556 262 EYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY-CDAL 340 (405)
Q Consensus 262 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~-~~~~ 340 (405)
||+.++.+..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 80 E~~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 80 DFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp ECCSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred hhhcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccc
Confidence 9998877665543 356789999999999999999999999999999999999999999999999999965433 2333
Q ss_pred CCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 341 SDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 341 ~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
...+||+.|+|||++.. ..|+.++|||||||++|||++|..||.+.+..+.+..+.+..
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~ 217 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 217 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhc
Confidence 45679999999999864 467999999999999999999999999999999988887653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-46 Score=356.16 Aligned_cols=220 Identities=28% Similarity=0.496 Sum_probs=187.3
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEEC--Cc--cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCCeeEEee
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYK--DE--PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPNVIKFVA 249 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~--~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g 249 (405)
.||+++|.+++.||+|+||.||+|.+. +. .||||.+......+. .+.|.+|+++|+++ +|||||+++|
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~~~~ 78 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-------HRDFAGELEVLCKLGHHPNIINLLG 78 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHH-------HHHHHHHHHHHHhccCCCCEeeEEE
Confidence 468899999999999999999999985 33 577888764333221 45788999999999 7999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKL--------------EHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENV 315 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NI 315 (405)
+|.+.+.+++||||+++|+|.++|+.. ....+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 79 ~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NI 158 (309)
T d1fvra_ 79 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI 158 (309)
T ss_dssp EEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceE
Confidence 999999999999999999999999753 246799999999999999999999999999999999999
Q ss_pred EECCCCcEEEEecCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHH
Q 015556 316 LIDQEFHLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG-TIPYEEMNPIQAAFA 394 (405)
Q Consensus 316 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG-~~Pf~~~~~~e~~~~ 394 (405)
|++.++.+||+|||++.............||..|+|||.+.+..|+.++|||||||++|||++| ..||.+.+..+....
T Consensus 159 L~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~ 238 (309)
T d1fvra_ 159 LVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 238 (309)
T ss_dssp EECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred EEcCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 9999999999999999765554555566799999999999999999999999999999999995 568999999888888
Q ss_pred HHhcccC
Q 015556 395 VVNKVNF 401 (405)
Q Consensus 395 i~~~~~~ 401 (405)
+.++..+
T Consensus 239 i~~~~~~ 245 (309)
T d1fvra_ 239 LPQGYRL 245 (309)
T ss_dssp GGGTCCC
T ss_pred HHhcCCC
Confidence 7776443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=354.81 Aligned_cols=214 Identities=27% Similarity=0.503 Sum_probs=178.2
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--Cc----cEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DE----PVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~----~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
-++|.+++.||+|+||+||+|.+. |+ .||||.++.....+ ..++|.+|+.+|++++|||||+++|+|
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~HpnIv~l~g~~ 80 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-------ANKEILDEAYVMASVDNPHVCRLLGIC 80 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----C-------THHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHH-------HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 357999999999999999999985 33 58888886433222 256789999999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 252 KKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
.++. .+++|||+.+|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|
T Consensus 81 ~~~~-~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla 158 (317)
T d1xkka_ 81 LTST-VQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 158 (317)
T ss_dssp ESSS-EEEEEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred ecCC-eeEEEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccc
Confidence 8764 5688899999999998876 3567999999999999999999999999999999999999999999999999998
Q ss_pred ccccccC---CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 015556 332 CEEVYCD---ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 332 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
....... ......||+.|||||++.++.|+.++|||||||+||||+| |..||.+.+..+....+.++..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~ 231 (317)
T d1xkka_ 159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 231 (317)
T ss_dssp HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC
T ss_pred eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC
Confidence 6543222 2233468999999999999999999999999999999998 8999999887777666666544
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=354.38 Aligned_cols=227 Identities=26% Similarity=0.479 Sum_probs=196.2
Q ss_pred ccccccccccCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC
Q 015556 168 VDAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH 240 (405)
Q Consensus 168 ~~~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~ 240 (405)
+..-++|+|+.++|.++++||+|+||.||+|.+. ++.||||+++...... ....|.+|+.++++++
T Consensus 9 ~~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~-------~~~~~~~E~~il~~l~ 81 (308)
T d1p4oa_ 9 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-------ERIEFLNEASVMKEFN 81 (308)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH-------HHHHHHHHHHHGGGCC
T ss_pred CcCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChH-------HHHHHHHHHHHHHHcC
Confidence 3445789999999999999999999999999874 3689999987433221 1457899999999999
Q ss_pred CCCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 015556 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE--------HKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKP 312 (405)
Q Consensus 241 HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp 312 (405)
|||||+++|+|......++|||||++|+|.+++.... ...+++..+..++.|++.||.|||+++|+||||||
T Consensus 82 h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~ 161 (308)
T d1p4oa_ 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 161 (308)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSG
T ss_pred CCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcC
Confidence 9999999999999999999999999999999987532 23578899999999999999999999999999999
Q ss_pred CcEEECCCCcEEEEecCCccccccc---CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhC-CCCCCCCCH
Q 015556 313 ENVLIDQEFHLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG-TIPYEEMNP 388 (405)
Q Consensus 313 ~NILl~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG-~~Pf~~~~~ 388 (405)
+||||+.++++||+|||++...... .......||+.|+|||.+.+..++.++||||||+++|||++| ..||.+.+.
T Consensus 162 ~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~ 241 (308)
T d1p4oa_ 162 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241 (308)
T ss_dssp GGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred CceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999643322 122344689999999999999999999999999999999997 689999999
Q ss_pred HHHHHHHHhcccC
Q 015556 389 IQAAFAVVNKVNF 401 (405)
Q Consensus 389 ~e~~~~i~~~~~~ 401 (405)
.+....+.++...
T Consensus 242 ~~~~~~i~~~~~~ 254 (308)
T d1p4oa_ 242 EQVLRFVMEGGLL 254 (308)
T ss_dssp HHHHHHHHTTCCC
T ss_pred HHHHHHHHhCCCC
Confidence 9998888876544
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=353.84 Aligned_cols=220 Identities=29% Similarity=0.480 Sum_probs=176.7
Q ss_pred ccccccCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-CCCC
Q 015556 172 DEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-HNPN 243 (405)
Q Consensus 172 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~Hpn 243 (405)
++|+|+.++|.+++.||+|+||.||+|.+. ++.||||+++...... ..+.+.+|+.++.++ +|+|
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~-------~~~~~~~e~~~l~~~~~h~~ 78 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-------EHRALMSELKILIHIGHHLN 78 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH-------HHHHHHHHHHHHHHHCCCTT
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH-------HHHHHHHHHHHHHhhcCCCe
Confidence 568889999999999999999999999974 2579999986433221 245677888888887 6899
Q ss_pred eeEEeeEeec-CCeeEEEEeecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 015556 244 VIKFVAACKK-PPVYCVITEYLSEGSLRAYLHKLE--------------HKTLPLPKLIAIALDIARGMEYIHSQGVIHR 308 (405)
Q Consensus 244 Iv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHr 308 (405)
|+.+++++.+ +..+++|||||++|+|.+++.... ...+++..++.++.||+.||.|||+++||||
T Consensus 79 iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHr 158 (299)
T d1ywna1 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 158 (299)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCC
Confidence 9999998865 456899999999999999998642 2358899999999999999999999999999
Q ss_pred CCCCCcEEECCCCcEEEEecCCccccccc---CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhC-CCCCC
Q 015556 309 DLKPENVLIDQEFHLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAG-TIPYE 384 (405)
Q Consensus 309 DIkp~NILl~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG-~~Pf~ 384 (405)
||||+||||+.++.+||+|||+|...... .......||+.|||||++.+..++.++|||||||++|||++| ..||.
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999643322 223455799999999999999999999999999999999995 67898
Q ss_pred CCCHHHHHHHHHhc
Q 015556 385 EMNPIQAAFAVVNK 398 (405)
Q Consensus 385 ~~~~~e~~~~i~~~ 398 (405)
+....+.+..++..
T Consensus 239 ~~~~~~~~~~~~~~ 252 (299)
T d1ywna1 239 GVKIDEEFCRRLKE 252 (299)
T ss_dssp TCCCSHHHHHHHHH
T ss_pred CCCHHHHHHHHHhc
Confidence 87766666555543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-46 Score=350.19 Aligned_cols=218 Identities=27% Similarity=0.410 Sum_probs=177.5
Q ss_pred cccCCCeeecceeeeeeeEEEEEEEECC-----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 175 TVDLSQLFLGLRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 175 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
.|+.++|.+.+.||+|+||.||+|++.+ ..||||++......+. ...+.|.+|+.+|++++|||||+++|
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~-----~~~~~~~~Ei~~l~~l~H~nIv~~~g 78 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP-----EAMDDFIREVNAMHSLDHRNLIRLYG 78 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------C-----HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCH-----HHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 4667889999999999999999998742 3689999865433222 12467899999999999999999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
+|.++ .+++|||||++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 79 ~~~~~-~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfG 156 (273)
T d1u46a_ 79 VVLTP-PMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG 156 (273)
T ss_dssp EECSS-SCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred EEeec-chheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccch
Confidence 99764 668999999999999988763 4569999999999999999999999999999999999999999999999999
Q ss_pred Cccccccc----CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015556 330 IACEEVYC----DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 330 ~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~~Pf~~~~~~e~~~~i~~~~ 399 (405)
++...... .......|+..|+|||++.+..++.++|||||||++|||+| |..||.+.+..+....+.+..
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~ 231 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 231 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC
Confidence 98653222 12234468899999999999999999999999999999998 899999999999988887664
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=350.67 Aligned_cols=214 Identities=26% Similarity=0.425 Sum_probs=182.7
Q ss_pred CCeeecceeeeeeeEEEEEEEEC---CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc---CCCCeeEEeeEee
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK---DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL---HNPNVIKFVAACK 252 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~---~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~ 252 (405)
++|.++++||+|+||+||+|++. ++.||||+++.....+.. ...+.+|+.+|+.| +||||++++++|.
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~------~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~ 80 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------PLSTIREVAVLRHLETFEHPNVVRLFDVCT 80 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC------BCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH------HHHHHHHHHHHHHHhhcCCCCcceeeeeec
Confidence 68999999999999999999984 467999999764333221 12345777777666 7999999999985
Q ss_pred c-----CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEe
Q 015556 253 K-----PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIAD 327 (405)
Q Consensus 253 ~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~D 327 (405)
. ...++++|||+.++.+.. ........+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~e~~~~~~~~~-~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 81 VSRTDRETKLTLVFEHVDQDLTTY-LDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp EEECSSEEEEEEEEECCSCBHHHH-HHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred ccccccCceEEEEEEeccCCchhh-hhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecc
Confidence 3 357899999998765544 4444567899999999999999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 328 FGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 328 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
||++.............||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+++..
T Consensus 160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 231 (305)
T d1blxa_ 160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231 (305)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred hhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence 999976666666677889999999999999999999999999999999999999999999999988887654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-45 Score=350.10 Aligned_cols=224 Identities=27% Similarity=0.451 Sum_probs=192.8
Q ss_pred cccccccccCCCeeecceeeeeeeEEEEEEEEC-------CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhc-C
Q 015556 169 DAADEHTVDLSQLFLGLRFAHGAHSRLYHGIYK-------DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRL-H 240 (405)
Q Consensus 169 ~~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~ 240 (405)
.....|.++.++|.+++.||+|+||.||+|.+. ++.||||+++...... ....|.+|+.+++++ +
T Consensus 13 ~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~E~~~~~~l~~ 85 (311)
T d1t46a_ 13 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT-------EREALMSELKVLSYLGN 85 (311)
T ss_dssp CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-------HHHHHHHHHHHHHHHCC
T ss_pred CCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHH-------HHHHHHHHHHHHHhccC
Confidence 345678999999999999999999999999873 3589999997543322 146788999999999 6
Q ss_pred CCCeeEEeeEeecCCeeEEEEeecCCCCHHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 015556 241 NPNVIKFVAACKKPPVYCVITEYLSEGSLRAYLHKLE----------------HKTLPLPKLIAIALDIARGMEYIHSQG 304 (405)
Q Consensus 241 HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~qi~~aL~yLH~~g 304 (405)
|||||+++|+|.+...+++|||||++|+|.++++... ...+++..++.++.||+.||+|||+++
T Consensus 86 HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ 165 (311)
T d1t46a_ 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN 165 (311)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999999999998643 235889999999999999999999999
Q ss_pred ceecCCCCCcEEECCCCcEEEEecCCccccccc---CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHh-CC
Q 015556 305 VIHRDLKPENVLIDQEFHLKIADFGIACEEVYC---DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVA-GT 380 (405)
Q Consensus 305 IiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~ellt-G~ 380 (405)
||||||||+|||++.++.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|||+| |.
T Consensus 166 ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~ 245 (311)
T d1t46a_ 166 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245 (311)
T ss_dssp CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCC
Confidence 999999999999999999999999999654322 12234568999999999999999999999999999999999 77
Q ss_pred CCCCCCCHHHHHHHHHhcc
Q 015556 381 IPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 381 ~Pf~~~~~~e~~~~i~~~~ 399 (405)
.||...+..+.+.++++..
T Consensus 246 p~~~~~~~~~~~~~~i~~~ 264 (311)
T d1t46a_ 246 SPYPGMPVDSKFYKMIKEG 264 (311)
T ss_dssp CSSTTCCSSHHHHHHHHHT
T ss_pred CCCCCCCHHHHHHHHHhcC
Confidence 7888888877777777654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-44 Score=344.35 Aligned_cols=216 Identities=25% Similarity=0.388 Sum_probs=182.8
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCCe
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPPV 256 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 256 (405)
+++|.+.+.||+|+||+||+|+++ |+.||||++......+. ..+++.+|+.+|++++|||||++++++.+++.
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 74 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG------IPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGC------CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred CCCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChH------HHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence 368999999999999999999987 69999999976543322 14678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcccccc
Q 015556 257 YCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEVY 336 (405)
Q Consensus 257 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~~ 336 (405)
.+++|||+.++.+..+... ...+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||.+.....
T Consensus 75 ~~i~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 75 LVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (286)
T ss_dssp EEEEEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred eeEEEEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceeccc
Confidence 9999999977666555543 57899999999999999999999999999999999999999999999999999865432
Q ss_pred -cCCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Q 015556 337 -CDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVNF 401 (405)
Q Consensus 337 -~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~~ 401 (405)
........|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+.+.++.+....
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~ 219 (286)
T d1ob3a_ 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT 219 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred CccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence 2223445689999999998654 5699999999999999999999999999999988887765443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-45 Score=345.04 Aligned_cols=203 Identities=29% Similarity=0.453 Sum_probs=172.0
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC--CCCeeEEeeEeecC
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH--NPNVIKFVAACKKP 254 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~ 254 (405)
++|.+++.||+|+||+||+|++. |+.||||++......+.... ....++.+|+.+|++++ |||||++++++.++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~--~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEEC--TTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhh--hHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 57999999999999999999986 78999999975432211000 00123568999999997 89999999999999
Q ss_pred CeeEEEEeecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC-CCcEEEEecCCcc
Q 015556 255 PVYCVITEYLSE-GSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-EFHLKIADFGIAC 332 (405)
Q Consensus 255 ~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~-~~~vkL~DFG~a~ 332 (405)
..+++||||+.+ +++.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|.
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CeEEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccce
Confidence 999999999976 688888876 467999999999999999999999999999999999999985 4799999999996
Q ss_pred cccccCCCCCCCCCCcccCccccccccC-CchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 333 EEVYCDALSDDPGTYRWMAPEMIKHKSY-GRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 333 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
.... .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...
T Consensus 160 ~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 160 LLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp ECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred eccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 5433 34456789999999999987765 67799999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=343.49 Aligned_cols=208 Identities=25% Similarity=0.361 Sum_probs=177.5
Q ss_pred CeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec----
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK---- 253 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~---- 253 (405)
+|..++.||+|+||+||+|++. |+.||||++...... +.+|+.+|++++|||||+++++|..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------------~~~Ei~il~~l~h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------------KNRELQIMRKLDHCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------------CCHHHHHHHHCCCTTBCCEEEEEEEC--C
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------------HHHHHHHHHhcCCCCCCcEEEEEEecCcc
Confidence 6888999999999999999996 789999999754322 2379999999999999999999853
Q ss_pred --CCeeEEEEeecCCCCHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCC-cEEEEecC
Q 015556 254 --PPVYCVITEYLSEGSLRAYLHK-LEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEF-HLKIADFG 329 (405)
Q Consensus 254 --~~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~-~vkL~DFG 329 (405)
...+|+|||||+++.+..+... .....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 89 ~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG 168 (350)
T d1q5ka_ 89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 168 (350)
T ss_dssp CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEeccc
Confidence 3357899999976544433332 2356799999999999999999999999999999999999998775 89999999
Q ss_pred CcccccccCCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 330 IACEEVYCDALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 330 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
++.............||..|+|||.+.+ ..|+.++|||||||++|||++|..||...+..+.+..+++..
T Consensus 169 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~ 239 (350)
T d1q5ka_ 169 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239 (350)
T ss_dssp TCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred chhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHh
Confidence 9977666666667789999999998865 568999999999999999999999999999998888887643
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-43 Score=341.05 Aligned_cols=212 Identities=25% Similarity=0.359 Sum_probs=176.4
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC-
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP- 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~- 255 (405)
++|.++++||+|+||+||+|++. ++.||||++...... ...+++.+|+.+|++|+||||+++++++....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-------~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-------TYCQRTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH-------HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcCh-------HHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence 56999999999999999999986 799999999754321 12467889999999999999999999997643
Q ss_pred ---eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 256 ---VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 256 ---~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
..+++|+++.+|+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++.
T Consensus 81 ~~~~~~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 81 EQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp TTCCCEEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cccceEEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 23445566779999999976 579999999999999999999999999999999999999999999999999986
Q ss_pred ccccc----CCCCCCCCCCcccCcccccc-ccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 333 EEVYC----DALSDDPGTYRWMAPEMIKH-KSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 333 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
..... ......+||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+.+..+.....+....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~ 230 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhcc
Confidence 43322 22455679999999999854 4678999999999999999999999999998887777665443
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-43 Score=336.76 Aligned_cols=210 Identities=27% Similarity=0.516 Sum_probs=170.9
Q ss_pred eecceeeeeeeEEEEEEEECC-----ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec-CC
Q 015556 182 FLGLRFAHGAHSRLYHGIYKD-----EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK-PP 255 (405)
Q Consensus 182 ~~~~~lG~G~~g~Vy~~~~~~-----~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~ 255 (405)
.+.++||+|+||+||+|.+.+ ..||||.+....... ..++|.+|+++|++++|||||+++|+|.+ ++
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~-------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 102 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-------EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 102 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHH-------HHHHHHHHHHHHHTCCCTTBCCCCEEEEETTT
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHH-------HHHHHHHHHHHHHhCCCCCEeEEeEEEEecCC
Confidence 346789999999999999853 258999986433211 15779999999999999999999999865 56
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
.+++|||||++|+|.+++.. ....+++..++.++.|++.||.|||+.+|+||||||+||||++++.+||+|||++....
T Consensus 103 ~~~lv~E~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 103 SPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 181 (311)
T ss_dssp EEEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred ceEEEEEEeecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence 89999999999999999876 34567888999999999999999999999999999999999999999999999996543
Q ss_pred ccC-----CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhcc
Q 015556 336 YCD-----ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYE-EMNPIQAAFAVVNKV 399 (405)
Q Consensus 336 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~-~~~~~e~~~~i~~~~ 399 (405)
... ......||+.|+|||.+.+..++.++||||||+++|||++|..||. ..+..+....+.++.
T Consensus 182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~ 251 (311)
T d1r0pa_ 182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 251 (311)
T ss_dssp TTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC
T ss_pred ccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence 222 2223468999999999999999999999999999999999766665 455555555555543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-43 Score=340.65 Aligned_cols=213 Identities=24% Similarity=0.404 Sum_probs=178.6
Q ss_pred ccccCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEe
Q 015556 174 HTVDLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAAC 251 (405)
Q Consensus 174 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 251 (405)
|.+ .++|.+++.||+|+||+||+|.+. |+.||||+++.....+. ..+++.+|+.+|++++|||||+++++|
T Consensus 14 ~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~------~~~~~~~Ei~il~~l~hpniv~l~~~~ 86 (346)
T d1cm8a_ 14 WEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL------FAKRAYRELRLLKHMRHENVIGLLDVF 86 (346)
T ss_dssp ECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHH------HHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred eec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChH------HHHHHHHHHHHHHhcCCCCeeEEEEEe
Confidence 344 478999999999999999999986 79999999975443322 256788999999999999999999999
Q ss_pred ecCC------eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEE
Q 015556 252 KKPP------VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKI 325 (405)
Q Consensus 252 ~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL 325 (405)
...+ .+|+||||+ +.+|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl 162 (346)
T d1cm8a_ 87 TPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKI 162 (346)
T ss_dssp CSCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred ccCccccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccccc
Confidence 7654 579999999 6688887765 67999999999999999999999999999999999999999999999
Q ss_pred EecCCcccccccCCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015556 326 ADFGIACEEVYCDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKV 399 (405)
Q Consensus 326 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~ 399 (405)
+|||+|.... ...+...||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+..
T Consensus 163 ~Dfg~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~ 235 (346)
T d1cm8a_ 163 LDFGLARQAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235 (346)
T ss_dssp CCCTTCEECC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred ccccceeccC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhcc
Confidence 9999996543 344567899999999998764 56899999999999999999999999999888877766543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-43 Score=337.19 Aligned_cols=214 Identities=20% Similarity=0.335 Sum_probs=177.1
Q ss_pred cCCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec-
Q 015556 177 DLSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK- 253 (405)
Q Consensus 177 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~- 253 (405)
++++|.++++||+|+||+||+|++. |+.||||++......+.. ..++.+|+.+|++++||||+++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~------~~~~~~E~~il~~l~h~nii~~~~~~~~~ 81 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF------PITALREIKILQLLKHENVVNLIEICRTK 81 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSS------CHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHH------HHHHHHHHHHHHHhcCCCccceEeeeecc
Confidence 4689999999999999999999985 789999998765443322 4567799999999999999999998855
Q ss_pred -------CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEE
Q 015556 254 -------PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIA 326 (405)
Q Consensus 254 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~ 326 (405)
...+|+||||+.++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 82 ~~~~~~~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~ 159 (318)
T d3blha1 82 ASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLA 159 (318)
T ss_dssp ---------CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred cccccccCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEee
Confidence 346899999998766654433 35678999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccc-----cCCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015556 327 DFGIACEEVY-----CDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNK 398 (405)
Q Consensus 327 DFG~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~ 398 (405)
|||++..... .......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+....+.+.
T Consensus 160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~ 237 (318)
T d3blha1 160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237 (318)
T ss_dssp CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHh
Confidence 9999854321 1233345799999999998755 6899999999999999999999999998888877766553
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=340.96 Aligned_cols=194 Identities=29% Similarity=0.482 Sum_probs=161.6
Q ss_pred CCeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC---
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP--- 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--- 255 (405)
.+|.+.++||+|+||.||+|+++|+.||||++.... .. ...+..|+..+.+++|||||+++++|.+..
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~--~~-------~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE--ER-------SWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG--HH-------HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc--hh-------HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc
Confidence 468899999999999999999999999999986321 10 112234566667789999999999997643
Q ss_pred -eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------CCceecCCCCCcEEECCCCcEEEE
Q 015556 256 -VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS--------QGVIHRDLKPENVLIDQEFHLKIA 326 (405)
Q Consensus 256 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--------~gIiHrDIkp~NILl~~~~~vkL~ 326 (405)
.+|+|||||++|+|.++|++ ..+++..++.++.|++.||.|||. +||+||||||+||||+.++.+||+
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~ 150 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred eEEEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence 58999999999999999987 479999999999999999999996 599999999999999999999999
Q ss_pred ecCCcccccccC-----CCCCCCCCCcccCccccccc------cCCchhhHHHHHHHHHHHHhCCCCCC
Q 015556 327 DFGIACEEVYCD-----ALSDDPGTYRWMAPEMIKHK------SYGRKVDVYSFGLILWEMVAGTIPYE 384 (405)
Q Consensus 327 DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~------~~~~k~DVwSlGvll~elltG~~Pf~ 384 (405)
|||++....... ......||+.|+|||++.+. .++.++|||||||+||||+||..||.
T Consensus 151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence 999986543322 23456799999999998654 36789999999999999999988763
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-42 Score=324.21 Aligned_cols=212 Identities=22% Similarity=0.355 Sum_probs=181.3
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecCC
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKPP 255 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 255 (405)
+++|.++++||+|+||+||+|++. ++.||||+++.....+.. ..++.+|+.+|++++||||++++++|.+..
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~------~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 74 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV------PSSALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTH------HHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHH------HHHHHHHHHHHHhcCcCCEEeecccccccc
Confidence 368999999999999999999985 688999999876544332 567889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCccccc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIACEEV 335 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~~~ 335 (405)
..++|||++.++.|..++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||.+....
T Consensus 75 ~~~iv~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 75 KLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEEEEECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred ceeEEeeecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhccc
Confidence 99999999999888887765 5788999999999999999999999999999999999999999999999999996544
Q ss_pred cc-CCCCCCCCCCcccCcccccccc-CCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHh
Q 015556 336 YC-DALSDDPGTYRWMAPEMIKHKS-YGRKVDVYSFGLILWEMVAGTIPY-EEMNPIQAAFAVVN 397 (405)
Q Consensus 336 ~~-~~~~~~~gt~~y~aPE~~~~~~-~~~k~DVwSlGvll~elltG~~Pf-~~~~~~e~~~~i~~ 397 (405)
.. .......++..|+|||++.... ++.++|||||||++|||++|+.|| ...+..+....+..
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~ 217 (292)
T d1unla_ 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217 (292)
T ss_dssp SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHH
T ss_pred CCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHh
Confidence 32 2334456788899999987665 699999999999999999999986 45555555555443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.8e-42 Score=326.57 Aligned_cols=196 Identities=19% Similarity=0.296 Sum_probs=171.0
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC-CCeeEEeeEeecCC
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFVAACKKPP 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~ 255 (405)
++|.+++.||+|+||+||+|++. |+.||||++...... ..+.+|+++++.|.| +||+.+++++.++.
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 74 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----------CCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----------HHHHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence 68999999999999999999986 689999998754432 235689999999975 89999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECC-----CCcEEEEecCC
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQ-----EFHLKIADFGI 330 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~-----~~~vkL~DFG~ 330 (405)
..++||||+ +++|.+++.. ....+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+
T Consensus 75 ~~~~vme~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EEEEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred ccEEEEEec-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccce
Confidence 999999998 7899999876 3457999999999999999999999999999999999999964 57899999999
Q ss_pred ccccccc--------CCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 015556 331 ACEEVYC--------DALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEM 386 (405)
Q Consensus 331 a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~ 386 (405)
|...... .......||+.|||||++.+..++.++|||||||++|||++|..||.+.
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~ 216 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCc
Confidence 9653321 1233457999999999999999999999999999999999999999754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=341.39 Aligned_cols=216 Identities=21% Similarity=0.362 Sum_probs=178.6
Q ss_pred ccCCCeeecceeeeeeeEEEEEEEE-----CCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC-CCeeEEee
Q 015556 176 VDLSQLFLGLRFAHGAHSRLYHGIY-----KDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN-PNVIKFVA 249 (405)
Q Consensus 176 i~~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~g 249 (405)
+.+++|.+++.||+|+||+||+|.. .|+.||||+++......+.. ..+++.+|+.+|++++| |||+++++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~----~~~~~~~E~~il~~l~h~pnIv~~~~ 96 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK----TTEHTRTERQVLEHIRQSPFLVTLHY 96 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES----SGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchH----HHHHHHHHHHHHHhccCCCeEEEeee
Confidence 5678899999999999999999987 26789999986432111100 13457789999999976 89999999
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
++.+...+++||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~~~~~~~v~e~~~~~~L~~~i~~--~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG 174 (322)
T d1vzoa_ 97 AFQTETKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 174 (322)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred eeccCCceeeeeecccccHHHHHHHh--cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeecc
Confidence 99999999999999999999999987 3567888999999999999999999999999999999999999999999999
Q ss_pred Cccccc--ccCCCCCCCCCCcccCccccccc--cCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015556 330 IACEEV--YCDALSDDPGTYRWMAPEMIKHK--SYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVN 397 (405)
Q Consensus 330 ~a~~~~--~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~ 397 (405)
++.... .........|++.|+|||.+.+. .++.++|||||||+||+|++|..||.+.+..+....+.+
T Consensus 175 ~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~ 246 (322)
T d1vzoa_ 175 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 246 (322)
T ss_dssp EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH
T ss_pred chhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 986432 22233455699999999999654 468899999999999999999999987655544444433
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-42 Score=334.68 Aligned_cols=211 Identities=25% Similarity=0.358 Sum_probs=172.7
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeec---
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKK--- 253 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--- 253 (405)
++|.+++.||+|+||+||+|++. |+.||||++......... .+++.+|+.+|++++|||||+++++|..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~------~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~ 90 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH------AKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHH------HHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHH------HHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence 67999999999999999999986 799999999865544322 4578899999999999999999999963
Q ss_pred ---CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCC
Q 015556 254 ---PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGI 330 (405)
Q Consensus 254 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~ 330 (405)
...+|+|||||.+ ++.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+
T Consensus 91 ~~~~~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 91 LEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp TTTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred cccCceeEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhh
Confidence 4688999999965 4545443 4689999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 331 ACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 331 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
+.............||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......++....
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~ 235 (355)
T d2b1pa1 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred hhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhcc
Confidence 8776666666777899999999999999999999999999999999999999999998888877765443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.1e-42 Score=331.12 Aligned_cols=202 Identities=24% Similarity=0.413 Sum_probs=173.2
Q ss_pred CCCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeec-
Q 015556 178 LSQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKK- 253 (405)
Q Consensus 178 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~- 253 (405)
.++|.++++||+|+||+||+|++. ++.||||+++... .+++.+|+.+|+.+. ||||+++++++..
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----------HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 368999999999999999999986 7999999996422 346779999999995 9999999999974
Q ss_pred -CCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCC-CcEEEEecCCc
Q 015556 254 -PPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQE-FHLKIADFGIA 331 (405)
Q Consensus 254 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~-~~vkL~DFG~a 331 (405)
...+++|||||.+++|..+. ..+++..+..++.||+.||.|||++||+||||||+||||+.+ +.+||+|||+|
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a 177 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 177 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGC
T ss_pred CCCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccc
Confidence 45689999999999986653 468999999999999999999999999999999999999865 46999999999
Q ss_pred ccccccCCCCCCCCCCcccCccccccc-cCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHH
Q 015556 332 CEEVYCDALSDDPGTYRWMAPEMIKHK-SYGRKVDVYSFGLILWEMVAGTIPYEEMN-PIQAAFAV 395 (405)
Q Consensus 332 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DVwSlGvll~elltG~~Pf~~~~-~~e~~~~i 395 (405)
.............+|+.|+|||.+.+. .++.++|||||||++|+|++|..||.... ..+....+
T Consensus 178 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i 243 (328)
T d3bqca1 178 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 243 (328)
T ss_dssp EECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH
T ss_pred eeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHH
Confidence 766655566777899999999998765 47999999999999999999999997644 44444333
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-41 Score=323.52 Aligned_cols=203 Identities=22% Similarity=0.331 Sum_probs=167.2
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC-eeEEeeEeecCC
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN-VIKFVAACKKPP 255 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~ 255 (405)
++|.+++.||+|+||.||+|++. |+.||||++....... ++..|+++++.++|+| |+.+.+++.++.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----------~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----------QLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSC----------CHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCH----------HHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence 46999999999999999999986 7899999988654332 3568999999998766 555666667888
Q ss_pred eeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEC---CCCcEEEEecCCcc
Q 015556 256 VYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLID---QEFHLKIADFGIAC 332 (405)
Q Consensus 256 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~---~~~~vkL~DFG~a~ 332 (405)
..++||||+ +++|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++ .+..+||+|||+|.
T Consensus 77 ~~~ivme~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 77 YNVMVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp EEEEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEEEEEEEc-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 999999999 5677777655 356799999999999999999999999999999999999985 45679999999996
Q ss_pred cccccC--------CCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015556 333 EEVYCD--------ALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAF 393 (405)
Q Consensus 333 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~ 393 (405)
...... ......||+.|||||++.+..++.++|||||||++|||++|..||......+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~ 223 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 223 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH
Confidence 543321 2234579999999999999999999999999999999999999998866655443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-42 Score=332.59 Aligned_cols=211 Identities=26% Similarity=0.355 Sum_probs=178.5
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCeeEEeeEeecC--
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNVIKFVAACKKP-- 254 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-- 254 (405)
++|.+++.||+|+||+||+|++. |+.||||++......... .+++.+|+.+|++++|||||++++++...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~------~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH------AKRTYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHH------HHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHH------HHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 67999999999999999999985 799999999765443321 45788999999999999999999998633
Q ss_pred ---CeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecCCc
Q 015556 255 ---PVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFGIA 331 (405)
Q Consensus 255 ---~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG~a 331 (405)
...++||+|+.+|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+|++|||++
T Consensus 92 ~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 92 LEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred cccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchh
Confidence 344666778889999999864 57999999999999999999999999999999999999999999999999998
Q ss_pred ccccccCCCCCCCCCCcccCcccccccc-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 015556 332 CEEVYCDALSDDPGTYRWMAPEMIKHKS-YGRKVDVYSFGLILWEMVAGTIPYEEMNPIQAAFAVVNKVN 400 (405)
Q Consensus 332 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DVwSlGvll~elltG~~Pf~~~~~~e~~~~i~~~~~ 400 (405)
..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+.+...
T Consensus 169 ~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~ 236 (348)
T d2gfsa1 169 RHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 236 (348)
T ss_dssp -CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 65432 334567999999999876654 58999999999999999999999999999888888776544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4e-35 Score=286.42 Aligned_cols=198 Identities=27% Similarity=0.463 Sum_probs=160.8
Q ss_pred CCeeecceeeeeeeEEEEEEEEC--CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-----------CCCee
Q 015556 179 SQLFLGLRFAHGAHSRLYHGIYK--DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-----------NPNVI 245 (405)
Q Consensus 179 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv 245 (405)
++|.++++||+|+||+||+|++. |+.||||+++... ...+.+.+|+.+++.++ |+||+
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---------~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv 83 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---------VYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 83 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---------cchHHHHHHHHHHHHhcchhhhhhhhcCcCceE
Confidence 46999999999999999999985 7999999997421 11346678888888875 47899
Q ss_pred EEeeEeec--CCeeEEEEeecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEECCCC
Q 015556 246 KFVAACKK--PPVYCVITEYLSEG-SLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHS-QGVIHRDLKPENVLIDQEF 321 (405)
Q Consensus 246 ~l~g~~~~--~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIiHrDIkp~NILl~~~~ 321 (405)
++++++.. ....+++|+++..+ ....+........+++..+..++.||+.||.|||+ +||+||||||+||||+.++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~ 163 (362)
T d1q8ya_ 84 KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 163 (362)
T ss_dssp CCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred EEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccC
Confidence 99998864 35566777766444 45555555566789999999999999999999998 8999999999999997654
Q ss_pred ------cEEEEecCCcccccccCCCCCCCCCCcccCccccccccCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 015556 322 ------HLKIADFGIACEEVYCDALSDDPGTYRWMAPEMIKHKSYGRKVDVYSFGLILWEMVAGTIPYEEMN 387 (405)
Q Consensus 322 ------~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DVwSlGvll~elltG~~Pf~~~~ 387 (405)
.++|+|||.+..... ......||+.|+|||++....++.++|||||||++++|++|+.||...+
T Consensus 164 ~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 164 SPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp TTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 499999999865433 3456679999999999999999999999999999999999999997543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=3.5e-26 Score=203.35 Aligned_cols=172 Identities=19% Similarity=0.183 Sum_probs=122.5
Q ss_pred eeecceeeeeeeEEEEEEEEC-CccEEEEEEecCCCC-----h-----hHHHHHHHHHHHHHHHHHHHhcCCCCeeEEee
Q 015556 181 LFLGLRFAHGAHSRLYHGIYK-DEPVAVKIIRIPDDD-----E-----NETLAARLEKQFNREVALLSRLHNPNVIKFVA 249 (405)
Q Consensus 181 ~~~~~~lG~G~~g~Vy~~~~~-~~~vAVK~~~~~~~~-----~-----~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g 249 (405)
+.+|++||+|+||+||+|.+. |+.||||+++..... . ...........+..|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 357899999999999999975 789999998642111 0 00011122345667999999999999999886
Q ss_pred EeecCCeeEEEEeecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEECCCCcEEEEecC
Q 015556 250 ACKKPPVYCVITEYLSEGSLRAYLHKLEHKTLPLPKLIAIALDIARGMEYIHSQGVIHRDLKPENVLIDQEFHLKIADFG 329 (405)
Q Consensus 250 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIiHrDIkp~NILl~~~~~vkL~DFG 329 (405)
+.. .++||||+++..+. .++...+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||
T Consensus 82 ~~~----~~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 82 WEG----NAVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp EET----TEEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred ecC----CEEEEEeecccccc---------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECC
Confidence 643 26999999876542 24445667899999999999999999999999999999865 58999999
Q ss_pred CcccccccCCCCCCCCCCcccCccc-----cccccCCchhhHHHHHHHH
Q 015556 330 IACEEVYCDALSDDPGTYRWMAPEM-----IKHKSYGRKVDVYSFGLIL 373 (405)
Q Consensus 330 ~a~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~~~k~DVwSlGvll 373 (405)
+|...... ....|+...+ +..+.|+.++|+||+.--+
T Consensus 148 ~a~~~~~~-------~~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEE-------GWREILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTST-------THHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CcccCCCC-------CcHHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 98543211 1111221110 1236788999999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.53 E-value=9e-08 Score=86.41 Aligned_cols=128 Identities=13% Similarity=0.088 Sum_probs=84.7
Q ss_pred eeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcC-CCCeeEEeeEeecCCeeEEEEeecCCCC
Q 015556 190 GAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLH-NPNVIKFVAACKKPPVYCVITEYLSEGS 268 (405)
Q Consensus 190 G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~gs 268 (405)
++.+.||+....++.++||+......... ..+.+|..++..|. +--+.+++.++.+++..++||++++|.+
T Consensus 25 ~s~~~v~rv~~~~~~~vlk~~~~~~~~~~--------~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~ 96 (263)
T d1j7la_ 25 MSPAKVYKLVGENENLYLKMTDSRYKGTT--------YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL 96 (263)
T ss_dssp CSSSEEEEEECSSCEEEEEEECGGGTTST--------TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred CCCCcEEEEEeCCCeEEEEEcCCCcccch--------hhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccc
Confidence 44568999887788899998864332221 23457888888774 3335677788888889999999999877
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 015556 269 LRAYLHKLEHKTLPLPKLIAIALDIARGMEYIH----------------------------------------------- 301 (405)
Q Consensus 269 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH----------------------------------------------- 301 (405)
+.+.... ... ...++.+++..+..||
T Consensus 97 ~~~~~~~----~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T d1j7la_ 97 CSEEYED----EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE 169 (263)
T ss_dssp HHHHTTT----CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHH
T ss_pred ccccccc----ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHH
Confidence 7543211 011 1112223333333333
Q ss_pred ------HC------CceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 302 ------SQ------GVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 302 ------~~------gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
+. .++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 170 ~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 11 26899999999999987667799999874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.94 E-value=1.6e-05 Score=70.67 Aligned_cols=134 Identities=15% Similarity=0.098 Sum_probs=80.4
Q ss_pred eeee-eEEEEEEEECC-ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCC--CCeeEEeeEeecCCeeEEEEee
Q 015556 188 AHGA-HSRLYHGIYKD-EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHN--PNVIKFVAACKKPPVYCVITEY 263 (405)
Q Consensus 188 G~G~-~g~Vy~~~~~~-~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~lV~E~ 263 (405)
..|. .+.||+....+ ..++||........ .+..|..+++.|.. -.+.++++++.+++..++||+|
T Consensus 19 ~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~-----------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~ 87 (255)
T d1nd4a_ 19 TIGCSDAAVFRLSAQGRPVLFVKTDLSGALN-----------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 87 (255)
T ss_dssp SCTTSSCEEEEEECTTSCCEEEEEECSCTTS-----------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCcccCCeEEEEEeCCCCEEEEEeCCccCHh-----------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEe
Confidence 4444 36789988764 56888986543322 24577888877753 2356678888888889999999
Q ss_pred cCCCCHH--------------HHHHHhc-----CCCC--CHHHHHHHH--------------------HHHHHHHHHHHH
Q 015556 264 LSEGSLR--------------AYLHKLE-----HKTL--PLPKLIAIA--------------------LDIARGMEYIHS 302 (405)
Q Consensus 264 ~~~gsL~--------------~~l~~~~-----~~~l--~~~~~~~i~--------------------~qi~~aL~yLH~ 302 (405)
++|.++. ..+.+.. ...+ .......-. ......+..+.+
T Consensus 88 i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 167 (255)
T d1nd4a_ 88 VPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA 167 (255)
T ss_dssp CSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred eeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHH
Confidence 9875431 1122210 0000 111000000 011222334433
Q ss_pred C-------CceecCCCCCcEEECCCCcEEEEecCCcc
Q 015556 303 Q-------GVIHRDLKPENVLIDQEFHLKIADFGIAC 332 (405)
Q Consensus 303 ~-------gIiHrDIkp~NILl~~~~~vkL~DFG~a~ 332 (405)
. .++|+|+.|.|||++++..+-|+||+.+.
T Consensus 168 ~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 168 RMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp TCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 2 27999999999999987777899999874
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.52 E-value=0.00014 Score=69.35 Aligned_cols=75 Identities=15% Similarity=0.046 Sum_probs=45.2
Q ss_pred ceeeeeeeEEEEEEEEC--CccEEEEEEecC-----C-CChhHHHHHHHHHHHHHHHHHHHhcC-C--CCeeEEeeEeec
Q 015556 185 LRFAHGAHSRLYHGIYK--DEPVAVKIIRIP-----D-DDENETLAARLEKQFNREVALLSRLH-N--PNVIKFVAACKK 253 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~--~~~vAVK~~~~~-----~-~~~~~~~~~~~~~~~~~Ei~il~~l~-H--pnIv~l~g~~~~ 253 (405)
+.||.|....||+.... ++.|+||.-... + .... ..+...|.++|..+. + ..+.+++.+..
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~-------~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~- 103 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLT-------IDRARIESSALIRQGEHVPHLVPRVFYSDT- 103 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCC-------TTHHHHHHHHHHHHHTTCGGGSCCEEEEET-
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCC-------HHHHHHHHHHHHHhhhhCCCCcceEEEEcC-
Confidence 35688999999998764 578999975321 0 0000 112346777777663 2 34556665543
Q ss_pred CCeeEEEEeecCCCC
Q 015556 254 PPVYCVITEYLSEGS 268 (405)
Q Consensus 254 ~~~~~lV~E~~~~gs 268 (405)
...++|||++.+..
T Consensus 104 -~~~~lvmE~L~~~~ 117 (392)
T d2pula1 104 -EMAVTVMEDLSHLK 117 (392)
T ss_dssp -TTTEEEECCCTTSE
T ss_pred -CCCEEEEeccCCcc
Confidence 34468999997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.46 E-value=0.00014 Score=67.41 Aligned_cols=67 Identities=19% Similarity=0.130 Sum_probs=43.2
Q ss_pred eeEEEEEEEEC-CccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe--eEEee-----EeecCCeeEEEEe
Q 015556 191 AHSRLYHGIYK-DEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV--IKFVA-----ACKKPPVYCVITE 262 (405)
Q Consensus 191 ~~g~Vy~~~~~-~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI--v~l~g-----~~~~~~~~~lV~E 262 (405)
..-.||++... |+.|++|+.+..... ..++..|...+..|...+| +..+. .+...+..+.+++
T Consensus 34 ~EN~vy~v~~~dg~~~VlK~~rp~~~s---------~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~ 104 (325)
T d1zyla1 34 YENRVYQFQDEDRRRFVVKFYRPERWT---------ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 104 (325)
T ss_dssp SSSEEEEECCTTCCCEEEEEECTTTSC---------HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred ccceeEEEEcCCCCEEEEEEeCCCCCC---------HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEe
Confidence 34589999875 688999998743322 3456678888888753222 11111 2234567888999
Q ss_pred ecCC
Q 015556 263 YLSE 266 (405)
Q Consensus 263 ~~~~ 266 (405)
+++|
T Consensus 105 ~~~G 108 (325)
T d1zyla1 105 SVGG 108 (325)
T ss_dssp CCCC
T ss_pred ecCC
Confidence 9976
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.06 E-value=0.00066 Score=62.06 Aligned_cols=144 Identities=16% Similarity=0.093 Sum_probs=75.9
Q ss_pred CeeecceeeeeeeEEEEEEEECCccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCC-----eeEEe-e--Ee
Q 015556 180 QLFLGLRFAHGAHSRLYHGIYKDEPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPN-----VIKFV-A--AC 251 (405)
Q Consensus 180 ~~~~~~~lG~G~~g~Vy~~~~~~~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-----Iv~l~-g--~~ 251 (405)
++.-.+.|..|---+.|+....+..+++|++...... .++..|+.+|..|...+ .+... | +.
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~~----------~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~ 88 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEK----------NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLG 88 (316)
T ss_dssp CEEEEEEECC---EEEEEEEESSCCEEEEEECC---C----------CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCE
T ss_pred CceEeecCCCCcccCeEEEEECCCcEEEEEcCCCCCH----------HHHHHHHHHHHhhhhccccccccceecCCCcce
Confidence 3333345667778899999988888999998643221 23446777777775322 22110 0 11
Q ss_pred ecCCeeEEEEeecCCCCH--------------HHHHHHhc-CC------------------------CCCHHHHHHHHHH
Q 015556 252 KKPPVYCVITEYLSEGSL--------------RAYLHKLE-HK------------------------TLPLPKLIAIALD 292 (405)
Q Consensus 252 ~~~~~~~lV~E~~~~gsL--------------~~~l~~~~-~~------------------------~l~~~~~~~i~~q 292 (405)
......+.++.++.+... ...++... .. ..........+..
T Consensus 89 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 168 (316)
T d2ppqa1 89 ELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRP 168 (316)
T ss_dssp EETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHH
T ss_pred eeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHH
Confidence 123445566666655211 11111100 00 0000112222223
Q ss_pred HHHHHHHHHH----CCceecCCCCCcEEECCCCcEEEEecCCccc
Q 015556 293 IARGMEYIHS----QGVIHRDLKPENVLIDQEFHLKIADFGIACE 333 (405)
Q Consensus 293 i~~aL~yLH~----~gIiHrDIkp~NILl~~~~~vkL~DFG~a~~ 333 (405)
+...+...+. .|+||+|+.+.||+++.+...-|+||+.++.
T Consensus 169 ~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 169 EIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 3333333322 3699999999999999888779999998853
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.88 E-value=0.00087 Score=63.54 Aligned_cols=69 Identities=16% Similarity=0.270 Sum_probs=45.8
Q ss_pred ceeeeeeeEEEEEEEECC---------ccEEEEEEecCCCChhHHHHHHHHHHHHHHHHHHHhcCCCCe-eEEeeEeecC
Q 015556 185 LRFAHGAHSRLYHGIYKD---------EPVAVKIIRIPDDDENETLAARLEKQFNREVALLSRLHNPNV-IKFVAACKKP 254 (405)
Q Consensus 185 ~~lG~G~~g~Vy~~~~~~---------~~vAVK~~~~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~ 254 (405)
+.|+.|-.-.+|+....+ +.|.+++.-... .. -...+|..+++.+.-.++ .++++++.+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~~---------idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TE---------SHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CH---------HHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-hh---------hHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 567889999999988642 356676664221 11 123478888888853344 477877754
Q ss_pred CeeEEEEeecCCC
Q 015556 255 PVYCVITEYLSEG 267 (405)
Q Consensus 255 ~~~~lV~E~~~~g 267 (405)
++||||++|.
T Consensus 117 ---g~I~efi~g~ 126 (395)
T d1nw1a_ 117 ---GRLEEYIPSR 126 (395)
T ss_dssp ---EEEECCCCEE
T ss_pred ---ceEEEEeccc
Confidence 5899999874
|